FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Carvalho, SM
   Mansur, AAP
   Carvalho, IC
   Costa, EA
   Guedes, MIMC
   Kroon, EG
   Lobato, ZIP
   Mansur, HS
AF Carvalho, Sandhra M.
   Mansur, Alexandra A. P.
   Carvalho, Isadora C.
   Costa, Erica A.
   Guedes, Maria Isabel M. C.
   Kroon, Erna G.
   Lobato, Zelia I. P.
   Mansur, Herman S.
TI Fluorescent quantum dots-zika virus hybrid nanoconjugates for
   biolabeling, bioimaging, and tracking host-cell interactions
SO MATERIALS LETTERS
LA English
DT Article
DE Nano-biomaterials; Nanoconjugates; Bioconjugates; Nanoparticles for
   biomedical applications; Virus bioimaging; Nanomedicine
AB The earliest possible diagnosis and understanding of the infection mechanisms play a crucial role in the outcome of fighting viral diseases. Thus, we designed and developed for the first time, novel bioconjugates made of Ag-In-S@ZnS (ZAIS) fluorescent quantum dots coupled with ZIKA virus via covalent amide bond with carboxymethylcellulose (CMC) biopolymer for labeling and bioimaging the virus-host cell interactions mechanisms through confocal laser scanning microscopy. This work offers relevant insights regarding the profile of the ZIKA virus-nanoparticle conjugates interactions with VERO cells, which can be applied as a nanoplatform to elucidate the infection mechanisms caused by this viral disease. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Carvalho, Sandhra M.; Mansur, Alexandra A. P.; Carvalho, Isadora C.; Mansur, Herman S.] Fed Univ Minas Gerais UFMG, Ctr Nanosci Nanotechnol & Innovat DEMET, Belo Horizonte, MG, Brazil.
   [Carvalho, Sandhra M.; Costa, Erica A.; Guedes, Maria Isabel M. C.; Lobato, Zelia I. P.] Univ Fed Minas Gerais UFMG, Dept Med Vet Prevent, Escola Vet, LPVA, Belo Horizonte, MG, Brazil.
   [Kroon, Erna G.] Inst Ciencias Biol UFMG, Dept Microbiol, Belo Horizonte, MG, Brazil.
RP Lobato, ZIP; Mansur, HS (corresponding author), Univ Fed Minas Gerais, Escola Engn, Av Antonio Carlos 6627,Bloco 2 Sala 2233, BR-31270901 Belo Horizonte, MG, Brazil.
EM ziplobato@gmail.com; hmansur@demet.ufmg.br
RI de Carvalho, Sandhra Maria/AAZ-9362-2020
OI Mansur, Herman/0000-0002-3032-495X
FU CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG);
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [440911/2016-8]; FINEPCiencia Tecnologia e Inovacao (FINEP);
   DECIT/Ministerio da Saude do Brasil
FX This work was supported by the Brazilian agencies CAPES, FAPEMIG, CNPq
   (Process number 440911/2016-8), FINEP, DECIT/Ministerio da Saude do
   Brasil. The authors thank CeNano2I/CEMUCASI/UFMG and the Center of
   Microscopy/UFMG for the characterization facilities.
CR Akdas T, 2015, NANOSCALE, V7, P18105, DOI 10.1039/c5nr04291g
   Ashour HM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030186
   Bailey RE, 2004, PHYSICA E, V25, P1, DOI 10.1016/j.physe.2004.07.013
   Carvalho IC, 2020, J MOL LIQ, V304, DOI 10.1016/j.molliq.2020.112759
   Huber RG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09391-8
   Jiang YW, 2018, NAT REV MATER, V3, P473, DOI 10.1038/s41578-018-0062-3
   Mansur A.A.P., 2019, J MATER SCI-MATER EL, V2019, P1
   Mansur AAP, 2018, BIOCONJUGATE CHEM, V29, P1973, DOI 10.1021/acs.bioconjchem.8b00208
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Piccini LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140824
   Regulacio MD, 2013, NANOSCALE, V5, P2322, DOI 10.1039/c3nr34159c
   Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]
   Santana CP, 2019, MATER LETT, V252, P333, DOI 10.1016/j.matlet.2019.06.022
   Wu JT, 2020, NAT MED, DOI 10.1038/s41591-020-0822-7
   Xu GX, 2016, CHEM REV, V116, P12234, DOI 10.1021/acs.chemrev.6b00290
   Yang YB, 2020, NANO LETT, V20, P1417, DOI 10.1021/acs.nanolett.9b05103
NR 16
TC 0
Z9 0
U1 42
U2 42
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD OCT 15
PY 2020
VL 277
AR 128279
DI 10.1016/j.matlet.2020.128279
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA NH3DO
UT WOS:000564554500002
PM 32834256
OA Green Published
DA 2020-11-30
ER

PT J
AU Sacchetto, L
   Silva, NIO
   de Rezende, IM
   Arruda, MS
   Costa, TA
   de Mello, EM
   Oliveira, GFG
   Alves, PA
   de Mendonca, VE
   Stumpp, RGAV
   Prado, AIA
   Paglia, AP
   Perini, FA
   Nogueira, ML
   Kroon, EG
   de Thoisy, B
   Trindade, GD
   Drumond, BP
AF Sacchetto, Livia
   Oliveira Silva, Natalia Ingrid
   de Rezende, Izabela Mauricio
   Arruda, Matheus Soares
   Costa, Thais Alkifeles
   de Mello, Erica Munhoz
   Garcia Oliveira, Gabriela Fernanda
   Alves, Pedro Augusto
   de Mendonca, Vitor Emidio
   Antonelli Vidal Stumpp, Rodolfo German
   Alves Prado, Alaine Izabela
   Paglia, Adriano Pereira
   Perini, Fernando Araujo
   Nogueira, Mauricio Lacerda
   Kroon, Erna Geessien
   de Thoisy, Benoit
   Trindade, Giliane de Souza
   Drumond, Betania Paiva
TI Neighbor danger: Yellow fever virus epizootics in urban and urban-rural
   transition areas of Minas Gerais state, during 2017-2018 yellow fever
   outbreaks in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
AB Background From the end of 2016 until the beginning of 2019, Brazil faced a massive sylvatic yellow fever (YF) outbreak. The 2016-2019 YF epidemics affected densely populated areas, especially the Southeast region, causing thousands of deaths of humans and non-human primates (NHP). Methodology/Principal findings We conducted a molecular investigation of yellow fever virus (YFV) RNA in 781 NHP carcasses collected in the urban, urban-rural interface, and rural areas of Minas Gerais state, from January 2017 to December 2018. Samples were analyzed according to the period of sampling, NHP genera, sampling areas, and sampling areas/NHP genera to compare the proportions of YFV-positive carcasses and the estimated YFV genomic loads. YFV infection was confirmed in 38.1% of NHP carcasses (including specimens of the generaAlouatta,Callicebus,Callithrix, andSapajus), from the urban, urban-rural interface, and rural areas. YFV RNA detection was positively associated with epidemic periods (especially from December to March) and the rural environment. Higher median viral genomic loads (one million times) were estimated in carcasses collected in rural areas compared to urban ones. Conclusions/Significance The results showed the wide occurrence of YF in Minas Gerais in epidemic and non-epidemic periods. According to the sylvatic pattern of YF, a gradient of viral dissemination from rural towards urban areas was observed. A high YF positivity was observed for NHP carcasses collected in urban areas with a widespread occurrence in 67 municipalities of Minas Gerais, including large urban centers. Although there was no documented case of urban/AedesYFV transmission to humans in Brazil during the 2016-2019 outbreaks, YFV-infected NHP in urban areas with high infestation byAedes aegyptiposes risks for YFV urban/Aedestransmission and urbanization.
   Author summary Brazil faced the most massive sylvatic yellow fever (YF) outbreak in 2016-2019. The outbreak affected highly densely populated areas, and Minas Gerais was the most affected state with thousands of deaths of human and non-human primates (NHP). We investigated the yellow fever virus (YFV) RNA in NHP carcasses collected throughout Minas Gerais in 2017 and 2018. We demonstrated the wide occurrence of YFV-infected NHP, including the viral persistence during the non-epidemic dry season of 2017. YFV RNA was detected in NHP carcasses in the urban, urban-rural interface and rural areas. We have also detected new YF cases in 49 municipalities where YF cases have not been previously detected during the outbreaks. Estimates of YFV genomic load in naturally infected NHP carcasses showed high and similar loads in specimens (Alouatta,Callithrix, andCallicebus) collected in rural areas and lower genomic loads in the urban-rural interface and urbanCallithrixspecimens. The presence of YFV inside urban areas poses an imminent risk, although no human case was epidemiologically linked to urban/Aedestransmission during the last outbreaks in Brazil.
C1 [Sacchetto, Livia; Oliveira Silva, Natalia Ingrid; de Rezende, Izabela Mauricio; Arruda, Matheus Soares; Costa, Thais Alkifeles; Garcia Oliveira, Gabriela Fernanda; Kroon, Erna Geessien; Trindade, Giliane de Souza; Drumond, Betania Paiva] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [de Mello, Erica Munhoz] Ctr Controle Zoonoses, Belo Horizonte, MG, Brazil.
   [Alves, Pedro Augusto] Fundacao Oswaldo Cruz Minas, Inst Rene Rachou, Belo Horizonte, MG, Brazil.
   [de Mendonca, Vitor Emidio; Perini, Fernando Araujo] Univ Fed Minas Gerais, Dept Zool, Belo Horizonte, MG, Brazil.
   [Antonelli Vidal Stumpp, Rodolfo German; Alves Prado, Alaine Izabela; Paglia, Adriano Pereira] Univ Fed Minas Gerais, Dept Genet Ecol & Evolut, Belo Horizonte, MG, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto, Dept Dermatol Infect & Parasit Dis, Sao Paulo, Brazil.
   [de Thoisy, Benoit] Inst Pasteur, Cayenne, French Guiana.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM betaniadrumond@gmail.com
RI Paglia, Adriano P/A-7965-2012; Nogueira, Mauricio L/B-7599-2012
OI Paglia, Adriano P/0000-0001-9957-5506; Nogueira, Mauricio
   L/0000-0003-1102-2419; Alves, Pedro/0000-0002-9659-5621
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG) [APQ-01574-17]; Secretaria de
   Estado de Saude de Minas Gerais (SES-MG)/Secretaria de Estado de
   Planejamento de Minas Gerais (SEPLAG-MG)/Instituto Rene Rachou/Fundacao
   Oswaldo Cruz (IRR/FIOCRUZ) under Grant Yellow fever; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [440593/2016-6];
   Decit/SCTIE/MoH [440593/2016-6]; FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG); Coodernacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; RESERVOIRS program - European (ERDF/FEDER) funds;
   Collectivite Territoriale de la Guyane; Direction Regionale pour la
   Recherche et la Technologie; MicroBIOME project - Laboratoire
   d'Excellence CEBA "Investissement d'Avenir"French National Research
   Agency (ANR) [ANR10-LABX-2501]; FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG) [APQ-01989-18]; Fundacao de Amparo a Pesquisa do
   estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [13/21719-3]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)/BrazilCAPES [0001]; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Pro -Reitoria de
   Graduacao-Universidade Federal de Minas Gerais (UFMG); CNPq
   FAPEMIGNational Council for Scientific and Technological Development
   (CNPq)Minas Gerais State Research Foundation (FAPEMIG); CAPESCAPES
FX This work was supported by different agencies. BPD was supported by
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), under
   Grant APQ-01574-17, and Secretaria de Estado de Saude de Minas Gerais
   (SES-MG)/Secretaria de Estado de Planejamento de Minas Gerais
   (SEPLAG-MG)/Instituto Rene Rachou/Fundacao Oswaldo Cruz (IRR/FIOCRUZ)
   under Grant Yellow fever. GST was supported by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) under grant
   440593/2016-6 and Decit/SCTIE/MoH under grant 440593/2016-6. APP was
   supported by FAPEMIG and Coodernacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES). BdT was supported by the RESERVOIRS program
   supported by European (ERDF/FEDER) funds and assistance from
   Collectivite Territoriale de la Guyane and Direction Regionale pour la
   Recherche et la Technologie, and the MicroBIOME project granted by the
   Laboratoire d'Excellence CEBA "Investissement d'Avenir" under Grant
   ANR10-LABX-2501. PAA was supported by FAPEMIG under grant APQ-01989-18.
   MLN was supported by Fundacao de Amparo a Pesquisa do estado de Sao
   Paulo (FAPESP) under grant 13/21719-3. LS and IMR were supported by
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)/Brazil under graduate scholarship grant (0001) and NIOS was
   supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) under graduate scholarship grant, VEM was supported
   by Pro -Reitoria de Graduacao-Universidade Federal de Minas Gerais
   (UFMG) under graduate scholarship grant. MAS, TAC, and GFGO were
   supported by CNPq FAPEMIG, and CAPES undergraduate scholarship grants.
   BPD, APP, GST, EGK, and MLN are CNPq Research Fellows. CNPq:
   http://www.cnpq.br/CAPES: https://www.capes.gov.br/FAPEMIG:
   https://fapemig.br/pt/FAPESP: http://www.fapesp.br/Pro-Reitoria de
   Graduacao-Universidade Federal de Minas Gerais:
   https://www2.ufmg.br/prograd/The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR CAUSEY OR, 1950, AM J TROP MED, V30, P301
   CLARK HC, 1952, AM J TROP MED HYG, V1, P78, DOI 10.4269/ajtmh.1952.1.78
   Cunha MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41950-3
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   de Rezende IM, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7040206
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   Delatorre E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01079
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Gregorin R, 2006, REV BRAS ZOOL, V23, P64, DOI 10.1590/S0101-81752006000100005
   Groves C., 2001, PRIMATE TAXONOMY, P1
   IBGE, 2000, SIN PREL CENS DEM, P415
   IUCN, 2019, IUCN RED LIST THREAT
   KUMM HW, 1950, AM J TROP MED, V30, P733
   Mares-Guia MAMD, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-3966-x
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   MS-BR, 2017, MONT PER SAZ FEBR AM, P1
   MS-BR, 2019, MON FEBR AM BRAS 201, P1
   Mucci LF, 2016, J AM MOSQUITO CONTR, V32, P329, DOI 10.2987/16-6587.1
   Silva NIO, 2020, VIROL J, V17, DOI 10.1186/s12985-019-1277-7
   Paglia AP, 2012, OCCASIONAL PAPERS CO
   Pinheiro GG, 2019, INSECTS, V10, DOI 10.3390/insects10050136
   de Abreu FVS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190076
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   SES-MG, 2018, FEBR AM MIN GER B EP, P1
   SES-MG, 2017, SIT EP FEBR AM SILV, P1
   SES-MG, 2019, FEBR AM SILV MIN GER, P1
   Stan K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137911
   SVS-MS, 2018, MON PER SAZ FEBR AM, P1
   SVS-MS, 2019, FEBR AM FEBR NIL OC, P727
   SVS-MS, 2019, MON FEBR AM BRAS 201, P1
   SVS-MS, 2017, CTR OP EM SAUD PUBL, P1
   Teixeira B, 2015, WILDLIFE RES, V42, P579, DOI 10.1071/WR14148
   van Roosmalen Marc G.M., 2002, Neotropical Primates, V10, P1
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
NR 38
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2020
VL 14
IS 10
AR e0008658
DI 10.1371/journal.pntd.0008658
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA OB2OH
UT WOS:000578312500008
PM 33017419
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Stoffella-Dutra, AG
   de Oliveira, JS
   Costa, GB
   Kroon, EG
   Abrahao, JS
   LaBeaud, AD
   Drumond, BP
   de Oliveira, DB
   Trindade, GD
AF Stoffella-Dutra, Ana Gabriella
   de Oliveira, Jaqueline Silva
   Costa, Galileu Barbosa
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
   LaBeaud, Angelle Desiree
   Drumond, Betania Paiva
   de Oliveira, Danilo Bretas
   Trindade, Giliane de Souza
TI Absence of YF-neutralizing antibodies in vulnerable populations of
   Brazil: A warning for epidemiological surveillance and the potential
   risks for future outbreaks
SO VACCINE
LA English
DT Article
DE Yellow fever virus; YF-neutralizing antibodies; Epidemiological
   surveillance; Serological survey; Public health
ID YELLOW-FEVER; IMMUNITY
AB Yellow Fever (YF) is an acute febrile illness caused by yellow fever virus (YFV), a mosquito-borne flavivirus transmitted to humans and non-human primates. In Brazil, YF is a public health threat and may cause recurrent epidemics, even with the availability of a vaccine. We evaluated the sero-status for YFV in 581 individuals living in a risk area for YF in Brazil. The area presents history of cases and is located in the southeast region of country where outbreaks of YF have been reported since 2016. Through, a PRNT assay, we found 25.8% of individuals lacking YF-neutralizing antibodies. Furthermore, neutralizing antibodies were not detected in 10 individuals with proven vaccination. Our findings reinforce the importance of surveillance systems and the need of an urgent intensification of immunization programs in regions with YFV circulation. Monitoring susceptible individuals that could act as potential disseminators for YFV in risk areas should also be considered. (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Stoffella-Dutra, Ana Gabriella; de Oliveira, Jaqueline Silva; Kroon, Erna Geessien; Abrahao, Jonatas Santos; Drumond, Betania Paiva; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Costa, Galileu Barbosa] Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Nucleo Epidemiol & Bioestat, Salvador, BA, Brazil.
   [LaBeaud, Angelle Desiree] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA USA.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Diamantina, MG, Brazil.
RP Stoffella-Dutra, AG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM anagstoffella@gmail.com; giliane@icb.ufmg.br
OI Barbosa Costa, Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/MCTI) grantNational Council for Scientific and Technological
   Development (CNPq) [440593/2016-6]; Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation
   (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/MEC)CAPES; Departamento de Ciencia e Tecnologia (DECIT);
   Secretaria de Ciencia, Tecnologia, Inovacao e Insumos Estrategicos em
   Saude (SCTIE); Ministerio da Saude and Pro-Reitoria de Pesquisa/UFMG
   (PRPq-UFMG)
FX We thank colleagues from the Laboratorio de Virus (ICB-UFMG) for their
   excellent technical support. Financial support was provided by the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/MCTI) grant number 440593/2016-6, Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES/MEC), Departamento de Ciencia e
   Tecnologia (DECIT), Secretaria de Ciencia, Tecnologia, Inovacao e
   Insumos Estrategicos em Saude (SCTIE), Ministerio da Saude and
   Pro-Reitoria de Pesquisa/UFMG (PRPq-UFMG). EG Kroon, JS Abrahao, BP
   Drumond, and GS Trindade are researchers from CNPq.
CR Amaral CD, 2018, ECOHEALTH, V15, P577, DOI 10.1007/s10393-018-1353-2
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021
   Campi-Azevedo AC, 2019, EMERG INFECT DIS, V25, P1511, DOI 10.3201/eid2508.181432
   Campi-Azevedo AC, 2016, HUM VACC IMMUNOTHER, V12, P491, DOI 10.1080/21645515.2015.1082693
   Christian KA, 2017, HEALTH SECUR, V15, P453, DOI 10.1089/hs.2017.0004
   Costa GB, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111029
   Costa GB, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0575-6
   COSTA Z.G.A., 2005, EST CAR EP FEBR AM B
   Cutts FT, 2016, VACCINE, V34, P4103, DOI 10.1016/j.vaccine.2016.06.053
   Dimech W, 2016, VACCINE, V34, P4110, DOI 10.1016/j.vaccine.2016.06.002
   Domingo C, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0128-8
   Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012
   Estofolete CF, 2018, BRAZ J MICROBIOL, V49, P683, DOI 10.1016/j.bjm.2018.02.003
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Ferreira CD, 2018, EXPERT REV VACCINES, V17, P79, DOI 10.1080/14760584.2018.1406800
   Figueiredo PO, 2018, ECOHEALTH, V15, P864, DOI 10.1007/s10393-018-1364-z
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   IBF, 2018, BIOM MAT ATL
   IBGE, 2010, CENS DEM
   Lindenbach B.D, 2013, FIELDS VIROL
   LIRAa, 2019, LEV IND RAP AED AEG
   Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439
   Machado VW, 2013, REV SOC BRAS MED TRO, V46, P166, DOI 10.1590/0037-8682-0007-2012
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Romano APM, 2011, EPIDEMIOL SERV SAUDE, V20, P101, DOI 10.5123/S1679-49742011000100011
   Ministerio Da Saude, 2018, 27 MIN SAUD
   Ministerio Da Saude, 2019, 18 MIN SAUD
   Miyaji KT, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759002, 10.1590/s1678-9946201759002]
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Moura LC, 2016, REV VOZES VALES PUBL, V120
   Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429
   Silva NIO, 2020, VIROL J, V17, DOI 10.1186/s12985-019-1277-7
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
   SES/MG, 2019, DAD COB VAC MIN GERA
   SES/MG, 2019, FEBR AM SILV MIN GER
   SES/MG, 2018, B EPID MON CAS DENG
   Soper FL, 1942, FEBRE AMARELA PANAM
   Staples JE, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0205-6
   SVS, 2003, EP FEB AM SIL REG BA
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Vasconcelos PFC, 2018, MEM I OSWALDO CRUZ, V113, P135, DOI 10.1590/0074-02760170347
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Watson AM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040077
   WHO, 2013, POSITION PAPER, V88, P269
   WHO, 2007, GUID PLAQ RED NEUTR
   WHO, 2019, YELL FEV FACT SHEETS
   WHO, 2017, GLOB STRAT EL YELL F
   WHO. World health organization, 2020, YELL FEV INT TRAV HL
   Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18
NR 52
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD SEP 29
PY 2020
VL 38
IS 42
BP 6592
EP 6599
DI 10.1016/j.vaccine.2020.07.077
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA NU1TY
UT WOS:000573425200015
PM 32788140
DA 2020-11-30
ER

PT J
AU Toscano, ECD
   Sousa, LFD
   Lima, GK
   Mesquita, LA
   Vilela, MC
   Rodrigues, DH
   Ferreira, RN
   Soriani, FM
   Campos, MA
   Kroon, EG
   Teixeira, MM
   de Miranda, AS
   Rachid, MA
   Teixeira, AL
AF de Brito Toscano, Eliana Cristina
   da Cunha Sousa, Larissa Fonseca
   Lima, Graciela Kunrath
   Mesquita, Leonardo Antunes
   Vilela, Marcia Carvalho
   Rodrigues, David Henrique
   Ferreira, Rodrigo Novaes
   Soriani, Frederico Marianetti
   Campos, Marco Antonio
   Kroon, Erna Geessien
   Teixeira, Mauro Martins
   de Miranda, Aline Silva
   Rachid, Milene Alvarenga
   Teixeira, Antonio Lucio
TI Neuroinflammation is associated with reduced SOCS2 and SOCS3 expression
   during intracranial HSV-1 infection
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE Encephalitis; Apoptosis; SOCS2; SOCS3; Brain inflammation
ID HERPES-SIMPLEX ENCEPHALITIS; CENTRAL-NERVOUS-SYSTEM; VIRUS TYPE-1;
   CYTOKINE SIGNALING-3; SUPPRESSOR; ACTIVATION; INDUCTION; ABSENCE; MODEL
AB Herpes simplex virus type 1 (HSV-1) is the main etiological agent of acute and sporadic encephalitis. Proteins of the suppressor of cytokine signaling (SOCS) family have shown to regulate the inflammation during HSV-1 infection in the brain. However, the effects of SOCS2 and SOCS3 in viral encephalitis remain unclear. The aim of the current study is to investigate the potential association between SOCS2, SOCS3, cytokines, and hippocampal damage, especially neuronal apoptosis, during acute intracranial HSV-1 infection in mice. Male C57BL/6 mice were infected by intracranial route with 102 plaque-forming units (PFU) inoculum of purified HSV-1. At three days post-infection (3 d.p.i.), mice were euthanized and their hippocampi were collected for histopathological analysis, immunohistochemical reaction against active caspase-3 and quantification of SOCS2, SOCS3 and cytokines (tumoral necrosis factor (TNF), interleukin (IL) 1 beta, IL-6, IL-10; interferon (IFN)-alpha, IFN-beta, IFN-gamma) mRNA expression. Infected mice exhibited neuronal loss and hemorrhagic focus in Cornu Ammonis (CA) region. The apoptotic index was higher in infected mice compared to controls. HSV-1 infection was associated with increased hippocampal expression of TNF, IL1-beta, IL-6 and IFN alpha/IFN beta and decreased expression of IL-10, IFN-gamma, SOCS2 and SOCS3. Our results suggest that down regulation of SOCS2 and SOCS3 contributes to a pro-inflammatory environment associated with hippocampal damage and neuronal apoptosis during acute HSV-1 infection in mice.
C1 [de Brito Toscano, Eliana Cristina; Rachid, Milene Alvarenga] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil.
   [da Cunha Sousa, Larissa Fonseca; Lima, Graciela Kunrath; Ferreira, Rodrigo Novaes; de Miranda, Aline Silva] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil.
   [Mesquita, Leonardo Antunes; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Soriani, Frederico Marianetti] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.
   [Teixeira, Mauro Martins] Univ Fed Juiz Fora, Inst Ciencias Biol, Dept Bioquim & Imunol, Juiz De Fora, Brazil.
   [Teixeira, Antonio Lucio] Univ Texas Hlth Sci Ctr Houston, Neuropsychiat Program, Dept Psychiat & Behav Sci, Sch Med, Houston, TX 77030 USA.
   [Campos, Marco Antonio] Fiocruz Minas, Inst Rene Rachou, Belo Horizonte, MG, Brazil.
   [Vilela, Marcia Carvalho; Rodrigues, David Henrique] Univ Fed Juiz de Fora, Dept Ciencias Basicas & Vida, Juiz De Fora, Brazil.
RP Toscano, ECD; Rachid, MA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Patol Celular & Mol, Campus Pampulha,Av Antonio Carlos 6-627, Belo Horizonte, MG, Brazil.
EM elianacbtoscano@gmail.com; milenerachid@ufmg.br
RI Toscano, Eliana/D-6598-2018
OI Toscano, Eliana/0000-0002-8756-0689
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (Fapemig)Minas Gerais State Research Foundation (FAPEMIG)
FX We are grateful for the financial support provide by the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (Fapemig).
CR Ando Y, 2008, MICROBES INFECT, V10, P1514, DOI 10.1016/j.micinf.2008.09.005
   Baringer JR, 2008, NEUROL CLIN, V26, P657, DOI 10.1016/j.ncl.2008.03.005
   Bigley NJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00015
   Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002
   Boucher A, 2017, MED MALADIES INFECT, V47, P221, DOI 10.1016/j.medmal.2017.02.003
   Braun E, 2006, J GEN VIROL, V87, P2827, DOI 10.1099/vir.0.81850-0
   Campos M., 1993, CRITICAL PERIOD IRRE
   Croker BA, 2012, IMMUNOL CELL BIOL, V90, P124, DOI 10.1038/icb.2011.29
   Sousa LFD, 2016, BRAIN RES BULL, V127, P164, DOI 10.1016/j.brainresbull.2016.09.011
   de Miranda AS, 2012, BEHAV BRAIN RES, V230, P237, DOI 10.1016/j.bbr.2012.02.020
   Domingues RB, 2009, BRAZ J INFECT DIS, V13, P433, DOI 10.1590/S1413-86702009000600009
   ESIRI MM, 1982, J NEUROL SCI, V54, P209, DOI 10.1016/0022-510X(82)90183-6
   Frisch S, 2015, J NEUROL, V262, P563, DOI 10.1007/s00415-014-7604-4
   Gilden DH, 2007, NAT CLIN PRACT NEURO, V3, P82, DOI 10.1038/ncpneuro0401
   Guo YJ, 2011, INFLAMMATION, V34, P388, DOI 10.1007/s10753-010-9246-8
   Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08
   Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355
   Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417
   Mossman KL, 2005, VIRAL IMMUNOL, V18, P267, DOI 10.1089/vim.2005.18.267
   Ramakrishna C, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006822
   Rozenberg Flore, 2011, Infectious Disorders - Drug Targets, V11, P235
   Schachtele SJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-35
   Shives KD, 2017, J NEUROIMMUNOL, V308, P102, DOI 10.1016/j.jneuroim.2017.03.006
   Barbosa AAS, 2016, COMP IMMUNOL MICROB, V47, P26, DOI 10.1016/j.cimid.2016.05.003
   Vilela MC, 2008, NEUROSCI LETT, V445, P18, DOI 10.1016/j.neulet.2008.08.072
   Vilela MC, 2010, NEUROSCI LETT, V479, P58, DOI 10.1016/j.neulet.2010.05.028
   Vilela MC, 2009, ANN NY ACAD SCI, V1153, P256, DOI 10.1111/j.1749-6632.2008.03959.x
   Wang JP, 2012, J VIROL, V86, P2273, DOI 10.1128/JVI.06010-11
   Weissenbock H, 2000, BRAIN PATHOL, V10, P260, DOI 10.1111/j.1750-3639.2000.tb00259.x
   Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938
   Yokota S, 2005, VIROLOGY, V338, P173, DOI 10.1016/j.virol.2005.04.028
   Yokota S, 2004, J VIROL, V78, P6282, DOI 10.1128/JVI.78.12.6282-6286.2004
   Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093
   Yoshimura A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00020
NR 34
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD SEP 25
PY 2020
VL 736
AR 135295
DI 10.1016/j.neulet.2020.135295
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA NU7XA
UT WOS:000573851600016
PM 32800922
DA 2020-11-30
ER

PT J
AU da Costa, PSPM
   Oliveira, JS
   Domingos, IJD
   Silva, PHBE
   Dutra, AGS
   Amaral, CD
   Abrahao, JS
   Pereira, VBR
   Kroon, EG
   Costa, GB
   Trindade, GD
AF da Costa, Pedro Starling Pereira Martins
   Oliveira, Jaqueline Silva
   Domingos, Iago Jose da Silva
   Bastos e Silva, Pedro Henrique
   Dutra, Ana Gabriella Stoffella
   Amaral, Carolina Dourado
   Abrahao, Jonatas Santos
   Pereira, Virginia Bodelao Richini
   Kroon, Erna Geessien
   Costa, Galileu Barbosa
   Trindade, Giliane de Souza
TI Circulation of vaccinia virus in southern and south-eastern wildlife,
   Brazil
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article
DE ecological maintenance; molecular detection; vaccinia virus; VACV
   epidemiology; wildlife
AB We evaluated 345 wild animals from southern and south-eastern Brazil to understand their role in vaccinia virus (VACV) transmission cycle. VACV DNA was detected in rodents, marsupials, chiroptera and cingulate, expanding the knowledge of VACV host range in wildlife that could potentially act as source of infection in rural and urban areas.
C1 [da Costa, Pedro Starling Pereira Martins; Oliveira, Jaqueline Silva; Domingos, Iago Jose da Silva; Bastos e Silva, Pedro Henrique; Dutra, Ana Gabriella Stoffella; Amaral, Carolina Dourado; Abrahao, Jonatas Santos; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pereira, Virginia Bodelao Richini] Adolfo Lutz Inst, Bauru Reg Lab Ctr 2, Bauru, SP, Brazil.
   [Costa, Galileu Barbosa] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.
RP Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM giliane@icb.ufmg.br
OI Barbosa Costa, Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao de Amparo
   a Pesquisa do Estado de Minas GeraisMinas Gerais State Research
   Foundation (FAPEMIG); Pro-Reitoria de Pesquisa/UFMG (PRPq-UFMG)
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais; Pro-Reitoria de
   Pesquisa/UFMG (PRPq-UFMG)
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Costa GB, 2018, EMERG INFECT DIS, V24, P2338, DOI 10.3201/eid2412.171584
   Costa GB, 2017, ARCH VIROL, V162, P2369, DOI 10.1007/s00705-017-3353-x
   de Oliveira JS, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110340
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817
   Lima MT, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03327
   Miranda JB, 2017, EMERG INFECT DIS, V23, P931, DOI 10.3201/eid2306.161643
   PERES MG, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10010042
NR 10
TC 0
Z9 0
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
PD SEP
PY 2020
VL 67
IS 5
BP 1781
EP 1785
DI 10.1111/tbed.13537
EA MAR 2020
PG 5
WC Infectious Diseases; Veterinary Sciences
SC Infectious Diseases; Veterinary Sciences
GA NN9YC
UT WOS:000522675100001
PM 32150784
DA 2020-11-30
ER

PT J
AU Batista, ICA
   Quinan, BR
   Alves, EAR
   Jangola, STG
   Oliveira, ES
   Colombarolli, SG
   Ferreira, JGG
   Rocha, ESD
   Kroon, EG
   de Assis, RR
   de Oliveira, JG
   Fiuza, JA
   Calzavara-Silva, CE
AF Andrade Batista, Izabella Cristina
   Quinan, Barbara Resende
   Rocha Alves, Erica Alessandra
   Gaze Jangola, Soraya Torres
   Oliveira, Eneida Santos
   Colombarolli, Stella Garcia
   Goulart Ferreira, Jorge Gomes
   de Oliveira Rocha, Eliseu Soares
   Kroon, Erna Geessien
   de Assis, Rafael Ramiro
   de Oliveira, Jaquelline Germano
   Fiuza, Jacqueline Araujo
   Calzavara-Silva, Carlos Eduardo
TI Design and production of dengue virus chimeric proteins useful for
   developing tetravalent vaccines
SO VACCINE
LA English
DT Article
DE Dengue; Tetravalent vaccine; Chimeric proteins
ID CD8(+) T-CELLS; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES;
   IMMUNE-RESPONSE; DOMAIN-III; MICE; ENCEPHALITIS; INFECTION; EPITOPES;
   CD4(+)
AB Dengue virus (DENV) is a Flavivirus estimated to cause 390 million infections/year. Currently, there is no anti-viral specific treatment for dengue, and efficient DENV vector control is still unfeasible. Here, we designed and produced chimeric proteins containing potential immunogenic epitopes from the four DENV serotypes in an attempt to further compose safer, balanced tetravalent dengue vaccines.
   For this, South American DENV isolate sequences were downloaded from the NCBI/Virus Variation/ Dengue virus databases and intraserotype-aligned to generate four consensuses. Four homologous DENV sequences were retrieved using BLAST and then interserotype-aligned. In parallel, sequences were subjected to linear B epitope prediction analysis. Regions of the envelope and NS1 proteins that are highly homologous among the four DENV serotypes, non-conserved antigenic regions and the most antigenic epitopes found in the C, prM, E and NS1 DENV proteins were used to construct 11 chimeric peptides. Genes encoding the chimeric proteins were commercially synthesized, and proteins were expressed, purified by affinity chromatography and further subjected to ELISA assays using sera from individuals infected with DENVs 1, 2, 3 or 4. As a proof-of-concept, the chimeric EnvEpII protein was selected to immunize BALB/c and C57BL/6 mice strains. The immunization with EnvEpII protein associated with aluminum induced an increased number of T CD4(+) and CD8(+) cells, high production of IgG(1) and IgG(2) antibodies, and increased levels of IL-2 and IL-17 cytokines, in both mouse strains. Because the EnvEpII protein associated with aluminum induced an efficient cellular response by stimulating the production of IL-2, IL-4, IL-17 and induced a robust humoral response in mice, we conclude that it resembles an efficient specific response against DENV infection. Although further experiments are required, our results indicate that epitope selection by bioinformatic tools is efficient to create recombinant proteins that can be used as candidates for the development of vaccines against infectious diseases. (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Andrade Batista, Izabella Cristina; Rocha Alves, Erica Alessandra; Gaze Jangola, Soraya Torres; Oliveira, Eneida Santos; Colombarolli, Stella Garcia; Goulart Ferreira, Jorge Gomes; de Oliveira, Jaquelline Germano; Fiuza, Jacqueline Araujo; Calzavara-Silva, Carlos Eduardo] Fundacao Oswaldo Cruz, IRR, Grp Imunol Celular & Mol, Av Augusto de Lima 1715, Belo Horizonte, MG, Brazil.
   [de Oliveira Rocha, Eliseu Soares] Katal Biotecnol, R Leiria 1160, BR-31255100 Belo Horizonte, MG, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, ICB, Dept Microbiol, Av Presidente Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
   [Quinan, Barbara Resende] Univ Fed Minas Gerais, Hosp Clin, Av Prof Alfredo Balena 110, BR-30130100 Belo Horizonte, MG, Brazil.
   [de Assis, Rafael Ramiro] Univ Calif Irvine, Dept Physiol, Vaccine Res & Dev Ctr, Irvine, CA 92717 USA.
RP Fiuza, JA; Calzavara-Silva, CE (corresponding author), Fundacao Oswaldo Cruz, IRR, Grp Imunol Celular & Mol, Av Augusto de Lima 1715, Belo Horizonte, MG, Brazil.
EM izabellaandradeb@gmail.com; quinanb@gmail.com; erica.alves@fiocruz.br;
   soraya.gaze@cpqrr.fiocruz.br; eneida.oliveira@fiocruz.br;
   stella_colom-barolli@hotmail.com; jorgekorps@yahoo.com.br;
   eliseubiologia@gmail.com; ernagkroon@gmail.cozm; rramirod@hs.uci.edu;
   jaquelline.oliveira@fiocruz.br; jacqueline.fiuza@fiocruz.br;
   carlos.calzavara@fio-cruz.br
FU Conselho Nacional de Pesquisa (CNPq)National Council for Scientific and
   Technological Development (CNPq) [305618/2013-0, 439979/2016-1,
   401779/2015-7]; Fundacdo de Pesquisa de Minas Gerais (FAPEMIG) [CBB -
   APQ-0741-11]
FX This work was supported by Conselho Nacional de Pesquisa (CNPq)
   (305618/2013-0; 439979/2016-1, 401779/2015-7) and Fundacdo de Pesquisa
   de Minas Gerais (FAPEMIG) (CBB - APQ-0741-11).
CR Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050
   Amorim JH, 2016, VIROLOGY, V487, P41, DOI 10.1016/j.virol.2015.10.006
   [Anonymous], 2003, QLAEXPRESSIONIST HDB, P63
   Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400
   Avirutnan P, 2011, MBIO, V2, DOI 10.1128/mBio.00276-11
   Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839
   Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817
   Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156
   Buddhari D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003230
   Chaturvedi UC, 2009, INDIAN J MED RES, V129, P1
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Rocha ESD, 2013, J VIROL METHODS, V187, P114, DOI 10.1016/j.jviromet.2012.09.012
   Gagnon SJ, 1996, J VIROL, V70, P141, DOI 10.1128/JVI.70.1.141-147.1996
   Gil L, 2009, INT IMMUNOL, V21, P1175, DOI 10.1093/intimm/dxp082
   Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Hazenbos WLW, 1998, J IMMUNOL, V161, P3026
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Jain A, 2013, J CLIN IMMUNOL, V33, P613, DOI 10.1007/s10875-012-9855-0
   KAUFMAN BM, 1987, AM J TROP MED HYG, V36, P427, DOI 10.4269/ajtmh.1987.36.427
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   KURANE I, 1991, J VIROL, V65, P1823, DOI 10.1128/JVI.65.4.1823-1828.1991
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Remy Melissa M., 2014, Inflammation & Allergy Drug Targets, V13, P262
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Rivino L, 2016, EXPERT REV VACCINES, V15, P443, DOI 10.1586/14760584.2016.1116948
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Robinson CR, 1998, P NATL ACAD SCI USA, V95, P5929, DOI 10.1073/pnas.95.11.5929
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   Sjatha F, 2014, MICROBIOL IMMUNOL, V58, P126, DOI 10.1111/1348-0421.12125
   Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01
   Suzarte E, 2015, INT IMMUNOL, V27, P367, DOI 10.1093/intimm/dxv011
   Valdes I, 2009, VIROLOGY, V394, P249, DOI 10.1016/j.virol.2009.08.029
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Yauch LE, 2014, ADV VIRUS RES, V88, P315, DOI 10.1016/B978-0-12-800098-4.00007-6
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yoshida T, 2013, ARCH VIROL, V158, P1209, DOI 10.1007/s00705-013-1618-6
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
   Zuest R, 2015, VACCINE, V33, P1474, DOI 10.1016/j.vaccine.2015.01.074
   2009, ALC INJ EM DEPT, P1
NR 53
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD FEB 18
PY 2020
VL 38
IS 8
BP 2005
EP 2015
DI 10.1016/j.vaccine.2020.01.003
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA KS7ME
UT WOS:000518490000018
PM 31982262
DA 2020-11-30
ER

PT J
AU Malossi, CD
   Fioratti, EG
   Cardoso, JF
   Magro, AJ
   Kroon, EG
   de Aguiar, DM
   Borges, AMCM
   Nogueira, MF
   Ullmann, LS
   Araujo, JP
AF Malossi, Camila Dantas
   Fioratti, Eduardo Gorzoni
   Cardoso, Jedson Ferreira
   Magro, Angelo Jose
   Kroon, Erna Geessien
   de Aguiar, Daniel Moura
   Borges, Alice Mamede Costa Marque
   Nogueira, Marcia Furlan
   Ullmann, Leila Sabrina
   Araujo, Joao Pessoa, Jr.
TI High Genomic Variability in Equine Infectious Anemia Virus Obtained from
   Naturally Infected Horses in Pantanal, Brazil: An Endemic Region Case
SO VIRUSES-BASEL
LA English
DT Article
DE equine infectious anemia virus; molecular characterization; endemic
   region; RNA genome; equine
ID PATHOGENIC FIELD STRAIN; SINGLE-CELL; IN-VIVO; EIAV; EVOLUTION;
   VALIDATION; DIVERSITY; DIAGNOSIS; ORIGIN; SYSTEM
AB Equine infectious anemia virus (EIAV) is a persistent lentivirus that causes equine infectious anemia (EIA). In Brazil, EIAV is endemic in the Pantanal region, and euthanasia is not mandatory in this area. All of the complete genomic sequences from field viruses are from North America, Asia, and Europe, and only proviral genomic sequences are available. Sequences from Brazilian EIAV are currently available only for gag and LTR regions. Thus, the present study aimed for the first time to sequence the entire EIAV genomic RNA in naturally infected horses from an endemic area in Brazil. RNA in plasma from naturally infected horses was used for next-generation sequencing (NGS), and gaps were filled using Sanger sequencing methodology. Complete viral genomes of EIAV from two horses were obtained and annotated (Access Number: MN560970 and MN560971). Putative genes were analyzed and compared with previously described genes, showing conservation in gag and pol genes and high variations in LTR and env sequences. Amino acid changes were identified in the p26 protein, one of the most common targets used for diagnosis, and p26 molecular modelling showed surface amino acid alterations in some epitopes. Brazilian genome sequences presented 88.6% nucleotide identity with one another and 75.8 to 77.3% with main field strains, such as EIAV Liaoning, Wyoming, Ireland, and Italy isolates. Furthermore, phylogenetic analysis suggested that this Brazilian strain comprises a separate monophyletic group. These results may help to better characterize EIAV and to overcome the challenges of diagnosing and controlling EIA in endemic regions.
C1 [Malossi, Camila Dantas; Magro, Angelo Jose; Ullmann, Leila Sabrina; Araujo, Joao Pessoa, Jr.] Sao Paulo State Univ Unesp, Inst Biotechnol, BR-18607440 Botucatu, SP, Brazil.
   [Fioratti, Eduardo Gorzoni] Vales Jequitinhonha & Mucuri Fed Univ UFVJM, Agr Sci Inst ICA, BR-39803371 Unai, Brazil.
   [Cardoso, Jedson Ferreira] Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, Virol Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Aguiar, Daniel Moura; Borges, Alice Mamede Costa Marque] Univ Fed Mato Grosso, Virol & Rickettsiosis Lab, BR-78060900 Cuiaba, Brazil.
   [Nogueira, Marcia Furlan] EMBRAPA Pantanal, BR-79320900 Corumba, Brazil.
RP Araujo, JP (corresponding author), Sao Paulo State Univ Unesp, Inst Biotechnol, BR-18607440 Botucatu, SP, Brazil.
EM camilamalossi@gmail.com; efioratti@yahoo.com.br;
   jedson.cardoso@gmail.com; angelo.magro@unesp.br; ernagkroon@gmail.com;
   danmoura@ufmt.br; alicemmarques@hotmail.com; marcia.furlan@embrapa.br;
   ullmannleila@gmail.com; joao.pessoa@unesp.br
RI Aguiar, Daniel Moura/G-9081-2012; Moura de Aguiar, Daniel/F-1268-2013;
   Kroon, Erna/B-3631-2015
OI Moura de Aguiar, Daniel/0000-0001-8631-522X; Kroon,
   Erna/0000-0003-2721-3826; Cardoso, Jedson/0000-0002-3680-6327; Magro,
   Angelo Jose/0000-0002-4253-6992
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2014/13532-3]
FX This research was funded by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (2014/13532-3).
CR Autorino GL, 2016, VET MICROBIOL, V189, P15, DOI 10.1016/j.vetmic.2016.04.003
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Borges AMCM, 2013, RES VET SCI, V95, P76, DOI 10.1016/j.rvsc.2013.02.011
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Burke DS, 1997, EMERG INFECT DIS, V3, P253, DOI 10.3201/eid0303.970301
   Buzon MJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002314
   Capomaccio S, 2012, VET MICROBIOL, V157, P320, DOI 10.1016/j.vetmic.2012.01.015
   Capomaccio S, 2012, VIRUS RES, V163, P656, DOI 10.1016/j.virusres.2011.11.011
   Cappelli K, 2017, TRANSBOUND EMERG DIS, V64, P2104, DOI 10.1111/tbed.12631
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   CHONG YH, 1991, J VIROL, V65, P1007, DOI 10.1128/JVI.65.2.1007-1012.1991
   COGGINS L, 1972, AM J VET RES, V33, P11
   Cook RF, 2013, VET MICROBIOL, V167, P181, DOI 10.1016/j.vetmic.2013.09.031
   Craigo JK, 2010, CURR HIV RES, V8, P81, DOI 10.2174/157016210790416398
   Cursino AE, 2018, ARCH VIROL, V163, P2385, DOI 10.1007/s00705-018-3877-8
   Souza GDE, 2018, REV BRAS ZOOTECN, V47, DOI 10.1590/rbz4720170162
   Dong JB, 2013, J GEN VIROL, V94, P360, DOI 10.1099/vir.0.047498-0
   Dong JB, 2014, VET MICROBIOL, V174, P276, DOI 10.1016/j.vetmic.2014.08.004
   Dorey-Robinson DLW, 2019, TRANSBOUND EMERG DIS, V66, P2311, DOI 10.1111/tbed.13286
   Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003
   Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001
   Howe L, 2002, J VIROL, V76, P10588, DOI 10.1128/JVI.76.21.10588-10597.2002
   Hu Z, 2016, APPL MICROBIOL BIOT, V100, P10531, DOI 10.1007/s00253-016-7817-9
   Issel CJ, 2014, VET CLIN N AM-EQUINE, V30, P561, DOI 10.1016/j.cveq.2014.08.002
   Jara M., 2019, PHYLOGEOGRAPHY EQUIN, V1, P1, DOI [10.1101/867747, DOI 10.1101/867747]
   Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kerfeld CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001014
   Kruger F., TRIM GALORE
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Leroux C, 2004, VET RES, V35, P485, DOI 10.1051/vetres:2004020
   Leroux C, 2001, J VIROL, V75, P4570, DOI 10.1128/JVI.75.10.4570-4583.2001
   Nogueira MF, 2017, PESQUI VET BRASIL, V37, P227, DOI [10.1590/s0100-736x2017000300005, 10.1590/S0100-736X2017000300005]
   OIE, 2013, MANUAL DIAGNOSTIC TE, DOI 10.1007/s13398-014-0173-7.2
   Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385
   Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Quinlivan M, 2013, J GEN VIROL, V94, P612, DOI 10.1099/vir.0.047191-0
   Reis JKP, 2012, J VIROL METHODS, V180, P62, DOI 10.1016/j.jviromet.2011.12.012
   Ricotti S, 2016, VET MICROBIOL, V187, P41, DOI 10.1016/j.vetmic.2016.03.007
   Rozen S, 2000, Methods Mol Biol, V132, P365
   SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Schwartz EJ, 2015, J VIROL, V89, P6945, DOI 10.1128/JVI.00137-15
   Scicluna MT, 2018, J VIROL METHODS, V251, P111, DOI 10.1016/j.jviromet.2017.10.002
   Silva R. A. M. S., 1999, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V52, P9
   Silva R.A.M.S., 2001, EMBRAPA PANTANAL CIR, V29, P1
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Soutullo A, 2007, J MOL RECOGNIT, V20, P227, DOI 10.1002/jmr.825
   Tigre DM, 2017, ARCH VIROL, V162, P873, DOI 10.1007/s00705-016-3172-5
   Ullmann LS, 2015, J VIROL METHODS, V220, P60, DOI 10.1016/j.jviromet.2015.04.009
   Wang XF, 2018, J VIROL, V92, DOI [10.1128/JVI.02150-17, 10.1128/jvi.02150-17]
   Zheng YH, 1997, J VIROL, V71, P5031, DOI 10.1128/JVI.71.7.5031-5039.1997
NR 53
TC 1
Z9 1
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2020
VL 12
IS 2
AR 207
DI 10.3390/v12020207
PG 15
WC Virology
SC Virology
GA KW6DX
UT WOS:000521256600028
PM 32059508
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Rezende, IM
   Pereira, LS
   Fradico, JRB
   Xavier, MANP
   Alves, PA
   Campi-Azevedo, AC
   Speziali, E
   dos Santos, LZM
   Albuquerque, NS
   Penido, I
   Santos, TA
   Bom, APDA
   da Silva, AMV
   Fernandes, CB
   Calzavara, CE
   Kroon, EG
   Martins, OA
   Teixeira-Carvalho, A
   Drumond, BP
AF Rezende, Izabela Mauricio
   Pereira, Leonardo Soares
   Fradico, Jordana Rodrigues Barbosa
   Xavier, Marcelo Antonio Pascoal
   Alves, Pedro Augusto
   Campi-Azevedo, Ana Carolina
   Speziali, Elaine
   dos Santos, Livia Zignago Moreira
   Albuquerque, Natalia Soares
   Penido, Indiara
   Santos, Tayrine Araujo
   Bom, Ana Paula Dinis Ano
   da Silva, Andrea Marques Vieira
   Fernandes, Camilla Bayma
   Calzavara, Carlos Eduardo
   Kroon, Erna Geessien
   Martins-Filho, Olindo Assis
   Teixeira-Carvalho, Andrea
   Drumond, Betania Paiva
TI Late-Relapsing Hepatitis after Yellow Fever
SO VIRUSES-BASEL
LA English
DT Article
DE yellow fever virus; yellow fever; liver damage; viral persistence;
   hepatitis; liver biopsy; persistent infection; relapsing hepatitis;
   emerging virus; flavivirus
ID VIRUS; ASSAY
AB One patient presented hyporexia, asthenia, adynamia, and jaundice two months after acute yellow fever (YF) onset; plus laboratory tests indicating hepatic cytolysis and a rebound of alanine and aspartate transaminases, and total and direct bilirubin levels. Laboratory tests discarded autoimmune hepatitis, inflammatory or metabolic liver disease, and new infections caused by hepatotropic agents. Anti-YFV IgM, IgG and neutralizing antibodies were detected in different times, but no viremia. A liver biopsy was collected three months after YF onset and tested positive for YFV antigens and wild-type YFV-RNA (364 RNA-copies/gram/liver). Transaminases and bilirubin levels remained elevated for five months, and the arresting of symptoms persisted for six months after the acute YF onset. Several serum chemokines, cytokines, and growth factors were measured. A similar immune response profile was observed in the earlier phases of the disease, followed by more pronounced changes in the later stages, when transaminases levels returned to normal. The results indicated viral persistence in the liver and continual liver cell damage three months after YF onset and reinforced the need for extended follow-ups of YF patients. Further studies to investigate the role of possible viral persistence and the immune response causing relapsing hepatitis following YF are also necessary.
C1 [Rezende, Izabela Mauricio; Kroon, Erna Geessien; Drumond, Betania Paiva] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pereira, Leonardo Soares; dos Santos, Livia Zignago Moreira; Albuquerque, Natalia Soares; Penido, Indiara; Santos, Tayrine Araujo] Eduardo Menezes Hosp, BR-30622020 Belo Horizonte, MG, Brazil.
   [Fradico, Jordana Rodrigues Barbosa; Campi-Azevedo, Ana Carolina; Speziali, Elaine; Martins-Filho, Olindo Assis; Teixeira-Carvalho, Andrea] Fundacao Oswaldo Cruz FIOCRUZ, Grp Integrado Pesquisas Biomarcadores, Inst Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
   [Xavier, Marcelo Antonio Pascoal] Univ Fed Minas Gerais, Dept Anat Patol & Med Legal, Fac Menincina, BR-31270901 Belo Horizonte, MG, Brazil.
   [Xavier, Marcelo Antonio Pascoal; Alves, Pedro Augusto] Fundacao Oswaldo Cruz FIOCRUZ, Inst Rene Rachou, Imunologia Doencas Virais, BR-30190002 Belo Horizonte, MG, Brazil.
   [Bom, Ana Paula Dinis Ano; da Silva, Andrea Marques Vieira; Fernandes, Camilla Bayma] Fundacao Oswaldo Cruz FIOCRUZ, Lab Tecnol Imunol, Biomanguinhos, BR-21040900 Rio De Janeiro, Brazil.
   [Calzavara, Carlos Eduardo] Fundacao Oswaldo Cruz FIOCRUZ, Inst Rene Rachou, Imunol Celular & Mol, BR-30190002 Belo Horizonte, MG, Brazil.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM izabelamauriciorezende@gmail.com; leosoaresgallo@yahoo.com.br;
   jordanafradico@gmail.com; mpascoal@medicina.ufmg.br;
   pedroaugustoalves@yahoo.com.br; campiazevedo@gmail.com;
   fariaspeziali@gmail.com; lizms@msn.com; albuquerque.natalia@gmail.com;
   indypenido@hotmail.com; tayrine.araujo@fhemig.mg.gov.br;
   adinis@bio.fiocruz.br; amarques@bio.fiocruz.br;
   camilla.bayma@bio.fiocruz.br; calzavara@gmail.com; ernagkroon@gmail.com;
   oamfilho@gmail.com; atcteixeira@gmail.com; betaniadrumond@gmail.com
RI Alves, Pedro/T-7203-2019; Rezende, Izabela Mauricio/AAL-5766-2020;
   Kroon, Erna/B-3631-2015
OI Alves, Pedro/0000-0002-9659-5621; Rezende, Izabela
   Mauricio/0000-0003-2616-6300; Kroon, Erna/0000-0003-2721-3826;
   Martins-Filho, Olindo Assis/0000-0002-5494-4889; Pereira,
   Leonardo/0000-0002-5426-0655
FU Fundacao Oswaldo Cruz/Secretaria de Saude de Minas Gerais/Secretaria de
   Planejamento de Minas Gerais/Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (FIOCRUZ/SES-MG/SPLAG-MG/FAPEMIG); National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [307423/2015-8,
   440911/2016-8]; Brazilian Federal Agency for Support and Evaluation of
   Graduate Education (CAPES)CAPES [001, 88881130799/2016-01]; Department
   for Science and Technology/Brazilian Ministry of Health (DECIT/MS);
   Minas Gerais State Agency for Research (FAPEMIG)Minas Gerais State
   Research Foundation (FAPEMIG) [APQ-01989-18, APQ-04178-17]
FX This work was supported by the Fundacao Oswaldo Cruz/Secretaria de Saude
   de Minas Gerais/Secretaria de Planejamento de Minas Gerais/Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais
   (FIOCRUZ/SES-MG/SPLAG-MG/FAPEMIG) under grant yellow fever; National
   Council for Scientific and Technological Development (CNPq) under Grant
   307423/2015-8 and 440911/2016-8; Brazilian Federal Agency for Support
   and Evaluation of Graduate Education (CAPES) under grants PRINT/CAPES,
   001, and 88881130799/2016-01; Department for Science and
   Technology/Brazilian Ministry of Health (DECIT/MS); and Minas Gerais
   State Agency for Research (FAPEMIG) under grants APQ-01989-18 and
   APQ-04178-17. E.G.K, O.A.M.-F., A.T.-C, and B.P.D. are CNPq researchers.
CR Alm E, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1226-z
   Denis B, 2019, EMERG INFECT DIS, V25, P1248, DOI 10.3201/eid2506.190069
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   FRANCIS TI, 1972, B WORLD HEALTH ORGAN, V46, P659
   Kallas EG, 2019, LANCET INFECT DIS, V19, P750, DOI 10.1016/S1473-3099(19)30125-2
   Kar PK, 2009, INDIAN J MED RES, V129, P335
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   OUDART JL, 1970, B WORLD HEALTH ORGAN, V42, P95
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Waggoner JJ, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00827-18
   Wieten RW, 2016, VACCINE, V34, P1247, DOI 10.1016/j.vaccine.2016.01.037
NR 13
TC 1
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2020
VL 12
IS 2
AR 222
DI 10.3390/v12020222
PG 9
WC Virology
SC Virology
GA KW6DX
UT WOS:000521256600063
PM 32079143
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Asse, LR
   Kronenberger, T
   Serafim, MSM
   Sousa, YV
   Franco, ID
   Valli, M
   Bolzani, VD
   Monteiro, GC
   Prates, JLB
   Kroon, EG
   Mota, BEF
   Ferreira, DD
   de Oliveira, RB
   Maltarollo, VG
AF Asse Junior, Leonardo Rander
   Kronenberger, Thales
   Magalhaes Serafim, Mateus Sa
   Sousa, Yamara Viana
   Franco, Isabella Drumond
   Valli, Marilia
   Bolzani, Vanderlan da Silva
   Monteiro, Gustavo Claro
   Bruno Prates, Joao Lucas
   Kroon, Erna Geessien
   Fernandes Mota, Bruno Eduardo
   Ferreira, Diego dos Santos
   de Oliveira, Renata Barbosa
   Maltarollo, Vinicius Goncalves
TI Virtual screening of antibacterial compounds by similarity search of
   Enoyl-ACP reductase (FabI) inhibitors
SO FUTURE MEDICINAL CHEMISTRY
LA English
DT Article
DE antibacterial; FabI inhibitors; ligand-based virtual screening; MRSA;
   similarity search; Staphylococcus aureus
ID STAPHYLOCOCCUS-AUREUS; CURCUMIN; SHAPE; DISCOVERY; AFN-1252; SAFETY;
   PHARMACOKINETICS; PROLIFERATION; TOLERABILITY; CRIZOTINIB
AB Aim: Antibiotic resistance is an alarming issue, as multidrug-resistant bacteria are growing worldwide, hence the decrease of therapeutic potential of available antibiotic arsenal. Among these bacteria, Staphylococcus aureus was pointed by the WHO in the pathogens list to be prioritized in drug development. Methods: We report the use of chemical similarity models for the virtual screening of new antibacterial with structural similarity to known inhibitors of FabI. The potential inhibitors were experimentally evaluated for antibacterial activity and membrane disrupting capabilities. Results & conclusion: These models led to the finding of four new compounds with antibacterial activity, one of which having antimicrobial activity already reported in the literature.
C1 [Asse Junior, Leonardo Rander; Franco, Isabella Drumond; Ferreira, Diego dos Santos; de Oliveira, Renata Barbosa; Maltarollo, Vinicius Goncalves] Univ Fed Minas Gerais, Fac Farma, Dept Prod Farmaceut, Av Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kronenberger, Thales] Univ Hosp Tubingen, Dept Internal Med 8, Otfried Muller Str 14, D-72076 Tubingen, Germany.
   [Magalhaes Serafim, Mateus Sa; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Av Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Sousa, Yamara Viana; Fernandes Mota, Bruno Eduardo] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Av Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Valli, Marilia; Bolzani, Vanderlan da Silva; Monteiro, Gustavo Claro; Bruno Prates, Joao Lucas] Univ Estadual Paulista UNESP, Inst Quim, Dept Quim Organ, Nucleo Bioensaios Biossintese & Ecofis Prod Nat N, BR-14800060 Araraquara, SP, Brazil.
RP Maltarollo, VG (corresponding author), Univ Fed Minas Gerais, Fac Farma, Dept Prod Farmaceut, Av Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM maltarollo@ufmg.br
RI Serafim, Mateus Sa Magalhaes/AAL-9280-2020; Valli, Marilia/W-9603-2019;
   Oliveira, Renata B/G-4505-2015
OI Serafim, Mateus Sa Magalhaes/0000-0002-7505-8659; Valli,
   Marilia/0000-0003-1106-183X; Oliveira, Renata B/0000-0001-5884-2567;
   Kronenberger, Thales/0000-0001-6933-7590; Mota,
   Bruno/0000-0003-0348-4875
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [456984/2014-3]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2013/07600-3, 2014/50926-0]; Universidade Federal de Minas
   Gerais; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2019/05967-3]; Finatec [120/2017]; Termo de Execucao
   Descentralizado Arbocontrol [74/2016]
FX The authors would like to thank Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) grant #456984/2014-3, Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) grants #2013/07600-3
   (CIBFar-CEPID), #2014/50926-0 (INCT BioNat CNPq/FAPESP) and the
   Universidade Federal de Minas Gerais for financial support. EG Kroon is
   a fellow from CNPq. M Valli acknowledges scholarships #2019/05967-3 from
   FAPESP, #120/2017 from Finatec, and Termo de Execucao Descentralizado
   Arbocontrol #74/2016 for grant support and research fellowship. The
   authors have no other relevant affiliations or financial involvement
   with any organization or entity with a financial interest in or
   financial conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Al-Doori Z, 2017, J MOL BIOL RES, V7, P112, DOI 10.5539/jmbr.v7n1p112
   Al-Doori Z, 2003, J ANTIMICROB CHEMOTH, V51, P185, DOI 10.1093/jac/dkg013
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   [Anonymous], 2016, QUACPAC 2003 OPENEYE
   [Anonymous], 2010, OMEGA 2514 OPENEYE S
   [Anonymous], 2018, EON 2303 OPENEYE SCI
   Assadian O, 2011, GMS HYG INFECT CONTR, V6, DOI 10.3205/dgkh000163
   Balemans W, 2010, NATURE, V463, pE3, DOI 10.1038/nature08667
   Baltch AL, 2007, ANTIMICROB AGENTS CH, V51, P1559, DOI 10.1128/AAC.00973-06
   Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280
   Bostrom J, 2013, J MED CHEM, V56, P3273, DOI 10.1021/jm301818g
   Center for Disease Control and Prevention, 2013, US CDC REP ANT RES T
   Center for Disease Control and Prevention, 2016, METH RES STAPH AUR M
   Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939
   Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a
   Christie S. M., 2018, US patent, Patent No. [2,0180,072,666 A1, 20180072666]
   Clinical and Laboratory Standards Institute, 2017, PERFORMANCE STANDARD
   Davis A, 2014, HDB MED CHEM PRINCIP, P505
   Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226
   Drwal MN, 2014, NUCLEIC ACIDS RES, V42, pW53, DOI 10.1093/nar/gku401
   Du ZY, 2006, EUR J MED CHEM, V41, P213, DOI 10.1016/j.ejmech.2005.10.012
   Ferreira RS, 2011, QUIM NOVA, V34, P1770, DOI 10.1590/S0100-40422011001000010
   Fradera Xavier, 2017, Curr Protoc Chem Biol, V9, P196, DOI 10.1002/cpch.27
   Gomes MFR, 2015, CHEMO OPEN ACCESS, V4, P149, DOI [10.4172/ 2167- 7700.1000149, DOI 10.4172/2167-7700.1000149]
   Goncalves FDA, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2076.00013, 10.3389/fmicb.2016.00013]
   Groundwater PW, 2017, BIOCHEMISTRY-US, V56, P514, DOI 10.1021/acs.biochem.6b00879
   Gunes H, 2016, TOXICOL IND HEALTH, V32, P246, DOI 10.1177/0748233713498458
   Hafkin B, 2016, ANTIMICROB AGENTS CH, V60, P1695, DOI 10.1128/AAC.01741-15
   Hafkin B, 2015, FUTURE MICROBIOL, V10, P1805, DOI 10.2217/fmb.15.101
   Halder S, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1476-7
   Hamza A, 2012, J CHEM INF MODEL, V52, P963, DOI 10.1021/ci200617d
   Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365
   Heerding DA, 2001, BIOORG MED CHEM LETT, V11, P2061, DOI 10.1016/S0960-894X(01)00404-8
   Hevener KE, 2012, J MED CHEM, V55, P268, DOI 10.1021/jm201168g
   Hunt T, 2016, J CHEMOTHERAPY, V28, P164, DOI 10.1179/1973947815Y.0000000075
   Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474
   Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+
   Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h
   Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128
   Janssen HJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-7
   Kaur S, 2010, EUR J MED CHEM, V45, P4209, DOI 10.1016/j.ejmech.2010.06.015
   Kazandjian D, 2014, ONCOLOGIST, V19, pE5, DOI 10.1634/theoncologist.2014-0241
   Kerns EH, 2015, DRUG LIKE PROPERTIES
   Khatkar A, 2015, RES CHEM INTERMEDIAT, V41, P299, DOI 10.1007/s11164-013-1192-2
   Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951
   Kingry LC, 2013, J BACTERIOL, V195, P351, DOI 10.1128/JB.01957-12
   Kirchmair J, 2009, J CHEM INF MODEL, V49, P678, DOI 10.1021/ci8004226
   Kronenberger T, 2017, FUTURE MED CHEM, V9, P135, DOI 10.4155/fmc-2016-0179
   Lima AN, 2016, EXPERT OPIN DRUG DIS, V11, P225, DOI 10.1517/17460441.2016.1146250
   Lino CI, 2018, EUR J MED CHEM, V151, P248, DOI 10.1016/j.ejmech.2018.03.083
   Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e
   MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9
   Meissner KA, 2019, CHEM BIOL DRUG DES, V93, P300, DOI 10.1111/cbdd.13416
   Miller WH, 2002, J MED CHEM, V45, P3246, DOI 10.1021/jm020050+
   Miller WH, 2004, [No title captured], Patent No. [US6762201B1, 6762201]
   Mistry TL, 2017, ACS INFECT DIS, V3, P54, DOI 10.1021/acsinfecdis.6b00123
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e
   NAKAUCHI M, 2002, FOOD PRESERV SCI, V28, P183
   Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150
   Ntie-Kang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078085
   Orme I, 2001, ANTIMICROB AGENTS CH, V45, P1943
   Pilon AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07451-x
   Braga SFP, 2017, BIOORGAN MED CHEM, V25, P1889, DOI 10.1016/j.bmc.2017.02.009
   Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891
   Ramnauth J, 2009, BIOORG MED CHEM LETT, V19, P5359, DOI 10.1016/j.bmcl.2009.07.094
   Sahu Arvind, 2013, South Asian J Cancer, V2, P91, DOI 10.4103/2278-330X.110506
   Sampson PB, 2009, BIOORG MED CHEM LETT, V19, P5355, DOI 10.1016/j.bmcl.2009.07.129
   Seefeld MA, 2003, J MED CHEM, V46, P1627, DOI 10.1021/jm0204035
   Seefeld MA, 2001, BIOORG MED CHEM LETT, V11, P2241, DOI 10.1016/S0960-894X(01)00405-X
   Serafim MSM, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.814
   Shave S, 2018, ACS OMEGA, V3, P2564, DOI 10.1021/acsomega.7b02091
   Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886
   Takhi M, 2015, [No title captured], Patent No. [US9062075B2, 9062075B2]
   Takhi M, 2014, EUR J MED CHEM, V84, P382, DOI 10.1016/j.ejmech.2014.07.036
   Tonge P, 2018, [No title captured], Patent No. [US10071965B2, 10071965]
   Tyagi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121313
   Valli M, 2013, J NAT PROD, V76, P439, DOI 10.1021/np3006875
   World Health Organization, 2017, WHO PUBL LIST BACT W
   Yao JJ, 2010, BIOORG MED CHEM LETT, V20, P56, DOI 10.1016/j.bmcl.2009.11.042
   Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707
   Yun DG, 2016, APPL MICROBIOL BIOT, V100, P5505, DOI 10.1007/s00253-016-7415-x
NR 82
TC 1
Z9 1
U1 2
U2 5
PU FUTURE SCI LTD
PI LONDON
PA UNITED HOUSE, 2 ALBERT PL, LONDON, N3 1QB, ENGLAND
SN 1756-8919
EI 1756-8927
J9 FUTURE MED CHEM
JI Future Med. Chem.
PD JAN
PY 2020
VL 12
IS 1
BP 51
EP 68
DI 10.4155/fmc-2019-0158
PG 18
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA KM8PM
UT WOS:000514403500005
PM 31729258
DA 2020-11-30
ER

PT J
AU Marinho, PES
   Alvarenga, PPM
   Lima, MT
   Andrade, AD
   Candiani, TMS
   Crispim, APC
   Gasparini, MCS
   Castro, FS
   de Sousa, AZA
   Viegas, ECC
   de Oliveira, DB
   Christo, PP
   Kroon, EG
AF Marinho, Paula Eillanny Silva
   Alvarenga, Pedro Paulo Martins
   Lima, Mauricio Teixeira
   de Souza Andrade, Adriana
   Candiani, Talitah Michel Sanchez
   Crispim, Ana Paula Correa
   Gasparini, Mirela Cristina Soares
   Castro, Fabrizia Santos
   de Sousa, Aline Zocrato Alves
   Viegas, Eisler Cristiane Carvalho
   de Oliveira, Danilo Bretas
   Christo, Paulo Pereira
   Kroon, Erna Geessien
TI Central and peripheral nervous system involvement in Zika virus
   infection in a child
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Zika virus; Central nervous system; Children; Peripheral nervous system
AB A 7-year-old boy that presented an encephalomyeloradiculitis and no classic symptoms of arboviruses. Zika virus (ZIKV) was confirmed by molecular analyses of cerebrospinal fluid and 1 year later by plaque reduction neutralization test. This case demonstrates that ZIKV can be associated with diffuse nervous system infection in children.
C1 [Marinho, Paula Eillanny Silva; Lima, Mauricio Teixeira; de Souza Andrade, Adriana; Crispim, Ana Paula Correa; Gasparini, Mirela Cristina Soares; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Inst Ciencias Biol, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
   [Alvarenga, Pedro Paulo Martins; Candiani, Talitah Michel Sanchez; Castro, Fabrizia Santos; de Sousa, Aline Zocrato Alves; Viegas, Eisler Cristiane Carvalho] Hosp Infantil Joao Paulo II, FHEMIG, Belo Horizonte, MG, Brazil.
   [Alvarenga, Pedro Paulo Martins] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med Diamantina, Teofilo Otoni, MG, Brazil.
   [Christo, Paulo Pereira] Inst Ensino & Pesquisa Santa Casa Belo Horizonte, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Inst Ciencias Biol, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Christo, Paulo Pereira/AAK-9780-2020
OI Christo, Paulo Pereira/0000-0003-1224-5243; Teixeira Lima,
   Mauricio/0000-0002-0830-3909
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior(CAPES)CAPES; Departamento de Ciencia e Tecnologia (DECIT) do
   Ministerio da Saude; Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX The authors received financial support from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior(CAPES), Departamento de
   Ciencia e Tecnologia (DECIT) do Ministerio da Saude and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). EGK is a fellow
   from CNPq.
CR Amoore Louise, 2017, SECURING ALGORITHMS, V48, P1
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Duca LM, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0557-x
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   Tyler KL, 2017, JAMA NEUROL, V74, P1169, DOI 10.1001/jamaneurol.2017.1471
NR 9
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD DEC
PY 2019
VL 25
IS 6
BP 893
EP 896
DI 10.1007/s13365-019-00770-x
PG 4
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA KI9UO
UT WOS:000511704500017
PM 31222674
DA 2020-11-30
ER

PT J
AU de Rezende, IM
   Alves, PA
   Arruda, MS
   Goncalves, AP
   Oliveira, GFG
   Pereira, LS
   Dutra, MRT
   Campi-Azevedo, AC
   Valim, V
   Tourinho, R
   de Oliveira, JG
   Calzavara, CE
   Said, RFD
   Kroon, EG
   Martins, OA
   Teixeira-Carvalho, A
   Drumond, BP
AF de Rezende, Izabela Mauricio
   Alves, Pedro Augusto
   Arruda, Matheus Soares
   Goncalves, Andreza Parreiras
   Oliveira, Gabriela Fernanda Garcia
   Pereira, Leonardo Soares
   Dutra, Maria Rita Teixeira
   Campi-Azevedo, Ana Carolina
   Valim, Valeria
   Tourinho, Renata
   de Oliveira, Jaquelline Germano
   Calzavara, Carlos Eduardo
   Said, Rodrigo Fabiano do Carmo
   Kroon, Erna Geessien
   Martins-Filho, Olindo Assis
   Teixeira-Carvalho, Andrea
   Drumond, Betania Paiva
TI Yellow Fever Virus Genotyping Tool and Investigation of Suspected
   Adverse Events Following Yellow Fever Vaccination
SO VACCINES
LA English
DT Article
DE yellow fever virus; YFV-17DD; adverse event; arbovirus; yellow fever;
   vaccination; immunisation; vaccine; genotyping; wild-type virus
ID PCR
AB The yellow fever (YF) vaccine consists of an attenuated virus, and despite its relative safety, some adverse events following YF vaccination have been described. At the end of 2016, Brazil experienced the most massive sylvatic yellow fever outbreak over the last 70 years and an intense campaign of YF vaccination occurred in Minas Gerais state in Southeast Brazil from 2016 to 2018. The present study aimed to develop a genotyping tool and investigate 21 cases of suspected adverse events following YF vaccination. Initial in silico analyses were performed using partial NS5 nucleotide sequences to verify the discriminatory potential between wild-type and vaccine viruses. Samples from patients were screened for the presence of the YFV RNA, using 5 ' UTR as the target, and then used for amplification of partial NS5 gene amplification, sequencing, and phylogenetic analysis. Genotyping indicated that 17 suspected cases were infected by the wild-type yellow fever virus, but four cases remained inconclusive. The genotyping tool was efficient in distinguishing the vaccine from wild-type virus, and it has the potential to be used for the differentiation of all yellow fever virus genotypes.
C1 [de Rezende, Izabela Mauricio; Arruda, Matheus Soares; Oliveira, Gabriela Fernanda Garcia; Pereira, Leonardo Soares; Kroon, Erna Geessien; Drumond, Betania Paiva] Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Alves, Pedro Augusto; Goncalves, Andreza Parreiras; Campi-Azevedo, Ana Carolina; de Oliveira, Jaquelline Germano; Calzavara, Carlos Eduardo; Martins-Filho, Olindo Assis; Teixeira-Carvalho, Andrea] Fundacao Oswaldo Cruz, Inst Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
   [Pereira, Leonardo Soares; Dutra, Maria Rita Teixeira] Fundacao Hosp Estado Minas Gerais, Hosp Eduardo de Menezes, BR-30622020 Belo Horizonte, MG, Brazil.
   [Valim, Valeria] Univ Fed Espirito Santo, Empresa Brasileira Serv Hosp, Hosp Univ Cassiano Antonio Moraes, BR-29075910 Vitoria, ES, Brazil.
   [Tourinho, Renata] Fundacao Oswaldo Cruz, Biomanguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Said, Rodrigo Fabiano do Carmo] Secretaria Estado Saude Minas Gerais, BR-31630900 Belo Horizonte, MG, Brazil.
   [Said, Rodrigo Fabiano do Carmo] Secretaria Vigilancia Saude, Minist Saude, Dept Vigilancia Doencas Transmissiveis, BR-70058900 Brasilia, DF, Brazil.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
EM izabelamauriciorezende@gmail.com; pedroaugustoalves@yahoo.com.br;
   matheusmtsa@hotmail.com; andreza.parreiras@hotmail.com;
   gabrielafernandag@gmail.com; leosoaresgallo@yahoo.com.br;
   mariaritatdutra@gmail.com; campiazevedo@gmail.com; val.valim@gmail.com;
   renata.tourinho@bio.fiocruz.br; jaquelline.oliveira@fiocruz.br;
   calzavara@gmail.com; rodrigo.said@saude.gov.br; ernagkroon@gmail.com;
   oamfilho@gmail.com; atcteixeira@gmail.com; betaniadrumond@gmail.com
RI Rezende, Izabela Mauricio/AAL-5766-2020; Alves, Pedro/T-7203-2019;
   Kroon, Erna/B-3631-2015
OI Rezende, Izabela Mauricio/0000-0003-2616-6300; Alves,
   Pedro/0000-0002-9659-5621; Pereira, Leonardo/0000-0002-5426-0655;
   OLIVEIRA, JAQUELLINE/0000-0002-0487-8748; Kroon,
   Erna/0000-0003-2721-3826; Martins-Filho, Olindo
   Assis/0000-0002-5494-4889
FU Fundacao Oswaldo Cruz/Secretaria de Saude de Minas Gerais/Secretaria de
   Planejamento de Minas Gerais/Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (FIOCRUZ/SES-MG/SPLAG-MG/FAPEMIG)
   [Fiocruz-VPPIS-004-FIO-18]; National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq) [440911/2016-8]; Department for Science
   and Technology/Brazilian Ministry of Health (DECIT/MS);  [APQ-01989-18];
    [APQ-04178-17]
FX Financial support was provided by Fundacao Oswaldo Cruz
   (Fiocruz-VPPIS-004-FIO-18), Fundacao Oswaldo Cruz/Secretaria de Saude de
   Minas Gerais/Secretaria de Planejamento de Minas Gerais/Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais
   (FIOCRUZ/SES-MG/SPLAG-MG/FAPEMIG) (grant yellow fever); National Council
   for Scientific and Technological Development (CNPq) (440911/2016-8,
   research fellowship); Department for Science and Technology/Brazilian
   Ministry of Health (DECIT/MS), FAPEMIG (APQ-01989-18, APQ-04178-17).
   E.G.K, O.A.M.-F., A.T.C, and B.P.D. are CNPq researcher fellowships.
CR [Anonymous], 2010, NEW YORK TIMES  1007, VZ, P1, DOI DOI 10.1109/IEEESTD.2010.5514475
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021
   Campi-Azevedo AC, 2016, HUM VACC IMMUNOTHER, V12, P491, DOI 10.1080/21645515.2015.1082693
   Costa-Pereira C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006462
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Fischer C, 2017, EMERG INFECT DIS, V23, P1867, DOI 10.3201/eid2311.171131
   Holford NC, 2008, ANN NY ACAD SCI, V1137, P108, DOI 10.1196/annals.1448.006
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Ministerio da Saude (BR), 2014, MAN VIG EP EV ADV PO
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Porudominsky R, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/RPSP.2018.75, 10.26633/rpsp.2018.75]
   Rambaut A., 2015, TREEANNOTATOR
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Soper F.L., 1942, PAN AM J PUBLIC HLTH, P1207
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Vincent AT, 2017, J MICROBIOL METH, V138, P60, DOI 10.1016/j.mimet.2016.02.016
   WHO, 2013, WEEKL EP REC VACC VA
   World Health Organization, 2008, DET INV SER ADV EV F
   World Health Organization (WHO), 2017, EL YELL FEV EP 2026
NR 29
TC 1
Z9 1
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD DEC
PY 2019
VL 7
IS 4
AR 206
DI 10.3390/vaccines7040206
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA KA3PC
UT WOS:000505709700001
PM 31817103
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Silva, ML
   Stehmann, JR
   Serafim, MSM
   Vale, VV
   Gontijo, DC
   Brandao, GC
   Kroon, EG
   de Oliveira, AB
AF Silva, Marlene Lourenco
   Stehmann, Joao Renato
   Magalhaes Serafim, Mateus Sa
   Vale, Valdicley Vieira
   Gontijo, Douglas Costa
   Brandao, Geraldo Celio
   Kroon, Erna Geessien
   de Oliveira, Alaide Braga
TI Himatanthus bracteatus stem extracts present anti-flavivirus activity
   while an isolated sesquiterpene glucoside present only anti-Zika virus
   activity in vitro
SO NATURAL PRODUCT RESEARCH
LA English
DT Article; Early Access
DE Himatanthus bracteatus; Zika virus; yellow fever virus; dengue virus;
   plumieride; spectroscopic analyses
AB The hexane and ethanol extracts from Himatanthus bracteatus (Apocynaceae) stems were evaluated for antiviral activity against Zika virus, yellow fever virus and dengue virus 2 and for cytotoxicity in Vero cells by MTT assay. The ethanol extract showed good antiviral activity against the three viruses with selective indexes (SI) > 10 and its fractionation led to the isolation of the known plumieride that was active only against Zika virus (SI of 15.97).
C1 [Silva, Marlene Lourenco; Gontijo, Douglas Costa; de Oliveira, Alaide Braga] Univ Fed Minas Gerais, Dept Prod Farmaceut, Belo Horizonte, MG, Brazil.
   [Stehmann, Joao Renato] Univ Fed Minas Gerais, Dept Bot, Belo Horizonte, MG, Brazil.
   [Magalhaes Serafim, Mateus Sa; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Vale, Valdicley Vieira] Univ Fed Para, Programa Posgrad Ciencias Farmaceut, Belem, Para, Brazil.
   [Brandao, Geraldo Celio] Univ Fed Ouro Preto, Escola Farm, Ouro Preto, Brazil.
RP Gontijo, DC; de Oliveira, AB (corresponding author), Univ Fed Minas Gerais, Dept Prod Farmaceut, Belo Horizonte, MG, Brazil.
EM gontijo.douglas@outlook.com; bragalaide@gmail.com
RI Serafim, Mateus Sa Magalhaes/AAL-9280-2020; VALE, VALDICLEY
   VIEIRA/ABA-6548-2020
OI Serafim, Mateus Sa Magalhaes/0000-0002-7505-8659; VALE, VALDICLEY
   VIEIRA/0000-0001-6570-4875; Brandao, Geraldo Celio/0000-0002-7330-051X
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG) [APQ-01410-14];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [440911/2016]; CapesCAPES [2058/2016]; DECIT/MS; CNPqNational Council
   for Scientific and Technological Development (CNPq)
FX To FAPEMIG Process APQ-01410-14 for financial support to ABO. To CNPq
   Process 440911/2016, Capes Process 2058/2016 and DECIT/MS for financial
   support to EGK. To CNPq for scholarship to MLS and fellowship to ABO.
CR BrandAo GC, 2010, THESIS
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   Ferreira PG, 2018, ARCH VIROL, V163, P1567, DOI 10.1007/s00705-018-3774-1
   Gandhi GR, 2016, PHYTOMEDICINE, V23, P1830, DOI 10.1016/j.phymed.2016.11.005
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Linhares JCS, 2010, THESIS
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Pugas Rejane Martins, 2018, Hoehnea, V45, P405, DOI 10.1590/2236-8906-23/2017
   Segun PA, 2019, NAT PROD RES, DOI 10.1080/14786419.2019.1644505
   Vale VV, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0643-1
   Vanderlei M.F., 1991, J BRAZIL CHEM SOC, V2, P51
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Veloso MP, 1999, BIOCHEM SYST ECOL, V27, P669, DOI 10.1016/S0305-1978(98)00125-2
   de Almeida SCX, 2017, REV BRAS FARMACOGN, V27, P788, DOI 10.1016/j.bjp.2017.10.002
NR 14
TC 0
Z9 0
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
DI 10.1080/14786419.2019.1690487
EA NOV 2019
PG 5
WC Chemistry, Applied; Chemistry, Medicinal
SC Chemistry; Pharmacology & Pharmacy
GA JO0HZ
UT WOS:000497269700001
PM 31746240
DA 2020-11-30
ER

PT J
AU Serafim, MSM
   Lavorato, SN
   Kronenberger, T
   Sousa, YV
   Oliveira, GP
   dos Santos, SG
   Kroon, EG
   Maltarollo, VG
   Alves, RJ
   Mota, BEF
AF Serafim, Mateus S. M.
   Lavorato, Stefania N.
   Kronenberger, Thales
   Sousa, Yamara, V
   Oliveira, Graziele P.
   dos Santos, Simone G.
   Kroon, Erna G.
   Maltarollo, Vinicius G.
   Alves, Ricardo J.
   Mota, Bruno E. F.
TI Antibacterial activity of synthetic 1,3-bis(aryloxy)propan-2-amines
   against Gram-positive bacteria
SO MICROBIOLOGYOPEN
LA English
DT Article
DE 3-bis(aryloxy)propan-2-amines; antibacterial; gram-positive bacteria;
   MRSA; synthetic 1; target prediction
ID INHIBITORS; PROTEIN; VANCOMYCIN; COLISTIN; SCAFFOLD; DOCKING
AB Synthetic 1,3-bis(aryloxy)propan-2-amines have been shown in previous studies to possess several biological activities, such as antifungal and antiprotozoal. In the present study, we describe the antibacterial activity of new synthetic 1,3-bis(aryloxy)propan-2-amines against Gram-positive pathogens (Streptococcus pyogenes, Enterococcus faecalis and Staphylococcus aureus) including Methicillin-resistant S. aureus strains. Our compounds showed minimal inhibitory concentrations (MIC) in the range of 2.5-10 mu g/ml (5.99-28.58 mu M), against different bacterial strains. The minimal bactericidal concentrations found were similar to MIC, suggesting a bactericidal mechanism of action of these compounds. Furthermore, possible molecular targets were suggested by chemical similarity search followed by docking approaches. Our compounds are similar to known ligands targeting the cell division protein FtsZ, Quinolone resistance protein norA and the Enoyl-[acyl-carrier-protein] reductase FabI. Taken together, our data show that synthetic 1,3-bis(aryloxy)propan-2-amines are active against Gram-positive bacteria, including multidrug-resistant strains and can be a promising lead in the development of new antibacterial compounds for the treatment of these infections.
C1 [Serafim, Mateus S. M.; Sousa, Yamara, V; Mota, Bruno E. F.] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil.
   [Lavorato, Stefania N.; Maltarollo, Vinicius G.; Alves, Ricardo J.] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Belo Horizonte, MG, Brazil.
   [Kronenberger, Thales] Univ Hosp Tubingen, Dept Internal Med 8, Tubingen, Germany.
   [Oliveira, Graziele P.; dos Santos, Simone G.; Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Lavorato, Stefania N.] UFOB, Ctr Ciencias Biol & Saude, Rua Prof Jose Seabra de Lemos 316, BR-47808021 Barreiras, BA, Brazil.
RP Mota, BEF (corresponding author), Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil.
EM brunofmota@gmail.com
RI Alves, Ricardo J/I-7978-2015; Lavorato, Stefania N/J-7829-2015;
   LAVORATO, STEFANIA/ABD-6754-2020; Serafim, Mateus Sa
   Magalhaes/AAL-9280-2020
OI LAVORATO, STEFANIA/0000-0002-8887-8859; Serafim, Mateus Sa
   Magalhaes/0000-0002-7505-8659; Oliveira, Graziele/0000-0002-8521-0351;
   Mota, Bruno/0000-0003-0348-4875
FU Fundacao de Amparo a Pesquisa do Estado de Minas GeraisMinas Gerais
   State Research Foundation (FAPEMIG); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq); Pro-Reitoria de Pesquisa, Universidade
   Federal de Minas Gerais
FX Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico; Pro-Reitoria de Pesquisa,
   Universidade Federal de Minas Gerais
CR Alder Jeffrey, 2004, Curr Infect Dis Rep, V6, P251, DOI 10.1007/s11908-004-0042-1
   Baltch AL, 2007, ANTIMICROB AGENTS CH, V51, P1559, DOI 10.1128/AAC.00973-06
   Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031
   BIAGI GL, 1970, J MED CHEM, V13, P511, DOI 10.1021/jm00297a038
   BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013
   Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011
   CDC, 2013, ANT RES THREATS US
   Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24
   Clinical and Laboratory Standards Institute, 1999, METH DET BACT ACT AN, V19
   CLSI, 2017, M100 CLSI
   Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398
   Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
   Fritsche A, 2008, BIOORGAN MED CHEM, V16, P3489, DOI 10.1016/j.bmc.2008.02.019
   Gao ML, 2017, EUR J MED CHEM, V127, P286, DOI 10.1016/j.ejmech.2017.01.004
   Gomes MFR, 2015, CHEMO OPEN ACCESS, V4, P149, DOI [10.4172/ 2167- 7700.1000149, DOI 10.4172/2167-7700.1000149]
   Hagras M, 2017, J MED CHEM, V60, P4074, DOI 10.1021/acs.jmedchem.7b00392
   Hawkins P. C. D., 2010, OMEGA 2 5 1 4
   Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365
   Heerding DA, 2003, BIOORG MED CHEM LETT, V13, P3771, DOI 10.1016/j.bmcl.2003.07.010
   Jacobitz AW, 2014, J BIOL CHEM, V289, P8891, DOI 10.1074/jbc.M113.509273
   Thai KM, 2015, MED CHEM, V11, P135, DOI 10.2174/1573406410666140902110903
   KING LC, 1952, J AM CHEM SOC, V74, P3338, DOI 10.1021/ja01133a036
   Kronenberger T, 2017, FUTURE MED CHEM, V9, P135, DOI 10.4155/fmc-2016-0179
   Lavorato SN, 2017, MED CHEM RES, V26, P1052, DOI 10.1007/s00044-017-1805-1
   Lavorato SN, 2015, MEM I OSWALDO CRUZ, V110, P566, DOI 10.1590/0074-02760150007
   Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1
   Lobanovska M, 2017, YALE J BIOL MED, V90, P135
   Malhotra-Kumar S, 2016, LANCET INFECT DIS, V16, P283, DOI 10.1016/S1473-3099(16)00012-8
   Mistry TL, 2017, ACS INFECT DIS, V3, P54, DOI 10.1021/acsinfecdis.6b00123
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OpenEye Scientific Software, 2016, QUACPAC 2016
   Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o
   Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Vallone A, 2018, EUR J MED CHEM, V150, P698, DOI 10.1016/j.ejmech.2018.03.024
   Vijayalakshmi P, 2014, INTERDISCIP SCI, V6, P331, DOI 10.1007/s12539-012-0229-3
   Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpbi.3]
   Yuxiu L., 2000, CHINESE J SYNTHETIC, V8, P511
NR 38
TC 4
Z9 4
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-8827
J9 MICROBIOLOGYOPEN
JI MicrobiologyOpen
PD NOV
PY 2019
VL 8
IS 11
SI SI
AR e814
DI 10.1002/mbo3.814
PG 15
WC Microbiology
SC Microbiology
GA JW6ZP
UT WOS:000503198300004
PM 30773849
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Costa, GB
   Marinho, PES
   Vilela, APP
   Saraiva-Silva, AT
   Crispim, APC
   Borges, IA
   Dutra, AGS
   Lobato, ZIP
   dos Reis, JKP
   de Oliveira, DB
   Drumond, BP
   Kroon, EG
   Trindade, GD
AF Costa, Galileu Barbosa
   Silva Marinho, Paula Eillany
   Pessoa Vilela, Ana Paula
   Saraiva-Silva, Ana Teresa
   Correia Crispim, Ana Paula
   Borges, Iara Apolinario
   Stoffella Dutra, Ana Gabriella
   Portela Lobato, Zelia Ines
   Pimenta dos Reis, Jenner Karlison
   de Oliveira, Danilo Bretas
   Drumond, Betania Paiva
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
TI Silent Circulation of the Saint Louis Encephalitis Virus among Humans
   and Equids, Southeast Brazil
SO VIRUSES-BASEL
LA English
DT Article
DE Saint Louis encephalitis virus; seroprevalence; epidemiology;
   asymptomatic cases; public health burden
ID INFECTION; ARBOVIRUSES; STRAINS
AB Saint Louis encephalitis virus (SLEV) is a mosquito-borne flavivirus that occurs throughout the Americas, and is considered a public health threat. In Brazil, SLEV has been detected from human cases associated with dengue-like disease, but no neurological symptoms were reported. Furthermore, the epidemiology of SLEV in human populations is still poorly explored in the country. We reported serological and molecular detection of SLEV in a healthy population of equids and humans from rural areas in Southeast Brazil. A plaque reduction neutralization test was applied, and neutralizing antibodies were detected in 11 individuals (4.6%) and 60 horses (21.5%). A qPCR targeting the 5'UTR region and reverse transcription-PCR (RT-PCR) targeting the non-structural protein (NS5) gene were performed and three individuals tested positive in both assays. Subsequent phylogenetic analysis confirmed SLEV circulation and its findings suggest the occurrence of an asymptomatic or subclinical presence in human and animal cases, correlating with the risks for outbreaks and consequently burden of SLEV infections to public health. Preventive strategies should include improved surveillance in regions with a high probability of SLEV occurrence, improvement in diagnostic methods, and evaluation of exposure/risk factors that can favor SLEV emergence.
C1 [Costa, Galileu Barbosa; Silva Marinho, Paula Eillany; Pessoa Vilela, Ana Paula; Saraiva-Silva, Ana Teresa; Correia Crispim, Ana Paula; Borges, Iara Apolinario; Stoffella Dutra, Ana Gabriella; Drumond, Betania Paiva; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Dept Med Vet Prevent, Lab Pesquisa Virol Anim, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pimenta dos Reis, Jenner Karlison] Univ Fed Minas Gerais, Dept Med Vet Prevent, Lab Retroviroses, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, BR-39100000 Diamantina, Brazil.
   [Costa, Galileu Barbosa] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.
RP Costa, GB; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Costa, GB (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.
EM galileu@wustl.edu; ei_lanny@hotmail.com; pessoavilela58@gmail.com;
   anateresasaraivasilva@gmail.com; anapbio2@gmail.com;
   borges2805@gmail.com; anagstoffella@gmail.com; ziplobato@gmail.com;
   jennerkpr@gmail.com; danilobretas@yahoo.com.br;
   betaniadrumond@gmail.com; ernagkroon@gmail.com; gitrindade@yahoo.com.br
RI Reis, Jenner/AAJ-9164-2020; Kroon, Erna/B-3631-2015
OI Reis, Jenner/0000-0003-0395-358X; Pessoa Vilela, Ana
   Paula/0000-0001-9030-0688; Barbosa Costa, Galileu/0000-0001-7360-6722;
   Kroon, Erna/0000-0003-2721-3826
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [440593/2016-6]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES)CAPES; Departamento de Ciencia e Tecnologia
   (DECIT); Secretaria de Ciencia, Tecnologia, Inovacao e Insumos
   Estrategicos em Saude (SCTIE); Ministerio da Saude; Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas Gerais State Research
   Foundation (FAPEMIG); Pro-Reitoria de Pesquisa/UFMG (PRPq)
FX We thank colleagues from the Laboratorio de Virus (ICB-UFMG) for their
   excellent technical support. Financial support was provided by the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   grant number 440593/2016-6, Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES), Departamento de Ciencia e Tecnologia (DECIT),
   Secretaria de Ciencia, Tecnologia, Inovacao e Insumos Estrategicos em
   Saude (SCTIE), Ministerio da Saude, Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG), and Pro-Reitoria de Pesquisa/UFMG
   (PRPq). Z.I.P. Lobato, J. K. P. Reis, E.G. Kroon, B.P. Drumond and G.S.
   Trindade are researchers from CNPq.
CR Diaz LA, 2006, EMERG INFECT DIS, V12, P1752, DOI 10.3201/eid1211.060486
   Diaz LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001489
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Borges IA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00402
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Centers for Disease Control and Prevention, SAINT LOUIS ENC
   Companhia de Tecnologia da InformacAo do Estado de Minas Gerais Brasil, CLIM VEG REL
   Costa GB, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0575-6
   Heinen LBD, 2015, REV INST MED TROP SP, V57, P215, DOI 10.1590/S0036-46652015000300006
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   Diaz A, 2018, EMERG INFECT DIS, V24, P2150, DOI 10.3201/eid2412.180372
   Diaz LA, 2003, ENTOMOLVECT, V10, P551
   Rivarola ME, 2017, VIROLOGY, V505, P181, DOI 10.1016/j.virol.2017.02.023
   Instituto Estadual de Florestas (IEF), COB VEG MIN GER
   Johnson BW, 2009, CLIN VACCINE IMMUNOL, V16, P1052, DOI 10.1128/CVI.00095-09
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   MONATH TP, 1980, AM J TROP MED HYG, V29, P948, DOI 10.4269/ajtmh.1980.29.948
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Figueiredo LTM, 2014, REV SOC BRAS MED TRO, V47, P541, DOI 10.1590/0037-8682-0197-2014
   Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706
   Pierson T.C., 2013, FIELDS VIROLOGY, V6, P747
   Pupo M, 2006, EMERG INFECT DIS, V12, P1022, DOI 10.3201/eid1206.051235
   Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3
   Romano-Lieber NS, 2000, REV SAUDE PUBL, V34, P236, DOI 10.1590/S0034-89102000000300005
   Rosa R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002537
   Silva JR, 2014, REV SOC BRAS MED TRO, V47, P414, DOI 10.1590/0037-8682-0117-2014
   Spinsanti L, 2007, T ROY SOC TROP MED H, V101, P1248, DOI 10.1016/j.trstmh.2007.08.011
   SPINSANTI Lorena Ivana, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P59, DOI 10.1590/S0036-46652002000200001
   TAVARES-NETO J, 1986, Memorias do Instituto Oswaldo Cruz, V81, P351, DOI 10.1590/S0074-02761986000400001
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007
NR 32
TC 2
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1029
DI 10.3390/v11111029
PG 10
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300057
PM 31694207
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Antunes, JMAD
   Borges, IA
   Trindade, GD
   Kroon, EG
   Cruvinel, TMD
   Peres, MG
   Megid, J
AF Azevedo de Paula Antunes, Joao Marcelo
   Borges, Iara Apolinario
   Trindade, Giliane de Souza
   Kroon, Erna Geessien
   de Andrade Cruvinel, Tatiana Morosini
   Peres, Marina Gea
   Megid, Jane
TI Exposure of free-ranging capybaras (Hydrochoerus hydrochaeris) to the
   vaccinia virus
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article
DE Orthopoxvirus; rodents; wildlife
ID SAO-PAULO STATE; MOLECULAR EVIDENCE; TRANSMISSION; HUMANS; DOGS;
   ORTHOPOXVIRUS; ANTIBODIES; INFECTION; SMALLPOX; OUTBREAK
AB The aim of this study was to evaluate the possibility of free-ranging animals/hunting dogs as sources of infection in the vaccinia virus (VACV) transmission chain. Serological, cell culture and molecular assays were conducted in 56 free-ranging animals and 22 hunting dogs. ELISA/neutralizing assays showed that two (2.5%) capybaras (Hydrochoerus hydrochaeris) had anti-OPV positive antibodies, while all samples tested negative through PCR/cell culture. After being hit by cars on roads, capybaras that exhibited neither clinical signs nor any association with bovine outbreaks had neutralizing antibodies against the Orthopoxvirus, as detected through plaque-reduction neutralizing tests and ELISA. Evidence exists regarding peridomestic capybaras acting as a source of the virus and serving as a link between wild and urban environments, thus contributing to viral maintenance.
C1 [Azevedo de Paula Antunes, Joao Marcelo] Univ Fed Rural Semirido FERSA, Hosp Vet Jeronimo Dix Huit Rosado Maia, Mossoro, RN, Brazil.
   [Borges, Iara Apolinario; Trindade, Giliane de Souza; Kroon, Erna Geessien] Univ Fed Minas Gerais, ICB, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [de Andrade Cruvinel, Tatiana Morosini] UNIRP Ctr Univ Rio Preto, Sao Jose Do Rio Preto, Brazil.
   [Peres, Marina Gea; Megid, Jane] UNESP Univ Estadual Julio de Mesquita Filho, Botucatu, SP, Brazil.
RP Megid, J (corresponding author), Fac Med Vet & Zootecnia, Dept Higiene Vet & Saude Publ, Rua Prof Dr Valter Mauricio Correa S-N, Botucatu, SP, Brazil.
EM jane.megid@unesp.br
RI Antunes, Joao/D-2467-2012; Kroon, Erna/B-3631-2015
OI Antunes, Joao/0000-0003-3922-1428; Kroon, Erna/0000-0003-2721-3826;
   Megid, Jane/0000-0002-6540-7157
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2015, EMERG INFECT DIS, V21, P695, DOI 10.3201/eid2104.140351
   Andreani J, 2019, EMERG INFECT DIS, V25, P212, DOI 10.3201/eid2502.171433
   Barbosa AV, 2014, J INFECT DEV COUNTR, V8, P1646, DOI 10.3855/jidc.5216
   Costa GB, 2018, EMERG INFECT DIS, V24, P2338, DOI 10.3201/eid2412.171584
   de Oliveira JS, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110340
   Fiorello CV, 2017, ACTA TROP, V167, P183, DOI 10.1016/j.actatropica.2016.12.020
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   Guberti V, 2014, HYSTRIX, V25, P3, DOI 10.4404/hystrix-25.1-10114
   ICTV, 2018, REP VIR TAX
   Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817
   Dutra LAL, 2017, ARCH VIROL, V162, P439, DOI 10.1007/s00705-016-3121-3
   Lima MT, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03327
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   Medeiros-Silva Daniela Carla, 2013, Results Immunol, V3, P104, DOI 10.1016/j.rinim.2013.10.002
   Megid J, 2012, EMERG INFECT DIS, V18, P189, DOI 10.3201/eid1801.110692
   Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003
   Miranda JB, 2017, EMERG INFECT DIS, V23, P931, DOI 10.3201/eid2306.161643
   Ninove L, 2009, EMERG INFECT DIS, V15, P781, DOI 10.3201/eid1505.090235
   Oliveira G, 2015, VIRUSES-BASEL, V7, P1218, DOI 10.3390/v7031218
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   PERES MG, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10020051
   PERES MG, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10010042
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   Soetan BK, 2014, IRISH J MED SCI, V183, P629, DOI 10.1007/s11845-013-1064-1
   Valadas S, 2010, J PARASITOL, V96, P521, DOI 10.1645/GE-2368.1
   Yai LEO, 2008, J PARASITOL, V94, P1060, DOI 10.1645/GE-1548.1
NR 32
TC 0
Z9 0
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
PD MAR
PY 2020
VL 67
IS 2
BP 481
EP 485
DI 10.1111/tbed.13376
EA OCT 2019
PG 5
WC Infectious Diseases; Veterinary Sciences
SC Infectious Diseases; Veterinary Sciences
GA KS3SN
UT WOS:000490751200001
PM 31574216
DA 2020-11-30
ER

PT J
AU Marinho, PES
   Alvarenga, PPM
   Crispim, APC
   Candiani, TMS
   Alvarenga, AM
   Bechler, IM
   Alves, PA
   Dornas, FP
   de Oliveira, DB
   Bentes, AA
   Christo, PP
   Kroon, EG
AF Marinho, Paula E. S.
   Alvarenga, Pedro P. M.
   Crispim, Ana P. C.
   Candiani, Talitah M. S.
   Alvarenga, Alice M.
   Bechler, Isabela M.
   Alves, Pedro A.
   Dornas, Fabio P.
   de Oliveira, Danilo B.
   Bentes, Aline A.
   Christo, Paulo P.
   Kroon, Erna G.
TI Wild-Type Yellow Fever Virus RNA in Cerebrospinal Fluid of Child
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB We report a 3-year-old child who was hospitalized because of severe manifestations of the central nervous system. The child died after 6 days of hospitalization. Analysis of postmortem cerebrospinal fluid showed the presence of yellow fever virus RNA. Nucleotide sequencing confirmed that the virus was wild-type yellow fever virus.
C1 [Marinho, Paula E. S.; Crispim, Ana P. C.; Bentes, Aline A.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627 Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
   [Alvarenga, Pedro P. M.; Candiani, Talitah M. S.; Alvarenga, Alice M.; Bechler, Isabela M.; Bentes, Aline A.] Hosp Infantil Joao Paulo II, Belo Horizonte, MG, Brazil.
   [Alves, Pedro A.] Inst Rene Rachou, Belo Horizonte, MG, Brazil.
   [Dornas, Fabio P.; de Oliveira, Danilo B.] Univ Fed Vales Jequitinhonha & Mucuri, Diamantina, Brazil.
   [Christo, Paulo P.] Inst Ensino & Pesquisa Santa Casa Belo Horizonte, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627 Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM ernagkroon@gmail.com
RI Dornas, Fabio/AAI-3582-2020; Alves, Pedro/T-7203-2019; Christo, Paulo
   Pereira/AAK-9780-2020
OI Dornas, Fabio/0000-0001-7926-5551; Alves, Pedro/0000-0002-9659-5621;
   Christo, Paulo Pereira/0000-0003-1224-5243
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq);
   Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES [001];
   Fundacao de Amparo a Pesquisa do Estado de Minas GeraisMinas Gerais
   State Research Foundation (FAPEMIG)
FX The study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, the Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil, the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (finance code 001), and Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais. E.G.K. is a fellow of Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais.
CR Alhakimi HA, 2015, AIMS PUBLIC HEALTH, V2, P132, DOI 10.3934/publichealth.2015.1.132
   [Anonymous], 1966, JAMA, V198, P671
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021
   de Oliveira DB, 2017, J NEUROL SCI, V375, P390, DOI 10.1016/j.jns.2017.02.025
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Ekenna O, 2010, West Afr J Med, V29, P91
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Gerin M, 2014, ARCH PEDIATRIE, V21, P384, DOI 10.1016/j.arcped.2014.01.014
   Horwood PF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.15
   JONES EMM, 1972, B WORLD HEALTH ORGAN, V46, P653
   Kwagonza L, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3440-y
   MIMS CA, 1957, BRIT J EXP PATHOL, V38, P329
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   Secretariat of Health Surveillance Ministry of Health, 2017, 26 SECR HLTH SURV MI
NR 15
TC 3
Z9 3
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2019
VL 25
IS 8
BP 1567
EP 1570
DI 10.3201/eid2508/181479
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA IJ5MF
UT WOS:000475946500020
PM 31310221
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Borges, I
   Rodrigues, RAL
   Dornas, FP
   Almeida, G
   Aquino, I
   Bonjardim, CA
   Kroon, EG
   La Scola, B
   Abrahao, JS
AF Borges, Iara
   Lima Rodrigues, Rodrigo Araujo
   Dornas, Fabio Pio
   Almeida, Gabriel
   Aquino, Isabella
   Bonjardim, Claudio Antonio
   Kroon, Erna Geessien
   La Scola, Bernard
   Abrahao, Jonatas Santos
TI Trapping the Enemy: Vermamoeba vermiformis Circumvents Faustovirus
   Mariensis Dissemination by Enclosing Viral Progeny inside Cysts
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE antiviral; cysts; faustovirus; vermoameba; virus control
ID AMOEBAL ENCYSTMENT; ACANTHAMOEBA; INTERFERONS; VIRUSES
AB Viruses depend on cells to replicate and can cause considerable damage to their hosts. However, hosts have developed a plethora of antiviral mechanisms to counterattack or prevent viral replication and to maintain homeostasis. Advantageous features are constantly being selected, affecting host-virus interactions and constituting a harsh race for supremacy in nature. Here, we describe a new antiviral mechanism unveiled by the interaction between a giant virus and its amoebal host. Faustovirus mariensis infects Vermamoeba vermiformis, a free-living amoeba, and induces cell lysis to disseminate into the environment. Once infected, the cells release a soluble factor that triggers the encystment of neighbor cells, preventing their infection. Remarkably, infected cells stimulated by the factor encyst and trap the viruses and viral factories inside cyst walls, which are no longer viable and cannot excyst. This unprecedented mechanism illustrates that a plethora of antiviral strategies remains to be discovered in nature.
   IMPORTANCE Understanding how viruses of microbes interact with its hosts is not only important from a basic scientific point of view but also for a better comprehension of the evolution of life. Studies involving large and giant viruses have revealed original and outstanding mechanisms concerning virus-host relationships. Here, we report a mechanism developed by Vermamoeba vermiformis, a free-living amoeba, to reduce Faustovirus mariensis dissemination. Once infected, V. vermiformis cells release a factor that induces the encystment of neighbor cells, preventing infection of further cells and/or trapping the viruses and viral factories inside the cyst walls. This phenomenon reinforces the need for more studies regarding large/giant viruses and their hosts.
C1 [Borges, Iara; Lima Rodrigues, Rodrigo Araujo; Aquino, Isabella; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Dornas, Fabio Pio] Univ Fed Vales Jequitinhonha e Mucuri, Diamantina, Brazil.
   [Almeida, Gabriel] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.
   [La Scola, Bernard] Aix Marseille Univ, IHU Mediterranee Infect, URMITE, UM63,CNRS 7278,IRD 198,INSERM 1095, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Dornas, Fabio/AAI-3582-2020; Almeida, Gabriel MF/I-8910-2012
OI Dornas, Fabio/0000-0001-7926-5551; Almeida, Gabriel
   MF/0000-0003-2317-5092; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Saude (MS-DECIT)
FX In addition, we acknowledge the financial support from Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do estado de Minas Gerais (FAPEMIG), and the Ministerio da
   Saude (MS-DECIT).
CR Arantes TS, 2016, J VIROL, V90, P5246, DOI 10.1128/JVI.00177-16
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Bautista MA, 2015, MBIO, V6, DOI 10.1128/mBio.02565-14
   Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002
   Boratto P, 2015, J VIROL, V89, P2962, DOI 10.1128/JVI.03177-14
   Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422
   Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240
   Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704
   Doron S, 2018, SCIENCE, V359, DOI 10.1126/science.aar4120
   Andrade ACDP, 2017, J VIROL, V91, DOI 10.1128/JVI.01335-17
   Silva LKD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22398-3
   Silva LKD, 2016, CURR OPIN MICROBIOL, V31, P9, DOI 10.1016/j.mib.2016.01.003
   Erez Z, 2017, NATURE, V541, P488, DOI 10.1038/nature21049
   Fischer MG, 2016, NATURE, V540, P288, DOI 10.1038/nature20593
   Fouque E, 2015, J EUKARYOT MICROBIOL, V62, P327, DOI 10.1111/jeu.12185
   Fouque E, 2012, EUKARYOT CELL, V11, P382, DOI 10.1128/EC.05301-11
   Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105
   Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lambrecht E, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00754-17, 10.1128/aem.00754-17]
   Lambrecht E, 2015, APPL ENVIRON MICROB, V81, P5604, DOI 10.1128/AEM.01031-15
   Rodrigues RAL, 2018, J VIROL, V92, DOI 10.1128/JVI.00372-18
   Mushegian A, 2001, J CELL BIOL, V155, P705, DOI 10.1083/jcb.200107040
   Neff RJ, 1964, METHOD CELL PHYSIOL, V1, P56
   Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Schuster FL, 2002, CLIN MICROBIOL REV, V15, P342, DOI 10.1128/CMR.15.3.342-354.2002
   Secombes CJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00209
   Seed KD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004847
   Tan DM, 2015, MBIO, V6, DOI 10.1128/mBio.00627-15
   Yoshikawa G, 2019, J VIROL, V93, DOI 10.1128/JVI.02130-18
   Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223
NR 34
TC 3
Z9 3
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2019
VL 93
IS 14
AR e00312-19
DI 10.1128/JVI.00312-19
PG 19
WC Virology
SC Virology
GA IF7OM
UT WOS:000473273500006
PM 31019058
OA Green Published, Bronze, Green Accepted
DA 2020-11-30
ER

PT J
AU Bentes, AA
   Kroon, EG
   Romanelli, RMD
AF Bentes, Aline Almeida
   Kroon, Erna Geessien
   de Castro Romanelli, Roberta Maia
TI Neurological manifestations of pediatric arboviral infections in the
   Americas
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Review
DE Neurological manifestations; Dengue virus; Zika virus; Chikungunya
   virus; Yellow fever virus
ID DENGUE VIRUS; CLINICAL-FEATURES; ENCEPHALITIS SYNDROME; CHIKUNGUNYA
   VIRUS; CHILDREN; FEVER; ENCEPHALOPATHY; COMPLICATIONS; MENINGITIS;
   EPIDEMIC
AB Dengue, Zika, Chikungunya and yellow fever viruses are arboviruses transmitted by the mosquito Aedes aegypti. These viruses exhibit marked neurotropism but have rarely been studied. Here, we conduct an integrative review of the neurological manifestations caused by these arboviruses in the pediatric population. Data on patients under 18 years of age were extracted from literature databases. The most frequently reported neurological manifestations were encephalitis, meningitis, seizures, hypotonia, paresis, and behavioral changes. This review highlights the importance of accurately diagnosing these arboviral infections in children and adolescents with neurological manifestations.
C1 [Bentes, Aline Almeida; de Castro Romanelli, Roberta Maia] Univ Fed Minas Gerais, Dept Pediat, Belo Horizonte, MG, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Ave Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Bentes, Aline Almeida] FHEMIG, Hosp Infantil Joao Paulo II, Belo Horizonte, MG, Brazil.
   [Bentes, Aline Almeida; de Castro Romanelli, Roberta Maia] Univ Fed Minas Gerais, Dept Pediat, Fac Med, Ave Prof Alfredo Balena,190 Santa Efigenia, BR-30130100 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Ave Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM alinebentes2000@gmail.com; kroone@icb.ufmg.br; rmcromanelli@gmail.com
RI Romanelli, Roberta M/H-4124-2018; Kroon, Erna/V-5444-2019; Kroon,
   Erna/B-3631-2015
OI Romanelli, Roberta M/0000-0002-1660-0751; Kroon,
   Erna/0000-0003-2721-3826
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Ai JH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2572-9
   Alhakimi HA, 2015, AIMS PUBLIC HEALTH, V2, P132, DOI 10.3934/publichealth.2015.1.132
   Ali S, 2017, PROC EUR CONF ENTREP, P12
   Araujo F., 2012, EMERGING INFECT DIS, V18
   Baldacara L., 2013, J NEUROPSYCHIATRY CL, V25, P1
   Bermudez JE, 2011, KASMERA, V39, P49
   Bhatt GC, 2012, TROP DOCT, V42, P106, DOI 10.1258/td.2011.110391
   Bhoopat L, 1996, ASIAN PAC J ALLERGY, V14, P107
   Biswas NM, 2014, INDIAN J MED RES, V140, P793
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Britt C, 2018, CRIT POLIT THEOR, P1, DOI 10.1007/978-3-319-70784-6
   Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848
   Feitoza HAC, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311x00178915, 10.1590/0102-311X00178915]
   Chen QL, 2016, ENVIRON INT, V92-93, P1, DOI 10.1016/j.envint.2016.03.026
   Chokephaibulkit K, 2001, PEDIATR INFECT DIS J, V20, P216, DOI 10.1097/00006454-200102000-00020
   Chowdhury R. N., 2011, Journal of Medicine, V12, P185
   de Oliveira DB, 2017, J NEUROL SCI, V375, P390, DOI 10.1016/j.jns.2017.02.025
   Sa PKD, 2017, REV SOC BRAS MED TRO, V50, P265, DOI 10.1590/0037-8682-0375-2016
   de Souza Luiz Jose, 2016, DENG ZIK CHIK DIAGN
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   Eldi P, 2017, MOL THER, V25, P2332, DOI 10.1016/j.ymthe.2017.06.017
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Ernould S, 2008, ARCH PEDIATRIE, V15, P253, DOI 10.1016/j.arcped.2007.10.019
   Fong C. Y., 2016, J CLIN NEUROSCI, P1
   Fong CY, 2014, PEDIATR INFECT DIS J, V33, P1092, DOI 10.1097/INF.0000000000000382
   Ganesan K, 2008, AM J NEURORADIOL, V29, P1636, DOI 10.3174/ajnr.A1133
   Garg RK, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0855-9
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, P7
   Gerardin P., 2016, NEUROLOGY, V86
   Goncalves E, 2011, REV INST MED TROP SP, V53, P223, DOI 10.1590/S0036-46652011000400009
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Goswami RP, 2012, J INFECT DEV COUNTR, V6, P208, DOI 10.3855/jidc.2241
   Gupta D., 2015, INDIAN J PEDIAT
   Horwood PF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.15
   Jain P, 2014, JPN J INFECT DIS, V67, P197, DOI 10.7883/yoken.67.197
   JONES EMM, 1972, B WORLD HEALTH ORGAN, V46, P653
   Kalita J, 2005, Electromyogr Clin Neurophysiol, V45, P357
   Kalita J, 2006, CLIN NEUROPHYSIOL, V117, P2252, DOI 10.1016/j.clinph.2006.07.132
   Kamath Shrishu R., 2006, Indian Journal of Pediatrics, V73, P889, DOI 10.1007/BF02859281
   Kankirawatana P., 2000, JOUNAL CHILD NEUROLO, V15
   Kumar R, 2008, J NEUROL SCI, V269, P41, DOI 10.1016/j.jns.2007.12.018
   Landais A., 2017, J NEUROL SCI
   Le Bomin A, 2008, Med Trop (Mars), V68, P491
   Lee YS, 2010, PEDIATR INFECT DIS J, V29, P275, DOI 10.1097/INF.0b013e3181bce34d
   Lewthwait P., 2009, EMERGING INFECT DIS, V15
   Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   Nunez RM, 2017, REV CHIL PEDIATR-CHI, V88, P765, DOI 10.4067/S0370-41062017000600765
   Maurya Pradeep K, 2016, J Clin Neuromuscul Dis, V18, P72
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Misra UK, 2006, J NEUROL SCI, V244, P117, DOI 10.1016/j.jns.2006.01.011
   Murthy JMK, 2010, NEUROL INDIA, V58, P581, DOI 10.4103/0028-3886.68654
   Muzaffar J., 2006, SMJ Singapore Medical Journal, V47, P975
   NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P398
   Diniz LMO, 2019, PEDIATR INFECT DIS J, V38, P300, DOI [10.1097/INF.0000000000002051, 10.1097/inf.0000000000002051]
   Palma-da Cunha-Matta A, 2004, REV NEUROLOGIA, V39, P233
   Pan American Health Organization, 2018, NUMB REP CAS CHIK FE
   Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341
   Patterson J., 2016, W J EMERG MED, VXVII
   Paules C. I., 2017, N ENGL J MED
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Raboni SM, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12700
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Saini L, 2017, NEUROL INDIA, V65, P636, DOI [10.4103/neuroindia.NI_1367_15, 10.4103/neuroindia.ni_1367_15]
   Salazar M. I., 2013, TRANSFUS APHER SCI
   Samra JA, 2017, J CHILD NEUROL, V32, P712, DOI 10.1177/0883073817701879
   Sanguansermsri T, 1976, ACUTE ENCEPHALOPATHY, P10
   Shaikh T, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.28_suppl.57
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Sharma S., 2015, INFECT DIS OBSTET GY, V16
   Shishu R., 2006, INDIAN J PEDIAT, V73
   Sil A., 2016, TROP DOCT, P1
   Marinho PES, 2017, EMERG INFECT DIS, V23, P115, DOI 10.3201/eid2301.160817
   Singh A., 2017, INDIAN PEDIAT, V54
   Sinhabahu Vindika Prasad, 2014, BMC Res Notes, V7, P795, DOI 10.1186/1756-0500-7-795
   Sistayanarain Anchalee, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P221
   Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068
   Solbrig MV, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0550-4
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Srey VH, 2002, AM J TROP MED HYG, V66, P200, DOI 10.4269/ajtmh.2002.66.200
   Staples J. E., 2015, MMWR-MORBID MORTAL W, V64, P19
   Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672
   Thisyakorn Usa, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P504
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Villar L., 2015, NEW ENGL J MED, V372, P2
   Wichmann O, 2017, VACCINE, V35, P5535, DOI 10.1016/j.vaccine.2017.08.066
   Witayathawornwong P., 2005, SE ASIAN J TROP MED, V36
   Zucker J., 2017, EMERGING INFECT DIS, V23
NR 91
TC 4
Z9 4
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JUL
PY 2019
VL 116
BP 49
EP 57
DI 10.1016/j.jcv.2019.04.006
PG 9
WC Virology
SC Virology
GA IB4LQ
UT WOS:000470243900011
PM 31103802
DA 2020-11-30
ER

PT J
AU Araujo, SD
   Cordeiro, TME
   Belisario, AR
   Araujo, RFD
   Marinho, PES
   Kroon, EG
   de Oliveira, DB
   Teixeira, MM
   Silva, ACSE
AF Araujo, Stanley de Almeida
   Macedo e Cordeiro, Thiago
   Belisario, Andre Rolim
   de Almeida Araujo, Roberto Ferreira
   Silva Marinho, Paula Eillanny
   Kroon, Erna Geessien
   de Oliveira, Danilo Bretas
   Teixeira, Mauro Martins
   Simoes e Silva, Ana Cristina
TI First report of collapsing variant of focal segmental glomerulosclerosis
   triggered by arbovirus: dengue and Zika virus infection
SO CLINICAL KIDNEY JOURNAL
LA English
DT Article
DE arbovirus; chronic kidney disease; dengue infection; focal segmental
   glomerulosclerosis; renal histopahology
ID HEPATITIS-C; NEPHROPATHY; ENTRY; CELLS; FSGS
AB Background. The collapsing variant of focal segmental glomerulosclerosis (FSGS) is the most aggressive form of FSGS and is characterized by at least one glomerulus with segmental or global collapse and overlying podocyte hypertrophy and hyperplasia. Viruses can act as aetiological agents of secondary FSGS. This study aims to establish an aetiological link between dengue virus (DENV) infection and the collapsing variant of FSGS and to analyse possible influences of the apolipoprotein 1 (APOL1) gene risk alleles on the disease.
   Methods. Biopsies and medical records were gathered from 700 patients of the Instituto de Nefropatologia, Belo Horizonte, Brazil. Screening for the collapsing variant of FSGS was performed and serological, immunohistochemical, tissue polymerase chain reaction (PCR) and genetic analysis were conducted.
   Results. Eight patients were identified with positive DENV serology and negative serological and/or tissue markers for hepatitis B virus, hepatitis C virus, Epstein-Barr virus, human immunodeficiency virus, cytomegalovirus and parvovirus B19. In PCR analysis, six patients had positive markers for DENV strain genetic material, one patient had positive markers for co-infection of Zika virus (ZIKV) and DENV and one patient had positive markers only for ZIKV infection. Six of the eight patients did not show risk alleles of the APOL1 gene. One patient had only one risk allele (G1) and the sample from another did not contain enough DNA for genetic analysis to be performed.
   Conclusions. This study provided strong evidence that DENV can infect renal tissue and possibly functions as a second hit to the development of the collapsing variant of FSGS. Nonetheless, this study also highlights the possible implication of ZIKV infection in FSGS and supports the argument that risk alleles of the APOL1 gene may not be implicated in the susceptibility to FSGS in these patients.
C1 [Araujo, Stanley de Almeida; de Almeida Araujo, Roberto Ferreira] Inst Nefro Patol, Belo Horizonte, MG, Brazil.
   [Araujo, Stanley de Almeida; Macedo e Cordeiro, Thiago; Belisario, Andre Rolim; de Almeida Araujo, Roberto Ferreira; Teixeira, Mauro Martins; Simoes e Silva, Ana Cristina] Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, Belo Horizonte, MG, Brazil.
   [Silva Marinho, Paula Eillanny; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med Diamantina, Diamantina, Brazil.
   [Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Biol Sci, Lab Immunopharmacol, Natl Inst Sci & Technol Dengue, Belo Horizonte, MG, Brazil.
RP Silva, ACSE (corresponding author), Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, Belo Horizonte, MG, Brazil.
EM acssilva@hotmail.com
RI Araujo, Stanley A/H-5895-2017; Simoes e Silva, Ana Cristina/A-4409-2013
OI Simoes e Silva, Ana Cristina/0000-0001-9222-3882
FU Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado de Minas GeraisMinas Gerais State Research Foundation (FAPEMIG);
   National Institute of Science and Technology in Dengue
FX This study was partially supported by grants from the Brazilian National
   Research Council, Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais and the National Institute of Science and Technology in Dengue.
   M.M.T. and A.C.S.e.S. are recipients of productivity research
   fellowships from the Brazilian National Research Council. The results
   presented in this article have not been published previously in whole or
   part, except in abstract form.
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Angioi A, 2016, J NEPHROL, V29, P517, DOI 10.1007/s40620-016-0333-2
   Bariety J, 1998, KIDNEY INT, V53, P918, DOI 10.1046/j.1523-1755.1998.00845.x
   Barsoum RS, 2007, NEPHROL DIAL TRANSPL, V22, P1840, DOI 10.1093/ndt/gfm205
   Besse W, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0330-7
   BOONPUCKNAVIG V, 1976, ARCH PATHOL LAB MED, V100, P206
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   CARBONE L, 1989, AM J MED, V87, P389, DOI 10.1016/S0002-9343(89)80819-8
   Chandra P, 2013, CLIN KIDNEY J, V6, P1, DOI 10.1093/ckj/sft002
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Cheung KT, 2018, IMMUNOBIOLOGY, V223, P356, DOI 10.1016/j.imbio.2017.10.044
   Colares VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087716
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024
   Dettmar AK, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7351964
   Duchateau PN, 2001, J LIPID RES, V42, P620
   Fine DM, 2012, J AM SOC NEPHROL, V23, P343, DOI 10.1681/ASN.2011060562
   Fowell AJ, 2008, LIVER INT, V28, P889, DOI 10.1111/j.1478-3231.2008.01672.x
   FUTRAKUL P, 1973, Journal of the Medical Association of Thailand, V56, P33
   Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032
   Joshi A, 2012, CLIN KIDNEY J, V5, P320, DOI 10.1093/ckj/sfs059
   Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112
   Khaira A, 2009, CLIN EXP NEPHROL, V13, P373, DOI 10.1007/s10157-008-0124-8
   Kopp JB, 2015, J AM SOC NEPHROL, V26, P1443, DOI 10.1681/ASN.2013111242
   Kruzel-Davila E, 2017, SEMIN NEPHROL, V37, P490, DOI 10.1016/j.semnephrol.2017.07.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Limou S, 2015, KIDNEY INT, V88, P28, DOI 10.1038/ki.2015.109
   Lum Lcs, 2014, Malays Fam Physician, V9, P2
   Mikulak J, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0296-3
   Mikulak J, 2010, NEPHRON EXP NEPHROL, V115, pE15, DOI 10.1159/000312882
   Perdomo-Celis F, 2017, ACTA TROP, V167, P1, DOI 10.1016/j.actatropica.2016.12.011
   Prevencaoe combate Dengue Chikungunya e Zika, 2016, B EPIDEMIOLOGICO, V47, P38
   Sperati CJ, 2013, CLIN NEPHROL, V80, P231, DOI 10.5414/CN107337
   Thomas DB, 2006, KIDNEY INT, V69, P920, DOI 10.1038/sj.ki.5000160
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wyatt CM, 2012, ANNU REV MED, V63, P147, DOI 10.1146/annurev-med-041610-134224
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 37
TC 2
Z9 2
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2048-8505
EI 2048-8513
J9 CLIN KIDNEY J
JI Clin. Kidney J.
PD JUN
PY 2019
VL 12
IS 3
BP 355
EP 361
DI 10.1093/ckj/sfy104
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA JI4PP
UT WOS:000493450200007
PM 31198534
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Silva, LCF
   Araujo, R
   Rodrigues, L
   Oliveira, GP
   Dornas, FP
   La Scola, B
   Kroon, EG
   Abrahao, JS
AF Silva, Lorena C. F.
   Araujo, Rodrigo
   Rodrigues, Lima
   Oliveira, Graziele Pereira
   Dornas, Fabio Pio
   La Scola, Bernard
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI Microscopic Analysis of the Tupanvirus Cycle in Vermamoeba vermiformis
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Tupanvirus; viral characterization; viral cycle; giant viruses;
   Vermamoeba vermiformis
ID DNA VIRUSES; GIANT; MIMIVIRUS
AB Since Acanthamoeba polyphaga mimivirus (APMV) was identified in 2003, several other giant viruses of amoebae have been isolated, highlighting the uniqueness of this group. In this context, the tupanviruses were recently isolated from extreme environments in Brazil, presenting virions with an outstanding tailed structure and genomes containing the most complete set of translation genes of the virosphere. Unlike other giant viruses of amoebae, tupanviruses present a broad host range, being able to replicate not only in Acanthamoeba sp. but also in other amoebae, such as Vermamoeba vermiformis, a widespread, free-living organism. Although the Tupanvirus cycle in A. castellanii has been analyzed, there are no studies concerning the replication of tupanviruses in other host cells. Here, we present an in-depth microscopic study of the replication cycle of Tupanvirus in V. vermiformis. Our results reveal that Tupanvirus can enter V. vermiformis and generate new particles with similar morphology to when infecting A. castellanii cells. Tupanvirus establishes a well-delimited electron-dense viral factory in V. vermiformis, surrounded by lamellar structures, which appears different when compared with different A. castellanii cells. Moreover, viral morphogenesis occurs entirely in the host cytoplasm within the viral factory, from where complete particles, including the capsid and tail, are sprouted. Some of these particles have larger tails, which we named "supertupans." Finally, we observed the formation of defective particles, presenting abnormalities of the tail and/or capsid. Taken together, the data presented here contribute to a better understanding of the biology of tupanviruses in previously unexplored host cells.
C1 [Silva, Lorena C. F.; Araujo, Rodrigo; Rodrigues, Lima; Oliveira, Graziele Pereira; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Dornas, Fabio Pio] Univ Fed Vale Jequitinhonha & Mucuri, Dept Farm, Fac Ciencias Basicas & Saude, Diamantina, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, Fac Med, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Dornas, Fabio/AAI-3582-2020
OI Dornas, Fabio/0000-0001-7926-5551; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012; Oliveira, Graziele/0000-0002-8521-0351
FU CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); MS;
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX We would like to thank colleagues from Gepvig, Laboratorio de Virus,
   IHU-Aix Marseille University and Microscopy Center of UFMG for their
   excellent support. We also would like to thank CAPES, FAPEMIG, MS, and
   CNPq for financial support (Decit/SCTIE/MoH). EK, BLS, JA, RR, and LS
   are members of a CAPES-COFECUB project. JA and EK are CNPq researchers.
CR Abrahao JS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-120
   Abrahao J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03168-1
   Arantes TS, 2016, J VIROL, V90, P5246, DOI 10.1128/JVI.00177-16
   Colson P, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.197
   Andrade ACDP, 2019, J VIROL, V93, DOI 10.1128/JVI.01942-18
   Andrade ACDP, 2017, J VIROL, V91, DOI 10.1128/JVI.01335-17
   Silva LKD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22398-3
   GROSSEGESSE M, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9100296
   Kuznetsov YG, 2013, J VIROL, V87, P11200, DOI 10.1128/JVI.01372-13
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Rodrigues RAL, 2019, ARCH VIROL, V164, P325, DOI 10.1007/s00705-018-4067-4
   Rodrigues RAL, 2015, J VIROL, V89, P11812, DOI 10.1128/JVI.01976-15
   Maruri-Avidal L, 2011, J VIROL, V85, P2504, DOI 10.1128/JVI.02505-10
   Moss B, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010199
   Mutsafi Y, 2014, VIROLOGY, V466, P3, DOI 10.1016/j.virol.2014.05.037
   Mutsafi Y, 2010, P NATL ACAD SCI USA, V107, P5978, DOI 10.1073/pnas.0912737107
   Oliveira G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36552-4
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Suzan-Monti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000328
   VISVESVARA GS, 1975, J PROTOZOOL, V22, P245, DOI 10.1111/j.1550-7408.1975.tb05860.x
   Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114
NR 25
TC 7
Z9 7
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 3
PY 2019
VL 10
AR 671
DI 10.3389/fmicb.2019.00671
PG 9
WC Microbiology
SC Microbiology
GA HR8GB
UT WOS:000463393600001
PM 31001237
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Figueiredo, PD
   de Oliveira, DB
   Figueiredo, LB
   Costa, GB
   Alves, PA
   Guedes, MIMC
   Barbosa-Stancioli, EF
   Drumond, BP
   Abrahao, JS
   Kroon, EG
   Trindade, GD
AF Figueiredo, Poliana de Oliveira
   de Oliveira, Danilo Bretas
   Figueiredo, Leandra Barcelos
   Costa, Galileu Barbosa
   Alves, Pedro Augusto
   Maldonado Coelho Guedes, Maria Isabel
   Barbosa-Stancioli, Edel Figueiredo
   Drumond, Betania Paiva
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
TI Molecular detection and phylogeny of bovine viral diarrhea virus 1 among
   cattle herds from Northeast, Southeast, and Midwest regions, Brazil
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE BVDV; 5' UTR; Brazilian cattle; Economic burden; Veterinary pathogen
ID GENETIC DIVERSITY; BEEF-CATTLE; HOBI-LIKE; BVDV; INFECTION; PESTIVIRUS;
   PATHOGENESIS; PREVALENCE; FREQUENCY
AB We examined the circulating BVDV species and genotypes among cattle herds from Northeast, Southeast, and Midwest regions in Brazil. A total of 77 animals tested positive through standard PCR. Phylogenetic analyses revealed the presence of BVDV-1a, highlighting the need for better surveillance strategies to prevent BVDV spread in the country.
C1 [Figueiredo, Poliana de Oliveira; de Oliveira, Danilo Bretas; Figueiredo, Leandra Barcelos; Costa, Galileu Barbosa; Alves, Pedro Augusto; Drumond, Betania Paiva; Abrahao, Jonatas Santos; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Diamantina, MG, Brazil.
   [Alves, Pedro Augusto] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Imunol Doencas Virais, Belo Horizonte, MG, Brazil.
   [Maldonado Coelho Guedes, Maria Isabel] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Lab Pesquisa Virol Anim, Belo Horizonte, MG, Brazil.
   [Barbosa-Stancioli, Edel Figueiredo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virol Basica & Aplicada, Belo Horizonte, MG, Brazil.
RP Figueiredo, PD; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
EM polianaofigueiredo@yahoo.com.br; gitrindade@yahoo.com.br
RI Barbosa-Stancioli, Edel F/J-7230-2012; Alves, Pedro/T-7203-2019; Kroon,
   Erna/V-5444-2019
OI Barbosa-Stancioli, Edel F/0000-0001-6584-4333; Alves,
   Pedro/0000-0002-9659-5621; Barbosa Costa, Galileu/0000-0001-7360-6722
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX This work has received financial support from Brazilian agencies CAPES,
   CNPq, and FAPEMIG.
CR Alves PA, 2016, COMP IMMUNOL MICROB, V49, P70, DOI 10.1016/j.cimid.2016.09.005
   Bachofen C, 2008, VET MICROBIOL, V131, P93, DOI 10.1016/j.vetmic.2008.02.023
   Bachofen C, 2013, J VIROL METHODS, V190, P1, DOI 10.1016/j.jviromet.2013.03.015
   Bianchi E, 2011, PESQUI VET BRASIL, V31, P649, DOI 10.1590/S0100-736X2011000800003
   Brodersen BW, 2014, VET PATHOL, V51, P453, DOI 10.1177/0300985813520250
   Chaves N.P., 2012, Arq. Inst. Biol., V79, P495
   Cortez A, 2006, PESQUI VET BRASIL, V26, P211, DOI 10.1590/S0100-736X2006000400005
   de Brito WMED, 2004, GOIAS REV PATOL TROP, V33, P45
   Matos ACD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030120
   Fernandes LG, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1412-5
   Flores E.F., 2003, BIOLOGICO SAO PAULO, V65, P3
   Fulton RW, 2003, VACCINE, V21, P2980, DOI 10.1016/S0264-410X(03)00118-X
   Giammarioli M, 2015, VIRUS GENES, V50, P147, DOI 10.1007/s11262-014-1132-2
   Guarino H, 2008, PREV VET MED, V85, P34, DOI 10.1016/j.prevetmed.2007.12.012
   Hassig M, 2015, SCHWEIZ ARCH TIERH, V157, P441, DOI 10.17236/sat00029
   Headley SA, 2018, J VET DIAGN INVEST, V30, P249, DOI 10.1177/1040638717739945
   Houe H, 1999, VET MICROBIOL, V64, P89, DOI 10.1016/S0378-1135(98)00262-4
   Jackova A, 2008, VET RES COMMUN, V32, P7, DOI 10.1007/s11259-007-9012-z
   Jones LR, 2001, VET MICROBIOL, V81, P367, DOI 10.1016/S0378-1135(01)00367-4
   Laguardia-Nascimento M, 2017, ARCH VIROL, V162, P2797, DOI 10.1007/s00705-017-3407-0
   Laguardia-Nascimento M, 2016, J VET DIAGN INVEST, V28, P377, DOI 10.1177/1040638716645836
   Lanyon SR, 2014, VET J, V199, P201, DOI 10.1016/j.tvjl.2013.07.024
   Luzzago C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/147145
   Maya L, 2016, ARCH VIROL, V161, P529, DOI 10.1007/s00705-015-2688-4
   Moennig V, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010029
   Nagai M, 2008, VIRUS GENES, V36, P135, DOI 10.1007/s11262-007-0190-0
   Otonel RAA, 2014, TROP ANIM HEALTH PRO, V46, P87, DOI 10.1007/s11250-013-0451-y
   Pinior B, 2017, PREV VET MED, V137, P77, DOI 10.1016/j.prevetmed.2016.12.014
   Ribeiro MB, 1987, B EPABA, V11
   Richter V, 2017, VET J, V220, P80, DOI 10.1016/j.tvjl.2017.01.005
   Richtzenhain L. J., 1999, Arquivos do Instituto Biologico (Sao Paulo), V66, P107
   Ridpath JF, 1998, MOL CELL PROBE, V12, P101, DOI 10.1006/mcpr.1998.0158
   Ridpath JF, 2010, VET CLIN N AM-FOOD A, V26, P105, DOI 10.1016/j.cvfa.2009.10.007
   SAMARA S. I., 2004, BRAZ J VET RES ANIM, V41, P396, DOI DOI 10.1590/S1413-
   Silveira S, 2018, TRANSBOUND EMERG DIS, V65, pe113, DOI 10.1111/tbed.12689
   Silveira S, 2017, TRANSBOUND EMERG DIS, V64, P613, DOI 10.1111/tbed.12427
   Stahl K, 2007, VET RES, V38, P517, DOI 10.1051/vetres:2007012
   Tago D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157450
   Talafha AQ, 2009, TROP ANIM HEALTH PRO, V41, P499, DOI 10.1007/s11250-008-9214-6
   VanderWaal K, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170808
   vanRijn PA, 1997, VIROLOGY, V237, P337, DOI 10.1006/viro.1997.8792
   Weber MN, 2014, VIRUS RES, V191, P117, DOI 10.1016/j.virusres.2014.07.035
   Yesilbag K, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060128
   2008, VET REC, V162, P211, DOI DOI 10.1136/VR.162.7.211
   2009, VIROLOGY, V385, P351, DOI DOI 10.1016/J.VIROL.2008.12.004
NR 45
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD APR
PY 2019
VL 50
IS 2
BP 571
EP 577
DI 10.1007/s42770-019-00064-8
PG 7
WC Microbiology
SC Microbiology
GA HW9TN
UT WOS:000467033700029
PM 30879262
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Andrade, ACDP
   Boratto, PVD
   Rodrigues, RAL
   Bastos, TM
   Azevedo, BL
   Dornas, FP
   Oliveira, DB
   Drumond, BP
   Kroon, EG
   Abrahao, JS
AF dos Santos Pereira Andrade, Ana Claudia
   de Miranda Boratto, Paulo Victor
   Lima Rodrigues, Rodrigo Araujo
   Bastos, Talita Machado
   Azevedo, Bruna Luiza
   Dornas, Fabio Pio
   Oliveira, Danilo Bretas
   Drumond, Betania Paiva
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
TI New Isolates of Pandoraviruses: Contribution to the Study of Replication
   Cycle Steps
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE pandoravirus; giant virus; replication cycle; viral morphogenesis; viral
   release; virus diversity
ID GIANT VIRUSES; DNA VIRUSES; ENDOCYTOBIONT; ACANTHAMOEBA; AMEBAS; ORIGIN
AB Giant viruses are complex members of the virosphere, exhibiting outstanding structural and genomic features. Among these viruses, the pandoraviruses are some of the most intriguing members, exhibiting giant particles and genomes presenting at up to 2.5 Mb, with many genes having no known function. In this work, we analyzed, by virological and microscopic methods, the replication cycle steps of three new pandoravirus isolates from samples collected in different regions of Brazil. Our data indicate that all analyzed pandoravirus isolates can deeply modify the Acanthamoeba cytoplasmic environment, recruiting mitochondria and membranes into and around the electron-lucent viral factories. We also observed that the viral factories start forming before the complete degradation of the cellular nucleus. Various patterns of pandoravirus particle morphogenesis were observed, and the assembly of the particles seemed to be started either by the apex or by the opposite side. On the basis of the counting of viral particles during the infection time course, we observed that pandoravirus particles could undergo exocytosis after their morphogenesis in a process that involved intense recruitment of membranes that wrapped the just-formed particles. The treatment of infected cells with brefeldin affected particle exocytosis in two of the three analyzed strains, indicating biological variability among isolates. Despite such particle exocytosis, the lysis of host cells also contributed to viral release. This work reinforces knowledge of and reveals important steps in the replication cycle of pandoraviruses.
   IMPORTANCE The emerging Pandoraviridae family is composed of some of the most complex viruses known to date. Only a few pandoravirus isolates have been described until now, and many aspects of their life cycle remain to be elucidated. A comprehensive description of the replication cycle is pivotal to a better understanding of the biology of the virus. For this report, we describe new pandoraviruses and used different methods to better characterize the steps of the replication cycle of this new group of viruses. Our results provide new information about the diversity and biology of these giant viruses.
C1 [dos Santos Pereira Andrade, Ana Claudia; de Miranda Boratto, Paulo Victor; Lima Rodrigues, Rodrigo Araujo; Bastos, Talita Machado; Azevedo, Bruna Luiza; Drumond, Betania Paiva; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Dornas, Fabio Pio; Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Diamantina, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Dornas, Fabio/AAI-3582-2020
OI Dornas, Fabio/0000-0001-7926-5551; de Azevedo, Bruna
   Luiza/0000-0003-2348-9649; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012
CR Abergel C, 2015, FEMS MICROBIOL REV, V39, P779, DOI 10.1093/femsre/fuv037
   Abrahao J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03168-1
   Aherfi S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01486
   Aherfi S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00349
   Andrade ACDP, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0930-x
   Andreani J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110300
   Antwerpen MH, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00136-15
   Atoni E, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010030
   Bajrai LH, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110278
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Brinkman NE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195350
   Dornas FP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01086
   Andrade ACDP, 2017, J VIROL, V91, DOI 10.1128/JVI.01335-17
   Silva LKD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22398-3
   Filee J, 2010, INTERVIROLOGY, V53, P354, DOI 10.1159/000312920
   Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59
   Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009
   Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001
   Kerepesi C, 2017, ARCH VIROL, V162, P1671, DOI 10.1007/s00705-017-3286-4
   KORN ED, 1967, J CELL BIOL, V34, P219, DOI 10.1083/jcb.34.1.219
   La Scola B, 2003, SCIENCE, V299, P2033
   Legendre M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04698-4
   Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Rodrigues RAL, 2018, J VIROL, V92, DOI 10.1128/JVI.00372-18
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Mutsafi Y, 2010, P NATL ACAD SCI USA, V107, P5978, DOI 10.1073/pnas.0912737107
   Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Scheid P, 2008, PARASITOL RES, V102, P945, DOI 10.1007/s00436-007-0858-3
   Scheid P, 2016, CURR OPIN MICROBIOL, V31, P58, DOI 10.1016/j.mib.2016.02.005
   Scheid P, 2014, PARASITOL RES, V113, P2407, DOI 10.1007/s00436-014-3932-7
   Schulz F, 2017, SCIENCE, V356, P82, DOI 10.1126/science.aal4657
   Suarez C, 2015, CELL MICROBIOL, V17, P1683, DOI 10.1111/cmi.12468
   Suarez C, 2013, CELL MICROBIOL, V15, P1883, DOI 10.1111/cmi.12156
   Temmam S, 2017, TRANSBOUND EMERG DIS, V64, P1159, DOI 10.1111/tbed.12481
   Temmam S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139810
   Verneau J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00428
   Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223
NR 42
TC 6
Z9 6
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2019
VL 93
IS 5
AR e01942-18
DI 10.1128/JVI.01942-18
PG 12
WC Virology
SC Virology
GA HL8VZ
UT WOS:000459022000028
PM 30541841
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Aspahan, MC
   Leonhard, SE
   Gomez, RS
   Rocha, ED
   Vilela, MRD
   Alvarenga, PPM
   Marinho, PES
   Kroon, EG
   Meira, F
AF Aspahan, Maira Cardoso
   Leonhard, Sonja Emily
   Gomez, Rodrigo Santiago
   Rocha, Eder da Silva
   da Silva Vilela, Michelle Ramos
   Martins Alvarenga, Pedro Paulo
   Silva Marinho, Paula Eillanny
   Kroon, Erna Geessien
   Meira, Fidel
TI Neuromyelitis optica spectrum disorder associated with Zika virus
   infection
SO NEUROLOGY-CLINICAL PRACTICE
LA English
DT Editorial Material
C1 [Aspahan, Maira Cardoso; Gomez, Rodrigo Santiago; Rocha, Eder da Silva; da Silva Vilela, Michelle Ramos; Meira, Fidel] Madre Teresa Hosp, Dept Neurol, Belo Horizonte, MG, Brazil.
   [Leonhard, Sonja Emily] Erasmus Univ, Med Sch, Dept Neurol, Rotterdam, Netherlands.
   [Martins Alvarenga, Pedro Paulo; Silva Marinho, Paula Eillanny; Kroon, Erna Geessien] Univ Fed Minas Gerais, Virus Lab, Belo Horizonte, MG, Brazil.
RP Aspahan, MC (corresponding author), Madre Teresa Hosp, Dept Neurol, Belo Horizonte, MG, Brazil.
EM maiaspahan@gmail.com
OI Leonhard, Sonja/0000-0003-4832-6926
FU European Union's Horizon 2020 research and innovation programme through
   ZikaPLAN project [734584]; Fundacao de Amparoa Pesquisa do Estado de
   Minas GeraisMinas Gerais State Research Foundation (FAPEMIG); Fundacao
   CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG);
   CNpqNational Council for Scientific and Technological Development
   (CNPq); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq)
FX M.C. Aspahan reports no disclosures. S.E. Leonhard reports participation
   on the European Union's Horizon 2020 research and innovation programme
   through ZikaPLAN project under grant agreement no. 734584. R.S. Gomez,
   E. da Silva Rocha, and M. Ramos da Silva Vilela report no disclosures.
   P.P. Martins Alvarenga receives research support from Fundacao de
   Amparoa Pesquisa do Estado de Minas Gerais. P. E. Silva Marinho receives
   research support from Fundacao CAPES, FAPEMIG, and CNpq. E.G. Kroon
   serves as an Associate Editor for Virology Journal and for Frontiers in
   Microbiology and receives research support from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Fundacao CAPES, and FAPEMIG.
   F. Meira reports no disclosures. Full disclosure form information
   provided by the authors is available with the full text of this article
   at Neurology.org/cp.
CR Bharucha T, 2016, NEUROPATH APPL NEURO, V42, P317, DOI 10.1111/nan.12326
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Sellner J, 2010, J AUTOIMMUN, V34, P371, DOI 10.1016/j.jaut.2009.09.013
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729
NR 7
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2163-0402
EI 2163-0933
J9 NEUROL-CLIN PRACT
JI Neurol.-Clin. Pract.
PD FEB
PY 2019
VL 9
IS 1
BP E1
EP E3
DI 10.1212/CPJ.0000000000000546
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA IF5HL
UT WOS:000473111800001
PM 30859012
OA Green Published
DA 2020-11-30
ER

PT J
AU Lima, MT
   Oliveira, GP
   Afonso, JAB
   Souto, RJC
   de Mendonca, CL
   Dantas, AFM
   Abrahao, JS
   Kroon, EG
AF Lima, Mauricio Teixeira
   Oliveira, Graziele Pereira
   Bastos Afonso, Jose Augusto
   Cavancanti Souto, Rodolfo Jose
   de Mendonca, Carla Lopes
   Medeiros Dantas, Antonio Flavio
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
TI An Update on the Known Host Range of the Brazilian Vaccinia Virus: An
   Outbreak in Buffalo Calves
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE vaccinia virus; buffalopox; bovine vaccinia; bubaline; buffalo diseases
ID SAO-PAULO STATE; BOVINE VACCINIA; MOLECULAR CHARACTERIZATION;
   HYDROCHOERUS-HYDROCHAERIS; CANTAGALO VIRUS; WATER-BUFFALO; CATTLE;
   ORTHOPOXVIRUS; DISEASE; HUMANS
AB Even nearly forty years after the eradication of smallpox, members of the Poxviridae family continue to be the focus of an increasing number of studies. Among these studies, prominently stands vaccinia virus, an orthopoxvirus that is associated with bovine vaccinia outbreaks. Although more frequently associated with infections in cattle and humans, the host range of vaccinia virus is not restricted only to these hosts. There are several instances of molecular and serological evidence of circulation of vaccinia virus among wildlife species. In addition, viral isolation has confirmed a broad spectrum of vaccinia virus hosts. In this report, we provide a brief update on the host range of Brazilian vaccinia virus, and present a case description of an outbreak in domestic buffalo calves from Northeastern Brazil that corroborates previous serological and molecular studies. Furthermore, in the present study, vaccinia virus has been isolated for the first time in buffaloes, and referred to as vaccinia virus Pernambuco (VACV-PE). Phylogenetic reconstruction was based on A56R clustered VACV-PE with vaccinia virus isolates belonging to group 1 Brazilian vaccinia virus. Furthermore, the vaccinia virus genome was detected in the milk of a lactating cow, which thereby revealed a pathway for future studies on the possible impact of vaccinia virus on buffalo milk and milk products. Taken together, these results provide the first description of clinical disease caused by vaccinia virus in buffaloes in South America. They also raise new questions about the chain of transmission of this virus.
C1 [Lima, Mauricio Teixeira; Oliveira, Graziele Pereira; Abrahao, Jonatas Santos; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Bastos Afonso, Jose Augusto; Cavancanti Souto, Rodolfo Jose; de Mendonca, Carla Lopes] Univ Fed Rural Pernambuco, Clin Bovinos, Campus Garanhuns, Garanhuns, Brazil.
   [Medeiros Dantas, Antonio Flavio] Univ Fed Campine Grande, Unidade Acad Med Vet, Campus Patos, Patos de Minas, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM ernagkroon@gmail.com
RI Kroon, Erna/V-5444-2019; Afonso, Jose Augusto Bastos/J-2337-2016
OI Afonso, Jose Augusto Bastos/0000-0003-4874-2356; Oliveira,
   Graziele/0000-0002-8521-0351; Teixeira Lima,
   Mauricio/0000-0002-0830-3909
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq);
   Pro-Reitoria de Pesquisa da UFMG (PRPq-UFMG); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas Gerais State Research
   Foundation (FAPEMIG); Ministerio da Agricultura, Pecuaria e
   Abastecimento (MAPA)
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Pro-Reitoria de Pesquisa da UFMG (PRPq-UFMG),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA). AD, JSA, and EK are CNPq
   researchers.
CR Abrahao JS, 2017, EQUINE VET J, V49, P221, DOI 10.1111/evj.12571
   Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Amoroso MG, 2013, RES VET SCI, V94, P813, DOI 10.1016/j.rvsc.2012.12.009
   Assis FL, 2015, ARCH VIROL, V160, P2703, DOI 10.1007/s00705-015-2549-1
   Assis FL, 2012, EMERG INFECT DIS, V18, P2035, DOI 10.3201/eid1812.120145
   Babolin Lilian dos Santos, 2016, Arq. Inst. Biol., V83, pe0832014, DOI 10.1590/1808-1657000832014
   Barbosa AV, 2014, J INFECT DEV COUNTR, V8, P1646, DOI 10.3855/jidc.5216
   Bera BC, 2012, VIRUS GENES, V45, P488, DOI 10.1007/s11262-012-0788-8
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   COCKRILL WR, 1981, BRIT VET J, V137, P8
   Coras B, 2005, LANCET, V365, P446
   Costa GB, 2017, EMERG INFECT DIS, V23, P360, DOI 10.3201/eid2302.161341
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   da Silva TG, 2018, CIENC RURAL, V48, DOI 10.1590/0103-8478cr20170723
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Assis FL, 2012, EMERG INFECT DIS, V18, P698, DOI 10.3201/eid1804.111800
   de Oliveira JS, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110340
   de Oliveira TML, 2018, TRANSBOUND EMERG DIS, V65, pe40, DOI 10.1111/tbed.12666
   Matos ACD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030120
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Eder I, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120375
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   Gerber PF, 2012, J VET DIAGN INVEST, V24, P355, DOI 10.1177/1040638711435231
   Guarner J, 2004, EMERG INFECT DIS, V10, P426, DOI 10.3201/eid1003.030878
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kik M, 2009, P INT C DIS ZOOL WIL
   Kile JC, 2005, ARCH PEDIAT ADOL MED, V159, P1022, DOI 10.1001/archpedi.159.11.1022
   Klein J, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-53
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Laguardia-Nascimento M, 2016, J VET DIAGN INVEST, V28, P377, DOI 10.1177/1040638716645836
   Dutra LAL, 2017, ARCH VIROL, V162, P439, DOI 10.1007/s00705-016-3121-3
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lima MT, 2018, EMERG INFECT DIS, V24, P161, DOI 10.3201/eid2401.170430
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Long J. L, 2003, INTRO MAMMALS WORLD, DOI [10.1086/428221, DOI 10.1086/428221]
   de Oliveira TML, 2015, FOODBORNE PATHOG DIS, V12, P898, DOI 10.1089/fpd.2015.1974
   MARENNIKOVA SS, 1977, J INFECT DIS, V135, P358, DOI 10.1093/infdis/135.3.358
   McCollum AM, 2014, CLIN INFECT DIS, V58, P260, DOI 10.1093/cid/cit703
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Miranda JB, 2017, EMERG INFECT DIS, V23, P931, DOI 10.3201/eid2306.161643
   Franco-Luiz APM, 2016, EMERG INFECT DIS, V22, P2174, DOI 10.3201/eid2212.160447
   Franco-Luiz APM, 2016, COMP IMMUNOL MICROB, V46, P16, DOI 10.1016/j.cimid.2016.03.003
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Newman FK, 2003, J CLIN MICROBIOL, V41, P3154, DOI 10.1128/JCM.41.7.3154-3157.2003
   Oliveira DB, 2013, AM J TROP MED HYG, V89, P1142, DOI 10.4269/ajtmh.13-0369
   OLIVEIRA GP, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9110331
   Oliveira G, 2015, VIRUSES-BASEL, V7, P1218, DOI 10.3390/v7031218
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Pilaski J, 1988, VIRUS DIS LAB CAPTIV, DOI [10.1007/978-1-4613-2091-3_5, DOI 10.1007/978-1-4613-2091-3_5]
   Rehfeld IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127350
   Reynolds MG, 2012, CURR OPIN VIROL, V2, P335, DOI 10.1016/j.coviro.2012.02.004
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Sambrook J., 1989, MOL CLONING LAB MANU, P1626, DOI [10.1016/0092-8674(90)90210-6, DOI 10.1016/0092-8674(90)90210-6]
   Sheikh PA, 2006, AGR SYST, V87, P313, DOI 10.1016/j.agsy.2005.02.003
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Singh RK, 2012, INDIAN J VIROL, V23, P1, DOI 10.1007/s13337-012-0068-1
   Stahel ABJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083695
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120328
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Usme-Ciro JA, 2017, EMERG INFECT DIS, V23, P649, DOI 10.3201/eid2304.161041
   Yadav S, 2010, ARCH VIROL, V155, P255, DOI 10.1007/s00705-009-0562-y
   Zafar A, 2007, EMERG INFECT DIS, V13, P902, DOI 10.3201/eid1306.061068
NR 72
TC 3
Z9 4
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 22
PY 2019
VL 9
AR 3327
DI 10.3389/fmicb.2018.03327
PG 10
WC Microbiology
SC Microbiology
GA HI2DI
UT WOS:000456254800001
PM 30723465
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Oliveira, G
   Silva, L
   Leao, T
   Mougari, S
   da Fonseca, FG
   Kroon, EG
   La Scola, B
   Abrahao, JS
AF Oliveira, Graziele
   Silva, Lorena
   Leao, Thiago
   Mougari, Said
   da Fonseca, Flavio Guimaraes
   Kroon, Erna Geessien
   La Scola, Bernard
   Abrahao, Jonatas Santos
TI Tupanvirus-infected amoebas are induced to aggregate with uninfected
   cells promoting viral dissemination
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MANNOSE-BINDING PROTEIN; GIANT VIRUS; ACANTHAMOEBA; PATHOGENESIS;
   PHAGOCYTOSIS
AB The discovery of giant viruses in the last years has fascinated the scientific community due to virus particles size and genome complexity. Among such fantastic discoveries, we have recently described tupanviruses, which particles present a long tail, and has a genome that contains the most complete set of translation-related genes ever reported in the known virosphere. Here we describe a new kind of virus-host interaction involving tupanvirus. We observed that tupanvirus-infected amoebas were induced to aggregate with uninfected cells, promoting viral dissemination and forming giant host cell bunches. Even after mechanical breakdown of bunches, amoebas reaggregated within a few minutes. This remarkable interaction between infected and uninfected cells seems to be promoted by the expression of a mannose receptor gene. Our investigations demonstrate that the pre-treatment of amoebas with free mannose inhibits the formation of bunches, in a concentration-dependent manner, suggesting that amoebal-bunch formation correlates with mannose receptor gene expression. Finally, our data suggest that bunch-forming cells are able to interact with uninfected cells promoting the dissemination and increase of tupanvirus progeny.
C1 [Oliveira, Graziele; Silva, Lorena; Leao, Thiago; da Fonseca, Flavio Guimaraes; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Mougari, Said; La Scola, Bernard] Aix Marseille Univ, IHU Mediterranee Infect, AP HM, URMITE,UM63,CNRS 7278,IRD 198,INSERM 1095, 19-21 Blvd Jean Moulin, F-13005 Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019
OI Oliveira, Graziele/0000-0002-8521-0351; Mougari,
   Said/0000-0002-9319-5454
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq); CAPES (Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior)CAPES; FAPEMIG (Fundacao de Amparo a Pesquisa do estado
   de Minas Gerais)Minas Gerais State Research Foundation (FAPEMIG);
   PRPq-UFMG (Pro-Reitoria de Pesquisa of UFMG); Microscopy Center of UFMG
FX We are grateful to our colleagues from Laboratorio de Virus of
   Universidade Federal de Minas Gerais. In addition, we thank CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), CAPES
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), FAPEMIG
   (Fundacao de Amparo a Pesquisa do estado de Minas Gerais), PRPq-UFMG
   (Pro-Reitoria de Pesquisa of UFMG) and the Microscopy Center of UFMG.
   F.G.F; E.G.K and J.S.A are CNPq researchers. E.G.K.; B.L.S. and J.S.A.
   are members of a CAPES-COFECUB project.
CR Abrahao J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03168-1
   Abrahao Jonatas Santos, 2016, Curr Protoc Microbiol, V41, DOI 10.1002/cpmc.2
   Aherfi S, 2014, VIROLOGY, V466, P27, DOI 10.1016/j.virol.2014.07.014
   ALLEN PG, 1990, J CELL PHYSIOL, V145, P508, DOI 10.1002/jcp.1041450317
   Andreani J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110300
   Bajrai LH, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110278
   Barre A, 1997, PLANT MOL BIOL, V33, P691, DOI 10.1023/A:1005704616565
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Cao ZY, 1998, J BIOL CHEM, V273, P15838, DOI 10.1074/jbc.273.25.15838
   Andrade ACDP, 2017, J VIROL, V91, DOI 10.1128/JVI.01335-17
   Garate M, 2006, INVEST OPHTH VIS SCI, V47, P1056, DOI 10.1167/iovs.05-0477
   Garate M, 2005, INFECT IMMUN, V73, P5775, DOI 10.1128/IAI.73.9.5775-5781.2005
   Garate M, 2004, J BIOL CHEM, V279, P29849, DOI 10.1074/jbc.M402334200
   Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x
   Kim JH, 2012, EXP PARASITOL, V132, P287, DOI 10.1016/j.exppara.2012.08.007
   La Scola B, 2003, SCIENCE, V299, P2033
   Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Rodrigues RAL, 2015, J VIROL, V89, P11812, DOI 10.1128/JVI.01976-15
   Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003
   Niederkorn JY, 1999, MICROBES INFECT, V1, P437, DOI 10.1016/S1286-4579(99)80047-1
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Reed L. J., 1938, AM J EPIDEMIOL, V128, P192
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Sergeev V. N., 2002, Mikrobiologiya, V71, P725
   Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6
   Sorokin DY, 2014, EXTREMOPHILES, V18, P791, DOI 10.1007/s00792-014-0670-9
   Yang ZT, 1997, INFECT IMMUN, V65, P439, DOI 10.1128/IAI.65.2.439-445.1997
   Yoo KT, 2012, KOREAN J PARASITOL, V50, P365, DOI 10.3347/kjp.2012.50.4.365
NR 29
TC 8
Z9 8
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 17
PY 2019
VL 9
AR 183
DI 10.1038/s41598-018-36552-4
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HH7ZS
UT WOS:000455951300031
PM 30655573
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Cardoso, FD
   de Rezende, IM
   Barros, ELT
   Sacchetto, L
   Garces, TCDS
   Silva, NIO
   Alves, PA
   Soares, JO
   Kroon, EG
   Pereira, ACTD
   Drumond, BP
   Ferreira, GP
AF Cardoso, Felipe Daniel
   de Rezende, Izabela Mauricio
   Teixeira Barros, Emanuela Lima
   Sacchetto, Livia
   de Carvalho Souza Garces, Tereza Cristina
   Oliveira Silva, Natalia Ingrid
   Alves, Pedro Augusto
   Soares, Jefferson Oliveira
   Kroon, Erna Geessien
   Toledo da Cunha Pereira, Anna Carolina
   Drumond, Betania Paiva
   Ferreira, Gustavo Portela
TI Circulation of Chikungunya virus East-Central-South Africa genotype
   during an outbreak in 2016-17 in Piaui State, Northeast Brazil
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Chikungunya virus; Brazil; ECSA genotype; Arbovirus; Togavirus;
   Alphavirus; Molecular surveillance; Epidemiology; E1 gene
ID REUNION ISLAND; INFECTION; SEROPREVALENCE
AB Chikungunya virus (CHIKV) is an arbovirus that emerged in the Americas in 2013. Infection with CHIKV is symptomatic in most of the cases and patients can develop chronic arthralgia that lasts from months to years in over 40% of the cases. The East-Central-South Africa (ECSA) genotype was introduced in Brazil in 2014. in Bahia State. Here we report the circulation of the CHIKV ECSA genotype in Piaui State. Northeast Brazil. during the years 2016-2017. The phylogenetic analysis revealed a single introduction of this lineage probably in 2015 and its maintenance at least until 2017. This analysis has also demonstrated the proximity of this genotype with isolates from neighboring Stales. and its partial nucleotide sequence of the viral E1 gene revealed a synapomorphy synonyms. This finding highlights the spread of the ECSA genotype in Brazil and supports its circulation in the Brazilian Northeast.
C1 [Cardoso, Felipe Daniel; Teixeira Barros, Emanuela Lima; de Carvalho Souza Garces, Tereza Cristina; Soares, Jefferson Oliveira; Toledo da Cunha Pereira, Anna Carolina; Ferreira, Gustavo Portela] Univ Fed Piaui, Campus Ministro Reis Velloso,Av Sao Sebastiao 281, BR-64202020 Parnaiba, Piaui, Brazil.
   [de Rezende, Izabela Mauricio; Sacchetto, Livia; Oliveira Silva, Natalia Ingrid; Kroon, Erna Geessien; Drumond, Betania Paiva] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Alves, Pedro Augusto] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
RP Ferreira, GP (corresponding author), Univ Fed Piaui, Campus Ministro Reis Velloso,Av Sao Sebastiao 281, BR-64202020 Parnaiba, Piaui, Brazil.
EM gtvpf@ufpi.edu.br
RI Rezende, Izabela Mauricio/AAL-5766-2020; Silva, Natalia/AAL-6048-2020;
   Sacchetto, Livia/B-8841-2019; Alves, Pedro/T-7203-2019; Kroon,
   Erna/B-3631-2015; S Oliveira, Jefferson/G-2729-2015
OI Rezende, Izabela Mauricio/0000-0003-2616-6300; Silva,
   Natalia/0000-0003-3449-8313; Sacchetto, Livia/0000-0001-9716-6899;
   Alves, Pedro/0000-0002-9659-5621; Kroon, Erna/0000-0003-2721-3826;
   Barros, Emanuela Lima Teixeira/0000-0003-2048-4922; Cardoso, Felipe
   Daniel/0000-0001-8700-524X; S Oliveira, Jefferson/0000-0003-4192-8238
FU Piaui Research Foundation - FAPEPI; Prefeitura Municipal de Parnaiba;
   Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [456707/2014-0];
   Coordination for the Improvement of Higher Education Personnel
   CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This study was supported by grants from Piaui Research Foundation -
   FAPEPI, Prefeitura Municipal de Parnaiba and from Brazilian National
   Research Council (CNPq) 456707/2014-0. ELTB, TCCSG, IMR and LS. were
   supported by graduate fellowships from the Coordination for the
   Improvement of Higher Education Personnel CAPES. NIOS was supported by a
   graduate fellowship from CNPq. EGK and BPD are fellows of CNPq. The
   funding agencies had no role in data collection, data analysis, data
   interpretation, and writing of this manuscript.
CR Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   BEAST Developers, TRACER
   BEAST Developers, TREEANNOTATOR
   Brasil. Ministerio da Saude, 2016, B EPIDEMIOL, V47, P1
   Brasil Ministerio da Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V47, P1
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860019, 10.1590/S1678-9946201860019]
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Feldstein LR, 2017, EMERG INFECT DIS, V23, P673, DOI 10.3201/eid2304.161562
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kumar CVMN, 2007, INDIAN J MED RES, V126, P534
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Machado LC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007332
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Ministerio da Saude Monitoramento dos casos de dengue, 2018, B EPIDEMIOLOGICO, V49, P1
   Nakkhara P, 2013, T ROY SOC TROP MED H, V107, P789, DOI 10.1093/trstmh/trt083
   Paixao ES, 2018, T ROY SOC TROP MED H, V112, P301, DOI 10.1093/trstmh/try063
   Porter Kevin R., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P408
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3
   Rambaut A, FIGTREE
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tang BL, 2012, CELL MICROBIOL, V14, P1354, DOI 10.1111/j.1462-5822.2012.01825.x
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 42
TC 1
Z9 1
U1 0
U2 2
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2019
VL 61
AR e57
DI 10.1590/S1678-9946201961057
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JC9QN
UT WOS:000489611000005
PM 31618377
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Scarponi, CFO
   Kroon, EG
   Vieira, DS
   Fernandes, AP
   Gomes, KB
   Mota, BEF
AF Scarponi, Cristiane F. O.
   Kroon, Erna G.
   Vieira, Deusilene S.
   Fernandes, Ana Paula
   Gomes, Karina B.
   Mota, Bruno E. F.
TI Molecular epidemiology of Hepatitis delta virus infection in Minas
   Gerais state from Brazil, an area outside the hyperendemic region of the
   Amazon Basin
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Hepatitis D virus genotype 1; seroprevalence; molecular epidemiology;
   Brazil
ID RISK-FACTORS; PREVALENCE; GENOTYPE; COINFECTION
AB BACKGROUND Hepatitis delta virus (HDV) infections in hepatitis B virus (HBV) carriers are the most severe form of viral hepatitis. HDV prevalence is high in the Brazilian Amazon, but studies in other regions of the country are still scarce and often underestimated its prevalence by including a small numbers of individuals.
   OBJECTIVE This study aimed to determine the serological prevalence of hepatitis D, the genotypes circulating and to evaluate the associated risk factors for acquisition of HDV in Minas Gerais state, Brazil.
   METHODS We screened plasma samples (n = 498) from HBV chronic carriers for anti-HD antibodies using a commercial enzyme-linked immunosorbent assay (ELISA) kit. For those samples that were positive for anti-HD antibodies, we performed a reverse transcriptase (RT) nested-polymerase chain reaction (nested-PCR) in order to detect the viral genome and identify the viral genotypes circulating in the state.
   FINDINGS The prevalence was 6.22% (31/498). Blood transfusion was the only risk factor associated with HDV infection [risk ratio: 3.73; 95% confidence interval (CI): 1.44 to 9.65]. For 26 anti-HD positive patients, HDAg gene sequences were determined and in all patients HDV genotype 1 was found.
   CONCLUSIONS This study confirmed the circulation of HDV in Minas Gerais, an area previously considered non-endemic for hepatitis D in Brazil. The prevalence found in this study is much higher when compared to other studies performed in Brazil, probably because the population in our study was selected with minimal bias. Furthermore, in 26 anti-HD positive plasma samples, we were also able to detect the viral genome, indicating that these patients were experienced an active infection at the time of sample collection. These findings emphasise the importance of anti-HD testing in HBV infected individuals, which may contribute to this disease control in Brazil.
C1 [Scarponi, Cristiane F. O.; Fernandes, Ana Paula; Gomes, Karina B.; Mota, Bruno E. F.] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil.
   [Scarponi, Cristiane F. O.] Fundacao Ezequiel Dias, Inst Octavio Magalhaes, Belo Horizonte, MG, Brazil.
   [Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Vieira, Deusilene S.] Fundacao Oswaldo Cruz Fiocruz, Porto Velho, RO, Brazil.
RP Mota, BEF (corresponding author), Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil.
EM brunofmota@gmail.com
RI DALLACQUA, DEUSILENE/ABA-3597-2020
OI Mota, Bruno/0000-0003-0348-4875
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG) [APQ-01202-14];
   UFMG intramural funds; CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX FAPEMIG (grant number APQ-01202-14), UFMG intramural funds.; APF, KBG
   and EGK were supported by CNPq (CNPq Research Fellowship - PQ).
CR Amini N, 2011, HEPAT MON, V11, P960, DOI 10.5812/kowsar.1735143X.805
   Botelho-Souza LF, 2015, INTERVIROLOGY, V58, P166, DOI 10.1159/000431040
   CASEY JL, 1993, P NATL ACAD SCI USA, V90, P9016, DOI 10.1073/pnas.90.19.9016
   Cross TJS, 2008, J MED VIROL, V80, P277, DOI 10.1002/jmv.21078
   Santos MDC, 2016, VIRUS RES, V224, P6, DOI 10.1016/j.virusres.2016.08.003
   Crispim MAE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-94
   Ferraz M L, 1985, Rev Paul Med, V103, P228
   Fouad R, 2016, J MED VIROL, V88, P837, DOI 10.1002/jmv.24412
   Gheorghe L, 2015, J GASTROINTEST LIVER, V24, P413, DOI 10.15403/jgld.2014.1121.244.dtv
   Gish RG, 2013, J GASTROEN HEPATOL, V28, P1521, DOI 10.1111/jgh.12217
   Ho E, 2013, J MED VIROL, V85, P1513, DOI 10.1002/jmv.23653
   Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9
   Kushner T, 2015, J HEPATOL, V63, P586, DOI 10.1016/j.jhep.2015.04.025
   Lago BV, 2018, J MED VIROL, V90, P1358, DOI 10.1002/jmv.25196
   Lempp FA, 2016, NAT REV GASTRO HEPAT, V13, P580, DOI 10.1038/nrgastro.2016.126
   Liao BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115888
   Mendes-Correa MC, 2011, INT J INFECT DIS, V15, pE828, DOI 10.1016/j.ijid.2011.08.003
   Braga WSM, 2012, REV SOC BRAS MED TRO, V45, P691, DOI 10.1590/S0037-86822012000600007
   Motamedifar M, 2015, IRAN J MED SCI, V40, P448
   Ribeiro L C, 2000, Rev Soc Bras Med Trop, V33, P599, DOI 10.1590/S0037-86822000000600013
   Rizzetto M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021576
   SALDANHA JA, 1990, J GEN VIROL, V71, P1603, DOI 10.1099/0022-1317-71-7-1603
   STRAUSS E, 1987, T ROY SOC TROP MED H, V81, P73, DOI 10.1016/0035-9203(87)90288-4
   Tahaei Seyed Mohammad Ebrahim, 2014, Gastroenterol Hepatol Bed Bench, V7, P144
NR 24
TC 1
Z9 1
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR e190074
DI 10.1590/0074-02760190074
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IT7SV
UT WOS:000483078500001
PM 31460570
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Figueiredo, PO
   Silva, ATS
   Oliveira, JS
   Marinho, PE
   Rocha, FT
   Domingos, GP
   Poblete, PCP
   Oliveira, LBS
   Duarte, DC
   Bonjardim, CA
   Abrahao, JS
   Kroon, EG
   Drumond, BP
   Oliveira, DB
   Trindade, GS
AF Figueiredo, P. O.
   Silva, A. T. S.
   Oliveira, J. S.
   Marinho, P. E.
   Rocha, F. T.
   Domingos, G. P.
   Poblete, P. C. P.
   Oliveira, L. B. S.
   Duarte, D. C.
   Bonjardim, C. A.
   Abrahao, J. S.
   Kroon, E. G.
   Drumond, B. P.
   Oliveira, D. B.
   Trindade, G. S.
TI Detection and Molecular Characterization of Yellow Fever Virus, 2017,
   Brazil
SO ECOHEALTH
LA English
DT Article
DE Yellow fever virus; Non-human primates; Emerging infectious diseases;
   Zoonotic virus; Arboviruses; Outbreak
ID NONHUMAN-PRIMATES; OUTBREAK; STATE; RNA
AB At the end of 2016, Brazil experienced an unprecedented yellow fever (YF) outbreak. Clinical, molecular and ecological aspects of human and non-human primate (NHP) samples collected at the beginning of the outbreak are described in this study. Spatial distribution analyses demonstrated a strong overlap between human and NHP cases. Through molecular analyses, we showed that the outbreak had a sylvatic origin, caused by the South American genotype 1 YFV, which has already been shown to circulate in Brazil. As expected, the clusters of cases were identified in regions with a low vaccination coverage. Our findings highlight the importance of the synchronization of animal surveillance and health services to identify emerging YF cases, thereby promoting a better response to the vulnerable population.
C1 [Figueiredo, P. O.; Silva, A. T. S.; Oliveira, J. S.; Marinho, P. E.; Bonjardim, C. A.; Abrahao, J. S.; Kroon, E. G.; Drumond, B. P.; Trindade, G. S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Rocha, F. T.; Domingos, G. P.; Oliveira, D. B.] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Ctr Integrado Pesquisa Saude, Campus JK,Rodovia MGT 367,KM 583,5000, BR-39100000 Diamantina, MG, Brazil.
   [Poblete, P. C. P.; Duarte, D. C.] Zoovet Consultoria LTDA, Ave Amazonas 2474, BR-30180001 Belo Horizonte, MG, Brazil.
   [Oliveira, L. B. S.] Pontificia Univ Catolica Minas Gerais, Rua Dom Jose Gaspar,702, BR-30535000 Belo Horizonte, MG, Brazil.
RP Figueiredo, PO (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM polianaofigueiredo@yahoo.com.br
RI Kroon, Erna/V-5444-2019
FU Brazilian agency CAPESCAPES; Brazilian agency CNPqNational Council for
   Scientific and Technological Development (CNPq); MCTIC/FNDCT-CNPq/
   MEC-CAPES/ MS-Decit [14/2016]
FX We are thankful to Zoovet Clinica e Consultoria LTDA and Bicho do Mato
   Meio Ambiente, which provided NHP samples from Conceicao do Mato Dentro,
   Minas Gerais, Brazil. We thank Galileu Barbosa Costa for the critical
   review of this work and Grant M. Williams for English review. We also
   thank colleagues from the Laboratorio de Virus (ICB-UFMG) for their
   excellent technical support. This work has received financial support
   from Brazilian agencies CAPES and CNPq in accordance with the
   MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit/ No 14/2016 - Prevencao e Combate
   ao virus Zika.
CR [Anonymous], 2017, MIN SAUD AN FIM SURT
   [Anonymous], 2017, COBERTURA VACINAL FE
   [Anonymous], 2005, MAN VIG EP EM PRIM N
   [Anonymous], 2017, AT INV CAS SUSP FEBR
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Carrington CVF, 2013, INFECT GENET EVOL, V13, P198, DOI 10.1016/j.meegid.2012.08.015
   Costa ZGA, 2011, REV PAN AMAZ SAUDE, V2, P11, DOI DOI 10.5123/S2176-62232011000100002
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Dierssen U, 2008, J CLIN VIROL, V42, P58, DOI 10.1016/j.jcv.2007.11.016
   Engelmann F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003295
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Jorge TR, 2017, ACTA TROP, V166, P114, DOI 10.1016/j.actatropica.2016.09.030
   Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185
   Leal SG, 2016, REV SOC BRAS MED TRO, V49, P29, DOI 10.1590/0037-8682-0363-2015
   Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390
   Ministerio da Saude, 2017, INF ESP FEBR AM BRAS
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Moreno ES, 2013, REV INST MED TROP SP, V55, P45, DOI 10.1590/S0036-46652013000100008
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   Pessanha JEM, 2009, YELLOW FEVER VISION, V19
   Plowright RK, 2017, NAT REV MICROBIOL, V15, P502, DOI 10.1038/nrmicro.2017.45
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   [WHO World Health Organization], 2017, YELL FEV VACC REC AM
   World Health Organization, 2008, DET INV SER ADV EV F
NR 32
TC 4
Z9 4
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD DEC
PY 2018
VL 15
IS 4
BP 864
EP 870
DI 10.1007/s10393-018-1364-z
PG 7
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA HC1VP
UT WOS:000451591600016
PM 30117000
DA 2020-11-30
ER

PT J
AU Costa, GB
   de Almeida, LR
   Cerqueira, AGR
   Mesquita, WU
   de Oliveira, JS
   Miranda, JB
   Saraiva-Silva, AT
   Abrahao, JS
   Drumond, BP
   Kroon, EG
   Pereira, PLL
   Soares, DFD
   Trindade, GD
AF Costa, Galileu Barbosa
   de Almeida, Lara Ribeiro
   Ribeiro Cerqueira, Aline Gabriele
   Mesquita, Wander Ulisses
   de Oliveira, Jaqueline Silva
   Miranda, Julia Bahia
   Saraiva-Silva, Ana Teresa
   Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Kroon, Erna Geessien
   Lithg Pereira, Pedro Lucio
   de Magalhaes Soares, Danielle Ferreira
   Trindade, Giliane de Souza
TI Vaccinia Virus among Domestic Dogs and Wild Coatis, Brazil, 2013-2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID MOLECULAR EVIDENCE; INFECTION; HUMANS; CATTLE; PAULO
AB To determine their potential role as a source of human infection, we tested domestic dogs (urban) and wild coatis (wild) in Brazil for vaccinia virus. Our findings of positive neutralizing antibodies and quantitative PCR results for 35/184 dogs and 13/90 coatis highlight a potential public health risk.
C1 [Costa, Galileu Barbosa] Univ Fed Minas Gerais, Inst Ciencias Biol, Microbiol Dept, Lab Virus,Microbiol, Belo Horizonte, MG, Brazil.
   [de Almeida, Lara Ribeiro; Ribeiro Cerqueira, Aline Gabriele; de Oliveira, Jaqueline Silva; Miranda, Julia Bahia; Saraiva-Silva, Ana Teresa; Abrahao, Jonatas Santos; Drumond, Betania Paiva; Kroon, Erna Geessien; Lithg Pereira, Pedro Lucio; de Magalhaes Soares, Danielle Ferreira; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Mesquita, Wander Ulisses] Univ Fed Ouro Preto, Ouro Preto, Brazil.
RP Costa, GB; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Microbiol, Ave Presidente Antonio Carlos 6627,Campus Pamulha, BR-3127090 Belo Horizonte, MG, Brazil.
EM galileuk1@gmail.com; giliane@icb.ufmg.br
RI Costa, Galileu Barbosa/M-5768-2019; Kroon, Erna/V-5444-2019
OI Barbosa Costa, Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Pro-Reitoria de
   Pesquisa/Universidade Federal de Minas Gerais; Fundacao de Amparo a
   Pesquisa do Estado de Minas GeraisMinas Gerais State Research Foundation
   (FAPEMIG)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior, Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais, and Pro-Reitoria de Pesquisa/Universidade Federal de Minas
   Gerais. J.S.A., E.G.K., and G.S.T. are researchers from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico.
CR A, DFD, V5, P43, DOI DOI 10.1002/CPMC.13
   Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Costa GB, 2017, EMERG INFECT DIS, V23, P360, DOI 10.3201/eid2302.161341
   de Oliveira JS, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110340
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Gallardo-Romero NF, 2016, J WILDLIFE DIS, V52, P609, DOI 10.7589/2015-10-291
   Geessien Kroon E, 2016, CURR PROTOC MICROBIO, V42, DOI 10.1002/cpmc.13
   Dutra LAL, 2017, ARCH VIROL, V162, P439, DOI 10.1007/s00705-016-3121-3
   Miranda JB, 2017, EMERG INFECT DIS, V23, P931, DOI 10.3201/eid2306.161643
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   PERES MG, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10020051
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   Smith KC, 1999, J SMALL ANIM PRACT, V40, P495, DOI 10.1111/j.1748-5827.1999.tb03003.x
   von Bomhard W, 2011, VET DERMATOL, V22, P111, DOI 10.1111/j.1365-3164.2010.00923.x
NR 16
TC 3
Z9 3
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2018
VL 24
IS 12
BP 2338
EP 2342
DI 10.3201/eid2412.171584
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HA9JM
UT WOS:000450617500025
PM 30457519
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Terzian, ACB
   Zini, N
   Sacchetto, L
   Rocha, RF
   Parra, MCP
   Del Sarto, JL
   Dias, ACF
   Coutinho, F
   Rayra, J
   da Silva, RA
   Costa, VV
   Fernandes, NCCDA
   Ressio, R
   Diaz-Delgado, J
   Guerra, J
   Cunha, MS
   Catao-Dias, JL
   Bittar, C
   Reis, AFN
   dos Santos, INP
   Ferreira, ACM
   Cruz, LEAA
   Rahal, P
   Ullmann, L
   Malossi, C
   de Araujo, JP
   Widen, S
   de Rezende, IM
   Mello, E
   Pacca, CC
   Kroon, EG
   Trindade, G
   Drumond, B
   Chiaravalloti-Neto, F
   Vasilakis, N
   Teixeira, MM
   Nogueira, ML
AF Terzian, Ana Carolina B.
   Zini, Nathalia
   Sacchetto, Livia
   Rocha, Rebeca Froes
   Pereira Parra, Maisa Carla
   Del Sarto, Juliana Lemos
   Fialho Dias, Ana Carolina
   Coutinho, Felipe
   Rayra, Jessica
   da Silva, Rafael Alves
   Costa, Vivian Vasconcelos
   Couto De Azevedo Fernandes, Natalia Coelho
   Ressio, Rodrigo
   Diaz-Delgado, Josue
   Guerra, Juliana
   Cunha, Mariana S.
   Catao-Dias, Jose Luiz
   Bittar, Cintia
   Negri Reis, Andreia Francesli
   Penha dos Santos, Izalco Nuremberg
   Marascalchi Ferreira, Andreia Cristina
   Arao Antonio Cruz, Lilian Elisa
   Rahal, Paula
   Ullmann, Leila
   Malossi, Camila
   de Araujo, Joao Pessoa, Jr.
   Widen, Steven
   de Rezende, Izabela Mauricio
   Mello, Erica
   Pacca, Carolina Colombelli
   Kroon, Erna Geessien
   Trindade, Giliane
   Drumond, Betania
   Chiaravalloti-Neto, Francisco
   Vasilakis, Nikos
   Teixeira, Mauro M.
   Nogueira, Mauricio Lacerda
TI Evidence of natural Zika virus infection in neotropical non-human
   primates in Brazil
SO SCIENTIFIC REPORTS
LA English
DT Article
ID YELLOW-FEVER; CALLITHRIX-JACCHUS; MODEL; IDENTIFICATION; TRANSMISSION;
   CHIKUNGUNYA; EMERGENCE; OUTBREAK; VIREMIA
AB In Africa, Old World Primates are involved in the maintenance of sylvatic circulation of ZIKV. However, in Brazil, the hosts for the sylvatic cycle remain unknown. We hypothesized that free-living NHPs might play a role in urban/periurban ZIKV dynamics, thus we undertook an NH P ZIKV investigation in two cities in Brazil. We identified ZIKV-positive NHPs and sequences obtained were phylogenetically related to the American lineage of ZIKV. Additionally, we inoculated four C. penicillata with ZIKV and our results demonstrated that marmosets had a sustained viremia. The natural and experimental infection of NHPs with ZIKV, support the hypothesis that NHPs may be a vertebrate host in the maintainance of ZIKV transmission/circulation in urban tropical settings. Further studies are needed to understand the role they may play in maintaining the urban cycle of the ZIKV and how they may be a conduit in establishing an enzootic transmission cycle in tropical Latin America.
C1 [Terzian, Ana Carolina B.; Zini, Nathalia; Pereira Parra, Maisa Carla; da Silva, Rafael Alves; Nogueira, Mauricio Lacerda] Sao Jose do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Sacchetto, Livia; de Rezende, Izabela Mauricio; Kroon, Erna Geessien; Trindade, Giliane; Drumond, Betania] Univ Fed Minas Gerais, Lab Virus, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Rocha, Rebeca Froes; Del Sarto, Juliana Lemos; Fialho Dias, Ana Carolina; Coutinho, Felipe; Rayra, Jessica; Costa, Vivian Vasconcelos; Teixeira, Mauro M.] Univ Fed Minas Gerais, Ctr Drug Res & Dev, Inst Ciencias Biol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Couto De Azevedo Fernandes, Natalia Coelho; Ressio, Rodrigo; Diaz-Delgado, Josue; Guerra, Juliana; Cunha, Mariana S.] IAL, Ave Dr Arnaldo,351-7 Andar,Sala 706, BR-01246000 Sao Paulo, SP, Brazil.
   [Catao-Dias, Jose Luiz] Univ Sao Paulo, FMVZ, LAPOCM, Lab Wildlife Comparat Pathol,Dept Pathol,Sch Vet, Ave Orlando Marques de Paiva 87, BR-05508270 Sao Paulo, SP, Brazil.
   [Bittar, Cintia; Rahal, Paula] Sao Paulo State Univ, Inst Biosci Letters & Exact Sci, Dept Biol, Sao Jose Rio Preto IBILCE,UNESP, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Negri Reis, Andreia Francesli; Penha dos Santos, Izalco Nuremberg; Marascalchi Ferreira, Andreia Cristina; Arao Antonio Cruz, Lilian Elisa] Epidemiol Surveillance Dept Sao Jose Do Rio Preto, Ave Romeu Strazzi 199, BR-15084010 Sao Jose Do Rio Preto, SP, Brazil.
   [Ullmann, Leila; Malossi, Camila; de Araujo, Joao Pessoa, Jr.] Sao Paulo State Univ Unesp, Inst Biotechnol, Alameda Tecomarias S-N, BR-18607440 Botucatu, SP, Brazil.
   [Widen, Steven] Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Mello, Erica] Belo Horizonte Council, Ctr Controle Zoonoses, Rua Edna Quintel 173, BR-31270705 Belo Horizonte, MG, Brazil.
   [Pacca, Carolina Colombelli] Faceres Med Sch, Ave Anisio Haddad 6751, BR-15090305 Sao Jose Do Rio Preto, SP, Brazil.
   [Chiaravalloti-Neto, Francisco] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Ave Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.
RP Nogueira, ML (corresponding author), Sao Jose do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Bittar, Cintia/A-5042-2015; CATAO-DIAS, JOSE LUIZ/C-4897-2012; Neto,
   Francisco Chiaravalloti/F-8006-2012; Costa, Vivian VVC/I-2499-2018;
   Nogueira, Mauricio L/B-7599-2012; Guerra, Juliana Mariotti/H-5310-2012;
   Rahal, Paula/D-3871-2012; Teixeira, Mauro M/A-4587-2008; Rezende,
   Izabela Mauricio/AAL-5766-2020; Fernandes, Natalia/H-4537-2012; Kroon,
   Erna/V-5444-2019; Sacchetto, Livia/B-8841-2019; Vasilakis,
   Nikos/ABE-7318-2020
OI Bittar, Cintia/0000-0002-2048-4589; CATAO-DIAS, JOSE
   LUIZ/0000-0003-2999-3395; Neto, Francisco
   Chiaravalloti/0000-0003-2686-8740; Costa, Vivian
   VVC/0000-0002-0175-642X; Nogueira, Mauricio L/0000-0003-1102-2419;
   Guerra, Juliana Mariotti/0000-0002-0326-7187; Rahal,
   Paula/0000-0001-5693-6148; Teixeira, Mauro M/0000-0002-6944-3008;
   Rezende, Izabela Mauricio/0000-0003-2616-6300; Fernandes,
   Natalia/0000-0003-4754-4200; Sacchetto, Livia/0000-0001-9716-6899; Reis,
   AlessanRSS/0000-0001-8486-7469; Dantas Malossi,
   Camila/0000-0002-3841-2479
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/21719-3, 2016/15021-1, 2015/12295-0,
   2014/23159-8]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440593/2016-6]; INCT-Dengue; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES/Finance)
   [001]; NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1U01AI115577]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U01AI115577,
   U01AI115577, U01AI115577, U01AI115577] Funding Source: NIH RePORTER
FX We thank colleagues from Laboratorio de Virus and the team from
   Laboratorio de Zoonoses/Prefeitura de Belo Horizonte/MG. We thank Dr.
   Scott Weaver for critical reviewing of the manuscript. This work is
   supported by the Sao Paulo Research Foundation (FAPESP) via grants
   2013/21719-3 and 2016/15021-1 (MLN) and fellowships 2015/12295-0 (ACBT)
   and 2014/23159-8 (LSU). Additional support was provided by the FAPESP
   Zika Network, FAPEMIG (APQ01574-17), and CNPq (440593/2016-6) and
   INCT-Dengue. IMR and LS received fellowships from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES/Finance Code
   001). MLN and GST are CNPq Research Fellows. NV Zika work is supported
   by NIH grant 1U01AI115577 (NV).
CR Andrade EHP, 2016, AM J TROP MED HYG, V94, P1080, DOI 10.4269/ajtmh.15-0892
   [Anonymous], 2018, JORNAL BRASIL DESINF
   Ausubel F.M., 2003, CURRENT PROTOCOLS MO
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   BrazilGovNews, 2017, BRAZILGOVNEWS
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carrion R, 2012, CURR OPIN VIROL, V2, P357, DOI 10.1016/j.coviro.2012.02.007
   CHIU CY, 2017, SCI REP UK, V7
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Colombo TE, 2016, ACTA TROP, V164, P84, DOI 10.1016/j.actatropica.2016.09.004
   CONCEA, 2015, NORM CONCEA PROD MAN, P209
   Consoli RAGB, 1998, PRINCIPAIS MOSQUITOS
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   De Oliveira-Filho E. F, 2018, TRANSBOUND EMERG DIS, P1
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Dos Santos Marina Nogueira, 2014, Revista de Etologia, V13, P37
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Elias Colombo T, 2017, CLIN LAB VIROLOGICAL
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S., 2016, BIORXIV, DOI [10.1101/049395., DOI 10.1101/049395]
   Ferreira MS, 2014, IMMUNOL LETT, V158, P126, DOI 10.1016/j.imlet.2013.12.008
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Forattini O. P, 2002, CULICIDOLOGIA MED, V2
   Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI
   Garcia CC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001171
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Machado DC, 2012, INTERVIROLOGY, V55, P475, DOI 10.1159/000337166
   Mansfield K, 2003, COMPARATIVE MED, V53, P383
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Ministerio da Saude, 2017, INF ESP FEBR AM BRAS
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/msphere.00523-17, 10.1128/mSphere.00523-17]
   Nei M., 2000, MOL EVOLUTION PHYLOG
   Omatsu T, 2012, J MED PRIMATOL, V41, P289, DOI 10.1111/j.1600-0684.2012.00552.x
   Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0
   Osuna CE, 2017, NAT MED, V23, P264, DOI 10.1038/nm0217-264b
   Rylands AB, 2008, IUCN RED LIST THREAT
   SEFEROVIC M, 2018, SCI REP UK, V8
   Terzian ACB, 2017, EMERG INFECT DIS, V23, P1891, DOI 10.3201/eid2311.170078
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Vasilakis N, 2008, AM J TROP MED HYG, V79, P128, DOI 10.4269/ajtmh.2008.79.128
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   WHO, 2017, DIS OUTBREAK NEWS
NR 64
TC 27
Z9 27
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 30
PY 2018
VL 8
AR 16034
DI 10.1038/s41598-018-34423-6
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GY6SV
UT WOS:000448727000004
PM 30375482
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Sacchetto, L
   Zauli, DAG
   Costa, GB
   Guagliardo, SAJ
   Alvim, LB
   Marinho, FLD
   Abrahao, JS
   Trindade, GD
   Kroon, EG
   Mateo, ECC
   Drumond, BP
AF Sacchetto, Livia
   Gomes Zauli, Danielle Alves
   Costa, Galileu Barbosa
   Guagliardo, Sarah Anne J.
   Alvim, Luige Biciati
   de Oliveira Marinho, Feliciana Lage
   Abrahao, Jonatas Santos
   Trindade, Giliane de Souza
   Kroon, Erna Geessien
   Cueva Mateo, Elvis Cristian
   Drumond, Betania Paiva
TI Screening for Zika virus RNA in sera of suspected cases: a retrospective
   cross-sectional study
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Cross-sectional study; Epidemiology; Brazil; Dengue virus;
   Chikungunya virus
ID CASE SERIES; BRAZIL; INFECTION; OUTBREAK
AB Background: Zika virus (ZIKV) became a global human health concern owing to its rapid spread worldwide and its association with congenital and neurological disorders. The current epidemiological profile of arboviruses in Brazil is characterized by widespread co-circulation of Dengue virus, Chikungunya virus, and ZIKV throughout the country. These viruses cause acute diseases frequently with overlapping symptoms, which could result in an inaccurate diagnosis based solely on clinical and epidemiological grounds. Here we conducted a screening for ZIKV RNA in serum samples from patients across Brazil with suspected ZIKV infection.
   Methods: Using RT-qPCR, we investigated ZIKV RNA in 3001 serum samples. Samples were passively acquired through a private laboratory network, between December 2015 and August 2016, from 27 Brazilian Federative Units. We performed descriptive statistics on demographic variables including sex, age, and geographic location.
   Results: ZIKV was detected in 11.4% (95%CI = 10.3-12.6%) of the sera. ZIKV RNA was detected in sera collected throughout the country, but during the analyzed period, RNA was more frequently detected in samples from the Southeast, Midwest, and North regions (3.9 to 5.8 times higher) when compared to the Northeast and South regions.
   Conclusions: These data reinforce the importance of laboratory diagnosis, surveillance systems, and further epidemiological studies to understand the dynamics of outbreaks and diseases associated with ZIKV and other arboviruses.
C1 [Sacchetto, Livia; Costa, Galileu Barbosa; Abrahao, Jonatas Santos; Trindade, Giliane de Souza; Kroon, Erna Geessien; Drumond, Betania Paiva] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Bloco F4,Sala 258,Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Gomes Zauli, Danielle Alves; Alvim, Luige Biciati; de Oliveira Marinho, Feliciana Lage; Cueva Mateo, Elvis Cristian] Inst Hermes Pardini, Vespasiano, MG, Brazil.
   [Costa, Galileu Barbosa; Guagliardo, Sarah Anne J.] US Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA USA.
   [Guagliardo, Sarah Anne J.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
   [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Programa Posgrad Ciencias Biol, Juiz De Fora, MG, Brazil.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Bloco F4,Sala 258,Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Drumond, BP (corresponding author), Univ Fed Juiz de Fora, Programa Posgrad Ciencias Biol, Juiz De Fora, MG, Brazil.
EM betaniadrumond@ufmg.br
RI Kroon, Erna/V-5444-2019; Costa, Galileu Barbosa/M-5768-2019; Sacchetto,
   Livia/B-8841-2019
OI Sacchetto, Livia/0000-0001-9716-6899; Barbosa Costa,
   Galileu/0000-0001-7360-6722
FU Hermes Pardini Institute; Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
   [APQ-01703-14]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; Pro-Reitoria de Pesquisa da Universidade Federal
   de Minas Gerais;  [MCTIC/FNDCT-CNPq/ MEC-CAPES/MS-Decit-14/2016]
FX The study was supported by Hermes Pardini Institute, Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-01703-14],
   MCTIC/FNDCT-CNPq/ MEC-CAPES/MS-Decit-14/2016, Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Pro-Reitoria
   de Pesquisa da Universidade Federal de Minas Gerais. Livia Sacchetto is
   fellow from CAPES. Giliane de Souza Trindade, Jonatas Santos Abrahao and
   Erna Geessien Kroon are CNPq researchers.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bioclin QUIBASA, 2017, BIOG ZIK VIR PCR
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, 2016, CHIK
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Centres for Disease Control and Prevention, DENGUE
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Ministerio da Saude Brasil, 2016, PROC SER AD VIG FEBR
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization, 2016, ZIK VIR
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2017, B EPIDEMIOLOGICO, V48
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2017, B EP
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2016, B EPIDEMIOLOGICO, V47
   Smith DR, 2017, CRIT REV MICROBIOL, V43, P405, DOI [10.1080/1040841x.2016.1230974, 10.1080/1040841X.2016.1230974]
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 25
TC 0
Z9 0
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD OCT 11
PY 2018
VL 15
AR 155
DI 10.1186/s12985-018-1070-z
PG 8
WC Virology
SC Virology
GA GW9EK
UT WOS:000447284700001
PM 30305112
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Amaral, CD
   Costa, GB
   de Souza, WM
   Alves, PA
   Borges, IA
   Tolardo, AL
   Romeiro, MF
   Drumond, BP
   Abrahao, JS
   Kroon, EG
   Paglia, AP
   Figueiredo, LTM
   Trindade, GD
AF Amaral, Carolina Dourado
   Costa, Galileu Barbosa
   de Souza, William Marciel
   Alves, Pedro Augusto
   Borges, Iara Apolinario
   Tolardo, Aline Lavado
   Romeiro, Marilia Farignoli
   Drumond, Betania Paiva
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
   Paglia, Adriano Pereira
   Moraes Figueiredo, Luiz Tadeu
   Trindade, Giliane de Souza
TI Silent Orthohantavirus Circulation Among Humans and Small Mammals from
   Central Minas Gerais, Brazil
SO ECOHEALTH
LA English
DT Article
DE Orthohantavirus; Juquitiba virus; Rural population; Serosurvey; Small
   mammals; Disease ecology; Ecoepidemiology
ID HANTAVIRUS PULMONARY SYNDROME; SEROLOGICAL EVIDENCE; EMERGING PATHOGENS;
   SOUTHERN BRAZIL; ANDES-VIRUS; SAO-PAULO; INFECTION; STATE; RODENTS;
   AMERICA
AB New World orthohantaviruses are emerging RNA viruses that cause hantavirus cardiopulmonary syndrome (HCPS). These viruses are a burden to public health around the world with a lethality rate of around 60%. In South America, rodents of Sigmodontinae subfamily are the main reservoirs of orthohantaviruses. We described a serosurvey for orthohantaviruses circulation in an apparently healthy human population and small mammals from rural areas in Central Minas Gerais State, Brazil. A total of 240 individuals and 50 small mammals (26 rodents belonging to 10 different species and 24 marsupials from 4 different species) were sampled during 2012-2013. The seroprevalence rates of IgG/IgM antibodies in humans were 7.1 and 1.6%, respectively. Only one rodent, an Oligoryzomys nigripes captured in peridomestic area, tested positive for IgG antibodies and viral RNA. Our findings suggest a silent circulation of orthohantaviruses in a region of intensive agriculture production. The detection of seropositive humans in an area with a lack of previous HCPS reports highlights potential oligosymptomatic cases and the need for surveillance strategies that could reduce the risk of future outbreaks.
C1 [Amaral, Carolina Dourado; Costa, Galileu Barbosa; Borges, Iara Apolinario; Drumond, Betania Paiva; Abrahao, Jonatas Santos; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Souza, William Marciel; Tolardo, Aline Lavado; Romeiro, Marilia Farignoli; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Pesquisa Virol, Sao Paulo, Brazil.
   [Alves, Pedro Augusto] Inst Rene Rachou, Lab Imunol Doencas Virais, Fiocruz, MG, Brazil.
   [Paglia, Adriano Pereira] Univ Fed Minas Gerais, Lab Ecol & Conservacao, Belo Horizonte, MG, Brazil.
RP Costa, GB; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos, BR-31270901 Belo Horizonte, MG, Brazil.
EM galileuk1@gmail.com; giliane@icb.ufmg.br
RI de Souza, William Marciel/D-3044-2017; Paglia, Adriano P/A-7965-2012;
   Kroon, Erna/V-5444-2019; Costa, Galileu Barbosa/M-5768-2019; Alves,
   Pedro/T-7203-2019
OI de Souza, William Marciel/0000-0002-0025-8293; Paglia, Adriano
   P/0000-0001-9957-5506; Alves, Pedro/0000-0002-9659-5621; Barbosa Costa,
   Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Pro-Reitoria
   de Pesquisa/UFMG (PRPq)
FX We are thankful to colleagues from the Laboratorio de Virus (ICB-UFMG)
   and Centro de Pesquisa em Virologia, Faculdade de Medicina de Ribeirao
   Preto, for their excellent technical support. Financial support was
   provided by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG), and Pro-Reitoria de Pesquisa/UFMG (PRPq). J.S.
   Abrahao, E.G. Kroon, A. Paglia, L.T. Figueiredo, and G.S. Trindade are
   researchers from CNPq.
CR Araujo J, 2011, ARCH VIROL, V156, P1269, DOI 10.1007/s00705-011-0968-1
   Badra SJ, 2012, REV SOC BRAS MED TRO, V45, P468, DOI [10.1590/S0037-86822012005000005, 10.1590/s0037-86822012005000005]
   Borba L. d., 2013, CASE REPORTS, V2013
   Carver S, 2015, BIOSCIENCE, V65, P651, DOI 10.1093/biosci/biv047
   Costa GB, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0575-6
   Cruz CD, 2012, EMERG INFECT DIS, V18, P750, DOI 10.3201/eid1805.111111
   Vieira CJD, 2016, REV SOC BRAS MED TRO, V49, P348, DOI 10.1590/0037-8682-0026-2016
   de Oliveira RC, 2014, EMERG INFECT DIS, V20, P1568, DOI 10.3201/eid2009.131472
   de Oliveira RC, 2014, VIRUSES-BASEL, V6, P1929, DOI 10.3390/v6051929
   de Oliveira SV, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0036-5
   de Oliveira SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085137
   de Souza WM, 2011, REV SOC BRAS MED TRO, V44, P131, DOI 10.1590/s0037-86822011005000013
   Elliot R. M., 2013, FIELDS VIROLOGY, P1244
   Figueiredo LTM, 2008, BRAZ J MED BIOL RES, V41, P596, DOI 10.1590/S0100-879X2008000700008
   Figueiredo LTM, 2009, EMERG INFECT DIS, V15, P561, DOI 10.3201/eid1504.080289
   Firth C, 2012, J VIROL, V86, P13756, DOI 10.1128/JVI.02341-12
   Galeno H, 2002, EMERG INFECT DIS, V8, P657, DOI 10.3201/eid0807.010277
   Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1
   Guo WP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003159
   Guterres A, 2013, INFECT GENET EVOL, V18, P262, DOI 10.1016/j.meegid.2013.05.027
   Hjelle B, 2010, VIRUSES-BASEL, V2, P2559, DOI 10.3390/v2122559
   Holmes R, 2000, EMERG INFECT DIS, V6, P560, DOI 10.3201/eid0605.000523
   Instituto Brasileiro de Geografia e Estatistica-IBGE, 2017, EST POP 2017
   Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09
   Kruger DH, 2015, J CLIN VIROL, V64, P128, DOI 10.1016/j.jcv.2014.08.033
   Gimaque JBL, 2012, MEM I OSWALDO CRUZ, V107, P135, DOI 10.1590/S0074-02762012000100019
   Limongi JE, 2009, EMERG INFECT DIS, V15, P1981, DOI 10.3201/eid1512.090229
   Machado AM, 2013, VIRUSES-BASEL, V5, P2272, DOI 10.3390/v5092272
   Mattar S, 2004, EMERG INFECT DIS, V10, P2263, DOI 10.3201/eid1012.040821
   Medeiros DBA, 2010, MEM I OSWALDO CRUZ, V105, P665, DOI 10.1590/S0074-02762010000500011
   Mendes WS, 2004, EMERG INFECT DIS, V10, P1496, DOI 10.3201/eid1008.040002
   Menezes Filho HR, 2016, EPIDEMIOLIA SERVICOS, V25, P1, DOI [10.5123/S1679-49742016002100003, DOI 10.5123/S1679-49742016002100003]
   MILLS JN, 1995, J MAMMAL, V76, P716, DOI 10.2307/1382742
   Miranda JB, 2017, EMERG INFECT DIS, V23, P931, DOI 10.3201/eid2306.161643
   Montgomery JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001840
   Figueiredo LTM, 2009, AM J TROP MED HYG, V81, P273, DOI 10.4269/ajtmh.2009.81.273
   Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277
   Munoz-Zanzi C, 2015, VIRUSES-BASEL, V7, P2006, DOI 10.3390/v7042006
   Cuong NV, 2015, VECTOR-BORNE ZOONOT, V15, P65, DOI 10.1089/vbz.2014.1603
   Oliveira RC, 2009, ACTA TROP, V112, P212, DOI 10.1016/j.actatropica.2009.07.029
   Ore RMC, 2012, VECTOR-BORNE ZOONOT, V12, P683, DOI 10.1089/vbz.2011.0820
   Pereira GW, 2012, REV SOC BRAS MED TRO, V45, P117, DOI 10.1590/S0037-86822012000100022
   Pini N, 2003, EMERG INFECT DIS, V9, P1070
   Raboni SM, 2009, J GEN VIROL, V90, P2166, DOI 10.1099/vir.0.011585-0
   Rivas YJ, 2003, ANN TROP MED PARASIT, V97, P61, DOI 10.1179/000349803125002788
   Santos IO, 2013, REV SOC BRAS MED TRO, V46, P30, DOI 10.1590/S0037-86822012005000002
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2017, CAS CONF HANT BRAS G
   da Rosa EST, 2011, EMERG INFECT DIS, V17, P1527, DOI 10.3201/eid1708.101547
   Trindade GD, 2014, REV SOC BRAS MED TRO, V47, P778, DOI 10.1590/0037-8682-0033-2014
   Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066
   Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609
NR 51
TC 4
Z9 4
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD SEP
PY 2018
VL 15
IS 3
BP 577
EP 589
DI 10.1007/s10393-018-1353-2
PG 13
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA GX8MH
UT WOS:000448039100010
PM 30105563
DA 2020-11-30
ER

PT J
AU Cursino, AE
   Vilela, APP
   Franco-Luiz, APM
   de Oliveira, JG
   Nogueira, MF
   Araujo, JP
   de Aguiar, DM
   Kroon, EG
AF Cursino, Andreia Elisa
   Pessoa Vilela, Ana Paula
   Moreira Franco-Luiz, Ana Paula
   de Oliveira, Jaquelline Germano
   Nogueira, Marcia Furlan
   Araujo Junior, Joo Pessoa
   de Aguiar, Daniel Moura
   Kroon, Erna Geessien
TI Equine infectious anemia virus in naturally infected horses from the
   Brazilian Pantanal
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID PATHOGENIC FIELD STRAIN; MOLECULAR CHARACTERIZATION;
   NUCLEOTIDE-SEQUENCE; TISSUE MACROPHAGES; PERIPHERAL-BLOOD; 2006
   OUTBREAK; DISEASE; LOCALIZATION; TRANSMISSION; DIAGNOSIS
AB Equine infectious anemia (EIA) has a worldwide distribution, and is widespread in Brazil. The Brazilian Pantanal presents with high prevalence comprising equine performance and indirectly the livestock industry, since the horses are used for cattle management. Although EIA is routinely diagnosed by the agar gel immunodiffusion test (AGID), this serological assay has some limitations, so PCR-based detection methods have the potential to overcome these limitations and act as complementary tests to those currently used. Considering the limited number of equine infectious anemia virus (EIAV) sequences which are available in public databases and the great genome variability, studies of EIAV detection and characterization molecular remain important. In this study we detected EIAV proviral DNA from 23 peripheral blood mononuclear cell (PBMCs) samples of naturally infected horses from Brazilian Pantanal using a semi-nested-PCR (sn-PCR). The serological profile of the animals was also evaluated by AGID and ELISA for gp90 and p26. Furthermore, the EIAV PCR amplified DNA was sequenced and phylogenetically analyzed. Here we describe the first EIAV sequences of the 5' LTR of the tat gene in naturally infected horses from Brazil, which presented with 91% similarity to EIAV reference sequences. The Brazilian EIAV sequences also presented variable nucleotide similarities among themselves, ranging from 93,5% to 100%. Phylogenetic analysis showed that Brazilian EIAV sequences grouped in a separate clade relative to other reference sequences. Thus this molecular detection and characterization may provide information about EIAV circulation in Brazilian territories and improve phylogenetic inferences.
C1 [Cursino, Andreia Elisa; Pessoa Vilela, Ana Paula; Moreira Franco-Luiz, Ana Paula; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Cincias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Pessoa Vilela, Ana Paula] Univ Fed Santa Catarina, Hosp Univ, Lab Biol Mol Microbiol & Sorol, Florianopolis, SC, Brazil.
   [Moreira Franco-Luiz, Ana Paula] Viriontech Brasil Ind Insumos & Serv Biotecnol, Belo Horizonte, MG, Brazil.
   [de Oliveira, Jaquelline Germano] Fiocruz Minas, Inst Rene Rachou, Belo Horizonte, MG, Brazil.
   [Nogueira, Marcia Furlan] Embrapa Pantanal, Corumba, MS, Brazil.
   [Araujo Junior, Joo Pessoa] Univ Estadual Paulista, Inst Biociencias, Dept Microbiol & Imunol, UNESP, Botucatu, SP, Brazil.
   [Araujo Junior, Joo Pessoa] Univ Estadual Paulista, Inst Biotecnol, UNESP, Botucatu, SP, Brazil.
   [de Aguiar, Daniel Moura] Univ Fed Mato Grosso, Lab Virol & Rickettsioses, Fac Med Vet, Cuiaba, MT, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Cincias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
EM ernagkroon@gmail.com
RI Araujo, JP/Q-3043-2019; Vilela, Ana Paula Pessoa/Q-7538-2018; Kroon,
   Erna/V-5444-2019; Araujo, Joao Pessoa/C-2444-2012; Aguiar, Daniel
   Moura/G-9081-2012; Kroon, Erna/B-3631-2015
OI Araujo, JP/0000-0002-9153-1485; Vilela, Ana Paula
   Pessoa/0000-0001-9030-0688; Araujo, Joao Pessoa/0000-0002-9153-1485;
   Kroon, Erna/0000-0003-2721-3826
FU Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)
   [02.12.01.030.00.00]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [307423/2015-8]; Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation
   (FAPEMIG); Fundacao de Amparo a Pesquisa do Estado de Mato Grosso
   (FAPEMAT) [330980/2012]
FX This study was funded by Empresa Brasileira de Pesquisa Agropecuaria
   (EMBRAPA - Grant 02.12.01.030.00.00), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq - Grant 307423/2015-8),
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG),
   Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT -
   330980/2012). EGK, JPAG and DMA are fellows from CNPq.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   [Anonymous], OIE TERR MAN 2013 EQ
   [Anonymous], OIE LIST DIS INF INF
   BAZZO J.C, 2012, R GEOGR, V29, P141
   Borges AMCM, 2013, RES VET SCI, V95, P76, DOI 10.1016/j.rvsc.2013.02.011
   Capomaccio S, 2012, VIRUS RES, V163, P656, DOI 10.1016/j.virusres.2011.11.011
   Cappelli K, 2017, TRANSBOUND EMERG DIS, V64, P2104, DOI 10.1111/tbed.12631
   Cappelli K, 2011, J CLIN MICROBIOL, V49, P27, DOI 10.1128/JCM.01311-10
   COGGINS L, 1970, CORNELL VET, V60, P330
   Cook RF, 2013, VET MICROBIOL, V167, P181, DOI 10.1016/j.vetmic.2013.09.031
   Cook RF, 1998, J VIROL, V72, P1383, DOI 10.1128/JVI.72.2.1383-1393.1998
   Cook RF, 2002, J VIROL METHODS, V105, P171, DOI 10.1016/S0166-0934(02)00101-5
   Cook SJ, 2001, VET MICROBIOL, V79, P93, DOI 10.1016/S0378-1135(00)00348-5
   Craigo JK, 2013, VIRUSES-BASEL, V5, P2963, DOI 10.3390/v5122963
   Cullinane A, 2007, VET REC, V161, P647, DOI 10.1136/vr.161.19.647
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Dong JB, 2013, J GEN VIROL, V94, P360, DOI 10.1099/vir.0.047498-0
   Dong JB, 2012, ARCH VIROL, V157, P2105, DOI 10.1007/s00705-012-1406-8
   Dong JB, 2014, VET MICROBIOL, V174, P276, DOI 10.1016/j.vetmic.2014.08.004
   DORN P, 1990, J VIROL, V64, P1616, DOI 10.1128/JVI.64.4.1616-1624.1990
   Gaudaire D, 2018, TRANSBOUND EMERG DIS, V65, pe7, DOI 10.1111/tbed.12657
   Gregg K, 2009, THERIOGENOLOGY, V72, P289, DOI 10.1016/j.theriogenology.2009.03.009
   Harrold SM, 2000, J VIROL, V74, P3112, DOI 10.1128/JVI.74.7.3112-3121.2000
   International Committee on Taxonomy of Viruses (ICTV), 2017, RETROVIRIDAE
   ISSEL CJ, 1993, J VET DIAGN INVEST, V5, P137, DOI 10.1177/104063879300500136
   ISSEL CJ, 1988, VET MICROBIOL, V17, P251, DOI 10.1016/0378-1135(88)90069-7
   KAWAKAMI T, 1987, VIROLOGY, V158, P300, DOI 10.1016/0042-6822(87)90202-9
   KIM CH, 1992, J VIROL, V66, P3879, DOI 10.1128/JVI.66.6.3879-3882.1992
   Kuhar U, 2014, EQUINE VET J, V46, P386, DOI 10.1111/evj.12138
   Langemeier JL, 1996, J CLIN MICROBIOL, V34, P1481, DOI 10.1128/JCM.34.6.1481-1487.1996
   Leroux C, 2004, VET RES, V35, P485, DOI 10.1051/vetres:2004020
   Lichtenstein DL, 1996, J VIROL, V70, P3346, DOI 10.1128/JVI.70.6.3346-3354.1996
   McGuire TC, 2000, J GEN VIROL, V81, P2735, DOI 10.1099/0022-1317-81-11-2735
   MCGUIRE TC, 1971, AM J PATHOL, V62, P283
   Mealey RH, 2007, EQUINE INFECT DIS, P213
   Nagarajan MM, 2001, J VIROL METHODS, V94, P97, DOI 10.1016/S0166-0934(01)00283-X
   Nogueira MF, 2017, PESQUI VET BRASIL, V37, P227, DOI [10.1590/s0100-736x2017000300005, 10.1590/S0100-736X2017000300005]
   Oaks JL, 1998, J VIROL, V72, P7263, DOI 10.1128/JVI.72.9.7263-7269.1998
   Parreira DR, 2016, ACTA TROP, V163, P98, DOI 10.1016/j.actatropica.2016.08.005
   Petropoulos C, 1997, RETROVIRUSES
   Quinlivan M, 2007, VET REC, V160, P611, DOI 10.1136/vr.160.18.611
   Quinlivan M, 2013, J GEN VIROL, V94, P612, DOI 10.1099/vir.0.047191-0
   RUSHLOW K, 1986, VIROLOGY, V155, P309, DOI 10.1016/0042-6822(86)90195-9
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SELLON DC, 1992, J VIROL, V66, P5906, DOI 10.1128/JVI.66.10.5906-5913.1992
   Sharav T, 2017, J VET MED SCI, V79, P1884, DOI 10.1292/jvms.17-0202
   SHERMAN L, 1988, J VIROL, V62, P120, DOI 10.1128/JVI.62.1.120-126.1988
   Silva RAMS, 2004, PROGRAMA PREVENCAO C
   Silva RAMS, 2001, 29 EMBR PANT, V29
   STEPHENS RM, 1990, J VIROL, V64, P3716, DOI 10.1128/JVI.64.8.3716-3725.1990
   Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tigre DM, 2017, ARCH VIROL, V162, P873, DOI 10.1007/s00705-016-3172-5
   Tu YB, 2007, ARCH VIROL, V152, P209, DOI 10.1007/s00705-006-0830-z
   Wang XF, 2011, ARCH VIROL, V156, P353, DOI 10.1007/s00705-010-0877-8
   WHETTER L, 1990, J VIROL, V64, P5750, DOI 10.1128/JVI.64.12.5750-5756.1990
   Zheng YH, 2000, VIRUS RES, V68, P93, DOI 10.1016/S0168-1702(00)00147-7
NR 57
TC 2
Z9 2
U1 0
U2 7
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD SEP
PY 2018
VL 163
IS 9
BP 2385
EP 2394
DI 10.1007/s00705-018-3877-8
PG 10
WC Virology
SC Virology
GA GS2YM
UT WOS:000443432000009
PM 29752558
OA Green Published
DA 2020-11-30
ER

PT J
AU Faria, NR
   Kraemer, MUG
   Hill, SC
   de Jesus, JG
   Aguiar, RS
   Iani, FCM
   Xavier, J
   Quick, J
   du Plessis, L
   Dellicour, S
   Theze, J
   Carvalho, RDO
   Baele, G
   Wu, CH
   Silveira, PP
   Arruda, MB
   Pereira, MA
   Pereira, GC
   Lourenco, J
   Obolski, U
   Abade, L
   Vasylyeva, TI
   Giovanetti, M
   Yi, D
   Weiss, DJ
   Wint, GRW
   Shearer, FM
   Funk, S
   Nikolay, B
   Fonseca, V
   Adelino, TER
   Oliveira, MAA
   Silva, MVF
   Sacchetto, L
   Figueiredo, PO
   Rezende, IM
   Mello, EM
   Said, RFC
   Santos, DA
   Ferraz, ML
   Brito, MG
   Santana, LF
   Menezes, MT
   Brindeiro, RM
   Tanuri, A
   dos Santos, FCP
   Cunha, MS
   Nogueira, JS
   Rocco, IM
   da Costa, AC
   Komninakis, SCV
   Azevedo, V
   Chieppe, AO
   Araujo, ESM
   Mendonca, MCL
   dos Santos, CC
   dos Santos, CD
   Mares-Guia, AM
   Nogueira, RMR
   Sequeira, PC
   Abreu, RG
   Garcia, MHO
   Abreu, AL
   Okumoto, O
   Kroon, EG
   de Albuquerque, CFC
   Lewandowski, K
   Pullan, ST
   Carroll, M
   de Oliveira, T
   Sabino, EC
   Souza, RP
   Suchard, MA
   Lemey, P
   Trindade, GS
   Drumond, BP
   Filippis, AMB
   Loman, NJ
   Cauchemez, S
   Alcantara, LCJ
   Pybus, OG
AF Faria, N. R.
   Kraemer, M. U. G.
   Hill, S. C.
   de Jesus, J. Goes
   Aguiar, R. S.
   Iani, F. C. M.
   Xavier, J.
   Quick, J.
   du Plessis, L.
   Dellicour, S.
   Theze, J.
   Carvalho, R. D. O.
   Baele, G.
   Wu, C. -H.
   Silveira, P. P.
   Arruda, M. B.
   Pereira, M. A.
   Pereira, G. C.
   Lourenco, J.
   Obolski, U.
   Abade, L.
   Vasylyeva, T. I.
   Giovanetti, M.
   Yi, D.
   Weiss, D. J.
   Wint, G. R. W.
   Shearer, F. M.
   Funk, S.
   Nikolay, B.
   Fonseca, V.
   Adelino, T. E. R.
   Oliveira, M. A. A.
   Silva, M. V. F.
   Sacchetto, L.
   Figueiredo, P. O.
   Rezende, I. M.
   Mello, E. M.
   Said, R. F. C.
   Santos, D. A.
   Ferraz, M. L.
   Brito, M. G.
   Santana, L. F.
   Menezes, M. T.
   Brindeiro, R. M.
   Tanuri, A.
   dos Santos, F. C. P.
   Cunha, M. S.
   Nogueira, J. S.
   Rocco, I. M.
   da Costa, A. C.
   Komninakis, S. C. V.
   Azevedo, V.
   Chieppe, A. O.
   Araujo, E. S. M.
   Mendonca, M. C. L.
   dos Santos, C. C.
   dos Santos, C. D.
   Mares-Guia, A. M.
   Nogueira, R. M. R.
   Sequeira, P. C.
   Abreu, R. G.
   Garcia, M. H. O.
   Abreu, A. L.
   Okumoto, O.
   Kroon, E. G.
   de Albuquerque, C. F. C.
   Lewandowski, K.
   Pullan, S. T.
   Carroll, M.
   de Oliveira, T.
   Sabino, E. C.
   Souza, R. P.
   Suchard, M. A.
   Lemey, P.
   Trindade, G. S.
   Drumond, B. P.
   Filippis, A. M. B.
   Loman, N. J.
   Cauchemez, S.
   Alcantara, L. C. J.
   Pybus, O. G.
TI Genomic and epidemiological monitoring of yellow fever virus
   transmission potential
SO SCIENCE
LA English
DT Article
ID SPREAD; BRAZIL; ANGOLA
AB The yellow fever virus (YFV) epidemic in Brazil is the largest in decades. The recent discovery of YFV in Brazilian Aedes species mosquitos highlights a need to monitor the risk of reestablishment of urban YFV transmission in the Americas. We use a suite of epidemiological, spatial, and genomic approaches to characterize YFV transmission. We show that the age and sex distribution of human cases is characteristic of sylvatic transmission. Analysis of YFV cases combined with genomes generated locally reveals an early phase of sylvatic YFV transmission and spatial expansion toward previously YFV-free areas, followed by a rise in viral spillover to humans in late 2016. Our results establish a framework for monitoring YFV transmission in real time that will contribute to a global strategy to eliminate future YFV epidemics.
C1 [Faria, N. R.; Kraemer, M. U. G.; Hill, S. C.; du Plessis, L.; Theze, J.; Lourenco, J.; Obolski, U.; Abade, L.; Vasylyeva, T. I.; Wint, G. R. W.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, M. U. G.] Harvard Med Sch, Dept Pediat, Boston, MA USA.
   [de Jesus, J. Goes; Xavier, J.; Giovanetti, M.; Araujo, E. S. M.; Mendonca, M. C. L.; dos Santos, C. C.; dos Santos, C. D.; Mares-Guia, A. M.; Nogueira, R. M. R.; Sequeira, P. C.; de Oliveira, T.; Filippis, A. M. B.; Alcantara, L. C. J.] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Aguiar, R. S.; Silveira, P. P.; Arruda, M. B.; Menezes, M. T.; Brindeiro, R. M.; Tanuri, A.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Mol Virol Lab, Rio De Janeiro, Brazil.
   [Iani, F. C. M.; Pereira, M. A.; Pereira, G. C.; Adelino, T. E. R.; Oliveira, M. A. A.; Silva, M. V. F.] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Iani, F. C. M.; Carvalho, R. D. O.; Giovanetti, M.; Fonseca, V.; Sacchetto, L.; Figueiredo, P. O.; Rezende, I. M.; Mello, E. M.; Azevedo, V.; Kroon, E. G.; Trindade, G. S.; Drumond, B. P.; Alcantara, L. C. J.] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Quick, J.; Loman, N. J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Dellicour, S.; Baele, G.; Lemey, P.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium.
   [Wu, C. -H.] Univ Oxford, Dept Stat, Oxford, England.
   [Abade, L.] Univ Oxford, Global Hlth Network, Oxford, England.
   [Yi, D.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.
   [Weiss, D. J.; Shearer, F. M.] Univ Oxford, Nuffield Dept Med, Big Data Inst, Malaria Atlas Project, Oxford, England.
   [Funk, S.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Ctr Bioinformat, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, CNRS, Genom Evolut Modelisat & Sante UMR2000, Paris, France.
   [Fonseca, V.; de Oliveira, T.] Univ KwaZulu Natal, KwaZulu Natal Res Innovat & Sequencing Platform K, Sch Lab Med & Med Sci, Durban, South Africa.
   [Said, R. F. C.; Santos, D. A.; Ferraz, M. L.; Brito, M. G.; Santana, L. F.] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   [dos Santos, F. C. P.; Cunha, M. S.; Nogueira, J. S.; Rocco, I. M.; Souza, R. P.] Adolfo Lutz Inst, Nucleo Doencas Transmissao Vetorial, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Univ Fed Sao Paulo, Retrovirol Lab, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Sch Med ABC FMABC, Clin Immunol Lab, Santo Andre, SP, Brazil.
   [Chieppe, A. O.] Coordenacao Vigilancia Epidemiol Estado Rio de Ja, Rio De Janeiro, Brazil.
   [Abreu, R. G.; Garcia, M. H. O.] Minist Saude, Dept Vigilancia Doencas Transmissiveis, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Abreu, A. L.; Okumoto, O.] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Labs Saude Publ, Brasilia, DF, Brazil.
   [de Albuquerque, C. F. C.] OMS, OPAS, Brasilia, DF, Brazil.
   [Lewandowski, K.; Pullan, S. T.] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Carroll, M.] Publ Hlth England, NIHR HPRU Emerging & Zoonot Infect, London, England.
   [de Oliveira, T.] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.
   [Suchard, M. A.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA USA.
   [Suchard, M. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath & Human Genet, Los Angeles, CA 90095 USA.
RP Faria, NR; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Alcantara, LCJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
EM nuno.faria@zoo.ox.ac.uk; luiz.alcantara@ioc.fiocruz.br;
   oliver.pybus@zoo.ox.ac.uk
RI Rezende, Izabela Mauricio/AAL-5766-2020; Sabino, Ester
   Cerdeira/F-7750-2010; Sacchetto, Livia/B-8841-2019; Komninakis, Shirley
   V/B-2915-2010; Azevedo, Vasco A/B-1556-2019; Azevedo, Vasco
   A.C/F-4315-2011; Kroon, Erna/V-5444-2019; Pybus, Oliver G/B-2640-2012;
   Giovanetti, Marta/AAK-7408-2020; Aguiar, Renato S/G-3542-2015; da-Costa,
   Antonio Charlys/G-1548-2010; Loman, Nicholas/Z-1573-2019; Fonseca,
   Vagner/R-5813-2019; Faria, Nuno R/I-2975-2012; Funk, Stefan/B-7629-2015;
   Dellicour, Simon/AAE-9054-2020; du Plessis, Louis/K-1667-2013; Baele,
   Guy/R-8157-2017
OI Rezende, Izabela Mauricio/0000-0003-2616-6300; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Sacchetto, Livia/0000-0001-9716-6899;
   Komninakis, Shirley V/0000-0001-7784-3418; Azevedo, Vasco
   A/0000-0002-4775-2280; Azevedo, Vasco A.C/0000-0002-4775-2280; Pybus,
   Oliver G/0000-0002-8797-2667; Aguiar, Renato S/0000-0001-5180-3717;
   da-Costa, Antonio Charlys/0000-0001-5516-5177; Fonseca,
   Vagner/0000-0001-5521-6448; Faria, Nuno R/0000-0001-8839-2798; Funk,
   Stefan/0000-0002-2012-0080; Dellicour, Simon/0000-0001-9558-1052; Wu,
   Chieh-Hsi/0000-0001-9386-725X; Pereira de Souza,
   Renato/0000-0003-1315-7085; Alcantara, Luiz/0000-0002-6769-9931; Theze,
   Julien/0000-0001-8188-9494; du Plessis, Louis/0000-0003-0352-6289; De
   Jesus, Jaqueline/0000-0002-5404-272X; Iani, Felipe/0000-0002-3629-8529;
   Carvalho, Rodrigo/0000-0003-0216-7173; Funk,
   Sebastian/0000-0002-2842-3406; Pullan, Steven/0000-0002-8983-599X;
   Baele, Guy/0000-0002-1915-7732; Xavier, Joilson/0000-0003-3916-2018;
   Vasylyeva, Tetyana/0000-0002-9736-7022; Hill, Sarah/0000-0002-2995-2596
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [400354/2016-0]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2016/01735-2, 2017/00021-9]; Sir Henry Dale Fellowship
   [204311/Z/16/Z]; internal GCRF grant [005073]; John Fell Research Fund
   [005166]; ERCEuropean Research Council (ERC) [614725-PATHPHYLODYN];
   Oxford Martin School; Branco Weiss Fellowship; National Institute of
   Child Health and Human DevelopmentUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Eunice
   Kennedy Shriver National Institute of Child Health & Human Development
   (NICHD) [T32HD040128]; National Library of Medicine of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM) [R01LM010812, R01LM011965]; Fonds Wetenschappelijk
   Onderzoek (FWO, Flanders, Belgium)FWO; Interne Fondsen KU
   Leuven/Internal Funds KU Leuven; EU's Horizon 2020 Programme through
   ZIKAlliance [734548]; Investissement d'Avenir programFrench National
   Research Agency (ANR); Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program [ANR-10-LABX-62-IBEID]; Models of
   Infectious Disease Agent Study of the National Institute of General
   Medical Sciences; AXA Research Fund; Association Robert Debre; European
   Research CouncilEuropean Research Council (ERC) [725422-ReservoirDOCS];
   Wellcome TrustWellcome Trust [206298/Z/17/Z]; Research Foundation,
   Flanders (Fonds voor Wetenschappelijk Onderzoek, Vlaanderen)FWO
   [G066215N, G0D5117N, G0B9317N]; EUNICE KENNEDY SHRIVER NATIONAL
   INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [T32HD040128, T32HD040128, T32HD040128, T32HD040128,
   T32HD040128, T32HD040128, T32HD040128] Funding Source: NIH RePORTER;
   EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD040128,
   T32HD040128, T32HD040128, T32HD040128, T32HD040128, T32HD040128,
   T32HD040128, T32HD040128, T32HD040128] Funding Source: NIH RePORTER;
   NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM) [R01LM010812, R01LM010812, R01LM010812, R01LM010812,
   R01LM010812, R01LM011965, R01LM010812, R01LM011965, R01LM010812,
   R01LM010812, R01LM011965, R01LM011965] Funding Source: NIH RePORTER
FX This work was supported in part by CNPq 400354/2016-0 and FAPESP
   2016/01735-2. N.R.F. is supported by a Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN) and from the Oxford Martin School.
   M.U.G.K. acknowledges funding from a Branco Weiss Fellowship,
   administered by ETH Zurich, a Training Grant from the National Institute
   of Child Health and Human Development (T32HD040128), and the National
   Library of Medicine of the National Institutes of Health (R01LM010812
   and R01LM011965). S.D. is funded by the Fonds Wetenschappelijk Onderzoek
   (FWO, Flanders, Belgium). G.B. acknowledges support from the Interne
   Fondsen KU Leuven/Internal Funds KU Leuven. A.C.d.C. is funded by FAPESP
   2017/00021-9. B.B.N. and S.C. are supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant 734548), the Investissement
   d'Avenir program, the Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), the
   Models of Infectious Disease Agent Study of the National Institute of
   General Medical Sciences, the AXA Research Fund, and the Association
   Robert Debre. P.L. and M.A.S. acknowledge funding from the European
   Research Council (grant agreement 725422-ReservoirDOCS) and from the
   Wellcome Trust Collaborative Award 206298/Z/17/Z. P.L. acknowledges
   support from the Research Foundation, Flanders (Fonds voor
   Wetenschappelijk Onderzoek, Vlaanderen, G066215N, G0D5117N, and
   G0B9317N).
CR Auguste AJ, 2015, EMERG INFECT DIS, V21, P99, DOI 10.3201/eid2101.140814
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Brasil, 2017, B EPIDEMIOLOGICO, V48
   Camara FP, 2011, REV SOC BRAS MED TRO, V44, P297, DOI [10.1590/S0037-86822011005000024, 10.1590/s0037-86822011005000024]
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   CHANG GJJ, 1995, J VIROL, V69, P5773, DOI 10.1128/JVI.69.9.5773-5780.1995
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   do Nascimento Rafaela Almeida, 2013, Neotropical Biology and Conservation, V8, P79, DOI 10.4013/nbc.2013.82.03
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.31257, 10.7554/eLife.37324, 10.7554/elife.37324]
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3
   FRANCO Odair, 1969, HIST FEBRE AMARELA B
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gill MS, 2016, SYST BIOL, V65, P1041, DOI 10.1093/sysbio/syw050
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Jung L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129789
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/s1473-3099(16)30513-8, 10.1016/S1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   PAHO, 2009, OUTBR YELL FEV PAR
   Pan American Health Organization/World Health Organization, 2018, EP UPD YELL FEV 16 F
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46
   Segura M. N. O., 2007, ATLAS CULICIDEOS AMA, V167
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Stephens PR, 2017, ECOLOGY, V98, P1476, DOI 10.1002/ecy.1799
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Vainio J., 1998, YELLOW FEVER
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078
   Vaughan TG, 2014, BIOINFORMATICS, V30, P2272, DOI 10.1093/bioinformatics/btu201
   von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81236-0
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
NR 49
TC 79
Z9 80
U1 0
U2 14
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 31
PY 2018
VL 361
IS 6405
BP 894
EP +
DI 10.1126/science.aat7115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS3UB
UT WOS:000443547000033
PM 30139911
OA Green Accepted, Bronze
DA 2020-11-30
ER

PT J
AU Ananworanich, J
   Pinyakorn, S
   Avihingsanon, A
   Sophonphan, J
   Sacdalan, C
   Kroon, E
   Colby, D
   Suttichom, D
   Prueksakaew, P
   Ubolyam, S
   Trichavaroj, R
   de Souza, M
   Michael, N
   Robb, ML
   Phanuphak, P
   Phanuphak, N
AF Ananworanich, J.
   Pinyakorn, S.
   Avihingsanon, A.
   Sophonphan, J.
   Sacdalan, C.
   Kroon, E.
   Colby, D.
   Suttichom, D.
   Prueksakaew, P.
   Ubolyam, S.
   Trichavaroj, R.
   de Souza, M.
   Michael, N.
   Robb, M. L.
   Phanuphak, P.
   Phanuphak, N.
CA RV254 SEARCH 010 Study Grp
   HIV-NAT 006 Study Grp
TI Favorable clinical phenotype reached in less than half of people treated
   in acute HIV infection
SO JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
LA English
DT Meeting Abstract
C1 [Ananworanich, J.; Pinyakorn, S.; de Souza, M.; Robb, M. L.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA.
   [Ananworanich, J.; Pinyakorn, S.; de Souza, M.; Michael, N.; Robb, M. L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA.
   [Ananworanich, J.] Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands.
   [Avihingsanon, A.; Sophonphan, J.; Ubolyam, S.; Phanuphak, P.] Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand.
   [Sacdalan, C.; Kroon, E.; Colby, D.; Suttichom, D.; Prueksakaew, P.; de Souza, M.; Phanuphak, P.; Phanuphak, N.] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand.
   [Trichavaroj, R.] Armed Forces Res Inst Med Sci, Bangkok, Thailand.
RI Kroon, Erna/V-5444-2019; Phanuphak, Nittaya/AAA-8579-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 1758-2652
J9 J INT AIDS SOC
JI J. Int. AIDS Soc.
PD JUL
PY 2018
VL 21
SU 6
SI SI
MA WEPDB0102
BP 120
EP 120
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GO4RZ
UT WOS:000440002700248
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU de Rezende, IM
   Sacchetto, L
   de Mello, EM
   Alves, PA
   Iani, FCD
   Adelino, TER
   Duarte, MM
   Cury, ALF
   Bernardes, AFL
   Santos, TA
   Pereira, LS
   Dutra, MRT
   Ramalho, DB
   de Thoisy, B
   Kroon, EG
   Trindade, GD
   Drumond, BP
AF de Rezende, Izabela Mauricio
   Sacchetto, Livia
   de Mello, Erica Munhoz
   Alves, Pedro Augusto
   de Melo Iani, Felipe Campos
   Ribeiro Adelino, Talita Emile
   Duarte, Myrian Morato
   Furtado Cury, Ana Luisa
   Leal Bernardes, Andre Felipe
   Santos, Tayrine Araujo
   Pereira, Leonardo Soares
   Teixeira Dutra, Maria Rita
   Ramalho, Dario Brock
   de Thoisy, Benoit
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
   Drumond, Betania Paiva
TI Persistence of Yellow fever virus outside the Amazon Basin, causing
   epidemics in Southeast Brazil, from 2016 to 2018
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PHYML
AB Background
   Yellow fever (YF) is endemic in the Brazilian Amazon Basin, and sporadic outbreaks take place outside the endemic area in Brazil. Since 2016, YF epidemics have been occurring in Southeast Brazil, with more than 1,900 human cases and more than 1,600 epizooties of non-human primates (NHPs) reported until April 2018. Previous studies have demonstrated that Yellow fever virus (YFV) causing outbreaks in 2017 formed a monophyletic group.
   Methodology/Principal findings
   Aiming to decipher the origin of the YFV responsible for the recent epidemics, we obtained nucleotide sequences of YFV detected in humans (n = 6) and NHPs (n = 10) from Minas Gerais state during 2017 +/- 2018. Next, we performed evolutionary analyses and discussed the results in the light of epidemiological records (official numbers of YFV cases at each Brazilian Federative unit, reported by the Brazilian Ministry of Health). Nucleotide sequences of YFV from Southeast Brazil from 2016 to 2018 were highly conserved and formed a monophyletic lineage (BR-YFV_2016/18) within the genotype South America I. Different clusters were observed within lineage BR-YFV_2016/18, one containing the majority of isolates (from humans and NHPs), indicating the sylvatic transmission of YFV. We also detected a cluster characterized by two synapomorphies (amino acid substitutions) that contained YFV only associated with NHP what should be further investigated. The topology of lineage BRYFV_2016/18 was congruent with epidemiological and temporal patterns of the ongoing epidemic. YFV isolates detected in 2016, in Sao Paulo state were located in the most basal position of the lineage, followed by the isolates from Minas Gerais and Esp oA rito Santo obtained in 2017 and 2018. The most recent common ancestor of the lineage BRYFV_2016/18 dated to 2015 (95% credible intervals = 2014 +/- 2016), in a period that was coincident with the reemergence of YFV in the Midwest region of Brazil.
   Conclusions
   The results demonstrated a single introduction of YFV in the Southeast region and the silent viral circulation before the onset of the outbreaks in 2016. Evolutionary analyses combined with epidemiological records supported the idea that BR- YFV_2016/18 was probably introduced from the Midwest into the Southeast region, possibly in Sao Paulo state. The persistence of YFV in the Southeast region, causing epidemics from 2016 to 2018, suggests that this region presents suitable ecological and climatic conditions for YFV maintenance during the epidemic and interepidemic seasons. This fact poses risks for the establishing of YF enzootic cycles and epidemics, outside the Amazon Basin in Brazil. YF surveillance and studies of viral dynamics deserve particular attention, especially in Midwest, Southeast and neighbor regions which are the main areas historically associated with YF outbreaks outside the Amazon Basin. YFV persistence in Southeast Brazil should be carefully considered in the context of public health, especially for public health decision-makers and researchers.
C1 [de Rezende, Izabela Mauricio; Sacchetto, Livia; Kroon, Erna Geessien; Trindade, Giliane de Souza; Drumond, Betania Paiva] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [de Mello, Erica Munhoz] Ctr Controle Zoonoses Prefeitura Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Alves, Pedro Augusto] Fundacao Oswaldo Cruz, Inst Rene Rachou, Lab Imunol Doencas Virais, Belo Horizonte, MG, Brazil.
   [de Melo Iani, Felipe Campos; Ribeiro Adelino, Talita Emile; Duarte, Myrian Morato; Furtado Cury, Ana Luisa; Leal Bernardes, Andre Felipe] Fundacao Ezequiel Dias LACEN MG, Serv Virol & Riquetsioses, Belo Horizonte, MG, Brazil.
   [Santos, Tayrine Araujo; Pereira, Leonardo Soares; Teixeira Dutra, Maria Rita; Ramalho, Dario Brock] Fundacao Hosp Estado Minas Gerais, Hosp Eduardo Menezes, Belo Horizonte, MG, Brazil.
   [de Thoisy, Benoit] Inst Pasteur, Lab Interact Virus Hotes, Cayenne, French Guiana.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
EM betaniadrumond@ufmg.br
RI Sacchetto, Livia/B-8841-2019; Rezende, Izabela Mauricio/AAL-5766-2020;
   Alves, Pedro/T-7203-2019; Kroon, Erna/V-5444-2019
OI Sacchetto, Livia/0000-0001-9716-6899; Rezende, Izabela
   Mauricio/0000-0003-2616-6300; Alves, Pedro/0000-0002-9659-5621; Pereira,
   Leonardo/0000-0002-5426-0655; Iani, Felipe/0000-0002-3629-8529
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG) [APQ01574-17]; Pro-Reitoria
   de Pesquisa da Universidade Federal de Minas Gerais (PRPq-UFMG); GdST
   [440593/2016-6]; EGK [440911/2016-8]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); CNPqNational Council
   for Scientific and Technological Development (CNPq); ERDF from European
   Commission; Institut Pasteur de La Guyane; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX This work was supported by grant APQ01574-17, received by BPD from
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG;
   http://www.fapemig.br) and from Pro-Reitoria de Pesquisa da Universidade
   Federal de Minas Gerais (PRPq-UFMG; https://www.ufmg.br/prpq). Grants
   440593/2016-6 and 440911/2016-8 were received by GdST and EGK,
   respectively, by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq; http://www.cnpq.br). GdST and EGK are fellowships
   from CNPq. BdT received grant (Project RESERVOIRS) from ERDF from
   European Commission and Institut Pasteur de La Guyane. IMdR and LS
   received scholarships from Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES; www.capes.gov.br). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Araujo FAA, 2011, EPIDEMIOL SERV SAUDE, V20, P527, DOI 10.5123/S1679-49742011000400012
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   IBGE, 2018, I BRAS GEOGR EST
   Jorge TR, 2017, ACTA TROP, V166, P114, DOI 10.1016/j.actatropica.2016.09.030
   Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Ministe A rio da Sau A de, 2018, FEBR AM MIN SAUD AT
   Ministerio da Saude, 2001, DATASUS FEBR AM
   Ministerio da Saude, 2018, MON PER SAZ FEBR AM, V16
   Ministerio da Saude, 2018, MON PER SAZ FEB AM, V11, P11
   Ministerio da Saude, 2007, DATASUS FEBRE AMAREL
   Ministerio da Saude, 2015, REEM FEBR AM SILV BR, V46
   Ministerio da Saude, 2017, EM EP FEBR AM BRAS P, V48
   Ministerio do Meio Ambiente-MMA, 2018, DOWNL DAD GEOGR
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   QGIS Development Team (YEAR), 2009, QGIS GEOGR INF SYST
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Secretaria Estadual de Saude / SES-MG, 2018, INF FEBR AM
   Secretaria Estadual de Saude / SES-MG, 2017, COB VAC FEBR AM MIN
   Secretaria Estadual de Saude / SES-MG, 2018, INF EP FEBR AM 17 04, P12
   Secretaria Estadual de Saude / SES-MG, 2017, B EP FEBR AM MIN GER, V20
   Secretaria Estadual de Saude / SES-MG, 2018, INF EP FEBR AM 05 01
   Secretaria Estadual de Saude / SES-SP, 2017, B EP EP, P6
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
NR 32
TC 25
Z9 25
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2018
VL 12
IS 6
AR e0006538
DI 10.1371/journal.pntd.0006538
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GL8CX
UT WOS:000437442000027
PM 29864115
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Ferreira, FV
   Aguiar, ERGR
   Olmo, RP
   de Oliveira, KPV
   Silva, EG
   Sant'Anna, MRV
   Gontijo, ND
   Kroon, EG
   Imler, JL
   Marques, JT
AF Ferreira, Flavia Viana
   Guimaraes Rocha Aguiar, Eric Roberto
   Olmo, Roenick Proveti
   Vieira de Oliveira, Karla Pollyanna
   Silva, Emanuele Guimaraes
   Viana Sant'Anna, Mauricio Roberto
   Gontijo, Nelder de Figueiredo
   Kroon, Erna Geessien
   Imler, Jean Luc
   Marques, Joao Trindade
TI The small non-coding RNA response to virus infection in the Leishmania
   vector Lutzomyia longipalpis
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VESICULAR STOMATITIS-VIRUS; PHLEBOTOMINE SAND FLIES; CONTINUOUS
   CELL-LINE; NEW-JERSEY SEROTYPE; ANTIVIRAL IMMUNITY; SHANNONI DIPTERA;
   SINDBIS VIRUS; TOSCANA-VIRUS; AEDES-AEGYPTI; PIRNA PATHWAY
AB Sandflies are well known vectors for Leishmania but also transmit a number of arthropodborne viruses (arboviruses). Few studies have addressed the interaction between sandflies and arboviruses. RNA interference (RNAi) mechanisms utilize small non-coding RNAs to regulate different aspects of host-pathogen interactions. The small interfering RNA (siRNA) pathway is a broad antiviral mechanism in insects. In addition, at least in mosquitoes, another RNAi mechanism mediated by PIWI interacting RNAs (piRNAs) is activated by viral infection. Finally, endogenous microRNAs (miRNA) may also regulate host immune responses. Here, we analyzed the small non-coding RNA response to Vesicular stomatitis virus (VSV) infection in the sandfly Lutzoymia longipalpis. We detected abundant production of virus-derived si-RNAs after VSV infection in adult sandflies. However, there was no production of virus-derived piRNAs and only mild changes in the expression of vector miRNAs in response to infection. We also observed abundant production of virus-derived siRNAs against two other viruses in Lutzomyia Lulo cells. Together, our results suggest that the siRNA but not the piRNA pathway mediates an antiviral response in sandflies. In agreement with this hypothesis, pre-treatment of cells with dsRNA against VSV was able to inhibit viral replication while knock-down of the central siRNA component, Argonaute-2, led to increased virus levels. Our work begins to elucidate the role of RNAi mechanisms in the interaction between L. longipalpis and viruses and should also open the way for studies with other sandfly-borne pathogens.
C1 [Ferreira, Flavia Viana; Guimaraes Rocha Aguiar, Eric Roberto; Olmo, Roenick Proveti; Vieira de Oliveira, Karla Pollyanna; Silva, Emanuele Guimaraes; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Ferreira, Flavia Viana; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Viana Sant'Anna, Mauricio Roberto; Gontijo, Nelder de Figueiredo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Imler, Jean Luc] Univ Strasbourg, CNRS M3I UPR9022, Inserm MIR U1257, Strasbourg, France.
   [Guimaraes Rocha Aguiar, Eric Roberto] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Kroon, Erna/V-5444-2019; Olmo, Roenick/AAF-6412-2020; Marques, Joao
   T/F-7683-2012; Aguiar, Eric RGR/L-7989-2018; Aguiar, Eric/T-5076-2019;
   Gontijo, Nelder/D-2539-2013
OI Marques, Joao T/0000-0002-3457-3320; Aguiar, Eric
   RGR/0000-0002-8143-5756; Aguiar, Eric/0000-0002-8143-5756; Gontijo,
   Nelder/0000-0003-3357-2497
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenancao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Agence
   Nationale de la Recherche, Investissement d'AvenirProgramsFrench
   National Research Agency (ANR) [ANR-11-ASV3-002, ANR-10-LABX-36,
   ANR-11-EQPX-0022]
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (http://www.cnpq.br),
   Coordenancao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   (http://www.capes.gov.br/) and Fundacao de Amparo a Pesquisa do Estado
   de Minas Gerais (FAPEMIG) (http://www.fapemig.br) to JTM and EGK; and
   Agence Nationale de la Recherche
   (http://www.agence-nationale-recherche.fr/)(ANR-11-ASV3-002),
   Investissement d'AvenirPrograms (ANR-10-LABX-36; ANR-11-EQPX-0022) to
   JLI. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Adelman ZN, 2001, INSECT MOL BIOL, V10, P265, DOI 10.1046/j.1365-2583.2001.00267.x
   Alkan C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004519
   Bichaud L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001328
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Campbell CL, 2014, INSECT MOL BIOL, V23, P132, DOI 10.1111/imb.12070
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Chang YJE, 2000, J VIROL, V74, P4174, DOI 10.1128/JVI.74.9.4174-4182.2000
   Charrel RN, 2007, EMERG INFECT DIS, V13, P465, DOI 10.3201/eid1303.061086
   Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07
   Clarke GR, 1996, J VET DIAGN INVEST, V8, P105, DOI 10.1177/104063879600800117
   COMER JA, 1990, AM J TROP MED HYG, V42, P483, DOI 10.4269/ajtmh.1990.42.483
   COMER JA, 1992, J MED ENTOMOL, V29, P368, DOI 10.1093/jmedent/29.2.368
   Corbeil A, 2001, GENOME RES, V11, P1198, DOI 10.1101/gr.GR-1802R
   DAROSA APAT, 1984, AM J TROP MED HYG, V33, P999, DOI 10.4269/ajtmh.1984.33.999
   Depaquit J, 2010, EUROSURVEILLANCE, V15, P40
   DHANDA V, 1970, INDIAN J MED RES, V58, P179
   Dietrich I, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00090-17
   Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688
   Galbraith DA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004713
   Gammon DB, 2015, CURR OPIN INSECT SCI, V8, P111, DOI 10.1016/j.cois.2015.01.006
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313
   Aguiar ERGR, 2016, WIRES RNA, V7, P824, DOI 10.1002/wrna.1361
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Khoo CCH, 2013, INSECT MOL BIOL, V22, P104, DOI 10.1111/imb.12008
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Liu JS, 2013, J INSECT PHYSIOL, V59, P646, DOI 10.1016/j.jinsphys.2013.03.013
   Llewellyn ZN, 2002, VIRUS RES, V89, P65, DOI 10.1016/S0168-1702(02)00113-2
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Marques J, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/712603
   Mbow ML, 1998, J IMMUNOL, V161, P5571
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Moriconi M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005660
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nayak A, 2013, CURR TOP MICROBIOL, V371, P183, DOI 10.1007/978-3-642-37765-5_7
   Petit M, 2016, P NATL ACAD SCI USA, V113, pE4218, DOI 10.1073/pnas.1607952113
   Remoli ME, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1488-3
   Rey GJ, 2000, MEM I OSWALDO CRUZ, V95, P103, DOI 10.1590/S0074-02762000000100017
   Rossi E, 2008, ACTA TROP, V105, P158, DOI 10.1016/j.actatropica.2007.10.005
   Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schnettler E, 2013, J VIROL, V87, P2441, DOI 10.1128/JVI.02848-12
   Shrinet J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002616
   Sidwell RW, 2003, ANTIVIR RES, V57, P101, DOI 10.1016/S0166-3542(02)00203-6
   Slonchak A, 2014, J VIROL, V88, P8457, DOI 10.1128/JVI.00317-14
   Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525
   Spellberg MJ, 2015, P NATL ACAD SCI USA, V112, P14587, DOI 10.1073/pnas.1517124112
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Telleria EL, 2012, J BIOL CHEM, V287, P12985, DOI 10.1074/jbc.M111.331561
   TESH RB, 1988, ANNU REV ENTOMOL, V33, P169, DOI 10.1146/annurev.en.33.010188.001125
   TESH RB, 1987, AM J TROP MED HYG, V36, P653, DOI 10.4269/ajtmh.1987.36.653
   TESH RB, 1971, AM J EPIDEMIOL, V93, P491
   TESH RB, 1983, J MED ENTOMOL, V20, P199, DOI 10.1093/jmedent/20.2.199
   TESH RB, 1969, AM J EPIDEMIOL, V90, P255, DOI 10.1093/oxfordjournals.aje.a121068
   TESH RB, 1974, AM J TROP MED HYG, V23, P258, DOI 10.4269/ajtmh.1974.23.258
   TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436
   Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
NR 65
TC 4
Z9 6
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2018
VL 12
IS 6
AR e0006569
DI 10.1371/journal.pntd.0006569
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GL8CX
UT WOS:000437442000044
PM 29864168
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Parra, MCP
   Favaro, EA
   Dibo, MR
   Mondini, A
   Eiras, AE
   Kroon, EG
   Teixeira, MM
   Nogueira, ML
   Chiaravalloti-Neto, F
AF Pereira Parra, Maisa Carla
   Favaro, Eliane Aparecida
   Dibo, Margareth Regina
   Mondini, Adriano
   Eiras, Alvaro Eduardo
   Kroon, Erna Geessien
   Teixeira, Mauro Martins
   Nogueira, Mauricio Lacerda
   Chiaravalloti-Neto, Francisco
TI Using adult & IT;Aedes aegypti & IT; females to predict areas at risk
   for dengue transmission: A spatial case-control study
SO ACTA TROPICA
LA English
DT Article
DE Dengue virus; Entomological index; Aedes aegypti; Spatial analysis
ID AEDES-AEGYPTI; DIPTERA-CULICIDAE; FIELD-EVALUATION; SAO-PAULO; RIO
   PRETO; VIRUS; TRAPS; IDENTIFICATION; SURVEILLANCE; DISPERSAL
AB Introduction: Traditional indices for measuring dengue fever risk in a given area are based on the immature forms of the vector (larvae and pupae surveys). However, this is inefficient because only adult female mosquitoes actually transmit the virus. Based on these assumptions, our objective was to evaluate the association between an entomological index obtained from adult mosquito traps and the occurrence of dengue in a hyperendemic area. Additionally, we compared its cost to that of the Breteau Index (BI).
   Material and methods: We performed this study in Sao Jose do Rio Preto, SP, Brazil, between the epidemiological weeks of 36/2012 and 19/2013. BG-Sentinel and BG-Mosquitito traps were installed to capture adult mosquitoes. Positive and negative cases of dengue fever were computed and geocoded. We generated biweekly thematic maps of the entomological index, generated by calculating the number of adult Aedes aegypti females (NAF) per 100 households during a week by kriging, and based on the number of mosquitoes captured. The relation between the occurrence of dengue fever and the NAF was tested using a spatial case-control design and a generalized additive model and was controlled by the coordinates of the positive and negative cases of dengue fever.
   Results: Our analyses showed that increases in dengue fever cases occurred in parallel with increases in the number of Ae. aegypti females. The entomological index produced in our study correlates positively with the incidence of dengue, particularly during intervals when vector control measures were applied less intensively. The operational costs of our index were lower than those of the BI: NAF used 71.5% less human resources necessary to measure the Bl.
   Conclusions: Spatial analysis techniques and the number of adult Ae. aegypti females were used to produce an indicator of dengue risk. The index can be applied at various levels of spatial aggregation for an entire study area, as well as for sub-areas, such as city blocks. Even though the index is adequate to predict dengue risk, it should be tested and validated in various scenarios before routine use.
C1 [Pereira Parra, Maisa Carla; Favaro, Eliane Aparecida; Nogueira, Mauricio Lacerda] Fac Med Sao Jose Do Rio Preto, Lab Pesquisa Virol, Ave Brigadeiro Faria Lima 5416, Sao Jose Do Rio Preto, SP, Brazil.
   [Dibo, Margareth Regina] Superintendencia Controle Endem, Lab Entomol, Rua Cardeal Arcoverde 2878, BR-05408003 Sao Paulo, SP, Brazil.
   [Mondini, Adriano] Univ Estadual Paulista, Lab Saude Publ, Fac Ciencias Farmaceut, UNESP, Campus Araraquara,Rodovia Araraquara Jau Km 1, Araraquara, SP, Brazil.
   [Eiras, Alvaro Eduardo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Ave Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Ave Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
   [Teixeira, Mauro Martins] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Ave Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
   [Chiaravalloti-Neto, Francisco] Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Ave Doutor Arnaldo 715, Sao Paulo, SP, Brazil.
RP Chiaravalloti-Neto, F (corresponding author), Univ Sao Paulo, Fac Saude Publ, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
EM maisapparra@hotmail.com; eliane_favaro@yahoo.com.br;
   medibo@sucen.sp.gov.br; amondini@fcfar.unesp.br; alvaro@icb.ufmg.br;
   kroone@icb.ufmg.br; mmtex@icb.ufmg.br; mnogueira@famerp.br;
   franciscochiara@usp.br
RI Teixeira, Mauro M/A-4587-2008; Nogueira, Mauricio L/B-7599-2012; Eiras,
   Alvaro/Z-6023-2019; Neto, Francisco Chiaravalloti/F-8006-2012; Mondini,
   Adriano/AAB-4358-2020; Kroon, Erna/V-5444-2019; Mondini,
   Adriano/F-7446-2012
OI Teixeira, Mauro M/0000-0002-6944-3008; Nogueira, Mauricio
   L/0000-0003-1102-2419; Eiras, Alvaro/0000-0002-3045-0673; Neto,
   Francisco Chiaravalloti/0000-0003-2686-8740; Mondini,
   Adriano/0000-0002-5557-9721; Mondini, Adriano/0000-0002-5557-9721
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX We received grants from Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo - FAPESP (Grant 2013/21719-3 to MLN and FCN) and Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico - CNPq - (research fellows
   for MLN and FCN).
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Angel Bennet, 2008, Journal of Vector Borne Diseases, V45, P56
   Attaway DF, 2016, ACTA TROP, V158, P248, DOI 10.1016/j.actatropica.2016.02.018
   Barbosa GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002873
   Barrera R, 2016, BIOMEDICA, V36, P454, DOI 10.7705/biomedica.v36i3.2892
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Barbosa AAC, 2010, REV BRAS ENTOMOL, V54, P328, DOI 10.1590/S0085-56262010000200017
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   Chiaravalloti-Neto F, 2015, ACTA TROP, V142, P167, DOI 10.1016/j.actatropica.2014.11.017
   Coelho GE, 2012, REV INST MED TROP SP, V54, pS13, DOI 10.1590/S0036-46652012000700006
   Colombo TE, 2016, ACTA TROP, V164, P84, DOI 10.1016/j.actatropica.2016.09.004
   Colombo TE, 2013, REV INST MED TROP SP, V55, P275, DOI 10.1590/S0036-46652013000400009
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858
   CVE-Centro de VigilAncia Epidemiologica Prof. Alexandre Vranjac. Guia de vigilancia epidemiologica, 2012, GUIA VIGILANCIA EPID
   de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Fletcher R., 2014, CLIN EPIDEMIOLOGY
   Focks D.A., 2004, REV ENTOMOLOGICAL SA
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Forattini O. P., 2002, CULICIDOLOGIA MED ID, VII
   Gomes de AC, 1998, INF EPIDEMIOL SUS, V7, P49, DOI DOI 10.5123/S0104-16731998000300006
   Hapairai LK, 2013, J MED ENTOMOL, V50, P731, DOI 10.1603/ME12270
   Hastie T., 1990, GEN ADDITIVE MODELS
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Lau KW, 2013, TROP BIOMED, V30, P36
   Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277
   Machado DC, 2012, INTERVIROLOGY, V55, P475, DOI 10.1159/000337166
   Maciel-de-Freitas R, 2008, MEM I OSWALDO CRUZ, V103, P602, DOI 10.1590/S0074-02762008000600016
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   de Figueiredo RMP, 2013, REV SOC BRAS MED TRO, V46, P221, DOI 10.1590/0037-8682-1096-2013
   R Core Team, 2017, R LANG ENV STAT COMP
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Ribeiro Jr P. J., 2001, R NEWS, V1, P14
   Rocco IM, 2012, REV INST MED TROP SP, V54, P49, DOI 10.1590/S0036-46652012000100009
   Rodriguez -Morales A. J., 2016, F1000 RES, P5
   Ruiz-Moreno D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1348-y
   Staler LM., 2011, SCI PLENA, V7
   SUCEN, 1997, MAN VIG ENT AED AEG
   SUCEN, 2017, AT VIG CONTR DENG SU
   SVS, 2017, B EP BEPA
   Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004500
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zayed A, 2012, ACTA TROP, V123, P62, DOI 10.1016/j.actatropica.2012.03.004
   Zeidler Julianna Dias, 2008, Rev. Saúde Pública, V42, P986, DOI 10.1590/s0034-89102008000600002
NR 50
TC 4
Z9 4
U1 0
U2 12
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUN
PY 2018
VL 182
BP 43
EP 53
DI 10.1016/j.actatropica.2018.02.018
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GD5BT
UT WOS:000430520700007
PM 29462598
OA Green Published
DA 2020-11-30
ER

PT J
AU de Oliveira, LC
   Brasil, BSAF
   Unger, B
   Trindade, GS
   Abrahao, JS
   Kroon, EG
   Traktman, P
   Bonjardim, CA
AF de Oliveira, Leonardo C.
   Brasil, Bruno S. A. F.
   Unger, Bethany
   Trindade, Giliane S.
   Abrahao, Jonatas S.
   Kroon, Erna G.
   Traktman, Paula
   Bonjardim, Claudio A.
TI The Host Factor Early Growth Response Gene (EGR-1) Regulates Vaccinia
   virus Infectivity during Infection of Starved Mouse Cells
SO VIRUSES-BASEL
LA English
DT Article
DE early growth response-1 (EGR-1); mitogen-activated protein kinase
   (MAPK); Vaccinia virus; virus-host cell interaction
ID TRANSCRIPTION FACTOR YY1; LATE PROMOTER; BRAIN PLASTICITY;
   CANCER-TREATMENT; BINDING PROTEIN; IMMUNE EVASION; POXVIRUS;
   IDENTIFICATION; INTERMEDIATE; KINASE
AB Evolution has equipped poxvirus genomes with the coding capacity for several virus-host interaction products which interfere with host cell gene expression and protein function, creating an adequate intracellular environment for a productive infection. We show here that Vaccinia virus (VACV) induces the expression of the cellular transcription factor EGR-1 (early growth response-1) in Mouse Embryonic Fibroblasts (MEFs) through the MEK (mitogen-activated protein kinase (MAPK)/ERK)/ERK (extracellular signal-regulated kinases) pathway, from 3 to 12 h post infection (h.p.i.). By using starved egr-1 knockout (egr-1(-/-)) MEFs, we demonstrate that VACV replication is reduced by similar to 1 log in this cell line. Although western blotting and electron microscopy analyses revealed no difference in VACV gene expression or morphogenesis, the specific infectivity of VACV propagated in egr-1(-/-) MEFs was lower than virus propagated in wild type (WT) cells. This lower infectivity was due to decreased VACV DNA replication during the next cycle of infection. Taken together, these results revealed that EGR-1 appears to facilitate VACV replication in starved fibroblasts by affecting viral particles infectivity.
C1 [de Oliveira, Leonardo C.; Brasil, Bruno S. A. F.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal, BR-31270901 Belo Horizonte, Minas, Brazil.
   [de Oliveira, Leonardo C.; Brasil, Bruno S. A. F.; Trindade, Giliane S.; Abrahao, Jonatas S.; Kroon, Erna G.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [Unger, Bethany] Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA.
   [Traktman, Paula] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.
   [Traktman, Paula] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal, BR-31270901 Belo Horizonte, Minas, Brazil.; Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM ldeolive2@gmail.com; brunosafb@gmail.com; bugs@mcw.edu;
   gitrindade@yahoo.com.br; jonatas.abrahao@gmail.com;
   ernagkroon@gmail.com; traktman@musc.edu; cbonjardim29@gmail.com
RI Kroon, Erna/V-5444-2019; Brasil, Bruno S. A. F./E-8817-2012
OI Brasil, Bruno S. A. F./0000-0002-8690-2157; Traktman,
   Paula/0000-0002-6517-0225
FU Fundacao de Amparo a Pesquisa do Estado de Minas GeraisMinas Gerais
   State Research Foundation (FAPEMIG) [FAPEMIG-CBB-APQ-01670-11,
   CBB-AUC-00071-15]; Coordenadoria de Aperfeicoamento de Pessoal de Nivel
   Superior [CAPES-AUXPE/PROEX/2015]; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [CNPq-477187/2010-2]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [RO1 AI063620, R01 AI21758]; CNPqNational Council for Scientific
   and Technological Development (CNPq); NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI063620, R01AI063620,
   R01AI063620, R01AI063620, R01AI063620] Funding Source: NIH RePORTER
FX The authors are grateful to Angela S. Lopes, Ilda M.V. Gama (in
   memorian), Joao R. dos Santos, Andreza A. Carvalho and Gisele O.L.
   Rodrigues, for their secretarial/technical assistance. This work was
   supported by Grants awarded to CAB from Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG-CBB-APQ-01670-11; CBB-AUC-00071-15),
   Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES-AUXPE/PROEX/2015). Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq-477187/2010-2). PT was supported by NIH
   grants RO1 AI063620 and R01 AI21758. BSAFB and LCO were recipients of a
   pre-doctoral fellowship from CNPq. CAB, EGK, JSA and GST are recipients
   of research fellowships from CNPq.
CR Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   Ausubel F. M, 1998, CURRENT PROTOCOLS MO, P118
   Bonjardim CA, 2017, VIROLOGY, V507, P267, DOI 10.1016/j.virol.2016.12.011
   BROWN JP, 1985, NATURE, V313, P491, DOI 10.1038/313491a0
   Broyles SS, 1999, J BIOL CHEM, V274, P35662, DOI 10.1074/jbc.274.50.35662
   Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0
   Burdon JJ, 2013, CURR OPIN PLANT BIOL, V16, P400, DOI 10.1016/j.pbi.2013.05.003
   Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006
   Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   de Oliveira JS, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110340
   De Silva FS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-145
   Duclot F, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00035
   Dyson OF, 2010, J BIOL CHEM, V285, P37491, DOI 10.1074/jbc.M110.159103
   Fan Y, 2011, J NEUROIMMUNE PHARM, V6, P121, DOI 10.1007/s11481-010-9217-8
   Fukuhara H, 2016, CANCER SCI, V107, P1373, DOI 10.1111/cas.13027
   Haddad D, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00096
   Hsia S C, 2013, Br Microbiol Res J, V3, P706
   Johnston JB, 2004, CELL MICROBIOL, V6, P695, DOI 10.1111/j.1462-5822.2004.00423.x
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Katsafanas GC, 2004, J BIOL CHEM, V279, P52210, DOI 10.1074/jbc.M411033200
   Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005
   Knipe D. M, 2013, FIELDS VIROLOGY, P2130
   Knutson BA, 2006, J VIROL, V80, P6784, DOI 10.1128/JVI.02705-05
   Knutson BA, 2009, J GEN VIROL, V90, P1592, DOI 10.1099/vir.0.006924-0
   Lefkowitz EJ, 2006, VIRUS RES, V117, P105, DOI 10.1016/j.virusres.2006.01.016
   Leite F.G.G., 2017, ARCH VIROL
   Liu CT, 1998, CANCER GENE THER, V5, P3
   McCart JA, 2001, CANCER RES, V61, P8751
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   Mo M, 2009, P NATL ACAD SCI USA, V106, P19527, DOI 10.1073/pnas.0905893106
   Moss B, 2013, COLD SPRING HARB PER, V5
   Oh J, 2005, J VIROL, V79, P12852, DOI 10.1128/JVI.79.20.12852-12860.2005
   Olson VA, 2004, J CLIN MICROBIOL, V42, P1940, DOI 10.1128/JCM.42.5.1940-1946.2004
   Park YJ, 2016, CANCER LETT, V370, P222, DOI 10.1016/j.canlet.2015.10.021
   Postigo A, 2009, CELL MICROBIOL, V11, P1208, DOI 10.1111/j.1462-5822.2009.01327.x
   Romagnoli L, 2008, VIROLOGY, V375, P331, DOI 10.1016/j.virol.2008.02.021
   ROSALES R, 1994, J BIOL CHEM, V269, P14260
   Sambrook J., 1989, MOL CLONING LAB MANU, P78
   Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049
   Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509
   Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6
   Simpson-Holley M, 2011, J VIROL, V85, P1581, DOI 10.1128/JVI.02247-10
   Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0
   SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0
   Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178
   TWARDZIK DR, 1985, P NATL ACAD SCI USA, V82, P5300, DOI 10.1073/pnas.82.16.5300
   Veyrac A, 2014, PROG MOL BIOL TRANSL, V122, P89, DOI 10.1016/B978-0-12-420170-5.00004-0
   Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124
   Vockerodt M, 2013, J PATHOL, V230, P399, DOI 10.1002/path.4198
   Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132
   Wright CF, 1998, J VIROL, V72, P1446, DOI 10.1128/JVI.72.2.1446-1451.1998
   Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033
   Yoder JD, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-10
   Yoo NK, 2008, CELL MICROBIOL, V10, P583, DOI 10.1111/j.1462-5822.2007.01047.x
NR 55
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2018
VL 10
IS 4
AR 140
DI 10.3390/v10040140
PG 13
WC Virology
SC Virology
GA GJ3HZ
UT WOS:000435184400001
PM 29561772
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Pires, MA
   Rodrigues, NFS
   de Oliveira, DB
   de Assis, FL
   Costa, GB
   Kroon, EG
   Mota, BEF
AF Pires, Mariana A.
   Rodrigues, Nathalia F. S.
   de Oliveira, Danilo B.
   de Assis, Felipe L.
   Costa, Galileu B.
   Kroon, Erna G.
   Mota, Bruno E. F.
TI In vitro susceptibility to ST-246 and Cidofovir corroborates the
   phylogenetic separation of Brazilian Vaccinia virus into two clades
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Poxvirus; Brazilian Vaccinia virus; ST-246; Cidofovir; Antivirals
ID NONHUMAN-PRIMATES; COMPOUND ST-246; CANTAGALO VIRUS; ORTHOPOXVIRUS;
   SMALLPOX; MONKEYPOX; EFFICACY; COWPOX; STRAIN; RESISTANCE
AB The Orthopoxvirus (OPV) genus of the Poxviridae family contains several human pathogens, including Vaccinia virus (VACV), which have been implicating in outbreaks of a zoonotic disease called Bovine Vaccinia in Brazil. So far, no approved treatment exists for OPV infections, but ST-246 and Cidofovir (CDV) are now in clinical development. Therefore, the objective of this work was to evaluate the susceptibility of five strains of Brazilian VACV (Br-VACV) to ST-246 and Cidofovir. The susceptibility of these strains to both drugs was evaluated by plaque reduction assay, extracellular virus's quantification in the presence of ST-246 and one-step growth curve in cells treated with CDV. Besides that, the ORFs F13L and E9L were sequenced for searching of polymorphisms associated with drug resistance. The effective concentration of 50% (EC50) from both drugs varies significantly for different strains (from 0.0054 to 0.051 mu M for ST-246 and from 27.14 to 61.23 mu M for CDV). ST-246 strongly inhibits the production of extracellular virus for all isolates in concentrations as low as 0.1 mu M and it was observed a relevant decrease of progeny production for all Br-VACV after CDV treatment. Sequencing of the F13L and E9L ORFs showed that Br-VACV do not present the polymorphism(s) associated with resistance to ST-246 and CDV. Taken together, our results showed that ST-246 and CDV are effective against diverse, wild VACV strains and that the susceptibility of Br-VACV to these drugs mirrored the phylogenetic split of these isolates into two groups. Thus, both ST-246 and CDV are of great interest as compounds to treat individuals during Bovine Vaccinia outbreaks in Brazil.
C1 [Pires, Mariana A.; Rodrigues, Nathalia F. S.; Mota, Bruno E. F.] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Lab Microbiol Clin, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo B.; de Assis, Felipe L.; Costa, Galileu B.; Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo B.] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Campus JK,Rodovia MGT367,KM 583,5000, Diamantina, Brazil.
RP Mota, BEF (corresponding author), Univ Fed Minas Gerais, Fac Farm, Sala 4112,Bloco 3,Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM brunofmota@ufmg.br
RI Costa, Galileu Barbosa/M-5768-2019; Kroon, Erna/V-5444-2019
OI Rodrigues, Nathalia/0000-0002-2008-6476; Barbosa Costa,
   Galileu/0000-0001-7360-6722; Mota, Bruno/0000-0003-0348-4875
FU Brazilian National Council for Scientific and Technologic Development
   (CNPq, Brazil); UFMG intramural funds (PRPq, UFMG, Brazil)
FX This work was supported by grants provided by the Brazilian National
   Council for Scientific and Technologic Development (CNPq, Brazil) and by
   UFMG intramural funds (PRPq, UFMG, Brazil). The sponsors had no role in
   study design and in collection, analysis and interpretation of data.
   This work was carried out despite serious cuts in the Science and
   Technology budget made by the current illegitimate government of Brazil.
CR Andrei G, 2006, J VIROL, V80, P9391, DOI 10.1128/JVI.00605-06
   Andrei G, 2010, VIRUSES-BASEL, V2, P2803, DOI 10.3390/v2122803
   Assis FL, 2012, EMERG INFECT DIS, V18, P2035, DOI 10.3201/eid1812.120145
   Baker R, 2003, ANTIVIR RES, V57, P13, DOI 10.1016/S0166-3542(02)00196-1
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   de Oliveira DB, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/275617
   DESOUZA TG, 2003, EMERG INFECT DIS, V9, P155, DOI DOI 10.3201/EID0902.020244
   Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Duraffour S, 2007, ANTIVIR THER, V12, P1205
   Duraffour S, 2015, J ANTIMICROB CHEMOTH, V70, P1367, DOI 10.1093/jac/dku545
   Duraffour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055808
   Duroffour S, 2008, ANTIVIR THER, V13, P977
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Farlow J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-110
   Goff A, 2007, VIRUS RES, V128, P88, DOI 10.1016/j.virusres.2007.04.014
   Grosenbach DW, 2010, P NATL ACAD SCI USA, V107, P838, DOI 10.1073/pnas.0912134107
   Huggins J, 2009, ANTIMICROB AGENTS CH, V53, P2620, DOI 10.1128/AAC.00021-09
   Jesus DM, 2009, INT J ANTIMICROB AG, V33, P75, DOI 10.1016/j.ijantimicag.2008.07.015
   Jordan R, 2009, ANTIMICROB AGENTS CH, V53, P1817, DOI 10.1128/AAC.01596-08
   Keith KA, 2004, ANTIMICROB AGENTS CH, V48, P1869, DOI 10.1128/AAC.48.5.1869-1871.2004
   Keith KA, 2003, ANTIMICROB AGENTS CH, V47, P2193, DOI 10.1128/AAC.47.7.2193-2198.2003
   Kornbluth RS, 2006, ANTIMICROB AGENTS CH, V50, P4038, DOI 10.1128/AAC.00380-06
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Franco-Luiz APM, 2016, COMP IMMUNOL MICROB, V46, P16, DOI 10.1016/j.cimid.2016.03.003
   Mucker EM, 2013, ANTIMICROB AGENTS CH, V57, P6246, DOI 10.1128/AAC.00977-13
   Santos-Fernandes E, 2013, ANTIVIR RES, V97, P301, DOI 10.1016/j.antiviral.2012.11.010
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Smee DF, 2003, CHEMOTHERAPY, V49, P126, DOI 10.1159/000070618
   Smith SK, 2009, ANTIMICROB AGENTS CH, V53, P1007, DOI 10.1128/AAC.01044-08
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74
   Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005
NR 38
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD APR
PY 2018
VL 152
BP 36
EP 44
DI 10.1016/j.antiviral.2018.02.005
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GB9ML
UT WOS:000429397800005
PM 29427676
DA 2020-11-30
ER

PT J
AU Borges, IA
   Reynolds, MG
   McCollum, AM
   Figueiredo, PO
   Ambrosio, LLD
   Vieira, FN
   Costa, GB
   Matos, ACD
   Almeida, VMD
   Ferreira, PCP
   Lobato, ZIP
   dos Reis, JKP
   Kroon, EG
   Trindade, GS
AF Borges, Iara A.
   Reynolds, Mary G.
   McCollum, Andrea M.
   Figueiredo, Poliana O.
   Ambrosio, Lara L. D.
   Vieira, Flavia N.
   Costa, Galileu B.
   Matos, Ana C. D.
   Almeida, Valeria M. de Andrade
   Ferreira, Paulo C. P.
   Lobato, Zelia I. P.
   dos Reis, Jenner K. P.
   Kroon, Erna G.
   Trindade, Giliane S.
TI Serological Evidence of Orthopoxvirus Circulation Among Equids,
   Southeast Brazil
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Vaccinia virus; horsepox; bovine vaccinia; Equine Vaccinia; Horse
   diseases
ID VACCINIA-VIRUS; SMALLPOX VACCINE; BOVINE VACCINIA; INFECTION; OUTBREAK;
   CATTLE; HORSEPOX; DISEASE; HUMANS
AB Since 1999 Vaccinia virus (VACV) outbreaks involving bovines and humans have been reported in Brazil; this zoonosis is known as Bovine Vaccinia (BV) and is mainly an occupational disease of milkers. It was only in 2008 (and then again in 2011 and 2014) however, that VACV was found causing natural infections in Brazilian equids. These reports involved only equids, no infected humans or bovines were identified, and the sources of infections remain unknown up to date. The peculiarities of Equine Vaccinia outbreaks (e.g., absence of human infection), the frequently shared environments, and fomites by equids and bovines in Brazilian farms and the remaining gaps in BV epidemiology incited a question over OPV serological status of equids in Brazil. For this report, sera from 621 equids - representing different species, ages, sexes and locations of origin within Minas Gerais State, southeast Brazil - were examined for the presence of anti-Orthopoxvirus (OPV) antibodies. Only 74 of these were sampled during an Equine Vaccinia outbreak, meaning some of these specific animals presented typical lesions of OPV infections. The majority of sera, however, were sampled from animals without typical signs of OPV infection and during the absence of reported Bovine or Equine Vaccinia outbreaks. Results suggest the circulation of VACV among equids of southeast Brazil even prior to the time of the first VACV outbreak in 2008. There is a correlation of OPVs outbreaks among bovines and equids although many gaps remain to our understanding of its nature. The data obtained may even be carefully associated to recent discussion over OPVs history. Moreover, data is available to improve the knowledge and instigate new researches regarding OPVs circulation in Brazil and worldwide.
C1 [Borges, Iara A.; Figueiredo, Poliana O.; Ambrosio, Lara L. D.; Vieira, Flavia N.; Costa, Galileu B.; Matos, Ana C. D.; Almeida, Valeria M. de Andrade; Ferreira, Paulo C. P.; Lobato, Zelia I. P.; dos Reis, Jenner K. P.; Kroon, Erna G.; Trindade, Giliane S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Reynolds, Mary G.; McCollum, Andrea M.] Ctr Dis Control & Prevent CDC, Atlanta, GA USA.
RP Borges, IA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM borges2805@gmail.com
RI Kroon, Erna/V-5444-2019; Costa, Galileu Barbosa/M-5768-2019; Reis,
   Jenner/AAJ-9164-2020
OI Reis, Jenner/0000-0003-0395-358X; Reynolds, Mary/0000-0001-7882-4614;
   Barbosa Costa, Galileu/0000-0001-7360-6722; Lobato,
   Zelia/0000-0002-9399-3691
CR Abrahao JS, 2017, EQUINE VET J, V49, P221, DOI 10.1111/evj.12571
   Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Baxby D, 1999, VACCINE, V17, P301, DOI 10.1016/S0264-410X(98)00207-2
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   D'Anunciacao L, 2012, VECTOR-BORNE ZOONOT, V12, P61, DOI 10.1089/vbz.2011.0671
   Damaso CR, 2018, LANCET INFECT DIS, V18, pE55, DOI 10.1016/S1473-3099(17)30445-0
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Emerson GL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007666
   Esparza J, 2017, VACCINE, V35, P7222, DOI 10.1016/j.vaccine.2017.11.003
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Gallardo-Romero NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043881
   Barbosa CHG, 2016, CIENC RURAL, V46, P519, DOI 10.1590/0103-8478cr20150289
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Matos A. C. D., 2013, P 24 C BRAS VIR 8 EN, V18, P240
   Newman FK, 2003, J CLIN MICROBIOL, V41, P3154, DOI 10.1128/JCM.41.7.3154-3157.2003
   Rivetti AV, 2013, VET MICROBIOL, V162, P103, DOI 10.1016/j.vetmic.2012.09.005
   Schrick L, 2017, NEW ENGL J MED, V377, P1491, DOI 10.1056/NEJMc1707600
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
NR 25
TC 1
Z9 1
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAR 8
PY 2018
VL 9
AR 402
DI 10.3389/fmicb.2018.00402
PG 7
WC Microbiology
SC Microbiology
GA FY5BA
UT WOS:000426839900001
PM 29568288
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Silva, LKD
   Andrade, ACDP
   Dornas, FP
   Rodrigues, RAL
   Arantes, T
   Kroon, EG
   Bonjardim, CA
   Abrahao, JS
AF dos Santos Silva, Ludmila Karen
   dos Santos Pereira Andrade, Ana Claudia
   Dornas, Fabio Pio
   Lima Rodrigues, Rodrigo Araujo
   Arantes, Thalita
   Kroon, Erna Geessien
   Bonjardim, Claudio Antonio
   Abrahao, Jonatas Santos
TI Cedratvirus getuliensis replication cycle: an in-depth morphological
   analysis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ACANTHAMOEBA-CASTELLANII; VIRUS FACTORIES; GIANT VIRUSES; LATEX BEADS;
   DNA VIRUSES; PHAGOCYTOSIS; MIMIVIRUS; AMEBAS; MORPHOGENESIS; AUTOPHAGY
AB The giant viruses are the largest and most complex viruses in the virosphere. In the last decade, new members have constantly been added to this group. Here, we provide an in-depth descriptive analysis of the replication cycle of Cedratvirus getuliensis, one of the largest viruses known to date. We tracked the virion entry, the early steps of virus factory and particles morphogenesis, and during this phase, we observed a complex and unique sequential organization of immature particle elements, including horseshoe and rectangular compartments, revealed by transverse and longitudinal sections, respectively, until the formation of the final ovoid-shaped striped virion. The genome and virion proteins are incorporated through a longitudinal opening in the immature virion, followed by the incorporation of the second cork and thickening of the capsid well. Moreover, many cell modifications occur during viral infection, including intense membrane trafficking important to viral morphogenesis and release, as evidenced by treatment using brefeldin A. Finally, we observed that Cedratvirus getuliensis particles are released after cellular lysis, although we obtained microscopic evidence that some particles are released by exocytosis. The present study provides new information on the unexplored steps in the life cycle of cedratviruses.
C1 [dos Santos Silva, Ludmila Karen; dos Santos Pereira Andrade, Ana Claudia; Dornas, Fabio Pio; Lima Rodrigues, Rodrigo Araujo; Arantes, Thalita; Kroon, Erna Geessien; Bonjardim, Claudio Antonio; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Dornas, Fabio Pio] Univ Fed Minas Gerais, Ctr Microscopia, Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Dornas, Fabio/AAI-3582-2020
OI Dornas, Fabio/0000-0001-7926-5551; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX The authors would like to thank our colleagues from Gepvig and the
   Laboratorio de Virus for their excellent technical support. The authors
   would also like to thank the CNPq, CAPES and FAPEMIG for scholarships
   and the Center of Microscopy of UFMG. J.S.A., C.A.B. and E.G.K. are CNPq
   researchers.
CR Abrahao J. S., 2016, CURRENT PROTOCOLS MI, V41
   Abrahao JS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-120
   Alsam S, 2005, PARASITOL RES, V96, P402, DOI 10.1007/s00436-005-1401-z
   Andreani J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110300
   Arantes TS, 2016, J VIROL, V90, P5246, DOI 10.1128/JVI.00177-16
   Bajrai LH, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110278
   Bertelli C, 2017, ENVIRON MICROBIOL, V19, P4022, DOI 10.1111/1462-2920.13813
   Campos RK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-95
   Chrisman CJ, 2010, APPL ENVIRON MICROB, V76, P6056, DOI 10.1128/AEM.00812-10
   Colson P, 2017, ANNU REV VIROL, V4, P61, DOI 10.1146/annurev-virology-101416-041816
   Colson P, 2012, INTERVIROLOGY, V55, P321, DOI 10.1159/000336562
   Dornas FP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01086
   Andrade ACDP, 2017, J VIROL, V91, DOI 10.1128/JVI.01335-17
   Fabre E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15087
   de Castro IF, 2013, CELL MICROBIOL, V15, P24, DOI 10.1111/cmi.12029
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   Jha BK, 2014, ANTIMICROB AGENTS CH, V58, P6235, DOI 10.1128/AAC.03164-14
   KORN ED, 1967, J CELL BIOL, V34, P219, DOI 10.1083/jcb.34.1.219
   Kuznetsov YG, 2013, J VIROL, V87, P11200, DOI 10.1128/JVI.01372-13
   La Scola B, 2003, SCIENCE, V299, P2033
   Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Levasseur A, 2016, GENOME BIOL EVOL, V8, P2333, DOI 10.1093/gbe/evw153
   LWOFF A, 1966, SCIENCE, V152, P1216, DOI 10.1126/science.152.3726.1216
   Moon EK, 2015, ANTIMICROB AGENTS CH, V59, P4020, DOI 10.1128/AAC.05165-14
   Mutsafi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003367
   Mutsafi Y, 2010, P NATL ACAD SCI USA, V107, P5978, DOI 10.1073/pnas.0912737107
   Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058
   Okamoto K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13390-4
   Pagnier I, 2013, INTERVIROLOGY, V56, P354, DOI 10.1159/000354556
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Saadi H, 2013, CLIN INFECT DIS, V57, pE127, DOI 10.1093/cid/cit354
   Soto-Arredondo KJ, 2014, PARASITOLOGY, V141, P531, DOI 10.1017/S0031182013001923
   Suarez C, 2015, CELL MICROBIOL, V17, P1683, DOI 10.1111/cmi.12468
   Suarez C, 2013, CELL MICROBIOL, V15, P1883, DOI 10.1111/cmi.12156
   Suzan-Monti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000328
   TAYLOR WM, 1995, J PARASITOL, V81, P603, DOI 10.2307/3283860
   WETZEL MG, 1969, J CELL BIOL, V43, P90, DOI 10.1083/jcb.43.1.90
NR 40
TC 12
Z9 12
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 5
PY 2018
VL 8
AR 4000
DI 10.1038/s41598-018-22398-3
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FY0ZI
UT WOS:000426540800033
PM 29507337
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Abrahao, J
   Silva, L
   Silva, LS
   Khalil, JYB
   Rodrigues, R
   Arantes, T
   Assis, F
   Boratto, P
   Andrade, M
   Kroon, EG
   Ribeiro, B
   Bergier, I
   Seligmann, H
   Ghigo, E
   Colson, P
   Levasseur, A
   Kroemer, G
   Raoult, D
   La Scola, B
AF Abrahao, Jonatas
   Silva, Lorena
   Silva, Ludmila Santos
   Khalil, Jacques Yaacoub Bou
   Rodrigues, Rodrigo
   Arantes, Thalita
   Assis, Felipe
   Boratto, Paulo
   Andrade, Miguel
   Kroon, Erna Geessien
   Ribeiro, Bergmann
   Bergier, Ivan
   Seligmann, Herve
   Ghigo, Eric
   Colson, Philippe
   Levasseur, Anthony
   Kroemer, Guido
   Raoult, Didier
   La Scola, Bernard
TI Tailed giant Tupanvirus possesses the most complete translational
   apparatus of the known virosphere
SO NATURE COMMUNICATIONS
LA English
DT Article
ID VIRUSES; EVOLUTION; PROTEINS; LINEAGE
AB Here we report the discovery of two Tupanvirus strains, the longest tailed Mimiviridae members isolated in amoebae. Their genomes are 1.44-1.51 Mb linear double-strand DNA coding for 1276-1425 predicted proteins. Tupanviruses share the same ancestors with mimivirus lineages and these giant viruses present the largest translational apparatus within the known virosphere, with up to 70 tRNA, 20 aaRS, 11 factors for all translation steps, and factors related to tRNA/mRNA maturation and ribosome protein modification. Moreover, two sequences with significant similarity to intronic regions of 18 S rRNA genes are encoded by the tupanviruses and highly expressed. In this translation-associated gene set, only the ribosome is lacking. At high multiplicity of infections, tupanvirus is also cytotoxic and causes a severe shutdown of ribosomal RNA and a progressive degradation of the nucleus in host and non-host cells. The analysis of tupanviruses constitutes a new step toward understanding the evolution of giant viruses.
C1 [Abrahao, Jonatas; Silva, Lorena; Silva, Ludmila Santos; Seligmann, Herve; Ghigo, Eric; Colson, Philippe; Levasseur, Anthony; Raoult, Didier; La Scola, Bernard] Aix Marseille Univ, IHU Mediterranee Infect, AP HM, IRD 198,MEPHI, 19-21 Bd Jean Moulin, F-13005 Marseille, France.
   [Abrahao, Jonatas; Silva, Lorena; Silva, Ludmila Santos; Rodrigues, Rodrigo; Arantes, Thalita; Assis, Felipe; Boratto, Paulo; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [Khalil, Jacques Yaacoub Bou] CNRS, F-13005 Marseille, France.
   [Andrade, Miguel; Ribeiro, Bergmann] Univ Brasilia, Inst Ciencias Biol, Lab Microscopia Eletron & Virol, Dept Biol Celular, BR-70910900 Brasilia, DF, Brazil.
   [Bergier, Ivan] Embrapa Pantanal, Lab Biomass Convers, R 21 Setembro 1880, BR-79320900 Corumba, MS, Brazil.
   [Kroemer, Guido] Gustave Roussy Canc Campus, Cell Biol & Metabol Platforms, F-94805 Villejuif, France.
   [Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Natl Canc 11, F-75006 Paris, France.
   [Kroemer, Guido] INSERM, F-75654 Paris, France.
   [Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, F-75015 Paris, France.
   [Kroemer, Guido] Univ Paris 06, F-75005 Paris, France.
   [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France.
   [Kroemer, Guido] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, SE-17176 Stockholm, Sweden.
RP Raoult, D; La Scola, B (corresponding author), Aix Marseille Univ, IHU Mediterranee Infect, AP HM, IRD 198,MEPHI, 19-21 Bd Jean Moulin, F-13005 Marseille, France.
EM didier.raoult@gmail.com; bernard.la-scola@univ-amu.fr
RI Kroon, Erna/V-5444-2019; Kroemer, Guido/AAY-9859-2020; Seligmann,
   Herve/D-4720-2012; Ribeiro, Bergmann Morais/C-7114-2015; Bergier,
   Ivan/M-8660-2019; Andrade, Miguel/AAX-3066-2020; KROEMER,
   Guido/B-4263-2013
OI Ribeiro, Bergmann Morais/0000-0002-1061-196X; Bergier,
   Ivan/0000-0002-1076-8617; KROEMER, Guido/0000-0002-9334-4405; Araujo
   Lima Rodrigues, Rodrigo/0000-0001-7148-4012; Levasseur,
   Anthony/0000-0003-2989-7539
FU Mediterranee Infection Foundation; Centro de Microscopia da UFMG; CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq); CAPES
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)CAPES;
   FAPEMIG (Fundacao de Amparo a Pesquisa do estado de Minas Gerais)Minas
   Gerais State Research Foundation (FAPEMIG); French Government under the
   ''Investissements d'avenir'' (Investments for the Future) programFrench
   National Research Agency (ANR) [10-IAHU03]
FX We thank our colleagues from URMITE and Laboratorio de Virus of
   Universidade Federal de Minas Gerais for their assistance, particularly
   Julien Andreani, Jean-Pierre Baudoin, Gilles Audoly, Amina Cherif
   Louazani, Lina Barrassi, Priscilla Jardot, Eric Chabrieres, Philippe
   Decloquement, Nicholas Armstrong, Said Azza, Emeline Baptiste, Claudio
   Bonjardim, Paulo Ferreira, Giliane Trindade and Betania Drumond. In
   addition, we thank the Mediterranee Infection Foundation, Centro de
   Microscopia da UFMG, CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior) and FAPEMIG (Fundacao de Amparo a Pesquisa do
   estado de Minas Gerais) for their financial support. We thank Petrobras
   for the collection of sediments from ocean. This work was also supported
   by the French Government under the ''Investissements d'avenir''
   (Investments for the Future) program managed by the Agence Nationale de
   la Recherche (ANR, fr: National Agency for Research), (reference:
   Mediterranee Infection 10-IAHU03). J.A., B.R. and E.K. are CNPq
   researchers. B.L.S., J.A., L.S., P.C., and E.G.K. are members of a
   CAPES-COFECUB project.
CR Abrahao JS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006532
   Ageno M., 1973, MICRON, V4, P376, DOI DOI 10.1016/0047-7206(73)90002-2
   Andreani J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110300
   Antwerpen MH, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00136-15
   Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Assis FL, 2015, VIRUSES-BASEL, V7, P3483, DOI 10.3390/v7072782
   Chaikeeratisak V, 2017, SCIENCE, V355, P194, DOI 10.1126/science.aal2130
   Claverie JM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-110
   Csaba G, 2016, ACTA MICROBIOL IMM H, V63, P279, DOI 10.1556/030.63.2016.001
   Filee J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00593
   Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107
   Forterre P, 2013, ISME J, V7, P233, DOI 10.1038/ismej.2012.110
   Fournier GP, 2011, ORIGINS LIFE EVOL B, V41, P621, DOI 10.1007/s11084-011-9261-2
   Gonzalez-Flores Jonathan N, 2013, Biomol Concepts, V4, P349, DOI 10.1515/bmc-2013-0007
   Jha S, 2017, NATURE, V546, P651, DOI 10.1038/nature22814
   Korobeinikova AV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P562, DOI 10.1134/S0006297912060028
   La Scola B, 2003, SCIENCE, V299, P2033
   Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Rodrigues RAL, 2015, J VIROL, V89, P11812, DOI 10.1128/JVI.01976-15
   Nunes A, 2014, INFECT GENET EVOL, V23, P49, DOI 10.1016/j.meegid.2014.01.029
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Raina M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00171
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858
   Raoult D, 2010, LANCET, V375, P104, DOI 10.1016/S0140-6736(09)61958-9
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Schulz F, 2017, SCIENCE, V356, P82, DOI 10.1126/science.aal4657
   Smith JE, 2009, PARASITOLOGY, V136, P1901, DOI 10.1017/S0031182009991818
   Sorokin DY, 2014, EXTREMOPHILES, V18, P791, DOI 10.1007/s00792-014-0670-9
   Suhre K, 2005, P NATL ACAD SCI USA, V102, P14689, DOI 10.1073/pnas.0506465102
   Suzan-Monti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000328
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Yutin N, 2014, VIROLOGY, V466, P38, DOI 10.1016/j.virol.2014.06.032
NR 35
TC 90
Z9 91
U1 1
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 27
PY 2018
VL 9
AR 749
DI 10.1038/s41467-018-03168-1
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX5WF
UT WOS:000426152600002
PM 29487281
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Sedda, L
   Vilela, APP
   Aguiar, ERGR
   Gaspar, CHP
   Goncalves, ANA
   Olmo, RP
   Silva, ATS
   da Silveira, LD
   Eiras, AE
   Drumond, BP
   Kroon, EG
   Marques, JT
AF Sedda, Luigi
   Pessoa Vilela, Ana Paula
   Guimaraes Rocha Aguiar, Eric Roberto
   Pessoa Gaspar, Caio Henrique
   Aquime Goncalves, Andre Nicolau
   Olmo, Roenick Proveti
   Saraiva Silva, Ana Teresa
   da Silveira, Lizia de Cassia
   Eiras, Alvaro Eduardo
   Drumond, Betania Paiva
   Kroon, Erna Geessien
   Marques, Joao Trindade
TI The spatial and temporal scales of local dengue virus transmission in
   natural settings: a retrospective analysis
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Dengue virus serotypes 1 and 3;
   Bivariate point-process; Kriging; Geostatistical additive models; Urban
   dengue
ID AEDES-ALBOPICTUS DIPTERA; RIO-DE-JANEIRO; POLYMERASE-CHAIN-REACTION;
   AEGYPTI MOSQUITOS; LARVAL INDEXES; SEROTYPES 1; SAO-PAULO; CULICIDAE;
   VECTOR; SURVEILLANCE
AB Background: Dengue is a vector-borne disease caused by the dengue virus (DENV). Despite the crucial role of Aedes mosquitoes in DENV transmission, pure vector indices poorly correlate with human infections. Therefore there is great need for a better understanding of the spatial and temporal scales of DENV transmission between mosquitoes and humans. Here, we have systematically monitored the circulation of DENV in individual Aedes spp. mosquitoes and human patients from Caratinga, a dengue endemic city in the state of Minas Gerais, in Southeast Brazil. From these data, we have developed a novel stochastic point process pattern algorithm to identify the spatial and temporal association between DENV infected mosquitoes and human patients.
   Methods: The algorithm comprises of: (i) parameterization of the variogram for the incidence of each DENV serotype in mosquitoes; (ii) identification of the spatial and temporal ranges and variances of DENV incidence in mosquitoes in the proximity of humans infected with dengue; and (iii) analysis of the association between a set of environmental variables and DENV incidence in mosquitoes in the proximity of humans infected with dengue using a spatio-temporal additive, geostatistical linear model.
   Results: DENV serotypes 1 and 3 were the most common virus serotypes detected in both mosquitoes and humans. Using the data on each virus serotype separately, our spatio-temporal analyses indicated that infected humans were located in areas with the highest DENV incidence in mosquitoes, when incidence is calculated within 2.5-3 km and 50 days (credible interval 30-70 days) before onset of symptoms in humans. These measurements are in agreement with expected distances covered by mosquitoes and humans and the time for virus incubation. Finally, DENV incidence in mosquitoes found in the vicinity of infected humans correlated well with the low wind speed, higher air temperature and northerly winds that were more likely to favor vector survival and dispersal in Caratinga.
   Conclusions: We have proposed a new way of modeling bivariate point pattern on the transmission of arthropodborne pathogens between vector and host when the location of infection in the latter is known. This strategy avoids some of the strong and unrealistic assumptions made by other point-process models. Regarding virus transmission in Caratinga, our model showed a strong and significant association between high DENV incidence in mosquitoes and the onset of symptoms in humans at specific spatial and temporal windows. Together, our results indicate that vector surveillance must be a priority for dengue control. Nevertheless, localized vector control at distances lower than 2.5 km around premises with infected vectors in densely populated areas are not likely to be effective.
C1 [Sedda, Luigi] Univ Lancaster, CHICAS, Furness Bldg, Lancaster LA1 4YG, England.
   [Pessoa Vilela, Ana Paula; Guimaraes Rocha Aguiar, Eric Roberto; Aquime Goncalves, Andre Nicolau; Olmo, Roenick Proveti; Saraiva Silva, Ana Teresa; da Silveira, Lizia de Cassia; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Pessoa Vilela, Ana Paula; Pessoa Gaspar, Caio Henrique; Drumond, Betania Paiva; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Guimaraes Rocha Aguiar, Eric Roberto] Univ Fed Bahia, Inst Ciencias Saude, BR-40110100 Salvador, BA, Brazil.
   [Eiras, Alvaro Eduardo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-30270901 Belo Horizonte, MG, Brazil.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Olmo, Roenick/AAF-6412-2020; Aguiar, Eric RGR/L-7989-2018; Marques, Joao
   T/F-7683-2012; Sedda, Luigi/ABD-8784-2020; Vilela, Ana Paula
   Pessoa/Q-7538-2018; Eiras, Alvaro/Z-6023-2019; Kroon, Erna/V-5444-2019;
   Aguiar, Eric/T-5076-2019
OI Aguiar, Eric RGR/0000-0002-8143-5756; Marques, Joao
   T/0000-0002-3457-3320; Vilela, Ana Paula Pessoa/0000-0001-9030-0688;
   Eiras, Alvaro/0000-0002-3045-0673; Aguiar, Eric/0000-0002-8143-5756;
   Sedda, Luigi/0000-0002-9271-6596
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX This work was supported with grants from CAPES, CNPq and FAPEMIG to EGK
   and JTM. EGK and JTM are researchers from CNPq.
CR Azil AH, 2014, J VECTOR ECOL, V39, P153, DOI 10.1111/j.1948-7134.2014.12082.x
   Barmak DH, 2016, PHYSICA A, V447, P129, DOI 10.1016/j.physa.2015.12.015
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Cecilio SG, 2015, J VECTOR ECOL, V40, P71, DOI 10.1111/jvec.12134
   Chadee DD, 2009, ACTA TROP, V112, P174, DOI 10.1016/j.actatropica.2009.07.017
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen CF, 2010, VECTOR-BORNE ZOONOT, V10, P1017, DOI 10.1089/vbz.2008.0069
   Cheong YL, 2013, INT J ENV RES PUB HE, V10, P6319, DOI 10.3390/ijerph10126319
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Costa ACC, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0219-6
   Cressie N Statistics, 2015, STAT SPATIAL DATA
   Cummins B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002500
   Taranto MFD, 2015, TROP MED INT HEALTH, V20, P77, DOI 10.1111/tmi.12402
   de Bronzoni RV Morais, 2005, J CLIN MICROBIOL, V43, P7
   de Castro MG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-3
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   Degener CM, 2015, MEM I OSWALDO CRUZ, V110, P517, DOI 10.1590/0074-02760140374
   Depradine CA, 2004, INT J ENVIRON HEAL R, V14, P429, DOI 10.1080/09603120400012868
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   Diggle P. J., 2013, STAT ANAL SPATIAL SP
   Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Favaro EA, 2006, J VECTOR ECOL, V31, P285, DOI 10.3376/1081-1710(2006)31[285:PSOASA]2.0.CO;2
   de Figueiredo MLG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-60
   Gaye A, 2014, TROP MED INT HEALTH, V19, P1355, DOI 10.1111/tmi.12373
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Heringer M, 2015, T ROY SOC TROP MED H, V109, P268, DOI 10.1093/trstmh/trv006
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Kan CC, 2008, AM J TROP MED HYG, V79, P344, DOI 10.4269/ajtmh.2008.79.344
   Karl S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-447
   Khalid B, 2015, INT J BIOMETEOROL, V59, P267, DOI 10.1007/s00484-014-0840-6
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277
   Maciel-de-Freitas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065252
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Mendez-Galvan J, 2014, SOUTHWEST ENTOMOL, V39, P307, DOI 10.3958/059.039.0208
   Mercado-Hernandez R, 2003, J AM MOSQUITO CONTR, V19, P15
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Mwangangi JM, 2012, PARASITOL RES, V110, P61, DOI 10.1007/s00436-011-2449-6
   Naish S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092524
   Nino L, 2008, BIOMEDICA, V28, P578, DOI 10.7705/biomedica.v28i4.64
   de Melo DPO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042125
   Pepin KM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0659-y
   Pepin KM, 2013, EMERG INFECT DIS, V19, P542, DOI 10.3201/eid1904.120117
   Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28
   Pinheiro J. C, 2012, NLME PACKAGE LINEAR, V6
   Piovezan R, 2013, J VECTOR ECOL, V38, P317, DOI 10.1111/j.1948-7134.2013.12046.x
   Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648
   Richards SL, 2012, J MED ENTOMOL, V49, P942, DOI 10.1603/ME11293
   Rosa-Freitas Maria Goreti, 2006, Rev Panam Salud Publica, V20, P256, DOI 10.1590/S1020-49892006000900006
   Sanchez L, 2006, EMERG INFECT DIS, V12, P800
   Schlather M., 2012, ADV CHALLENGES SPACE, P25, DOI DOI 10.1007/978-3-642-17086-7_2
   Sedda L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1024-5
   Simoes TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064773
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Sun CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088025
   Taber ED, 2017, J VECTOR ECOL, V42, P3, DOI 10.1111/jvec.12234
   Talagala T, 2015, EPIDEMIOL BIOSTAT PU, V12, DOI 10.2427/11522
   Telle O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146539
   Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004
   Vargas WP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2097-3
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Vikram K, 2015, J VECTOR DIS, V52, P129
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649
   Wang CG, 2014, ASIA-PAC J PUBLIC HE, V26, P48, DOI 10.1177/1010539513490195
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Wen TH, 2015, APPL GEOGR, V62, P256, DOI 10.1016/j.apgeog.2015.05.003
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
   Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004964
   Wong GKL, 2017, BUILD ENVIRON, V112, P63, DOI 10.1016/j.buildenv.2016.11.028
   Wong GKL, 2016, SCI TOTAL ENVIRON, V573, P222, DOI 10.1016/j.scitotenv.2016.08.102
   World Health Organization, 2009, DENG GUID DIAGN TREA
   ZIMMERMAN DL, 1993, MATH GEOL, V25, P453, DOI 10.1007/BF00894779
NR 88
TC 4
Z9 4
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 2
PY 2018
VL 11
AR 79
DI 10.1186/s13071-018-2662-6
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FU9CY
UT WOS:000424154800001
PM 29394906
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Andrade, ACDP
   Arantes, TS
   Rodrigues, RAL
   Machado, TB
   Dornas, FP
   Landell, MF
   Furst, C
   Borges, LGA
   Dutra, LAL
   Almeida, G
   Trindade, GDS
   Bergier, I
   Abrahao, W
   Borges, IA
   Cortines, JR
   de Oliveira, DB
   Kroon, EG
   Abrahao, JS
AF Andrade, Ana Claudia dos S. P.
   Arantes, Thalita S.
   Rodrigues, Rodrigo A. L.
   Machado, Talita B.
   Dornas, Fabio P.
   Landell, Melissa F.
   Furst, Cinthia
   Borges, Luiz G. A.
   Dutra, Lara A. L.
   Almeida, Gabriel
   Trindade, Giliane de S.
   Bergier, Ivan
   Abrahao, Walter
   Borges, Iara A.
   Cortines, Juliana R.
   de Oliveira, Danilo B.
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI Ubiquitous giants: a plethora of giant viruses found in Brazil and
   Antarctica
SO VIROLOGY JOURNAL
LA English
DT Article
DE Giant viruses; Prospection; Brazil; Antarctica; Pandoravirus;
   Cedratvirus; Marseillevirus; Mimivirus
ID 1ST ISOLATION; DNA VIRUSES; MARSEILLEVIRUS; MIMIVIRUS; PATIENT; GENOME;
   HIGHLIGHTS; LINEAGE; AMEBAS; STOOL
AB Background: Since the discovery of giant viruses infecting amoebae in 2003, many dogmas of virology have been revised and the search for these viruses has been intensified. Over the last few years, several new groups of these viruses have been discovered in various types of samples and environments. In this work, we describe the isolation of 68 giant viruses of amoeba obtained from environmental samples from Brazil and Antarctica.
   Methods: Isolated viruses were identified by hemacolor staining, PCR assays and electron microscopy (scanning and/or transmission).
   Results: A total of 64 viruses belonging to the Mimiviridae family were isolated (26 from lineage A, 13 from lineage B, 2 from lineage C and 23 from unidentified lineages) from different types of samples, including marine water from Antarctica, thus being the first mimiviruses isolated in this extreme environment to date. Furthermore, a marseillevirus was isolated from sewage samples along with two pandoraviruses and a cedratvirus (the third to be isolated in the world so far).
   Conclusions: Considering the different type of samples, we found a higher number of viral groups in sewage samples. Our results reinforce the importance of prospective studies in different environmental samples, therefore improving our comprehension about the circulation anddiversity of these viruses in nature.
C1 [Andrade, Ana Claudia dos S. P.; Arantes, Thalita S.; Rodrigues, Rodrigo A. L.; Machado, Talita B.; Dornas, Fabio P.; Trindade, Giliane de S.; Borges, Iara A.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Landell, Melissa F.] Univ Fed Alagoas, Lab Diversidade Mol, Inst Ciencias Biol & Saude, Maceio, Brazil.
   [Furst, Cinthia] Univ Fed Espirito Santo, Dept Patol, Maruipe, Brazil.
   [Borges, Luiz G. A.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Borges, Luiz G. A.] Pontificia Univ Catolica Rio Grande do Sul, Inst Petroleo & Recursos Nat IPR, Porto Alegre, RS, Brazil.
   [Dutra, Lara A. L.; Almeida, Gabriel] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.
   [Bergier, Ivan] Embrapa Pantanal, Corumba, Brazil.
   [Abrahao, Walter] Univ Fed Vicosa, Vicosa, MG, Brazil.
   [Cortines, Juliana R.] Univ Fed Rio de Janeiro, Dept Virol, Rio De Janeiro, Brazil.
   [de Oliveira, Danilo B.] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Diamantina, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Almeida, Gabriel MF/I-8910-2012; Landell, Melissa F/N-9546-2013;
   Cortines, Juliana/V-3997-2019; Bergier, Ivan/M-8660-2019; Kroon,
   Erna/V-5444-2019; Dornas, Fabio/AAI-3582-2020; Borges, Luiz Gustavo dos
   Anjos/G-6445-2015
OI Almeida, Gabriel MF/0000-0003-2317-5092; Landell, Melissa
   F/0000-0001-6848-0803; Bergier, Ivan/0000-0002-1076-8617; Dornas,
   Fabio/0000-0001-7926-5551; Borges, Luiz Gustavo dos
   Anjos/0000-0002-6987-0309; Cortines, Juliana/0000-0003-2481-9267; Araujo
   Lima Rodrigues, Rodrigo/0000-0001-7148-4012
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPMEIG; Brazilian National Science and Technology
   Institute on Antarctic Environmental Research (INCT-APA) [CNPq
   574018/2008]; Brazilian Antarctic Program, PROANTAR, as part of the IPY
   [403, 520194/2006-3]
FX The scholarships were provided by CNPq, CAPES and FAPMEIG. The financial
   and logistic support were provided by The Brazilian National Science and
   Technology Institute on Antarctic Environmental Research (INCT-APA, CNPq
   574018/2008) and Brazilian Antarctic Program, PROANTAR, as part of the
   IPY Activity no. 403 'MIDIAPI Microbial Diversity of Terrestrial and
   Maritime ecosystems in Antarctic Peninsula' (520194/2006-3). JSA, EGK,
   GST are CNPq researchers.
CR Abrahao JS, 2017, PLOS GENET, V16, P1
   Aherfi S, 2016, EMERG INFECT DIS, V22, P2008, DOI 10.3201/eid2211.160189
   Aherfi S, 2016, LANCET INFECT DIS, V16, pE225, DOI 10.1016/S1473-3099(16)30051-2
   Aherfi S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00349
   Andrade KR, 2015, ARCH VIROL, V160, P477, DOI 10.1007/s00705-014-2257-2
   Andreani J, 2017, J VIROL, V91, DOI 10.1128/JVI.00212-17
   Andreani J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110300
   Antwerpen MH, 2015, GENOME ANNOUNC, V3, P1
   Assis FL, 2015, VIRUSES-BASEL, V7, P3483, DOI 10.3390/v7072782
   Bajrai LH, 2016, VIRUSES, V8, P1
   Benamar S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00003
   Bertelli C, 2017, ENVIRON MICROBIOL, V19, P4022, DOI 10.1111/1462-2920.13813
   Boratto PVM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01256
   Boughalmi M, 2013, INTERVIROLOGY, V56, P386, DOI 10.1159/000354560
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Campos RK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-95
   Colson P, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.197
   Colson P, 2016, CURR OPIN MICROBIOL, V31, P199, DOI 10.1016/j.mib.2016.04.012
   Dare RK, 2008, EMERG INFECT DIS, V14, P465, DOI 10.3201/eid1403.071027
   Dornas FP, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030076
   Dornas FP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01086
   Dornas FP, 2014, EMERG INFECT DIS, V20, P469, DOI 10.3201/eid2003.131050
   dos Santos RN, 2016, SCI REP-UK, V6, DOI 10.1038/srep35237
   Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62
   Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001
   Kerepesi C, 2017, ARCH VIROL, V162, P1671, DOI 10.1007/s00705-017-3286-4
   Kerepesi C, 2016, ARCH VIROL, V161, P721, DOI 10.1007/s00705-015-2720-8
   Khalil JYB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00026
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919
   Dutra LAL, 2017, ARCH VIROL, V162, P439, DOI 10.1007/s00705-016-3121-3
   Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Popgeorgiev N, 2013, J CLIN VIROL, V58, P722, DOI 10.1016/j.jcv.2013.10.001
   Popgeorgiev N, 2013, J CLIN MICROBIOL, V51, P4102, DOI 10.1128/JCM.01918-13
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Saadi H, 2013, INTERVIROLOGY, V56, P424, DOI 10.1159/000354564
   Saadi H, 2013, CLIN INFECT DIS, V57, pE127, DOI 10.1093/cid/cit354
   Sambrook J., 2001, MOL CLONING SAMBROOK
   Santini S, 2013, P NATL ACAD SCI USA, V110, P10800, DOI 10.1073/pnas.1303251110
   Scheid P, 2016, CURR OPIN MICROBIOL, V31, P58, DOI 10.1016/j.mib.2016.02.005
   Sharma V, 2015, FRONT MICROBIOL, V6, P1
   Sharma V, 2016, CURR OPIN MICROBIOL, V31, P16, DOI 10.1016/j.mib.2015.12.010
   Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108
   Zhang W., 2015, SCI REPORTS, V5, P1, DOI DOI 10.1038/SREP10791
NR 48
TC 20
Z9 21
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JAN 24
PY 2018
VL 15
AR 22
DI 10.1186/s12985-018-0930-x
PG 10
WC Virology
SC Virology
GA FU2LW
UT WOS:000423682700001
PM 29368617
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Calixto, R
   Oliveira, G
   Lima, M
   Andrade, AC
   Trindade, GD
   de Oliveira, DB
   Kroon, EG
AF Calixto, Rafael
   Oliveira, Graziele
   Lima, Mauricio
   Andrade, Ana Claudia
   Trindade, Giliane de Souza
   de Oliveira, Danilo Bretas
   Kroon, Erna Geessien
TI A Model to Detect Autochthonous Group 1 and 2 Brazilian Vaccinia virus
   Coinfections: Development of a qPCR Tool for Diagnosis and Pathogenesis
   Studies
SO VIRUSES-BASEL
LA English
DT Article
DE Vaccinia virus; qPCR; coinfection; mice model
ID REAL-TIME PCR; MELTING CURVE ANALYSIS; BOVINE VACCINIA; SYBR GREEN;
   STRAINS; ORTHOPOXVIRUSES; OUTBREAK; HUMANS; CATTLE; STATE
AB Vaccinia virus (VACV) is the etiological agent of bovine vaccinia (BV), an emerging zoonosis that has been associated with economic losses and social effects. Despite increasing reports of BV outbreaks in Brazil, little is known about the biological interactions of Brazilian VACV (VACV-BR) isolates during coinfections; furthermore, there are no tools for the diagnosis of these coinfections. In this study, a tool to co-detect two variants of VACV was developed to provide new information regarding the pathogenesis, virulence profile, and viral spread during coinfection with VACV-BR isolates. To test the quantitative polymerase chain reactions (qPCR) tool, groups of BALB/c mice were intranasally monoinfected with Pelotas virus 1Group II (PV1-GII) and Pelotas virus 2Group I (PV2-GI), or were coinfected with PV1-GII and PV2-GI. Clinical signs of the mice were evaluated and the viral load in lung and spleen were detected using simultaneous polymerase chain reactions (PCR) targeting the A56R (hemagglutinin) gene of VACV. The results showed that qPCR for the quantification of viral load in coinfection was efficient and highly sensitive. Coinfected mice presented more severe disease and a higher frequency of VACV detection in lung and spleen, when compared to monoinfected groups. This study is the first description of PV1 and PV2 pathogenicity during coinfection in mice, and provides a new method to detect VACV-BR coinfections.
C1 [Calixto, Rafael; Oliveira, Graziele; Lima, Mauricio; Andrade, Ana Claudia; Trindade, Giliane de Souza; de Oliveira, Danilo Bretas; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med Diamantina, BR-39100000 Dimantina, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM calixtomicro@yahoo.com.br; graziufmg@yahoo.com.br;
   maurili15@hotmail.com; ana.andrade2008@hotmail.com;
   gitrindade@yahoo.com.br; danilobretas@yahoo.com.br; kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019
OI Teixeira Lima, Mauricio/0000-0002-0830-3909
FU Fundacao de Amparo a Pesquisado Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Coordenadoria de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX We thank colleagues from Laboratorio de Virus (ICB-UFMG). This work was
   supported by research grants from Fundacao de Amparo a Pesquisado Estado
   de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Coordenadoria de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES). EGK and GST are researchers from
   CNPq.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Assis FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050413
   Assis FL, 2012, EMERG INFECT DIS, V18, P2035, DOI 10.3201/eid1812.120145
   Balboni A, 2015, J VIROL METHODS, V222, P34, DOI 10.1016/j.jviromet.2015.05.009
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Carletti F, 2005, J VIROL METHODS, V129, P97, DOI 10.1016/j.jviromet.2005.05.020
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I. K., 2014, FIELDS VIROLOGY, V2, P2160
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Fedele CG, 2006, J CLIN MICROBIOL, V44, P4464, DOI 10.1128/JCM.00276-06
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Moss B., 2014, FIELDS VIROLOGY, V2, P2129
   Nitsche A, 2006, CLIN CHEM, V52, P316, DOI 10.1373/clinchem.2005.060335
   Oliveira DB, 2013, AM J TROP MED HYG, V89, P1142, DOI 10.4269/ajtmh.13-0369
   Oliveira G, 2015, VIRUSES-BASEL, V7, P1218, DOI 10.3390/v7031218
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Venkatesan G, 2014, J VIROL METHODS, V201, P44, DOI 10.1016/j.jviromet.2014.02.007
   Zheng LL, 2013, J VIROL METHODS, V187, P15, DOI 10.1016/j.jviromet.2012.06.024
NR 28
TC 1
Z9 1
U1 0
U2 1
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2018
VL 10
IS 1
AR 15
DI 10.3390/v10010015
PG 10
WC Virology
SC Virology
GA FV2RE
UT WOS:000424414900015
PM 29301202
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Lima, MT
   Oliveira, GP
   Assis, FL
   de Oliveira, DB
   Vaz, SM
   Trindade, GD
   Abrahao, JS
   Kroon, EG
AF Lima, Mauricio Teixeira
   Oliveira, Graziele Pereira
   Assis, Felipe Lopes
   de Oliveira, Danilo Bretas
   Vaz, Sidiner Mesquita
   Trindade, Giliane de Souza
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
TI Ocular Vaccinia Infection in Dairy Worker, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID VIRUS
AB We studied a clinical case of vaccinia virus that caused an ocular manifestation in a dairy worker in Brazil. Biologic and molecular analyses identified a co-infection with 2 isolates from different Brazilian vaccinia virus phylogenetic groups.
C1 [Lima, Mauricio Teixeira; Oliveira, Graziele Pereira; Assis, Felipe Lopes; de Oliveira, Danilo Bretas; Trindade, Giliane de Souza; Abrahao, Jonatas Santos; Kroon, Erna Geessien] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Vaz, Sidiner Mesquita] Casa Caridade Carangola, Carangola, Brazil.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Diamantina, Diamantina, Brazil.
   [Lima, Mauricio Teixeira] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Bloco F4,Sala 258,Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RP Lima, MT; Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Bloco F4,Sala 258,Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM maurili15@hotmail.com; ernagkroon@gmail.com
RI Kroon, Erna/V-5444-2019
OI Teixeira Lima, Mauricio/0000-0002-0830-3909
CR Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I, 2007, FIELDS VIROLOGY, P2947
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   Griffiths EC, 2011, J INFECTION, V63, P200, DOI 10.1016/j.jinf.2011.06.005
   Hu G, 2004, AM J OPHTHALMOL, V137, P554, DOI 10.1016/j.ajo.2003.09.013
   Lewis FMT, 2006, EMERG INFECT DIS, V12, P134, DOI 10.3201/eid1201.051126
   Oliveira G, 2015, VIRUSES-BASEL, V7, P1218, DOI 10.3390/v7031218
   Stefanska I, 2013, ADV EXP MED BIOL, V756, P291, DOI 10.1007/978-94-007-4549-0_36
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
NR 10
TC 2
Z9 2
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2018
VL 24
IS 1
BP 161
EP 162
DI 10.3201/eid2401.170430
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FR2SW
UT WOS:000418918500028
PM 29260673
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Oliveira, GP
   Lima, MT
   Arantes, TS
   Assis, FL
   Rodrigues, RAL
   da Fonseca, FG
   Bonjardim, CA
   Kroon, EG
   Colson, P
   La Scola, B
   Abrahao, JS
AF Oliveira, Graziele Pereira
   Lima, Mauricio Teixeira
   Arantes, Thalita Souza
   Assis, Felipe Lopes
   Lima Rodrigues, Rodrigo Araujo
   da Fonseca, Flavio Guimaraes
   Bonjardim, Claudio Antonio
   Kroon, Erna Geessien
   Colson, Philippe
   La Scola, Bernard
   Abrahao, Jonatas Santos
TI The Investigation of Promoter Sequences of Marseilleviruses Highlights a
   Remarkable Abundance of the AAATATTT Motif in Intergenic Regions
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE lateral gene transfer; Marseilleviridae; gene expression; promoter
ID COMPLETE GENOME SEQUENCE; GIANT VIRUS; GENE; MEMBER; AMEBAS
AB Viruses display a wide range of genomic profiles and, consequently, a variety of gene expression strategies. Specific sequences associated with transcriptional processes have been described in viruses, and putative promoter motifs have been elucidated for some nucleocytoplasmic large DNA viruses (NCLDV). Among NCLDV, the Marseilleviridae is a well-recognized family because of its genomic mosaicism. The marseilleviruses have an ability to incorporate foreign genes, especially from sympatric organisms inhabiting Acanthamoeba, its main known host. Here, we identified for the first time an eight-nucleotide A/T-rich promoter sequence (AAATATTT) associated with 55% of marseillevirus genes that is conserved in all marseilleviruses lineages, a higher level of conservation than that of any giant virus described to date. We instigated our prediction about the promoter motif by biological assays and by evaluating how single mutations in this octamer can impact gene expression. The investigation of sequences that regulate the expression of genes relative to lateral transfer revealed that the promoter motifs do not appear to be incorporated by marseilleviruses from donor organisms. Indeed, analyses of the intergenic regions that regulate lateral gene transfer-related genes have revealed an independent origin of the marseillevirus intergenic regions that does not match gene-donor organisms. About 50% of AAATATTT motifs spread throughout intergenic regions of the marseilleviruses are present as multiple copies. We believe that such multiple motifs are associated with increased expression of a given gene or are related to incorporation of foreign genes into the mosaic genome of marseilleviruses.
   IMPORTANCE The marseilleviruses draw attention because of the peculiar features of their genomes; however, little is known about their gene expression patterns or the factors that regulate those expression patterns. The limited published research on the expression patterns of the marseilleviruses and their unique genomes has led us to study the promoter motif sequences in the intergenic regions of the marseilleviruses. This work is the first to analyze promoter sequences in the genomes of the marseilleviruses. We also suggest a strong capacity to acquire foreign genes and to express those genes mediated by multiple copies of the promoter motifs available in intergenic regions. These findings contribute to an understanding of genomic expansion and plasticity observed in these giant viruses.
C1 [Oliveira, Graziele Pereira; Lima, Mauricio Teixeira; Arantes, Thalita Souza; Assis, Felipe Lopes; Lima Rodrigues, Rodrigo Araujo; da Fonseca, Flavio Guimaraes; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Colson, Philippe; La Scola, Bernard] Aix Marseille Univ, AP HM, IHU Mediterranee Infect, URMITE,UM63,CNRS 7278,IRD 198,INSERM 1095, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019
OI Teixeira Lima, Mauricio/0000-0002-0830-3909; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012
CR Aherfi S, 2016, EMERG INFECT DIS, V22, P2008, DOI 10.3201/eid2211.160189
   Aherfi S, 2016, LANCET INFECT DIS, V16, pE225, DOI 10.1016/S1473-3099(16)30051-2
   Aherfi S, 2014, ARCH VIROL, V159, P2349, DOI 10.1007/s00705-014-2023-5
   Aherfi S, 2013, VIRUS GENES, V47, P550, DOI 10.1007/s11262-013-0965-4
   Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203
   BAILEY TL, 1994, P 2 INT C INT SYST M, P28
   Boughalmi M, 2013, INTERVIROLOGY, V56, P386, DOI 10.1159/000354560
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787
   Clarke M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r11
   DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1
   Dornas FP, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030076
   Doutre G, 2014, J VIROL, V88, P14340, DOI 10.1128/JVI.02414-14
   Fabre E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15087
   Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107
   Fitzgerald LA, 2008, VIROLOGY, V380, P388, DOI 10.1016/j.virol.2008.07.025
   Garcia-Escudero R, 2000, J VIROL, V74, P8176, DOI 10.1128/JVI.74.17.8176-8182.2000
   Haberle V, 2016, SEMIN CELL DEV BIOL, V57, P11, DOI 10.1016/j.semcdb.2016.01.014
   Jakob NJ, 2001, VIROLOGY, V286, P182, DOI 10.1006/viro.2001.0963
   La Scola B, 2003, SCIENCE, V299, P2033
   Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109
   Nalcacioglu R, 2007, J GEN VIROL, V88, P2488, DOI 10.1099/vir.0.82947-0
   Oliveira GP, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010016
   Popgeorgiev N, 2013, J CLIN MICROBIOL, V51, P4102, DOI 10.1128/JCM.01918-13
   Popgeorgiev N, 2013, J INFECT DIS, V208, P1042, DOI 10.1093/infdis/jit292
   Raoult D, 2010, INTERVIROLOGY, V53, P321, DOI 10.1159/000312917
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944
   Salem TZ, 2008, ARCH VIROL, V153, P149, DOI 10.1007/s00705-007-1081-3
   Suhre K, 2005, P NATL ACAD SCI USA, V102, P14689, DOI 10.1073/pnas.0506465102
   Takemura M, 2016, MICROBES ENVIRON, V31, P442, DOI 10.1264/jsme2.ME16107
   Thomas V, 2011, ENVIRON MICROBIOL, V13, P1454, DOI 10.1111/j.1462-2920.2011.02446.x
   Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6
   Yang ZL, 2011, J VIROL, V85, P9899, DOI 10.1128/JVI.05446-11
   YATES PR, 1995, BIOCHEM SOC T, V23, pS139, DOI 10.1042/bst023139s
NR 35
TC 4
Z9 4
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2017
VL 91
IS 21
AR e01088-17
DI 10.1128/JVI.01088-17
PG 10
WC Virology
SC Virology
GA FK0UI
UT WOS:000413195400030
PM 28794030
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Andrade, ACDP
   Rodrigues, RAL
   Oliveira, GP
   Andrade, KR
   Bonjardim, CA
   La Scola, B
   Kroon, EG
   Abrahao, JS
AF dos Santos Pereira Andrade, Ana Claudia
   Lima Rodrigues, Rodrigo Araujo
   Oliveira, Graziele Pereira
   Andrade, Ketyllen Reis
   Bonjardim, Claudio Antonio
   La Scola, Bernard
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
TI Filling Knowledge Gaps for Mimivirus Entry, Uncoating, and Morphogenesis
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE mimivirus; electron microscopy; replication cycle; phagocytosis; fibril
   acquisition area
ID VIRUS; FACTORIES
AB Since the discovery of mimivirus, its unusual structural and genomic features have raised great interest in the study of its biology; however, many aspects concerning its replication cycle remain uncertain. In this study, extensive analyses of electron microscope images, as well as biological assay results, shed light on unclear points concerning the mimivirus replication cycle. We found that treatment with cytochalasin, a phagocytosis inhibitor, negatively impacted the incorporation of mimivirus particles by Acanthamoeba castellanii, causing a negative effect on viral growth in amoeba monolayers. Treatment of amoebas with bafilomicin significantly impacted mimivirus uncoating and replication. In conjunction with microscopic analyses, these data suggest that mimiviruses indeed depend on phagocytosis for entry into amoebas, and particle uncoating (and stargate opening) appears to be dependent on phagosome acidification. In-depth analyses of particle morphogenesis suggest that the mimivirus capsids are assembled from growing lamellar structures. Despite proposals from previous studies that genome acquisition occurs before the acquisition of fibrils, our results clearly demonstrate that the genome and fibrils can be acquired simultaneously. Our data suggest the existence of a specific area surrounding the core of the viral factory where particles acquire the surface fibrils. Furthermore, we reinforce the concept that defective particles can be formed even in the absence of virophages. Our work provides new information about unexplored steps in the life cycle of mimivirus.
   IMPORTANCE Investigating the viral life cycle is essential to a better understanding of virus biology. The combination of biological assays and microscopic images allows a clear view of the biological features of viruses. Since the discovery of mimivirus, many studies have been conducted to characterize its replication cycle, but many knowledge gaps remain to be filled. In this study, we conducted a new examination of the replication cycle of mimivirus and provide new evidence concerning some stages of the cycle which were previously unclear, mainly entry, uncoating, and morphogenesis. Furthermore, we demonstrate that atypical virion morphologies can occur even in the absence of virophages. Our results, along with previous data, allow us to present an ultimate model for the mimivirus replication cycle.
C1 [dos Santos Pereira Andrade, Ana Claudia; Lima Rodrigues, Rodrigo Araujo; Oliveira, Graziele Pereira; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Andrade, Ketyllen Reis] Fiocruz MS, Lab Imunopatol Doencas Virais, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, IRD 3R198, CNRS UMR 6236, URMITE, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019
OI Araujo Lima Rodrigues, Rodrigo/0000-0001-7148-4012
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX We also thank CNPq, CAPES, and FAPEMIG for scholarships and the Center
   of Microscopy of UFMG. J.S.A., C.A.B., and E.G.K. are CNPq researchers.
   J.S.A., E.G.K., and B.L.S. are members of a CAPES-COFECUB project.
CR Abrahao JS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-120
   Abrahao JS, 2014, J VIROL METHODS, V207, P6, DOI 10.1016/j.jviromet.2014.06.001
   Arantes TS, 2016, J VIROL, V90, P5246, DOI 10.1128/JVI.00177-16
   Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Campos RK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-95
   Cerritelli ME, 2003, J MOL BIOL, V327, P1, DOI 10.1016/S0022-2836(03)00117-7
   Colson P, 2012, INTERVIROLOGY, V55, P321, DOI 10.1159/000336562
   Desnues C, 2012, NAT REV MICROBIOL, V10, P234, DOI 10.1038/nrmicro2676-c3
   Dornas FP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01086
   Fridmann-Sirkis Y, 2016, J VIROL, V90, P10039, DOI 10.1128/JVI.01319-16
   Gaia M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094923
   Gong CW, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00005
   Khalil JYB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00026
   Kuznetsov YG, 2013, J VIROL, V87, P11200, DOI 10.1128/JVI.01372-13
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218
   Rodrigues RAL, 2015, J VIROL, V89, P11812, DOI 10.1128/JVI.01976-15
   Maruri-Avidal L, 2011, J VIROL, V85, P2504, DOI 10.1128/JVI.02505-10
   Mutsafi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003367
   Mutsafi Y, 2010, P NATL ACAD SCI USA, V107, P5978, DOI 10.1073/pnas.0912737107
   Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Saadi H, 2013, INTERVIROLOGY, V56, P424, DOI 10.1159/000354564
   Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6
   Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750
   Suzan-Monti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000328
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109
   Yuan N, 2015, HAEMATOLOGICA, V100, P345, DOI 10.3324/haematol.2014.113324
   Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114
NR 31
TC 18
Z9 18
U1 2
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2017
VL 91
IS 22
AR e01335-17
DI 10.1128/JVI.01335-17
PG 12
WC Virology
SC Virology
GA FL1WP
UT WOS:000414005400029
PM 28878069
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU de Oliveira, JS
   Figueiredo, PD
   Costa, GB
   de Assis, FL
   Drumond, BP
   da Fonseca, FG
   Nogueira, ML
   Kroon, EG
   Trindade, GD
AF de Oliveira, Jaqueline Silva
   Figueiredo, Poliana de Oliveira
   Costa, Galileu Barbosa
   de Assis, Felipe Lopes
   Drumond, Betania Paiva
   da Fonseca, Flavio Guimaraes
   Nogueira, Mauricio Lacerda
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
TI Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the
   Ugly
SO VIRUSES-BASEL
LA English
DT Review
DE orthopoxvirus; smallpox vaccine; vaccinia virus; zoonosis; public
   health; ecology; host range; natural infections
ID SAO-PAULO STATE; BOVINE VACCINIA; HYDROCHOERUS-HYDROCHAERIS; MOLECULAR
   CHARACTERIZATION; CLINICAL DESCRIPTION; ECZEMA VACCINATUM; MAHARASHTRA
   STATE; SMALLPOX VACCINE; VARIOLA MINOR; OUTBREAK
AB The orthopoxviruses (OPV) comprise several emerging viruses with great importance to human and veterinary medicine, including vaccinia virus (VACV), which causes outbreaks of bovine vaccinia (BV) in South America. Historically, VACV is the most comprehensively studied virus, however, its origin and natural hosts remain unknown. VACV was the primary component of the smallpox vaccine, largely used during the smallpox eradication campaign. After smallpox was declared eradicated, the vaccination that conferred immunity to OPV was discontinued, favoring a new contingent of susceptible individuals to OPV. VACV infections occur naturally after direct contact with infected dairy cattle, in recently vaccinated individuals, or through alternative routes of exposure. In Brazil, VACV outbreaks are frequently reported in rural areas, affecting mainly farm animals and humans. Recent studies have shown the role of wildlife in the VACV transmission chain, exploring the role of wild rodents as reservoirs that facilitate VACV spread throughout rural areas. Furthermore, VACV circulation in urban environments and the significance of this with respect to public health, have also been explored. In this review, we discuss the history, epidemiological, ecological and clinical aspects of natural VACV infections in Brazil, also highlighting alternative routes of VACV transmission, the factors involved in susceptibility to infection, and the natural history of the disease in humans and animals, and the potential for dissemination to urban environments.
C1 [de Oliveira, Jaqueline Silva; Figueiredo, Poliana de Oliveira; Costa, Galileu Barbosa; Drumond, Betania Paiva; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Assis, Felipe Lopes] US FDA, Silver Spring, MD 20993 USA.
   [da Fonseca, Flavio Guimaraes] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virol Basica & Aplicada, BR-31270901 Belo Horizonte, MG, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Dept Doencas Infecciosas Parasitarias, BR-15090000 Sao Paulo, Brazil.
RP Costa, GB; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM jaquelinebmedica@hotmail.com; polianaofigueiredo@yahoo.com.br;
   galileuk1@gmail.com; felipelopesassis@gmail.com;
   betaniadrumond@gmail.com; fdafonseca@icb.ufmg.br; mnogueira@famerp.br;
   ernagkroon@gmail.com; giliane@icb.ufmg.br
RI Nogueira, Mauricio L/B-7599-2012; Kroon, Erna/V-5444-2019; Costa,
   Galileu Barbosa/M-5768-2019
OI Nogueira, Mauricio L/0000-0003-1102-2419; Barbosa Costa,
   Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Pro-Reitoria
   de Pesquisa/UFMG (PRPq)
FX We are thankful colleagues from the Laboratorio de Virus (ICB-UFMG) for
   their excellent technical support. We are also grateful to Joel Barratt
   for English reviewing process and for appropriate and constructive
   suggestions on the manuscript. Financial support was provided by the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and
   Pro-Reitoria de Pesquisa/UFMG (PRPq). F.G. da Fonseca, M.L. Nogueira,
   E.G. Kroon, and G.S. Trindade are researchers from CNPq.
CR Abrahao JS, 2017, EQUINE VET J, V49, P221, DOI 10.1111/evj.12571
   Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2010, J CLIN VIROL, V48, P69, DOI 10.1016/j.jcv.2010.02.001
   Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1
   Abrahao JS, 2015, EMERG INFECT DIS, V21, P695, DOI 10.3201/eid2104.140351
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Alves PA, 2016, COMP IMMUNOL MICROB, V49, P70, DOI 10.1016/j.cimid.2016.09.005
   Assis FL, 2013, EMERG INFECT DIS, V19, P2045, DOI 10.3201/eid1912.120937
   Assis FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050413
   Barbosa AV, 2014, J INFECT DEV COUNTR, V8, P1646, DOI 10.3855/jidc.5216
   Batista V. H., 2009, VIRUS REV RES, DOI 10.17525/vrr.v14i1.27
   BAXBY D, 1971, ARCH GES VIRUSFORSCH, V35, P70, DOI 10.1007/BF01249754
   Baxby D, 1981, JENNERS SMALLPOX VAC
   BEHBEHANI AM, 1983, MICROBIOL REV, V47, P455, DOI 10.1128/MMBR.47.4.455-509.1983
   Bhanuprakash V, 2010, TRANSBOUND EMERG DIS, V57, P375, DOI 10.1111/j.1865-1682.2010.01158.x
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   CHANDRA R, 1986, ACTA VIROL, V30, P390
   Costa GB, 2015, EMERG INFECT DIS, V21, P2244, DOI 10.3201/eid2112.141249
   Costa GB, 2017, EMERG INFECT DIS, V23, P360, DOI 10.3201/eid2302.161341
   Costa GB, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0575-6
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   da Fonseca FG, 2011, FUTURE VIROL, V6, P697, DOI 10.2217/FVL.11.46
   Damaso CR, 2018, LANCET INFECT DIS, V18, pE55, DOI 10.1016/S1473-3099(17)30445-0
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I., 2013, POXVIRUSES, p[2160, 2184]
   de Oliveira JS, 2017, VACCINE, V35, P3281, DOI 10.1016/j.vaccine.2017.04.048
   DEQUADRO.CC, 1972, B WORLD HEALTH ORGAN, V46, P165
   DiGiacomo R. F., 1994, BIOL LAB RABBIT
   Downie A. W., 1939, IMMUNOLOGICAL RELATI
   Downie A. W., 1939, STUDY LESIONS PRODUC
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Duggan AT, 2016, CURR BIOL, V26, P3407, DOI 10.1016/j.cub.2016.10.061
   DUMBELL K, 1993, ARCH VIROL, V128, P257, DOI 10.1007/BF01309438
   Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   Fassbender P, 2016, EMERG INFECT DIS, V22, P553, DOI 10.3201/eid2203.151158
   FENNER F, 1958, VIROLOGY, V5, P502, DOI 10.1016/0042-6822(58)90042-4
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   Goyal T, 2013, J DERMATOL, V52, P1224, DOI [10.1111/ijd.12120, DOI 10.1111/IJD.12120]
   Guedes MIMC, 2013, TRANSBOUND EMERG DIS, V60, P552, DOI 10.1111/j.1865-1682.2012.01372.x
   Gurav YK, 2011, PREV VET MED, V100, P242, DOI 10.1016/j.prevetmed.2011.03.008
   Henderson DA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0113
   Henderson DA, 2009, SMALLPOX DEATH DIS I
   Hughes CM, 2011, EMERG INFECT DIS, V17, P730, DOI 10.3201/eid1704.101010
   Kolhapure RM, 1997, INDIAN J MED RES, V106, P441
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Kugelman JR, 2014, EMERG INFECT DIS, V20, P232, DOI 10.3201/eid2002.130118
   Laguardia-Nascimento M, 2017, ARCH VIROL, V162, P2797, DOI 10.1007/s00705-017-3407-0
   Laguardia-Nascimento M, 2016, J VET DIAGN INVEST, V28, P377, DOI 10.1177/1040638716645836
   Dutra LAL, 2017, ARCH VIROL, V162, P439, DOI 10.1007/s00705-016-3121-3
   Lederman E, 2009, VACCINE, V27, P375, DOI 10.1016/j.vaccine.2008.11.019
   Lederman ER, 2012, J INFECT DIS, V206, P1372, DOI 10.1093/infdis/jis510
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   de Oliveira TML, 2015, FOODBORNE PATHOG DIS, V12, P898, DOI 10.1089/fpd.2015.1974
   de Oliveira TML, 2010, FOODBORNE PATHOG DIS, V7, P1491, DOI 10.1089/fpd.2010.0597
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   Medaglia MLG, 2015, J VIROL, V89, P11909, DOI 10.1128/JVI.01833-15
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Megid J, 2012, EMERG INFECT DIS, V18, P189, DOI 10.3201/eid1801.110692
   Ferraz KMPMD, 2010, POPUL ECOL, V52, P263, DOI 10.1007/s10144-009-0181-1
   Ministerio da Agricultura Pecuaria e Abastecimento (MAPA), 2015, DAD REB BOV BAB BRAS
   Miranda JB, 2017, EMERG INFECT DIS, V23, P931, DOI 10.3201/eid2306.161643
   Moojen V., 1996, VIROSES CONFUNDIVEIS
   Franco-Luiz APM, 2016, EMERG INFECT DIS, V22, P2174, DOI 10.3201/eid2212.160447
   Franco-Luiz APM, 2016, COMP IMMUNOL MICROB, V46, P16, DOI 10.1016/j.cimid.2016.03.003
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Moussatche N, 2008, J INFECT DEV COUNTR, V2, P156, DOI 10.3855/jidc.258
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Nalca A, 2010, DRUG DES DEV THER, V4, P71
   Nedunchelliyan S, 1992, Indian J Public Health, V36, P57
   Oliveira DB, 2013, AM J TROP MED HYG, V89, P1142, DOI 10.4269/ajtmh.13-0369
   Oliveira GP, 2014, AM J TROP MED HYG, V90, P1021, DOI 10.4269/ajtmh.13-0621
   Olson VA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9090242
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P4118, DOI 10.1128/AAC.00762-07
   Quiner CA, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-017-0100-1
   Quixabeira-Santos JC, 2011, EMERG INFECT DIS, V17, P726, DOI 10.3201/eid1704.101581
   Rehfeld IS, 2017, J DAIRY SCI, V100, P7051, DOI 10.3168/jds.2017-12560
   Rehfeld IS, 2013, RES VET SCI, V95, P752, DOI 10.1016/j.rvsc.2013.05.005
   Rehfeld IS, 2017, RES VET SCI, V114, P233, DOI 10.1016/j.rvsc.2017.03.022
   Rehfeld IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127350
   Rivetti AV, 2013, VET MICROBIOL, V162, P103, DOI 10.1016/j.vetmic.2012.09.005
   RODRIGUESDASILVA G, 1963, PUBLIC HEALTH REP, V78, P165, DOI 10.2307/4591745
   Sanchez-Sampedro L, 2015, VIRUSES-BASEL, V7, P1726, DOI 10.3390/v7041726
   Sant'ana F. F, 2013, PESQUI VET BRASIL, P860, DOI [10.1590/S0100-736X2013000700006, DOI 10.1590/S0100-736X2013000700006]
   Schatzmayr G. H, 2005, VIRUS REV RES, V10, DOI 10.17525/vrrjournal.v10i2.249
   Schatzmayr HG, 2009, REV SOC BRAS MED TRO, V42, P672, DOI 10.1590/S0037-86822009000600012
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   Shchelkunov SN, 2011, VACCINE, V29, pD49, DOI 10.1016/j.vaccine.2011.05.037
   Gomes JAS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/974067
   Silva L., 2008, VIROSES EMERGENTES B, P132
   Silva P, 1985, BRAS MED VET ZOOTEC, V38, P323
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Singh RK, 2012, INDIAN J VIROL, V23, P1, DOI 10.1007/s13337-012-0068-1
   Singh R. K, 2006, INDIA REV SCI TECH, V25, P981, DOI 10.20506/rst.25.3.1708
   Theves C, 2014, CLIN MICROBIOL INFEC, V20, P210, DOI 10.1111/1469-0691.12536
   THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19
   Trindade G, 2014, J VACCINES VACCIN, V5, DOI [10.4172/2157-7560.1000i101, DOI 10.4172/2157-7560.1000I101]
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120328
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Usme-Ciro JA, 2017, EMERG INFECT DIS, V23, P649, DOI 10.3201/eid2304.161041
   Venkatesan G, 2010, VET ITAL, V46, P439
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Wertheimer ER, 2012, VACCINE, V30, P985, DOI 10.1016/j.vaccine.2011.12.049
   Young GE, 2011, EMERG INFECT DIS, V17, P718, DOI 10.3201/eid1704.101316
   Zafar A, 2007, EMERG INFECT DIS, V13, P902, DOI 10.3201/eid1306.061068
NR 119
TC 15
Z9 15
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2017
VL 9
IS 11
AR 340
DI 10.3390/v9110340
PG 21
WC Virology
SC Virology
GA FO4KB
UT WOS:000416810300030
PM 29140260
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Leite, FGG
   Torres, AA
   De Oliveira, LC
   Da Cruz, AFP
   Soares-Martins, JAP
   Pereira, ACTC
   Trindade, GS
   Abrahao, JS
   Kroon, EG
   Ferreira, PCP
   Bonjardim, CA
AF Leite, Flavia G. G.
   Torres, Alice A.
   De Oliveira, Leonardo C.
   Da Cruz, Andre F. P.
   Soares-Martins, Jamaria A. P.
   Pereira, Anna C. T. C.
   Trindade, Giliane S.
   Abrahao, Jonatas S.
   Kroon, Erna G.
   Ferreira, Paulo C. P.
   Bonjardim, Claudio A.
TI c-Jun integrates signals from both MEK/ERK and MKK/JNK pathways upon
   vaccinia virus infection
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID ACTIVATED PROTEIN-KINASES; TRANSCRIPTION FACTOR; SUSTAINED ACTIVATION;
   JNK; REPLICATION; AP-1; PHOSPHORYLATION; MULTIPLICATION; CYTOSKELETON;
   INDUCTION
AB Usurpation of the host's signalling pathways is a common strategy employed by viruses to promote their successful replication. Here we show that infection with the orthopoxvirus vaccinia virus (VACV) leads to sustained stimulation of c-Jun activity during the entire infective cycle. This stimulation is temporally regulated through MEK/ERK or MKK/JNK pathways, i.e. during the early/mid phase (1 to 6 hpi) and in the late phase (9 to 24 hpi) of the infective cycle, respectively. As a transcriptional regulator, upon infection with VACV, c-Jun is translocated from the cytoplasm to the nucleus, where it binds to the AP-1 DNA sequence found at the promoter region of its target genes. To investigate the role played by c-Jun during VACV replication cycle, we generated cell lines that stably express a c-Jun-dominant negative (DNc-Jun) mutation. Our data revealed that c-Jun is required during early infection to assist with viral DNA replication, as demonstrated by the decreased amount of viral DNA found in the DNc-Jun cells. We also demonstrated that c-Jun regulates the expression of the early growth response gene (egr-1), a gene previously shown to affect VACV replication mediated by MEK/ERK signalling. VACV-induced stimulation of the MKK/JNK/JUN pathway impacts viral dissemination, as we observed a significant reduction in both viral yield, during late stages of infection, and virus plaque size. Collectively, our data suggest that, by modulating the host's signalling pathways through a common target such as c-Jun, VACV temporally regulates its infective cycle in order to successfully replicate and subsequently spread.
C1 [Leite, Flavia G. G.; Torres, Alice A.; De Oliveira, Leonardo C.; Da Cruz, Andre F. P.; Soares-Martins, Jamaria A. P.; Pereira, Anna C. T. C.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Signal Transduct Grp Orthopoxviruses, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Leite, Flavia G. G.; Torres, Alice A.; De Oliveira, Leonardo C.; Da Cruz, Andre F. P.; Soares-Martins, Jamaria A. P.; Pereira, Anna C. T. C.; Trindade, Giliane S.; Abrahao, Jonatas S.; Kroon, Erna G.; Ferreira, Paulo C. P.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Lab Virus, Ave Antonio Carlos,6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Leite, Flavia G. G.] Francis Crick Inst, Cellular Signalling & Cytoskeletal Funct Lab, London NW1 1AT, England.
   [Torres, Alice A.] Univ Cambridge, Tennis Court Rd, Cambridge CB2 1QP, England.
   [Soares-Martins, Jamaria A. P.] Waukesha Cty Tech Coll, Dept Math & Sci, 800 Main St, Pewaukee, WI 53072 USA.
   [Pereira, Anna C. T. C.] Univ Fed Piaui, Lab Biochem & Biol Microorganisms & Plants, Campus Parnaiba,Ave Sao Sebastiao,2819, BR-64202020 Parnaiba 64202020, PI, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Signal Transduct Grp Orthopoxviruses, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Lab Virus, Ave Antonio Carlos,6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM flavia.leite@crick.ac.uk; licetorres@gmail.com;
   jamariapinheiro@gmail.com; actcp@ufpi.edu.br;
   claudio.bonjardim@pq.cnpq.br
RI Abreu Torres, Alice/B-1475-2018; Kroon, Erna/V-5444-2019
OI Abreu Torres, Alice/0000-0003-2352-2584; 
FU Fundacao para o Desenvolvimento da Ciencia do Estado de Minas Gerais
   (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Conselho Nacional para o Desenvolvimento Cientifico e
   Tecnologico (CNPq)/BRAZILNational Council for Scientific and
   Technological Development (CNPq)
FX This study was funded by the Fundacao para o Desenvolvimento da Ciencia
   do Estado de Minas Gerais (FAPEMIG), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), and the Conselho Nacional para o
   Desenvolvimento Cientifico e Tecnologico (CNPq)/BRAZIL.
CR Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071
   Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114
   Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   Avey D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004993
   Benn J, 1996, J VIROL, V70, P4978, DOI 10.1128/JVI.70.8.4978-4985.1996
   Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002
   Brady G, 2014, CYTOKINE GROWTH F R, V25, P611, DOI 10.1016/j.cytogfr.2014.07.004
   Caceres A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003719
   Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220
   Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   Dunn C, 2002, CELL SIGNAL, V14, P585, DOI 10.1016/S0898-6568(01)00275-3
   Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209
   Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715
   Husain M, 2001, J VIROL, V75, P7528, DOI 10.1128/JVI.75.16.7528-7542.2001
   Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123
   Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7
   Leite F, 2015, VIRUS RES, V209, P87, DOI 10.1016/j.virusres.2015.01.024
   Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404
   Liu XueQiao, 2016, J Virol, V90, P1129, DOI 10.1128/JVI.01410-15
   Liu XQ, 2012, J VIROL, V86, P3143, DOI 10.1128/JVI.06923-11
   MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254
   Moss B, 2007, FIELDS VIROLOGY, V2, P2905
   Moss B, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010199
   Nijhara R, 2001, J VIROL, V75, P10348, DOI 10.1128/JVI.75.21.10348-10358.2001
   Oh J, 2005, J VIROL, V79, P12852, DOI 10.1128/JVI.79.20.12852-12860.2005
   Pereira ACTC, 2012, J VIROL, V86, P172, DOI 10.1128/JVI.05638-11
   Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012
   Sambrook J., 1989, MOL CLONING LAB MANU
   Santos CR, 2006, J VIROL, V80, P7667, DOI 10.1128/JVI.00967-06
   Schreck I, 2011, BIOCHEM BIOPH RES CO, V407, P735, DOI 10.1016/j.bbrc.2011.03.092
   Schwachtgen J L, 2000, DNA Seq, V10, P429, DOI 10.3109/10425170009015615
   Schweneker M, 2012, J VIROL, V86, P2323, DOI 10.1128/JVI.06166-11
   Shi WF, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0227-7
   Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509
   Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0
   Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09
   Torres AA, 2016, J GEN VIROL, V97, P2346, DOI 10.1099/jgv.0.000525
   Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870
   Xie JP, 2005, J VIROL, V79, P15027, DOI 10.1128/JVI.79.24.15027-15037.2005
   Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033
   Zeke A, 2016, MICROBIOL MOL BIOL R, V80, P793, DOI 10.1128/MMBR.00043-14
   Zhang W., 2016, SCI REP, V6, P1, DOI DOI 10.1038/srep22034
NR 47
TC 6
Z9 6
U1 1
U2 3
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD OCT
PY 2017
VL 162
IS 10
BP 2971
EP 2981
DI 10.1007/s00705-017-3446-6
PG 11
WC Virology
SC Virology
GA FH1OL
UT WOS:000410909200005
PM 28620810
DA 2020-11-30
ER

PT J
AU Dornas, FP
   Boratto, PVM
   Costa, GB
   Silva, LCF
   Kroon, EG
   La Scola, B
   Trindade, G
   Abrahao, JS
AF Dornas, Fabio P.
   Boratto, Paulo V. M.
   Costa, Galileu B.
   Silva, Lorena C. F.
   Kroon, Erna G.
   La Scola, Bernard
   Trindade, Giliane
   Abrahao, Jonatas S.
TI Detection of mimivirus genome and neutralizing antibodies in humans from
   Brazil
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID GIANT VIRUSES; PNEUMONIA; PATIENT; AMEBAS
AB In recent years, giant viruses belonging to the family Mimiviridae have been proposed to be infectious agents in humans. In this work we provide evidence of mimivirus genome and neutralizing antibodies detection in humans.
C1 [Dornas, Fabio P.; Boratto, Paulo V. M.; Costa, Galileu B.; Silva, Lorena C. F.; Kroon, Erna G.; Trindade, Giliane; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Lab Virus, Inst Ciencias Biol, Ave Antonio Carlos, BR-6627 Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, IRD 3R198, UMR 6236, URMITE,CNRS, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Lab Virus, Inst Ciencias Biol, Ave Antonio Carlos, BR-6627 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Costa, Galileu Barbosa/M-5768-2019; Dornas, Fabio/AAI-3582-2020; Kroon,
   Erna/V-5444-2019
OI Dornas, Fabio/0000-0001-7926-5551; Barbosa Costa,
   Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao de Amparo
   a Pesquisa do Estado de Minas GeraisMinas Gerais State Research
   Foundation (FAPEMIG); Ministerio da Agricultura, Pecuaria e
   Abastecimento; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior-COFEUB
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior, the Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais, and the Ministerio da Agricultura, Pecuaria e Abastecimento.
   F.P.D. was supported by a fellowship from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-COFEUB. J.S.A, E.G.K. and
   G.S.T. are researchers of the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico.
CR Abrahao JS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-120
   Aherfi S, 2016, LANCET INFECT DIS, V16, pE225, DOI 10.1016/S1473-3099(16)30051-2
   Colson P, 2016, CURR OPIN MICROBIOL, V31, P199, DOI 10.1016/j.mib.2016.04.012
   Dornas FP, 2014, EMERG INFECT DIS, V20, P469, DOI 10.3201/eid2003.131050
   Dornas FP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087811
   Silva LKD, 2015, J CLIN VIROL, V66, P62, DOI 10.1016/j.jcv.2015.03.008
   Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905
   La Scola B, 2003, SCIENCE, V299, P2033
   Saadi H, 2013, INTERVIROLOGY, V56, P424, DOI 10.1159/000354564
   Saadi H, 2013, CLIN INFECT DIS, V57, pE127, DOI 10.1093/cid/cit354
NR 10
TC 4
Z9 4
U1 1
U2 5
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD OCT
PY 2017
VL 162
IS 10
BP 3205
EP 3207
DI 10.1007/s00705-017-3455-5
PG 3
WC Virology
SC Virology
GA FH1OL
UT WOS:000410909200033
PM 28667442
DA 2020-11-30
ER

PT J
AU Rodrigues, RAL
   Andrade, ACDP
   Boratto, PVD
   Trindade, GD
   Kroon, EG
   Abrahao, JS
AF Rodrigues, Rodrigo A. L.
   Andrade, Ana C. dos S. P.
   Boratto, Paulo V. de M.
   Trindade, Giliane de S.
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI An Anthropocentric View of the Virosphere-Host Relationship
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE virosphere; anthropocentric; virus-host relationship; network;
   metavirome
ID VIRAL METAGENOMICS; GIANT VIRUSES; HUMAN VIROME; ENCEPHALITIS;
   EVOLUTION; INFECTIONS; EMERGENCE; DISCOVERY; GENOMICS; DISEASE
AB For over a century, viruses have been known as the most abundant and diverse group of organisms on Earth, forming a virosphere. Based on extensive meta-analyses, we present, for the first time, a wide and complete overview of virus-host network, covering all known viral species. Our data indicate that most of known viral species, regardless of their genomic category, have an intriguingly narrow host range, infecting only 1 or 2 host species. Our data also show that the known virosphere has expanded based on viruses of human interest, related to economical, medical or biotechnological activities. In addition, we provide an overview of the distribution of viruses on different environments on Earth, based on meta-analyses of available metaviromic data, showing the contrasting ubiquity of head-tailed phages against the specificity of some viral groups in certain environments. Finally, we uncovered all human viral species, exploring their diversity and the most affected organic systems. The virus-host network presented here shows an anthropocentric view of the virology. It is therefore clear that a huge effort and change in perspective is necessary to see more than the tip of the iceberg when it comes to virology.
C1 [Rodrigues, Rodrigo A. L.; Andrade, Ana C. dos S. P.; Boratto, Paulo V. de M.; Trindade, Giliane de S.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019
OI Araujo Lima Rodrigues, Rodrigo/0000-0001-7148-4012
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq); CAPES (Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior)CAPES; FAPEMIG (Fundacao de Amparo a Pesquisa do estado
   de Minas Gerais)Minas Gerais State Research Foundation (FAPEMIG)
FX This work was supported by CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior) and FAPEMIG (Fundacao de Amparo a Pesquisa do
   estado de Minas Gerais).
CR Alavandi SV, 2012, INDIAN J VIROL, V23, P88, DOI 10.1007/s13337-012-0075-2
   BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971
   Bastian M., 2009, P INT AAAI C WEBL SO, P361, DOI DOI 10.1136/QSHC.2004.010033
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Cava F, 2009, EXTREMOPHILES, V13, P213, DOI 10.1007/s00792-009-0226-6
   Chuong EB, 2013, BIOESSAYS, V35, P853, DOI 10.1002/bies.201300059
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Dietzgen RG, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110303
   Durkovic J, 2013, ANN BOT-LONDON, V111, P215, DOI 10.1093/aob/mcs274
   Ebrahimi-Mameghani M, 2017, CLIN NUTR, V36, P1001, DOI 10.1016/j.clnu.2016.07.004
   Enquist L.W., 2013, FIELDS VIROLOGY, P1
   Forterre P, 2010, INTERVIROLOGY, V53, P362, DOI 10.1159/000312921
   Gallone B, 2016, CELL, V166, P1397, DOI 10.1016/j.cell.2016.08.020
   Godfrey-Faussett P, 2016, LANCET, V387, P1141, DOI 10.1016/S0140-6736(16)00699-1
   Goel AK, 2015, WORLD J CLIN CASES, V3, P20, DOI 10.12998/wjcc.v3.i1.20
   Govindan Balaji, 2016, Indian J Sex Transm Dis AIDS, V37, P115
   Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X
   Halary S, 2016, CURR OPIN MICROBIOL, V31, P34, DOI 10.1016/j.mib.2016.01.005
   Hillman BI, 2004, ADV VIRUS RES, V63, P423, DOI 10.1016/S0065-3527(04)63007-7
   Holmfeldt K, 2013, P NATL ACAD SCI USA, V110, P12798, DOI 10.1073/pnas.1305956110
   Jackson AC, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0540-y
   Jackson AC, 2016, J NEUROVIROL, V22, P8, DOI 10.1007/s13365-015-0351-1
   Jiang H, 2017, VIROL SIN, V32, P32, DOI 10.1007/s12250-016-3899-x
   Kondo H, 2013, ADV VIRUS RES, V86, P177, DOI 10.1016/B978-0-12-394315-6.00007-6
   Korb VC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030131
   Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   La Scola B, 2003, SCIENCE, V299, P2033
   Langan KM, 2015, CURR OPIN INFECT DIS, V28, P547, DOI 10.1097/QCO.0000000000000217
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Lipinska AP, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-015-0577-9
   Luk Alison W. S., 2014, Life-Basel, V4, P681, DOI 10.3390/life4040681
   LWOFF A, 1957, J GEN MICROBIOL, V17, P239, DOI 10.1099/00221287-17-2-239
   Menezes CB, 2016, MICROB CELL, V3, P404, DOI 10.15698/mic2016.09.526
   Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8
   Mihara T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030066
   O'Malley MA, 2008, STUD HIST PHI PART C, V39, P314, DOI 10.1016/j.shpsc.2008.06.005
   Panahi Y, 2016, CURR PHARM DESIGN, V22, P164, DOI 10.2174/1381612822666151112145226
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Popgeorgiev N, 2013, INTERVIROLOGY, V56, P395, DOI 10.1159/000354561
   Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858
   Rascovan N, 2016, ANNU REV MICROBIOL, V70, P125, DOI 10.1146/annurev-micro-102215-095431
   REGANOLD JP, 2016, NAT PLANTS, V2
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016
   Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6
   Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177
   Steger G, 2016, ADV VIRUS RES, V94, P141, DOI 10.1016/bs.aivir.2015.11.002
   Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160
   Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134
   Thurber RV, 2009, CURR OPIN MICROBIOL, V12, P582, DOI 10.1016/j.mib.2009.08.008
   Vainio EJ, 2016, VIRUS RES, V219, P2, DOI 10.1016/j.virusres.2015.10.014
   Vila J, 2016, FEMS MICROBIOL REV, V40, P437, DOI 10.1093/femsre/fuw005
   Volkova E, 2012, J VIROL, V86, P4715, DOI 10.1128/JVI.00331-12
   Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999
   Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354
   Zhang CY, 2013, BIOCHEM SOC T, V41, P458, DOI 10.1042/BST20120338
NR 58
TC 7
Z9 7
U1 0
U2 20
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD AUG 30
PY 2017
VL 8
AR 1673
DI 10.3389/fmicb.2017.01673
PG 11
WC Microbiology
SC Microbiology
GA FF1IL
UT WOS:000408653000001
PM 28912772
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Costa, GB
   Lavergne, A
   Darcissac, E
   Lacoste, V
   Drumond, BP
   Abrahao, JS
   Kroon, EG
   de Thoisy, B
   Trindade, GD
AF Costa, Galileu Barbosa
   Lavergne, Anne
   Darcissac, Edith
   Lacoste, Vincent
   Drumond, Betania Paiva
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
   de Thoisy, Benoit
   Trindade, Giliane de Souza
TI Absence of vaccinia virus detection in a remote region of the Northern
   Amazon forests, 2005-2015
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID MOLECULAR CHARACTERIZATION; ZOONOTIC OUTBREAK; CATTLE; ORTHOPOXVIRUS;
   STATE; SPREAD; HUMANS; PAULO
AB Vaccinia virus (VACV) circulates in Brazil and other South America countries and is responsible for a zoonotic disease that usually affects dairy cattle and humans, causing economic losses and impacting animal and human health. Furthermore, it has been detected in wild areas in the Brazilian Amazon. To better understand the natural history of VACV, we investigated its circulation in wildlife from French Guiana, a remote region in the Northern Amazon forest. ELISA and plaque reduction neutralization tests were performed to detect anti-orthopoxvirus antibodies. Real-time and standard PCR targeting C11R, A56R and A26L were applied to detect VACV DNA in serum, saliva and tissue samples. No evidence of VACV infection was found in any of the samples tested. These findings provide additional information on the VACV epidemiological puzzle. The virus could nevertheless be circulating at low levels that were not detected in areas where no humans or cattle are present.
C1 [Costa, Galileu Barbosa; Drumond, Betania Paiva; Abrahao, Jonatas Santos; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Lavergne, Anne; Darcissac, Edith; Lacoste, Vincent; de Thoisy, Benoit] Inst Pasteur, Lab Interact Virus Hotes, 23 Ave Pasteur,BP 6010, Cayenne 97306, French Guiana.
RP Costa, GB; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM galileuk1@gmail.com; gitrindade@yahoo.com.br
RI Kroon, Erna/V-5444-2019; Costa, Galileu Barbosa/M-5768-2019; Kroon, Erna
   Geessien/B-3631-2015; LACOSTE, Vincent/V-2321-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; LACOSTE,
   Vincent/0000-0002-3173-4053; Barbosa Costa, Galileu/0000-0001-7360-6722
FU CAROLIA; RESERVOIRS through ERDF funds; European CommissionEuropean
   CommissionEuropean Commission Joint Research Centre
   [REGPOT-CT-2011-285837-STRonGer]; "Investissements d'Avenir' grantFrench
   National Research Agency (ANR)
FX This study was funded by two European projects, CAROLIA and RESERVOIRS,
   through ERDF funds and a European Commission
   "REGPOT-CT-2011-285837-STRonGer'' grant within the FP7. This work also
   benefited from an "Investissements d'Avenir' grant managed by Agence
   Nationale de la Recherche, France (CEBA, ref. ANR-10-LABX-25-01).
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   de Assis FL, 2013, EMERG INFECT DIS, V19, P2017, DOI 10.3201/eid1912.130589
   de Thoisy B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004378
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Geessien Kroon E, 2016, CURR PROTOC MICROBIO, V42
   Guedes MIMC, 2013, TRANSBOUND EMERG DIS, V60, P552, DOI 10.1111/j.1865-1682.2012.01372.x
   Hansen MC, 2013, SCIENCE, V342, P850, DOI 10.1126/science.1244693
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Dutra LAL, 2017, ARCH VIROL, V162, P439, DOI 10.1007/s00705-016-3121-3
   Medaglia MLG, 2015, J VIROL, V89, P11909, DOI 10.1128/JVI.01833-15
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Franco-Luiz APM, 2016, EMERG INFECT DIS, V22, P2174, DOI 10.3201/eid2212.160447
   Franco-Luiz APM, 2016, COMP IMMUNOL MICROB, V46, P16, DOI 10.1016/j.cimid.2016.03.003
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Oliveira DB, 2013, AM J TROP MED HYG, V89, P1142, DOI 10.4269/ajtmh.13-0369
   Oliveira G, 2015, VIRUSES-BASEL, V7, P1218, DOI 10.3390/v7031218
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Quixabeira-Santos JC, 2011, EMERG INFECT DIS, V17, P726, DOI 10.3201/eid1704.101581
   Trindade GD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120328
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Usme-Ciro JA, 2017, EMERG INFECT DIS, V23, P649, DOI 10.3201/eid2304.161041
NR 26
TC 2
Z9 2
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD AUG
PY 2017
VL 162
IS 8
BP 2369
EP 2373
DI 10.1007/s00705-017-3353-x
PG 5
WC Virology
SC Virology
GA FA5QE
UT WOS:000405497700022
PM 28389806
DA 2020-11-30
ER

PT J
AU Silva, FC
   Rodrigues, NG
   Duarte, LP
   Lula, IS
   Sinisterra, RD
   Vieira, SA
   Rodrigues, RAL
   Kroon, EG
   Oliveira, PL
   Farias, LM
   Magalhaes, PP
   Silva, GDF
AF Silva, Fernando C.
   Rodrigues, Nessa G.
   Duarte, Lucienir P.
   Lula, Ivana S.
   Sinisterra, Ruben D.
   Vieira-Filho, Sidney A.
   Rodrigues, Rodrigo A. L.
   Kroon, Erna G.
   Oliveira, Patricia L.
   Farias, Luiz M.
   Magalhaes, Paula P.
   Silva, Garcia D. F.
TI Antidiarrheal activity of extracts from Maytenus gonoclada and
   inhibition of Dengue virus by lupeol
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE Antidiarrheal; Celastraceae; Pentacyclic Triterpene; Antiviral Activity
ID C-13 NMR-SPECTRA; TRITERPENES; ASSIGNMENT; H-1
AB Diarrhea is an infectious disease caused by bacterial, virus, or protozoan, and dengue is caused by virus, included among the neglected diseases in several underdeveloped and developing countries, with an urgent demand for new drugs. Considering the antidiarrheal potential of species of Maytenus genus, a phytochemical investigation followed by antibacterial activity test with extracts of branches and heartwood and bark of roots from Maytenus gonoclada were conducted. Moreover, due the frequency of isolation of lupeol from Maytenus genus the antiviral activity against Dengue virus and cytotoxicity of lupeol and its complex with beta-cyclodextrins were also tested. The results indicated the bioactivity of ethyl acetate extract from branches and ethanol extract from heartwood of roots of M. gonoclada against diarrheagenic bacteria. The lupeol showed potent activity against Dengue virus and low cytotoxicity in LLC-MK2 cells, but its complex with beta-cyclodextrin was inactive. Considering the importance of novel and selective antiviral drug candidates the results seem to be promising.
C1 [Silva, Fernando C.] Univ Estado Minas Gerais, Dept Licenciaturas, Ave Parana 3001, BR-35501170 Divinopolis, MG, Brazil.
   [Rodrigues, Nessa G.; Duarte, Lucienir P.; Lula, Ivana S.; Sinisterra, Ruben D.; Silva, Garcia D. F.] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Quim, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Vieira-Filho, Sidney A.] Univ Fed Ouro Preto, Dept Farm, Escola Farm, Campus Morro Cruzeiro, BR-35400000 Ouro Preto, MG, Brazil.
   [Rodrigues, Rodrigo A. L.; Kroon, Erna G.; Oliveira, Patricia L.; Farias, Luiz M.; Magalhaes, Paula P.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RP Silva, FC (corresponding author), Univ Estado Minas Gerais, Dept Licenciaturas, Ave Parana 3001, BR-35501170 Divinopolis, MG, Brazil.
EM fcsquimico@yahoo.com.br
RI Silva, Fernando C/I-5381-2013; Sinisterra, Ruben/AAD-8965-2020; Kroon,
   Erna/V-5444-2019; vieira, Sabrina n/X-1702-2018; Duarte, Lucienir Pains
   P/J-6307-2012
OI Silva, Fernando C/0000-0002-6413-3334; Sinisterra,
   Ruben/0000-0001-7656-1849; Duarte, Lucienir Pains P/0000-0002-8885-6625
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX The authors are thankful to the financial support provided by Fundacao
   de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).
CR AGRAWAL PK, 1992, PROG NUCL MAG RES SP, V24, P1, DOI 10.1016/0079-6565(92)80011-4
   Ahmed AS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-100
   Alves JS, 2000, MAGN RESON CHEM, V38, P201, DOI 10.1002/(SICI)1097-458X(200003)38:3<201::AID-MRC622>3.3.CO;2-S
   Baggio CH, 2009, J ETHNOPHARMACOL, V123, P385, DOI 10.1016/j.jep.2009.03.037
   Betancur-Galvis LA, 1999, MEM I OSWALDO CRUZ, V94, P531, DOI 10.1590/S0074-02761999000400019
   BOOTH SJ, 1977, ANTIMICROB AGENTS CH, V11, P718, DOI 10.1128/AAC.11.4.718
   Burns D, 2000, MAGN RESON CHEM, V38, P488, DOI 10.1002/1097-458X(200007)38:7<488::AID-MRC704>3.3.CO;2-7
   Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI
   Gomes JPM, 2011, REV BRAS FARMACOGN, V21, P963, DOI 10.1590/S0102-695X2011005000153
   GONZALEZ AG, 1987, PHYTOCHEMISTRY, V26, P2785, DOI 10.1016/S0031-9422(00)83591-8
   Ioele G, 2014, FUTURE MED CHEM, V6, P35, DOI [10.4155/fmc.13.187, 10.4155/FMC.13.187]
   Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818
   Lendl A, 2005, PHYTOCHEMISTRY, V66, P2381, DOI 10.1016/j.phytochem.2005.07.002
   Loftsson T, 1996, J PHARM SCI, V85, P1017, DOI 10.1021/js950534b
   MAHATO SB, 1994, PHYTOCHEMISTRY, V37, P1517, DOI 10.1016/S0031-9422(00)89569-2
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Navaneethan U, 2008, NAT CLIN PRACT GASTR, V5, P637, DOI 10.1038/ncpgasthep1264
   Oliveira MLG, 2007, MAGN RESON CHEM, V45, P895, DOI 10.1002/mrc.2062
   PATRA A, 1987, MAGN RESON CHEM, V25, P95, DOI 10.1002/mrc.1260250202
   Rodrigues VG, 2015, QUIM NOVA, V38, P237, DOI 10.5935/0100-4042.20150001
   Rodrigues VG, 2012, QUIM NOVA, V35, P1375, DOI 10.1590/S0100-40422012000700017
   Saleem M, 2010, NAT PROD REP, V27, P238, DOI 10.1039/b916096e
   Santos Vanda Lucia dos, 2007, Rev. bras. farmacogn., V17, P336, DOI 10.1590/S0102-695X2007000300006
   Siddique HR, 2011, LIFE SCI, V88, P285, DOI 10.1016/j.lfs.2010.11.020
   Silva FC, 2013, CHEM NAT COMPD+, V49, P571, DOI 10.1007/s10600-013-0676-z
   Silva FC, 2011, J CHEM RES, P555, DOI 10.3184/174751911X13161944590173
   Silva FC, 2011, J BRAZIL CHEM SOC, V22, P943, DOI 10.1590/S0103-50532011000500018
   Silverstein R. M., 2007, IDENTIFICACAO ESPECT
   Quintans JDS, 2013, PHYTOMEDICINE, V20, P436, DOI 10.1016/j.phymed.2012.12.009
   Sotanaphun U, 1998, PHYTOCHEMISTRY, V49, P1749, DOI 10.1016/S0031-9422(98)00290-8
   Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c
   Tanaka T, 2004, CHEM PHARM BULL, V52, P1242, DOI 10.1248/cpb.52.1242
   Torres-Romero D, 2010, J AGR FOOD CHEM, V58, P10847, DOI 10.1021/jf1022115
   Wandji J, 2000, PHYTOCHEMISTRY, V54, P811, DOI 10.1016/S0031-9422(00)00040-6
NR 34
TC 5
Z9 5
U1 0
U2 3
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD JUL-SEP
PY 2017
VL 89
IS 3
BP 1555
EP 1564
DI 10.1590/0001-3765201720160046
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FH9XF
UT WOS:000411569900015
PM 28954173
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Trindade, GD
   Pereira-Oliveira, G
   Figueiredo, PD
   Costa, G
   Franco-Liuz, APM
   Assis, FL
   de Oliveira, DB
   Paim, LRM
   Oliveira, CED
   Neto, ALM
   Kroon, EG
AF Abrahao, J. S.
   de Souza Trindade, G.
   Pereira-Oliveira, G.
   de Oliveira Figueiredo, P.
   Costa, G.
   Moreira Franco-Liuz, A. P.
   Lopes Assis, F.
   Bretas de Oliveira, D.
   Mottos Paim, L. R.
   de Araujo Oliveira, C. E.
   Lemos Maio Neto, A.
   Geessien Kroon, E.
TI Detection of Vaccinia virus during an outbreak of exanthemous oral
   lesions in Brazilian equids
SO PFERDEHEILKUNDE
LA German
DT Editorial Material
C1 [Abrahao, J. S.; de Souza Trindade, G.; Pereira-Oliveira, G.; de Oliveira Figueiredo, P.; Costa, G.; Moreira Franco-Liuz, A. P.; Lopes Assis, F.; Bretas de Oliveira, D.; Mottos Paim, L. R.; de Araujo Oliveira, C. E.; Lemos Maio Neto, A.; Geessien Kroon, E.] Univ Fed Minas Gerais, Lab Virus, Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Lab Virus, Belo Horizonte, MG, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU HIPPIATRIKA VERLAG MBH
PI STUTTGART
PA POSTFACH 102251, 70018 STUTTGART, GERMANY
SN 0177-7726
J9 PFERDEHEILKUNDE
JI Pferdeheilkunde
PD JUL-AUG
PY 2017
VL 33
IS 4
BP 403
EP 403
PG 1
WC Veterinary Sciences
SC Veterinary Sciences
GA FC7AL
UT WOS:000406992700033
DA 2020-11-30
ER

PT J
AU de Oliveira, JS
   Costa, GB
   Luiz, APMF
   Leite, JA
   Bonjardim, CA
   Abrahao, JS
   Drumond, BP
   Kroon, EG
   Trindade, GD
AF de Oliveira, Jaqueline Silva
   Costa, Galileu Barbosa
   Moreira Franco Luiz, Ana Paula
   Leite, Juliana Almeida
   Bonjardim, Claudio Antonio
   Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
TI Cross-sectional study involving healthcare professionals in a Vaccinia
   virus endemic area
SO VACCINE
LA English
DT Article
DE Orthopoxvirus; Vaccinia virus; Healthcare professionals; Knowledge;
   Unpreparedness serological survey
ID SMALLPOX VACCINE; ORTHOPOXVIRUS; MONKEYPOX; CATTLE; SEROPREVALENCE
AB Orthopoxviruses (OPV) are emerging viruses with great importance in human and veterinary medicine, such as Vaccinia virus (VACV), which causes outbreaks of bovine vaccinia (BV) in South America. The clinical aspects of BV are similar to other vesicular infections, complicating the clinical diagnosis. This crosssectional study evaluated the knowledge of Healthcare Professionals about BV and revealed their unpreparedness about BV in a VACV hyper-endemic area in Brazil, highlighting the public health issues associated with VACV infections. This study presents an opportunity to discuss the importance of vaccination for healthcare professionals who work in areas of VACV circulation and brings an educational measure on VACV infections for health professionals around the world. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [de Oliveira, Jaqueline Silva; Costa, Galileu Barbosa; Moreira Franco Luiz, Ana Paula; Bonjardim, Claudio Antonio; Abrahao, Jonatas Santos; Drumond, Betania Paiva; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Leite, Juliana Almeida] Oswaldo Cruz Fdn FIOCRUZ, Inst Oswaldo Cruz, Resp Virus Lab, Rio De Janeiro, Brazil.
   [Leite, Juliana Almeida] WHO, Pan Amer Hlth Org, Washington, DC USA.
RP Costa, GB (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM galileuk1@gmail.com; gitrindade@yahoo.com.br
RI Kroon, Erna/V-5444-2019; Costa, Galileu Barbosa/M-5768-2019
OI Barbosa Costa, Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX We thank colleagues from Laboratorio de Virus (ICB/UFMG) for their
   excellent technical support. We also thank Hugo Jose Valencia Rivero for
   helping to review the educative material translation for Spanish, and
   Susan Realegeno from NCEZID/CDC for manuscript language reviewing. We
   are grateful for the assistance of Mirtes Ribeiro, Antonio Moreira,
   Mariana Sobral Pedrosa and Serro Health Secretary. Financial support was
   provided by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG). CA Bonjardim, EG Kroon, JS Abrahao, and GS Trindade
   are researchers from CNPq.
CR Assis FL, 2012, EMERG INFECT DIS, V18, P2035, DOI 10.3201/eid1812.120145
   Bass J, 2013, INT HEALTH, V5, P237, DOI 10.1093/inthealth/iht029
   Costa GB, 2015, EMERG INFECT DIS, V21, P2244, DOI 10.3201/eid2112.141249
   Costa GB, 2017, EMERG INFECT DIS, V23, P360, DOI 10.3201/eid2302.161341
   Costa GB, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0575-6
   de Sant'Ana FJF, 2013, PESQUI VET BRASIL, V33, P860, DOI 10.1590/S0100-736X2013000700006
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   Isaacs Stuart N, 2012, Methods Mol Biol, V890, P1, DOI 10.1007/978-1-61779-876-4_1
   Kennedy RB, 2009, VACCINE, V27, P3319, DOI 10.1016/j.vaccine.2009.01.086
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Dutra LAL, 2017, ARCH VIROL, V162, P439, DOI 10.1007/s00705-016-3121-3
   Franco-Luiz APM, 2016, EMERG INFECT DIS, V22, P2174, DOI 10.3201/eid2212.160447
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   NeffJM Lane JM, 2002, JAMA-J AM MED ASSOC, V288, P1901
   Pereira Oliveira Graziele, 2014, Am J Trop Med Hyg, V90, P1021, DOI 10.4269/ajtmh.13-0621
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Petersen BW, 2016, MMWR-MORBID MORTAL W, V65, P257, DOI 10.15585/mmwr.mm6510a2
   Reynolds MG, 2013, AM J TROP MED HYG, V88, P982, DOI 10.4269/ajtmh.12-0758
   Roess AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001356
   Tan XL, 2012, CLIN VACCINE IMMUNOL, V19, P418, DOI 10.1128/CVI.05521-11
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Usme-Ciro JA, 2017, EMERG INFECT DIS, V23, P649, DOI 10.3201/eid2304.161041
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Zafar A, 2007, EMERG INFECT DIS, V13, P902, DOI 10.3201/eid1306.061068
NR 26
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 5
PY 2017
VL 35
IS 25
BP 3281
EP 3285
DI 10.1016/j.vaccine.2017.04.048
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EX3LS
UT WOS:000403134200001
PM 28495317
OA Bronze
DA 2020-11-30
ER

PT J
AU Miranda, JB
   Borges, IA
   Campos, SPS
   Vieira, FN
   de Azara, TMF
   Marques, FA
   Costa, GB
   Luis, APMF
   de Oliveira, JS
   Ferreira, PCP
   Bonjardim, CA
   da Silva, SLM
   Eiras, AE
   Abrahao, JS
   Kroon, EG
   Drumond, BP
   Paglia, AP
   Trindade, GD
AF Miranda, Julia B.
   Borges, Iara A.
   Campos, Samantha P. S.
   Vieira, Flavia N.
   de Azara, Tatiana M. F.
   Marques, Fernanda A.
   Costa, Galileu B.
   Luis, Ana Paula M. F.
   de Oliveira, Jaqueline S.
   Ferreira, Paulo Cesar P.
   Bonjardim, Claudio Antonio
   da Silva, Silvio L. M.
   Eiras, Alvaro E.
   Abrahao, Jonatas S.
   Kroon, Erna G.
   Drumond, Betania P.
   Paglia, Adriano P.
   Trindade, Giliane de S.
TI Serologic and Molecular Evidence of Vaccinia Virus Circulation among
   Small Mammals from Different Biomes, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID RIO-DE-JANEIRO; ORTHOPOXVIRUS; POXVIRUS; OUTBREAK; HUMANS; STATE;
   CATTLE; GUIDELINES; INFECTION; STRAINS
AB Vaccinia virus (VACV) is a zoonotic agent that causes a disease called bovine vaccinia, which is detected mainly in milking cattle and humans in close contact with these animals. Even though many aspects of VACV infection have been described, much is still unknown about its circulation in the environment and its natural hosts/reservoirs. To investigate the presence of Orthopoxvirus antibodies or VACV DNA, we captured small rodents and marsupials in 3 areas of Minas Gerais state, Brazil, and tested their samples in a laboratory. A total of 336 animals were tested; positivity ranged from 18.1% to 25.5% in the 3 studied regions located in different biomes, including the Atlantic Forest and the Cerrado. Analysis of nucleotide sequences indicated co-circulation of VACV groups I and II. Our findings reinforce the possible role played by rodents and marsupials in VACV maintenance and its transmission chain.
C1 [Miranda, Julia B.; Borges, Iara A.; Campos, Samantha P. S.; Vieira, Flavia N.; de Azara, Tatiana M. F.; Marques, Fernanda A.; Costa, Galileu B.; Luis, Ana Paula M. F.; de Oliveira, Jaqueline S.; Ferreira, Paulo Cesar P.; Bonjardim, Claudio Antonio; Eiras, Alvaro E.; Abrahao, Jonatas S.; Kroon, Erna G.; Drumond, Betania P.; Paglia, Adriano P.; Trindade, Giliane de S.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [da Silva, Silvio L. M.] Inst Fed Educ Ciencia & Tecnol Sudeste Minas Gera, Rio Pomba, Brazil.
RP Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Sala 258,Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM gitrindade@yahoo.com.br
RI Azara, Tatiana/AAR-1604-2020; Costa, Galileu Barbosa/M-5768-2019;
   Miranda, Julia/N-6480-2019; Kroon, Erna/V-5444-2019; Eiras,
   Alvaro/Z-6023-2019; Paglia, Adriano P/A-7965-2012
OI Eiras, Alvaro/0000-0002-3045-0673; Paglia, Adriano
   P/0000-0001-9957-5506; Barbosa Costa, Galileu/0000-0001-7360-6722
FU Departamento de Microbiologia; CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; PRPq-UFMG; FAPEMIGMinas
   Gerais State Research Foundation (FAPEMIG); MAPA
FX Financial support was provided by Departamento de Microbiologia, CNPq,
   CAPES, PRPq-UFMG, FAPEMIG, and MAPA. G.S.T., E.G.K., A.E.E., J.S.A., and
   A.P. are researchers from CNPq.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Assis FL, 2012, EMERG INFECT DIS, V18, P2035, DOI 10.3201/eid1812.120145
   Barbosa AV, 2014, J INFECT DEV COUNTR, V8, P1646, DOI 10.3855/jidc.5216
   Batagelj Vladimir, 1998, CONNECTIONS, P47, DOI DOI 10.1017/CB09780511996368
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   de Assis FL, 2012, EMERG INFECT DIS, V18, P698, DOI 10.3201/eid1804.111800
   Diniz S, 2001, ARQUIVO BRASILEIRO M, V53, P1
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Fenner F, 1989, THE ORTHOPOXVIRUSES, P317
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   MILLS JN, 1995, J MAMMAL, V76, P716, DOI 10.2307/1382742
   Moss B., 2013, FIELDS VIROLOGY, V2, P2129
   Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480
   Oliveira DB, 2013, AM J TROP MED HYG, V89, P1142, DOI 10.4269/ajtmh.13-0369
   Oliveira G, 2015, VIRUSES-BASEL, V7, P1218, DOI 10.3390/v7031218
   Paglia AP, 2012, OCCASIONAL PAPERS CO, V6, P76
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Rehfeld IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127350
   Reynolds MG, 2010, AM J TROP MED HYG, V82, P746, DOI 10.4269/ajtmh.2010.09-0716
   Schatzmayr HG, 2011, VACCINE, V29, pD65, DOI 10.1016/j.vaccine.2011.09.105
   Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
NR 40
TC 13
Z9 13
U1 0
U2 4
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2017
VL 23
IS 6
BP 931
EP 938
DI 10.3201/eid2306.161643
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EW1OB
UT WOS:000402259100006
PM 28518030
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU de Oliveira, DB
   Candiani, TM
   Franco-Luiz, APM
   Almeida, GMF
   Abrahao, JS
   Rios, M
   Coimbra, RS
   Kroon, EG
AF de Oliveira, Danilo B.
   Candiani, Talitah M.
   Franco-Luiz, Ana Paula M.
   Almeida, Gabriel M. F.
   Abrahao, Jonatas S.
   Rios, Maria
   Coimbra, Roney S.
   Kroon, Erna G.
TI Etiological agents of viral meningitis in children from a dengue-endemic
   area, Southeast region of Brazil
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Viral meningitis; Molecular diagnosis; Epidemiology; Dengue virus in CNS
ID RT-PCR ASSAY; NERVOUS-SYSTEM; ASEPTIC-MENINGITIS; ZIKA VIRUS; INFECTION;
   ENCEPHALITIS; ENTEROVIRUS
AB Meningitis is a disease with a global distribution that constitutes a worldwide burden, with viruses as the primary etiologic agents. The range of viral meningitis severity depends mainly on age, immune status and etiological agent. The aim of this work was to investigate the suspected cases of viral meningitis using molecular techniques to confirm the viral infection. The diagnosed virus was correlated with clinical findings and cytochemical parameters in cerebrospinal liquid (CSF) of patients. CSF of 70 children with the presumptive diagnosis of viral meningitis was analyzed by real time PCR (qPCR). Viruses were identified by qPCR in 44 CSF samples (62.9%). Among them, 31 were identified as Enterovirus (ENTV) (70.4%), six as Human herpes virus 3 (HHV-3) (13.6%), five as Dengue virus (DENV) (11.7%), one as Human herpes virus 1-2 (2.3%) and one as Human herpes virus 5 (2.3%). Patients in the HHV-positive groups had increased percentage of polymorphonuclear neutrophils (PMN) (mean of 81%) while the groups of patients with DENV and ENTV had a mean of 30.9%.
   This study contributes to the knowledge of the epidemiological distribution of viral agents in CNS infections in children. In addition, it raises the relevance of DENV as an agent of CNS infection, and reinforces the importance for molecular in the cases of CNV infection. (C) 2017 Elsevier B.V. All rights reserved.
C1 [de Oliveira, Danilo B.; Franco-Luiz, Ana Paula M.; Almeida, Gabriel M. F.; Abrahao, Jonatas S.; Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Candiani, Talitah M.] FHEMIG, Hosp Infantil Joao Paulo 2, BR-30130110 Belo Horizonte, MG, Brazil.
   [Rios, Maria] US FDA, Ctr Biol Res & Review, Silver Spring, MD 20993 USA.
   [Coimbra, Roney S.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Neurogen, BR-30190002 Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo B.] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med Diamantina, BR-39100000 Diamantina, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Lab Virus, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Almeida, Gabriel MF/I-8910-2012; Coimbra,
   Roney/B-3102-2013; Kroon, Erna Geessien/B-3631-2015
OI Almeida, Gabriel MF/0000-0003-2317-5092; Kroon, Erna
   Geessien/0000-0003-2721-3826; Coimbra, Roney/0000-0002-9204-0573
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG) [PPM
   00686-15]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [448185/2014-8]; CAPESCAPES [08/2014]
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (PPM 00686-15).
   D.B. Oliveira received fellowships from CNPq (448185/2014-8) and G.M.F
   Almeida received from CAPES (until 08/2014). E.G. Kroon, G.S. Trindade
   and J.S. Abrahao are researchers from CNPq.
CR Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953
   BERLIN LE, 1993, J INFECT DIS, V168, P888, DOI 10.1093/infdis/168.4.888
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chadwick DR, 2005, BRIT MED BULL, V75-76, P1, DOI 10.1093/bmb/ldh057
   Chan JF, 2016, J INFECT
   Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Dierssen U, 2008, J CLIN VIROL, V42, P58, DOI 10.1016/j.jcv.2007.11.016
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   JU JY, 1995, P NATL ACAD SCI USA, V92, P4347, DOI 10.1073/pnas.92.10.4347
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854
   Michos AG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000674
   Organizaca'o pan-americana da saude (OPAS), DAD DENG BRAS
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sinan, BRAZ NAT MAND DIS RE
   Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Somand D, 2009, EMERG MED CLIN N AM, V27, P89, DOI 10.1016/j.emc.2008.07.004
NR 20
TC 5
Z9 7
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD APR 15
PY 2017
VL 375
BP 390
EP 394
DI 10.1016/j.jns.2017.02.025
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ER4EN
UT WOS:000398752000078
PM 28320174
DA 2020-11-30
ER

PT J
AU Versiani, AF
   Astigarraga, RG
   Rocha, ESO
   Barboza, APM
   Kroon, EG
   Rachid, MA
   Souza, DG
   Ladeira, LO
   Barbosa-Stancioli, EF
   Jorio, A
   Da Fonseca, FG
AF Versiani, Alice F.
   Astigarraga, Ruiz G.
   Rocha, Eliseu S. O.
   Barboza, Ana Paula M.
   Kroon, Erna G.
   Rachid, Milene A.
   Souza, Daniele G.
   Ladeira, Luiz O.
   Barbosa-Stancioli, Edel F.
   Jorio, Ado
   Da Fonseca, Flavio G.
TI Multi-walled carbon nanotubes functionalized with recombinant Dengue
   virus 3 envelope proteins induce significant and specific immune
   responses in mice
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Dengue vaccine; Carbon nanotubes; Subunit vaccine; Nanoconjugate
ID DENGUE VIRUS; T-CELLS; IMMUNIZATION; VACCINES; ENHANCE; ANTIGEN
AB Background: Dengue is the most prevalent arthropod-borne viral disease in the world. In this article we present results on the development, characterization and immunogenic evaluation of an alternative vaccine candidate against Dengue.
   Methods: The MWNT-DENV3E nanoconjugate was developed by covalent functionalization of carboxylated multi-walled carbon nanotubes (MWNT) with recombinant dengue envelope (DENV3E) proteins. The recombinant antigens were bound to the MWNT using a diimide-activated amidation process and the immunogen was characterized by TEM, AFM and Raman Spectroscopy. Furthermore, the immunogenicity of this vaccine candidate was evaluated in a murine model.
   Results: Immunization with MWNT-DENV3E induced comparable IgG responses in relation to the immunization with non-conjugated proteins; however, the inoculation of the nanoconjugate into mice generated higher titers of neutralizing antibodies. Cell-mediated responses were also evaluated, and higher dengue-specific splenocyte proliferation was observed in cell cultures derived from mice immunized with MWNT-DENV3E when compared to animals immunized with the non-conjugated DENV3E.
   Conclusions: Despite the recent licensure of the CYD-TDV dengue vaccine in some countries, results from the vaccine's phase III trial have cast doubts about its overall efficacy and global applicability. While questions about the effectiveness of the CYD-TDV vaccine still lingers, it is wise to keep at hand an array of vaccine candidates, including alternative non-classical approaches like the one presented here.
C1 [Versiani, Alice F.; Astigarraga, Ruiz G.; Barbosa-Stancioli, Edel F.; Da Fonseca, Flavio G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Basic & Appl Virol, Belo Horizonte, MG, Brazil.
   [Rocha, Eliseu S. O.; Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Rachid, Milene A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol, Belo Horizonte, MG, Brazil.
   [Ladeira, Luiz O.] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Fis, Belo Horizonte, MG, Brazil.
   [Jorio, Ado] Univ Fed Minas Gerais, Dept Fis, Lab Nanoscopia, Belo Horizonte, MG, Brazil.
   [Souza, Daniele G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Microorganism Host Interact, Belo Horizonte, MG, Brazil.
RP Da Fonseca, FG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Basic & Appl Virol, Belo Horizonte, MG, Brazil.
EM fdafonseca@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Rachid, Milene Alvarenga/C-3530-2017; Kroon,
   Erna Geessien/B-3631-2015; Jorio, Ado/F-2141-2010; Barbosa-Stancioli,
   Edel F/J-7230-2012; Versiani, Alice/M-9782-2018
OI Rachid, Milene Alvarenga/0000-0002-3142-6552; Kroon, Erna
   Geessien/0000-0003-2721-3826; Jorio, Ado/0000-0002-5978-2735;
   Barbosa-Stancioli, Edel F/0000-0001-6584-4333; Versiani,
   Alice/0000-0003-1378-5380; Ladeira, Luiz Orlando/0000-0002-4935-6070
FU FAPEMIG (Pronex Bio-NC); CAPESCAPES; CNPq (Universal Grant)
   [470914/2012-2]; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This work was supported by FAPEMIG (Pronex Bio-NC), CAPES and CNPq
   (Universal Grant # 470914/2012-2). EG Kroon, DG Souza, LO Ladeira, A
   Jorio, EFB Stancioli and FG da Fonseca are CNPq fellowship recipients.
   Other than funding, sponsoring agencies had no role on the study design,
   collection and interpretation of the data, and writing of the
   manuscript. No writing assistance was utilized.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Andersen CAS, 2009, J IMMUNOL, V183, P2294, DOI 10.4049/jimmunol.0804091
   Babu JP, 2008, VACCINE, V26, P4655, DOI 10.1016/j.vaccine.2008.07.006
   de Faria PCB, 2014, NANO LETT, V14, P5458, DOI 10.1021/nl502911a
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bianco A, 2011, CHEM COMMUN, V47, P10182, DOI 10.1039/c1cc13011k
   Calegari LP, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0196-7
   Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011
   Rocha ESD, 2013, J VIROL METHODS, V187, P114, DOI 10.1016/j.jviromet.2012.09.012
   Delogu LG, 2012, NANOMEDICINE-UK, V7, P231, DOI [10.2217/nnm.11.101, 10.2217/NNM.11.101]
   Dresselhaus MS, 2010, PHILOS T R SOC A, V368, P5355, DOI 10.1098/rsta.2010.0213
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Ferlauto AS, 2006, APPL PHYS A-MATER, V84, P271, DOI 10.1007/s00339-006-3617-x
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079
   Hansen J, 2008, J INFECT DIS, V198, P758, DOI 10.1086/590670
   Hu PQ, 2004, J IMMUNOL, V172, P1595, DOI 10.4049/jimmunol.172.3.1595
   Hunsawong T, 2015, VACCINE, V33, P1702, DOI 10.1016/j.vaccine.2015.02.016
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jain KK, 2012, EXPERT OPIN DRUG DIS, V7, P1029, DOI 10.1517/17460441.2012.722078
   Jiang KY, 2004, J MATER CHEM, V14, P37, DOI 10.1039/b310359e
   Kam NWS, 2005, J AM CHEM SOC, V127, P6021, DOI 10.1021/ja050062v
   Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209
   Kraszewski S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040703
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Mathew A, 2014, FUTURE MICROBIOL, V9, P411, DOI 10.2217/fmb.13.171
   Men R, 2000, VACCINE, V18, P3113, DOI 10.1016/S0264-410X(00)00121-3
   Meng J, 2008, SMALL, V4, P1364, DOI 10.1002/smll.200701059
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Pantarotto D, 2003, CHEM BIOL, V10, P961, DOI 10.1016/j.chembiol.2003.09.011
   Pantarotto D, 2003, J AM CHEM SOC, V125, P6160, DOI 10.1021/ja034342r
   Pescatori M, 2013, BIOMATERIALS, V34, P4395, DOI 10.1016/j.biomaterials.2013.02.052
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Scheinberg DA, 2013, ADV DRUG DELIVER REV, V65, P2016, DOI 10.1016/j.addr.2013.07.013
   Silvestre BT, 2014, VACCINE, V32, P2160, DOI 10.1016/j.vaccine.2014.02.062
   Simon A, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-396
   Stayton PS, 2003, TRENDS BIOTECHNOL, V21, P465, DOI 10.1016/j.tibtech.2003.09.004
   Tregoning JS, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0028-2014
   Uehori J, 2003, INFECT IMMUN, V71, P4238, DOI 10.1128/IAI.71.8.4238-4249.2003
   Villa CH, 2011, ACS NANO, V5, P5300, DOI 10.1021/nn200182x
   WHO, 2016, WEEKL EP REC DENG VA, V30
   WHO, 2007, GUID PLAQ RED NEUTR
   Yandara N, 2008, VACCINE, V26, P5864, DOI 10.1016/j.vaccine.2008.08.014
NR 49
TC 22
Z9 22
U1 0
U2 22
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD APR 4
PY 2017
VL 15
AR 26
DI 10.1186/s12951-017-0259-4
PG 13
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA ER0ZB
UT WOS:000398517000001
PM 28376812
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Trindade, GD
   Pereira-Oliveira, G
   Figueiredo, PD
   Costa, G
   Franco-Luiz, APM
   Assis, FL
   de Oliveira, DB
   Paim, LRM
   Oliveira, CED
   Neto, ALM
   Kroon, EG
AF Abrahao, J. S.
   de Souza Trindade, G.
   Pereira-Oliveira, G.
   de Oliveira Figueiredo, P.
   Costa, G.
   Moreira Franco-Luiz, A. P.
   Lopes Assis, F.
   Bretas de Oliveira, D.
   Mattos Paim, L. R.
   de Araujo Oliveira, C. E.
   Maia Neto, A. Lemos
   Geessien Kroon, E.
TI Detection of Vaccinia virus during an outbreak of exanthemous oral
   lesions in Brazilian equids
SO EQUINE VETERINARY JOURNAL
LA English
DT Article
DE Horse; Vaccinia virus; orthopoxvirus; emerging infectious disease
ID BOVINE VACCINIA; HUMANS; CATTLE
AB Reasons for performing study: In August 2014, an outbreak of oral exanthematous disease in equids was reported in Brazil, affecting 11 donkeys and 3 mules.
   Objectives: To investigate if Vaccinia virus (VACV) was the aetiological agent in this outbreak.
   Study design: Investigation of clinical cases using serological, molecular and phylogenetic approaches.
   Methods: To analyse the presence of neutralising antibodies against VACV, samples were submitted in triplicate to a plaque-reduction neutralisation test (PRNT50%). On the basis of previous studies which detected VACV DNA in sera, we submitted extracted DNA samples to different polymerase chain reaction (PCR) platforms targeting Orthopoxvirus (OPV) genes (C11R, A56R and A26L). The PCR products were directly sequenced in both orientations using specific primers and capillary electrophoresis. The alignment and phylogenetic analysis of the A26L and A56R nucleotide sequences (maximum likelihood) were prepared with the obtained nucleotide fragments.
   Results: Serological and molecular data suggested VACV as the aetiological agent. The neutralising antibodies against OPV were detected in 5 (55.5%) of the equids, with titres 40 neutralising u/ml. Based on the results obtained from all PCR platforms, all samples were positive for OPV: 9 (100%) for A56R, 4 (44.4%) for C11R and 3 (33.3%) for A26L. The alignment of the nucleotide sequences of the A26L and A56R fragments revealed that the samples were highly similar to the homologous genes from other Brazilian VACV Group 1 isolates (98.8% identity on average). Furthermore, both the A26L and A56R sequences showed signature deletions also present in the sequences of Group 1 VACV isolates from Brazil.
   Conclusions: Our data raises questions about the role of equids in the chain of VACV epidemiology. The surveillance of equids in VACV-affected areas worldwide is relevant.
C1 [Abrahao, J. S.; de Souza Trindade, G.; Pereira-Oliveira, G.; de Oliveira Figueiredo, P.; Costa, G.; Moreira Franco-Luiz, A. P.; Lopes Assis, F.; Bretas de Oliveira, D.; Geessien Kroon, E.] Univ Fed Minas Gerais, Lab Virus, Belo Horizonte, MG, Brazil.
   [Mattos Paim, L. R.; de Araujo Oliveira, C. E.; Maia Neto, A. Lemos] ADAB Agencia Estadual Defesa Agr Bahia, Salvador, BA, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Lab Virus, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Costa, Galileu Barbosa/M-5768-2019; Kroon, Erna/V-5444-2019; Kroon,
   Erna/B-3631-2015
OI Kroon, Erna/0000-0003-2721-3826
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX Financially supported by CNPq, CAPES, and FAPEMIG. JSA, GST and EGK are
   CNPq researchers.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   desAssis F. L., 2012, BRAZIL EMERG INFECT, V18, P698
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Rivetti AV, 2013, VET MICROBIOL, V162, P103, DOI 10.1016/j.vetmic.2012.09.005
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
NR 11
TC 5
Z9 5
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0425-1644
EI 2042-3306
J9 EQUINE VET J
JI Equine Vet. J.
PD MAR
PY 2017
VL 49
IS 2
BP 221
EP 224
DI 10.1111/evj.12571
PG 4
WC Veterinary Sciences
SC Veterinary Sciences
GA EL9RP
UT WOS:000394958000018
PM 26875684
DA 2020-11-30
ER

PT J
AU Lucinda, N
   Figueiredo, MM
   Pessoa, NL
   Santos, BSAD
   Lima, GK
   Freitas, AM
   Machado, AMV
   Kroon, EG
   Antonelli, LRD
   Campos, MA
AF Lucinda, Natlia
   Figueiredo, Maria Marta
   Pessoa, Natalia Lima
   Alvares da Silva Santos, Beatriz Senra
   Lima, Graciela Kunrath
   Freitas, Arthur Molinari
   Vieira Machado, Alexandre Magalhaes
   Kroon, Erna Geessien
   do Valle Antonelli, Lis Ribeiro
   Campos, Marco Antonio
TI Dendritic cells, macrophages, NK and CD8(+) T lymphocytes play pivotal
   roles in controlling HSV-1 in the trigeminal ganglia by producing
   IL1-beta, iNOS and granzyme B
SO VIROLOGY JOURNAL
LA English
DT Article
DE Herpes simplex virus 1; Innate immunity; Dendritic cells; Macrophages;
   CD8(+) T lymphocytes; TLRs; Murine model; Neuropathogenesis;
   Encephalitis
ID HERPES-SIMPLEX-VIRUS; CENTRAL-NERVOUS-SYSTEM; INNATE IMMUNE-SYSTEM;
   NITRIC-OXIDE; INTERLEUKIN-1 FAMILY; LETHAL ENCEPHALITIS; ADAPTIVE
   IMMUNITY; INDUCED APOPTOSIS; VIRAL-INFECTION; TLR3 DEFICIENCY
AB Background: Herpes simplex virus type 1 (HSV-1) cause not only mild symptoms but also blindness and encephalitis. It was previously shown that the immune response against HSV-1 occurs mainly in the trigeminal ganglia (TG) and that Toll-like receptors 2 and 9 (TLR2/9) are important in mediating this response. It was also demonstrated that iNOS (nitric oxide synthase) and interleukin 1 beta (IL-1 beta) play an essential role in the defense against HSV-1 infection. Importantly, the present work aimed to identify the primary cells responsible for iNOS and IL-1 beta production and search for other important molecules and cells that might or might not depend on TLR2/9 receptors to mediate the immune response against HSV-1.
   Methods: C57BL/6 (wild type, WT) and TLR2/9(-/-) mice were infected by the intranasal route with HSV-1 (1 x 106 p.f.u.). Cells were obtained from the TG and spleen tissues and the profile of immune cells was determined by flow cytometry in infected and mock infected WT and knockout mice. The percentage of cells producing iNOS, IL-1 beta, granzyme B and perforin was also determined by flow cytometry. Chemokine monocyte chemoattractant protein-1 (MCP1) was measured by Cytometric Bead Array (CBA) in the TG, spleen and lung. Expression of type I interferons (IFNs), interleukins (IL) 5 and 10, IL-1 beta and granzyme B were quantified by real time PCR.
   Results: The results indicate that dendritic cells (DCs) and monocytes/macrophages (Mo/M phi) were the main sources of IL-1 beta and iNOS, respectively, which, together with type I IFNs, were essential for the immune response against HSV-1. Additionally, we showed that granzyme B produced by CD8(+) T and NK lymphocytes and MCP-1 were also important for this immune response. Moreover, our data indicate that the robust production of MCP-1 and granzyme B is either TLR-independent or down regulated by TLRs and occurs in the TG of TLR2/9(-/-) infected mice.
   Conclusion: Taken together, our data provide strong evidence that the responses mediated by DCs, Mo/M., NK and CD8(+) T lymphocytes through IL-1 beta, iNOS and granzyme B production, respectively, together with the production of type I IFN early in the infection, are crucial to host defense against HSV-1.
C1 [Lucinda, Natlia; Figueiredo, Maria Marta; Pessoa, Natalia Lima; Alvares da Silva Santos, Beatriz Senra; Freitas, Arthur Molinari; Vieira Machado, Alexandre Magalhaes; Campos, Marco Antonio] Fiocruz MS, Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Imunol Doencas Virais, Ave Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
   [Lima, Graciela Kunrath] Univ Fed Minas Gerais, Escola Vet, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [do Valle Antonelli, Lis Ribeiro] Fiocruz MS, Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Biol & Imunol Parasitaria, Ave Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
RP Campos, MA (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Imunol Doencas Virais, Ave Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM marcoasc@cpqrr.fiocruz.br
RI Antonelli, Lis/R-4910-2019; Kroon, Erna/V-5444-2019; Antonelli,
   Guido/K-7915-2016; Kroon, Erna Geessien/B-3631-2015; Pessoa,
   Natalia/AAL-6775-2020; Machado, Alexandre M Vieira/G-2468-2012; Campos,
   Marco A/C-4000-2013
OI Antonelli, Lis/0000-0002-4969-8812; Kroon, Erna
   Geessien/0000-0003-2721-3826; Pessoa, Natalia/0000-0002-4284-2674;
   Machado, Alexandre M Vieira/0000-0003-1506-4093; Campos, Marco
   A/0000-0003-4683-0176; Lucinda Pacheco Chaves,
   Natalia/0000-0001-7499-9687
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG,
   Brazil)Minas Gerais State Research Foundation (FAPEMIG); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Instituto Nacional de Ciencia e Tecnologia de
   Vacinas/CNPq/FAPEMIG (INCTV/CNPq/FAPEMIG; Brazil); Programa Estrategico
   de Pesquisa em Saude VI (PAPES)/FIOCRUZ/CNPq (Brazil)
FX Work supported by the Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG, Brazil, to MAC, MMF and EGK), the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil, to AMVM, EGK,
   LRVA, MMF and MAC), Instituto Nacional de Ciencia e Tecnologia de
   Vacinas/CNPq/FAPEMIG (INCTV/CNPq/FAPEMIG; Brazil, to AMVM, LRVA, MAC),
   and the Programa Estrategico de Pesquisa em Saude VI
   (PAPES)/FIOCRUZ/CNPq (Brazil, to MAC). AMVM, EGK, LRVA and MAC are
   Fellows from CNPq. The authors thank the program for technological
   development in tools for health-PDTIS-FIOCRUZ for the use of its
   facilities.
CR Andersen LL, 2015, J EXP MED, V212, P1371, DOI 10.1084/jem.20142274
   Aoyagi H, 2010, ODONTOLOGY, V98, P26, DOI 10.1007/s10266-009-0112-9
   Arduino PG, 2008, J ORAL PATHOL MED, V37, P107, DOI 10.1111/j.1600-0714.2007.00586.x
   Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907
   Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x
   Boivin G, 2002, EUR J NEUROSCI, V16, P29, DOI 10.1046/j.1460-9568.2002.02057.x
   Carr DJJ, 2006, CURR TOP MICROBIOL, V303, P47, DOI 10.1007/978-3-540-33397-5_3
   Carr DJJ, 2003, J VIROL, V77, P10037, DOI 10.1128/JVI.77.18.10037-10046.2003
   Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346
   Chang E, 2000, J VIROL, V74, P11832, DOI 10.1128/JVI.74.24.11832-11840.2000
   Chew T, 2009, VIRUSES-BASEL, V1, P979, DOI 10.3390/v1030979
   Dando SJ, 2014, CLIN MICROBIOL REV, V27, P691, DOI 10.1128/CMR.00118-13
   Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103
   Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924
   Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612
   Donaghy H, 2009, J VIROL, V83, P1952, DOI 10.1128/JVI.01578-08
   Egan KP, 2013, J NEUROVIROL, V19, P328, DOI 10.1007/s13365-013-0189-3
   Ellermann-Eriksen S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-59
   Gamba G, 2004, J MED VIROL, V73, P313, DOI 10.1002/jmv.20093
   Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010
   Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261
   Grubor-Bauk B, 2008, J VIROL, V82, P11073, DOI 10.1128/JVI.00205-08
   Hiebert PR, 2012, TRENDS MOL MED, V18, P732, DOI 10.1016/j.molmed.2012.09.009
   Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101
   Hosking MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000937
   Ida Hiroaki, 2005, Mod Rheumatol, V15, P315
   Ivanova EA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/327470
   Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Johnson AJ, 2008, J VIROL, V82, P9678, DOI 10.1128/JVI.01159-08
   Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737
   Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164
   Kodukula P, 1999, J IMMUNOL, V162, P2895
   Kogo J, 2006, BRAIN RES, V1122, P201, DOI 10.1016/j.brainres.2006.09.006
   Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102
   Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674
   Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100
   Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0
   Lee JJ, 2010, CLIN EXP ALLERGY, V40, P563, DOI 10.1111/j.1365-2222.2010.03484.x
   Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001
   Lim HK, 2014, NEUROLOGY, V83, P1888, DOI 10.1212/WNL.0000000000000999
   Lima GK, 2010, AM J PATHOL, V177, P2433, DOI 10.2353/ajpath.2010.100121
   MacLean A, 1998, J GEN VIROL, V79, P825, DOI 10.1099/0022-1317-79-4-825
   Mansur DS, 2005, AM J PATHOL, V166, P1419, DOI 10.1016/S0002-9440(10)62359-0
   Low-Calle AM, 2014, VIRUS RES, V180, P49, DOI 10.1016/j.virusres.2013.12.022
   Marques CP, 2004, GLIA, V47, P358, DOI 10.1002/glia.20045
   Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001
   Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999
   Melchjorsen J, 2009, VIRUSES-BASEL, V1, P737, DOI 10.3390/v1030737
   Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016
   Moon BG, 2004, J IMMUNOL, V172, P6020, DOI 10.4049/jimmunol.172.10.6020
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Mott KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093444
   Mott KR, 2008, CLIN VACCINE IMMUNOL, V15, P1859, DOI 10.1128/CVI.00318-08
   Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Nogueira ML, 1998, MEM I OSWALDO CRUZ, V93, P213, DOI 10.1590/S0074-02761998000200015
   O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097
   Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312
   Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937
   Pellett P, 2013, FIELDS VIROLOGY, V2, P1802
   Pereira RA, 2000, J VIROL, V74, P1029, DOI 10.1128/JVI.74.2.1029-1032.2000
   Rosato PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005028
   Salti SM, 2011, J IMMUNOL, V187, P6301, DOI 10.4049/jimmunol.1100891
   Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259
   Sarangi PP, 2008, J IMMUNOL, V180, P6297, DOI 10.4049/jimmunol.180.9.6297
   Sato A, 2006, P NATL ACAD SCI US, V103
   Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094
   Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7
   Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604
   Steiner I, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0414-8
   Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007
   Su CH, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0495-5
   Suazo PA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/593757
   Tanaka H, 2004, AM J RESP CELL MOL, V31, P62, DOI 10.1165/rcmb.2003-0305OC
   Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911
   TUMPEY TM, 1994, J IMMUNOL, V153, P2258
   Voskoboinik I, 2010, IMMUNOL REV, V235, P35, DOI 10.1111/j.0105-2896.2010.00896.x
   Wagner C, 2004, BLOOD, V103, P1099, DOI 10.1182/blood-2003-04-1069
   Wang JP, 2012, J VIROL, V86, P2273, DOI 10.1128/JVI.06010-11
   Wuest TR, 2011, J NEUROIMMUNOL, V234, P103, DOI 10.1016/j.jneuroim.2011.03.006
   Wuest TR, 2008, J IMMUNOL, V181, P7985, DOI 10.4049/jimmunol.181.11.7985
   Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831
   Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961
   Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522
   Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001
   Zolini GP, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-20
NR 87
TC 10
Z9 12
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD FEB 21
PY 2017
VL 14
AR 37
DI 10.1186/s12985-017-0692-x
PG 15
WC Virology
SC Virology
GA EN4PZ
UT WOS:000395990700003
PM 28222752
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Dutra, LAL
   Almeida, GMD
   Oliveira, GP
   Abrahao, JS
   Kroon, EG
   Trindade, GD
AF Leal Dutra, Lara Ambrosio
   de Freitas Almeida, Gabriel Magno
   Oliveira, Graziele Pereira
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
TI Molecular evidence of Orthopoxvirus DNA in capybara (Hydrochoerus
   hydrochaeris) stool samples
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID VACCINIA-VIRUS; BOVINE VACCINIA; HORIZONTAL TRANSMISSION; SOUTHEASTERN
   BRAZIL; POXVIRUS; CATTLE; DIFFERENTIATION; INFECTION; OUTBREAKS;
   SMALLPOX
AB Vaccinia virus (VACV) is responsible for outbreaks in Brazil and has immense potential as an emerging virus. VACV can be found naturally circulating in India, Pakistan and South America, where it causes infections characterised by exanthematic lesions in buffaloes, cattle and humans. The transmission cycle of Brazilian VACV has still not been fully characterised; one of the most important gaps in knowledge being the role of wild animals. Capybaras, which are restricted to the Americas, are the world's largest rodents and have peculiar characteristics that make them possible candidates for being part of a natural VACV reservoir. Here, we developed a method for detecting orthopoxvirus DNA in capybara stool samples, and have described for the first time the detection of orthopoxvirus DNA in capybaras samples from three different regions in Brazil. These findings strongly suggest that capybaras might be involved in the natural transmission cycle of VACV and furthermore represent a public health problem, when associated with Brazilian bovine vaccinia outbreaks. This makes infected animals an important factor to be considered when predicting and managing Brazilian VACV outbreaks.
C1 [Leal Dutra, Lara Ambrosio; de Freitas Almeida, Gabriel Magno; Oliveira, Graziele Pereira; Abrahao, Jonatas Santos; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
   [Leal Dutra, Lara Ambrosio; de Freitas Almeida, Gabriel Magno] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.
RP Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
EM giliane@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; Almeida,
   Gabriel MF/I-8910-2012
OI Kroon, Erna Geessien/0000-0003-2721-3826; Almeida, Gabriel
   MF/0000-0003-2317-5092
FU Fundacao de Amparo a Pesquisado Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Coordenadoria de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; European
   Research Council (ERC)European Research Council (ERC) [615146]; Finnish
   Centre of Excellence Program of the Academy of FinlandAcademy of Finland
   [252411]
FX This work was supported by research grants from Fundacao de Amparo a
   Pesquisado Estado de Minas Gerais (FAPEMIG), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenadoria de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). From April, 2016
   onwards LALD was funded by European Research Council (ERC) [EU
   FP7/2007-2013 (Micro-RIP 2014-2019, project #615146)]. From March 2016
   onwards GMFA was funded by the Finnish Centre of Excellence Program of
   the Academy of Finland (CoE in Biological Interactions 2012-2017,
   project #252411). We would like to thank Ana Paula Moreira for obtaining
   the samples from Pantanal and Juliano Leal de Paula from Nucleo de
   Analise de Genoma e Expressao Genica (NAGE)-Departamento de Bioquimica e
   Imunologia (ICB-UFMG). GST, JSA and EGK are researchers from CNPq.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140
   Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1
   Barbosa AV, 2014, J INFECT DEV COUNTR, V8, P1646, DOI 10.3855/jidc.5216
   Bhanuprakash V, 2010, ZOONOSES PUBLIC HLTH, V57, pE149, DOI 10.1111/j.1863-2378.2009.01314.x
   D'Anunciacao L, 2012, VECTOR-BORNE ZOONOT, V12, P61, DOI 10.1089/vbz.2011.0671
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DAMON IK, 2007, FIELDS VIROLOGY, P2947
   Ferraz KMPMD, 2007, J BIOGEOGR, V34, P223, DOI 10.1111/j.1365-2699.2006.01568.x
   Embrapa Pantanal, 2007, CAP DIS, P74
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Ferraz KMPMB, 2009, J MAMMAL, V90, P189, DOI 10.1644/07-MAMM-A-338.1
   Ferraz Katia Maria Paschoaletto Michi de Barros, 2003, Sci. agric. (Piracicaba, Braz.), V60, P191, DOI 10.1590/S0103-90162003000100029
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   HERRERA EA, 1989, J ANIM ECOL, V58, P667, DOI 10.2307/4855
   Hutson CL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004013
   Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0
   JOKLIK WK, 1962, J MOL BIOL, V5, P265, DOI 10.1016/S0022-2836(62)80070-9
   JOKLIK WK, 1964, J MOL BIOL, V10, P452, DOI 10.1016/S0022-2836(64)80066-8
   Krawczak FS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-7
   MEYER H, 1994, J GEN VIROL, V75, P1975, DOI 10.1099/0022-1317-75-8-1975
   Ferraz KMPMD, 2010, POPUL ECOL, V52, P263, DOI 10.1007/s10144-009-0181-1
   MONES A, 1986, MAMMALIAN SPECIES, V264, P1, DOI DOI 10.2307/3503784
   Moreira CA, 1955, MEMORIAS I OSWALDO C
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Moss B, 2007, FIELDS VIROLOGY, V2, P2905
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Rivetti AV, 2013, VET MICROBIOL, V162, P103, DOI 10.1016/j.vetmic.2012.09.005
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Sambrook J., 1989, MOL CLONING LAB MANU
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
NR 36
TC 10
Z9 10
U1 0
U2 3
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD FEB
PY 2017
VL 162
IS 2
BP 439
EP 448
DI 10.1007/s00705-016-3121-3
PG 10
WC Virology
SC Virology
GA EL0MD
UT WOS:000394315600012
PM 27771792
DA 2020-11-30
ER

PT J
AU Costa, GB
   Miranda, JB
   Almeida, GG
   de Oliveira, JS
   Pinheiro, MS
   Goncalves, SA
   dos Reis, JKP
   Goncalves, R
   Ferreira, PCP
   Bonjardim, CA
   Abrahao, JS
   Kroon, EG
   Trindade, GD
AF Costa, Galileu Barbosa
   Miranda, Julia Bahia
   Almeida, Gregorio Guilherme
   de Oliveira, Jaqueline Silva
   Pinheiro, Mariana Siqueira
   Goncalves, Stefanne Aparecida
   Pimenta dos Reis, Jenner Karlisson
   Goncalves, Ricardo
   Peregrino Ferreira, Paulo Cesar
   Bonjardim, Claudio Antonio
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
TI Detection of Vaccinia Virus in Urban Domestic Cats, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID ORTHOPOXVIRUS; HUMANS; CATTLE; PAULO
AB We investigated possible vaccinia virus (VACV) in urban house cats in Brazil. Serum samples from 6 cats were positive for VACV by PCR, indicating likely VACV circulation among house cats in urban areas of Brazil. This finding highlights the importance of epidenniologic surveillance to avoid outbreaks among urban human populations.
C1 [Costa, Galileu Barbosa; Miranda, Julia Bahia; Almeida, Gregorio Guilherme; de Oliveira, Jaqueline Silva; Pinheiro, Mariana Siqueira; Goncalves, Stefanne Aparecida; Pimenta dos Reis, Jenner Karlisson; Goncalves, Ricardo; Peregrino Ferreira, Paulo Cesar; Bonjardim, Claudio Antonio; Abrahao, Jonatas Santos; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
RP Trindade, GD (corresponding author), 6627 Ave Presidente Antonio Carlos, BR-31270901 Belo Horizonte, MG, Brazil.
EM giliane@icb.ufmg.br
RI Goncalves, Ricardo/I-2411-2018; Costa, Galileu Barbosa/M-5768-2019;
   Reis, Jenner/AAJ-9164-2020; Kroon, Erna Geessien/B-3631-2015; Miranda,
   Julia/N-6480-2019; Kroon, Erna/V-5444-2019
OI Reis, Jenner/0000-0003-0395-358X; Kroon, Erna
   Geessien/0000-0003-2721-3826; Barbosa Costa, Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Pro-Reitoria
   de Pesquisa/ UFMG (PRPq)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais (FAPEMIG), and Pro-Reitoria de
   Pesquisa/ UFMG (PRPq). C.A. Bonjardim, J.S. Abrahao, E.G. Kroon, J.K.P.
   Reis, and G.S. Trindade are researchers from CNPq.
CR BENNETT M, 1989, ARCH VIROL, V104, P19, DOI 10.1007/BF01313805
   Carletti F, 2009, EMERG INFECT DIS, V15, P499, DOI 10.3201/eid1503.080813
   Dutra LA, 2016, ARCH VIRAL
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Nowotny N, 1996, ZBL HYG UMWELTMED, V198, P452
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Tryland M, 1998, VET REC, V143, P105, DOI 10.1136/vr.143.4.105
NR 10
TC 7
Z9 7
U1 0
U2 3
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2017
VL 23
IS 2
BP 360
EP 362
DI 10.3201/eid2302.161341
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EJ3CI
UT WOS:000393088600038
PM 28098542
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Marinho, PES
   de Oliveira, DB
   Candiani, TMS
   Crispim, APC
   Alvarenga, PPM
   Castro, FCD
   Abrahao, JS
   Rios, M
   Coimbra, RS
   Kroon, EG
AF Silva Marinho, Paula Eillanny
   de Oliveira, Danii Bretas
   Sanchez Candiani, Talitah Michel
   Correia Crispim, Ana Paula
   Martins Alvarenga, Pedro Paulb
   dos Santos Castro, Fabrizia Cristina
   Abrahao, Jonatas Santos
   Rios, Maria
   Coimbra, Roney Santos
   Kroon, Erna Geessien
TI Meningitis Associated with Simultaneous Infection by Multiple Dengue
   Virus Serotypes in Children, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB To determine the causes of viral meningitis, we analyzed 22 cerebrospinal fluid samples collected during the 2014-2015 dengue epidemics in Brazil. We identified 3 serotypes of dengue virus (DENV-1, -2, and -3), as well as co-infection with 2 or 3 serotypes. We also detected the Asian II genotype of DENV-2.
C1 [Silva Marinho, Paula Eillanny; de Oliveira, Danii Bretas; Correia Crispim, Ana Paula; Abrahao, Jonatas Santos; Kroon, Erna Geessien] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Sanchez Candiani, Talitah Michel; Martins Alvarenga, Pedro Paulb; dos Santos Castro, Fabrizia Cristina] Hosp Infantil Joao Paulo II, Belo Horizonte, MG, Brazil.
   [Rios, Maria] US FDA, Silver Spring, MD USA.
   [Coimbra, Roney Santos] Fundacao Oswaldo Cruz, Belo Horizonte, MG, Brazil.
   [de Oliveira, Danii Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Teofilo Otoni, MG, Brazil.
   [Silva Marinho, Paula Eillanny; de Oliveira, Danii Bretas] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627 Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627 Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Coimbra, Roney/B-3102-2013; Kroon,
   Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Coimbra,
   Roney/0000-0002-9204-0573
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacdo
   de Aperfeicoamento de Pessoal de Nivel Superior; Fundacdo de Amparo a
   Pesquisa do Estado de Minas Gerais
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (to D.B.O. and E.G.K.),
   Coordenacdo de Aperfeicoamento de Pessoal de Nivel Superior (to
   P.E.S.M.), and Fundacdo de Amparo a Pesquisa do Estado de Minas Gerais.
CR Martins VDA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100535
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Chakravarti A, 2013, ARCH VIROL, V158, P571, DOI 10.1007/s00705-012-1522-5
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004
   Ferreira GP, 2010, MICROBES INFECT, V12, P546, DOI 10.1016/j.micinf.2010.03.007
   Figueiredo LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104516
   Garg RK, 2012, INFECTION, V40, P589, DOI 10.1007/s15010-012-0284-z
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Secretraria de vigilancia em Saude, 2015, B EPIDEMIOLOGICO
   Singh S, 2015, INFECT GENET EVOL, V34, P402, DOI 10.1016/j.meegid.2015.07.006
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Somand D, 2009, EMERG MED CLIN N AM, V27, P89, DOI 10.1016/j.emc.2008.07.004
   Thavara Usavadee, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P468
NR 14
TC 6
Z9 9
U1 0
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2017
VL 23
IS 1
BP 115
EP 118
DI 10.3201/eid2301.160817
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EG2AV
UT WOS:000390836400020
PM 27983492
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Andrade, ACDP
   Lima, MT
   Oliveira, GP
   Calixto, RS
   Souza, ELDE
   de Souza, DD
   Leite, CMD
   Ferreira, JMS
   Kroon, EG
   de Oliveira, DB
   Martins, FD
   Abrahao, JS
AF dos Santos Pereira Andrade, A. C.
   Teixeira Lima, M.
   Pereira Oliveira, G.
   Silva Calixto, R.
   Lorenna de Sales e Souza, E.
   da Gloria de Souza, D.
   de Almeida Leite, C. M.
   Siqueira Ferreira, J. M.
   Kroon, E. G.
   Bretas de Oliveira, D.
   dos Santos Martins, F.
   Abrahao, J. S.
TI Daily ingestion of the probiotic Lactobacillus paracasei ST11 decreases
   Vaccinia virus dissemination and lethality in a mouse model
SO BENEFICIAL MICROBES
LA English
DT Article
DE probiotics; virus; inflammation; Orthopoxvirus
ID SKIN INFLAMMATION; IMMUNE-RESPONSES; INFECTION; PROTECTION; STRAINS;
   SPREAD; CASEI
AB Vaccinia virus (VACV) is an important pathogen. Although studies have shown relationships between probiotics and viruses, the effect of probiotics on VACV infection is unknown. Therefore, this work aims to investigate the probiotics effects on VACV infection. Mice were divided into four groups, two non-infected groups, one receiving the probiotic, the other one not receiving it, and two groups infected intranasally with VACV Western Reserve (VACV-WR) receiving or not receiving the probiotic. Viral titres in organs and cytokine production in the lungs were analysed. Lung samples were also subjected to histological analysis. The intake of probiotic results in reduction in viral spread with a significant decrease of VACV titer on lung, liver and brain of treated group. In addition, treatment with the probiotic results in attenuated mice lung inflammation showing fewer lesions on histological findings and decreased lethality in mice infected with VACV. The ingestion of Lactobacillus paracasei ST11 (LPST11) after VACV infection resulted in 2/9 animal lethality compared with 4/9 in the VACV group. This is the first study on probiotics and VACV interactions, providing not only information about this interaction, but also proposing a model for future studies involving probiotics and other poxvirus.
C1 [dos Santos Pereira Andrade, A. C.; Teixeira Lima, M.; Pereira Oliveira, G.; Silva Calixto, R.; Lorenna de Sales e Souza, E.; da Gloria de Souza, D.; Kroon, E. G.; Bretas de Oliveira, D.; dos Santos Martins, F.; Abrahao, J. S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Almeida Leite, C. M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Siqueira Ferreira, J. M.] Univ Fed Sao Joao Rei, Lab Microbiol, Ave Sebastiao Goncalves Coelho 400, BR-35501296 Divinopolis, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Ferreira, Jaqueline/E-4630-2018; Kroon, Erna
   Geessien/B-3631-2015
OI Ferreira, Jaqueline/0000-0002-1779-1975; Kroon, Erna
   Geessien/0000-0003-2721-3826; Martins, Flaviano/0000-0003-0741-3062;
   Teixeira Lima, Mauricio/0000-0002-0830-3909
CR Abrahao J.S., EQUINE VET IN PRESS
   Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324
   Al Kassaa I, 2014, PROBIOTICS ANTIMICRO, V6, P177, DOI 10.1007/s12602-014-9162-6
   Barbosa RPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098685
   Campos M.A.S., 1993, REV MICROBIOL, V28, P474
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Chiu C, 2015, NAT IMMUNOL, V16, P18, DOI 10.1038/ni.3056
   Damon I.K., 2013, FIELDS VIROLOGY, V2, P2947
   Duniho SM, 2002, TOXICOL PATHOL, V30, P339, DOI 10.1080/01926230252929918
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002, GUID EV PROB FOOD
   Gueniche A, 2010, EUR J DERMATOL, V20, P731, DOI 10.1684/ejd.2010.1108
   Hori T, 2001, CLIN DIAGN LAB IMMUN, V8, P593, DOI 10.1128/CDLI.8.3.593-597.2001
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kalthoff D, 2014, VECTOR-BORNE ZOONOT, V14, P303, DOI 10.1089/vbz.2013.1442
   Kiso M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01563
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Lee YN, 2013, ANTIVIR RES, V98, P284, DOI 10.1016/j.antiviral.2013.03.013
   Lehtoranta L, 2014, EUR J CLIN MICROBIOL, V33, P1289, DOI 10.1007/s10096-014-2086-y
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Galan NNO, 2016, J APPL MICROBIOL, V120, P1041, DOI 10.1111/jam.13069
   Oliveira GP, 2014, AM J TROP MED HYG, V90, P1021, DOI 10.4269/ajtmh.13-0621
   Oliveira M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/807483
   Oyoshi MK, 2009, P NATL ACAD SCI USA, V106, P14954, DOI 10.1073/pnas.0904021106
   Perrin Y, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-1
   Reynolds MG, 2012, CURR OPIN VIROL, V2, P335, DOI 10.1016/j.coviro.2012.02.004
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Wassenberg J, 2011, CLIN EXP ALLERGY, V41, P565, DOI 10.1111/j.1365-2222.2011.03695.x
   Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265
NR 35
TC 1
Z9 1
U1 0
U2 5
PU WAGENINGEN ACADEMIC PUBLISHERS
PI WAGENINGEN
PA PO BOX 220, WAGENINGEN, 6700 AE, NETHERLANDS
SN 1876-2883
EI 1876-2891
J9 BENEF MICROBES
JI Benef. Mirbobes
PY 2017
VL 8
IS 1
BP 73
EP 80
DI 10.3920/BM2016.0074
PG 8
WC Microbiology; Nutrition & Dietetics
SC Microbiology; Nutrition & Dietetics
GA EM8HD
UT WOS:000395551200008
PM 27873547
DA 2020-11-30
ER

PT J
AU Oliveira, GP
   Andrade, ACDP
   Rodrigues, RAL
   Arantes, TS
   Boratto, PVM
   Silva, LKD
   Dornas, FP
   Trindade, GD
   Drumond, BP
   La Scola, B
   Kroon, EG
   Abrahao, JS
AF Oliveira, Graziele Pereira
   dos Santos Pereira Andrade, Ana Cludia
   Lima Rodrigues, Rodrigo Araujo
   Arantes, Thalita Souza
   Miranda Boratto, Paulo Victor
   dos Santos Silva, Ludmila Karen
   Dornas, Fabio Pio
   Trindade, Giliane de Souza
   Drumond, Betania Paiva
   La Scola, Bernard
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
TI Promoter Motifs in NCLDVs: An Evolutionary Perspective
SO VIRUSES-BASEL
LA English
DT Review
DE megavirales; NCLDV; giant viruses; promoter; transcription; evolution;
   MEGA-box
ID SWINE-FEVER-VIRUS; MAJOR CAPSID PROTEIN; RNA-POLYMERASE-II; GENOME-WIDE
   ANALYSIS; FROG VIRUS-3; GIANT VIRUSES; DNA VIRUSES; TRANSCRIPTION
   INITIATION; MACROMOLECULAR-SYNTHESIS; MUTATIONAL ANALYSIS
AB For many years, gene expression in the three cellular domains has been studied in an attempt to discover sequences associated with the regulation of the transcription process. Some specific transcriptional features were described in viruses, although few studies have been devoted to understanding the evolutionary aspects related to the spread of promoter motifs through related viral families. The discovery of giant viruses and the proposition of the new viral order Megavirales that comprise a monophyletic group, named nucleo-cytoplasmic large DNA viruses (NCLDV), raised new questions in the field. Some putative promoter sequences have already been described for some NCLDV members, bringing new insights into the evolutionary history of these complex microorganisms. In this review, we summarize the main aspects of the transcription regulation process in the three domains of life, followed by a systematic description of what is currently known about promoter regions in several NCLDVs. We also discuss how the analysis of the promoter sequences could bring new ideas about the giant viruses' evolution. Finally, considering a possible common ancestor for the NCLDV group, we discussed possible promoters' evolutionary scenarios and propose the term "MEGA-box"to designate an ancestor promoter motif ('TATATAAAATTGA') that could be evolved gradually by nucleotides gain and loss and point mutations.
C1 [Oliveira, Graziele Pereira; dos Santos Pereira Andrade, Ana Cludia; Lima Rodrigues, Rodrigo Araujo; Arantes, Thalita Souza; Miranda Boratto, Paulo Victor; dos Santos Silva, Ludmila Karen; Dornas, Fabio Pio; Trindade, Giliane de Souza; Drumond, Betania Paiva; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, URMITE, CNRS IRD INSERM U1095 UM63 7278 198, Fac Med, 27 Blvd Jean Moulin, F-13385 Marseille 05, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM graziufmg@yahoo.com.br; ana.andrade2008@hotmail.com;
   rodriguesral07@gmail.com; tsarantes@gmail.com; pvboratto@gmail.com;
   ludmilakaren@gmail.com; fabiopiod154@gmail.com; gitrindade@yahoo.com.br;
   betaniadrumond@gmail.com; bernard.la-scola@univ-amu.fr;
   ernagkroon@gmail.com; jonatas.abrahao@gmail.com
RI Dornas, Fabio/AAI-3582-2020; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015
OI Dornas, Fabio/0000-0001-7926-5551; Kroon, Erna
   Geessien/0000-0003-2721-3826; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012
CR Abergel C, 2007, J VIROL, V81, P12406, DOI 10.1128/JVI.01107-07
   Aravind L, 1999, NUCLEIC ACIDS RES, V27, P4658, DOI 10.1093/nar/27.23.4658
   Asgari S, 2007, J GEN VIROL, V88, P1120, DOI 10.1099/vir.0.82651-0
   BALDICK CJ, 1992, J VIROL, V66, P4710, DOI 10.1128/JVI.66.8.4710-4719.1992
   BAROUDY BM, 1980, J BIOL CHEM, V255, P4372
   BAROUDY BM, 1982, NUCLEIC ACIDS RES, V10, P5673, DOI 10.1093/nar/10.18.5673
   BARRAY S, 1987, ANN INST PASTEUR VIR, V138, P253, DOI 10.1016/S0769-2617(87)80009-6
   BECKMAN W, 1988, J VIROL, V62, P1271, DOI 10.1128/JVI.62.4.1271-1277.1988
   Bell SD, 1998, P NATL ACAD SCI USA, V95, P15218, DOI 10.1073/pnas.95.26.15218
   Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9
   Benamar S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00003
   Bigot Y, 1997, J GEN VIROL, V78, P1139, DOI 10.1099/0022-1317-78-5-1139
   Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530
   Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787
   Browning DF, 2016, NAT REV MICROBIOL, V14, P638, DOI 10.1038/nrmicro.2016.103
   Broyles SS, 1999, J BIOL CHEM, V274, P35662, DOI 10.1074/jbc.274.50.35662
   Broyles SS, 2010, FUTURE VIROL, V5, P639, DOI 10.2217/FVL.10.51
   BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0
   Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789
   Cheng XW, 2005, J INVERTEBR PATHOL, V89, P193, DOI 10.1016/j.jip.2005.06.011
   Cheng XW, 2000, J GEN VIROL, V81, P3083, DOI 10.1099/0022-1317-81-12-3083
   Chinchar VG, 2009, CURR TOP MICROBIOL, V328, P123
   Chinchar VG, 2011, VIRUSES-BASEL, V3, P1959, DOI 10.3390/v3101959
   Chuchird N, 2002, VIROLOGY, V295, P289, DOI 10.1006/viro.2002.1408
   Claverie JM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-110
   Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6
   Colson P, 2012, INTERVIROLOGY, V55, P321, DOI 10.1159/000336562
   Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606
   D'Costa SM, 2004, ARCH VIROL, V149, P723, DOI 10.1007/s00705-003-0232-4
   D'Costa SM, 2001, ARCH VIROL, V146, P2165, DOI 10.1007/s007050170027
   Damon I. K., 2014, FIELDS VIROLOGY, V2, P2160
   DARAI G, 1985, VIROLOGY, V146, P292, DOI 10.1016/0042-6822(85)90012-1
   Darcy TJ, 1999, J BACTERIOL, V181, P4424, DOI 10.1128/JB.181.14.4424-4429.1999
   DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1
   Dixon LK, 2013, VIRUS RES, V173, P3, DOI 10.1016/j.virusres.2012.10.020
   Dizman YA, 2012, VIRUS RES, V167, P353, DOI 10.1016/j.virusres.2012.05.025
   Durzynska J, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0400-7
   Elde NC, 2012, CELL, V150, P831, DOI 10.1016/j.cell.2012.05.049
   Federici B. A., 2005, VIRUS TAXONOMY, P261
   Filee J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00593
   Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107
   Fitzgerald LA, 2008, VIROLOGY, V380, P388, DOI 10.1016/j.virol.2008.07.025
   Fitzgerald LA, 2007, VIROLOGY, V358, P459, DOI 10.1016/j.virol.2006.08.034
   Fitzgerald LA, 2007, VIROLOGY, V358, P472, DOI 10.1016/j.virol.2006.08.033
   Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449
   Garcia-Escudero R, 2000, J VIROL, V74, P8176, DOI 10.1128/JVI.74.17.8176-8182.2000
   GOORHA R, 1977, J VIROL, V21, P802, DOI 10.1128/JVI.21.2.802-805.1977
   GOORHA R, 1978, VIROLOGY, V84, P32, DOI 10.1016/0042-6822(78)90216-7
   GOORHA R, 1981, J VIROL, V37, P496, DOI 10.1128/JVI.37.1.496-499.1981
   GRAVES MV, 1992, VIROLOGY, V188, P198, DOI 10.1016/0042-6822(92)90750-J
   Haberle V, 2016, SEMIN CELL DEV BIOL, V57, P11, DOI 10.1016/j.semcdb.2016.01.014
   HANGGI M, 1986, EMBO J, V5, P1071, DOI 10.1002/j.1460-2075.1986.tb04324.x
   HANSEN SK, 1995, CELL, V82, P565, DOI 10.1016/0092-8674(95)90029-2
   Hausner W, 1996, J BIOL CHEM, V271, P30144, DOI 10.1074/jbc.271.47.30144
   Huang YH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-224
   Hughes AL, 2005, MOL PHYLOGENET EVOL, V35, P186, DOI 10.1016/j.ympev.2004.12.008
   Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001
   Jakob NJ, 2001, VIROLOGY, V286, P182, DOI 10.1006/viro.2001.0963
   Kang M, 2004, VIROLOGY, V326, P150, DOI 10.1016/j.virol.2004.05.023
   Kawasaki T, 2004, VIROLOGY, V318, P214, DOI 10.1016/j.virol.2003.09.015
   KECK JG, 1990, CELL, V61, P801, DOI 10.1016/0092-8674(90)90190-P
   Knutson BA, 2008, VIRUS GENES, V36, P307, DOI 10.1007/s11262-008-0207-3
   Knutson BA, 2006, J VIROL, V80, P6784, DOI 10.1128/JVI.02705-05
   Koonin EV, 2015, ANN NY ACAD SCI, V1341, P10, DOI 10.1111/nyas.12728
   KUZNAR J, 1980, VIROLOGY, V101, P169, DOI 10.1016/0042-6822(80)90493-6
   Kyrpides NC, 1999, P NATL ACAD SCI USA, V96, P8545, DOI 10.1073/pnas.96.15.8545
   La Scola B., 2003, SCIENCE, P299
   Lacadie SA, 2016, FEBS J, V283, P4214, DOI 10.1111/febs.13747
   Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012
   Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Legendre M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-99
   Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109
   Levasseur A, 2016, GENOME BIOL EVOL, V8, P2333, DOI 10.1093/gbe/evw153
   Rodrigues RAL, 2015, J VIROL, V89, P11812, DOI 10.1128/JVI.01976-15
   LWOFF A, 1957, J GEN MICROBIOL, V17, P239, DOI 10.1099/00221287-17-2-239
   Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623
   McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100
   Moreira David, 2005, Science, V308, P1114
   Moss B, 1996, P NATL ACAD SCI USA, V93, P11341, DOI 10.1073/pnas.93.21.11341
   Moss B., 2014, FIELDS VIROLOGY, V2, P2129
   Moss B, 2013, VACCINE, V31, P4220, DOI 10.1016/j.vaccine.2013.03.042
   Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595
   Nalcacioglu R, 2003, VIROLOGY, V317, P321, DOI 10.1016/j.virol.2003.08.007
   Nalcacioglu R, 2007, J GEN VIROL, V88, P2488, DOI 10.1099/vir.0.82947-0
   Nasir A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-156
   Pallister J, 2005, ARCH VIROL, V150, P1911, DOI 10.1007/s00705-005-0532-y
   PALMER JR, 1995, J BACTERIOL, V177, P1844, DOI 10.1128/jb.177.7.1844-1849.1995
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Piegu B, 2015, MOL PHYLOGENET EVOL, V84, P44, DOI 10.1016/j.ympev.2014.12.013
   Portugal R, 2015, J GEN VIROL, V96, P408, DOI 10.1099/vir.0.070508-0
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   REITER WD, 1990, P NATL ACAD SCI USA, V87, P9509, DOI 10.1073/pnas.87.24.9509
   Ren B, 1998, EMBO J, V17, P1076, DOI 10.1093/emboj/17.4.1076
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Rodriguez JM, 2013, VIRUS RES, V173, P15, DOI 10.1016/j.virusres.2012.09.014
   Rodriguez JM, 1996, J VIROL, V70, P8584
   Sabin LR, 2013, MOL CELL, V49, P783, DOI 10.1016/j.molcel.2013.02.010
   SALAS J, 1988, VIROLOGY, V164, P280, DOI 10.1016/0042-6822(88)90646-0
   Salem TZ, 2008, ARCH VIROL, V153, P149, DOI 10.1007/s00705-007-1081-3
   Scheid P, 2016, CURR OPIN MICROBIOL, V31, P58, DOI 10.1016/j.mib.2016.02.005
   Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022
   Sharma V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00722
   Sharma V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00423
   Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520
   SOGO JM, 1984, VIROLOGY, V133, P271, DOI 10.1016/0042-6822(84)90394-5
   Stasiak K, 2003, J GEN VIROL, V84, P2999, DOI 10.1099/vir.0.19290-0
   Sugimoto I, 2000, VIROLOGY, V277, P119, DOI 10.1006/viro.2000.0590
   Suhre K, 2005, P NATL ACAD SCI USA, V102, P14689, DOI 10.1073/pnas.0506465102
   Suzan-Monti M, 2006, VIRUS RES, V117, P145, DOI 10.1016/j.virusres.2005.07.011
   Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736
   Tidona CA, 1997, ARCH VIROL, P49
   Tulman ER, 2009, CURR TOP MICROBIOL, V328, P43
   Van Etten JL, 2003, ANNU REV GENET, V37, P153, DOI 10.1146/annurev.genet.37.110801.143915
   Van Etten JL, 1999, ANNU REV MICROBIOL, V53, P447, DOI 10.1146/annurev.micro.53.1.447
   Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6
   Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002
   WEISS SB, 1959, J AM CHEM SOC, V81, P4118, DOI 10.1021/ja01524a087
   Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507
   Whelan S., 2014, FIELDS VIROLOGY, V2, P2160
   Williams T, 2005, ADV VIRUS RES, V65, P173, DOI 10.1016/S0065-3527(05)65006-3
   WILLIS DB, 1987, VIROLOGY, V161, P1, DOI 10.1016/0042-6822(87)90164-4
   WILLIS DB, 1985, J VIROL, V56, P495, DOI 10.1128/JVI.56.2.495-501.1985
   Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1
   Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Yamada T, 1997, VIROLOGY, V230, P361, DOI 10.1006/viro.1997.8486
   Yang ZL, 2012, J BIOL CHEM, V287, P31050, DOI 10.1074/jbc.M112.390054
   Yang ZL, 2011, J VIROL, V85, P9899, DOI 10.1128/JVI.05446-11
   Yang Z, 2011, J VIROL, V85, P5897, DOI 10.1128/JVI.00428-11
   YATES PR, 1995, BIOCHEM SOC T, V23, pS139, DOI 10.1042/bst023139s
   Yutin N, 2014, VIROLOGY, V466, P38, DOI 10.1016/j.virol.2014.06.032
   Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114
   Zhao KJ, 2003, VIRUS GENES, V27, P93, DOI 10.1023/A:1025132720885
NR 134
TC 10
Z9 10
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2017
VL 9
IS 1
AR 16
DI 10.3390/v9010016
PG 20
WC Virology
SC Virology
GA EO1RS
UT WOS:000396476200015
PM 28117683
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Brandao, GC
   Kroon, EG
   Souza, JD
   Oliveira, AB
AF Brandao, Geraldo Celio
   Kroon, Erna G.
   Souza Filho, Jose D.
   Oliveira, Alaide Braga
TI Antiviral Activity of Fridericia formosa (Bureau) L. G. Lohmann
   (Bignoniaceae) Extracts and Constituents
SO JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
ID ANTIOXIDANT C-GLUCOSYLXANTHONES; CHEMICAL-CONSTITUENTS; MINAS-GERAIS;
   XANTHONES; MANGIFERIN; FLAVONOIDS; LEAVES; STATE
AB A phytochemical study of Fridericia formosa (Bignoniaceae) ethanol extracts of leaves, stems, and fruits was guided by in vitro assays against vaccinia virus Western Reserve (VACV-WR), human herpes virus 1 (HSV-1), murine encephalomyocarditis virus (EMCV), and dengue virus type 2 (DENV-2) by the MTT method. All the ethanol extracts were active against DENV-2, HSV-1, and VACV-WR with best results for the fruits extract against DENV-2 (SI > 38.2). For VACV-WR and HSV-1, EC50 values > 200 mu g mL(-1) were determined, while no inhibition of the cytopathic effect was observed with EMCV. Five compounds were isolated and identified as the C-glucosylxanthones mangiferin (1), 2'-O-trans-caffeoylmangiferin (2), 2'-O-trans-coumaroylmangiferin (3), 2'-O- trans-cinnamoylmangiferin (5), and the flavonoid chrysin (4). The most active compound was 2'-O-trans-coumaroylmangiferin (3) with SI > 121.9 against DENV-2 and 108.7 for HSV-1. These results indicate that mangiferin cinnamoyl esters might be potential antiviral drugs.
C1 [Brandao, Geraldo Celio] Univ Fed Ouro Preto, Dept Farm, Escola Farm, Campus Morro Cruzeiro, BR-35400000 Ouro Preto, MG, Brazil.
   [Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, ICB, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Souza Filho, Jose D.] Univ Fed Minas Gerais, ICEX, Dept Quim, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Oliveira, Alaide Braga] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RP Oliveira, AB (corresponding author), Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM alaidebraga@terra.com.br
RI Kroon, Erna/V-5444-2019; DE SOUZA FILHO, Jose DIAS/ABF-1983-2020
OI DE SOUZA FILHO, Jose DIAS/0000-0002-3656-4882; Brandao, Geraldo
   Celio/0000-0002-7330-051X
FU FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais,
   Brazil)Minas Gerais State Research Foundation (FAPEMIG)
   [CDS-APQ-00270-13]; CAPES (Coordenacao de Aperfeic, oamrnto de Pessoal
   de Ensino Superior, Brazil)CAPES; CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Brazil)National Council for
   Scientific and Technological Development (CNPq); GeraldoCelio Brandao;
   Erna G. Kroon; Alaide Braga Oliveira
FX Thanks are due to Dr. J. A. Lombardi, Departamento de Botanica,
   Instituto de Biociencias, UNESP, Rio Claro, Brazil, for collection and
   taxonomical determination of F. formosa. This work was supported by
   funds from FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais, Brazil), Process no. CDS-APQ- 00270-13, and CAPES (Coordenacao
   de Aperfeic, oamrnto de Pessoal de Ensino Superior, Brazil) and CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)
   are also acknowledged for fellowships to GeraldoCelio Brandao, Erna G.
   Kroon, and Alaide Braga Oliveira.
CR Agrawal P. K., 1989, CARBON 13 NMR FLAVON, V28
   Bernal FA, 2015, MOLECULES, V20, P13165, DOI 10.3390/molecules200713165
   Betancur-Galvis LA, 1999, MEM I OSWALDO CRUZ, V94, P531, DOI 10.1590/S0074-02761999000400019
   Brandao G. C., 2011, Journal of Chemical and Pharmaceutical Research, V3, P223
   Brandao GC, 2010, LETT APPL MICROBIOL, V51, P469, DOI 10.1111/j.1472-765X.2010.02924.x
   Brandao G. C., 2013, REV FITOS, V8, P125
   Brandao GC, 2013, MOLECULES, V18, P9919, DOI 10.3390/molecules18089919
   Brandao GC, 2010, REV BRAS FARMACOGN, V20, P742, DOI [10.1590/S0102-695X2010005000035, 10.1590/S0102-695X2010000500015]
   Cao TW, 2013, PLANTA MED, V79, P697, DOI 10.1055/s-0032-1328399
   Catalano S, 1996, PHYTOCHEMISTRY, V42, P1605, DOI 10.1016/0031-9422(96)00154-9
   CHAUDHURI RK, 1971, PHYTOCHEMISTRY, V10, P2425, DOI 10.1016/S0031-9422(00)89890-8
   Chen LJ, 2003, J CHROMATOGR A, V988, P95, DOI 10.1016/S0021-9673(02)01954-4
   DERODRIGUEZ DJ, 1990, PLANTA MED, V56, P59, DOI 10.1055/s-2006-960884
   FINNEGAN RA, 1968, J PHARM SCI, V57, P1039, DOI 10.1002/jps.2600570631
   Gambelunghe Cristiana, 2003, Journal of Medicinal Food, V6, P387, DOI 10.1089/109662003772519967
   Gibbons RV, 2010, INT J ANTIMICROB AG, V36, pS36, DOI 10.1016/j.ijantimicag.2010.06.019
   Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215
   Martin F, 2008, J NAT PROD, V71, P1887, DOI 10.1021/np800406q
   Masibo M, 2008, COMPR REV FOOD SCI F, V7, P309, DOI 10.1111/j.1541-4337.2008.00047.x
   Oberste MS, 2009, EMERG INFECT DIS, V15, P640, DOI 10.3201/eid1504.081428
   Pauletti PM, 2003, QUIM NOVA, V26, P641, DOI 10.1590/S0100-40422003000500003
   Pauletti PM, 2003, J NAT PROD, V66, P1384, DOI 10.1021/np030100t
   Quixabeira-Santos JC, 2011, EMERG INFECT DIS, V17, P726, DOI 10.3201/eid1704.101581
   Shah K A, 2010, Pharmacogn Rev, V4, P42, DOI 10.4103/0973-7847.65325
   Simoes LR, 2011, LETT APPL MICROBIOL, V53, P602, DOI 10.1111/j.1472-765X.2011.03146.x
   Telang M, 2013, EXPERT OPIN THER PAT, V23, P1561, DOI 10.1517/13543776.2013.836182
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Wang RR, 2011, MOLECULES, V16, P4264, DOI 10.3390/molecules16054264
   WHO, 2016, DENG SEV DENG
   WHO, HERP SIMPL VIR
   Woo KJ, 2005, FEBS LETT, V579, P705, DOI 10.1016/j.febslet.2004.12.048
   Woo KJ, 2004, BIOCHEM BIOPH RES CO, V325, P1215, DOI 10.1016/j.bbrc.2004.09.225
   Yuldashev MP, 2005, CHEM NAT COMPD+, V41, P32, DOI 10.1007/s10600-005-0068-0
   Zhang H, 2014, J NAT PROD, V77, P1037, DOI 10.1021/np500124e
NR 35
TC 6
Z9 6
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9686
EI 1687-9694
J9 J TROP MED-US
JI J. Trop. Med.
PY 2017
VL 2017
AR 6106959
DI 10.1155/2017/6106959
PG 11
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EW1LN
UT WOS:000402252000001
PM 28634494
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Trindade, GD
   Emerson, GL
   Sammons, S
   Frace, M
   Govil, D
   Mota, BEF
   Abrahao, JS
   de Assis, FL
   Olsen-Rasmussen, M
   Goldsmith, CS
   Li, Y
   Carroll, D
   da Fonseca, FG
   Kroon, E
   Damon, IK
AF Trindade, Giliane de Souza
   Emerson, Ginny L.
   Sammons, Scott
   Frace, Michael
   Govil, Dhwani
   Fernandes Mota, Bruno Eduardo
   Abrahao, Jonatas Santos
   de Assis, Felipe Lopes
   Olsen-Rasmussen, Melissa
   Goldsmith, Cynthia S.
   Li, Yu
   Carroll, Darin
   da Fonseca, Flavio Guimaraes
   Kroon, Erna
   Damon, Inger K.
TI Serro 2 Virus Highlights the Fundamental Genomic and Biological Features
   of a Natural Vaccinia Virus Infecting Humans
SO VIRUSES-BASEL
LA English
DT Article
DE vaccinia virus; genome; virulence; outbreak; poxvirus; public health
ID MONOCLONAL-ANTIBODIES; SMALLPOX VACCINE; DRUG-RESISTANCE; CANTAGALO
   VIRUS; PROTECTS MICE; IN-VITRO; POXVIRUS; SEQUENCE; STRAINS; GENE
AB Vaccinia virus (VACV) has been implicated in infections of dairy cattle and humans, and outbreaks have substantially impacted local economies and public health in Brazil. During a 2005 outbreak, a VACV strain designated Serro 2 virus (S2V) was collected from a 30-year old male milker. Our aim was to phenotypically and genetically characterize this VACV Brazilian isolate. S2V produced small round plaques without associated comets when grown in BSC40 cells. Furthermore, S2V was less virulent than the prototype strain VACV-Western Reserve (WR) in a murine model of intradermal infection, producing a tiny lesion with virtually no surrounding inflammation. The genome of S2V was sequenced by primer walking. The coding region spans 184,572 bp and contains 211 predicted genes. Mutations in envelope genes specifically associated with small plaque phenotypes were not found in S2V; however, other alterations in amino acid sequences within these genes were identified. In addition, some immunomodulatory genes were truncated in S2V. Phylogenetic analysis using immune regulatory-related genes, besides the hemagglutinin gene, segregated the Brazilian viruses into two clusters, grouping the S2V into Brazilian VACV group 1. S2V is the first naturally-circulating human-associated VACV, with a low passage history, to be extensively genetically and phenotypically characterized.
C1 [Trindade, Giliane de Souza; Emerson, Ginny L.; Sammons, Scott; Frace, Michael; Govil, Dhwani; Olsen-Rasmussen, Melissa; Goldsmith, Cynthia S.; Li, Yu; Carroll, Darin; Damon, Inger K.] Ctr Dis Control & Prevent, Coordinating Ctr Infect Dis, CCID CDC, Atlanta, GA 30329 USA.
   [Trindade, Giliane de Souza; Fernandes Mota, Bruno Eduardo; Abrahao, Jonatas Santos; de Assis, Felipe Lopes; da Fonseca, Flavio Guimaraes; Kroon, Erna] Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Trindade, GD; Damon, IK (corresponding author), Ctr Dis Control & Prevent, Coordinating Ctr Infect Dis, CCID CDC, Atlanta, GA 30329 USA.; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
EM gitrindade@yahoo.com.br; dtt4@cdc.gov; ssammons@cdc.gov; mfrace@cdc.gov;
   dgovil@cdc.gov; brunofmota@gmail.com; jonatas.abrahao@gmail.com;
   felipelopesassis@gmail.com; mOlsen-Rasmussen@cdc.gov;
   cgoldsmith@cdc.gov; lay4@cdc.gov; dcarroll@cdc.gov;
   fdafonseca@icb.ufmg.br; kroone@icb.ufmg.br; IDamon@cdc.gov
RI Kroon, Erna/V-5444-2019; Kroon, Erna/B-3631-2015
OI Mota, Bruno/0000-0003-0348-4875; Kroon, Erna/0000-0003-2721-3826
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA)
FX We thank Joao Rodrigues dos Santos, Angela Sana Lopes, Ilda Gamma, and
   colleagues from Laboratorio de Virus (ICB-UFMG/Escola de Veterinaria)
   for their excellent technical support. We also thank the Instituto
   Mineiro de Agropecuaria (IMA) for technical support during the field
   expeditions. G.d.S.T., F.G.d.F., J.S.A. and E.K. are CNPq researchers.
   Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais (FAPEMIG), Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA). G.d.S.T., J.S.A., F.G.d.F.
   and E.K. are researchers from CNPq. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The findings and conclusions in this
   manuscript are those of the author(s) and do not necessarily represent
   the official position of the Centers for Disease Control and Prevention.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Aldaz-Carroll L, 2005, J VIROL, V79, P6260, DOI 10.1128/JVI.79.10.6260-6271.2005
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Andrei G, 2010, VIRUSES-BASEL, V2, P2803, DOI 10.3390/v2122803
   Assis FL, 2012, EMERG INFECT DIS, V18, P2035, DOI 10.3201/eid1812.120145
   Becker MN, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-58
   Bell E, 2004, VIROLOGY, V325, P425, DOI 10.1016/j.virol.2004.05.004
   Benhnia MREI, 2009, J VIROL, V83, P1201, DOI 10.1128/JVI.01797-08
   Berhanu A, 2008, J VIROL, V82, P3517, DOI 10.1128/JVI.01854-07
   Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607
   Bhattacharjee A. B., 1966, MED J, V60, P209
   BLASCO R, 1991, J VIROL, V65, P5910, DOI 10.1128/JVI.65.11.5910-5920.1991
   Bugert JJ, 1998, VIROLOGY, V242, P51, DOI 10.1006/viro.1997.9001
   Chen ZC, 2007, J VIROL, V81, P8989, DOI 10.1128/JVI.00906-07
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I., 2007, POXVIRUSES, P2049
   Damon IK, 2009, J GEN VIROL, V90, P1962, DOI 10.1099/vir.0.010553-0
   Davies DH, 2005, J VIROL, V79, P11724, DOI 10.1128/JVI.79.18.11724-11733.2005
   Domi A, 2008, J VIROL, V82, P4215, DOI 10.1128/JVI.00037-08
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114
   Ehlers A, 2002, BIOINFORMATICS, V18, P1544, DOI 10.1093/bioinformatics/18.11.1544
   Fenner F., 1988, SMALLPOX ITS ERADICA, V49
   Fernandes T., 1999, SAUDE MANGUINHOS, V6, P51
   Gammon DB, 2008, J VIROL, V82, P12520, DOI 10.1128/JVI.01528-08
   Grosenbach D. W., 2009, P NATL ACAD SCI USA, V2, P838, DOI [10.1073/pnas.091213410720080762, DOI 10.1073/PNAS.091213410720080762]
   Hansen AK, 2011, EUR J IMMUNOL, V41, P1948, DOI 10.1002/eji.201141413
   Henderson DA, 1998, EMERG INFECT DIS, V4, P488, DOI 10.3201/eid0403.980340
   Heraud JM, 2006, J IMMUNOL, V177, P2552, DOI 10.4049/jimmunol.177.4.2552
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Huemer HP, 2012, RES VET SCI, V92, P333, DOI 10.1016/j.rvsc.2011.03.011
   ISAACS SN, 1992, P NATL ACAD SCI USA, V89, P628, DOI 10.1073/pnas.89.2.628
   Jackson SS, 2005, J VIROL, V79, P6554, DOI 10.1128/JVI.79.10.6554-6559.2005
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Katz E, 2003, J VIROL, V77, P12266, DOI 10.1128/JVI.77.22.12266-12275.2003
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kinnunen PM, 2011, VECTOR-BORNE ZOONOT, V11, P1133, DOI 10.1089/vbz.2010.0170
   Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545
   Kornbluth RS, 2006, ANTIMICROB AGENTS CH, V50, P4038, DOI 10.1128/AAC.00380-06
   Kotwal Girish J., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P135
   Law M, 2002, J GEN VIROL, V83, P209, DOI 10.1099/0022-1317-83-1-209
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Leite JA, 2011, ARCH VIROL, V156, P617, DOI 10.1007/s00705-010-0900-0
   Lopes de S., 1965, AM J TROP MED HYG, V14, P156
   LUM GS, 1967, AM J TROP MED HYG, V16, P332, DOI 10.4269/ajtmh.1967.16.332
   Martinez J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000811
   McCausland MM, 2010, ANTIVIR THER, V15, P661, DOI 10.3851/IMP1573
   Medaglia MLG, 2015, J VIROL, V89, P11909, DOI 10.1128/JVI.01833-15
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005
   Moss B, 2006, VIROLOGY, V344, P48, DOI 10.1016/j.virol.2005.09.037
   Moss B., 2007, POXVIRIDAE THEIR REP, P2906
   Moussatche N, 2008, J INFECT DEV COUNTR, V2, P156, DOI 10.3855/jidc.258
   Myskiw C, 2009, J VIROL, V83, P6757, DOI 10.1128/JVI.02570-08
   OGUIURA N, 1993, J GEN VIROL, V74, P1409, DOI 10.1099/0022-1317-74-7-1409
   Puehler F, 1998, VIROLOGY, V248, P231, DOI 10.1006/viro.1998.9278
   Quixabeira-Santos JC, 2011, EMERG INFECT DIS, V17, P726, DOI 10.3201/eid1704.101581
   Rudraraju R, 2010, VACCINE, V28, P4997, DOI 10.1016/j.vaccine.2010.05.023
   Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   SHCHELKUNOV SN, 1993, FEBS LETT, V319, P163, DOI 10.1016/0014-5793(93)80059-4
   Silva P. L., 1986, BRAS MED VET ZOOTEC, V3, P323
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Smee Donald F., 2005, Antiviral Chemistry & Chemotherapy, V16, P203
   Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730
   SMITH GL, 1984, BIOTECHNOL GENET ENG, V2, P383, DOI 10.1080/02648725.1984.10647806
   SMITH GL, 1989, J GEN VIROL, V70, P2333, DOI 10.1099/0022-1317-70-9-2333
   Smith VP, 2002, J VIROL, V76, P1124, DOI 10.1128/JVI.76.3.1124-1134.2002
   Symons JA, 2002, J GEN VIROL, V83, P2833, DOI 10.1099/0022-1317-83-11-2833
   TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977
   Weltzin R, 2003, NAT MED, V9, P1125, DOI 10.1038/nm916
   Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005
NR 81
TC 9
Z9 9
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2016
VL 8
IS 12
AR 328
DI 10.3390/v8120328
PG 21
WC Virology
SC Virology
GA EI4SW
UT WOS:000392484600008
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Alves, PA
   Figueiredo, PO
   de Oliveira, CHS
   Barbosa, JD
   Lima, DHS
   Bomjardim, HA
   Silva, NS
   Campos, KF
   Oliveira, CMC
   Barbosa-Stancioli, EF
   Abrahao, JS
   Kroon, EG
   Trindade, GD
AF Alves, Pedro A.
   Figueiredo, Poliana O.
   de Oliveira, Cairo H. S.
   Barbosa, Jose D.
   Lima, Danillo H. S.
   Bomjardim, Henrique A.
   Silva, Natalia S.
   Campos, Karinny F.
   Oliveira, Carlos Magno C.
   Barbosa-Stancioli, Edel Figueiredo
   Abrahao, Jonatas S.
   Kroon, Erna G.
   Trindade, Giliane de Souza
TI Occurrence of Pseudocowpox virus associated to Bovine viral diarrhea
   virus-1, Brazilian Amazon
SO COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
LA English
DT Article
ID BOVINE PAPULAR STOMATITIS; VIRAL DIARRHEA VIRUS; VACCINIA-VIRUS;
   CLINICAL DESCRIPTION; ZOONOTIC OUTBREAK; MIDWESTERN BRAZIL; DAIRY-COWS;
   INFECTION; PARAPOXVIRUS; CHAIN
AB In 2011, an outbreak of severe vesicular disease occurred in the state of Para, Amazon region. Besides proliferative or verrucous lesions, cattle showed atypical clinical signs such as diarrhea and leading to death. The animals were submitted to clinical, pathological and molecular diagnosis, and laboratory tests have confirmed the presence of Pseudocowpox virus (PCPV), a Parapoxvirus genus member, and have also found Bovine viral diarrhea virus-1 (BVDV-1), probably causing persistent infection. The results of molecular diagnostics, followed by sequencing data demonstrated the circulation of both viruses (PCPV and BVDV-1) in an area previously affected by another poxvirus, as Vaccinia virus. The cocirculation between PCPV and BVDV-1 indicates a major concern for animal health because the clinical presentation can be a severe disease. This is the first detection of PCPV in the Brazilian Amazon. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Alves, Pedro A.; Figueiredo, Poliana O.; de Oliveira, Cairo H. S.; Barbosa-Stancioli, Edel Figueiredo; Abrahao, Jonatas S.; Kroon, Erna G.; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Barbosa, Jose D.; Lima, Danillo H. S.; Bomjardim, Henrique A.; Silva, Natalia S.; Campos, Karinny F.; Oliveira, Carlos Magno C.] Fed Univ Para, Castanhal, Para, Brazil.
RP Alves, PA (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM pedroaugustoalves@yahoo.com.br; giliane@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Barbosa-Stancioli, Edel F/J-7230-2012;
   Kroon, Erna/V-5444-2019; Alves, Pedro/T-7203-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Barbosa-Stancioli, Edel
   F/0000-0001-6584-4333; Alves, Pedro/0000-0002-9659-5621
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Pro reitoria
   de Pesquisa da UFMG (PRPq); MAPA (Ministerio da Agricultura Pecuaria e
   Abastecimento)
FX We thank Joao Rodrigues dos Santos and colleagues from the Laboratorio
   de Virus (ICB-UFMG) for their excellent technical support. Financial
   support was provided by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG), Pro reitoria de Pesquisa da UFMG
   (PRPq) and MAPA (Ministerio da Agricultura Pecuaria e Abastecimento). GS
   Trindade, EFB-Stancioli, PCP Ferreira and EG Kroon are researchers from
   CNPq.
CR Abrahao JS, 2012, VET REC, V171, P476, DOI 10.1136/vr.100634
   Abrahao JS, 2010, J CLIN VIROL, V48, P69, DOI 10.1016/j.jcv.2010.02.001
   BAKER JC, 1995, VET CLIN N AM-FOOD A, V11, P425, DOI 10.1016/S0749-0720(15)30460-6
   Bauermann FV, 2014, J CLIN MICROBIOL, V52, P3845, DOI 10.1128/JCM.01563-14
   BOHAC JG, 1980, CAN VET J, V21, P310
   Brodersen BW, 2014, VET PATHOL, V51, P453, DOI 10.1177/0300985813520250
   BROWNLIE J, 1990, VET MICROBIOL, V23, P371, DOI 10.1016/0378-1135(90)90169-V
   Buttner M, 2002, J VET MED B, V49, P7, DOI 10.1046/j.1439-0450.2002.00539.x
   Cargnelutti JF, 2012, J VET DIAGN INVEST, V24, P437, DOI 10.1177/1040638711435408
   Cargnelutti JF, 2014, CIENC RURAL, V44, P479, DOI 10.1590/S0103-84782014000300015
   CDC, 2012, HUMAN ORF VIRUS INFE
   Dal Pozzo F, 2011, J CLIN MICROBIOL, V49, P4397, DOI 10.1128/JCM.05281-11
   DAMON IK, 2007, FIELDS VIROLOGY, P2947
   de Assis FL, 2013, EMERG INFECT DIS, V19, P2017, DOI 10.3201/eid1912.130589
   de Oliveira CHS, 2012, VECTOR-BORNE ZOONOT, V12, P336, DOI 10.1089/vbz.2011.0725
   de Sant'Ana FJF, 2013, J VET DIAGN INVEST, V25, P267, DOI 10.1177/1040638713475799
   de Sant'Ana FJF, 2012, J VET DIAGN INVEST, V24, P442, DOI 10.1177/1040638711434799
   Fleming S.B., 2007, POXVIRUSES, P127
   Gerber PF, 2012, J VET DIAGN INVEST, V24, P355, DOI 10.1177/1040638711435231
   Givens MD, 2013, BIOLOGICALS, V41, P26, DOI 10.1016/j.biologicals.2012.06.003
   Inoshima Y, 2000, J VIROL METHODS, V84, P201, DOI 10.1016/S0166-0934(99)00144-5
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017
   Megid J, 2012, EMERG INFECT DIS, V18, P189, DOI 10.3201/eid1801.110692
   Nitsche A, 2006, CLIN CHEM, V52, P316, DOI 10.1373/clinchem.2005.060335
   Oliveira DB, 2013, AM J TROP MED HYG, V89, P1142, DOI 10.4269/ajtmh.13-0369
   Oliveira GP, 2014, AM J TROP MED HYG, V90, P1021, DOI 10.4269/ajtmh.13-0621
   Quixabeira-Santos JC, 2011, EMERG INFECT DIS, V17, P726, DOI 10.3201/eid1704.101581
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Schmidt C, 2013, VET MICROBIOL, V162, P245, DOI 10.1016/j.vetmic.2012.10.031
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Walz PH, 2010, J VET INTERN MED, V24, P476, DOI 10.1111/j.1939-1676.2010.0502.x
NR 35
TC 10
Z9 10
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0147-9571
EI 1878-1667
J9 COMP IMMUNOL MICROB
JI Comp. Immunol. Microbiol. Infect. Dis.
PD DEC
PY 2016
VL 49
BP 70
EP 75
DI 10.1016/j.cimid.2016.09.005
PG 6
WC Immunology; Microbiology; Veterinary Sciences
SC Immunology; Microbiology; Veterinary Sciences
GA EF7PP
UT WOS:000390521800009
PM 27865267
DA 2020-11-30
ER

PT J
AU Colombo, TE
   Vedovello, D
   Pacca-Mazaro, CC
   Mondini, A
   Araujo, JP
   Cabrera, E
   Lopes, JC
   dos Santos, INP
   Reis, AFN
   Costa, FR
   Cruz, LEAA
   Ferreira, J
   Rocha, ESD
   Kroon, EG
   Bronzoni, RVD
   Vasilakis, N
   Nogueira, ML
AF Colombo, Tatiana Elias
   Vedovello, Danila
   Pacca-Mazaro, Carolina Colombelli
   Mondini, Adriano
   Araujo, Joao Pessoa, Jr.
   Cabrera, Eliana
   Lopes, Jose Carlos
   Penha dos Santos, Izalco Nuremberg
   Negri Reis, Andreia Francesli
   Costa, Fabiana Rodrigues
   Arao Antonio Cruz, Lilian Elisa
   Ferreira, Jurandir, Jr.
   de Oliveira Rocha, Eliseu Soares
   Kroon, Erna Geessien
   de Morais Bronzoni, Roberta Vieira
   Vasilakis, Nikos
   Nogueira, Mauricio Lacerda
TI Dengue virus surveillance: Detection of DENV-4 in the city of Sao Jose
   do Rio Preto, SP, Brazil
SO ACTA TROPICA
LA English
DT Article
DE Dengue virus; Transmission; Phylogenetic analysis; Surveillance programs
ID SEROTYPE 4; CO-CIRCULATION; RORAIMA STATE; DE-JANEIRO; TYPE-4; DNA;
   HYPERENDEMICITY; GENOTYPES; HISTORY; FEVER
AB Dengue viruses are the most common arbovirus infection worldwide and are caused by four distinct serotypes of the dengue virus (DENV). In the present study, we assessed DENV transmission in Sao Jose do Rio Preto (SJRP) from 2010 to 2014. We analyzed blood samples from febrile patients who were attended at health care centers in SJRP. DENV detection was performed using multiplex RT-PCR, using flavivirus generic primers, based on the genes of the non-structural protein (NS5), followed by nestedPCR assay with species-specific primers. We analyzed 1549 samples, of which 1389 were positive for NS1 by rapid test. One thousand and eight-seven samples (78%) were confirmed as positive by multiplex RTPCR: DENV-4, 48.5% (528/1087); DENV-1, 41.5% (449/1087); DENV-2, 9.5% (104/1087); and co-infection (5 DENV-1/DENV-4, 1 DENV-1/DENV-2), 0.5% (6/1087). Phylogenetic analysis of the DENV-4 grouped the isolates identified in this study with the American genotype and the showed a relationship between isolates from SJRP and isolates from the northern region of South America. Taken together, our data shows the detection and emergence of new dengue genotype in a new region and reiterate the importance of surveillance programs to detect and trace the evolution of DENV. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Colombo, Tatiana Elias; Vedovello, Danila; Pacca-Mazaro, Carolina Colombelli; Mondini, Adriano; Cabrera, Eliana; Lopes, Jose Carlos; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
   [Araujo, Joao Pessoa, Jr.] Univ Estadual Paulista, Inst Biociencias Botucatu, Lab Virol, Botucatu, SP, Brazil.
   [Penha dos Santos, Izalco Nuremberg; Negri Reis, Andreia Francesli; Costa, Fabiana Rodrigues; Arao Antonio Cruz, Lilian Elisa; Ferreira, Jurandir, Jr.] Dept Vigilancia Saude, Prefeitura Sao Jose do Rio Preto, Sao Jose Do Rio Preto, SP, Brazil.
   [de Oliveira Rocha, Eliseu Soares; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [de Morais Bronzoni, Roberta Vieira] Univ Fed Mato Grosso, Inst Ciencias Saude, Sinop, MT, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Ctr Trop Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Nogueira, ML (corresponding author), Fac Med Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Pacca, Carolina Colombelli/B-8972-2017; Nogueira, Mauricio
   L/B-7599-2012; Mondini, Adriano/F-7446-2012; Araujo, JP/Q-3043-2019;
   Vasilakis, Nikos/ABE-7318-2020; Kroon, Erna Geessien/B-3631-2015; Kroon,
   Erna/V-5444-2019; Araujo, Joao Pessoa/C-2444-2012; Mondini,
   Adriano/AAB-4358-2020; CABRERA, ELIANA/B-3190-2016; Vedovello,
   Danila/M-5757-2014
OI Pacca, Carolina Colombelli/0000-0001-9252-2137; Nogueira, Mauricio
   L/0000-0003-1102-2419; Mondini, Adriano/0000-0002-5557-9721; Araujo,
   JP/0000-0002-9153-1485; Kroon, Erna Geessien/0000-0003-2721-3826;
   Araujo, Joao Pessoa/0000-0002-9153-1485; Mondini,
   Adriano/0000-0002-5557-9721; CABRERA, ELIANA/0000-0002-6967-5773;
   Vedovello, Danila/0000-0001-8585-8206
FU Pronex; INCT-Dengue; FAPESPFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP); CAPESCAPES
FX The authors gratefully acknowledge the Pronex, INCT-Dengue, FAPESP and
   CAPES for financial support.
CR Acosta-Bas C., 2005, REV BIOMED, V16, P113
   Acosta POA, 2011, EMERG INFECT DIS, V17, P1979, DOI 10.3201/eid1710.110776
   Aratijo T. P., 2002, REV SOC BRAS MED TRO, V35, P579
   Baroni C. J., 2009, RBAC, V41, P289
   Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Campos RD, 2013, J CLIN VIROL, V56, P86, DOI 10.1016/j.jcv.2012.10.006
   Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   da Rocha LA, 2009, REV SOC BRAS MED TRO, V42, P18, DOI 10.1590/S0037-86822009000100005
   de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   de Souza LJ, 2013, BRAZ J INFECT DIS, V17, P27, DOI 10.1016/j.bjid.2012.08.020
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   Fernandez J, 2011, ARCH VIROL, V156, P1865, DOI 10.1007/s00705-011-1049-1
   Figueiredo L T, 1990, Rev Soc Bras Med Trop, V23, P13, DOI 10.1590/S0037-86821990000100003
   Fonseca B. A. L., 2005, TRATADO INFECTOLOGIA, P251
   Forshey BM, 2009, EMERG INFECT DIS, V15, P1815, DOI 10.3201/eid1511.090663
   Foster JE, 2003, VIROLOGY, V306, P126, DOI 10.1016/S0042-6822(02)00033-8
   Franca E. L., 2011, Revista de Ciencias Medicas, V20, P121, DOI 10.24220/2318-0897v20n5/6a576
   Freire JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081450
   Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Heinz F, 2000, VIRUS TAXONOMY, P859
   Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017
   Libraty D. H., 2009, PLOS NEGLECT TROP D, V6, P1
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006245, 10.1590/s1518-8787.2016050006245]
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Pessanha JEM, 2010, REV PANAM SALUD PUBL, V27, P252, DOI 10.1590/S1020-49892010000400003
   Martins V. C. A., 2014, PLOS NEGLECT TROP D, V9, P390
   Melo P. R. S., 2012, AM J MOL BIOL, V2, P42
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Pinho ACO, 2015, EPIDEMIOL INFECT, V143, P3114, DOI 10.1017/S0950268815000229
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Romanos M. T. V., 2008, INTRO VIROLOGIA HUMA, V1, P399
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306
   Shu PY, 2009, AM J TROP MED HYG, V80, P1039, DOI 10.4269/ajtmh.2009.80.1039
   Souza R. P., 2011, PLOS NEGLECT TROP D, V5, P1
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Ullmann LS, 2015, J VIROL METHODS, V220, P60, DOI 10.1016/j.jviromet.2015.04.009
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063496
   Villabona-Arenas CJ, 2011, INFECT GENET EVOL, V11, P878, DOI 10.1016/j.meegid.2011.02.007
   Zeller H, 2013, CLIN MICROBIOL INFEC, V19, P693, DOI 10.1111/1469-0691.12230
NR 58
TC 9
Z9 9
U1 0
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD DEC
PY 2016
VL 164
BP 84
EP 89
DI 10.1016/j.actatropica.2016.09.004
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA ED7YD
UT WOS:000389087700013
PM 27609639
OA Green Published
DA 2020-11-30
ER

PT J
AU Franco-Luiz, APM
   Oliveira, DB
   Pereira, AF
   Gasparini, MCS
   Bonjardim, CA
   Ferreira, PCP
   Trindade, GD
   Puentes, R
   Furtado, A
   Abrahao, JS
   Kroon, EG
AF Moreira Franco-Luiz, Ana Paula
   Oliveira, Danilo Bretas
   Pereira, Alexandre Fagundes
   Soares Gasparini, Mirela Cristina
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Trindade, Giliane de Souza
   Puentes, Rodrigo
   Furtado, Agustin
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
TI Detection of Vaccinia Virus in Dairy Cattle Serum Samples from 2009,
   Uruguay
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID BOVINE VACCINIA; BRAZIL; OUTBREAK; BLOOD; DNA
AB We detected orthopoxvirus in 28 of 125 serum samples collected during 2009 from cattle in Uruguay. Two samples were PCR-positive for vaccinia virus and had sequences similar to those for vaccinia virus associated with outbreaks in Brazil. Autochthonous circulation of vaccinia virus in Uruguay and other South American countries cannot be ruled out.
C1 [Moreira Franco-Luiz, Ana Paula; Oliveira, Danilo Bretas; Pereira, Alexandre Fagundes; Soares Gasparini, Mirela Cristina; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Trindade, Giliane de Souza; Abrahao, Jonatas Santos; Kroon, Erna Geessien] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Diamantina, Brazil.
   [Puentes, Rodrigo; Furtado, Agustin] Univ Republ Oriental Uruguay, Fac Vet, Montevideo, Uruguay.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos,6627 Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM ernagkroon@gmail.com
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Puentes,
   Rodrigo/0000-0002-4618-9721
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas
   GeraisMinas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento; CAPESCAPES; CNPqNational Council
   for Scientific and Technological Development (CNPq)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais; and Ministerio da Agricultura,
   Pecuaria e Abastecimento.; A.P.M.F.L. received fellowships from CAPES.
   E.G.K., C.A. B., G.S.T., P.C.P. F., and J.S.A. received research
   fellowships from CNPq.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2015, EMERG INFECT DIS, V21, P695, DOI 10.3201/eid2104.140351
   Cohen JI, 2007, VACCINE, V25, P4571, DOI 10.1016/j.vaccine.2007.03.044
   Damon I, 2013, FIELDS VIROLOGY, V6, P2160
   de Sant'Ana FJF, 2013, J VET DIAGN INVEST, V25, P267, DOI 10.1177/1040638713475799
   Goyal T, 2013, INT J DERMATOL, V52, P1224, DOI 10.1111/ijd.12120
   Hutter S, 2014, MONITORING ASSESSMEN
   Kroon E, 2016, CURR PROTOC MICROBIO, V42, P43
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Savona MR, 2006, JAMA-J AM MED ASSOC, V295, P1898, DOI 10.1001/jama.295.16.1898
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
NR 15
TC 8
Z9 8
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2016
VL 22
IS 12
BP 2174
EP 2177
DI 10.3201/eid2212.160447
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA ED5SP
UT WOS:000388912900024
PM 27869601
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Vilela, MC
   Lima, GK
   Rodrigues, DH
   Lacerda-Queiroz, N
   Pedroso, VSP
   de Miranda, AS
   Rachid, MA
   Kroon, EG
   Campos, MA
   Teixeira, MM
   Teixeira, AL
AF Vilela, Marcia Carvalho
   Lima, Graciela Kunrath
   Rodrigues, David Henrique
   Lacerda-Queiroz, Norinne
   Pietra Pedroso, Vinicius Sousa
   de Miranda, Aline Silva
   Rachid, Milene Alvarenga
   Kroon, Erna Geessien
   Campos, Marco Antonio
   Teixeira, Mauro Martins
   Teixeira, Antonio Lucio
TI Platelet Activating Factor (PAF) Receptor Deletion or Antagonism
   Attenuates Severe HSV-1 Meningoencephalitis
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Article
DE Herpes simplex virus-1; Encephalitis; PAFR; PAFR antagonist 'UK-74,505';
   Chemokines
ID HERPES-SIMPLEX ENCEPHALITIS; CENTRAL-NERVOUS-SYSTEM; TOLL-LIKE
   RECEPTORS; TYPE-1 ENCEPHALITIS; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS;
   VIRUS ENCEPHALITIS; INTERFERON-GAMMA; T-LYMPHOCYTES; EXPRESSION
AB Herpes simplex virus type 1 (HSV-1) is a human pathogen that may cause severe encephalitis. The exacerbated immune response against the virus contributes to the disease severity and death. Platelet activating factor (PAF) is a mediator capable of inducing increase in vascular permeability, production of cytokines on endothelial cells and leukocytes. We aimed to investigate the activation of PAF receptor (PAFR) and its contribution to the severity of the inflammatory response in the brain following HSV-1 infection. C57BL/6 wild-type (WT) and PAFR deficient (PAFR(-/-)) mice were inoculated intracranially with 10(4) plaque-forming units (PFU) of HSV-1. Visualization of leukocyte recruitment was performed using intravital microscopy. Cells infiltration in the brain tissue were analyzed by flow cytometry. Brain was removed for chemokine assessment by ELISA and for histopathological analysis. The pharmacological inhibition by the PAFR antagonist UK-74,505 was also analyzed. In PAFR(-/-) mice, there was delayed lethality but no difference in viral load. Histopathological analysis of infected PAFR(-/-) mice showed that brain lesions were less severe when compared to their WT counterparts. Moreover, PAFR(-/-) mice showed less TCD4(+), TCD8(+) and macrophages in brain tissue. This reduction of the presence of leukocytes in parenchyma may be mechanistically explained by a decrease in leukocytes rolling and adhesion. PAFR(-/-) mice also presented a reduction of the chemokine CXCL9 in the brain. In addition, by antagonizing PAFR, survival of C57BL/6 infected mice increased. Altogether, our data suggest that PAFR plays a role in the pathogenesis of experimental HSV-1 meningoencephalitis, and its blockade prevents severe disease manifestation.
C1 [Vilela, Marcia Carvalho; Rodrigues, David Henrique; Lacerda-Queiroz, Norinne; Pietra Pedroso, Vinicius Sousa; de Miranda, Aline Silva; Rachid, Milene Alvarenga; Teixeira, Mauro Martins; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, Sala 281,30130-100 Ave Alfredo Balena, Belo Horizonte, MG, Brazil.
   [Vilela, Marcia Carvalho; Rodrigues, David Henrique] Univ Fed Juiz de Fora, Dept Ciencias Basicas Vida, Governador Valadares, MG, Brazil.
   [Lima, Graciela Kunrath; Kroon, Erna Geessien] ICB UFMG, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [de Miranda, Aline Silva] ICB UFMG, Dept Morfol, Belo Horizonte, MG, Brazil.
   [Rachid, Milene Alvarenga] ICB UFMG, Dept Patol Geral, Belo Horizonte, MG, Brazil.
   [Campos, Marco Antonio] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
RP Vilela, MC; Teixeira, AL (corresponding author), Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, Sala 281,30130-100 Ave Alfredo Balena, Belo Horizonte, MG, Brazil.; Vilela, MC (corresponding author), Univ Fed Juiz de Fora, Dept Ciencias Basicas Vida, Governador Valadares, MG, Brazil.
EM marciacvilela@gmail.com; altexjr@hotmail.com
RI Teixeira, Antonio L/N-3315-2014; Kroon, Erna Geessien/B-3631-2015;
   Kroon, Erna/V-5444-2019; Rachid, Milene Alvarenga/C-3530-2017
OI Teixeira, Antonio L/0000-0002-9621-5422; Kroon, Erna
   Geessien/0000-0003-2721-3826; Rachid, Milene
   Alvarenga/0000-0002-3142-6552
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa de Minas Gerais (Fapemig),
   BrazilMinas Gerais State Research Foundation (FAPEMIG)
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa de
   Minas Gerais (Fapemig), Brazil.
CR Aihara N, 2000, GENES CELLS, V5, P397, DOI 10.1046/j.1365-2443.2000.00333.x
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Anglen CS, 2003, J NEUROIMMUNOL, V140, P13, DOI 10.1016/S0165-5728(03)00159-0
   Aravalli RN, 2007, J NEUROIMMUNE PHARM, V2, P297, DOI 10.1007/s11481-007-9071-5
   Baringer JR, 2008, NEUROL CLIN, V26, P657, DOI 10.1016/j.ncl.2008.03.005
   Bedirli A, 2004, EUR SURG RES, V36, P136, DOI 10.1159/000077254
   Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001
   CABELLOS C, 1992, J CLIN INVEST, V90, P612, DOI 10.1172/JCI115900
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Domingues RB, 2009, BRAZ J INFECT DIS, V13, P433, DOI 10.1590/S1413-86702009000600009
   Garcia CC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001171
   Halford WP, 1996, J VIROL, V70, P5051, DOI 10.1128/JVI.70.8.5051-5060.1996
   Hu SX, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-123
   Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8
   ISSEKUTZ AC, 1986, LAB INVEST, V54, P275
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kamei S, 2009, CYTOKINE, V46, P187, DOI 10.1016/j.cyto.2009.01.004
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Lacerda-Queiroz N, 2012, AM J PATHOL, V180, P246, DOI 10.1016/j.ajpath.2011.09.038
   Landgraf RG, 2007, PROSTAG LEUKOTR ESS, V77, P163, DOI 10.1016/j.plefa.2007.08.011
   Liu MT, 2001, J IMMUNOL, V166, P1790, DOI 10.4049/jimmunol.166.3.1790
   Liu MT, 2001, J IMMUNOL, V167, P4091, DOI 10.4049/jimmunol.167.7.4091
   Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963
   Menasria R, 2013, J VIROL, V87, P7301, DOI 10.1128/JVI.00591-13
   Milatovic D, 2002, J NEUROVIROL, V8, P295, DOI 10.1080/13550280290100743
   Musto AE, 2011, EPILEPSIA, V52, P551, DOI 10.1111/j.1528-1167.2010.02920.x
   Persidsky Y, 2001, J NEUROIMMUNOL, V114, P57, DOI 10.1016/S0165-5728(00)00454-9
   Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405
   Rodrigues DH, 2011, BRAIN RES, V1385, P298, DOI 10.1016/j.brainres.2011.02.036
   Romagnani P, 1999, J AM SOC NEPHROL, V10, P2518
   Rosler A, 1998, J NEUROL SCI, V157, P82, DOI 10.1016/S0022-510X(98)00061-6
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Salmaggi A, 2002, J INTERF CYTOK RES, V22, P631, DOI 10.1089/10799900260100114
   Sellner J, 2005, NEUROSCI LETT, V374, P197, DOI 10.1016/j.neulet.2004.10.054
   Shields PL, 1999, J IMMUNOL, V163, P6236
   Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106
   Souza DG, 2003, BRIT J PHARMACOL, V139, P733, DOI 10.1038/sj.bjp.0705296
   Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693
   Tang QZ, 1996, J EXP MED, V184, P1435, DOI 10.1084/jem.184.4.1435
   TOWNSEND GC, 1994, INFECT IMMUN, V62, P3739, DOI 10.1128/IAI.62.9.3739-3744.1994
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Vilela MC, 2008, NEUROSCI LETT, V445, P18, DOI 10.1016/j.neulet.2008.08.072
   Vilela MC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-19
   Vilela MC, 2010, NEUROSCI LETT, V479, P58, DOI 10.1016/j.neulet.2010.05.028
   Vilela MC, 2009, ANN NY ACAD SCI, V1153, P256, DOI 10.1111/j.1749-6632.2008.03959.x
   Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9
NR 46
TC 3
Z9 3
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD DEC
PY 2016
VL 11
IS 4
BP 613
EP 621
DI 10.1007/s11481-016-9684-7
PG 9
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA EB4RX
UT WOS:000387362000002
PM 27193134
DA 2020-11-30
ER

PT J
AU Andrade, LG
   Albarnaz, JD
   Mugge, FLB
   David, BA
   Abraho, JS
   da Fonseca, FG
   Kroon, EG
   Menezes, GB
   McFadden, G
   Bonjardim, CA
AF Andrade, Luciana G.
   Albarnaz, Jonas D.
   Mugge, Fernanda L. B.
   David, Bruna A.
   Abraho, Jonatas S.
   da Fonseca, Flavio G.
   Kroon, Erna G.
   Menezes, Gustavo B.
   McFadden, Grant
   Bonjardim, Claudio A.
TI Vaccinia virus dissemination requires p21-activated kinase 1
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID ACTIN-BASED MOTILITY; HUMAN ARP2/3 COMPLEX; N-WASP; APOPTOTIC MIMICRY;
   VIRAL REPLICATION; CELL ENTRY; POXVIRUS; POLYMERIZATION; CYTOSKELETON;
   KINASE
AB The orthopoxvirus vaccinia virus (VACV) interacts with both actin and microtubule cytoskeletons in order to generate and spread progeny virions. Here, we present evidence demonstrating the involvement of PAK1 (p21-activated kinase 1) in the dissemination of VACV. Although PAK1 activation has previously been associated with optimal VACV entry via macropinocytosis, its absence does not affect the production of intracellular mature virions (IMVs) and extracellular enveloped virions (EEVs). Our data demonstrate that low-multiplicity infection of PAK1(-/-) MEFs leads to a reduction in plaque size followed by decreased production of both IMVs and EEVs, strongly suggesting that virus spread was impaired in the absence of PAK1. Confocal and scanning electron microscopy showed a substantial reduction in the amount of VACV-induced actin tails in PAK1(-/-) MEFs, but no significant alteration in the total amount of cell-associated enveloped virions (CEVs). Furthermore, the decreased VACV dissemination in PAK1(-/-) cells was correlated with the absence of phosphorylated ARPC1 (Thr21), a downstream target of PAK1 and a key regulatory subunit of the ARP2/3 complex, which is necessary for the formation of actin tails and viral spread. We conclude that PAK1, besides its role in virus entry, also plays a relevant role in VACV dissemination.
C1 [Andrade, Luciana G.; Albarnaz, Jonas D.; Mugge, Fernanda L. B.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Biol Sci, Signal Transduct Grp, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Andrade, Luciana G.; Albarnaz, Jonas D.; Mugge, Fernanda L. B.; Abraho, Jonatas S.; Kroon, Erna G.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Viruses Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [David, Bruna A.; Menezes, Gustavo B.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Immunobiophoton Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [da Fonseca, Flavio G.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Lab Basic & Appl Virol, BR-31270901 Belo Horizonte, MG, Brazil.
   [McFadden, Grant] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA.
   [Albarnaz, Jonas D.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Signal Transduct Grp, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Viruses Lab, BR-31270901 Belo Horizonte, MG, Brazil.
EM claudio.bonjardim@pq.cnpq.br
RI Albarnaz, Jonas Dutra/E-4526-2010; Kroon, Erna Geessien/B-3631-2015;
   Kroon, Erna/V-5444-2019
OI Albarnaz, Jonas Dutra/0000-0002-8792-813X; Kroon, Erna
   Geessien/0000-0003-2721-3826; McFadden, Grant/0000-0002-2556-3526;
   Mugge, Fernanda/0000-0003-2224-4551
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI080607]
FX This study was funded by Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (FAPEMIG), Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq), and National Institutes of Health (NIH) (grant
   number R01 AI080607).
CR Abella JVG, 2016, NAT CELL BIOL, V18, P76, DOI 10.1038/ncb3286
   Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114
   Alvarez DE, 2013, J CELL BIOL, V202, P1075, DOI 10.1083/jcb.201303055
   Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38
   Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742
   Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002
   Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855
   Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8
   Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005
   Donnelly SK, 2013, CURR BIOL, V23, P999, DOI 10.1016/j.cub.2013.04.051
   Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860
   Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8
   Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08
   Humphries AC, 2014, J CELL SCI, V127, P673, DOI 10.1242/jcs.141366
   Humphries AC, 2013, NAT REV MICROBIOL, V11, P551, DOI 10.1038/nrmicro3072
   Humphries AC, 2012, CELL HOST MICROBE, V12, P346, DOI 10.1016/j.chom.2012.08.002
   Hunter MP, 2013, INT J MOL SCI, V14, P7829, DOI 10.3390/ijms14047829
   Husain M, 2001, J VIROL, V75, P7528, DOI 10.1128/JVI.75.16.7528-7542.2001
   Johnston JB, 2003, J VIROL, V77, P6093, DOI 10.1128/JVI.77.11.6093-6100.2003
   Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karjalainen M, 2008, MOL BIOL CELL, V19, P2857, DOI 10.1091/mbc.E07-10-1094
   Laliberte JP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002446
   Laliberte JP, 2009, P NATL ACAD SCI USA, V106, P17517, DOI 10.1073/pnas.0909376106
   Law M, 2006, P NATL ACAD SCI USA, V103, P5989, DOI 10.1073/pnas.0601025103
   Leite F, 2015, VIRUS RES, V209, P87, DOI 10.1016/j.virusres.2015.01.024
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Moreau V, 2000, NAT CELL BIOL, V2, P441
   Moss B., 2007, VIROLOGY, V2905-2946
   Moss B, 2012, VIRUSES-BASEL, V4, P688, DOI 10.3390/v4050688
   Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509
   Nikolic DS, 2011, BLOOD, V118, P4841, DOI 10.1182/blood-2010-09-305417
   Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073
   Pereira ACTC, 2012, J VIROL, V86, P172, DOI 10.1128/JVI.05638-11
   Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265
   Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992
   Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754
   Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6
   Schelhaas M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002657
   Schepis A, 2006, TRAFFIC, V7, P308, DOI 10.1111/j.1600-0854.2005.00381.x
   Schmidt FI, 2012, CURR OPIN VIROL, V2, P20, DOI 10.1016/j.coviro.2011.11.007
   Schramm B, 2006, TRAFFIC, V7, P1352, DOI 10.1111/j.1600-0854.2006.00470.x
   Smith GL, 2004, VIRUS RES, V106, P189, DOI 10.1016/j.virusres.2004.08.015
   Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09
   Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574
   Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06
   Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079
   Van den Broeke C, 2010, TRENDS CELL BIOL, V20, P160, DOI 10.1016/j.tcb.2009.12.005
   Van den Broeke C, 2009, VIROLOGY, V385, P155, DOI 10.1016/j.virol.2008.11.050
   Villa NY, 2010, VIROLOGY, V401, P266, DOI 10.1016/j.virol.2010.02.027
   Ward BM, 2005, CELL MICROBIOL, V7, P1531, DOI 10.1111/j.1462-5822.2005.00614.x
   Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001
   Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773
   WOLFFE EJ, 1995, VIROLOGY, V211, P53, DOI 10.1006/viro.1995.1378
NR 55
TC 2
Z9 2
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD NOV
PY 2016
VL 161
IS 11
BP 2991
EP 3002
DI 10.1007/s00705-016-2996-3
PG 12
WC Virology
SC Virology
GA DY6QF
UT WOS:000385252100004
PM 27465567
DA 2020-11-30
ER

PT J
AU Sousa, LFD
   Rachid, MA
   Lima, GK
   de Miranda, AS
   Vilela, MD
   Queiroz, NL
   Rodrigues, DH
   Campos, MA
   Kroon, EG
   Machado, FS
   Teixeira, AL
AF da Cunha Sousa, Larissa Fonseca
   Rachid, Milene Alvarenga
   Lima, Graciela Kunrath
   de Miranda, Aline Silva
   Vilela, Marcia de Carvalho
   Queiroz, Norinne Lacerda
   Rodrigues, David Henrique
   Campos, Marco Antonio
   Kroon, Erna Geessien
   Machado, Fabiana Simao
   Teixeira, Antonio Lucio
TI Suppressor of cytokine signaling 2 (SOCS2) contributes to encephalitis
   in a model of Herpes infection in mice
SO BRAIN RESEARCH BULLETIN
LA English
DT Article
DE HSV-1; Encephalitis; SOCS2; Neuroinflammation
ID SIMPLEX-VIRUS-ENCEPHALITIS; CENTRAL-NERVOUS-SYSTEM; IMMUNE-RESPONSE;
   EXPRESSION; INDUCTION; LIPOXIN; FAMILY; BRAIN; BLOCK
AB The most severe manifestation of Herpes Simplex Type 1 virus (HSV-1) infection is encephalitis characterized by arousal impairment and seizures that can evolve to coma and death. Previous studies reported the involvement of suppressor of cytokine signaling (SOCS) proteins, specifically SOCS1 and SOCS3, in HSV-1 infection, suggesting that other members of this family could be involved in the immune response against HSV-1. No previous study has reported the role of SOCS2 in HSV-1 infection. In the current study, C57BL/6 wild-type mice (WT) and mice deficient in SOCS2 gene (SOCS2(-/-)) were subjected to intracranial inoculation with 10(2) plaque forming units (PFU) of HSV-1. Survival curve, neuroinflammatory parameters and neuropathology were evaluated. Infected SOCS2(-/-)mice had increased survival in comparison with infected WT animals. This better outcome was associated with reduced leukocyte infiltration, concentration of cytokines, and structural changes in the brain. SOCS2 seems to play a detrimental role in HSV-1 encephalitis. Moreover, the control of neuroinflammatory response in HSV-1 infection was of paramount importance to clinical outcome. (C) 2016 Elsevier Inc. All rights reserved.
C1 [da Cunha Sousa, Larissa Fonseca; Rachid, Milene Alvarenga; de Miranda, Aline Silva; Vilela, Marcia de Carvalho; Queiroz, Norinne Lacerda; Rodrigues, David Henrique; Machado, Fabiana Simao; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Imunofarmacol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   [Rachid, Milene Alvarenga] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Lab Apoptose, Belo Horizonte, MG, Brazil.
   [Lima, Graciela Kunrath; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Campos, Marco Antonio] Ctr Pesquisas Rene Rachou Fiocruz, Belo Horizonte, MG, Brazil.
   [Teixeira, Antonio Lucio] Univ Texas Hlth Sci Ctr Houston, Neuropsychiat Program, Dept Psychiat & Behav Sci, McGovern Med Sch, Houston, TX 77030 USA.
   [Teixeira, Antonio Lucio] Dept Psychiat & Behav Sci, Neuropsychiat Program, 1941 East Rd, Houston, TX USA.
RP Teixeira, AL (corresponding author), Univ Fed Minas Gerais, Sch Med, Div Neurosci, Interdisciplinary Lab Med Invest, Av Alfredo Balena 190,Sala 281, Belo Horizonte, MG, Brazil.
EM altexr@gmail.com
RI Teixeira, Antonio L/N-3315-2014; Kroon, Erna Geessien/B-3631-2015;
   Rachid, Milene Alvarenga/C-3530-2017; Kroon, Erna/V-5444-2019
OI Teixeira, Antonio L/0000-0002-9621-5422; Kroon, Erna
   Geessien/0000-0003-2721-3826; Rachid, Milene
   Alvarenga/0000-0002-3142-6552; Simao Machado,
   Fabiana/0000-0001-9272-5209
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Fapemig, BrazilMinas Gerais State Research Foundation (FAPEMIG)
   [APQ-04392-10]
FX This work was funded by CNPq and Fapemig (APQ-04392-10), Brazil.
CR Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Baringer JR, 2008, NEUROL CLIN, V26, P657, DOI 10.1016/j.ncl.2008.03.005
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   CHAN WL, 1989, J NEUROIMMUNOL, V23, P195, DOI 10.1016/0165-5728(89)90051-9
   Conrady CD, 2013, J IMMUNOL, V190, P2807, DOI 10.4049/jimmunol.1203265
   Conrady CD, 2009, J IMMUNOL, V182, P3678, DOI 10.4049/jimmunol.0803878
   Deb C, 2009, J NEUROIMMUNOL, V214, P33, DOI 10.1016/j.jneuroim.2009.06.013
   Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213
   Esper L, 2012, AM J PATHOL, V181, P130, DOI 10.1016/j.ajpath.2012.03.042
   Fitch MT, 2008, NAT CLIN PRACT NEURO, V4, P97, DOI 10.1038/ncpneuro0713
   Frey KG, 2009, J IMMUNOL, V183, P1253, DOI 10.4049/jimmunol.0900570
   Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568
   Larsen L, 2002, APMIS, V110, P833, DOI 10.1034/j.1600-0463.2002.1101201.x
   Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08
   Machado FS, 2006, IMMUNOL RES, V35, P209, DOI 10.1385/IR:35:3:209
   Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355
   Martinez-Torres F, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-40
   Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080
   Mossman KL, 2005, VIRAL IMMUNOL, V18, P267, DOI 10.1089/vim.2005.18.267
   Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219
   Nogueira ML, 2001, J CLIN PATHOL, V54, P103, DOI 10.1136/jcp.54.2.103
   Polizzotto MN, 2000, J COMP NEUROL, V423, P348
   Ransome MI, 2005, NEUROSCIENCE, V132, P673, DOI 10.1016/j.neuroscience.2004.12.041
   Rice P., 2005, MEDICINE, V33, P4
   Rozenberg Flore, 2011, Infectious Disorders - Drug Targets, V11, P235
   Schmidt N.J., 1979, CELL CULTURE TECHNIQ, P100
   Barbosa AAS, 2016, COMP IMMUNOL MICROB, V47, P26, DOI 10.1016/j.cimid.2016.05.003
   Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206
   Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954
   Vilela MC, 2008, NEUROSCI LETT, V445, P18, DOI 10.1016/j.neulet.2008.08.072
   Vilela MC, 2011, ARQ NEURO-PSIQUIAT, V69, P237, DOI 10.1590/S0004-282X2011000200019
   Vilela MC, 2010, NEUROSCI LETT, V479, P58, DOI 10.1016/j.neulet.2010.05.028
   Vilela MC, 2009, ANN NY ACAD SCI, V1153, P256, DOI 10.1111/j.1749-6632.2008.03959.x
   Wuest TR, 2008, FRONT BIOSCI-LANDMRK, V13, P4862, DOI 10.2741/3045
   Yokota S, 2005, VIROLOGY, V338, P173, DOI 10.1016/j.virol.2005.04.028
   Yokota S, 2004, J VIROL, V78, P6282, DOI 10.1128/JVI.78.12.6282-6286.2004
   Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093
NR 38
TC 5
Z9 5
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
EI 1873-2747
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD OCT
PY 2016
VL 127
BP 164
EP 170
DI 10.1016/j.brainresbull.2016.09.011
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA ED7YH
UT WOS:000389088100020
PM 27646480
DA 2020-11-30
ER

PT J
AU Costa, GB
   Augusto, LTS
   Leite, JA
   Ferreira, PCP
   Bonjardim, CA
   Abrahao, JS
   Kroon, EG
   Moreno, EC
   Trindade, GD
AF Costa, Galileu Barbosa
   Santos Augusto, Lidia Teodoro
   Leite, Juliana Almeida
   Peregrino Ferreira, Paulo Cesar
   Bonjardim, Claudio Antonio
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
   Moreno, Elizabeth Castro
   Trindade, Giliane de Souza
TI Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV
   immunity status and its implications for emergent zoonotic OPV
SO VIROLOGY JOURNAL
LA English
DT Article
ID VACCINIA-VIRUS; SMALLPOX VACCINATION; HUMAN MONKEYPOX; NEUTRALIZING
   ANTIBODY; ANTIVIRAL IMMUNITY; POPULATION; PREVALENCE; INFECTION;
   OUTBREAKS; EXPOSURE
AB Background: Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus, a virus from Orthopoxvirus genus (OPV) that affects mainly cattle herds and humans in rural areas in Brazil. Because most studies have focused on outbreaks situations, data on BV epidemiology is limited. A cross sectional study in Brazilian rural areas during 2012-2013 was conducted to determine the neutralizing antibodies seroprevalence and risk factors for BV.
   Methods: A structured questionnaire was applied to elicit demographics data and farming practices considered risk factors for BV exposure. Neutralizing anti-OPV antibodies were investigated using plaque reduction neutralization test. The neutralizing antibodies prevalence rates were calculated and the risk factor analysis was performed using multivariate logistic regression.
   Results: Two hundred and forty participants were enrolled in this study with a prevalence of neutralizing antibodies of 30.8 % (95 % confidence interval [CI], 25.3-36.9). In multivariate analysis, age > 35 years (Odds Ratio [OR] = 18.2; CI 95 % = 7.7 - 43.2) and previous outbreak in property (OR = 3.9; CI 95 % = 1.2 - 12.6) were independently associated with anti-OPV neutralizing antibodies.
   Conclusions: In this study, anti-OPV protective immunity (neutralizing antibody titers) was assessed in an endemic BV Brazilian rural area. Our findings indicate that epidemiological surveillance is required and should be applied by public health authorities to create interventions and/or prevention strategies to avoid viral spread causing future outbreaks among individuals who are under risk of infection.
C1 [Costa, Galileu Barbosa; Peregrino Ferreira, Paulo Cesar; Bonjardim, Claudio Antonio; Abrahao, Jonatas Santos; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
   [Costa, Galileu Barbosa; Trindade, Giliane de Souza] Av Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Santos Augusto, Lidia Teodoro] Inst Mineiro Agr, Serro, Brazil.
   [Leite, Juliana Almeida] Fiocruz MS, Oswaldo Cruz Fdn, Inst Oswaldo Cruz, Resp Virus Lab, Rio De Janeiro, Brazil.
   [Moreno, Elizabeth Castro] Fundacao Ctr Hematol & Hemoterapia Minas Gerais H, Belo Horizonte, MG, Brazil.
RP Costa, GB; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.; Costa, GB; Trindade, GD (corresponding author), Av Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM galileuk1@gmail.com; giliane@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Costa, Galileu Barbosa/M-5768-2019;
   Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Barbosa Costa,
   Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais (FAPEMIG). CA Bonjardim, JS
   Abrahao, EG Kroon and GS Trindade are researchers from CNPq.
CR Abrahao JS, 2015, EMERG INFECT DIS, V21, P695, DOI 10.3201/eid2104.140351
   Assis FL, 2012, EMERG INFECT DIS, V18, P2035, DOI 10.3201/eid1812.120145
   Costa GB, 2015, EMERG INFECT DIS, V21, P2244, DOI 10.3201/eid2112.141249
   Costa GB, 2013, VACCINE, V31, P4706, DOI [10.1016/j.vac, 10.1016/j.vaccine.2013.08.023]
   da Fonseca FG, 2011, FUTURE VIROL, V6, P697, DOI 10.2217/FVL.11.46
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Figueiredo PD, 2015, MEM I OSWALDO CRUZ, V110, P804, DOI 10.1590/0074-02760150215
   Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917
   Hatakeyama S, 2005, CLIN DIAGN LAB IMMUN, V12, P520, DOI 10.1128/CDLI.12.4.520-524.2005
   Hsieh SM, 2004, CLIN INFECT DIS, V38, P86, DOI 10.1086/380460
   Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115
   Isaacs Stuart N, 2012, Methods Mol Biol, V890, P1, DOI 10.1007/978-1-61779-876-4_1
   Kannangai R, 2000, J MED VIROL, V62, P293, DOI 10.1002/1096-9071(200010)62:2&lt;293::AID-JMV23&gt;3.0.CO;2-V
   Karem KL, 2007, CLIN VACCINE IMMUNOL, V14, P1318, DOI 10.1128/CVI.00148-07
   Kennedy RB, 2009, VACCINE, V27, P3319, DOI 10.1016/j.vaccine.2009.01.086
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Lederman ER, 2007, AM J TROP MED HYG, V77, P1150, DOI 10.4269/ajtmh.2007.77.1150
   Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033392
   Macneil Adam, 2011, BMC Res Notes, V4, P465, DOI 10.1186/1756-0500-4-465
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Newman FK, 2003, J CLIN MICROBIOL, V41, P3154, DOI 10.1128/JCM.41.7.3154-3157.2003
   Putz MM, 2005, J GEN VIROL, V86, P2955, DOI 10.1099/vir.0.81265-0
   Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299
   Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001
   Reynolds MG, 2010, AM J TROP MED HYG, V82, P746, DOI 10.4269/ajtmh.2010.09-0716
   Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540
   Schatzmayr HG, 2011, VACCINE, V29, pD65, DOI 10.1016/j.vaccine.2011.09.105
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Singh RK, 2012, INDIAN J VIROL, V23, P1, DOI 10.1007/s13337-012-0068-1
   Taub DD, 2008, AM J MED, V121, P1058, DOI 10.1016/j.amjmed.2008.08.019
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Viner KM, 2005, MICROBES INFECT, V7, P579, DOI 10.1016/j.micinf.2005.02.004
   Vora NM, 2015, NEW ENGL J MED, V372, P1223, DOI 10.1056/NEJMoa1407647
NR 36
TC 10
Z9 10
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUL 4
PY 2016
VL 13
AR 121
DI 10.1186/s12985-016-0575-6
PG 8
WC Virology
SC Virology
GA DQ6BY
UT WOS:000379290200002
PM 27377374
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Kroon, E
   Ananworanich, J
   Eubanks, K
   Intasan, J
   Pinyakorn, S
   Chomont, N
   Lewin, SR
   Palmer, S
   Trautmann, L
   Yang, H
   Chomchey, N
   Phanuphak, N
   Cooper, K
   Phanuphak, P
   de Souza, M
AF Kroon, E.
   Ananworanich, J.
   Eubanks, K.
   Intasan, J.
   Pinyakorn, S.
   Chomont, N.
   Lewin, S. R.
   Palmer, S.
   Trautmann, L.
   Yang, H.
   Chomchey, N.
   Phanuphak, N.
   Cooper, K.
   Phanuphak, P.
   de Souza, M.
CA SEARCH Study Grp
TI Effect of vorinostat, hydroxychloroquine and maraviroc combination
   therapy on viremia following treatment interruption in individuals
   initiating ART during acute HIV infection
SO JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
LA English
DT Meeting Abstract
C1 [Kroon, E.; Ananworanich, J.; Intasan, J.; Chomchey, N.; Phanuphak, N.; Phanuphak, P.] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand.
   [Ananworanich, J.; Pinyakorn, S.; Trautmann, L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Bethesda, MD USA.
   [Ananworanich, J.; Pinyakorn, S.; Trautmann, L.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA.
   [Eubanks, K.; Yang, H.; Cooper, K.; de Souza, M.] Cooper Human Syst, Cambridge, MA USA.
   [Chomont, N.] Univ Montreal, CRCHUM, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada.
   [Lewin, S. R.] Univ Melbourne, Peter Doherty Inst Infect, Melbourne, Australia.
   [Lewin, S. R.] Royal Melbourne Hosp, Melbourne, Australia.
   [Palmer, S.] Univ Sydney, Sydney, NSW, Australia.
   [Palmer, S.] Westmead Inst Med Res, Sydney, NSW, Australia.
   [Phanuphak, P.; de Souza, M.] Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand.
EM jananworanich@hivresearch.org
RI Phanuphak, Nittaya/AAA-8579-2019; Lewin, Sharon/Z-3297-2019; Kroon,
   Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 1758-2652
J9 J INT AIDS SOC
JI J. Int. AIDS Soc.
PD JUL
PY 2016
VL 19
SU 5
MA TUAX0101LB
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EM6AD
UT WOS:000395394300055
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Rodrigues, RAL
   Abrahao, JS
   Drumond, BP
   Kroon, EG
AF Lima Rodrigues, Rodrigo Araujo
   Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Kroon, Erna Geessien
TI Giants among larges: how gigantism impacts giant virus entry into
   amoebae
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID ACANTHAMOEBA-CASTELLANII; LEGIONELLA-PNEUMOPHILA; AMOEBAL ENCYSTMENT;
   DNA VIRUSES; PANDORAVIRUSES; SURVIVAL; CELLS
AB The proposed order Megavirales comprises the nucleocytoplasmic large DNA viruses (NCLDV), infecting a wide range of hosts. Over time, they co-evolved with different host cells, developing various strategies to penetrate them. Mimiviruses and other giant viruses enter cells through phagocytosis, while Marseillevirus and other large viruses explore endocytosis and macropinocytosis. These differing strategies might reflect the evolution of those viruses. Various scenarios have been proposed for the origin and evolution of these viruses, presenting one of the most enigmatic issues to surround these microorganisms. In this context, we believe that giant viruses evolved independently by massive gene/size gain, exploring the phagocytic pathway of entry into amoebas. In response to gigantism, hosts developed mechanisms to evade these parasites.
C1 [Lima Rodrigues, Rodrigo Araujo; Abrahao, Jonatas Santos; Drumond, Betania Paiva; Kroon, Erna Geessien] Univ Fed Minas Gerais, Brasil UFMG, ICB, Lab Virus,Dept Microbiol, BR-486 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Brasil UFMG, ICB, Lab Virus,Dept Microbiol, BR-486 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado de Minas GeraisMinas Gerais State Research
   Foundation (FAPEMIG)
FX Scholarships were provided by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, and Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais.
CR Abergel C, 2015, FEMS MICROBIOL REV, V39, P779, DOI 10.1093/femsre/fuv037
   Aherfi S, 2014, VIROLOGY, V466, P27, DOI 10.1016/j.virol.2014.07.014
   Arantes TS, 2016, J VIROL
   Benamar S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00003
   Berk SG, 1998, APPL ENVIRON MICROB, V64, P279
   Boratto P, 2015, J VIROL, V89, P2962, DOI 10.1128/JVI.03177-14
   Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6
   Colson P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018935
   Silva LKD, 2016, CURR OPIN MICROBIOL, V31, P9, DOI 10.1016/j.mib.2016.01.003
   Filee J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00593
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   Hussain M, 2009, ARCH VIROL, V154, P1737, DOI 10.1007/s00705-009-0512-8
   KILVINGTON S, 1990, J APPL BACTERIOL, V68, P519, DOI 10.1111/j.1365-2672.1990.tb02904.x
   Koonin EV, 2015, ANN NY ACAD SCI, V1341, P10, DOI 10.1111/nyas.12728
   KORN ED, 1967, J CELL BIOL, V34, P219, DOI 10.1083/jcb.34.1.219
   La Scola B., 2003, SCIENCE, P299
   La Scola B, 2014, MICROB PATHOGENESIS, V77, P131, DOI 10.1016/j.micpath.2014.09.005
   Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Leitsch D, 2010, EUKARYOT CELL, V9, P611, DOI 10.1128/EC.00300-09
   Rodrigues RAL, 2015, J VIROL, V89, P11812, DOI 10.1128/JVI.01976-15
   Lloyd D, 2014, EXP PARASITOL, V145, pS20, DOI 10.1016/j.exppara.2014.03.026
   Moon EK, 2008, EUKARYOT CELL, V7, P1513, DOI 10.1128/EC.00068-08
   Moss B., 2013, FIELDS VIROLOGY, V2, P2129
   Moss B, 2012, VIRUSES-BASEL, V4, P688, DOI 10.3390/v4050688
   Mutsafi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003367
   Mutsafi Y, 2010, P NATL ACAD SCI USA, V107, P5978, DOI 10.1073/pnas.0912737107
   Nasir A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-156
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Raoult D, 2010, INTERVIROLOGY, V53, P321, DOI 10.1159/000312917
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754
   Scheid P, 2014, PARASITOL RES, V113, P2407, DOI 10.1007/s00436-014-3932-7
   Schmitz-Esser S, 2008, APPL ENVIRON MICROB, V74, P5822, DOI 10.1128/AEM.01093-08
   Sharma V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00722
   Sharma V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00423
   Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6
   Steenbergen JN, 2004, INFECT IMMUN, V72, P3478, DOI 10.1128/IAI.72.6.3478-3488.2004
   Wang SW, 2014, J VIROL, V88, P13047, DOI 10.1128/JVI.01744-14
   Wheat WH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003405
   Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114
NR 45
TC 11
Z9 11
U1 0
U2 13
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
EI 1879-0364
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD JUN
PY 2016
VL 31
BP 88
EP 93
DI 10.1016/j.mib.2016.03.009
PG 6
WC Microbiology
SC Microbiology
GA DP4GK
UT WOS:000378454200014
PM 27039270
DA 2020-11-30
ER

PT J
AU Franco-Luiz, APM
   Pereira, AF
   de Oliveira, CHS
   Barbosa, JD
   Oliveira, DB
   Bonjardim, CA
   Ferreira, PCP
   Trindade, GD
   Abrahao, JS
   Kroon, EG
AF Moreira Franco-Luiz, Ana Paula
   Pereira, Alexandre Fagundes
   Sousa de Oliveira, Cairo Henrique
   Barbosa, Jose Diomedes
   Oliveira, Danilo Bretas
   Bonjardim, Cludio Antonio
   Peregrino Ferreira, Paulo Cesar
   Trindade, Giliane de Souza
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
TI The detection of Vaccinia virus confirms the high circulation of
   Orthopoxvirus in buffaloes living in geographical isolation, Marajo
   Island, Brazilian Amazon
SO COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
LA English
DT Article
DE Vaccinia virus; Orthopoxvirus; Buffaloes; Poxvirus; Brazil
AB In Brazil, serologic evidence of Orthopoxvirus (OPV) circulation showed positivity around 20% in cattle, humans, monkeys and rodents. Although OPV seropositivity has been described in buffalo herds in southeastern Brazil, no Vaccinia virus (VACV) (member of genus OPV) outbreaks in buffalo herds have been described in this country. This study aimed to investigate the detection of anti-OPV antibodies and to study the OPV genome in Brazilian buffalo herds. Our results demonstrated a high OPV seropositivity in buffalo herds on Marajo Island and molecular data confirmed the circulation of VACV. The geographical isolation conditionmight be a sine qua non condition to explain our results. (C) 2016 Published by Elsevier Ltd.
C1 [Moreira Franco-Luiz, Ana Paula; Pereira, Alexandre Fagundes; Oliveira, Danilo Bretas; Bonjardim, Cludio Antonio; Peregrino Ferreira, Paulo Cesar; Trindade, Giliane de Souza; Abrahao, Jonatas Santos; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
   [Sousa de Oliveira, Cairo Henrique] Univ Fed Goias, Escola Vet & Zootecnia, Setor Med Vet Prevent, Goiania, Go, Brazil.
   [Barbosa, Jose Diomedes] Fed Univ Para, Inst Med Vet, Hosp Vet Grandes Anim, Castanhal, PA, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM anapaulamluiz@gmail.com; alexandre210490@yahoo.com.br;
   cairo_henrique@yahoo.com.br; diomedes@ufpa.br;
   danilobretas@yahoo.com.br; claudio.bonjardim@pq.cnpq.br;
   peregrinopcp@hotmail.com; giliane@icb.ufmg.br;
   jonatas.abrahao@gmail.com; ernagkroon@gmail.com
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; De Oliveira,
   Cairo/0000-0002-3474-2796
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas
   GeraisMinas Gerais State Research Foundation (FAPEMIG) [FAPEMIG-PPM
   686-15, PPM 133-13]; Ministerio da Agricultura, Pecuaria e Abastecimento
   (MAPA); CAPESCAPES
FX We thank colleagues from the Laboratorio de Virus for their excellent
   technical support. Financial support was provided by the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG-PPM 686-15, PPM
   133-13) and Ministerio da Agricultura, Pecuaria e Abastecimento (MAPA).
   Franco-Luiz A.P.M. received fellowships from CAPES. E.G. Kroon, C.A.
   Bonjardim, G.S. Trindade and P.C.P. Ferreira are researchers from CNPq.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Cohen JI, 2007, VACCINE, V25, P4571, DOI 10.1016/j.vaccine.2007.03.044
   de Assis FL, 2013, EMERG INFECT DIS, V19, P2017, DOI 10.3201/eid1912.130589
   de Assis FL, 2012, EMERG INFECT DIS, V18, P698, DOI 10.3201/eid1804.111800
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Goodin DS, 2007, NEUROLOGY, V68, P977, DOI 10.1212/01.wnl.0000258545.73854.cf
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Montag LFD, 2011, RESEARCH IN BIODIVERSITY - MODELS AND APPLICATIONS, P261
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Savona MR, 2006, JAMA-J AM MED ASSOC, V295, P1898, DOI 10.1001/jama.295.16.1898
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
NR 16
TC 5
Z9 5
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0147-9571
EI 1878-1667
J9 COMP IMMUNOL MICROB
JI Comp. Immunol. Microbiol. Infect. Dis.
PD JUN
PY 2016
VL 46
BP 16
EP 19
DI 10.1016/j.cimid.2016.03.003
PG 4
WC Immunology; Microbiology; Veterinary Sciences
SC Immunology; Microbiology; Veterinary Sciences
GA DN7YU
UT WOS:000377296900003
PM 27260805
DA 2020-11-30
ER

PT J
AU Arantes, TS
   Rodrigues, RAL
   Silva, LKD
   Oliveira, GP
   de Souza, HL
   Khalil, JYB
   de Oliveira, DB
   Torres, AA
   da Silva, LL
   Colson, P
   Kroon, EG
   da Fonseca, FG
   Bonjardim, CA
   La Scola, B
   Abrahao, JS
AF Arantes, Thalita Souza
   Lima Rodrigues, Rodrigo Araujo
   dos Santos Silva, Ludmila Karen
   Oliveira, Graziele Pereira
   de Souza, Helton Luis
   Khalil, Jacques Y. B.
   de Oliveira, Danilo Bretas
   Torres, Alice Abreu
   da Silva, Luis Lamberti
   Colson, Philippe
   Kroon, Erna Geessien
   da Fonseca, Flavio Guimaraes
   Bonjardim, Claudio Antonio
   La Scola, Bernard
   Abrahao, Jonatas Santos
TI The Large Marseillevirus Explores Different Entry Pathways by Forming
   Giant Infectious Vesicles
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID VIRUS; ACANTHAMOEBA; AMEBAS; FAMILY
AB Triggering the amoebal phagocytosis process is a sine qua non condition for most giant viruses to initiate their replication cycle and consequently to promote their progeny formation. It is well known that the amoebal phagocytosis process requires the recognition of particles of >500 nm, and most amoebal giant viruses meet this requirement, such as mimivirus, pandoravirus, pithovirus, and mollivirus. However, in the context of the discovery of amoebal giant viruses in the last decade, Marseillevirus marseillevirus (MsV) has drawn our attention, because despite its ability to successfully replicate in Acanthamoeba, remarkably it does not fulfill the >500-nm condition, since it presents an similar to 250-nm icosahedrally shaped capsid. We deeply investigated the MsV cycle by using a set of methods, including virological, molecular, and microscopic (immunofluorescence, scanning electron microscopy, and transmission electron microscopy) assays. Our results revealed that MsV is able to form giant vesicles containing dozens to thousands of viral particles wrapped by membranes derived from amoebal endoplasmic reticulum. Remarkably, our results strongly suggested that these giant vesicles are able to stimulate amoebal phagocytosis and to trigger the MsV replication cycle by an acidification-independent process. Also, we observed that MsV entry may occur by the phagocytosis of grouped particles (without surrounding membranes) and by an endosome-stimulated pathway triggered by single particles. Taken together, not only do our data deeply describe the main features of MsV replication cycle, but this is the first time, to our knowledge, that the formation of giant infective vesicles related to a DNA virus has been described.
   IMPORTANCE
   Triggering the amoebal phagocytosis process is a sine qua non condition required by most giant viruses to initiate their replication cycle. This process requires the recognition of particles of >500 nm, and many giant viruses meet this requirement. However, MsV is unusual, as despite having particles of similar to 250 nm it is able to replicate in Acanthamoeba. Our results revealed that MsV is able to form giant vesicles, containing dozens to thousands of viral particles, wrapped in membranes derived from amoebal endoplasmic reticulum. Remarkably, our results strongly suggest that these giant vesicles are able to stimulate phagocytosis using an acidification-independent process. Our work not only describes the main features of the MsV replication cycle but also describes, for the first time to our knowledge, the formation of huge infective vesicles in a large DNA viruses.
C1 [Arantes, Thalita Souza; Lima Rodrigues, Rodrigo Araujo; dos Santos Silva, Ludmila Karen; Oliveira, Graziele Pereira; de Souza, Helton Luis; de Oliveira, Danilo Bretas; Torres, Alice Abreu; Kroon, Erna Geessien; da Fonseca, Flavio Guimaraes; Bonjardim, Claudio Antonio; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [da Silva, Luis Lamberti] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, SP, Brazil.
   [Khalil, Jacques Y. B.; Colson, Philippe; La Scola, Bernard] Aix Marseille Univ, URMITE CNRS UMR 6236, IRD 3R198, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Belo Horizonte, MG, Brazil.; La Scola, B (corresponding author), Aix Marseille Univ, URMITE CNRS UMR 6236, IRD 3R198, Marseille, France.
EM bernard.la-scola@univ-amu.fr; jonatas.abrahao@gmail.com
RI LA SCOLA, Bernard/P-6477-2016; Abreu Torres, Alice/B-1475-2018; Colson,
   Philippe/P-6355-2014; daSilva, Luis LP/AAD-5657-2019; Kroon,
   Erna/V-5444-2019; daSilva, Luis LP/A-9949-2010; Kroon, Erna
   Geessien/B-3631-2015
OI LA SCOLA, Bernard/0000-0001-8006-7704; Abreu Torres,
   Alice/0000-0003-2352-2584; Colson, Philippe/0000-0001-6285-0308;
   daSilva, Luis LP/0000-0003-3558-0087; daSilva, Luis
   LP/0000-0003-3558-0087; Kroon, Erna Geessien/0000-0003-2721-3826; Araujo
   Lima Rodrigues, Rodrigo/0000-0001-7148-4012
FU MCTI \ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [470645/2011-3]
FX This work, including the efforts of Jonatas Santos Abrahao, was funded
   by MCTI vertical bar Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (470645/2011-3).
CR Aherfi S, 2014, ARCH VIROL, V159, P2349, DOI 10.1007/s00705-014-2023-5
   Altan-Bonnet N, 2015, J VIROL, V89, P12242, DOI 10.1128/JVI.01452-15
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Dornas FP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01086
   Doutre G, 2014, J VIROL, V88, P14340, DOI 10.1128/JVI.02414-14
   Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278
   Kato S, 1959, BIKEN J, V2, P343
   Koch G, 1978, Front Biol, V46, P475
   La Scola B, 2003, SCIENCE, V299, P2033
   Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023
   Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Rodrigues RAL, 2015, J VIROL, V89, P11812, DOI 10.1128/JVI.01976-15
   Milrot E, 2016, CELL MICROBIOL, V18, P3, DOI 10.1111/cmi.12486
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Popgeorgiev N, 2013, J CLIN MICROBIOL, V51, P4102, DOI 10.1128/JCM.01918-13
   Popgeorgiev N, 2013, J INFECT DIS, V208, P1042, DOI 10.1093/infdis/jit292
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102
   Thomas V, 2011, ENVIRON MICROBIOL, V13, P1454, DOI 10.1111/j.1462-2920.2011.02446.x
   Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06
   Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x
   WEISMAN RA, 1967, BIOCHEMISTRY-US, V6, P485, DOI 10.1021/bi00854a017
NR 27
TC 36
Z9 38
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2016
VL 90
IS 11
BP 5246
EP 5255
DI 10.1128/JVI.00177-16
PG 10
WC Virology
SC Virology
GA DM2ES
UT WOS:000376160200005
PM 26984730
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Assis, F
   Trindade, G
   Drumond, B
   Frace, M
   Sammons, S
   Emerson, G
   Li, Y
   Carroll, D
   Batra, D
   Abrahao, J
   Kroon, E
AF Assis, Felipe
   Trindade, Giliane
   Drumond, Betania
   Frace, Mike
   Sammons, Scott
   Emerson, Ginny
   Li, Yu
   Carroll, Darin
   Batra, Dhwani
   Abrahao, Jonatas
   Kroon, Erna
TI Genome Sequence of Vaccinia virus Strain Lister-Butantan, a Lister
   Vaccine Variant Used during a Smallpox Eradication Campaign in Brazil
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB Here, we report the 187.8-kb genome sequence of Vaccinia virus Lister-Butantan, which was used in Brazil during the WHO smallpox eradication campaign. Its genome showed an average similarity of 98.18% with the original Lister isolate, highlighting the low divergence among related Vaccinia virus vaccine strains, even after several passages in animals and cell culture.
C1 [Assis, Felipe; Trindade, Giliane; Drumond, Betania; Abrahao, Jonatas; Kroon, Erna] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Frace, Mike; Sammons, Scott; Emerson, Ginny; Li, Yu; Carroll, Darin; Batra, Dhwani] Ctr Dis Control & Prevent, NCEZID, Atlanta, GA USA.
RP Abrahao, J (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Kroon, Erna/B-3631-2015
OI Kroon, Erna/0000-0003-2721-3826
CR Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Garcel A, 2007, J GEN VIROL, V88, P1906, DOI 10.1099/vir.0.82708-0
   Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006
   Medaglia MLG, 2015, J VIROL, V89, P11909, DOI 10.1128/JVI.01833-15
   Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005
NR 6
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD MAY-JUN
PY 2016
VL 4
IS 3
AR e00536-16
DI 10.1128/genomeA.00536-16
PG 2
WC Microbiology
SC Microbiology
GA VI1DQ
UT WOS:000460660100183
PM 27340056
OA Green Published, Other Gold
DA 2020-11-30
ER

PT J
AU Aguiar, ERGR
   Olmo, RP
   Paro, S
   Ferreira, FV
   de Faria, IJD
   Todjro, YMH
   Lobo, FP
   Kroon, EG
   Meignin, C
   Gatherer, D
   Imler, JL
   Marques, JT
AF Guimaraes Rocha Aguiar, Eric Roberto
   Olmo, Roenick Proveti
   Paro, Simona
   Ferreira, Flavia Viana
   da Silva de Faria, Isaque Joao
   Honore Todjro, Yaovi Mathias
   Lobo, Francisco Pereira
   Kroon, Erna Geessien
   Meignin, Carine
   Gatherer, Derek
   Imler, Jean-Luc
   Marques, Joao Trindade
TI Sequence-independent characterization of viruses based on the pattern of
   viral small RNAs produced by the host (vol 43, pg 6191, 2015)
SO NUCLEIC ACIDS RESEARCH
LA English
DT Correction
C1 [Guimaraes Rocha Aguiar, Eric Roberto; Olmo, Roenick Proveti; da Silva de Faria, Isaque Joao; Honore Todjro, Yaovi Mathias; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Guimaraes Rocha Aguiar, Eric Roberto; Olmo, Roenick Proveti; Paro, Simona; Meignin, Carine; Imler, Jean-Luc] CNRS, UPR9022, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France.
   [Ferreira, Flavia Viana; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Lobo, Francisco Pereira] Embrapa Informat Agr, Lab Multiusuario Bioinformat, BR-13083886 Sao Paulo, Brazil.
   [Meignin, Carine; Imler, Jean-Luc] Univ Strasbourg, Fac Sci Vie, F-67083 Strasbourg, France.
   [Gatherer, Derek] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England.
   [Imler, Jean-Luc] Univ Strasbourg USIAS, Inst Etud Avancees, F-67084 Strasbourg, France.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Olmo, Roenick/AAF-6412-2020; Kroon, Erna Geessien/B-3631-2015; Aguiar,
   Eric RGR/L-7989-2018
OI Kroon, Erna Geessien/0000-0003-2721-3826; Aguiar, Eric
   RGR/0000-0002-8143-5756; Gatherer, Derek/0000-0002-7385-5734; Pereira
   Lobo, Francisco/0000-0002-9671-9313; Meignin, Carine/0000-0002-6588-9045
CR Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
NR 1
TC 6
Z9 6
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 20
PY 2016
VL 44
IS 7
BP 3477
EP 3478
DI 10.1093/nar/gkw044
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DL7DM
UT WOS:000375800200049
PM 26801643
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Oliveira, DB
   Luiz, APMF
   Fagundes, A
   Pinto, CA
   Bonjardim, CA
   Trindade, GS
   Kroon, EG
   Abrahao, JS
   Ferreira, PCP
AF Oliveira, Danilo B.
   Moreira Franco Luiz, Ana Paula
   Fagundes, Alexandre
   Pinto, Carla Amaral
   Bonjardim, Claudio A.
   Trindade, Giliane S.
   Kroon, Erna G.
   Abrahao, Jonatas S.
   Ferreira, Paulo C. P.
TI Evidence of Apeu Virus Infection in Wild Monkeys, Brazilian Amazon
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID ARTHROPOD-BORNE VIRUSES; GROUP C; IDENTIFICATION
AB Orthobunyaviruses are arboviruses in which at least 30 members are human pathogens. The members of group C orthobunyaviruses were first isolated in the Brazilian Amazon in 1950, since that time little information is accumulated about ecology and the medical impact of these virus groups in Brazil. Herein, we describe the evidence of Apeu virus (APEUV; an Orthobunyavirus member) infection in wild monkeys from the Brazilian Amazon forest. APEUV was detected by using a neutralizing antibody in serum and its RNA, suggesting past and acute infection of Amazonian monkeys by this virus. These results altogether represent an important contribution of orthobunyavirus ecology in the Amazon and an update about recent circulation and risk for humans with expansion of the cities to Amazon forest.
C1 [Oliveira, Danilo B.; Moreira Franco Luiz, Ana Paula; Fagundes, Alexandre; Pinto, Carla Amaral; Bonjardim, Claudio A.; Trindade, Giliane S.; Kroon, Erna G.; Abrahao, Jonatas S.; Ferreira, Paulo C. P.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
   [Oliveira, Danilo B.; Moreira Franco Luiz, Ana Paula; Fagundes, Alexandre; Pinto, Carla Amaral; Bonjardim, Claudio A.; Trindade, Giliane S.; Kroon, Erna G.; Abrahao, Jonatas S.; Ferreira, Paulo C. P.] Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM danilobretas@yahoo.com.br; anapaulamluiz@gmail.com;
   alexandre210490@yahoo.com.br; carlaamaral@gmail.com;
   claudio.bonjardim@pq.cnpq.br; giliane@icb.ufmg.br; kroone@icb.ufmg.br;
   jonatas.abrahao@gmail.com; peregrinopcp@hotmail.com
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826
CR Blitvich BJ, 2012, AM J TROP MED HYG, V87, P1132, DOI 10.4269/ajtmh.2012.12-0188
   CASALS J, 1961, AM J TROP MED HYG, V10, P250, DOI 10.4269/ajtmh.1961.10.250
   Magalhaes CLD, 2011, ARCH VIROL, V156, P1173, DOI 10.1007/s00705-011-0976-1
   Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332
   Figueiredo LTM, 2006, REV SOC BRAS MED TRO, V39, P203, DOI 10.1590/S0037-86822006000200014
   GIBBS CJ, 1964, AM J TROP MED HYG, V13, P108, DOI 10.4269/ajtmh.1964.13.108
   Goodin DS, 2007, NEUROLOGY, V68, P977, DOI 10.1212/01.wnl.0000258545.73854.cf
   Hubalek Z, 2005, EMERG INFECT DIS, V11, P116, DOI 10.3201/eid1101.040444
   Iversson LB, 1980, REV SAUDE PUBL, V15, P587
   JU JY, 1995, P NATL ACAD SCI USA, V92, P4347, DOI 10.1073/pnas.92.10.4347
   King A.M.Q., 2012, 9 INT COMM TAX VIR
   Schmaljohn CS, 2007, FIELDS VIROLOGY, P1741
   SHOPE RE, 1962, AM J TROP MED HYG, V11, P283, DOI 10.4269/ajtmh.1962.11.283
NR 13
TC 3
Z9 3
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAR
PY 2016
VL 94
IS 3
BP 494
EP 496
DI 10.4269/ajtmh.14-0688
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DF5DS
UT WOS:000371372600004
PM 26787153
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Lima, MT
   Andrade, ACSP
   Oliveira, GP
   Calixto, RS
   Oliveira, DB
   Souza, ELS
   Trindade, GS
   Nicoli, JR
   Kroon, EG
   Martins, FS
   Abrahao, JS
AF Lima, Mauricio T.
   Andrade, Ana C. S. P.
   Oliveira, Graziele P.
   Calixto, Rafael S.
   Oliveira, Danilo B.
   Souza, Ericka L. S.
   Trindade, Giliane S.
   Nicoli, Jacques R.
   Kroon, Erna G.
   Martins, Flaviano S.
   Abrahao, Jonatas S.
TI Microbiota is an essential element for mice to initiate a protective
   immunity against Vaccinia virus
SO FEMS MICROBIOLOGY ECOLOGY
LA English
DT Article
DE microbiota; Vaccinia virus; virus-microbiota interactions; germ-free
   mice
ID GERM-FREE; INTESTINAL MICROBIOTA; COMMENSAL BACTERIA; GUT MICROBIOTA;
   ENTERIC VIRUS; INFECTION; PATHOGENICITY; ACTIVATION; SPREAD; SUIS
AB The gastrointestinal tract of vertebrates harbors one of the most complex ecosystems known in microbial ecology and this indigenous microbiota almost always has a profound influence on host-parasite relationships, which can enhance or reduce the pathology of the infection. In this context, the impact of the microbiota during the infection of several viral groups remains poorly studied, including the family Poxviridae. Vaccinia virus (VACV) is a member of this family and is the causative agent of bovine vaccinia, responsible for outbreaks that affect bovines and humans. To determine the influence of the microbiota in the development of the disease caused by VACV, a comparative study using a murine model was performed. Germ-free and conventional, 6-to 7-week-old Swiss NIH mice were infected by tail scarification and intranasally with VACV. Moreover, immunosuppression and microbiota reposition were performed, to establish the interactions among the host's immune system, microbiota and VACV. The data demonstrate that the microbiota is essential for the effective immune response of mice against VACV in intranasal inoculation and to control the virus at the primary site of infection. Furthermore, this study is the first to show that Swiss conventional mice are refractory to the intranasal infection of VACV.
C1 [Lima, Mauricio T.; Andrade, Ana C. S. P.; Oliveira, Graziele P.; Calixto, Rafael S.; Oliveira, Danilo B.; Souza, Ericka L. S.; Trindade, Giliane S.; Nicoli, Jacques R.; Kroon, Erna G.; Martins, Flaviano S.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Dept Microbiol, Ave Antonio Carlos 6627,Caixa Postal 486,Bloco F4, BR-31270901 Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Ave Antonio Carlos 6627,Caixa Postal 486,Bloco F4, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Martins,
   Flaviano/0000-0003-0741-3062; Teixeira Lima,
   Mauricio/0000-0002-0830-3909; Nicoli, Jacques Robert/0000-0003-2390-2608
FU Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais
   (PRPq-UFMG); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; Fundacao de Amparo a Pesquisa do estado de Minas
   Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX This work was supported by the grants Pro-Reitoria de Pesquisa da
   Universidade Federal de Minas Gerais (PRPq-UFMG) and by the support
   agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES) and Fundacao de Amparo a Pesquisa do estado de Minas Gerais
   (FAPEMIG).
CR Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011
   AHMED SA, 1994, IMMUNOPHARMACOLOGY, V28, P55
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017
   Damon I, 2013, FIELDS VIROLOGY, V6, P2160
   El Aidy S, 2013, GUT MICROBES, V4, P118, DOI 10.4161/gmic.23362
   Fenner F., 1988, SMALLPOX ITS ERADICA
   GOUET P, 1984, RES VET SCI, V36, P21, DOI 10.1016/S0034-5288(18)31995-7
   HARLEMAN JH, 1984, VET PARASITOL, V17, P27, DOI 10.1016/0304-4017(84)90062-1
   Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22
   Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108
   ISAAK DD, 1988, LEUKEMIA, V2, P540
   JOHNSON J, 1973, EXP PARASITOL, V33, P95, DOI 10.1016/0014-4894(73)90013-1
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kalthoff D, 2014, VECTOR-BORNE ZOONOT, V14, P303, DOI 10.1089/vbz.2013.1442
   Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060
   Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718
   Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960
   KOUTTAB NM, 1972, J IMMUNOL, V108, P591
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057
   Marietta E, 2015, IMMUNOLOGY, V145, P313, DOI 10.1111/imm.12474
   Martins WA, 2000, J MED MICROBIOL, V49, P387, DOI 10.1099/0022-1317-49-4-387
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Mota BEF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018924
   OWEN D, 1975, PARASITOLOGY, V71, P293, DOI 10.1017/S0031182000046734
   PHILLIPS BP, 1959, ANN NY ACAD SCI, V78, P308, DOI 10.1111/j.1749-6632.1959.tb53115.x
   Pleasants J.R., 1974, HDB LAB ANIMAL SCI, VI, P119
   PRZYJALK.ZW, 1969, EXP PARASITOL, V25, P8, DOI 10.1016/0014-4894(69)90047-2
   REID WM, 1967, EXP PARASITOL, V21, P149, DOI 10.1016/0014-4894(67)90076-8
   Reynolds MG, 2012, CURR OPIN VIROL, V2, P335, DOI 10.1016/j.coviro.2012.02.004
   RUTTER JM, 1975, INFECT IMMUN, V11, P395, DOI 10.1128/IAI.11.2.395-404.1975
   SALKOWSKI CA, 1987, INFECT IMMUN, V55, P2000, DOI 10.1128/IAI.55.9.2000-2005.1987
   Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009
   Sharon M, 2007, VACCINE, V25, P7743, DOI 10.1016/j.vaccine.2007.09.023
   SILVA ME, 1987, REV I MED TROP, V29, P284, DOI 10.1590/S0036-46651987000500004
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Souza DG, 2004, J IMMUNOL, V173, P4137, DOI 10.4049/jimmunol.173.6.4137
   Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008
   Torres MF, 2000, J MED MICROBIOL, V49, P209, DOI 10.1099/0022-1317-49-3-209
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399
   VIEIRA EC, 1987, REV I MED TROP, V29, P385, DOI 10.1590/S0036-46651987000600009
   VISCO RJ, 1972, J PARASITOL, V58, P320
   WESCOTT RB, 1968, EXP PARASITOL, V22, P245, DOI 10.1016/0014-4894(68)90099-4
   WESCOTT RB, 1964, J PARASITOL, V50, P138, DOI 10.2307/3276048
   Wilks J, 2013, IMMUNOL REV, V255, P222, DOI 10.1111/imr.12097
   Wilks J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002681
   WILSON KH, 1995, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 2ND EDITION, P245
NR 50
TC 3
Z9 4
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0168-6496
EI 1574-6941
J9 FEMS MICROBIOL ECOL
JI FEMS Microbiol. Ecol.
PD FEB
PY 2016
VL 92
IS 2
AR fiv147
DI 10.1093/femsec/fiv147
PG 8
WC Microbiology
SC Microbiology
GA DF3MX
UT WOS:000371249600001
PM 26610433
OA Bronze
DA 2020-11-30
ER

PT J
AU de Oliveira, DB
   Machado, G
   Almeida, GMD
   Ferreira, PCP
   Bonjardim, CA
   Trindade, GD
   Abrahao, JS
   Kroon, EG
AF de Oliveira, Danilo Bretas
   Machado, Guilherme
   de Freitas Almeida, Gabriel Magno
   Peregrino Ferreira, Paulo Cesar
   Bonjardim, Cludio Antonio
   Trindade, Giliane de Souza
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
TI Infection of the central nervous system with dengue virus 3 genotype I
   causing neurological manifestations in Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Central nervous system; Neurologic manifestations of dengue virus;
   Dengue virus 3 genotype I
AB A case of dengue virus 3 (DENV-3) genotype I infection with neurological manifestations occurred in Belo Horizonte, Minas Gerais in October 2012. The serotype was detected by PCR, and the genotype was assessed by sequencing and phylogenetic analysis of the C-prM region. The virus causing neurological manifestations clustered with other sequences of DENV-3 genotype I. Because neurological manifestations of DENV are possibly misdiagnosed in Brazil, this study serves as an alert of the importance of DENV diagnoses in CNS infections.
C1 [de Oliveira, Danilo Bretas; de Freitas Almeida, Gabriel Magno; Peregrino Ferreira, Paulo Cesar; Bonjardim, Cludio Antonio; Trindade, Giliane de Souza; Abrahao, Jonatas Santos; Kroon, Erna Geessien] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Machado, Guilherme] Hosp Risoleta Tolentino Neves, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Almeida, Gabriel MF/I-8910-2012;
   Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Almeida, Gabriel
   MF/0000-0003-2317-5092; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); Pro-Reitoria de Pesquisa da Universidade Federal de Minas
   Gerais (PRPq-UFMG)
FX This study was supported by grants from CNPq, CAPES, FAPEMIG and
   Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais
   (PRPq-UFMG).
CR Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012
   Araujo FMC, 2012, NEUROLOGY, V78, P736, DOI 10.1212/WNL.0b013e31824b94e9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Ferreira GP, 2010, MICROBES INFECT, V12, P546, DOI 10.1016/j.micinf.2010.03.007
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   JU JY, 1995, P NATL ACAD SCI USA, V92, P4347, DOI 10.1073/pnas.92.10.4347
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Ministerio da Saude do Brasil (MS), 2015, B EP DENG 2013 2015
   de Souza KPR, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-267
   Soares CN, 2010, INT J INFECT DIS, V14, pE150, DOI 10.1016/j.ijid.2009.03.016
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
NR 15
TC 5
Z9 11
U1 0
U2 7
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2016
VL 49
IS 1
BP 125
EP 129
DI 10.1590/0037-8682-0208-2015
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DH5RA
UT WOS:000372848300021
PM 27163577
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Andrade, EHP
   Figueiredo, LB
   Vilela, APP
   Rosa, JCC
   Oliveira, JG
   Zibaoui, HM
   Araujo, VEM
   Miranda, DPJ
   Ferreira, PCP
   Abrahao, JS
   Kroon, EG
AF Andrade, Elisa H. P.
   Figueiredo, Leandra B.
   Vilela, Ana P. P.
   Rosa, Julio C. C.
   Oliveira, Jaquelline G.
   Zibaoui, Hassan M.
   Araujo, Valdelaine E. M.
   Miranda, Daniela P. J.
   Ferreira, Paulo C. P.
   Abrahao, Jonatas S.
   Kroon, Erna G.
TI Spatial-Temporal Co-Circulation of Dengue Virus 1, 2, 3, and 4
   Associated with Coinfection Cases in a Hyperendemic Area of Brazil: A
   4-Week Survey
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID INFECTIONS; SEROTYPES; SAMPLES
AB Dengue is currently regarded as a major public health problem worldwide. In a hyperendemic region during an outbreak, we detected the co-circulation of all Dengue virus (DENV) serotypes including two different genotypes of DENV-3 and DENV-4, and concurrent infections with up to three serotypes were identified in symptomatic patients. A total of 49 acute phase plasma samples from patients clinically suspected of dengue were collected during the 4 weeks of May 2013. DENV-1-4 was detected by reverse transcriptase semi-nested polymerase chain reaction in 33 samples (67.3%), of which 26 DNA fragments were sequenced. Twenty samples (76.9%) were identified with a single DENV serotype and six (23.1%) with more than one serotype. DENV-3 was the predominant serotype of the outbreak. On the basis of phylogenetic analyses, DENV-1 isolates belong to genotype V, DENV-2 to American-Asian genotype, DENV-3 to genotypes I and III, and DENV-4 to genotypes I and II.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Andrade, Elisa H. P.; Zibaoui, Hassan M.; Araujo, Valdelaine E. M.] Prefeitura Municipal Contagem, Secretaria Saude, Contagem, Brazil.
   [Oliveira, Jaquelline G.] Fundacao Oswaldo Cruz FIOCRUZ, Lab Imunol Celular & Mol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Lab Epidemiol Doencas Infecciosas & Parasitarias, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Andrade, Elisa H. P.; Vilela, Ana P. P.; Rosa, Julio C. C.; Miranda, Daniela P. J.; Ferreira, Paulo C. P.; Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Figueiredo, Leandra B.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Ave Antonio Carlos,6627 Pampulha,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM elisahpandrade@yahoo.com.br; leandrabio@yahoo.com.br;
   pessoavilela58@gmail.com; jcbhrama@yahoo.com.br;
   elisahpandrade@yahoo.com; hassan.zibaoui@contagem.mg.gov.br;
   valdelainearaujo@yahoo.com.br; dmiranda@superig.com.br;
   peregrinopc48@gmail.com; jonatas.abrahao@gmail.com; ernagkroon@gmail.com
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; Vilela, Ana
   Paula Pessoa/Q-7538-2018
OI Kroon, Erna Geessien/0000-0003-2721-3826; Vilela, Ana Paula
   Pessoa/0000-0001-9030-0688
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)-PronexNational Council for Scientific and Technological
   Development (CNPq); INCT em Dengue; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation
   (FAPEMIG); Ministerio da Saude, DECIT
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)-Pronex and INCT em Dengue, Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and Ministerio da
   Saude, DECIT.
CR Bharaj P, 2008, VIROL J, V12, P542
   Chinnawirotpisan P, 2008, ARCH VIROL, V153, P2225, DOI 10.1007/s00705-008-0249-9
   Das S, 2008, J CLIN MICROBIOL, V46, P3276, DOI 10.1128/JCM.00163-08
   de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004
   Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lorono-Pino MA, 1999, AM J TROP MED HYG, V61, P725, DOI 10.4269/ajtmh.1999.61.725
   Posada D, 2011, JMODELTEST PHYLOGENE
   Souza KPR, 2013, VIROL J, V10, P1
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   VinodKumar CS, 2013, J INFECT PUBLIC HEAL, V6, P302, DOI 10.1016/j.jiph.2013.01.004
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   World Health Organization (WHO), 2013, DENG SEV DENG
NR 15
TC 12
Z9 12
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2016
VL 94
IS 5
BP 1080
EP 1084
DI 10.4269/ajtmh.15-0892
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EV4MS
UT WOS:000401735200024
PM 26976882
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Goncalves, VN
   Cantrell, CL
   Wedge, DE
   Ferreira, MC
   Soares, MA
   Jacob, MR
   Oliveira, FS
   Galante, D
   Rodrigues, F
   Alves, TMA
   Zani, CL
   Junior, PAS
   Murta, S
   Romanha, AJ
   Barbosa, EC
   Kroon, EG
   Oliveira, JG
   Gomez-Silva, B
   Galetovic, A
   Rosa, CA
   Rosa, LH
AF Goncalves, Vivian N.
   Cantrell, Charles L.
   Wedge, David E.
   Ferreira, Mariana C.
   Soares, Marco Aurelio
   Jacob, Melissa R.
   Oliveira, Fabio S.
   Galante, Douglas
   Rodrigues, Fabio
   Alves, Tania M. A.
   Zani, Carlos L.
   Junior, Policarpo A. S.
   Murta, Silvane
   Romanha, Alvaro J.
   Barbosa, Emerson C.
   Kroon, Erna G.
   Oliveira, Jaquelline G.
   Gomez-Silva, Benito
   Galetovic, Alexandra
   Rosa, Carlos A.
   Rosa, Luiz H.
TI Fungi associated with rocks of the Atacama Desert: taxonomy,
   distribution, diversity, ecology and bioprospection for bioactive
   compounds
SO ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID HEAT-RESISTANT; BLACK FUNGI; IN-VITRO; COMMUNITIES; PHYLOGENY;
   MACROALGAE; GENUS
AB This study assessed the diversity of cultivable rock-associated fungi from Atacama Desert. A total of 81 fungal isolates obtained were identified as 29 Ascomycota taxa by sequencing different regions of DNA. Cladosporium halotolerans, Penicillium chrysogenum and Penicillium cf. citrinum were the most frequent species, which occur at least in four different altitudes. The diversity and similarity indices ranged in the fungal communities across the latitudinal gradient. The Fisher-a index displayed the higher values for the fungal communities obtained from the siltstone and fine matrix of pyroclastic rocks with finer grain size, which are more degraded. A total of 23 fungal extracts displayed activity against the different targets screened. The extract of P. chrysogenum afforded the compounds a-linolenic acid and ergosterol endoperoxide, which were active against Cryptococcus neoformans and methicillin-resistance Staphylococcus aureus respectively. Our study represents the first report of a new habitat of fungi associated with rocks of the Atacama Desert and indicated the presence of interesting fungal community, including species related with saprobes, parasite/pathogen and mycotoxigenic taxa. The geological characteristics of the rocks, associated with the presence of rich resident/resilient fungal communities suggests that the rocks may provide a favourable microenvironment fungal colonization, survival and dispersal in extreme conditions.
C1 [Goncalves, Vivian N.; Ferreira, Mariana C.; Soares, Marco Aurelio; Kroon, Erna G.; Rosa, Carlos A.; Rosa, Luiz H.] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Oliveira, Fabio S.] Univ Fed Minas Gerais, Dept Geog, Belo Horizonte, MG, Brazil.
   [Cantrell, Charles L.; Wedge, David E.] USDA ARS, Nat Prod Utilizat Res Unit, Oxford, MS USA.
   [Jacob, Melissa R.] Univ Mississippi, Natl Ctr Nat Prod Res, Oxford, MS USA.
   [Galante, Douglas] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Luz Sincrotron, Campinas, SP, Brazil.
   [Rodrigues, Fabio] Univ Sao Paulo, Inst Quim, Sao Paulo, SP, Brazil.
   [Alves, Tania M. A.; Zani, Carlos L.; Junior, Policarpo A. S.; Murta, Silvane; Romanha, Alvaro J.; Barbosa, Emerson C.; Oliveira, Jaquelline G.] FIOCRUZ MG, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Romanha, Alvaro J.] Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitolo, Florianopolis, SC, Brazil.
   [Gomez-Silva, Benito; Galetovic, Alexandra] Univ Antofagasta, Biomed Dept, Antofagasta, Chile.
   [Gomez-Silva, Benito; Galetovic, Alexandra] Univ Antofagasta, Ctr Biotechnol & Bioengn CeBiB, Antofagasta, Chile.
RP Rosa, LH (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM lhrosa@icb.ufmg.br
RI GOMEZ-SILVA, BENITO/J-8324-2017; Kroon, Erna Geessien/B-3631-2015;
   Galante, Douglas/G-8752-2011; Zani, Carlos L/A-9658-2008; Kroon,
   Erna/V-5444-2019; Gomez-Silva, Benito/AAT-8215-2020
OI Kroon, Erna Geessien/0000-0003-2721-3826; Galante,
   Douglas/0000-0002-3265-2527; Zani, Carlos L/0000-0003-1859-177X;
   Gomez-Silva, Benito/0000-0002-7611-9943
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [Universal 471721/2013-1]; CNPq (INCT Criosfera)National Council for
   Scientific and Technological Development (CNPq); CNPq PROANTARNational
   Council for Scientific and Technological Development (CNPq)
   [407230/2013-0]; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [0050-13]; FapespFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2012/18936-0]; CAPESCAPES [23038.003478/2013-92]; FINEPCiencia
   Tecnologia e Inovacao (FINEP) [2084/07]; PDTIS FIOCRUZ; NIH, NIAID,
   Division of AIDSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI 27094]; USDA Agricultural
   Research ServiceUnited States Department of Agriculture (USDA)USDA
   Agricultural Research Service [58-6408-1-603]; CODEI [5394]; CeBiB
   [FB0001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI027094, R01AI027094, R01AI027094, R01AI027094,
   R01AI027094, R01AI027094, R01AI027094, R01AI027094, R01AI027094,
   R01AI027094, R01AI027094, R01AI027094, R01AI027094, R01AI027094,
   R01AI027094, R01AI027094, R01AI027094, R01AI027094, R01AI027094,
   R01AI027094, R01AI027094, R01AI027094, R01AI027094, R01AI027094,
   R01AI027094] Funding Source: NIH RePORTER
FX We acknowledge the financial support from CNPq (Universal 471721/2013-1
   and INCT Criosfera), CNPq PROANTAR 407230/2013-0, FAPEMIG (0050-13),
   Fapesp 2012/18936-0, CAPES (23038.003478/2013-92), FINEP (2084/07),
   PDTIS FIOCRUZ, NIH, NIAID, Division of AIDS Grant No. AI 27094 and the
   USDA Agricultural Research Service Specific Cooperative Agreement No.
   58-6408-1-603. Dr. B. Gomez-Silva and Dr. A. Galetovic were supported by
   CODEI 5394 and CeBiB FB0001. There is no conflict of interest among the
   authors. The authors thank Mr. Solomon Green III, Ms. J.L. Robertson,
   Mrs. R. Pace, Mrs. Amber Reichley and Ms. Marsha Wright for technical
   assistance.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Azua-Bustos A, 2012, FEBS LETT, V586, P2939, DOI 10.1016/j.febslet.2012.07.025
   Barrs VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064871
   Betancur-Galvis LA, 1999, MEM I OSWALDO CRUZ, V94, P531, DOI 10.1590/S0074-02761999000400019
   Bills G.F., 1993, U.S. Patent, Patent No. [5,183,826, 5183826]
   Burford EP, 2003, MINERAL MAG, V67, P1127, DOI 10.1180/0026461036760154
   Burford Euan P., 2003, Mycologist, V17, P98, DOI 10.1017/S0269915X03003112
   Buttachon S, 2012, TETRAHEDRON, V68, P3253, DOI 10.1016/j.tet.2012.02.024
   Callahan HL, 1997, ANTIMICROB AGENTS CH, V41, P818, DOI 10.1128/AAC.41.4.818
   Cantrell CL, 2008, J AGR FOOD CHEM, V56, P5062, DOI 10.1021/jf8008662
   Cantrell CL, 1999, PLANTA MED, V65, P732, DOI 10.1055/s-1999-14053
   Carvalho CR, 2012, SYMBIOSIS, V57, P95, DOI 10.1007/s13199-012-0182-2
   Clarke JDA, 2006, GEOMORPHOLOGY, V73, P101, DOI 10.1016/j.geomorph.2005.06.008
   Conley CA, 2006, ASTROBIOLOGY, V6, P521, DOI 10.1089/ast.2006.6.521
   Crits-Christoph A, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-28
   DIAKUMAKU E, 1995, SCI TOTAL ENVIRON, V167, P295, DOI 10.1016/0048-9697(95)04590-W
   Eamvijarn A, 2013, TETRAHEDRON, V69, P8583, DOI 10.1016/j.tet.2013.07.078
   Eamvijarn A, 2012, PLANTA MED, V78, P1767, DOI 10.1055/s-0032-1315301
   Egidi E, 2014, FUNGAL DIVERS, V65, P127, DOI 10.1007/s13225-013-0277-y
   Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998
   Frisvad JC, 2004, STUD MYCOL, P23
   Furbino LE, 2014, MICROB ECOL, V67, P775, DOI 10.1007/s00248-014-0374-9
   Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001
   GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995
   Godinho VM, 2013, ISME J, V7, P1434, DOI 10.1038/ismej.2013.77
   Gomez-Silva B., 2010, ASTROBIOLOGY EMERGEN, P199
   Gueidan C, 2008, STUD MYCOL, P111, DOI 10.3114/sim.2008.61.11
   Gunde-Cimerman N, 2000, FEMS MICROBIOL ECOL, V32, P235
   Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated
   Hartley AJ, 2005, J GEOL SOC LONDON, V162, P421, DOI 10.1144/0016-764904-071
   Hladki AI, 2009, MYCOLOGIA, V101, P733, DOI 10.3852/09-020
   Houbraken J, 2012, PERSOONIA, V29, P78, DOI 10.3767/003158512X660571
   Kirk P, 2008, DICT FUNGI
   Lorch JM, 2013, MYCOLOGIA, V105, P237, DOI 10.3852/12-207
   Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001
   MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757
   Navarro-Gonzalez R, 2003, SCIENCE, V302, P1018, DOI 10.1126/science.1089143
   NCCLS, 2006, NATL COMMITTEE CLIN, V26, P2
   NCCLS, 2003, NATL COMMITTEE CLIN, V23, P18
   NCCLS, 2002, NATL COMMITTEE CLIN, V22, P15
   NCCLS, 2002, NATL COMM CLIN LAB S, V22, P16
   NELSON PE, 1994, CLIN MICROBIOL REV, V7, P479, DOI 10.1128/CMR.7.4.479-504.1994
   Ortiz R, 2014, INT BIODETER BIODEGR, V86, P309, DOI 10.1016/j.ibiod.2013.10.002
   Paramo-Aguilera L, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue4-fulltext-6
   Pimentel F, 1976, EST ATAC, V4, P3
   Pohl C.H., 2011, MICROBIOLOGY BOOK SE, V3, P61
   Quang DN, 2005, PLANTA MED, V71, P1058, DOI 10.1055/s-2005-873129
   Romanha AJ, 2010, MEM I OSWALDO CRUZ, V105, P233, DOI 10.1590/S0074-02762010000200022
   Rosa LH, 2013, SYMBIOSIS, V60, P133, DOI 10.1007/s13199-013-0249-8
   Rosa LH, 2009, POLAR BIOL, V32, P161, DOI 10.1007/s00300-008-0515-z
   Ruibal C, 2009, STUD MYCOL, P123, DOI 10.3114/sim.2009.64.06
   Seifert KA, 2004, CAN J BOT, V82, P914, DOI [10.1139/B04-070, 10.1139/b04-070]
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tang Y, 2012, CAN J MICROBIOL, V58, P685, DOI [10.1139/w2012-042, 10.1139/W2012-042]
   Warren-Rhodes KA, 2006, MICROB ECOL, V52, P389, DOI 10.1007/s00248-006-9055-7
   White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1
   Woudenberg JHC, 2013, STUD MYCOL, P171, DOI 10.3114/sim0015
   Yaguchi T, 2012, J FOOD PROTECT, V75, P1806, DOI 10.4315/0362-028X.JFP-12-060
   Yang SS, 2010, PLANTA MED, V76, P1701, DOI 10.1055/s-0030-1249907
   Zalar P, 2007, STUD MYCOL, P157, DOI 10.3114/sim.2007.58.06
   Zanettin B, 1989, CLASSIFICATION IGNEO
   Zotti M, 2010, MED MYCOL, V48, P656, DOI 10.3109/13693780903420641
NR 62
TC 32
Z9 33
U1 1
U2 38
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-2912
EI 1462-2920
J9 ENVIRON MICROBIOL
JI Environ. Microbiol.
PD JAN
PY 2016
VL 18
IS 1
BP 232
EP 245
DI 10.1111/1462-2920.13005
PG 14
WC Microbiology
SC Microbiology
GA DE5LN
UT WOS:000370672600019
PM 26235221
DA 2020-11-30
ER

PT J
AU Rodrigues, RAL
   Silva, LKD
   Dornas, FP
   de Oliveira, DB
   Magalhaes, TFF
   Santos, DA
   Costa, AO
   Farias, LD
   Magalhaes, PP
   Bonjardim, CA
   Kroon, EG
   La Scola, B
   Cortines, JR
   Abrahao, JS
AF Lima Rodrigues, Rodrigo Araujo
   dos Santos Silva, Ludmila Karen
   Dornas, Fabio Pio
   de Oliveira, Danilo Bretas
   Ferreira Magalhaes, Thais Furtado
   Santos, Daniel Assis
   Costa, Adriana Oliveira
   Farias, Luiz de Macedo
   Magalhaes, Paula Prazeres
   Bonjardim, Claudio Antonio
   Kroon, Erna Geessien
   La Scola, Bernard
   Cortines, Juliana Reis
   Abrahao, Jonatas Santos
TI Mimivirus Fibrils Are Important for Viral Attachment to the Microbial
   World by a Diverse Glycoside Interaction Repertoire
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID ACANTHAMOEBA-CASTELLANII; GIANT MIMIVIRUS; 1ST ISOLATION; VIRUS;
   PNEUMONIA; GENOME; WILD; PATIENT; AMAZON; CELL
AB Acanthamoeba polyphaga mimivirus (APMV) is a giant virus from the Mimiviridae family. It has many unusual features, such as a pseudoicosahedral capsid that presents a starfish shape in one of its vertices, through which the similar to 1.2-Mb double-stranded DNA is released. It also has a dense glycoprotein fibril layer covering the capsid that has not yet been functionally characterized. Here, we verified that although these structures are not essential for viral replication, they are truly necessary for viral adhesion to amoebae, its natural host. In the absence of fibrils, APMV had a significantly lower level of attachment to the Acanthamoeba castellanii surface. This adhesion is mediated by glycans, specifically, mannose and N-acetylglucosamine (a monomer of chitin and peptidoglycan), both of which are largely distributed in nature as structural components of several organisms. Indeed, APMV was able to attach to different organisms, such as Gram-positive bacteria, fungi, and arthropods, but not to Gram-negative bacteria. This prompted us to predict that (i) arthropods, mainly insects, might act as mimivirus dispersers and (ii) by attaching to other microorganisms, APMV could be ingested by amoebae, leading to the successful production of viral progeny. To date, this mechanism has never been described in the virosphere.
   IMPORTANCE
   APMV is a giant virus that is both genetically and structurally complex. Its size is similar to that of small bacteria, and it replicates inside amoebae. The viral capsid is covered by a dense glycoprotein fibril layer, but its function has remained unknown, until now. We found that the fibrils are not essential for mimivirus replication but that they are truly necessary for viral adhesion to the cell surface. This interaction is mediated by glycans, mainly N-acetylglucosamine. We also verified that APMV is able to attach to bacteria, fungi, and arthropods. This indicates that insects might act as mimivirus dispersers and that adhesion to other microorganisms could facilitate viral ingestion by amoebae, a mechanism never before described in the virosphere.
C1 [Lima Rodrigues, Rodrigo Araujo; dos Santos Silva, Ludmila Karen; Dornas, Fabio Pio; de Oliveira, Danilo Bretas; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, ICB, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Ferreira Magalhaes, Thais Furtado; Santos, Daniel Assis] Univ Fed Minas Gerais, ICB, Dept Microbiol, Lab Micol, Belo Horizonte, MG, Brazil.
   [Farias, Luiz de Macedo; Magalhaes, Paula Prazeres] Univ Fed Minas Gerais, ICB, Dept Microbiol, Lab Microbiol Oral & Anaerobios, Belo Horizonte, MG, Brazil.
   [Costa, Adriana Oliveira] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil.
   [Cortines, Juliana Reis] Ctr Ciencias Saude, Dept Virol, Inst Microbiol Paulo de Goes, Ilha Fundao, Rio De Janeiro, RJ, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, URMITE CNRS UMR IRD 3R198 6236, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, ICB, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Dornas, Fabio/AAI-3582-2020; LA SCOLA, Bernard/P-6477-2016; Cortines,
   Juliana/V-3997-2019; Costa, Adriana Oliveira/AAD-3037-2020; Kroon,
   Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Dornas, Fabio/0000-0001-7926-5551; LA SCOLA,
   Bernard/0000-0001-8006-7704; Kroon, Erna Geessien/0000-0003-2721-3826;
   Santos, Daniel Assis/0000-0002-1108-5666; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012; Cortines, Juliana/0000-0003-2481-9267
FU CNPqNational Council for Scientific and Technological Development (CNPq)
FX We thank our colleagues from Gepvig and the Laboratorio de Virus for
   their excellent technical support. We thank CNPq for scholarship and the
   Center of Microscopy of UFMG. We thank Alvaro Eiras, UFMG, for the
   donation of mosquitoes. We also thank Daniel Heisey, Virginia
   Commonwealth University School of Medicine, for English corrections.
CR Abrahao JS, 2014, J VIROL METHODS, V207, P6, DOI 10.1016/j.jviromet.2014.06.001
   Andrade KR, 2015, ARCH VIROL, V160, P477, DOI 10.1007/s00705-014-2257-2
   Boughalmi M, 2013, VIRUSES-BASEL, V5, P2920, DOI 10.3390/v5122920
   Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108
   Campos RK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-95
   Dornas FP, 2014, EMERG INFECT DIS, V20, P469, DOI 10.3201/eid2003.131050
   Elloway EAG, 2004, J APPL MICROBIOL, V97, P1319, DOI 10.1111/j.1365-2672.2004.02430.x
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   Kuznetsov YG, 2010, VIROLOGY, V404, P127, DOI 10.1016/j.virol.2010.05.007
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2014, MICROB PATHOGENESIS, V77, P131, DOI 10.1016/j.micpath.2014.09.005
   Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x
   Lease HM, 2010, J MORPHOL, V271, P759, DOI 10.1002/jmor.10835
   Legendre M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-99
   Otta DA, 2012, PARASITOL RES, V111, P2017, DOI 10.1007/s00436-012-3050-3
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   Raoult D, 2007, CLIN INFECT DIS, V45, P95, DOI 10.1086/518608
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Saadi H, 2013, INTERVIROLOGY, V56, P424, DOI 10.1159/000354564
   Saadi H, 2013, CLIN INFECT DIS, V57, pE127, DOI 10.1093/cid/cit354
   SHARON N, 1984, IMMUNOL TODAY, V5, P143, DOI 10.1016/0167-5699(84)90237-8
   Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6
   Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414
   Sobhy H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00345
   Steenbergen JN, 2004, INFECT IMMUN, V72, P3478, DOI 10.1128/IAI.72.6.3478-3488.2004
   Verhoeven AB, 2010, BIOL BULL-US, V219, P178, DOI 10.1086/BBLv219n2p178
   Weiss IM, 2012, Z KRIST-CRYST MATER, V227, P723, DOI 10.1524/zkri.2012.1530
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114
NR 29
TC 28
Z9 29
U1 0
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2015
VL 89
IS 23
BP 11812
EP 11819
DI 10.1128/JVI.01976-15
PG 8
WC Virology
SC Virology
GA CZ1WM
UT WOS:000366896600007
PM 26378162
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Costa, GB
   Borges, IA
   Alves, PA
   Miranda, JB
   Luiz, APMF
   Ferreira, PCP
   Abrahao, JS
   Moreno, EC
   Kroon, EG
   Trindade, GD
AF Costa, Galileu B.
   Borges, Iara A.
   Alves, Pedro A.
   Miranda, Julia B.
   Luiz, Ana Paula M. F.
   Ferreira, Paulo C. P.
   Abrahao, Jonatas S.
   Moreno, Elizabeth C.
   Kroon, Erna G.
   Trindade, Giliane de Souza
TI Alternative Routes of Zoonotic Vaccinia Virus Transmission, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID SMALLPOX; OUTBREAK
C1 [Costa, Galileu B.; Borges, Iara A.; Alves, Pedro A.; Miranda, Julia B.; Luiz, Ana Paula M. F.; Ferreira, Paulo C. P.; Abrahao, Jonatas S.; Kroon, Erna G.; Trindade, Giliane de Souza] Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil.
   [Moreno, Elizabeth C.] Fundacao Hennominas, Belo Horizonte, MG, Brazil.
RP Trindade, GD (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM giliane@icb.ufmg.br
RI Alves, Pedro/T-7203-2019; Moreno, Elizabeth/X-5554-2018; Miranda,
   Julia/N-6480-2019; Costa, Galileu Barbosa/M-5768-2019; Kroon,
   Erna/V-5444-2019; Kroon, Erna/B-3631-2015
OI Alves, Pedro/0000-0002-9659-5621; Moreno, Elizabeth/0000-0002-8434-2483;
   Kroon, Erna/0000-0003-2721-3826; Barbosa Costa,
   Galileu/0000-0001-7360-6722
CR Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324
   Assis FL, 2013, EMERG INFECT DIS, V19, P2045, DOI 10.3201/eid1912.120937
   Gallwitz S, 2003, J CLIN MICROBIOL, V41, P4068, DOI 10.1128/JCM.41.9.4068-4070.2003
   Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917
   Inoshima Y, 2000, J VIROL METHODS, V84, P201, DOI 10.1016/S0166-0934(99)00144-5
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Lederman E, 2009, VACCINE, V27, P375, DOI 10.1016/j.vaccine.2008.11.019
   de Oliveira TML, 2010, FOODBORNE PATHOG DIS, V7, P1491, DOI 10.1089/fpd.2010.0597
   Oliveira GP, 2014, AM J TROP MED HYG, V90, P1021, DOI 10.4269/ajtmh.13-0621
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
NR 10
TC 6
Z9 6
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2015
VL 21
IS 12
BP 2244
EP 2246
DI 10.3201/eid2112.141249
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CX1MT
UT WOS:000365461000032
PM 26583465
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Boratto, PVM
   Arantes, TS
   Silva, LCF
   Assis, FL
   Kroon, EG
   La Scola, B
   Abrahao, JS
AF Boratto, Paulo V. M.
   Arantes, Thalita S.
   Silva, Lorena C. F.
   Assis, Felipe L.
   Kroon, Erna G.
   La Scola, Bernard
   Abrahao, Jonatas S.
TI Niemeyer Virus: A New Mimivirus Group A Isolate Harboring a Set of
   Duplicated Aminoacyl-tRNA Synthetase Genes
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Mimiviridae; Niemeyer virus; aminoacyl-tRNA synthetase; gene
   duplication; giant virus isolation
AB It is well recognized that gene duplication/acquisition is a key factor for molecular evolution, being directly related to the emergence of new genetic variants. The importance of such phenomena can also be expanded to the viral world, with impacts on viral fitness and environmental adaptations. In this work we describe the isolation and characterization of Niemeyer virus, a new mimivirus isolate obtained from water samples of an urban lake in Brazil. Genomic data showed that Niemeyer harbors duplicated copies of three of its four aminoacyl-tRNA synthetase genes (cysteinyl, methionyl, and tyrosyl RS). Gene expression analysis showed that such duplications allowed significantly increased expression of methionyl and tyrosyl aaRS mRNA by Niemeyer in comparison to APMV. Remarkably, phylogenetic data revealed that Niemeyer duplicated gene pairs are different, each one clustering with a different group of mimivirus strains. Taken together, our results raise new questions about the origins and selective pressures involving events of aaRS gain and loss among mimiviruses.
C1 [Boratto, Paulo V. M.; Arantes, Thalita S.; Silva, Lorena C. F.; Assis, Felipe L.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, URMITE CNRS UMR IRD 3R198 6236, Marseille, France.
RP La Scola, B (corresponding author), Aix Marseille Univ, URMITE CNRS UMR IRD 3R198 6236, Marseille, France.
EM bernard.la-scola@univ-amu.fr; jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826
CR Abrahao JS, 2014, J VIROL METHODS, V207, P6, DOI 10.1016/j.jviromet.2014.06.001
   Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Boughalmi M, 2013, ENVIRON MICROBIOL, V15, P2000, DOI 10.1111/1462-2920.12068
   Campos RK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-95
   Dornas FP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087811
   Gaia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061912
   Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956
   Konstantinidis KT, 2014, MICROBE, V9, P111, DOI [10.1128/microbe.9.111.1, DOI 10.1128/MICR0BE.9.111.1]
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   Shackelton LA, 2004, TRENDS MICROBIOL, V12, P458, DOI 10.1016/j.tim.2004.08.005
   Silva LCF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00539
   Simon-Loriere E, 2013, MOL BIOL EVOL, V30, P1916, DOI 10.1093/molbev/mst094
   Suhre K, 2005, J VIROL, V79, P14095, DOI 10.1128/JVI.79.22.14095-14101.2005
   Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109
   Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-51
   Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223
   Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8
NR 19
TC 17
Z9 18
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD NOV 10
PY 2015
VL 6
AR 1256
DI 10.3389/fmicb.2015.01256
PG 11
WC Microbiology
SC Microbiology
GA VF6TC
UT WOS:000443402200001
PM 26635738
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Assis, FL
   Franco-Luiz, APM
   Paim, LM
   Oliveira, GP
   Pereira, AF
   de Almeida, GMF
   Figueiredo, LB
   Tanus, A
   Trindade, GS
   Ferreira, PP
   Kroon, EG
   Abrahao, JS
AF Assis, Felipe L.
   Franco-Luiz, Ana Paula M.
   Paim, Luis M.
   Oliveira, Graziele P.
   Pereira, Alexandre F.
   de Almeida, Gabriel M. F.
   Figueiredo, Leandra B.
   Tanus, Adriano
   Trindade, Giliane S.
   Ferreira, Paulo P.
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI Horizontal study of vaccinia virus infections in an endemic area:
   epidemiologic, phylogenetic and economic aspects
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID POXVIRUS; SMALLPOX
AB Vaccinia virus (VACV), the etiological agent of bovine vaccinia (BV), is widespread in Brazil and present in most of the milk-producing regions. We conducted a horizontal study of BV in Bahia, a state of Brazil in which the production of milk is increasing. During 2011, human and bovine clinical samples were collected during outbreaks for BV diagnosis, virus isolation and molecular analysis. We collected data for epidemiological inferences. Vaccinia virus was detected in 87.7 % of the analyzed outbreaks, highlighting the effective circulation of VACV in Bahia. The molecular data showed the spreading of group 1 Brazilian VACV to Bahia. We observed a seasonal profile of BV, with its peak in the drier and cooler season. Manual milking was observed in 96 % of the visited properties, showing its importance to viral spread in herds. Under-notification of BV, ineffective animal trade surveillance, and bad milking practices have contributed to the spread of VACV in Brazil.
C1 [Assis, Felipe L.; Franco-Luiz, Ana Paula M.; Oliveira, Graziele P.; Pereira, Alexandre F.; de Almeida, Gabriel M. F.; Figueiredo, Leandra B.; Trindade, Giliane S.; Ferreira, Paulo P.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Paim, Luis M.; Tanus, Adriano] Agencia Estadual Def Agr Bahia, Anim Def Div, BR-46830000 Salvador, BA, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Inst Ciencias Biol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna Geessien/B-3631-2015; Almeida, Gabriel MF/I-8910-2012;
   Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Almeida, Gabriel
   MF/0000-0003-2317-5092; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA); Pro-Reitoria de Pesquisa
   da Universidade Federal de Minas Gerais (PRPq-UFMG)
FX We thank our colleagues from the Laboratorio de Virus for their
   excellent technical support. Financial support was provided by the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG),
   Ministerio da Agricultura, Pecuaria e Abastecimento (MAPA), and
   Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais
   (PRPq-UFMG). E.G. Kroon, G.S. Trindade and P.C.P. Ferreira are
   researchers from CNPq.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, VIROL J, V6, P1
   Assis FL, 2012, EMERG INFECT DIS, V18, P2035, DOI 10.3201/eid1812.120145
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   Buchen-Osmond C, 2013, ICTVDB UNIVERSAL VIR
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   Moss B, 2007, FIELDS VIROLOGY, P2906
   OBRIEN TC, 1971, APPL MICROBIOL, V21, P968, DOI 10.1128/AEM.21.5.968-970.1971
   Quixabeira-Santos JC, 2011, EMERG INFECT DIS, V17, P726, DOI 10.3201/eid1704.101581
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
NR 15
TC 6
Z9 7
U1 0
U2 1
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD NOV
PY 2015
VL 160
IS 11
BP 2703
EP 2708
DI 10.1007/s00705-015-2549-1
PG 6
WC Virology
SC Virology
GA CZ0ON
UT WOS:000366805400005
PM 26239343
DA 2020-11-30
ER

PT J
AU Borges, IA
   McCollum, AM
   Kroon, EG
   Trindade, GD
   Reynolds, MG
AF Borges, Iara A.
   McCollum, Andrea M.
   Kroon, Erna G.
   Trindade, Giliane D.
   Reynolds, Mary G.
TI INFLUENCE OF DAIRY PRODUCTION PRACTICES ON RISKS FOR BOVINE VACCINIA
   EXPOSURE IN CATTLE: BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Borges, Iara A.; Kroon, Erna G.; Trindade, Giliane D.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [McCollum, Andrea M.; Reynolds, Mary G.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2015
VL 93
IS 4
SU S
MA 1114
BP 340
EP 340
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA VB0ZJ
UT WOS:000412844103109
DA 2020-11-30
ER

PT J
AU Figueiredo, PD
   da Silva-Fernandes, AT
   Mota, BEF
   Costa, GB
   Borges, IA
   Ferreira, PCP
   Jonatas, SA
   Braga, EM
   Kroon, EG
   Trindade, GD
AF Figueiredo, Poliana de Oliveira
   da Silva-Fernandes, Andre Tavares
   Fernandes Mota, Bruno Eduardo
   Costa, Galileu Barbosa
   Borges, Iara Apolinario
   Peregrino Ferreira, Paulo Cesar
   Abrahao, Jonatas Santos
   Braga, Erika Martins
   Kroon, Erna Geesien
   Trindade, Giliane de Souza
TI Evaluating anti-Orthopoxvirus antibodies in individuals from Brazilian
   rural areas prior to the bovine vaccinia era
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Orthopoxvirus; smallpox vaccine; bovine vaccinia; retrospective
   serosurvey
ID SMALLPOX VACCINATION; CLINICAL DESCRIPTION; ANTIVIRAL IMMUNITY; VIRUS;
   CATTLE; INFECTION; OUTBREAKS; EXPOSURE; DISEASE; HUMANS
AB Vaccinia virus naturally circulates in Brazil and is the causative agent of a zoonotic disease known as bovine vaccinia (BV). We retrospectively evaluated two populations from the Amazon and Southeast Regions. BV outbreaks had not been reported in these regions before sample collection. Neutralising antibodies were found in 13 individuals (n = 132) with titres ranging from 100 = 6,400 neutralising units/mL. Univariate analysis identified age and vaccination as statistically significant risk factors in individuals from the Southeast Region. The absence of detectable antibodies in vaccinated individuals raises questions about the protection of smallpox vaccine years after vaccination and reinforces the need for surveillance of Orthopoxvirus in Brazilian populations without evidence of previous outbreaks.
C1 [Figueiredo, Poliana de Oliveira; da Silva-Fernandes, Andre Tavares; Fernandes Mota, Bruno Eduardo; Costa, Galileu Barbosa; Borges, Iara Apolinario; Peregrino Ferreira, Paulo Cesar; Abrahao, Jonatas Santos; Kroon, Erna Geesien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
   [Braga, Erika Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Malaria, Belo Horizonte, MG, Brazil.
RP Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
EM giliane@icb.ufmg.br
RI Costa, Galileu Barbosa/M-5768-2019; Braga, Erika M/A-6776-2008; Kroon,
   Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Braga, Erika M/0000-0001-5550-7157; Kroon, Erna
   Geessien/0000-0003-2721-3826; Barbosa Costa,
   Galileu/0000-0001-7360-6722; Mota, Bruno/0000-0003-0348-4875
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); PRPq-UFMG
FX CNPq, CAPES, FAPEMIG, PRPq-UFMG GST, PCPF, EMB and EGK are researchers
   from CNPq.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2010, J CLIN VIROL, V48, P69, DOI 10.1016/j.jcv.2010.02.001
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Braga EM, 1998, J INFECT DIS, V177, P1132, DOI 10.1086/517412
   Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461
   Costa GB, 2013, VACCINE, V31, P4706, DOI [10.1016/j.vac, 10.1016/j.vaccine.2013.08.023]
   da Fonseca FG, 2011, FUTURE VIROL, V6, P697, DOI 10.2217/FVL.11.46
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I, 2013, FIELDS VIROLOGY, P2160
   Damon IK, 2011, VACCINE, V29, pD54, DOI 10.1016/j.vaccine.2011.04.014
   de Assis FL, 2013, EMERG INFECT DIS, V19, P2017, DOI 10.3201/eid1912.130589
   de Sant'Ana FJF, 2013, J VET DIAGN INVEST, V25, P267, DOI 10.1177/1040638713475799
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917
   Hatakeyama S, 2005, CLIN DIAGN LAB IMMUN, V12, P520, DOI 10.1128/CDLI.12.4.520-524.2005
   Kennedy RB, 2009, VACCINE, V27, P3319, DOI 10.1016/j.vaccine.2009.01.086
   Kim SH, 2007, CLIN MICROBIOL INFEC, V13, P91, DOI 10.1111/j.1469-0691.2006.01576.x
   Cono Joanne, 2003, MMWR Recomm Rep, V52, P1
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Lederman ER, 2007, AM J TROP MED HYG, V77, P1150, DOI 10.4269/ajtmh.2007.77.1150
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   Macneil Adam, 2011, BMC Res Notes, V4, P465, DOI 10.1186/1756-0500-4-465
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Newman FK, 2003, J CLIN MICROBIOL, V41, P3154, DOI 10.1128/JCM.41.7.3154-3157.2003
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Reynolds MG, 2010, AM J TROP MED HYG, V82, P746, DOI 10.4269/ajtmh.2010.09-0716
   Schatzmayr HG, 2011, VACCINE, V29, pD65, DOI 10.1016/j.vaccine.2011.09.105
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   SILVA P L D, 1986, Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, V38, P323
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Singh RK, 2012, INDIAN J VIROL, V23, P1, DOI 10.1007/s13337-012-0068-1
   Storch GA, 2013, FIELDS VIROLOGY, P414
   Taub DD, 2008, AM J MED, V121, P1058, DOI 10.1016/j.amjmed.2008.08.019
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Vora NM, 2015, NEW ENGL J MED, V372, P1223, DOI 10.1056/NEJMoa1407647
NR 41
TC 3
Z9 5
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2015
VL 110
IS 6
BP 804
EP 808
DI 10.1590/0074-02760150215
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CV7BW
UT WOS:000364428100015
PM 26517662
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Aguiar, ERGR
   Olmo, RP
   Paro, S
   Ferreira, FV
   de Faria, IJD
   Todjro, YMH
   Lobo, FP
   Kroon, EG
   Meignin, C
   Gatherer, D
   Imler, JL
   Marques, JT
AF Guimaraes Rocha Aguiar, Eric Roberto
   Olmo, Roenick Proveti
   Paro, Simona
   Ferreira, Flavia Viana
   da Silva de Faria, Isaque Joao
   Honore Todjro, Yaovi Mathias
   Lobo, Francisco Pereira
   Kroon, Erna Geessien
   Meignin, Carine
   Gatherer, Derek
   Imler, Jean-Luc
   Marques, Joao Trindade
TI Sequence-independent characterization of viruses based on the pattern of
   viral small RNAs produced by the host
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID ANTIVIRAL IMMUNITY; GENOME SEQUENCE; AEDES-AEGYPTI; METAGENOMIC
   ANALYSIS; ENDOGENOUS SIRNAS; INTERFERENCE; DROSOPHILA; SUPPRESSION;
   INFECTION; DISCOVERY
AB Virus surveillance in vector insects is potentially of great benefit to public health. Large-scale sequencing of small and long RNAs has previously been used to detect viruses, but without any formal comparison of different strategies. Furthermore, the identification of viral sequences largely depends on similarity searches against reference databases. Here, we developed a sequence-independent strategy based on virus-derived small RNAs produced by the host response, such as the RNA interference pathway. In insects, we compared sequences of small and long RNAs, demonstrating that viral sequences are enriched in the small RNA fraction. We also noted that the small RNA size profile is a unique signature for each virus and can be used to identify novel viral sequences without known relatives in reference databases. Using this strategy, we characterized six novel viruses in the viromes of laboratory fruit flies and wild populations of two insect vectors: mosquitoes and sandflies. We also show that the small RNA profile could be used to infer viral tropism for ovaries among other aspects of virus biology. Additionally, our results suggest that virus detection utilizing small RNAs can also be applied to vertebrates, although not as efficiently as to plants and insects.
C1 [Guimaraes Rocha Aguiar, Eric Roberto; Olmo, Roenick Proveti; da Silva de Faria, Isaque Joao; Honore Todjro, Yaovi Mathias; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Guimaraes Rocha Aguiar, Eric Roberto; Olmo, Roenick Proveti; Paro, Simona; Meignin, Carine; Imler, Jean-Luc] CNRS, Inst Biol Mol & Cellulaire, UPR9022, F-67084 Strasbourg, France.
   [Ferreira, Flavia Viana; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Lobo, Francisco Pereira] Embrapa Informat Agr, Lab Multiusuario Bioinformat, BR-13083886 Sao Paulo, Brazil.
   [Meignin, Carine; Imler, Jean-Luc] Univ Strasbourg, Fac Sci, F-67083 Strasbourg, France.
   [Gatherer, Derek] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England.
   [Imler, Jean-Luc] Univ Strasbourg USIAS, Inst Etud Avancees, F-67084 Strasbourg, France.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Aguiar, Eric/T-5076-2019; Kroon, Erna/V-5444-2019; Marques, Joao
   T/F-7683-2012; Olmo, Roenick/AAF-6412-2020; Kroon, Erna
   Geessien/B-3631-2015; Aguiar, Eric RGR/L-7989-2018
OI Aguiar, Eric/0000-0002-8143-5756; Marques, Joao T/0000-0002-3457-3320;
   Kroon, Erna Geessien/0000-0003-2721-3826; Aguiar, Eric
   RGR/0000-0002-8143-5756; Gatherer, Derek/0000-0002-7385-5734
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [478986/2010-6, 590069/2011-0, 400648/2013-0, 473092/2013-1];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG) [CBB -
   APQ-01228-11, CBB-APQ-00239-14]; Agence Nationale de la RechercheFrench
   National Research Agency (ANR) [ANR-11-ASV3-002]; Investissement
   d'Avenir ProgramsFrench National Research Agency (ANR) [ANR-10-LABX-36,
   ANR-11-EQPX-0022]; National Institute of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1
   AI070167]; CAPESCAPES; CNPqNational Council for Scientific and
   Technological Development (CNPq); NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167] Funding
   Source: NIH RePORTER
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   [478986/2010-6; 590069/2011-0; 400648/2013-0; 473092/2013-1];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [CBB -
   APQ-01228-11; CBB-APQ-00239-14] (to J.T.M. and E.G.K.); Agence Nationale
   de la Recherche [ANR-11-ASV3-002]; Investissement d'Avenir Programs
   [ANR-10-LABX-36; ANR-11-EQPX-0022]; National Institute of Health [PO1
   AI070167] (to J.L.I.). E.R.G.R.A, R.P.O., F.V.F., I.J.S.F. and Y.M.H.T.
   received fellowships from CAPES and CNPq. Funding for open access
   charge: CAPES and CNPq.
CR Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   Adelman ZN, 2012, INSECT MOL BIOL, V21, P357, DOI 10.1111/j.1365-2583.2012.01141.x
   Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Ambrose RL, 2009, J GEN VIROL, V90, P2191, DOI 10.1099/vir.0.012104-0
   Arensburger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-606
   Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Cao MJ, 2014, P NATL ACAD SCI USA, V111, P14613, DOI 10.1073/pnas.1407131111
   Cook S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080720
   Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264
   Eddy Sean R, 2009, Genome Inform, V23, P205
   Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Girardi E, 2013, MBIO, V4, DOI 10.1128/mBio.00698-13
   Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Josset L, 2014, RNA BIOL, V11, P875, DOI 10.4161/rna.29442
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024
   Ladner J. T., 2014, MBIO, V5
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lepore LS, 1996, J INVERTEBR PATHOL, V68, P131, DOI 10.1006/jipa.1996.0070
   Li CX, 2015, ELIFE, V4, DOI 10.7554/eLife.05378
   Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758
   Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930
   Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040
   Marques J, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/712603
   Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004
   Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkt263]
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Mulder Nicola, 2007, V396, P59
   Munnink BBO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078454
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786
   Peng X, 2011, MBIO, V2
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120
   Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14
   Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163
   Vijayakumar K, 2013, SE ASIAN J TROP MED, V44, P54
   Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wang P, 2001, ARCH INSECT BIOCHEM, V47, P110, DOI 10.1002/arch.1041
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370
   Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
   Yamao T, 2009, ARCH VIROL, V154, P153, DOI 10.1007/s00705-008-0285-5
   Yan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019148
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 61
TC 52
Z9 53
U1 0
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL 27
PY 2015
VL 43
IS 13
BP 6191
EP 6206
DI 10.1093/nar/gkv587
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CP3JZ
UT WOS:000359776500008
PM 26040701
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Assis, FL
   Bajrai, L
   Abrahao, JS
   Kroon, EG
   Dornas, FP
   Andrade, KR
   Boratto, PVM
   Pilotto, MR
   Robert, C
   Benamar, S
   La Scola, B
   Colson, P
AF Assis, Felipe L.
   Bajrai, Leena
   Abrahao, Jonatas S.
   Kroon, Erna G.
   Dornas, Fabio P.
   Andrade, Ketyllen R.
   Boratto, Paulo V. M.
   Pilotto, Mariana R.
   Robert, Catherine
   Benamar, Samia
   La Scola, Bernard
   Colson, Philippe
TI Pan-Genome Analysis of Brazilian Lineage A Amoebal Mimiviruses
SO VIRUSES-BASEL
LA English
DT Article
DE Mimiviridae; Samba virus; pan-genome; mimivirus; Megavirales; Amazonia
   virus; oyster virus; Kroon virus; genomics
ID GIANT VIRUS; 1ST ISOLATION; MIMIVIRIDAE; GENE; SEQUENCE; WILD
AB Since the recent discovery of Samba virus, the first representative of the family Mimiviridae from Brazil, prospecting for mimiviruses has been conducted in different environmental conditions in Brazil. Recently, we isolated using Acanthamoeba sp. three new mimiviruses, all of lineage A of amoebal mimiviruses: Kroon virus from urban lake water; Amazonia virus from the Brazilian Amazon river; and Oyster virus from farmed oysters. The aims of this work were to sequence and analyze the genome of these new Brazilian mimiviruses (mimi-BR) and update the analysis of the Samba virus genome. The genomes of Samba virus, Amazonia virus and Oyster virus were 97%-99% similar, whereas Kroon virus had a low similarity (90%-91%) with other mimi-BR. A total of 3877 proteins encoded by mimi-BR were grouped into 974 orthologous clusters. In addition, we identified three new ORFans in the Kroon virus genome. Additional work is needed to expand our knowledge of the diversity of mimiviruses from Brazil, including if and why among amoebal mimiviruses those of lineage A predominate in the Brazilian environment.
C1 [Assis, Felipe L.; Abrahao, Jonatas S.; Kroon, Erna G.; Dornas, Fabio P.; Andrade, Ketyllen R.; Boratto, Paulo V. M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [Bajrai, Leena; Robert, Catherine; Benamar, Samia; La Scola, Bernard; Colson, Philippe] Aix Marseille Univ, URMITE, CNRS IRD INSERM U1095 UM63 7278 198, F-13385 Marseille, France.
   [Bajrai, Leena] King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah 21589, Saudi Arabia.
   [Pilotto, Mariana R.] Univ Fed Santa Catarina, Lab Virol Aplicada, Dept Microbiol & Parasitol, Ctr Ciencias Biol, BR-88040900 Florianopolis, SC, Brazil.
   [La Scola, Bernard; Colson, Philippe] Ctr Hosp Univ Timone, Assistance Publ Hop Marseille, Inst Hosp Univ IHU Mediterranee Infect, Pole Malad Infect & Trop Clin & Biol,Federat Bact, F-13385 Marseille, France.
RP Colson, P (corresponding author), Aix Marseille Univ, URMITE, CNRS IRD INSERM U1095 UM63 7278 198, F-13385 Marseille, France.
EM felipelopesassis@gmail.com; leenaasd@gmail.com;
   jonatas.abrahao@gmail.com; ernagkroon@gmail.com; fabiopiod154@gmail.com;
   ketyllen@yahoo.com.br; pvboratto@gmail.com; maryrp@gmail.com;
   catherine.robert@univ-amu.fr; benamarsamia@yahoo.fr;
   bernard.la-scola@univ-amu.fr; philippe.colson@univ-amu.fr
RI Kroon, Erna Geessien/B-3631-2015; LA SCOLA, Bernard/P-6477-2016;
   Pilotto, Mariana/AAY-6486-2020; Colson, Philippe/P-6355-2014; Kroon,
   Erna/V-5444-2019; Dornas, Fabio/AAI-3582-2020
OI Kroon, Erna Geessien/0000-0003-2721-3826; LA SCOLA,
   Bernard/0000-0001-8006-7704; Colson, Philippe/0000-0001-6285-0308;
   Dornas, Fabio/0000-0001-7926-5551; Pilotto, Mariana
   Rangel/0000-0002-3143-0930
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); Pro-Reitoria de Pesquisa da Universidade Federal de Minas
   Gerais (PRPq-UFMG)
FX We thank our colleagues from Gepvig and Laboratorio de Virus of
   Universidade Federal de Minas Gerais and the bioinformatics team of
   URMITE-Aix Marseille Universite for their excellent technical support.
   We would also like to thank CNPq, CAPES, FAPEMIG and Pro-Reitoria de
   Pesquisa da Universidade Federal de Minas Gerais (PRPq-UFMG) for
   financial support.
CR Andrade KR, 2015, ARCH VIROL, V160, P477, DOI 10.1007/s00705-014-2257-2
   Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487
   Boughalmi M, 2013, VIRUSES-BASEL, V5, P2920, DOI 10.3390/v5122920
   Boughalmi M, 2013, ENVIRON MICROBIOL, V15, P2000, DOI 10.1111/1462-2920.12068
   Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530
   Boyer M, 2010, INTERVIROLOGY, V53, P310, DOI 10.1159/000312916
   Campos RK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-95
   Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6
   Colson P, 2013, INTERVIROLOGY, V56, P376, DOI 10.1159/000354558
   Colson P, 2012, INTERVIROLOGY, V55, P321, DOI 10.1159/000336562
   Colson Philippe, 2011, Genome Biol Evol, V3, P737, DOI 10.1093/gbe/evr048
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147
   Dornas FP, 2014, EMERG INFECT DIS, V20, P469, DOI 10.3201/eid2003.131050
   Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107
   Galardini M, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-11
   Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62
   Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124
   Legendre Matthieu, 2012, Commun Integr Biol, V5, P102
   Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12
   Pagnier I, 2013, INTERVIROLOGY, V56, P354, DOI 10.1159/000354556
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   Saadi H, 2013, CLIN INFECT DIS, V57, pE127, DOI 10.1093/cid/cit354
   Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366
   Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108
   Suhre K, 2005, J VIROL, V79, P14095, DOI 10.1128/JVI.79.22.14095-14101.2005
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Williamson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042047
   Yoosuf N, 2014, VIRUS GENES, V48, P218, DOI 10.1007/s11262-013-1016-x
   Yoosuf N, 2014, VIROLOGY, V452, P125, DOI 10.1016/j.virol.2013.12.032
   Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109
   YUTIN N, 2013, VIROL J, V10
NR 40
TC 19
Z9 21
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUL
PY 2015
VL 7
IS 7
BP 3483
EP 3499
DI 10.3390/v7072782
PG 17
WC Virology
SC Virology
GA CQ1JJ
UT WOS:000360353200008
PM 26131958
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Silva, MVCP
   Kroon, EG
   Trindade, FC
   Nogueira, ML
   Bambirra, EA
AF Pereira Silva, Maria Valeria C.
   Kroon, Erna G.
   Trindade, Fernando C.
   Nogueira, Mauricio L.
   Bambirra, Eduardo A.
TI Detection of Human herpes virus 1 (HHV-1) in graft failure corneas: a
   study of 24 cases using polymerase chain reaction (PCR)
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Pereira Silva, Maria Valeria C.] Fed Univ Minas Gerias, Ophthalmol, Belo Horizonte, MG, Brazil.
   [Kroon, Erna G.; Trindade, Fernando C.; Nogueira, Mauricio L.; Bambirra, Eduardo A.] Fed Univ Minas Gerias, Belo Horizonte, MG, Brazil.
RI Nogueira, Mauricio L/B-7599-2012; Kroon, Erna/V-5444-2019
OI Nogueira, Mauricio L/0000-0003-1102-2419; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 1860
PG 2
WC Ophthalmology
SC Ophthalmology
GA CT5WQ
UT WOS:000362882204308
DA 2020-11-30
ER

PT J
AU Degener, CM
   de Azara, TMF
   Roque, RA
   Rosner, S
   Rocha, ESO
   Kroon, EG
   Codeco, CT
   Nobre, AA
   Ohly, JJ
   Geier, M
   Eiras, AE
AF Degener, Carolin Marlen
   Ferreira de Azara, Tatiana Mingote
   Roque, Rosemary Aparecida
   Roesner, Susanne
   Oliveira Rocha, Eliseu Soares
   Kroon, Erna Geessien
   Codeco, Claudia Torres
   Nobre, Aline Araujo
   Ohly, Joerg Johannes
   Geier, Martin
   Eiras, Alvaro Eduardo
TI Mass trapping with MosquiTRAPs does not reduce Aedes aegypti abundance
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE MosquiTRAP; mosquito traps; dengue control; mass trapping; Aedes aegypti
ID AUTOCIDAL GRAVID OVITRAP; DENGUE VECTOR CONTROL; LETHAL OVITRAP;
   FIELD-EVALUATION; DIPTERA; SURVEILLANCE; POPULATIONS; INSECTICIDE;
   STRATEGIES; CULICIDAE
AB The objective of this study was to evaluate the effectiveness of Aedes aegypti mass trapping using the sticky trap MosquiTRAP (MQT) by performing a cluster randomised controlled trial in Manaus, state of Amazonas, Brazil. After an initial questionnaire and baseline monitoring of adult Ae. aegypti abundance with BG-Sentinel (BGS) traps in six clusters, three clusters were randomly assigned to the intervention arm where each participating household received three MQTs for mass trapping during 17 months. The remaining three clusters (control arm) did not receive traps. The effect of mass trapping on adult Ae. aegypti abundance was monitored fortnightly with BGS traps. During the last two months of the study, a serological survey was conducted. After the study, a second questionnaire was applied in the intervention arm. Entomological monitoring indicated that MQT mass trapping did not reduce adult Ae. aegypti abundance. The serological survey indicated that recent dengue infections were equally frequent in the intervention and the control arm. Most participants responded positively to questions concerning user satisfaction. According to the results, there is no evidence that mass trapping with MQTs can be used as a part of dengue control programs. The use of this sticky trap is only recommendable for dengue vector monitoring.
C1 [Degener, Carolin Marlen; Ferreira de Azara, Tatiana Mingote; Eiras, Alvaro Eduardo] Univ Fed Minas Gerais, Dept Parasitol, Lab Ecol Quim Vetores, Belo Horizonte, MG, Brazil.
   [Oliveira Rocha, Eliseu Soares; Kroon, Erna Geessien] Univ Fed Minas Gerais, Lab Virus, Belo Horizonte, MG, Brazil.
   [Degener, Carolin Marlen; Codeco, Claudia Torres; Nobre, Aline Araujo] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil.
   [Ferreira de Azara, Tatiana Mingote] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   [Roque, Rosemary Aparecida] Univ Nilton Lins, Lab Entomol Aplicada, Manaus, Amazonas, Brazil.
   [Roesner, Susanne] Forel Klin, Abt Wissensch & Diagnost, Ellikon An Der Thur, Switzerland.
   [Ohly, Joerg Johannes] Univ Estado Amazonas, Ctr Estudos Super Trop Umido, Manaus, Amazonas, Brazil.
   [Geier, Martin] Biogents AG, Regensburg, Germany.
RP Degener, CM (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Lab Ecol Quim Vetores, Belo Horizonte, MG, Brazil.
EM carolindegener@hotmail.de
RI Kroon, Erna Geessien/B-3631-2015; Azara, Tatiana/AAR-1604-2020; Kroon,
   Erna/V-5444-2019; Eiras, Alvaro/Z-6023-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Eiras,
   Alvaro/0000-0002-3045-0673
CR Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Bates D, 2011, LME4 LINEAR MIXED EF
   Boccia TMQR, 2014, EPIDEMIOL INFECT, V142, P625, DOI 10.1017/S0950268813001350
   Chan K.L., 1972, VECTOR CONTROL SE AS, P85
   Chiaravalloti Neto Francisco, 2007, Cad. Saúde Pública, V23, P1656, DOI 10.1590/S0102-311X2007000700017
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   Favaro EA, 2006, J VECTOR ECOL, V31, P285, DOI 10.3376/1081-1710(2006)31[285:PSOASA]2.0.CO;2
   FAY R. W., 1966, MOSQUITO NEWS, V26, P531
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   IBGE - Instituto Brasileiro de Geografia e Estatistica, 2010, INF BAIRR 2 MUN
   Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6
   Kittayapong P, 2008, AM J TROP MED HYG, V78, P70, DOI 10.4269/ajtmh.2008.78.70
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Lenhart A, 2013, AM J TROP MED HYG, V88, P254, DOI 10.4269/ajtmh.2012.12-0423
   Maciel-de-Freitas R, 2008, MEM I OSWALDO CRUZ, V103, P602, DOI 10.1590/S0074-02762008000600016
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Ocampo CB, 2009, BIOMEDICA, V29, P282, DOI 10.7705/biomedica.v29i2.30
   Pepin KM, 2013, EMERG INFECT DIS, V19, P542, DOI 10.3201/eid1904.120117
   Perich MJ, 2003, MED VET ENTOMOL, V17, P205, DOI 10.1046/j.1365-2915.2003.00427.x
   Pinheiro J, 2010, R PCKG V, V3, P1
   R Development Core Team, 2010, R LANG ENV STAT COMP
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   Ritchie SA, 2003, J AM MOSQUITO CONTR, V19, P235
   Santos S. R. A., 2003, Dengue Bulletin, V27, P156
   Sithiprasasna R, 2003, J MED ENTOMOL, V40, P455, DOI 10.1603/0022-2585-40.4.455
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   Nam VS, 2012, AM J TROP MED HYG, V86, P850, DOI 10.4269/ajtmh.2012.11-0466
   Wood S., 2006, GEN ADDITIVE MODELS
   Zeichner BC, 1999, MED VET ENTOMOL, V13, P234, DOI 10.1046/j.1365-2915.1999.00192.x
NR 34
TC 7
Z9 7
U1 0
U2 7
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2015
VL 110
IS 4
BP 517
EP 527
DI 10.1590/0074-02760140374
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CL0DT
UT WOS:000356610000010
PM 25946154
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Silva, LCF
   Almeida, GMF
   Assis, FL
   Albarnaz, JD
   Boratto, PVM
   Dornas, FP
   Andrade, KR
   La Scola, B
   Kroon, EG
   da Fonseca, FG
   Abrahao, JS
AF Silva, Lorena C. F.
   Almeida, Gabriel M. F.
   Assis, Felipe L.
   Albarnaz, Jonas D.
   Boratto, Paulo V. M.
   Dornas, Fabio P.
   Andrade, Ketyllen R.
   La Scola, Bernard
   Kroon, Erna G.
   da Fonseca, Flavio G.
   Abrahao, Jonatas S.
TI Modulation of the expression of mimivirus-encoded translation-related
   genes in response to nutrient availability during Acanthamoeba
   castellanii infection
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE mimivirus; tRNA; aminoacyl-tRNA-synthetases; translation; gene
   expression
ID TRANSFER-RNA SYNTHETASES; VIRUS
AB The complexity of giant virus genomes is intriguing, especially the presence of genes encoding components of the protein translation machinery such as transfer RNAs and aminoacyl-tRNA-synthetases; these features are uncommon among other viruses. Although orthologs of these genes are codified by their hosts, one can hypothesize that having these translation-related genes might represent a gain of fitness during infection. Therefore, the aim of this study was to evaluate the expression of translation-related genes by mimivirus during infection of Acanthamoeba castellanii under different nutritional conditions. In silico analysis of amino acid usage revealed remarkable differences between the mimivirus isolates and the A. castellanii host. Relative expression analysis by quantitative PCR revealed that mimivirus was able to modulate the expression of eight viral translation-related genes according to the amoebal growth condition, with a higher induction of gene expression under starvation. Some mimivirus isolates presented differences in translation-related gene expression; notably, polymorphisms in the promoter regions correlated with these differences. Two mimivirus isolates did not encode the tryptophanyl-tRNA in their genomes, which may be linked with low conservation pressure based on amino acid usage analysis. Taken together, our data suggest that mimivirus can modulate the expression of translation-related genes in response to nutrient availability in the host cell, allowing the mimivirus to adapt to different hosts growing under different nutritional conditions.
C1 [Silva, Lorena C. F.; Assis, Felipe L.; Albarnaz, Jonas D.; Boratto, Paulo V. M.; Dornas, Fabio P.; Andrade, Ketyllen R.; Kroon, Erna G.; da Fonseca, Flavio G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Avenida Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
   [Almeida, Gabriel M. F.] Univ Fed Minas Gerais, AQUACEN Lab Nacl Referencia Doencas Anim Aquat, Minist Pesca & Aquicultura, BR-31270901 Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, URMITE CNRS UMR IRD3R198 6236, Marseille, France.
   [da Fonseca, Flavio G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virol Basica & Aplicada, BR-31270901 Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Avenida Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Dornas, Fabio/AAI-3582-2020; Kroon, Erna/V-5444-2019; LA SCOLA,
   Bernard/P-6477-2016; Kroon, Erna Geessien/B-3631-2015; R16, Direction
   Geoscience/H-9011-2012; Almeida, Gabriel MF/I-8910-2012; Albarnaz, Jonas
   Dutra/E-4526-2010; Oger, Phil M/C-8138-2012
OI Dornas, Fabio/0000-0001-7926-5551; LA SCOLA,
   Bernard/0000-0001-8006-7704; Kroon, Erna Geessien/0000-0003-2721-3826;
   Almeida, Gabriel MF/0000-0003-2317-5092; Albarnaz, Jonas
   Dutra/0000-0002-8792-813X; Oger, Phil M/0000-0001-6298-6870
FU CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG);
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX We would like to thank colleagues from Gepvig, Laboratorio de Virus, and
   Aix Marseille Universite for their excellent technical support. We also
   would like to thank CAPES, FAPEMIG, and CNPq for financial support.
CR Abergel C, 2007, J VIROL, V81, P12406, DOI 10.1128/JVI.01107-07
   Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108
   Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003
   Colson P, 2013, INTERVIROLOGY, V56, P364, DOI 10.1159/000354557
   Colson P, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00091
   Colson Philippe, 2011, Genome Biol Evol, V3, P737, DOI 10.1093/gbe/evr048
   Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404
   Jeudy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003122
   La Scola B, 2003, SCIENCE, V299, P2033
   Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109
   Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12
   NEIDHARDT FC, 1975, ANNU REV MICROBIOL, V29, P215, DOI 10.1146/annurev.mi.29.100175.001243
   Putzer H., 2000, MADAME CURIE BIOSCIE
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Ryckelynck M, 2005, J MOL BIOL, V354, P614, DOI 10.1016/j.jmb.2005.09.063
   Saini HK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-115
   VISVESVARA GS, 1975, J PROTOZOOL, V22, P245, DOI 10.1111/j.1550-7408.1975.tb05860.x
   Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655
NR 19
TC 9
Z9 9
U1 0
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 1
PY 2015
VL 6
AR 539
DI 10.3389/fmicb.2015.00539
PG 8
WC Microbiology
SC Microbiology
GA CK6AC
UT WOS:000356309000001
PM 26082761
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Godinho, VM
   Goncalves, VN
   Santiago, IF
   Figueredo, HM
   Vitoreli, GA
   Schaefer, CEGR
   Barbosa, EC
   Oliveira, JG
   Alves, TMA
   Zani, CL
   Junior, PAS
   Murta, SMF
   Romanha, AJ
   Kroon, EG
   Cantrell, CL
   Wedge, DE
   Duke, SO
   Ali, A
   Rosa, CA
   Rosa, LH
AF Godinho, Valeria M.
   Goncalves, Vivian N.
   Santiago, Iara F.
   Figueredo, Hebert M.
   Vitoreli, Gislaine A.
   Schaefer, Carlos E. G. R.
   Barbosa, Emerson C.
   Oliveira, Jaquelline G.
   Alves, Tania M. A.
   Zani, Carlos L.
   Junior, Policarpo A. S.
   Murta, Silvane M. F.
   Romanha, Alvaro J.
   Kroon, Erna Geessien
   Cantrell, Charles L.
   Wedge, David E.
   Duke, Stephen O.
   Ali, Abbas
   Rosa, Carlos A.
   Rosa, Luiz H.
TI Diversity and bioprospection of fungal community present in oligotrophic
   soil of continental Antarctica
SO EXTREMOPHILES
LA English
DT Article
DE Antarctica; Drug discovery; Ecology; Fungi; Taxonomy
ID PENICILLIUM; MACROALGAE; DERIVATIVES; ANTIFUNGAL; MICROFUNGI; TAXONOMY;
   DESV.
AB We surveyed the diversity and capability of producing bioactive compounds from a cultivable fungal community isolated from oligotrophic soil of continental Antarctica. A total of 115 fungal isolates were obtained and identified in 11 taxa of Aspergillus, Debaryomyces, Cladosporium, Pseudogymnoascus, Penicillium and Hypocreales. The fungal community showed low diversity and richness, and high dominance indices. The extracts of Aspergillus sydowii, Penicillium allii-sativi, Penicillium brevicompactum, Penicillium chrysogenum and Penicillium rubens possess antiviral, antibacterial, antifungal, antitumoral, herbicidal and antiprotozoal activities. Bioactive extracts were examined using H-1 NMR spectroscopy and detected the presence of secondary metabolites with chemical shifts. Our results show that the fungi present in cold-oligotrophic soil from Antarctica included few dominant species, which may have important implications for understanding eukaryotic survival in cold-arid oligotrophic soils. We hypothesize that detailed further investigations may provide a greater understanding of the evolution of Antarctic fungi and their relationships with other organisms described in that region. Additionally, different wild pristine bioactive fungal isolates found in continental Antarctic soil may represent a unique source to discover prototype molecules for use in drug and biopesticide discovery studies.
C1 [Godinho, Valeria M.; Goncalves, Vivian N.; Santiago, Iara F.; Figueredo, Hebert M.; Vitoreli, Gislaine A.; Kroon, Erna Geessien; Rosa, Carlos A.; Rosa, Luiz H.] Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Schaefer, Carlos E. G. R.] Univ Fed Vicosa, Dept Ciencia Solo, Vicosa, MG, Brazil.
   [Barbosa, Emerson C.; Oliveira, Jaquelline G.; Alves, Tania M. A.; Zani, Carlos L.; Junior, Policarpo A. S.; Murta, Silvane M. F.; Romanha, Alvaro J.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Romanha, Alvaro J.] Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil.
   [Cantrell, Charles L.; Wedge, David E.; Duke, Stephen O.] USDA ARS, Nat Prod Utilizat Res Unit, University, AL USA.
   [Ali, Abbas] Univ Mississippi, NCNPR, University, MS USA.
RP Rosa, LH (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
EM lhrosa@icb.ufmg.br
RI Schaefer, Carlos Ernesto/AAY-4977-2020; Kroon, Erna/V-5444-2019; Zani,
   Carlos L/A-9658-2008; Kroon, Erna Geessien/B-3631-2015
OI Zani, Carlos L/0000-0003-1859-177X; Kroon, Erna
   Geessien/0000-0003-2721-3826; Ernesto Goncalves Reynaud Schaefer,
   Carlos/0000-0001-5735-3227; Ernesto Goncalves Reynaud Schaefer,
   Carlos/0000-0001-7060-1598
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [PROANTAR 407230/2013-0]; CNPq (INCT Criosfera)National Council for
   Scientific and Technological Development (CNPq); FAPEMIGMinas Gerais
   State Research Foundation (FAPEMIG) [0050-13]; CAPESCAPES
   [23038.003478/2013-92]; FINEPCiencia Tecnologia e Inovacao (FINEP)
   [2084/07]; PDTIS Fiocruz
FX We acknowledge the financial support from CNPq (Processes PROANTAR
   407230/2013-0 and INCT Criosfera), FAPEMIG (0050-13), CAPES
   (23038.003478/2013-92), FINEP (2084/07), PDTIS Fiocruz. The authors
   thank Solomon Green III and Robert D. Johnson for technical assistance.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Arenz BE, 2011, SOIL BIOL BIOCHEM, V43, P308, DOI 10.1016/j.soilbio.2010.10.016
   Arenz BE, 2006, SOIL BIOL BIOCHEM, V38, P3057, DOI 10.1016/j.soilbio.2006.01.016
   Azmi OR, 1997, POLAR BIOL, V18, P128, DOI 10.1007/s003000050167
   Bensch K, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.67.01
   Betancur-Galvis LA, 1999, MEM I OSWALDO CRUZ, V94, P531, DOI 10.1590/S0074-02761999000400019
   BLOCK W, 1994, POLAR BIOL, V14, P293
   Bridge PD, 2012, FUNGAL ECOL, V5, P381, DOI 10.1016/j.funeco.2012.01.007
   Brunati M, 2009, MAR GENOM, V2, P43, DOI 10.1016/j.margen.2009.04.002
   Carvalho CR, 2012, SYMBIOSIS, V57, P95, DOI 10.1007/s13199-012-0182-2
   Corry J.E.L., 1987, FOOD BEVERAGE MYCOLO, P51
   D'Elia T, 2009, MYCOLOGIA, V101, P751, DOI 10.3852/08-184
   DANHEISER RL, 1986, J AM CHEM SOC, V108, P806, DOI 10.1021/ja00264a038
   Dayan FE, 2000, J CHEM ECOL, V26, P2079, DOI 10.1023/A:1005512331061
   EMBRAPA-Empresa Brasileira de Pesquisa Agropecuaria, 1997, MANUAL METODOS ANALI
   Fell JW, 2006, SOIL BIOL BIOCHEM, V38, P3107, DOI 10.1016/j.soilbio.2006.01.014
   FLETCHER LD, 1985, POLAR BIOL, V4, P81, DOI 10.1007/BF00442904
   Frisvad JC, 2004, STUD MYCOL, P1
   Furbino LE, 2014, MICROB ECOL, V67, P775, DOI 10.1007/s00248-014-0374-9
   GEHRKE C, 1995, OIKOS, V72, P213, DOI 10.2307/3546223
   GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995
   Godinho VM, 2013, ISME J, V7, P1434, DOI 10.1038/ismej.2013.77
   Goncalves VN, 2013, POLAR BIOL, V36, P1823, DOI 10.1007/s00300-013-1403-8
   Goncalves VN, 2012, FEMS MICROBIOL ECOL, V82, P459, DOI 10.1111/j.1574-6941.2012.01424.x
   Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated
   Houbraken J, 2012, PERSOONIA, V29, P78, DOI 10.3767/003158512X660571
   Ireland CM, 2003, PHARM BIOL, V41, P15, DOI 10.1080/1388020039051742
   Kirk P, 2008, DICT FUNGI
   Klich M. A., 2002, IDENTIFICATION COMMO
   Kuo S., 1996, METHODS SOIL ANAL CH, V5, P869, DOI DOI 10.2136/SSSAB00KSER5.3.C32
   Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1
   Lachance MA, 1999, CAN J MICROBIOL, V45, P172, DOI 10.1139/cjm-45-2-172
   Li DH, 2007, ARCH PHARM RES, V30, P1051
   Loque CP, 2010, POLAR BIOL, V33, P641, DOI 10.1007/s00300-009-0740-0
   Lorch JM, 2013, MYCOLOGIA, V105, P237, DOI 10.3852/12-207
   McRae CF, 1999, POLAR BIOL, V21, P97, DOI 10.1007/s003000050340
   MERCANTINI R, 1989, MYCOPATHOLOGIA, V106, P47, DOI 10.1007/BF00436926
   Meyer GH, 1967, ANTARCT J US, V2, P248
   Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001
   Moller C, 1996, MYCOLOGIA, V88, P922, DOI 10.2307/3761054
   Moller C, 1996, J IND MICROBIOL BIOT, V17, P359, DOI 10.1007/BF01574767
   MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757
   Pitt J., 1979, GENUS PENICILLIUM IT
   Pridgeon JW, 2009, J MED ENTOMOL, V46, P335, DOI 10.1603/033.046.0219
   Rao S, 2012, POLAR BIOL, V35, P567, DOI 10.1007/s00300-011-1102-2
   Ren H, 2010, ARCH PHARM RES, V33, P499, DOI 10.1007/s12272-010-0401-4
   Romanha AJ, 2010, MEM I OSWALDO CRUZ, V105, P233, DOI 10.1590/S0074-02762010000200022
   Rosa LH, 2013, SYMBIOSIS, V60, P133, DOI 10.1007/s13199-013-0249-8
   Rosa LH, 2009, POLAR BIOL, V32, P161, DOI 10.1007/s00300-008-0515-z
   Rosa LH, 2010, FEMS MICROBIOL ECOL, V73, P178, DOI 10.1111/j.1574-6941.2010.00872.x
   Rudolph ED, 1977, ADAPTATIONS ANTARCTI, P1211
   Ruisi Serena, 2007, Reviews in Environmental Science and Bio/Technology, V6, P127, DOI 10.1007/s11157-006-9107-y
   Santiago IF, 2012, EXTREMOPHILES, V16, P95, DOI 10.1007/s00792-011-0409-9
   Scott JA, 2008, BOTANY, V86, P732, DOI 10.1139/B08-060
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tang LIC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-3
   Teixeira MCA, 2002, PARASITOL RES, V88, P963, DOI 10.1007/s00436-002-0695-3
   Tosi S, 2002, POLAR BIOL, V25, P262, DOI 10.1007/s00300-001-0337-8
   Trisuwan K, 2011, J NAT PROD, V74, P1663, DOI 10.1021/np200374j
   Wedge D. E., 1998, SAAS Bulletin of Biochemistry and Biotechnology, V11, P1
   Wedge DE, 2009, J AGR FOOD CHEM, V57, P464, DOI 10.1021/jf802820d
   White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1
   WICKLOW DT, 1968, CAN J MICROBIOL, V14, P717, DOI 10.1139/m68-119
   YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027
   Zucconi L, 2012, POLAR BIOL, V35, P749, DOI 10.1007/s00300-011-1119-6
NR 65
TC 41
Z9 45
U1 0
U2 42
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005,
   JAPAN
SN 1431-0651
EI 1433-4909
J9 EXTREMOPHILES
JI Extremophiles
PD MAY
PY 2015
VL 19
IS 3
BP 585
EP 596
DI 10.1007/s00792-015-0741-6
PG 12
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA CG4XY
UT WOS:000353294100004
PM 25809294
DA 2020-11-30
ER

PT J
AU Silva, LKD
   Arantes, TS
   Andrade, KR
   Rodrigues, RAL
   Boratto, PVM
   Almeida, GMD
   Kroon, EG
   La Scola, B
   Clemente, WT
   Abrahao, JS
AF dos Santos Silva, Ludmila Karen
   Arantes, Thalita Souza
   Andrade, Ketyllen Reis
   Lima Rodrigues, Rodrigo Araujo
   Miranda Boratto, Paulo Victor
   de Freitas Almeida, Gabriel Magno
   Kroon, Erna Geessien
   La Scola, Bernard
   Clemente, Wanessa Trindade
   Abrahao, Jonatas Santos
TI High positivity of mimivirus in inanimate surfaces of a hospital
   respiratory-isolation facility, Brazil
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Mimivirus; Hospital environment; Pneumonia
ID PNEUMONIA; VIRUS
AB Background: Mimiviruses have been considered putative emerging pneumonia agents. Pneumonia is a leading cause of death related to infection throughout the world, with approximately 40% of cases presenting unknown etiology. Therefore, identifying new causative agents of community and nosocomial pneumonia is of major public health concern.
   Objective: We evaluated the distribution of these viruses in samples collected from different environments of one of the largest hospitals in Brazilian Southeast.
   Study design: We analyzed, by molecular and virological approaches, the distribution of mimivirus in 242 samples collected from inanimate surfaces in different hospital facilities.
   Results: A significant positivity of mimivirus in respiratory-isolation-facilities was observed (p < 0.001).
   Conclusion: Although the role of mimivirus as etiological agents of pneumonia is still under investigation, our results demonstrates interesting correlations that strengthens the need for control over the occurrence of these viruses in hospital facilities. (C) 2015 Elsevier B.V. All rights reserved.
C1 [dos Santos Silva, Ludmila Karen; Arantes, Thalita Souza; Andrade, Ketyllen Reis; Lima Rodrigues, Rodrigo Araujo; Miranda Boratto, Paulo Victor; de Freitas Almeida, Gabriel Magno; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Marseille Univ, Marseille, France.
   [Clemente, Wanessa Trindade] Univ Fed Minas Gerais, Hosp Clin, Comissao Controle Infeccao Hosp, BR-31270901 Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Inst Ciencias Biol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; Almeida,
   Gabriel MF/I-8910-2012; LA SCOLA, Bernard/P-6477-2016
OI Kroon, Erna Geessien/0000-0003-2721-3826; Almeida, Gabriel
   MF/0000-0003-2317-5092; LA SCOLA, Bernard/0000-0001-8006-7704; Araujo
   Lima Rodrigues, Rodrigo/0000-0001-7148-4012
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA); Pro-Reitoria de Pesquisa
   da Universidade Federal de Minas Gerais
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), the Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG), the Ministerio da Agricultura,
   Pecuaria e Abastecimento (MAPA), and the Pro-Reitoria de Pesquisa da
   Universidade Federal de Minas Gerais.
CR Andrade KR, 2015, ARCH VIROL, V160, P477, DOI 10.1007/s00705-014-2257-2
   Campos RK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-95
   Carlesso AM, 2007, REV SOC BRAS MED TRO, V40, P316, DOI 10.1590/S0037-86822007000300013
   Claverie JM, 2006, VIRUS RES, V117, P133, DOI 10.1016/j.virusres.2006.01.008
   Costa C, 2012, INTERVIROLOGY, V55, P303, DOI 10.1159/000329088
   da Silva MA, 2003, REV SAUDE PUBL, V37, P242, DOI 10.1590/S0034-89102003000200013
   Dare RK, 2008, EMERG INFECT DIS, V14, P465, DOI 10.3201/eid1403.071027
   Dornas FP, 2014, EMERG INFECT DIS, V20, P469, DOI 10.3201/eid2003.131050
   Dornas FP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087811
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538
   La Scola B, 2003, SCIENCE, V299, P2033
   Raoult D, 2007, CLIN INFECT DIS, V45, P95, DOI 10.1086/518608
   Saadi H, 2013, INTERVIROLOGY, V56, P424, DOI 10.1159/000354564
   Saadi H, 2013, CLIN INFECT DIS, V57, pE127, DOI 10.1093/cid/cit354
   Vanspauwen MJ, 2013, J MED VIROL, V85, P1836, DOI 10.1002/jmv.23655
   Vanspauwen MJ, 2012, RESP MED, V106, P1690, DOI 10.1016/j.rmed.2012.08.019
NR 17
TC 8
Z9 8
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD MAY
PY 2015
VL 66
BP 62
EP 65
DI 10.1016/j.jcv.2015.03.008
PG 4
WC Virology
SC Virology
GA CF6YE
UT WOS:000352702000015
PM 25866340
DA 2020-11-30
ER

PT J
AU Pascoal-Xavier, MA
   Figueiredo, ACC
   Gomes, LI
   Peruhype-Magalhaes, V
   Calzavara-Silva, CE
   Costa, MA
   Reis, IA
   Bonjardim, CA
   Kroon, EG
   de Oliveira, JG
   Ferreira, PCP
AF Pascoal-Xavier, Marcelo Antonio
   Cancado Figueiredo, Anna Carolina
   Gomes, Luciana Inacia
   Peruhype-Magalhaes, Vanessa
   Calzavara-Silva, Carlos Eduardo
   Costa, Marcelo Azevedo
   Reis, Ilka Afonso
   Bonjardim, Claudio Antonio
   Kroon, Erna Geessien
   de Oliveira, Jaquelline G.
   Peregrino Ferreira, Paulo Cesar
TI RAP1 GTPase Overexpression is Associated with Cervical Intraepithelial
   Neoplasia
SO PLOS ONE
LA English
DT Article
ID SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; G-PROTEINS; EXPRESSION;
   CANCER; BRD4; RAS; TUMORIGENESIS; P16(INK4A); ACTIVATION
AB RAP1 (RAS proximate 1), a small GTP-binding protein of the RAS superfamily, is a putative oncogene that is highly expressed in several malignant cell lines and types of cancers, including some types of squamous cell carcinoma. However, the participation of RAP1 in cervical carcinogenesis is unknown. We conducted a cross-sectional study of paraffin-embedded cervical biopsies to determine the association of RAP1 with cervical intraepithelial neoplasia (CIN). Standard and quantitative immunohistochemistry assessment of RAP1 expression in fixed tissue was performed on 183 paraffin-embedded cervical biopsies that were classified as normal or non-dysplastic mucosa (NDM) (n = 33); CIN grade 1 (n = 84) and CIN grade 2/3 (n = 66). A gradual increase in RAP1 expression in NDM < CIN 1 < CIN 2/3 (p<0.001) specimens was observed and was in agreement with the histopathologic diagnosis. A progressive increase in the RAP1 expression levels increased the risk of CIN 1 [ odds ratio (OR) = 3.50; 95% confidence interval (CI) 1.30-10.64] 3.5 fold and the risk of CIN 2/3 (OR=19.86, 95% CI 6.40-70.79) nearly 20 fold when compared to NDM. In addition, stereotype ordinal regression analysis showed that this progressive increase in RAP1 expression more strongly impacted CIN 2/3 than CIN 1. Our findings suggest that RAP1 may be a useful biomarker for the diagnosis of CIN.
C1 [Pascoal-Xavier, Marcelo Antonio; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; Peregrino Ferreira, Paulo Cesar] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Cancado Figueiredo, Anna Carolina; Gomes, Luciana Inacia; Peruhype-Magalhaes, Vanessa; Calzavara-Silva, Carlos Eduardo; de Oliveira, Jaquelline G.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Costa, Marcelo Azevedo] Univ Fed Minas Gerais, Escola Engn, Dept Engn Prod, Belo Horizonte, MG, Brazil.
   [Reis, Ilka Afonso] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Estat, Belo Horizonte, MG, Brazil.
RP de Oliveira, JG (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
EM jaque@cpqrr.fiocruz.br
RI Reis, Ilka Afonso/AAG-8007-2019; Kroon, Erna Geessien/B-3631-2015;
   Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Reis, Ilka
   Afonso/0000-0001-7199-8590; CALZAVARA-SILVA, CARLOS/0000-0002-1406-6401
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX This research was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq-www.cnpq.br), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES - www.capes.gov.br),
   and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG -
   www.fapemig.br). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abreu Mery Natali Silva, 2008, Cad. Saúde Pública, V24, ps581, DOI 10.1590/S0102-311X2008001600010
   Ahn J, 2009, STAT MED, V28, P3139, DOI 10.1002/sim.3693
   ANDERSON JA, 1984, J R STAT SOC B, V46, P1
   Banerjee Rajat, 2012, Small GTPases, V3, P192, DOI 10.4161/sgtp.20413
   Banerjee R, 2011, CELL SIGNAL, V23, P1110, DOI 10.1016/j.cellsig.2011.02.002
   Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073
   Chakrabarti O, 2004, J VIROL, V78, P5934, DOI 10.1128/JVI.78.11.5934-5945.2004
   Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004
   Furstenau DK, 2011, BREAST CANCER RES TR, V129, P361, DOI 10.1007/s10549-010-1227-y
   Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4
   Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254
   Gao QS, 1999, MOL CELL BIOL, V19, P733
   Gloerich M, 2011, TRENDS CELL BIOL, V21, P615, DOI 10.1016/j.tcb.2011.07.001
   Tiburcio MGS, 2014, EUR J GYNAECOL ONCOL, V35, P284
   Goto M, 2010, CLIN CANCER RES, V16, P65, DOI 10.1158/1078-0432.CCR-09-1122
   Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180
   Haws ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/j.jviromet.2004.08.007
   Husnjak K, 2000, J VIROL METHODS, V88, P125, DOI 10.1016/S0166-0934(00)00194-4
   Kim WJ, 2012, CANCER LETT, V320, P65, DOI 10.1016/j.canlet.2012.01.022
   Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174
   Lafuente EM, 2007, LEUKEMIA LYMPHOMA, V48, P987, DOI 10.1080/10428190701242341
   Lobato S, 2012, J GYNECOL ONCOL, V23, P11, DOI 10.3802/jgo.2012.23.1.11
   Mazibrada J, 2008, GYNECOL ONCOL, V108, P112, DOI 10.1016/j.ygyno.2007.08.095
   McBride AA, 2004, TRENDS MICROBIOL, V12, P527, DOI 10.1016/j.tim.2004.10.002
   McPhillips MG, 2006, J VIROL, V80, P9530, DOI 10.1128/JVI.01105-06
   Mendoza-Catalan MA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-116
   Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534
   Nellore A, 2009, J CLIN ENDOCR METAB, V94, P1026, DOI 10.1210/jc.2008-1042
   Nonogaki Suely, 2005, J Low Genit Tract Dis, V9, P219, DOI 10.1097/01.lgt.0000179861.67574.6b
   Portari EA, 2013, INT J GYNECOL PATHOL, V32, P501, DOI 10.1097/PGP.0b013e31826f5cf6
   Schmid MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060226
   Singh L, 2003, J VIROL, V77, P1614, DOI 10.1128/JVI.77.2.1614-1620.2003
   Tsoumpou I, 2009, CANCER TREAT REV, V35, P210, DOI 10.1016/j.ctrv.2008.10.005
   von Knebel Doeberitz M, 2012, EXPERT REV PROTEOMIC, V9, P149, DOI [10.1586/epr.12.13, DOI 10.1586/EPR.12.13]
   Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09
   zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798
NR 36
TC 1
Z9 1
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 9
PY 2015
VL 10
IS 4
AR e0123531
DI 10.1371/journal.pone.0123531
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CF5HQ
UT WOS:000352588500096
PM 25856570
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Jung, LRC
   Bomfim, MRQ
   Kroon, EG
   Nunes, AC
AF Cardoso Jung, Lenice Roteia
   Quaresma Bomfim, Maria Rosa
   Kroon, Erna Geessien
   Nunes, Alvaro Cantini
TI Identification of Leptospira serovars by RFLP of the RNA polymerase beta
   subunit gene (rpoB)
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Leptospira; rpoB gene; RFLP; serovar; DNA typing
ID 16S RIBOSOMAL-RNA; FAMILY LEPTOSPIRACEAE; PHYLOGENETIC ANALYSIS; SP
   NOV.; SEQUENCE; INTERROGANS; RELATEDNESS; SEROGROUPS; BORRELIA; STRATEGY
AB Leptospires are usually classified by methods based on DNA-DNA hybridization and the conventional cross-agglutination absorption test, which uses polyclonal antibodies against lipopolysaccharides. In this study, the amplification of the rpoB gene, which encodes the beta-subunit of RNA polymerase, was used as an alternative tool to identify Leptospira. DNA extracts from sixty-eight serovars were obtained, and the hypervariable region located between 1990 and 2500-bp in the rpoB gene was amplified by polymerase chain reaction (PCR). The 600-bp amplicons of the rpoB gene were digested with the restriction endonucleases TaqI, Tru1I, Sau3AI and MslI, and the restriction fragments were separated by 6% polyacrylamide gel electrophoresis. Thirty-five fragment patters were obtained from the combined data of restriction fragment length polymorphism (PCR-RFLP) analysis and used to infer the phylogenetic relationships among the Leptospira species and serovars. The species assignments obtained were in full agreement with the established taxonomic classifications. Twenty-two serovars were effectively identified based on differences in their molecular profiles. However, the other 46 serovars remained clustered in groups that included more than one serovar of different species. This study demonstrates the value of RFLP analysis of PCR-amplified rpoB as an initial method for identifying Leptospira species and serovars.
C1 [Cardoso Jung, Lenice Roteia; Nunes, Alvaro Cantini] Univ Fed Minas Gerais, Dept Biol Geral, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Quaresma Bomfim, Maria Rosa; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Quaresma Bomfim, Maria Rosa] Univ Ceuma, Dept Biol Parasitaria, Sao Luis, MA, Brazil.
RP Nunes, AC (corresponding author), Univ Fed Minas Gerais, Campus Pampulha,Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM cantini@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; BOMFIM, MARIA ROSA/AAT-8359-2020; NUNES, ALVARO
   CANTINI/F-1703-2017; Kroon, Erna Geessien/B-3631-2015
OI BOMFIM, MARIA ROSA/0000-0001-5738-3952; NUNES, ALVARO
   CANTINI/0000-0001-8844-8333; Kroon, Erna Geessien/0000-0003-2721-3826
FU Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)Minas Gerais
   State Research Foundation (FAPEMIG); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao de Amparo a
   Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA); PRPq/UFMG
FX This study was supported by the Fundacao de Amparo a Pesquisa de Minas
   Gerais (FAPEMIG), the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), the Fundacao de Amparo a Pesquisa e Desenvolvimento
   Cientifico do Maranhao (FAPEMA) and the PRPq/UFMG. We thank Dr. Elvio C.
   Moreira from the Department of Preventive Medicine of the Veterinary
   School of UFMG for providing the Leptospira strains and Dr. Regina M.
   Nardi Drummond and Dr. Vera Lucia dos Santos for their assistance at the
   laboratory facilities with the growing and maintenance of the Leptospira
   strains.
CR Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0
   Ahmed A, 2012, J BACTERIOL PARASITO, V3, P2
   Ahmed A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001374
   Ahmed A, 2010, INFECT GENET EVOL, V10, P955, DOI 10.1016/j.meegid.2010.06.002
   Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28
   [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   Balamurugan V, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-362
   Ben Salah I, 2008, MICROBIOL-SGM, V154, P3715, DOI 10.1099/mic.0.2008/020164-0
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Boonsilp S, 2013, PLOS NEGLECT TROP D, V9, pe824
   Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839
   Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06
   Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009
   ELLINGHAUSEN HC, 1973, ANN INST PASTEUR MIC, VB124, P477
   Gaget V, 2011, INT J SYST EVOL MICR, V61, P170, DOI 10.1099/ijs.0.019018-0
   Galloway RL, 2008, AM J TROP MED HYG, V78, P628, DOI 10.4269/ajtmh.2008.78.628
   Galloway RL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000824
   Khamis A, 2004, J CLIN MICROBIOL, V42, P3925, DOI 10.1128/JCM.42.9.3925-3931.2004
   Khamis A, 2003, APPL ENVIRON MICROB, V69, P6740, DOI 10.1128/AEM.69.11.6740-6749.2003
   Kim KS, 2003, FEMS MICROBIOL LETT, V226, P299, DOI 10.1016/S0378-1097(03)00618-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   La Scola B, 2006, J CLIN MICROBIOL, V44, P827, DOI 10.1128/JCM.44.3.827-832.2006
   La Scola B, 2006, FEMS MICROBIOL LETT, V263, P142, DOI 10.1111/j.1574-6968.2006.00377.x
   Lau CL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001669
   Lee SH, 2000, J CLIN MICROBIOL, V38, P2557, DOI 10.1128/JCM.38.7.2557-2562.2000
   Leon A, 2010, J CLIN MICROBIOL, V48, P581, DOI 10.1128/JCM.00543-09
   Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x
   Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10
   MARSHALL RB, 1981, J MED MICROBIOL, V14, P163, DOI 10.1099/00222615-14-1-163
   Miller MP, 1998, TFPGA TOOLS POPULATI
   Minegishi H, 2010, INT J SYST EVOL MICR, V60, P2398, DOI 10.1099/ijs.0.017160-0
   Mohammed H, 2011, BACTERIOL PARASITOL, V2, P6, DOI DOI 10.4172/2155-9597.1000120
   Mollet C, 1998, GENE, V207, P97, DOI 10.1016/S0378-1119(97)00618-5
   Morey RE, 2006, J CLIN MICROBIOL, V44, P3510, DOI 10.1128/JCM.00670-06
   NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771
   Pavan ME, 2008, COMP IMMUNOL MICROB, V31, P37, DOI 10.1016/j.cimid.2007.03.004
   Perolat P, 1998, INT J SYST BACTERIOL, V48, P851, DOI 10.1099/00207713-48-3-851
   Ramadass P, 2002, Indian J Med Microbiol, V20, P25
   Ramadass P, 1997, INT J SYST BACTERIOL, V47, P575, DOI 10.1099/00207713-47-2-575
   Renesto P, 2000, J CLIN MICROBIOL, V38, P2200
   Slack AT, 2009, INT J SYST EVOL MICR, V59, P705, DOI 10.1099/ijs.0.002766-0
   Sneath PHA, 1973, NUMERICAL TAXONOMY
   Vos M, 2012, PLOS ONE, V2
   WHO, 2006, INF CONS GLOB BURD L
   YASUDA PH, 1987, INT J SYST BACTERIOL, V37, P407, DOI 10.1099/00207713-37-4-407
NR 45
TC 3
Z9 4
U1 0
U2 6
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD APR-JUN
PY 2015
VL 46
IS 2
BP 465
EP 476
DI 10.1590/S1517-838246220120018
PG 12
WC Microbiology
SC Microbiology
GA CL3DX
UT WOS:000356831300017
PM 26273261
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Campos, RK
   Trindade, GD
   da Fonseca, FG
   Ferreira, PCP
   Kroon, EG
AF Abrahao, Jonatas Santos
   Campos, Rafael Kroon
   Trindade, Giliane de Souza
   da Fonseca, Flavio Guimaraes
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Outbreak of Severe Zoonotic Vaccinia Virus Infection, Southeastern
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID ORTHOPOXVIRUS; SMALLPOX; STRAINS
AB In 2010, a vaccinia virus isolate caused an atypically severe outbreak that affected humans and cattle in Brazil. Of 26 rural workers affected, 12 were hospitalized. Our data raise questions about the risk factors related to the increasing number and severity of vaccinia virus infections.
C1 [Abrahao, Jonatas Santos; Campos, Rafael Kroon; Trindade, Giliane de Souza; da Fonseca, Flavio Guimaraes; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais ICB, Dept Microbiol, Virus Lab, Inst Ciencias Biol, Av Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Campos, Rafael Kroon/AAB-5135-2020; Kroon, Erna
   Geessien/B-3631-2015
OI Campos, Rafael Kroon/0000-0002-4852-0449; Kroon, Erna
   Geessien/0000-0003-2721-3826
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais
   (PRPq-UFMG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA)
FX Financial support was provided by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Pro-Reitoria de Pesquisa da
   Universidade Federal de Minas Gerais (PRPq-UFMG), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais (FAPEMIG) and Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA). E.G.K., P.P.F., C.A.B.,
   G.S.T., and F.G.F. are CNPq researchers.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon IK, 2007, LIPPINCOTT WILLIAMS, VII, P2947
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Ducournau C, 2013, EMERG INFECT DIS, V19, P1996, DOI 10.3201/eid1912.130256
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Reynolds MG, 2012, CURR OPIN VIROL, V2, P335, DOI 10.1016/j.coviro.2012.02.004
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
NR 15
TC 25
Z9 28
U1 0
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2015
VL 21
IS 4
BP 695
EP 698
DI 10.3201/eid2104.140351
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CE2NK
UT WOS:000351652100024
PM 25811411
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Oliveira, G
   Assis, F
   Almeida, G
   Albarnaz, J
   Lima, M
   Andrade, AC
   Calixto, R
   Oliveira, C
   Neto, JD
   Trindade, G
   Ferreira, PC
   Kroon, EG
   Abrahao, J
AF Oliveira, Graziele
   Assis, Felipe
   Almeida, Gabriel
   Albarnaz, Jonas
   Lima, Mauricio
   Andrade, Ana Claudia
   Calixto, Rafael
   Oliveira, Cairo
   Neto, Jose Diomedes
   Trindade, Giliane
   Ferreira, Paulo Cesar
   Kroon, Erna Geessien
   Abrahao, Jonatas
TI From Lesions to Viral Clones: Biological and Molecular Diversity amongst
   Autochthonous Brazilian Vaccinia Virus
SO VIRUSES-BASEL
LA English
DT Article
ID BOVINE VACCINIA; SMALLPOX VACCINE; GENOMIC ANALYSIS; STRAINS; MONKEYPOX;
   HUMANS; INFECTION; OUTBREAK; POXVIRUS; STATE
AB Vaccinia virus (VACV) has had an important role for humanity because of its use during the smallpox eradication campaign. VACV is the etiologic agent of the bovine vaccinia (BV), an emerging zoonosis that has been associated with economic, social, veterinary and public health problems, mainly in Brazil and India. Despite the current and historical VACV importance, there is little information about its circulation, prevalence, origins and maintenance in the environment, natural reservoirs and diversity. Brazilian VACV (VACV-BR) are grouped into at least two groups based on genetic and biological diversity: group 1 (G1) and group 2 (G2). In this study, we went to the field and investigated VACV clonal diversity directly from exanthemous lesions, during BV outbreaks. Our results demonstrate that the G1 VACV-BR were more frequently isolated. Furthermore, we were able to co-detect the two variants (G1 and G2) in the same sample. Molecular and biological analysis corroborated previous reports and confirmed the co-circulation of two VACV-BR lineages. The detected G2 clones presented exclusive genetic and biological markers, distinct to reference isolates, including VACV-Western Reserve. Two clones presented a mosaic profile, with both G1 and G2 features based on the molecular analysis of A56R, A26L and C23L genes. Indeed, some SNPs and INDELs in A56R nucleotide sequences were observed among clones of the same virus population, maybe as a result of an increased mutation rate in a mixed population. These results provide information about the diversity profile in VACV populations, highlighting its importance to VACV evolution and maintenance in the environment.
C1 [Oliveira, Graziele; Assis, Felipe; Albarnaz, Jonas; Lima, Mauricio; Andrade, Ana Claudia; Calixto, Rafael; Trindade, Giliane; Ferreira, Paulo Cesar; Kroon, Erna Geessien; Abrahao, Jonatas] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [Almeida, Gabriel] Univ Fed Minas Gerais, AQUACEN Lab Nacl Oficial Referencia Doencas Anim, BR-31270901 Belo Horizonte, MG, Brazil.
   [Oliveira, Cairo] Univ Fed Minas Gerais, Dept Med Vet Prevent, Lab Retroviroses, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
   [Neto, Jose Diomedes] Fed Univ Para, Ctr Agr, Dept Ciencia Anim, BR-66075110 Belem, Para, Brazil.
RP Abrahao, J (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM graziufmg@yahoo.com.br; felipelopeasssis@gmail.com;
   gabriel.magno@gmail.com; jonasalbarnaz@yahoo.com.br;
   maurili15@hotmail.com; ana.andrade2008@hotmail.com;
   calixtomicro@yahoo.com.br; cairo_henrique@yahoo.com.br;
   diomedes@ufpa.br; gitrindade@yahoo.com.br; peregrinopcp@hotmail.com;
   ernagkroon@gmail.com; jonatas.abrahao@gmail.com
RI Albarnaz, Jonas Dutra/E-4526-2010; Kroon, Erna/V-5444-2019; Almeida,
   Gabriel MF/I-8910-2012; Kroon, Erna Geessien/B-3631-2015
OI Albarnaz, Jonas Dutra/0000-0002-8792-813X; Almeida, Gabriel
   MF/0000-0003-2317-5092; Kroon, Erna Geessien/0000-0003-2721-3826;
   Teixeira Lima, Mauricio/0000-0002-0830-3909; De Oliveira,
   Cairo/0000-0002-3474-2796
FU Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais
   (PRPq-UFMG); CNPqNational Council for Scientific and Technological
   Development (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG)
FX We thank colleagues from Laboratorio de Virus (ICB-UFMG). For assistance
   in collection of clinical specimens we thank Instituto Mineiro de
   Agropecuaria(IMA), Laboratorio de Virologia Animal da Escola de Medicina
   Veterinaria of UFMG and Empresa Brasileira de Pesquisa Agropecuaria.
   (EMBRAPA). We thank Juliano Leal de Paula from Nucleo de Analise de
   Genoma e Expressao Genica (NAGE)-Departamento de Bioquimica e Imunologia
   (ICB-UFMG). We thank Pro-Reitoria de Pesquisa da Universidade Federal de
   Minas Gerais (PRPq-UFMG) and support agencies (CNPq, CAPES and FAPEMIG)
   for the financial support.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Assis FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050413
   Assis FL, 2012, EMERG INFECT DIS, V18, P2035, DOI 10.3201/eid1812.120145
   Batista V. H., 2009, VIRUS REV RES, V14, P1
   BEDSON HS, 1964, J HYG-CAMBRIDGE, V62, P147, DOI 10.1017/S0022172400039887
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043730
   Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I. K., 2014, POXVIRUSES FIELDS VI, V2, P2160
   Deng Y, 2009, VACCINE, V27, P2085, DOI 10.1016/j.vaccine.2009.02.003
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Emerson GL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007666
   Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134
   FENNER F, 1958, VIROLOGY, V5, P530, DOI 10.1016/0042-6822(58)90043-6
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Garcel A, 2009, VACCINE, V27, P708, DOI 10.1016/j.vaccine.2008.11.063
   Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0
   Hendrickson RC, 2010, VIRUSES-BASEL, V2, P1933, DOI 10.3390/v2091933
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kalthoff D, 2014, VECTOR-BORNE ZOONOT, V14, P303, DOI 10.1089/vbz.2013.1442
   Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Kugelman JR, 2014, EMERG INFECT DIS, V20, P232, DOI 10.3201/eid2002.130118
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Liu CX, 2013, SCI CHINA LIFE SCI, V56, P531, DOI 10.1007/s11427-013-4484-2
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005
   Okeke MI, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-119
   Oliveira DB, 2013, AM J TROP MED HYG, V89, P1142, DOI 10.4269/ajtmh.13-0369
   Oliveira GP, 2014, AM J TROP MED HYG, V90, P1021, DOI 10.4269/ajtmh.13-0621
   Osborne JD, 2007, VACCINE, V25, P8807, DOI 10.1016/j.vaccine.2007.10.040
   Pahlitzsch R, 2006, CLIN INFECT DIS, V43, P737, DOI 10.1086/506937
   Qin L, 2014, J VIROL, V88, P5277, DOI 10.1128/JVI.00022-14
   Qin L, 2013, VIROLOGY, V442, P59, DOI 10.1016/j.virol.2013.03.025
   Qin L, 2011, J VIROL, V85, P13049, DOI 10.1128/JVI.05779-11
   Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299
   Reynolds MG, 2012, CURR OPIN VIROL, V2, P335, DOI 10.1016/j.coviro.2012.02.004
   Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Sambrook J., 2001, MOL CLONING LAB MANU
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
NR 54
TC 10
Z9 10
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAR
PY 2015
VL 7
IS 3
BP 1218
EP 1237
DI 10.3390/v7031218
PG 20
WC Virology
SC Virology
GA CE6JP
UT WOS:000351943000017
PM 25785515
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Boratto, P
   Albarnaz, JD
   Almeida, GMD
   Botelho, L
   Fontes, ACL
   Costa, AO
   Santos, DD
   Bonjardim, CA
   La Scola, B
   Kroon, EG
   Abrahao, JS
AF Boratto, Paulo
   Albarnaz, Jonas Dutra
   de Freitas Almeida, Gabriel Magno
   Botelho, Lucas
   Lima Fontes, Alide Caroline
   Costa, Adriana Oliveira
   Santos, Daniel de Assis
   Bonjardim, Claudio Antonio
   La Scola, Bernard
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
TI Acanthamoeba polyphaga Mimivirus Prevents Amoebal Encystment-Mediating
   Serine Proteinase Expression and Circumvents Cell Encystment
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID FREE-LIVING AMEBAS; DRINKING-WATER; CASTELLANII; HUMANS; SPP.
AB Acanthamoeba is a genus of free-living amoebas distributed worldwide. Few studies have explored the interactions between these protozoa and their infecting giant virus, Acanthamoeba polyphaga mimivirus (APMV). Here we show that, once the amoebal encystment is triggered, trophozoites become significantly resistant to APMV. Otherwise, upon infection, APMV is able to interfere with the expression of a serine proteinase related to amoebal encystment and the encystment can no longer be triggered.
C1 [Boratto, Paulo; Albarnaz, Jonas Dutra; de Freitas Almeida, Gabriel Magno; Botelho, Lucas; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Lima Fontes, Alide Caroline; Santos, Daniel de Assis] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Micol, Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, IRD 3R198, URMITE CNRS UMR 6236, Marseille, France.
   [Costa, Adriana Oliveira] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Almeida, Gabriel MF/I-8910-2012; Costa, Adriana Oliveira/AAD-3037-2020;
   LA SCOLA, Bernard/P-6477-2016; Kroon, Erna Geessien/B-3631-2015;
   Albarnaz, Jonas Dutra/E-4526-2010; Kroon, Erna/V-5444-2019
OI Almeida, Gabriel MF/0000-0003-2317-5092; LA SCOLA,
   Bernard/0000-0001-8006-7704; Kroon, Erna Geessien/0000-0003-2721-3826;
   Albarnaz, Jonas Dutra/0000-0002-8792-813X; Santos, Daniel
   Assis/0000-0002-1108-5666
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA); Pro-Reitoria de Pesquisa
   da Universidade Federal de Minas Gerais (PRPq-UFMG)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais (FAPEMIG), Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA), and Pro-Reitoria de
   Pesquisa da Universidade Federal de Minas Gerais (PRPq-UFMG). E.G.K. and
   C.A.B. are researchers from CNPq.
CR Bagheri HR, 2010, IRAN J PARASITOL, V5, P19
   Delafont V, 2013, WATER RES, V47, P6958, DOI 10.1016/j.watres.2013.07.047
   Horn M, 2004, J EUKARYOT MICROBIOL, V51, P509, DOI 10.1111/j.1550-7408.2004.tb00278.x
   Iqbal J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-56
   Khan NA, 2014, PARASITOLOGY, V141, P869, DOI 10.1017/S003118201300231X
   La Scola B, 2001, CLIN MICROBIOL INFEC, V7, P75, DOI 10.1046/j.1469-0691.2001.00193.x
   Malliaris SD, 2004, MED MYCOL, V42, P149, DOI 10.1080/13693786310001616500
   Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003
   MICHEL R, 1995, ZBL HYG UMWELTMED, V196, P532
   Moon EK, 2008, EUKARYOT CELL, V7, P1513, DOI 10.1128/EC.00068-08
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   Schuster FL, 2004, INT J PARASITOL, V34, P1001, DOI 10.1016/j.ijpara.2004.06.004
   Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6
NR 13
TC 7
Z9 8
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2015
VL 89
IS 5
BP 2962
EP 2965
DI 10.1128/JVI.03177-14
PG 4
WC Virology
SC Virology
GA CC2XD
UT WOS:000350207400047
PM 25520511
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Andrade, KR
   Boratto, PPVM
   Rodrigues, FP
   Silva, LCF
   Dornas, FP
   Pilotto, MR
   La Scola, B
   Almeida, GMF
   Kroon, EG
   Abraho, JS
AF Andrade, Ketyllen R.
   Boratto, Paulo P. V. M.
   Rodrigues, Felipe P.
   Silva, Lorena C. F.
   Dornas, Fabio P.
   Pilotto, Mariana R.
   La Scola, Bernard
   Almeida, Gabriel M. F.
   Kroon, Erna G.
   Abraho, Jonatas S.
TI Oysters as hot spots for mimivirus isolation
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID GIANT VIRUSES; CRASSOSTREA-GIGAS; LINEAGE; GENES
AB Viruses are ubiquitous organisms, but their role in the ecosystem and their prevalence are still poorly understood. Mimiviruses are extremely complex and large DNA viruses. Although metagenomic studies have suggested that members of the family Mimiviridae are abundant in oceans, there is a lack of information about the association of mimiviruses with marine organisms. In this work, we demonstrate by molecular and virological methods that oysters are excellent sources for mimiviruses isolation. Our data not only provide new information about the biology of these viruses but also raise questions regarding the role of oyster consumption as a putative source of mimivirus infection in humans.
C1 [Andrade, Ketyllen R.; Boratto, Paulo P. V. M.; Rodrigues, Felipe P.; Silva, Lorena C. F.; Dornas, Fabio P.; Almeida, Gabriel M. F.; Kroon, Erna G.; Abraho, Jonatas S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Pilotto, Mariana R.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, URMITE CNRS UMR 6236, IRD 3R198, Marseille, France.
RP Abraho, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Dornas, Fabio/AAI-3582-2020; Pilotto, Mariana/AAY-6486-2020; Almeida,
   Gabriel MF/I-8910-2012; LA SCOLA, Bernard/P-6477-2016; Kroon, Erna
   Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Dornas, Fabio/0000-0001-7926-5551; Almeida, Gabriel
   MF/0000-0003-2317-5092; LA SCOLA, Bernard/0000-0001-8006-7704; Kroon,
   Erna Geessien/0000-0003-2721-3826; Pilotto, Mariana
   Rangel/0000-0002-3143-0930
CR Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Boughalmi M, 2013, VIRUSES-BASEL, V5, P2920, DOI 10.3390/v5122920
   Campos RK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-95
   Carvalho AFU, 2007, Braz. J. Biol., V67, P787, DOI 10.1590/S1519-69842007000400031
   Claverie JM, 2009, J INVERTEBR PATHOL, V101, P172, DOI 10.1016/j.jip.2009.03.011
   Colson Philippe, 2011, Genome Biol Evol, V3, P737, DOI 10.1093/gbe/evr048
   Correa AD, 2012, MEM I OSWALDO CRUZ, V107, P11, DOI 10.1590/S0074-02762012000100002
   Davison AJ, 2005, J GEN VIROL, V86, P41, DOI 10.1099/vir.0.80382-0
   Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109
   Dornas FP, 2014, EMERG INFECT DIS, V20, P469, DOI 10.3201/eid2003.131050
   Dornas FP, 2014, PLOS ONE, V2, P1
   Filee J, 2009, J INVERTEBR PATHOL, V101, P169, DOI 10.1016/j.jip.2009.03.010
   Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107
   Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62
   Haley B, 2013, GENOME ANNOUNCEMENTS, V1, P1
   Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009
   Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003
   La Scola B, 2003, SCIENCE, V299, P2033
   Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109
   Souza DSM, 2013, INT J FOOD MICROBIOL, V167, P337, DOI 10.1016/j.ijfoodmicro.2013.09.019
   Monier A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r106
   Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12
   Pagnier I, 2013, INTERVIROLOGY, V56, P354, DOI 10.1159/000354556
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   Raoult D, 2007, CLIN INFECT DIS, V45, P95, DOI 10.1086/518608
   RENAULT T, 1995, VET RES, V26, P539
   Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x
   Saadi H, 2013, INTERVIROLOGY, V56, P424, DOI 10.1159/000354564
   Schaeffer J, 2013, INT J FOOD MICROBIOL, V166, P244, DOI 10.1016/j.ijfoodmicro.2013.07.022
   Silva LCF, 2014, MICROBES INFECT, V16, P187, DOI 10.1016/j.micinf.2013.11.011
   Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160
   Van Etten JL, 2011, VIRUSES-BASEL, V3, P32, DOI 10.3390/v3010032
   Willis JE, 2014, INT J FOOD MICROBIOL, V173, P72, DOI 10.1016/j.ijfoodmicro.2013.11.033
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Yamada T, 2011, CURR OPIN VIROL, V1, P58, DOI 10.1016/j.coviro.2011.05.008
   Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109
   Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223
NR 37
TC 28
Z9 30
U1 0
U2 19
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD FEB
PY 2015
VL 160
IS 2
BP 477
EP 482
DI 10.1007/s00705-014-2257-2
PG 6
WC Virology
SC Virology
GA CB2CE
UT WOS:000349433500015
PM 25344898
DA 2020-11-30
ER

PT J
AU Taranto, MFD
   Pessanha, JEM
   dos Santos, M
   Andrade, ACDP
   Camargos, VN
   Alves, SN
   Oliveira, CD
   Taranto, AG
   dos Santos, LL
   de Magalhaes, JC
   Kroon, EG
   Figueiredo, LB
   Drumond, BP
   Ferreira, JMS
AF da Rocha Taranto, Martinelle Ferreira
   Marques Pessanha, Jose Eduardo
   dos Santos, Michelli
   dos Santos Pereira Andrade, Ana Claudia
   Camargos, Vidyleison Neves
   Alves, Stenio Nunes
   Oliveira, Claudia Di Lorenzo
   Taranto, Alex Gutterres
   dos Santos, Luciana Lara
   de Magalhaes, Jose Carlos
   Kroon, Erna Geessien
   Figueiredo, Leandra Barcelos
   Drumond, Betania Paiva
   Siqueira Ferreira, Jaqueline Maria
TI Dengue outbreaks in Divinopolis, south-eastern Brazil and the geographic
   and climatic distribution of Aedes albopictus and Aedes aegypti in
   2011-2012
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE Aedes albopictus; Aedes aegypti; dengue; entomological index; ovitraps;
   Aedes albopictus; Aedes aegypti; dengue; indice entomologique; pieges a
   OEufs; Aedes albopictus; Aedes aegypti; dengue; indice entomologico;
   ovitrampas
ID RIO-DE-JANEIRO; DIPTERA; CULICIDAE; VIRUS; TEMPERATURE; DYNAMICS;
   HISTORY; TRANSMISSION; REEMERGENCE; MOSQUITOS
AB ObjectiveTo entomologically monitor Aedes spp. and correlate the presence of these vectors with the recent epidemic of dengue in Divinopolis, Minas Gerais State, Brazil.
   MethodsOvitraps were installed at 44 points in the city, covering six urban areas, from May 2011 to May 2012. After collection, the eggs were incubated until hatching. In the 4th stage of development, the larvae were classified as Ae.aegypti or Ae.albopictus.
   ResultsIn total, 25633 Aedes spp. eggs were collected. February was the month with the highest incidence, with 5635 eggs collected and a hatching rate of 46.7%. Ae.aegypti eggs had the highest hatching rate, at 72.3%, whereas Ae.albopictus eggs had 27.7%. Climate and population density influenced the number of eggs found. Indicators of vector presence were positively correlated with the occurrence of dengue cases.
   ConclusionThese data reinforce the need for entomological studies, highlight the relevance of Ae.albopictus as a possible disease vector and demonstrate its adaptation. Ae.albopictus, most commonly found in forested areas, comprised a substantial proportion of the urban mosquito population.
   ObjectifSurveiller entomologiquement Aedes spp. et correler la presence de ces vecteurs avec l'epidemie recente de dengue a Divinopolis, dans l'Etat de Minas Gerais, au Bresil.
   MethodesDes pieges a OEufs ont ete installes a 44 points de la ville, couvrant 6 zones urbaines, de mai 2011 a mai 2012. Apres la collecte, les OEufs ont ete incubes jusqu'a l'eclosion. Au 4(eme) stade de developpement, les larves ont ete classees comme Ae. aegypti ou Ae. albopictus.
   ResultatsAu total, 25 633 OEufs d'Aedes spp. ont ete collectes. Fevrier etait le mois avec l'incidence la plus elevee, avec 5635 OEufs collectes et un taux d'eclosion de 46,7%. Les OEufs d'Ae. aegypti avaient le taux d'eclosion le plus eleve de 72,3% par rapport a 27,7% pour les OEufs d'Ae. albopictus. Le climat et la densite de population influencaient le nombre d'OEufs trouves. Les indicateurs de la presence de vecteurs etaient positivement correles a la survenue des cas de dengue.
   ConclusionCes donnees renforcent la necessite d'etudes entomologiques, mettent en evidence la pertinence de Ae. albopictus comme un possible vecteur de la maladie et demontrent son adaptation. Ae. albopictus, plus souvent retrouve dans les zones boisees, comprend une proportion importante de la population de moustiques urbains.
   ObjetivoRealizar una monitorizacion entomologica de Aedes spp. y correlacionar la presencia de estos vectores con la epidemia reciente de dengue en Divinopolis, Estado de Minas Gerais, Brasil.
   MetodosSe instalaron ovitrampas en 44 puntos de la ciudad, cubriendo 6 areas urbanas, entre Mayo del 2011 y Mayo del 2012. Tras su recoleccion, los huevos se incubaron hasta que eclosionaron. En el 4to estadio de desarrollo, las larvas se clasificaron como Ae. aegypti o Ae. albopictus.
   ResultadosEn total se recolectaron 25,633 huevos de Aedes spp. Febrero fue el mes con la mayor incidencia: se recolectaron 5,635 huevos con una tasa de eclosion del 46.7%. Los huevos de Ae. aegypti tenian la mayor tasa de eclosion (72.3%) que los de Ae. albopictus (27.7%). El clima y la densidad poblacional influian sobre el numero de huevos encontrados. Los indicadores de presencia vectorial estaban positivamente correlacionados con los casos de dengue.
   ConclusionEstos datos refuerzan la necesidad de estudios entomologicos, subrayan la relevancia de Ae. albopictus como un posible vector de enfermedad y demuestran su adaptacion. Ae. albopictus, comunmente encontrado en areas forestales, es tambien una parte sustancial de la poblacion urbana de mosquitos.
C1 [da Rocha Taranto, Martinelle Ferreira; dos Santos, Michelli; dos Santos Pereira Andrade, Ana Claudia; Camargos, Vidyleison Neves; Alves, Stenio Nunes; Oliveira, Claudia Di Lorenzo; Taranto, Alex Gutterres; dos Santos, Luciana Lara; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei, Campus Ctr Oeste Dona Lindu, BR-35501293 Divinopolis, MG, Brazil.
   [Marques Pessanha, Jose Eduardo] Secretaria Municipal Saude Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Marques Pessanha, Jose Eduardo] Univ Fed Minas Gerais, Observ Saude Urbana, Belo Horizonte, MG, Brazil.
   [de Magalhaes, Jose Carlos] Univ Fed Sao Joao del Rei, Dept Quim Biotecnol & Engn Bioproc, Ouro Branco, Brazil.
   [dos Santos Pereira Andrade, Ana Claudia; Kroon, Erna Geessien; Figueiredo, Leandra Barcelos] Univ Fed Minas Gerais, Virus Lab, Belo Horizonte, MG, Brazil.
   [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Virol Lab, Juiz De Fora, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao del Rei, Microbiol Lab, Campus Ctr Oeste Dona Lindu, Rua Sebastiao Goncalves Coelho 400, BR-35501293 Divinopolis, MG, Brazil.
EM jaque@ufsj.edu.br
RI Alves, Stenio Nunes/B-6031-2013; Oliveira, Claudia/O-2326-2019; Kroon,
   Erna Geessien/B-3631-2015; Santos, Luciana L/C-9688-2013; Kroon,
   Erna/V-5444-2019; Taranto, Alex G/F-8618-2012; Santos, Michelli
   dos/Q-2341-2019; Ferreira, Jaqueline/E-4630-2018; Camargos,
   Vidyleison/AAN-2202-2020
OI Alves, Stenio Nunes/0000-0002-4103-2266; Oliveira,
   Claudia/0000-0001-8533-8155; Kroon, Erna Geessien/0000-0003-2721-3826;
   Santos, Luciana L/0000-0001-6186-4062; Taranto, Alex
   G/0000-0002-6086-1043; Santos, Michelli dos/0000-0003-0257-6620;
   Ferreira, Jaqueline/0000-0002-1779-1975; Camargos,
   Vidyleison/0000-0002-7926-0950; Taranto, Martinelle/0000-0001-5556-4506
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); PRONEX
   CNPq/FAPEMIGNational Council for Scientific and Technological
   Development (CNPq)Minas Gerais State Research Foundation (FAPEMIG)
   [550106/2010-3]; CapesCAPES
FX We thank Adriana Aparecida Gomes, Wanderson Teixeira and the health
   agents of the Secretaria Municipal de Saude/Prefeitura Municipal de
   Divinopolis, MG, for their contributions to this work. We are grateful
   for financial support from FAPEMIG, PRONEX CNPq/FAPEMIG 550106/2010-3
   and Capes.
CR Alencar CHM, 2008, REV APS, V11, P459
   Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009
   Chadee DD, 2009, ACTA TROP, V111, P279, DOI 10.1016/j.actatropica.2009.05.012
   Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   de Carvalho-Leandro D, 2010, REV BRAS ENTOMOL, V54, P701, DOI 10.1590/S0085-56262010000400025
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   Decker KD, 2012, JNP-J NURSE PRACT, V8, P389, DOI 10.1016/j.nurpra.2011.09.004
   Degallier N, 2003, REV SAUDE PUBL, V37, P386, DOI 10.1590/s0034-89102003000300019
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036
   Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020
   FAY R. W., 1965, MOSQUITO NEWS, V25, P276
   Gomes de AC, 1998, INF EPIDEMIOL SUS, V7, P49, DOI DOI 10.5123/S0104-16731998000300006
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Khormi HM, 2011, SCI TOTAL ENVIRON, V409, P4713, DOI 10.1016/j.scitotenv.2011.08.028
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Le Goff G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-207
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030178
   Ministerio da Saude: FUNASA-FundacAo Nacional de Saude, 2001, DENG INSTR PESS COMB, P84
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   NOGUEIRA RMR, 1991, MEM I OSWALDO CRUZ, V86, P269, DOI 10.1590/S0074-02761991000200018
   Nunes LS, 2011, BIOTA AMAZONIA, V1, P26
   Padmanabha H, 2012, J INSECT PHYSIOL, V58, P1597, DOI 10.1016/j.jinsphys.2012.09.015
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   PEDRO Antonio, 1923, Brasil-Medico, V1, P173
   Pessanha José Eduardo Marques, 2011, Rev. Soc. Bras. Med. Trop., V44, P103, DOI 10.1590/S0037-86822011000100023
   Ponce G, 2004, REV SALUD PUBLICA NU, V5, P1
   Prophiro JS, 2011, REV SOC BRAS MED TRO, V44, P300, DOI [10.1590/s0037-86822011005000025, 10.1590/S0037-86822011005000025]
   REITER P, 1991, J AM MOSQUITO CONTR, V7, P52
   Reiter Paul, 1997, P425
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   SEMUSA, 2010, B EP
   SEMUSA, 2001, B EP
   Silva HHG, 1999, REV SOC BRAS MED TRO, V32, P349, DOI DOI 10.1590/S0037-86821999000400003
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   SINAN, 2014, SYST REP NOT COND
   Thenmozhi V, 2007, JPN J INFECT DIS, V60, P245
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
NR 51
TC 9
Z9 9
U1 1
U2 41
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD JAN
PY 2015
VL 20
IS 1
BP 77
EP 88
DI 10.1111/tmi.12402
PG 12
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA AW0GX
UT WOS:000345970400010
PM 25328988
OA Bronze
DA 2020-11-30
ER

PT J
AU Albarnaz, JD
   De Oliveira, LC
   Torres, AA
   Palhares, RM
   Casteluber, MC
   Rodrigues, CM
   Cardozo, PL
   De Souza, AMR
   Pacca, CC
   Ferreira, PCP
   Kroon, EG
   Nogueira, ML
   Bonjardim, CA
AF Albarnaz, Jonas D.
   De Oliveira, Leonardo C.
   Torres, Alice A.
   Palhares, Rafael M.
   Casteluber, Marisa C.
   Rodrigues, Claudiney M.
   Cardozo, Pablo L.
   De Souza, Aryadina M. R.
   Pacca, Carolina C.
   Ferreira, Paulo C. P.
   Kroon, Erna G.
   Nogueira, Mauricio L.
   Bonjardim, Claudio A.
TI MEK/ERK activation plays a decisive role in yellow fever virus
   replication: Implication as an antiviral therapeutic target
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Yellow fever virus; Flavivirus; U0126; MEK1/2
ID MEK-INHIBITOR U0126; PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; SIGNALING
   PATHWAY; ENVELOPE PROTEIN; DENGUE VIRUS; PCR ASSAYS; IN-VITRO; VACCINIA;
   IDENTIFICATION
AB Exploiting the inhibition of host signaling pathways aiming for discovery of potential antiflaviviral compounds is clearly a beneficial strategy for the control of life-threatening diseases caused by flaviviruses. Here we describe the antiviral activity of the MEK1/2 inhibitor U0126 against Yellow fever virus 170 vaccine strain (YFV-17D). Infection of VERO cells with YFV-17D stimulates ERK1/2 phosphorylation early during infection. Pharmacological inhibition of MEK1/2 through U0126 treatment of VERO cells blockades not only the YFV-stimulated ERK1/2 phosphorylation, but also inhibits YFV replication by similar to 99%. U0126 was also effective against dengue virus (DENV-2 and -3) and Saint-Louis encephalitis virus (SLEV). Levels of NS4AB, as detected by immunofluorescence, are diminished upon treatment with the inhibitor, as well as the characteristic endoplasmic reticulum membrane invagination stimulated during the infection. Though not protective, treatment of YFV-infected, adult BALB/c mice with U0126 resulted in significant reduction of virus titers in brains. Collectively, our data suggest the potential targeting of the MEK1/2 kinase as a therapeutic tool against diseases caused by flaviviruses such as yellow fever, adverse events associated with yellow fever vaccination and dengue. C) 2014 Elsevier BA/. All rights reserved.
C1 [Albarnaz, Jonas D.; De Oliveira, Leonardo C.; Torres, Alice A.; Palhares, Rafael M.; Casteluber, Marisa C.; Rodrigues, Claudiney M.; Cardozo, Pablo L.; De Souza, Aryadina M. R.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Grp Transducao Sinal Flavivirus, BR-31270901 Belo Horizonte, MG, Brazil.
   [Albarnaz, Jonas D.; De Oliveira, Leonardo C.; Torres, Alice A.; Palhares, Rafael M.; Casteluber, Marisa C.; Rodrigues, Claudiney M.; Cardozo, Pablo L.; De Souza, Aryadina M. R.; Ferreira, Paulo C. P.; Kroon, Erna G.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pacca, Carolina C.; Nogueira, Mauricio L.] Fac Med Sao Jose de Rio Preto, Sao Paulo, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Grp Flaviviruses Viruses Lab, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM claudio.bonjardim@pq.cnpq.br
RI Cardozo, Pablo Leal/V-8093-2019; Kroon, Erna Geessien/B-3631-2015; Abreu
   Torres, Alice/B-1475-2018; Pacca, Carolina Colombelli/B-8972-2017;
   Nogueira, Mauricio L/B-7599-2012; Kroon, Erna/V-5444-2019; Albarnaz,
   Jonas Dutra/E-4526-2010
OI Cardozo, Pablo Leal/0000-0001-5877-9393; Kroon, Erna
   Geessien/0000-0003-2721-3826; Abreu Torres, Alice/0000-0003-2352-2584;
   Pacca, Carolina Colombelli/0000-0001-9252-2137; Nogueira, Mauricio
   L/0000-0003-1102-2419; Albarnaz, Jonas Dutra/0000-0002-8792-813X;
   Palhares, Rafael/0000-0003-2512-8273
FU Minas Gerais State's Foundation (FAPEMIG)Minas Gerais State Research
   Foundation (FAPEMIG) [CBB - APQ-01670-11]; National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [477187/2010-2];
   PRONEX-Dengue [550106/2010-3]; CNPqNational Council for Scientific and
   Technological Development (CNPq); Brazilian Federal Agency (CAPES)CAPES;
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); CAPESCAPES
FX This work was supported by the Minas Gerais State's Foundation for
   Research Support (FAPEMIG) - (CBB - APQ-01670-11 to C.A.B.); the
   National Council for Scientific and Technological Development (CNPq)
   -(477187/2010-2 to C.A.B.) and PRONEX-Dengue - (550106/2010-3 to E.G.K.
   and M.L.N.).The authors are grateful to Dr. Charles Rice (Rockfeller
   University, USA) who kindly provided us with Antibody anti-YFV NS4AB.
   J.D.A., L.C.O. and P.L.C. were recipients of pre-doctoral and scientific
   initiation fellowships, respectively, from CNPq. A.A.T. and A.M.R.S. are
   recipients of fellowships from Brazilian Federal Agency for Support and
   Evaluation of Graduate Education (CAPES) and FAPEMIG, respectively.
   R.M.P. and C.C.P. were recipients of master fellowships from CAPES.
   M.C.C. was recipient of a post-doctoral fellowship from FAPEMIG. C.M.R.
   is recipient of a post-doctoral fellowship from CNPq. C.A.B., E.G.K.,
   M.L.N. and P.C.P.F. are recipients of research fellowships from CNPq.
CR Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   Bonaldo MC, 2014, HUM VACC IMMUNOTHER, V10, P1256, DOI 10.4161/hv.28117
   Bray M, 2008, ANTIVIR RES, V78, P1, DOI 10.1016/j.antiviral.2007.12.007
   Briand S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000483
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   De Beeck AO, 2004, J VIROL, V78, P12591, DOI 10.1128/JVI.78.22.12591-12602.2004
   De Clercq E, 2013, BIOCHEM PHARMACOL, V85, P727, DOI 10.1016/j.bcp.2012.12.011
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   Droebner K, 2011, ANTIVIR RES, V92, P195, DOI 10.1016/j.antiviral.2011.08.002
   Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Ferreira GP, 2010, MICROBES INFECT, V12, P546, DOI 10.1016/j.micinf.2010.03.007
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gupta N, 2011, FEMS IMMUNOL MED MIC, V62, P110, DOI 10.1111/j.1574-695X.2011.00792.x
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   Martin M, 2001, LANCET, V358, P98, DOI 10.1016/S0140-6736(01)05327-2
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Mazzocca A, 2005, J BIOL CHEM, V280, P11329, DOI 10.1074/jbc.M410161200
   Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Morais ATS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-205
   Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642
   Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498
   Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014
   Pereira ACTC, 2012, J VIROL, V86, P172, DOI 10.1128/JVI.05638-11
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pinto R, 2011, ANTIVIR RES, V92, P45, DOI 10.1016/j.antiviral.2011.05.009
   Planz O, 2013, ANTIVIR RES, V98, P457, DOI 10.1016/j.antiviral.2013.04.008
   Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Robertson SE, 2006, MOL BIOL CELL, V17, P645, DOI 10.1091/mbc.E05-07-0662
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Scherbik SV, 2010, J VIROL, V84, P8721, DOI 10.1128/JVI.00144-10
   Smith J.L., 2014, J VIROL IN PRESS
   Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09
   Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
   Wang ZQ, 2004, BRAIN RES, V996, P55, DOI 10.1016/j.brainres.2003.09.074
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Yang TC, 2010, MICROBES INFECT, V12, P643, DOI 10.1016/j.micinf.2010.04.007
   Zhao LJ, 2013, CELL STRESS CHAPERON, V18, P495, DOI 10.1007/s12192-013-0405-3
   Zhao LJ, 2006, J LEUKOCYTE BIOL, V80, P424, DOI 10.1189/jlb.0106014
   Zhao LJ, 2005, EXP CELL RES, V305, P23, DOI 10.1016/j.yexcr.2004.12.024
NR 49
TC 21
Z9 21
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD NOV
PY 2014
VL 111
BP 82
EP 92
DI 10.1016/j.antiviral.2014.09.004
PG 11
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA AT8LP
UT WOS:000345185100013
PM 25241249
DA 2020-11-30
ER

PT J
AU Trindade, GD
   Fernandes, ATD
   Costa, GB
   Figueiredo, PD
   Abrahao, JS
   Kroon, EG
   Figueiredo, LTM
   da Fonseca, FG
AF Trindade, Giliane de Souza
   da Silva Fernandes, Andre Tavares
   Costa, Galileu Barbosa
   Figueiredo, Poliana de Oliveira
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
   Moraes Figueiredo, Luiz Tadeu
   da Fonseca, Flavio Guimaraes
TI Could hantavirus circulation superpose areas of highly endemic vaccinia
   virus outbreaks? A retrospective seroepidemiological study in State of
   Minas Gerais
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Hantavirus; Rural population; Bovine vaccinia
ID INFECTION; REGIONS; PAULO
AB Introduction: Hantavirus infections have been described in several regions in Brazil through seroepidemiological studies. Usually, populations are associated with rural and wild environment mainly due to close contact to species of Sigmodontinae rodents, considered hantavirus reservoirs. Methods: A retrospective serosurvey was conducted to access the hantavirus seroprevalence in people living in regions affected by bovine vaccinia outbreaks. Results: Sera from 53 patients were analyzed and none of them presented anti-hantavirus IgG antibodies. Conclusions: This study presents an opportunity to analyze seronegativity despite close and recurrent contact with known hantavirus reservoirs. Aspects of hantavirus and bovine vaccinia emergence are also discussed.
C1 [Trindade, Giliane de Souza; Costa, Galileu Barbosa; Figueiredo, Poliana de Oliveira; Abrahao, Jonatas Santos; Kroon, Erna Geessien] Univ Fed Minas Gerais, ICB, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [da Silva Fernandes, Andre Tavares] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, RJ, Brazil.
   [Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Pesquisa Virol, Ribeirao Preto, SP, Brazil.
   [da Fonseca, Flavio Guimaraes] Univ Fed Minas Gerais, ICB, Dept Microbiol, Lab Virol Basica & Aplicada, BR-31270901 Belo Horizonte, MG, Brazil.
RP Trindade, GD (corresponding author), Univ Fed Minas Gerais, ICB, Dept Microbiol, Virus Lab, Av Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM giliane@icb.ufmg.br
RI Costa, Galileu Barbosa/M-5768-2019; Kroon, Erna/V-5444-2019; Costa,
   Galileu/C-3319-2014; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Barbosa Costa,
   Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Fundacao de Amparo a Pesquisa do Estado de Minas
   GeraisMinas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior, Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais, Ministerio da Agricultura, Pecuaria
   e Abastecimento. G.S. Trindade, E.G. Kroon and F.G. da Fonseca are CNPq
   fellowship recipients.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Badra SJ, 2012, REV SOC BRAS MED TRO, V45, P468, DOI [10.1590/S0037-86822012005000005, 10.1590/s0037-86822012005000005]
   de Souza WM, 2012, REV INST MED TROP SP, V54, P193, DOI 10.1590/S0036-46652012000400002
   Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Lima DM, 2011, REV SOC BRAS MED TRO, V44, P795, DOI 10.1590/S0037-86822011000600031
   Gimaque JBL, 2012, MEM I OSWALDO CRUZ, V107, P135, DOI 10.1590/S0074-02762012000100019
   Limongi JE, 2009, EMERG INFECT DIS, V15, P1981, DOI 10.3201/eid1512.090229
   Limongi JE, 2007, REV SOC BRAS MED TRO, V40, P295, DOI 10.1590/S0037-86822007000300009
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Medeiros DBA, 2010, MEM I OSWALDO CRUZ, V105, P665, DOI 10.1590/S0074-02762010000500011
   Figueiredo LTM, 2009, AM J TROP MED HYG, V81, P273, DOI 10.4269/ajtmh.2009.81.273
   Pereira GW, 2012, REV SOC BRAS MED TRO, V45, P117, DOI 10.1590/S0037-86822012000100022
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Schatzmayr HG, 2011, VACCINE, V29, pD65, DOI 10.1016/j.vaccine.2011.09.105
NR 15
TC 1
Z9 1
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD NOV-DEC
PY 2014
VL 47
IS 6
BP 778
EP 782
DI 10.1590/0037-8682-0033-2014
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AZ4PE
UT WOS:000348204000016
PM 25626659
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Boratto, P
   Dornas, FP
   Silva, LC
   Campos, RK
   Almeida, GMF
   Kroon, EG
   La Scola, B
AF Abrahao, Jonatas S.
   Boratto, Paulo
   Dornas, Fabio P.
   Silva, Lorena C.
   Campos, Rafael K.
   Almeida, Gabriel M. F.
   Kroon, Erna G.
   La Scola, Bernard
TI Growing a giant: Evaluation of the virological parameters for mimivirus
   production
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Mimivirus; Amoebae; Virus production; Total particles, Viral genome,
   giant virus
ID VIRUSES; HIGHLIGHTS; AMEBAS
AB Acanthamoeba polyphaga mimivirus (APMV) was described in 2003, and due to its unique structural and genetic complexity, the viral family Mimiviridae was created. APMV prompted the creation of an open field of study on the function of hundreds of never-before-seen open reading frames (ORFs) and their roles in virus-host interactions. In recent years, several giant viruses have been isolated from different environments and specimens. Although the scientific community has experienced a remarkable advancement in the comprehension of the mimivirus replication cycle in the last years, few studies have been devoted to the investigation of the methodological features and conditions for mimivirus cultivation. In this work, conditions for the cultivation of mimivirus isolates were investigated to obtain relevant information about the production of infectious particles, total viral particles and viral DNA. The results suggest that low viral doses are more efficient for the production of infectious particles, yielding up to 5000 TCID50 for each inoculated TCID50. Besides methodological information, these data also reveal, for the first time, the ratio between total and infectious particles (in TCID50) that are produced during mimivirus cultivation in laboratory conditions. All of this information can be used as a worldwide guide for the production of mimiviruses and can help prompt mimivirological studies in different fields. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Abrahao, Jonatas S.; Boratto, Paulo; Dornas, Fabio P.; Silva, Lorena C.; Campos, Rafael K.; Almeida, Gabriel M. F.; Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Abrahao, Jonatas S.; La Scola, Bernard] Aix Marseille Univ, URMITE, Fac Med, CNRS IRD INSERM U1095 UM63 7278 198, Marseille, France.
RP Abrahao, JS (corresponding author), Dept Microbiol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Abrahao, Jonatas/B-3895-2015; Almeida, Gabriel
   MF/I-8910-2012; Campos, Rafael Kroon/AAB-5135-2020; Kroon, Erna
   Geessien/B-3631-2015; Dornas, Fabio/AAI-3582-2020; LA SCOLA,
   Bernard/P-6477-2016
OI Abrahao, Jonatas/0000-0001-9420-1791; Almeida, Gabriel
   MF/0000-0003-2317-5092; Campos, Rafael Kroon/0000-0002-4852-0449; Kroon,
   Erna Geessien/0000-0003-2721-3826; Dornas, Fabio/0000-0001-7926-5551; LA
   SCOLA, Bernard/0000-0001-8006-7704
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Pro-Reitoria de Pesquisa da UFMG (PRPq-UFMG); CAPESCAPES;
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); MAPA
FX We thank all colleagues from the Laboratorio de Virus (ICB-UFMG) for
   technical support. Financial support was provided by CNPq, Pro-Reitoria
   de Pesquisa da UFMG (PRPq-UFMG), CAPES, FAPEMIG, and MAPA.
CR Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Campos RK, 2012, J CLIN VIROL, V55, P323, DOI 10.1016/j.jcv.2012.08.009
   Condit R., 2007, FIELDS VIROLOGY, VII, P26
   Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109
   Dornas FP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087811
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   Kuznetsov YG, 2014, J VIROL, V88, P3055, DOI 10.1128/JVI.03772-13
   La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538
   La Scola B, 2003, SCIENCE, V299, P2033
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410
   Mutsafi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003367
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sambrook J, 1989, LAB MANUAL
   Silva L.C., 2013, MICROBES INFECT, V13, pS1286
   Smallwood Sherin E, 2010, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14a01s17
   Staib Caroline, 2004, Methods Mol Biol, V269, P77
   Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109
NR 21
TC 6
Z9 6
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD OCT
PY 2014
VL 207
BP 6
EP 11
DI 10.1016/j.jviromet.2014.06.001
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA AP7GR
UT WOS:000342246300002
PM 24972367
DA 2020-11-30
ER

PT J
AU Franco-Luiz, APM
   Fagundes-Pereira, A
   Costa, GB
   Alves, PA
   Oliveira, DB
   Bonjardim, CA
   Ferreira, PCP
   Trindade, GD
   Panei, CJ
   Galosi, CM
   Abrahao, JS
   Kroon, EG
AF Moreira Franco-Luiz, Ana Paula
   Fagundes-Pereira, Alexandre
   Costa, Galileu Barbosa
   Alves, Pedro Augusto
   Oliveira, Danilo Bretas
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Trindade, Giliane de Souza
   Javier Panei, Carlos
   Monica Galosi, Cecilia
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
TI Spread of Vaccinia Virus to Cattle Herds, Argentina, 2011
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID BOVINE VACCINIA; BRAZIL
C1 [Moreira Franco-Luiz, Ana Paula; Fagundes-Pereira, Alexandre; Costa, Galileu Barbosa; Alves, Pedro Augusto; Oliveira, Danilo Bretas; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Trindade, Giliane de Souza; Abrahao, Jonatas Santos; Kroon, Erna Geessien] Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil.
   [Javier Panei, Carlos; Monica Galosi, Cecilia] Univ Nacl La Plata, Buenos Aires, DF, Argentina.
   [Javier Panei, Carlos] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.
   [Monica Galosi, Cecilia] Comis Invest Cient Prov Buenos Aires, Buenos Aires, DF, Argentina.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM ernagkroon@gmail.com
RI Alves, Pedro/T-7203-2019; Costa, Galileu Barbosa/M-5768-2019; Kroon,
   Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Costa,
   Galileu/C-3319-2014; Abrahao, Jonatas/B-3895-2015
OI Alves, Pedro/0000-0002-9659-5621; Kroon, Erna
   Geessien/0000-0003-2721-3826; Abrahao, Jonatas/0000-0001-9420-1791;
   Barbosa Costa, Galileu/0000-0001-7360-6722
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Cohen JI, 2007, VACCINE, V25, P4571, DOI 10.1016/j.vaccine.2007.03.044
   Damon I, 2007, FIELDS VIROLOGY, P2947
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Savona MR, 2006, JAMA-J AM MED ASSOC, V295, P1895
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
NR 10
TC 14
Z9 14
U1 0
U2 17
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2014
VL 20
IS 9
BP 1576
EP 1578
DI 10.3201/eid2009.140154
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AO3JY
UT WOS:000341226700031
PM 25153340
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Figueiredo, LB
   Sakamoto, T
   Coelho, LFL
   Rocha, ESD
   Cota, MMG
   Ferreira, GP
   de Oliveira, JG
   Kroon, EG
AF Figueiredo, Leandra Barcelos
   Sakamoto, Tetsu
   Leomil Coelho, Luiz Felipe
   de Oliveira Rocha, Eliseu Soares
   Gomes Cota, Marcela Menezes
   Ferreira, Gustavo Portela
   de Oliveira, Jaquelline Germano
   Kroon, Erna Geessien
TI Dengue Virus 2 American-Asian Genotype Identified during the 2006/2007
   Outbreak in Piaui, Brazil Reveals a Caribbean Route of Introduction and
   Dissemination of Dengue Virus in Brazil
SO PLOS ONE
LA English
DT Article
ID RIO-DE-JANEIRO; CO-CIRCULATION; TYPE-2; EVOLUTION; EMERGENCE; PROTEIN;
   STATE
AB Dengue virus (DENV) is the most widespread arthropod-borne virus, and the number and severity of outbreaks has increased worldwide in recent decades. Dengue is caused by DENV-1, DENV-2, DENV-3 and DENV-4 which are genetically distant. The species has been subdivided into genotypes based on phylogenetic studies. DENV-2, which was isolated from dengue fever patients during an outbreak in Piaui, Brazil in 2006/2007 was analyzed by sequencing the envelope (E) gene. The results indicated a high similarity among the isolated viruses, as well as to other DENV-2 from Brazil, Central America and South America. A phylogenetic and phylogeographic analysis based on DENV-2E gene sequences revealed that these viruses are grouped together with viruses of the American-Asian genotype in two distinct lineages. Our results demonstrate the co-circulation of two American-Asian genotype lineages in northeast Brazil. Moreover, we reveal that DENV-2 lineage 2 was detected in Piaui before it disseminated to other Brazilian states and South American countries, indicating the existence of a new dissemination route that has not been previously described.
C1 [Figueiredo, Leandra Barcelos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
   [Sakamoto, Tetsu] Univ Fed Minas Gerais, Lab Biodados, Belo Horizonte, MG, Brazil.
   [Leomil Coelho, Luiz Felipe] Univ Fed Alfenas, Lab Vacinas, Alfenas, MG, Brazil.
   [de Oliveira Rocha, Eliseu Soares; Gomes Cota, Marcela Menezes] Univ Fed Minas Gerais, Virus Lab, Belo Horizonte, MG, Brazil.
   [Ferreira, Gustavo Portela] Univ Fed Piaui, Lab Biotecnol, Parnaiba, Piaui, Brazil.
   [de Oliveira, Jaquelline Germano] Fundacao Oswaldo Cruz, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
EM ernagkroon@gmail.cozm
RI Coelho, Luiz FL/G-5853-2012; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015; Sakamoto, Tetsu/N-7951-2014
OI Kroon, Erna Geessien/0000-0003-2721-3826; Sakamoto,
   Tetsu/0000-0003-3023-0117; Coelho, Luiz Felipe/0000-0003-4289-384X;
   Rocha, Eliseu/0000-0002-2854-0768
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); INCT;
   PRONEX-Dengue, Departamento de Ciencia e Tecnologia do Ministerio da
   Saude (DECIT/MS)
FX This study was funded by Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG), INCT and PRONEX-Dengue, Departamento de Ciencia e
   Tecnologia do Ministerio da Saude (DECIT/MS). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Amarilla AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-113
   Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459
   Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011
   de Castro JAF, 2003, MEM I OSWALDO CRUZ, V98, P1021, DOI 10.1590/S0074-02762003000800007
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   DESOUZA RV, 1995, MEM I OSWALDO CRUZ, V90, P345, DOI 10.1590/S0074-02761995000300006
   Drummond A., 2002, BEAUTI BAYESIAN EVOL
   Drummond A.J., 2002, BEAST BAYESIAN EVOLU
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   Gardella-Garcia CE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-117
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   Mendez JA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-64
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996
   Posada D, 2011, JMODELTEST PHYLOGENE
   Rambaut A, 2002, TREEANOTATOR V1 6 1
   Rambaut A., 2006, TREE FIGURE DRAWING
   Rambaut A., 2003, TRACER MCMC TRACE AN
   Rambaut A, 2013, PATH O GEN SOFTWARE
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811
   Thiel HJ, 2007, FIELDS VIROLOGY, P810
   Twiddy SS, 2002, J GEN VIROL, V83, P1679, DOI 10.1099/0022-1317-83-7-1679
   Vasconcelos Pedro F. Da C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P253
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Wang WK, 2000, J CLIN MICROBIOL, V38, P3306, DOI 10.1128/JCM.38.9.3306-3310.2000
   Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0
NR 47
TC 7
Z9 7
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 15
PY 2014
VL 9
IS 8
AR e104516
DI 10.1371/journal.pone.0104516
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AN8UD
UT WOS:000340879300029
PM 25127366
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Rocha, RP
   Livonesi, MC
   Fumagalli, MJ
   Rodrigues, NF
   da Costa, LCF
   dos Santos, MCSG
   Rocha, ESD
   Kroon, EG
   Malaquias, LCC
   Coelho, LFL
AF Rocha, Raissa Prado
   Livonesi, Marcia Cristina
   Fumagalli, Marcilio Jorge
   Rodrigues, Naiara Ferreira
   Felipe da Costa, Lauro Cesar
   Silva Gomes dos Santos, Michelle Cristina
   de Oliveira Rocha, Eliseu Soares
   Kroon, Erna Geessien
   Cotta Malaquias, Luiz Cosme
   Leomil Coelho, Luiz Felipe
TI Evaluation of tetravalent and conserved synthetic peptides vaccines
   derived from Dengue virus Envelope domain I and II
SO VIRUS RESEARCH
LA English
DT Article
DE Dengue virus; Peptides; Vaccine; Envelope protein
ID T-CELLS; IMMUNE-RESPONSE; ANTIBODIES; INFECTION; FEVER
AB Dengue is a major worldwide public health problem, especially in the tropical and subtropical regions of the world. Primary infection with a single Dengue virus (DENV) serotype causes a mild, self-limiting febrile illness called dengue fever. However, a subset of patients experiencing a secondary infection with a different serotype progress to the severe form of the disease, called dengue hemorrhagic fever. In this study, the vaccine potential of three tetravalent and conserved synthetic peptides derived from DENV envelope domain I (named Pep01) and II (named Pep02 and Pep03) was evaluated. Human dengue IgM/IgG positive serum (n = 16) showed reactivity against Pep01, Pep02 and Pep03 in different degrees. Mice immunization experiments showed that these peptides were able to induce a humoral response characterized by antibodies with low neutralizing activity. The spleen cells derived from mice immunized with the peptides showed a significant cytotoxic activity (only for Pep02 and Pep03), a high expression of IL-10 (P < 0.01) and a reduced expression of TNF-alpha and IFN-gamma (P < 0.001) compared to DENV-1 infected splenocytes. Thus these peptides, and specially the Pep03, can induce a humoral response characterized by antibodies with low neutralizing activities and probably a T cell response that could be beneficial to induce an effective immune response against all DENV serotypes and do not contributed to the immunopathogenesis. However, further studies in peptide sequence will be required to induce the production of neutralizing antibodies against all four DENV serotypes and also to improve immunogenicity of these peptides. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Rocha, Raissa Prado; Fumagalli, Marcilio Jorge; Rodrigues, Naiara Ferreira; Felipe da Costa, Lauro Cesar; Silva Gomes dos Santos, Michelle Cristina; Cotta Malaquias, Luiz Cosme; Leomil Coelho, Luiz Felipe] Univ Fed Alfenas, Inst Ciencias Biomed, Lab Vacinas, BR-37130000 Ctr Alfenas, MG, Brazil.
   [Livonesi, Marcia Cristina] Univ Fed Alfenas, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-37130000 Ctr Alfenas, MG, Brazil.
   [de Oliveira Rocha, Eliseu Soares; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.
RP Coelho, LFL (corresponding author), Univ Fed Alfenas, Inst Ciencias Biomed, Lab Vacinas, Rua Gabriel Monteiro 700, BR-37130000 Ctr Alfenas, MG, Brazil.
EM coelho@unifal-mg.edu.br
RI Kroon, Erna/V-5444-2019; Coelho, Luiz FL/G-5853-2012; Rocha,
   Raissa/ABF-1480-2020; Fumagalli, Marcilio/ABE-1183-2020; Kroon, Erna
   Geessien/B-3631-2015
OI Fumagalli, Marcilio/0000-0002-0207-5423; Kroon, Erna
   Geessien/0000-0003-2721-3826; Rocha, Eliseu/0000-0002-2854-0768; Coelho,
   Luiz Felipe/0000-0003-4289-384X
FU The Minas Gerais State Research Foundation (FAPEMIG) [APQ-04684-10]
FX Financial support was provided by The Minas Gerais State Research
   Foundation (FAPEMIG) grant APQ-04684-10.
CR Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dong T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001192
   Guzman MG, 2010, EXPERT REV VACCINES, V9, P137, DOI 10.1586/ERV.09.139
   Halstead SB, 2012, PAEDIATR INT CHILD H, V32, P5, DOI 10.1179/2046904712Z.00000000045
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mazumder R, 2007, VIRUS GENES, V35, P175, DOI 10.1007/s11262-007-0103-2
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Niedrig M, 1999, TROP MED INT HEALTH, V4, P867, DOI 10.1046/j.1365-3156.1999.00496.x
   Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12
   Rodenhuis-Zybert IA, 2011, TRENDS MICROBIOL, V19, P248, DOI 10.1016/j.tim.2011.02.002
   Rodrigues NF, 2013, VACCINE, V31, P5062, DOI 10.1016/j.vaccine.2013.08.078
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7
   Schieffelin JS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-28
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Wan SW, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-37
NR 20
TC 8
Z9 8
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD AUG 8
PY 2014
VL 188
BP 122
EP 127
DI 10.1016/j.virusres.2014.04.009
PG 6
WC Virology
SC Virology
GA AL4TS
UT WOS:000339128300016
PM 24768848
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Dornas, FP
   Silva, LCF
   Almeida, GM
   Boratto, PVM
   Colson, P
   La Scola, B
   Kroon, EG
AF Abrahao, Jnatas S.
   Dornas, Fabio P.
   Silva, Lorena C. F.
   Almeida, Gabriel M.
   Boratto, Paulo V. M.
   Colson, Phillipe
   La Scola, Bernard
   Kroon, Erna G.
TI Acanthamoeba polyphaga mimivirus and other giant viruses: an open field
   to outstanding discoveries
SO VIROLOGY JOURNAL
LA English
DT Review
DE Giant viruses; Mimiviridae; Mimivirus
ID LARGE DNA VIRUSES; VENTILATOR-ASSOCIATED PNEUMONIA; TRANSFER-RNA
   SYNTHETASES; ATOMIC-FORCE MICROSCOPY; FREE-LIVING AMEBAS; GENOME
   SEQUENCE; GENE REPERTOIRE; 1ST ISOLATION; VIROPHAGE; EUKARYOTES
AB In 2003, Acanthamoeba polyphaga mimivirus (APMV) was first described and began to impact researchers around the world, due to its structural and genetic complexity. This virus founded the family Mimiviridae. In recent years, several new giant viruses have been isolated from different environments and specimens. Giant virus research is in its initial phase and information that may arise in the coming years may change current conceptions of life, diversity and evolution. Thus, this review aims to condense the studies conducted so far about the features and peculiarities of APMV, from its discovery to its clinical relevance.
C1 [Abrahao, Jnatas S.; Dornas, Fabio P.; Silva, Lorena C. F.; Almeida, Gabriel M.; Boratto, Paulo V. M.; Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Colson, Phillipe; La Scola, Bernard] Aix Marseille Univ, Inserm 1095, URMITE, UM63,CNRS 7278,IRD 198, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Ave Antonio Carlos,6627,Caixa Postal 486,Bloco F4, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Abrahao, Jonatas/B-3895-2015; Colson, Philippe/P-6355-2014; Dornas,
   Fabio/AAI-3582-2020; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015; LA SCOLA, Bernard/P-6477-2016; Almeida, Gabriel
   MF/I-8910-2012
OI Abrahao, Jonatas/0000-0001-9420-1791; Colson,
   Philippe/0000-0001-6285-0308; Dornas, Fabio/0000-0001-7926-5551; Kroon,
   Erna Geessien/0000-0003-2721-3826; LA SCOLA,
   Bernard/0000-0001-8006-7704; Almeida, Gabriel MF/0000-0003-2317-5092
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao de Amparo
   a Pesquisa do Estado de Minas GeraisMinas Gerais State Research
   Foundation (FAPEMIG); Pro-Reitoria de Pesquisa da UFMG; Centro de
   Microscopia da UFMG
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior, the Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais, Pro-Reitoria de Pesquisa da UFMG, and Centro de Microscopia da
   UFMG. F.G.K. is researcher of the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico.
CR Abergel C, 2007, J VIROL, V81, P12406, DOI 10.1128/JVI.01107-07
   Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Azza S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-39
   Boratto PVM, 2014, ARCH VIROL, V159, P1039, DOI 10.1007/s00705-013-1924-z
   Boughalmi M, 2013, VIRUSES-BASEL, V5, P2920, DOI 10.3390/v5122920
   Bousbia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058111
   Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108
   Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042
   Campos RK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-95
   Campos RK, 2012, J CLIN VIROL, V55, P323, DOI 10.1016/j.jcv.2012.08.009
   Claverie JM, 2009, CURR TOP MICROBIOL, V328, P89
   Claverie Jean-Michel, 2013, Commun Integr Biol, V6, pe25685, DOI 10.4161/cib.25685
   Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003
   Claverie JM, 2009, ANNU REV GENET, V43, P49, DOI 10.1146/annurev-genet-102108-134255
   Claverie JM, 2009, J INVERTEBR PATHOL, V101, P172, DOI 10.1016/j.jip.2009.03.011
   Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6
   Colson P, 2013, INTERVIROLOGY, V56, P364, DOI 10.1159/000354557
   Colson P, 2013, INTERVIROLOGY, V56, P376, DOI 10.1159/000354558
   Colson P, 2013, J CLIN VIROL, V57, P191, DOI 10.1016/j.jcv.2013.03.018
   Colson P, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00091
   Colson P, 2012, INTERVIROLOGY, V55, P321, DOI 10.1159/000336562
   Colson P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018935
   Colson P, 2010, INTERVIROLOGY, V53, P330, DOI 10.1159/000312918
   Costa AO, 2010, J EUKARYOT MICROBIOL, V57, P70, DOI 10.1111/j.1550-7408.2009.00453.x
   Costa C, 2012, INTERVIROLOGY, V55, P303, DOI 10.1159/000329088
   Coulon C, 2010, J CLIN MICROBIOL, V48, P2689, DOI 10.1128/JCM.00309-10
   Dai W, 2013, NATURE, V502, P707, DOI 10.1038/nature12604
   Dare RK, 2008, EMERG INFECT DIS, V14, P465, DOI 10.3201/eid1403.071027
   Desnues C, 2010, INTERVIROLOGY, V53, P293, DOI 10.1159/000312914
   Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109
   Desnues C, 2012, ADV VIRUS RES, V82, P63, DOI 10.1016/B978-0-12-394621-8.00013-3
   Dornas FP, 2014, EMERG INFECT DIS, V20, P469, DOI 10.3201/eid2003.131050
   Dornas FP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087811
   Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412
   Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107
   Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004
   Hakim M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050649
   Harriff Melanie, 2008, V465, P433, DOI 10.1007/978-1-59745-207-6_28
   Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59
   Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905
   Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001
   Khan M, 2007, MICROB PATHOGENESIS, V42, P56, DOI 10.1016/j.micpath.2006.08.004
   KILVINGTON S, 1990, J APPL BACTERIOL, V68, P519, DOI 10.1111/j.1365-2672.1990.tb02904.x
   Klose T, 2010, INTERVIROLOGY, V53, P268, DOI 10.1159/000312911
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Kuznetsov YG, 2013, J VIROL, V87, P11200, DOI 10.1128/JVI.01372-13
   La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218
   La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Legendre M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-99
   Luther KB, 2011, J BIOL CHEM, V286, P43701, DOI 10.1074/jbc.M111.309096
   Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003
   Marrie TJ, 2012, SEMIN RESP CRIT CARE, V33, P244, DOI 10.1055/s-0032-1315636
   Matsuo J, 2008, APPL ENVIRON MICROB, V74, P6397, DOI 10.1128/AEM.00841-08
   McPherson A, 2011, METHODS MOL BIOL, V736, P171, DOI 10.1007/978-1-61779-105-5_12
   Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12
   Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12
   Mutsafi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003367
   Mutsafi Y, 2010, P NATL ACAD SCI USA, V107, P5978, DOI 10.1073/pnas.0912737107
   Nasir A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-156
   Pagnier I, 2013, INTERVIROLOGY, V56, P354, DOI 10.1159/000354556
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Piacente F, 2012, J BIOL CHEM, V287, P3009, DOI 10.1074/jbc.M111.314559
   Popgeorgiev N, 2013, J INFECT DIS, V208, P1042, DOI 10.1093/infdis/jit292
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   Raoult D, 2006, ANN INTERN MED, V144, P702, DOI 10.7326/0003-4819-144-9-200605020-00025
   Renesto P, 2006, J VIROL, V80, P11678, DOI 10.1128/JVI.00940-06
   Rohr U, 1998, APPL ENVIRON MICROB, V64, P1822
   Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x
   Saadi H, 2013, INTERVIROLOGY, V56, P424, DOI 10.1159/000354564
   Saadi H, 2013, CLIN INFECT DIS, V57, pE127, DOI 10.1093/cid/cit354
   Saini HK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-115
   Shah N, 2014, J VIROL, V88, P838, DOI 10.1128/JVI.03141-13
   Sheik AR, 2014, ISME J, V8, P212, DOI 10.1038/ismej.2013.135
   Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005
   Silva LCF, 2014, MICROBES INFECT, V16, P187, DOI 10.1016/j.micinf.2013.11.011
   Slimani M, 2013, INTERVIROLOGY, V56, P434, DOI 10.1159/000354566
   Suhre K, 2005, P NATL ACAD SCI USA, V102, P14689, DOI 10.1073/pnas.0506465102
   Turner P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-434
   Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338
   Vanspauwen MJ, 2013, J MED VIROL, V85, P1836, DOI 10.1002/jmv.23655
   Vanspauwen MJ, 2012, RESP MED, V106, P1690, DOI 10.1016/j.rmed.2012.08.019
   Vincent A, 2009, CRIT CARE MED, V37, P111, DOI 10.1097/CCM.0b013e318192fa8b
   Visvesvara Govinda S, 2013, Handb Clin Neurol, V114, P153, DOI 10.1016/B978-0-444-53490-3.00010-8
   Williams TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021080
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Yoosuf N, 2014, VIRUS GENES, V48, P218, DOI 10.1007/s11262-013-1016-x
   Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109
   Yutin N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-158
   Yutin N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-106
   Yutin N, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-161
   Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-51
   Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114
NR 99
TC 30
Z9 30
U1 0
U2 35
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUN 30
PY 2014
VL 11
AR 120
DI 10.1186/1743-422X-11-120
PG 12
WC Virology
SC Virology
GA AK5JW
UT WOS:000338461800001
PM 24976356
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Oliveira, GP
   Fernandes, ATS
   de Assis, FL
   Alves, PA
   Luiz, APMF
   Figueiredo, LB
   de Almeida, CMC
   Travassos, CEPF
   Trindade, GD
   Abrahao, JS
   Kroon, EG
AF Oliveira, Graziele Pereira
   Silva Fernandes, Andre Tavares
   de Assis, Felipe Lopes
   Alves, Pedro Augusto
   Moreira Franco Luiz, Ana Paula
   Figueiredo, Leandra Barcelos
   Costa de Almeida, Claudia Maria
   Pires Ferreira Travassos, Carlos Eurico
   Trindade, Giliane de Souza
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
TI Short Report: Intrafamilial Transmission of Vaccinia virus during a
   Bovine Vaccinia Outbreak in Brazil: A New Insight in Viral Transmission
   Chain
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID RIO-DE-JANEIRO; SMALLPOX; CATTLE; ORTHOPOXVIRUS; INFECTION; POXVIRUS;
   HUMANS; STATE
AB Bovine vaccinia (BV) is an emerging zoonosis caused by the Vaccinia virus (VACV), genus Orthopoxvirus (OPV), Poxviridae family. In general, human cases are related to direct contact with sick cattle but there is a lack of information about human-to-human transmission of VACV during BV outbreaks. In this study, we epidemiologically and molecularly show a case of VACV transmission between humans in Sao Francisco de Itabapoana County, Rio de Janeiro state. Our group collected samples from the patients, a 49-year-old patient and his son. Our results showed that patients had developed anti-OPV IgG or IgM antibodies and presented neutralizing antibodies against OPV. The VACV isolates displayed high identity (99.9%) and were grouped in the same phylogenetic tree branch. Our data indicate that human-to-human VACV transmission occurred during a BV outbreak, raising new questions about the risk factors of the VACV transmission chain.
C1 [Oliveira, Graziele Pereira; Silva Fernandes, Andre Tavares; de Assis, Felipe Lopes; Alves, Pedro Augusto; Moreira Franco Luiz, Ana Paula; Trindade, Giliane de Souza; Abrahao, Jonatas Santos; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Costa de Almeida, Claudia Maria; Pires Ferreira Travassos, Carlos Eurico] Univ Estadual Norte Fluminense, Ctr Ciencias & Tecnol Agr, Hosp Vet, Lab Sanidade Anim, Rio De Janeiro, Brazil.
RP Kroon, EG (corresponding author), Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM graziufmg@yahoo.com.br; fernandeserthal@gmail.com;
   felipelopesassis@gmail.com; pedroaugustoalves@yahoo.com.br;
   anapaulamluiz@gmail.com; leandrabio@yahoo.com.br; calmeida@uenf.br;
   cakatrav@uenf.br; gitrindade@yahoo.com.br; jonatas.abrahao@gmail.com;
   kroone@icb.ufmg.br
RI Alves, Pedro/T-7203-2019; Kroon, Erna/V-5444-2019; Abrahao,
   Jonatas/B-3895-2015; Kroon, Erna/B-3631-2015
OI Alves, Pedro/0000-0002-9659-5621; Abrahao, Jonatas/0000-0001-9420-1791;
   Kroon, Erna/0000-0003-2721-3826
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); MAPA
FX Financial support was provided by CNPq, CAPES, FAPEMIG, and MAPA. GST
   and EGK received a fellowship from CNPq.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Batista V. H., 2009, VIRUS REV RES, V14, P1
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I, 2007, FIELDS VIROLOGY, P2079
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   OVERMAN JR, 1957, VIROLOGY, V3, P173, DOI 10.1016/0042-6822(57)90031-4
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Sambrook E., 1989, MOL CLONING
   SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   WOLFF HL, 1968, B WORLD HEALTH ORGAN, V38, P492
NR 19
TC 7
Z9 7
U1 0
U2 12
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUN
PY 2014
VL 90
IS 6
BP 1021
EP 1023
DI 10.4269/ajtmh.13-0621
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA AI4FD
UT WOS:000336820200008
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU Campos, RK
   Boratto, PV
   Assis, FL
   Aguiar, ERGR
   Silva, LCF
   Albarnaz, JD
   Dornas, FP
   Trindade, GS
   Ferreira, PP
   Marques, JT
   Robert, C
   Raoult, D
   Kroon, EG
   La Scola, B
   Abrahao, JS
AF Campos, Rafael K.
   Boratto, Paulo V.
   Assis, Felipe L.
   Aguiar, Eric R. G. R.
   Silva, Lorena C. F.
   Albarnaz, Jonas D.
   Dornas, Fabio P.
   Trindade, Giliane S.
   Ferreira, Paulo P.
   Marques, Joao T.
   Robert, Catherine
   Raoult, Didier
   Kroon, Erna G.
   La Scola, Bernard
   Abrahao, Jonatas S.
TI Samba virus: a novel mimivirus from a giant rain forest, the Brazilian
   Amazon
SO VIROLOGY JOURNAL
LA English
DT Article
DE Mimiviridae; DNA virus; Giant virus; NCLDV; Virophage; Amazon; Brazil
ID PNEUMONIA PATIENTS; VIROPHAGE; RELATIVES; AMEBAS
AB Background: The identification of novel giant viruses from the nucleocytoplasmic large DNA viruses group and their virophages has increased in the last decade and has helped to shed light on viral evolution. This study describe the discovery, isolation and characterization of Samba virus (SMBV), a novel giant virus belonging to the Mimivirus genus, which was isolated from the Negro River in the Brazilian Amazon. We also report the isolation of an SMBV-associated virophage named Rio Negro (RNV), which is the first Mimivirus virophage to be isolated in the Americas.
   Methods/results: Based on a phylogenetic analysis, SMBV belongs to group A of the putative Megavirales order, possibly a new virus related to Acanthamoeba polyphaga mimivirus (APMV). SMBV is the largest virus isolated in Brazil, with an average particle diameter about 574 nm. The SMBV genome contains 938 ORFs, of which nine are ORFans. The 1,213.6 kb SMBV genome is one of the largest genome of any group A Mimivirus described to date. Electron microscopy showed RNV particle accumulation near SMBV and APMV factories resulting in the production of defective SMBV and APMV particles and decreasing the infectivity of these two viruses by several logs.
   Conclusion: This discovery expands our knowledge of Mimiviridae evolution and ecology.
C1 [Campos, Rafael K.; Boratto, Paulo V.; Assis, Felipe L.; Silva, Lorena C. F.; Albarnaz, Jonas D.; Dornas, Fabio P.; Trindade, Giliane S.; Ferreira, Paulo P.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Lab Virus, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Aguiar, Eric R. G. R.; Marques, Joao T.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270 Belo Horizonte, MG, Brazil.
   [Robert, Catherine; Raoult, Didier; La Scola, Bernard] Aix Marseille Univ, Fac Med, INSERM U1095, URMITE,CNRS IRD 7278 198, Marseille, France.
RP La Scola, B (corresponding author), Aix Marseille Univ, Fac Med, INSERM U1095, URMITE,CNRS IRD 7278 198, Marseille, France.
EM bernard.la-scola@univ-amu.fr; jonatas.abrahao@gmail.com
RI Abrahao, Jonatas/B-3895-2015; Kroon, Erna/V-5444-2019; Aguiar, Eric
   RGR/L-7989-2018; Campos, Rafael Kroon/AAB-5135-2020; Marques, Joao
   T/F-7683-2012; LA SCOLA, Bernard/P-6477-2016; Kroon, Erna
   Geessien/B-3631-2015; Dornas, Fabio/AAI-3582-2020; Aguiar,
   Eric/T-5076-2019; Albarnaz, Jonas Dutra/E-4526-2010
OI Abrahao, Jonatas/0000-0001-9420-1791; Aguiar, Eric
   RGR/0000-0002-8143-5756; Campos, Rafael Kroon/0000-0002-4852-0449;
   Marques, Joao T/0000-0002-3457-3320; LA SCOLA,
   Bernard/0000-0001-8006-7704; Kroon, Erna Geessien/0000-0003-2721-3826;
   Dornas, Fabio/0000-0001-7926-5551; Aguiar, Eric/0000-0002-8143-5756;
   Albarnaz, Jonas Dutra/0000-0002-8792-813X; raoult,
   didier/0000-0002-0633-5974
CR Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Boughalmi M, 2012, ENVIRON MICROBIOL, V53, P344
   Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108
   Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003
   Claverie JM, 2009, J INVERTEBR PATHOL, V101, P172, DOI 10.1016/j.jip.2009.03.011
   Culley AI, 2011, CURR OPIN VIROL, V1, P52, DOI 10.1016/j.coviro.2011.05.003
   Dare RK, 2008, EMERG INFECT DIS, V14, P465, DOI 10.3201/eid1403.071027
   Desnues C, 2010, INTERVIROLOGY, V53, P293, DOI 10.1159/000312914
   Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109
   Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412
   Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107
   Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62
   Krupovic M, 2011, NAT REV MICROBIOL, V9, P762, DOI 10.1038/nrmicro2676
   La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218
   Legendre Matthieu, 2012, Commun Integr Biol, V5, P102
   Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Slimani M, 2013, J VIROL, V87, P4783, DOI 10.1128/JVI.02948-12
   Suzan-Monti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000328
   Williamson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042047
   Xiao CA, 2005, J MOL BIOL, V353, P493, DOI 10.1016/j.jmb.2005.08.060
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Yamada T, 2011, CURR OPIN VIROL, V1, P58, DOI 10.1016/j.coviro.2011.05.008
   Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108
   Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114
NR 28
TC 65
Z9 66
U1 0
U2 19
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD MAY 14
PY 2014
VL 11
AR 95
DI 10.1186/1743-422X-11-95
PG 11
WC Virology
SC Virology
GA AH1DA
UT WOS:000335858700001
PM 24886672
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Wildner, LM
   Bazzo, ML
   Liedke, SC
   Nogueira, CL
   Segat, G
   Senna, SG
   Schlindwein, AD
   de Oliveira, JG
   Rovaris, DB
   Bonjardim, CA
   Kroon, EG
   Ferreira, PCP
AF Wildner, Leticia Muraro
   Bazzo, Maria Luiza
   Liedke, Susie Coutinho
   Nogueira, Christiane Lourenco
   Segat, Gabriela
   Senna, Simone Goncalves
   Schlindwein, Aline Daiane
   de Oliveira, Jaquelline Germano
   Rovaris, Darcita B.
   Bonjardim, Claudio A.
   Kroon, Erna G.
   Ferreira, Paulo C. P.
TI Mycobacteria mobility shift assay: a method for the rapid identification
   of Mycobacterium tuberculosis and nontuberculous mycobacteria
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE nontuberculous mycobacteria; mycobacteria mobility shift assay;
   mycobacterial identification
ID INFECTIONS; LEVEL
AB The identification of mycobacteria is essential because tuberculosis (TB) and mycobacteriosis are clinically indistinguishable and require different therapeutic regimens. The traditional phenotypic method is time consuming and may last up to 60 days. Indeed, rapid, affordable, specific and easy-to-perform identification methods are needed. We have previously described a polymerase chain reaction-based method called a mycobacteria mobility shift assay (MMSA) that was designed for Mycobacterium tuberculosis complex (MTC) and nontuberculous mycobacteria (NTM) species identification. The aim of this study was to assess the MMSA for the identification of MTC and NTM clinical isolates and to compare its performance with that of the PRA-hsp65 method. A total of 204 clinical isolates (102 NTM and 102 MTC) were identified by the MMSA and PRA-hsp65. For isolates for which these methods gave discordant results, definitive species identification was obtained by sequencing fragments of the 16S rRNA and hsp65 genes. Both methods correctly identified all MTC isolates. Among the NTM isolates, the MMSA alone assigned 94 (92.2%) to a complex or species, whereas the PRA-hsp65 method assigned 100% to a species. A 91.5% agreement was observed for the 94 NTM isolates identified by both methods. The MMSA provided correct identification for 96.8% of the NTM isolates compared with 94.7% for PRA-hsp65. The MMSA is a suitable auxiliary method for routine use for the rapid identification of mycobacteria.
C1 [Wildner, Leticia Muraro; Bazzo, Maria Luiza; Liedke, Susie Coutinho; Nogueira, Christiane Lourenco; Segat, Gabriela; Senna, Simone Goncalves] Univ Fed Santa Catarina, Lab Biol Mol & Micobacterias, Florianopolis, SC, Brazil.
   [Schlindwein, Aline Daiane] Univ Fed Santa Catarina, Lab Protozool, Florianopolis, SC, Brazil.
   [de Oliveira, Jaquelline Germano] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil.
   [Rovaris, Darcita B.] Lab Cent Estado Santa Catarina, Florianopolis, SC, Brazil.
   [Bonjardim, Claudio A.; Kroon, Erna G.; Ferreira, Paulo C. P.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
RP Wildner, LM (corresponding author), Univ Fed Santa Catarina, Lab Biol Mol & Micobacterias, Florianopolis, SC, Brazil.
EM leticiamw@gmail.com
RI Bonjardim, Claudio A/J-2601-2014; Kroon, Erna Geessien/B-3631-2015;
   Schlindwein, Aline Daiane/J-4416-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Schlindwein, Aline
   Daiane/0000-0003-0996-6242; Bazzo, Maria Luiza/0000-0003-1292-0974
FU CNPqNational Council for Scientific and Technological Development (CNPq)
FX CNPq
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Andrejak C, 2010, AM J RESP CRIT CARE, V181, P514, DOI 10.1164/rccm.200905-0778OC
   BODDINGHAUS B, 1990, J CLIN MICROBIOL, V28, P1751
   Chimara E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-48
   Duarte RS, 2009, J CLIN MICROBIOL, V47, P2149, DOI 10.1128/JCM.00027-09
   Esfahani BN, 2012, CURR MICROBIOL, V65, P493, DOI 10.1007/s00284-012-0188-2
   EUZEBY JP, 2012, LIST PROKARYOTIC NAM
   Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x
   Gopinath K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000615
   Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST
   Grubek-Jaworska H, 2009, EUR J CLIN MICROBIOL, V28, P739, DOI 10.1007/s10096-008-0694-0
   Hafner B, 2004, MOL CELL PROBE, V18, P59, DOI 10.1016/j.mcp.2003.09.003
   Katoch VM, 2004, INDIAN J MED RES, V120, P290
   Leao SC, 2005, J MICROBIOL METH, V61, P193, DOI 10.1016/j.mimet.2004.11.015
   LIPPKE JA, 1987, APPL ENVIRON MICROB, V53, P2588, DOI 10.1128/AEM.53.10.2588-2589.1987
   Maiga M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036902
   de Lima CAM, 2013, MEM I OSWALDO CRUZ, V108, P457, DOI 10.1590/S0074-0276108042013010
   MS - Ministerio da Saude Brasil, 2008, MAN NAC VIG LAB TUB
   Neonakis IK, 2008, J MICROBIOL METH, V75, P1, DOI 10.1016/j.mimet.2008.05.023
   Pedro Heloisa da Silveira Paro, 2008, J. bras. pneumol., V34, P950, DOI 10.1590/S1806-37132008001100010
   Piersimoni C, 2009, EMERG INFECT DIS, V15, P1351, DOI 10.3201/eid1509.081259
   Rocha AD, 2002, J CLIN MICROBIOL, V40, P4191, DOI 10.1128/JCM.40.11.4191-4196.2002
   ROGALL T, 1990, INT J SYST BACTERIOL, V40, P323, DOI 10.1099/00207713-40-4-323
   Satyanarayana G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-113
   Shi XC, 2012, CHINESE MED J-PEKING, V125, P3292, DOI 10.3760/cma.j.issn.0366-6999.2012.18.018
   TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993
   Waleria-Aleixo A, 2000, DIAGN MICR INFEC DIS, V36, P225, DOI 10.1016/S0732-8893(00)00112-7
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
NR 28
TC 2
Z9 2
U1 0
U2 7
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2014
VL 109
IS 3
BP 356
EP 361
DI 10.1590/0074-0276130458
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AJ7VV
UT WOS:000337909100013
PM 24821059
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Boratto, PVM
   Dornas, FP
   Andrade, KR
   Rodrigues, R
   Peixoto, F
   Silva, LCF
   La Scola, B
   Costa, AO
   de Almeida, GMF
   Kroon, EG
   Abrahao, JS
AF Boratto, Paulo V. M.
   Dornas, Fabio P.
   Andrade, Ketyllen R.
   Rodrigues, Rodrigo
   Peixoto, Felipe
   Silva, Lorena C. F.
   La Scola, Bernard
   Costa, Adriana Oliveira
   Freitas de Almeida, Gabriel Magno
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI Amoebas as mimivirus bunkers: increased resistance to UV light, heat and
   chemical biocides when viruses are carried by amoeba hosts
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID FREE-LIVING AMEBAS; ACANTHAMOEBA-POLYPHAGA; LEGIONELLA-PNEUMOPHILA;
   GIANT VIRUSES; WATER; PNEUMONIA; IDENTIFICATION; PATHOGENICITY;
   HOSPITALS; SURVIVAL
AB Amoebas of the genus Acanthamoeba are protists that are associated with human disease and represent a public health concern. They can harbor pathogenic microorganisms, acting as a platform for pathogen replication. Acanthamoeba polyphaga mimivirus (APMV), the type species of the genus Mimivirus, family Mimiviridae, represents the largest group of amoeba-associated viruses that has been described to date. Recent studies have demonstrated that APMV and other giant viruses may cause pneumonia. Amoebas can survive in most environments and tolerate various adverse conditions, including UV light irradiation, high concentrations of disinfectants, and a broad range of temperatures. However, it is unknown how the amoebal intracellular environment influences APMV stability and resistance to adverse conditions. Therefore, in this work, we evaluated the stability of APMV, either purified or carried by the amoeba host, under extreme conditions, including UV irradiation, heat and exposure to six different chemical biocides. After each treatment, the virus was titrated in amoebas using the TCID50 method. APMV was more stable in all resistance tests performed when located inside its host. Our results demonstrate that Acanthamoeba acts as a natural bunker for APMV, increasing viral resistance to extreme physical and chemical conditions. The data raise new questions regarding the survival of APMV in nature and in hospital environments.
C1 [Boratto, Paulo V. M.; Dornas, Fabio P.; Andrade, Ketyllen R.; Rodrigues, Rodrigo; Peixoto, Felipe; Silva, Lorena C. F.; Freitas de Almeida, Gabriel Magno; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Virus Lab, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, URMITE CNRS UMR 6236, IRD 3R198, Marseille, France.
   [Costa, Adriana Oliveira] Univ Fed Minas Gerais, Fac Farm, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Virus Lab, Inst Ciencias Biol, Av Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Almeida, Gabriel MF/I-8910-2012; LA SCOLA, Bernard/P-6477-2016; Abrahao,
   Jonatas/B-3895-2015; Kroon, Erna/V-5444-2019; Dornas,
   Fabio/AAI-3582-2020; Kroon, Erna Geessien/B-3631-2015; Costa, Adriana
   Oliveira/AAD-3037-2020
OI Almeida, Gabriel MF/0000-0003-2317-5092; LA SCOLA,
   Bernard/0000-0001-8006-7704; Abrahao, Jonatas/0000-0001-9420-1791;
   Dornas, Fabio/0000-0001-7926-5551; Kroon, Erna
   Geessien/0000-0003-2721-3826; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA); Pro-Reitoria de Pesquisa
   da Universidade Federal de Minas Gerais (PRPq-UFMG)
FX We thank Joao Rodrigues dos Santos, Gisele Cirilo dos Santos and
   colleagues from Gepvig and the Laboratorio de Virus for their excellent
   technical support. We also thank Fundacao de Amparo a Pesquisa de Minas
   Gerais (FAPEMIG) and the Pro-Reitoria de Pesquisa da Universidade
   Federal de Minas Gerais. Financial support was provided by the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA) and Pro-Reitoria de
   Pesquisa da Universidade Federal de Minas Gerais (PRPq-UFMG). E.G. Kroon
   is a researcher from CNPq.
CR Bagheri HR, 2010, IRAN J PARASITOL, V5, P19
   Campos RK, 2012, J CLIN VIROL, V55, P323, DOI 10.1016/j.jcv.2012.08.009
   Carlesso AM, 2007, REV SOC BRAS MED TRO, V40, P316, DOI 10.1590/S0037-86822007000300013
   Costa AO, 2010, J EUKARYOT MICROBIOL, V57, P70, DOI 10.1111/j.1550-7408.2009.00453.x
   Coulon C, 2010, J CLIN MICROBIOL, V48, P2689, DOI 10.1128/JCM.00309-10
   Del Buey MA, 2012, AM J OPHTHALMOL, V153, P399, DOI 10.1016/j.ajo.2011.07.025
   Fouque E, 2012, EUKARYOT CELL, V11, P382, DOI 10.1128/EC.05301-11
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030
   KILVINGTON S, 1990, J APPL BACTERIOL, V68, P519, DOI 10.1111/j.1365-2672.1990.tb02904.x
   La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2001, CLIN MICROBIOL INFEC, V7, P75, DOI 10.1046/j.1469-0691.2001.00193.x
   Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003
   MICHEL R, 1995, ZBL HYG UMWELTMED, V196, P532
   Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   Raoult D, 2010, INTERVIROLOGY, V53, P321, DOI 10.1159/000312917
   Rohr U, 1998, APPL ENVIRON MICROB, V64, P1822
   ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179
   Saadi H, 2013, CLIN INFECT DIS, V57, pE127, DOI 10.1093/cid/cit354
   Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6
   Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798
   Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256
   Storey MV, 2004, SCAND J INFECT DIS, V36, P656, DOI 10.1080/00365540410020785
   Stothard DR, 1998, J EUKARYOT MICROBIOL, V45, P45, DOI 10.1111/j.1550-7408.1998.tb05068.x
   Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006
   Vincent A, 2009, CRIT CARE MED, V37, P111, DOI 10.1097/CCM.0b013e318192fa8b
   Vincent A, 2010, INTERVIROLOGY, V53, P304, DOI 10.1159/000312915
NR 29
TC 11
Z9 11
U1 0
U2 12
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD MAY
PY 2014
VL 159
IS 5
BP 1039
EP 1043
DI 10.1007/s00705-013-1924-z
PG 5
WC Virology
SC Virology
GA AG9ZB
UT WOS:000335777600021
PM 24271007
DA 2020-11-30
ER

PT J
AU Oliveira, DB
   Campos, RK
   Soares, MS
   Barros, RB
   Batista, TCA
   Ferreira, PCP
   Bonjardim, CA
   Trindade, GS
   Abrahao, JS
   Kroon, EG
AF Oliveira, D. B.
   Campos, R. K.
   Soares, M. S.
   Barros, R. B.
   Batista, T. C. A.
   Ferreira, P. C. P.
   Bonjardim, C. A.
   Trindade, G. S.
   Abrahao, J. S.
   Kroon, Erna Geessien
TI Outbreak of herpangina in the Brazilian Amazon in 2009 caused by
   Enterovirus B
SO ARCHIVES OF VIROLOGY
LA English
DT Article
DE Herpangina; Enterovirus B; Picornavirus
ID MOUTH-DISEASE; FOOT; HAND; A9
AB In October 2009, our laboratory was contacted by a Brazilian Public Health organization regarding a severe community outbreak of an acute exanthematic and febrile disease in the Brazilian Amazon that primarily affected children. A total of 44 patients with febrile disease were identified by the local public health system, 37 of whom were children between 1 and 9 years of age. Molecular virological and phylogenetic characterization revealed that enterovirus B was the etiological agent of this outbreak, which was characterized by a clinical presentation known as herpangina.
C1 [Oliveira, D. B.; Campos, R. K.; Ferreira, P. C. P.; Bonjardim, C. A.; Trindade, G. S.; Abrahao, J. S.; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [Soares, M. S.; Barros, R. B.; Batista, T. C. A.] Secretaria Estado Saude Tocantins, Palmas, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Bonjardim, Claudio A/J-2601-2014; Kroon, Erna Geessien/B-3631-2015;
   Kroon, Erna/V-5444-2019; Campos, Rafael Kroon/AAB-5135-2020; Abrahao,
   Jonatas/B-3895-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Campos, Rafael
   Kroon/0000-0002-4852-0449; Abrahao, Jonatas/0000-0001-9420-1791
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX We thank Joao Rodrigues dos Santos and colleagues from the Laboratorio
   de Virus for their excellent technical support. Financial support was
   provided by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG). D. B. Oliveira and R. K. Campos received fellowships
   from CNPq. E. G. Kroon, C. A. Bonjardim, G. S. Trindade and P. C. P.
   Ferreira are researchers from CNPq.
CR Cui AL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-72
   Eisenhut M, 2000, J INFECTION, V40, P297, DOI 10.1053/jinf.2000.0650
   Huang YC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-33
   JU JY, 1995, P NATL ACAD SCI USA, V92, P4347, DOI 10.1073/pnas.92.10.4347
   Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18
   King A.M.Q., 2012, 9 INT COMM TAX VIR
   Minor P, 2010, OXFORD TXB MED
   PALLANSCH M, 2007, FIELDS VIROLOGY, P840
   Park K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-205
   Park SH, 2011, CLIN LAB, V57, P959
   PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975
   Rhoades RE, 2011, VIROLOGY, V411, P288, DOI 10.1016/j.virol.2010.12.014
   Siafakas N, 2001, J CLIN LAB ANAL, V15, P87, DOI 10.1002/jcla.7
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
NR 14
TC 8
Z9 11
U1 0
U2 1
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD MAY
PY 2014
VL 159
IS 5
BP 1155
EP 1157
DI 10.1007/s00705-013-1858-5
PG 3
WC Virology
SC Virology
GA AG9ZB
UT WOS:000335777600035
PM 24197788
DA 2020-11-30
ER

PT J
AU Silva, LCF
   Almeida, GMF
   Oliveira, DB
   Dornas, FP
   Campos, RK
   La Scola, B
   Ferreira, PCP
   Kroon, EG
   Abrahao, JS
AF Silva, Lorena C. F.
   Almeida, Gabriel M. F.
   Oliveira, Danilo B.
   Dornas, Fabio P.
   Campos, Rafael K.
   La Scola, Bernard
   Ferreira, Paulo C. P.
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI A resourceful giant: APMV is able to interfere with the human type I
   interferon system
SO MICROBES AND INFECTION
LA English
DT Article
DE Mimiviridae; Interferon; Phagocytes; PBMCs
ID GENE-EXPRESSION; III INTERFERON; VIRUS; MIMIVIRUS; RECEPTOR; GENOME;
   INDUCTION
AB Acanthamoeba polyphaga mimivirus (APMV) is a giant, double-stranded virus of the Mimiviridae family that was discovered in 2003. Recent studies have shown that this virus is able to replicate in murine and human phagocytes and might be considered a putative human pathogen that causes pneumonia. However, there is little data regarding APMV and its host defense relationship. In the present study, we investigated how some components of the interferon (IFN) system are stimulated by APMV in human peripheral blood mononuclear cells (PBMCs) and how APMV replication is affected by IFN treatment. Our results demonstrated that APMV is able to replicate in human PBMCs, inducing type I Interferons (IFNs) but inhibiting interferon stimulated genes (ISG) induction by viroceptor and STAT-1 and STAT-2 dephosphorylation independent mechanisms. We also showed that APMV is resistant to the antiviral action of interferon-alpha2 (IFNA2) but is sensitive to the antiviral action of interferon-beta (IFNB1). Our results demonstrated the productive infection of professional phagocytes with APMV and showed that this virus is recognized by the immune system of vertebrates and inhibits it. It provides the first data regarding APMV and the IFN system interaction and raise new and relevant evolutional questions about the relationship between APMV and vertebrate hosts. (C) 2013 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Silva, Lorena C. F.; Almeida, Gabriel M. F.; Oliveira, Danilo B.; Dornas, Fabio P.; Campos, Rafael K.; Ferreira, Paulo C. P.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, URMITE, CNRS UMR 6236, IRD 3RI98, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Belo Horizonte, MG, Brazil.
EM lorena.farmacia@yahoo.com.br; gabriel.magno@gmail.com;
   danilobretas@yahoo.com.br; fabiopiod@hotmail.com;
   rafaelkcampos@gmail.com; bernard.lascola@univmed.fr;
   peregrinopcp@hotmail.com; Icroone@icb.ufmg.br; jonatas.abrahao@gmail.com
RI Almeida, Gabriel MF/I-8910-2012; LA SCOLA, Bernard/P-6477-2016; Dornas,
   Fabio/AAI-3582-2020; Campos, Rafael Kroon/AAB-5135-2020; Kroon,
   Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Almeida, Gabriel MF/0000-0003-2317-5092; LA SCOLA,
   Bernard/0000-0001-8006-7704; Dornas, Fabio/0000-0001-7926-5551; Campos,
   Rafael Kroon/0000-0002-4852-0449; Kroon, Erna
   Geessien/0000-0003-2721-3826
CR Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002
   Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422
   Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108
   Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003
   Dare RK, 2008, EMERG INFECT DIS, V14, P465, DOI 10.3201/eid1403.071027
   Almeida GMD, 2008, ANTIVIR RES, V80, P302, DOI 10.1016/j.antiviral.2008.06.016
   de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667
   FERREIRA PCP, 1979, J CLIN MICROBIOL, V9, P471
   Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541
   Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676
   Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004
   Hillyer P, 2012, IMMUNOL CELL BIOL, V90, P774, DOI 10.1038/icb.2011.109
   Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048
   La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538
   La Scola B, 2003, SCIENCE, V299, P2033
   Larcher C, 2006, EUR J CLIN MICROBIOL, V25, P681, DOI 10.1007/s10096-006-0214-z
   Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001
   Mann BA, 2008, J INTERF CYTOK RES, V28, P367, DOI 10.1089/jir.2007.0113
   Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   MARTINS RMB, 1989, J INTERFERON RES, V9, P379, DOI 10.1089/jir.1989.9.379
   Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12
   Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08
   Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12
   Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   Raoult D, 2007, CLIN INFECT DIS, V45, P95, DOI 10.1086/518608
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732
   SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4
   Vanspauwen MJ, 2012, RESP MED, V106, P1690, DOI 10.1016/j.rmed.2012.08.019
   WAIBLER Z, 2009, VACCINIA J VIRO, V83, P1563
NR 37
TC 15
Z9 15
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD MAR
PY 2014
VL 16
IS 3
BP 187
EP 195
DI 10.1016/j.micinf.2013.11.011
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA AY9IU
UT WOS:000347864600003
PM 24295593
DA 2020-11-30
ER

PT J
AU Degener, CM
   Eiras, AE
   Azara, TMF
   Roque, RA
   Rosner, S
   Codeco, CT
   Nobre, AA
   Rocha, ESO
   Kroon, EG
   Ohly, JJ
   Geier, M
AF Degener, C. M.
   Eiras, A. E.
   Azara, T. M. F.
   Roque, R. A.
   Roesner, S.
   Codeco, C. T.
   Nobre, A. A.
   Rocha, E. S. O.
   Kroon, E. G.
   Ohly, J. J.
   Geier, M.
TI Evaluation of the Effectiveness of Mass Trapping With BG-Sentinel Traps
   for Dengue Vector Control: A Cluster Randomized Controlled Trial in
   Manaus, Brazil
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE BG-Sentinel; mosquito trap; dengue control; mass trapping; Aedes aegypti
ID AEDES-AEGYPTI DIPTERA; RIO-DE-JANEIRO; FIELD-EVALUATION; LETHAL OVITRAP;
   CULICIDAE; EFFICACY; QUEENSLAND; STRATEGIES; ALBOPICTUS; AUSTRALIA
AB The objective of this study was to assess the effectiveness of BG-Sentinel (BGS) traps for mass trapping at the household level to control the dengue vector, Aedes aegypti (L.), in Manaus (Brazil) by performing a cluster randomized controlled trial. After an initial questionnaire and baseline monitoring, 6 out of 12 clusters were randomly allocated to the intervention arm, where participating premises received one BGS trap for mass trapping. The other six clusters did not receive traps and were considered as the control arm. Biweekly monitoring with BGS in both arms assessed the impact of mass trapping. At the end of the study, a serological survey was conducted and a second questionnaire was conducted in the intervention arm. Entomological monitoring indicated that mass trapping with BGS traps significantly reduced the abundance of adult female Ae. aegypti during the first five rainy months. In the subsequent dry season when the mosquito population was lower, no effect of mass trapping was observed. Fewer Ae. aegypti females were measured in the intervention arm during the next rainy period, but no significant difference between arms was observed. The serological survey revealed that in participating houses of mass trapping areas recent dengue infections were less common than in control areas, although this effect was not statistically significant. The majority of participants responded positively to questions concerning user satisfaction. Our results suggest that BGS traps are a promising tool which might be deployed as part of dengue control programs; however, further investigations and larger scale studies are necessary.
C1 [Degener, C. M.; Eiras, A. E.; Azara, T. M. F.] Univ Fed Minas Gerais, Dept Parasitol, Lab Ecol Quim Vetores, BR-31270901 Belo Horizonte, MG, Brazil.
   [Roque, R. A.] Univ Nilton Lins, Lab Entomol Aplicada, BR-69058030 Manaus, Amazonas, Brazil.
   [Roesner, S.] Forel Klin, Abt Wissensch & Diagnost, CH-8548 Ellikon An Der Thur, Switzerland.
   [Codeco, C. T.; Nobre, A. A.] Fundacao Oswaldo Cruz, Programa Comp Cient, BR-21045900 Rio De Janeiro, Brazil.
   [Rocha, E. S. O.; Kroon, E. G.] Univ Fed Minas Gerais, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Ohly, J. J.] Univ Estado Amazonas, BR-69050030 Manaus, Amazonas, Brazil.
   [Geier, M.] Biogents AG, D-93055 Regensburg, Germany.
RP Degener, CM (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Lab Ecol Quim Vetores, BR-31270901 Belo Horizonte, MG, Brazil.
EM carosufmg@ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Eiras, Alvaro/Z-6023-2019; Kroon,
   Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Eiras,
   Alvaro/0000-0002-3045-0673; Rocha, Eliseu/0000-0002-2854-0768
FU World BankThe World Bank India; University of the State of Amazonas;
   CAPESCAPES; CNPq(PRONEX-Dengue)National Council for Scientific and
   Technological Development (CNPq) [550131/2008-8]; INCT-Dengue
FX We are very grateful to all inhabitants of Cidade Nova neighborhood, who
   participated in the study. We thank all contributors from FVS, namely,
   Luzia Mustafa, Ricardo Passos, and Wanderson Sampaio, and with special
   thanks to all field workers. Contributors from the Virology Department
   of the FMT-HVD under supervision of Maria Paula Gomes Mourao, are highly
   appreciated for the collection of blood samples. We thank the Entomology
   Department of the FMT-HVD, which is under supervision of Maria das
   Gracas Vale Barbosa and Nelson Ferreira Fe, for assistance in processing
   the catch bags that returned from the field. We thank Wouter Karsten
   Vahl for valuable suggestions on the manuscript. The study received
   financial support from The World Bank, the University of the State of
   Amazonas,CAPES,CNPq(PRONEX-Dengue, grant 550131/2008-8) and INCT-Dengue.
CR Ball TS, 2010, J MED ENTOMOL, V47, P649, DOI 10.1603/ME09218
   Bates D., 2011, LME4 LINEAR MIXED EF
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Charlwood J.D., 1979, Acta Amazonica, V9, P271
   Christophers S., 1960, AEDES AEGYPTI L YELL
   da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017
   Rocha ESD, 2013, J VIROL METHODS, V187, P114, DOI 10.1016/j.jviromet.2012.09.012
   DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Faraway J. J., 2005, EXTENDING LINEAR MOD
   de Azara TMF, 2013, MEM I OSWALDO CRUZ, V108, P229, DOI 10.1590/0074-0276108022013016
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   (IBGE) Instituto Brasilleiro de Geografia e Estatistica, 2010, CENS 2010
   Johnson PH, 2012, J MED ENTOMOL, V49, P29, DOI 10.1603/ME11116
   Kittayapong P, 2008, AM J TROP MED HYG, V78, P70, DOI 10.4269/ajtmh.2008.78.70
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Krueger A, 2007, TROP MED INT HEALTH, V12, P1105, DOI 10.1111/j.1365-3156.2007.01893.x
   Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Ministerio da Saude, 2009, NORM MAN TECN A
   Ministerio da Saude, 2012, NORM MAN TECN A
   Barata EAMD, 2007, REV SAUDE PUBL, V41, P375, DOI 10.1590/s0034-89102007000300008
   Ocampo CB, 2009, BIOMEDICA, V29, P282, DOI 10.7705/biomedica.v29i2.30
   Paz-Soldan VA, 2011, AM J TROP MED HYG, V84, P208, DOI 10.4269/ajtmh.2011.09-0615
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   Perich MJ, 2003, MED VET ENTOMOL, V17, P205, DOI 10.1046/j.1365-2915.2003.00427.x
   PINHEIRO F P, 1981, American Journal of Tropical Medicine and Hygiene, V30, P149
   Pinheiro J, 2010, NLME LINEAR NONLINEA, V3, P1
   R Development Core Team, 2010, R LANG ENV STAT COMP
   RACHOU RENE G., 1956, REV BRASIL MALARIOL E DOENC AS TROP, V8, P267
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   Rocha EMM, 1998, REV SAUDE PUBL, V32, P98, DOI 10.1590/S0034-89101998000100015
   Salazar FV, 2012, J VECTOR ECOL, V37, P8, DOI 10.1111/j.1948-7134.2012.00195.x
   Schmaedick MA, 2008, J AM MOSQUITO CONTR, V24, P319, DOI 10.2987/5652.1
   Sithiprasasna R, 2003, J MED ENTOMOL, V40, P455, DOI 10.1603/0022-2585-40.4.455
   Thammapalo S, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/652564
   Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994
   Williams CR, 2007, J MED ENTOMOL, V44, P345, DOI 10.1603/0022-2585(2007)44[345:AAPSUB]2.0.CO;2
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2
   Wood S., 2006, GEN ADDITIVE MODELS
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zar J. H., 2010, BIOSTATISTICAL ANAL, Vxiii
NR 43
TC 34
Z9 34
U1 0
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAR
PY 2014
VL 51
IS 2
BP 408
EP 420
DI 10.1603/ME13107
PG 13
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA AC5CW
UT WOS:000332539500014
PM 24724291
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Dornas, FP
   Rodrigues, FP
   Boratto, PVM
   Silva, LCF
   Ferreira, PCP
   Bonjardim, CA
   Trindade, GS
   Kroon, EG
   La Scola, B
   Abrahao, JS
AF Dornas, Fabio P.
   Rodrigues, Felipe P.
   Boratto, Paulo V. M.
   Silva, Lorena C. F.
   Ferreira, Paulo C. P.
   Bonjardim, Claudio A.
   Trindade, Giliane S.
   Kroon, Erna G.
   La Scola, Bernard
   Abrahao, Jonatas S.
TI Mimivirus Circulation among Wild and Domestic Mammals, Amazon Region,
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID FREE-LIVING AMEBAS; PNEUMONIA; MICROORGANISMS; VIRUS
AB To investigate circulation of mimiviruses in the Amazon Region of Brazil, we surveyed 513 serum samples from domestic and wild mammals. Neutralizing antibodies were detected in 15 sample pools, and mimivirus DNA was detected in 9 pools of serum from capuchin monkeys and in 16 pools of serum from cattle.
C1 [Dornas, Fabio P.; Rodrigues, Felipe P.; Boratto, Paulo V. M.; Silva, Lorena C. F.; Ferreira, Paulo C. P.; Bonjardim, Claudio A.; Trindade, Giliane S.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, IRD 3R198, URMITE CNRS UMR 6236, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Av Antonio Carlos, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.co
RI Kroon, Erna Geessien/B-3631-2015; Dornas, Fabio/AAI-3582-2020; Kroon,
   Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Abrahao,
   Jonatas/B-3895-2015; LA SCOLA, Bernard/P-6477-2016
OI Kroon, Erna Geessien/0000-0003-2721-3826; Dornas,
   Fabio/0000-0001-7926-5551; Abrahao, Jonatas/0000-0001-9420-1791; LA
   SCOLA, Bernard/0000-0001-8006-7704
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao de Amparo
   a Pesquisa do Estado de Minas GeraisMinas Gerais State Research
   Foundation (FAPEMIG); Ministerio da Agricultura, Pecuaria e
   Abastecimento; Pro-Reitoria de Pesquisa da Universidade Federal de Minas
   Gerais
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior, the Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais, the Ministerio da Agricultura, Pecuaria e Abastecimento, and the
   Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais. F.P.D.
   was supported by a fellowship from the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior. E.G.K., C.A.B., G.S.T., and P.C.P.F. are
   researchers of the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   [Anonymous], 2008, PLOS PATHOG, V4, DOI DOI 10.1371/J0URNAL.PPAT.1000087
   Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Berger P, 2006, EMERG INFECT DIS, V12, P248
   Boughalmi M, 2013, ENVIRON MICROBIOL, V15, P2000, DOI 10.1111/1462-2920.12068
   Colson P, 2013, J CLIN VIROL, V57, P191, DOI 10.1016/j.jcv.2013.03.018
   Colson P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018935
   Fouque E, 2012, EUKARYOT CELL, V11, P382, DOI 10.1128/EC.05301-11
   Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004
   Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905
   La Scola B, 2003, SCIENCE, V299, P2033
   Raoult D, 2007, CLIN INFECT DIS, V45, P95, DOI 10.1086/518608
   Saadi H, 2013, CLIN INFECT DIS, V57, pE127, DOI 10.1093/cid/cit354
   Vanspauwen MJ, 2013, J MED VIROL, V85, P1836, DOI 10.1002/jmv.23655
   Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223
NR 15
TC 20
Z9 20
U1 0
U2 7
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAR
PY 2014
VL 20
IS 3
BP 469
EP 472
DI 10.3201/eid2003.131050
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AC3PO
UT WOS:000332433900020
PM 24564967
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Almeida, GMD
   de Oliveira, DB
   Botelho, LM
   Silva, LKD
   Guedes, ACM
   Santos, FPST
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF de Freitas Almeida, Gabriel Magno
   de Oliveira, Danilo Bretas
   Botelho, Lucas Moreira
   dos Santos Silva, Ludmila Karen
   Martins Guedes, Antonio Carlos
   Sena Teixeira Santos, Flavia Patricia
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Differential upregulation of human 2 ' 5 ' OAS genes on systemic
   sclerosis: Detection of increased basal levels of OASL and OAS2 genes
   through a qPCR based assay
SO AUTOIMMUNITY
LA English
DT Article
DE 2 ' 5 ' Oligoadenylate synthetases; autoimmunities; homeostasis;
   interferon; scleroderma
ID 2'-5' OLIGOADENYLATE SYNTHETASE; 2,5-OLIGOADENYLATE SYNTHETASE;
   ANTIVIRAL ACTIVITY; T-LYMPHOCYTES; IN-VITRO; PROTEIN; INTERFERONS;
   SCLERODERMA; ISOFORMS; ENZYME
AB 2'5'OAS are template-independent RNA polymerases with antiviral activity and important to homeostasis maintenance. Here we have developed quantitative PCR (qPCR) reactions for the detection of each individual 2'5'OAS human gene and used them to evaluate these gene levels in systemic sclerosis patients cells. The method was efficient for quantification of 2'5'OAS genes on human cells after interferon (IFN) treatment, and revealed that primary cells from patients with systemic sclerosis have increased basal levels of OASL and OAS2 genes. When treated, patients cells are able to induce all four 2'5'OAS genes. Our hypothesis is that abnormally circulating type I IFNs on the disease could be establishing a desensitized state on patients cells, making them refractory to subsequent IFN doses, and that OASL and OAS2 genes upregulation may be due to an IFN-independent stimulus. Further characterizing the biological activities of these genes, their induction pathways and their regulatory functions can lead to better understanding of systemic sclerosis molecular mechanisms and of their biological activities.
C1 [de Freitas Almeida, Gabriel Magno; de Oliveira, Danilo Bretas; Botelho, Lucas Moreira; dos Santos Silva, Ludmila Karen; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Belo Horizonte, MG, Brazil.
   [Martins Guedes, Antonio Carlos; Sena Teixeira Santos, Flavia Patricia] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
RP Almeida, GMD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
EM gabriel.magno@gmail.com
RI Bonjardim, Claudio A/J-2601-2014; Almeida, Gabriel MF/I-8910-2012;
   Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Almeida, Gabriel MF/0000-0003-2317-5092; Kroon, Erna
   Geessien/0000-0003-2721-3826
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX This work was supported by research grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenadoria de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG).
CR Abraham DJ, 2005, TRENDS IMMUNOL, V26, P587, DOI 10.1016/j.it.2005.09.004
   Assassi S, 2010, ARTHRITIS RHEUM-US, V62, P589, DOI 10.1002/art.27224
   Cagliani R, 2012, HUM GENET, V131, P87, DOI 10.1007/s00439-011-1053-2
   Chizzolini C, 2011, AUTOIMMUN REV, V10, P276, DOI 10.1016/j.autrev.2010.09.016
   Dan MX, 2012, MOL BIOL REP, V39, P7813, DOI 10.1007/s11033-012-1624-x
   de Oliveira DB, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/275617
   Denton CP, 2004, BEST PRACT RES CL RH, V18, P271, DOI 10.1016/j.berh.2004.03.001
   Dugan JW, 2009, MOL IMMUNOL, V47, P560, DOI 10.1016/j.molimm.2009.09.025
   Eskildsen S, 2003, NUCLEIC ACIDS RES, V31, P3166, DOI 10.1093/nar/gkg427
   Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200
   Ghosh A, 2001, J BIOL CHEM, V276, P25447, DOI 10.1074/jbc.M100496200
   Hikami K, 2008, BIOCHEM BIOPH RES CO, V373, P403, DOI 10.1016/j.bbrc.2008.06.054
   HOVANESSIAN AG, 1977, NATURE, V268, P537, DOI 10.1038/268537a0
   Hovnanian A, 1998, GENOMICS, V52, P267, DOI 10.1006/geno.1998.5443
   Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006
   Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107
   Kristiansen H, 2010, J VIROL, V84, P11898, DOI 10.1128/JVI.01003-10
   Lee MS, 2013, NAT IMMUNOL, V14, P346, DOI 10.1038/ni.2535
   Coelho LFL, 2008, IMMUNOL LETT, V118, P110, DOI 10.1016/j.imlet.2008.03.016
   Coelho LFL, 2007, ARCH DERMATOL RES, V299, P259, DOI 10.1007/s00403-007-0737-x
   Marques J, 2008, J GEN VIROL, V89, P2767, DOI 10.1099/vir.0.2008/003558-0
   Melchjorsen J, 2009, J INTERF CYTOK RES, V29, P199, DOI 10.1089/jir.2008.0050
   Molteni M, 1999, CLIN EXP IMMUNOL, V116, P164
   Rebouillat D, 2000, GENOMICS, V70, P232, DOI 10.1006/geno.2000.6382
   Valentini G, 2001, J CLIN IMMUNOL, V21, P210, DOI 10.1023/A:1011024313525
   Wang Q, 1997, DNA CELL BIOL, V16, P1385, DOI 10.1089/dna.1997.16.1385
   WITT PL, 1993, J INTERFERON RES, V13, P17, DOI 10.1089/jir.1993.13.17
   Ye S, 2007, CLIN RHEUMATOL, V26, P186, DOI 10.1007/s10067-006-0260-z
NR 28
TC 5
Z9 5
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0891-6934
EI 1607-842X
J9 AUTOIMMUNITY
JI Autoimmunity
PD MAR
PY 2014
VL 47
IS 2
BP 119
EP 126
DI 10.3109/08916934.2013.866102
PG 8
WC Immunology
SC Immunology
GA AB6NH
UT WOS:000331905600006
PM 24328427
DA 2020-11-30
ER

PT J
AU Dornas, FP
   Silva, LCF
   de Almeida, GM
   Campos, RK
   Boratto, PVM
   Franco-Luiz, APM
   La Scola, B
   Ferreira, PCP
   Kroon, EG
   Abrahao, JS
AF Dornas, Fabio P.
   Silva, Lorena C. F.
   de Almeida, Gabriel M.
   Campos, Rafael K.
   Boratto, Paulo V. M.
   Franco-Luiz, Ana P. M.
   La Scola, Bernard
   Ferreira, Paulo C. P.
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI Acanthamoeba polyphaga mimivirus Stability in Environmental and Clinical
   Substrates: Implications for Virus Detection and Isolation
SO PLOS ONE
LA English
DT Article
ID PUTATIVE PNEUMONIA AGENT; GIANT VIRUSES; MARINE; SEQUENCES; VIROPHAGE;
   RELATIVES; SEAWATER
AB Viruses are extremely diverse and abundant and are present in countless environments. Giant viruses of the Megavirales order have emerged as a fascinating research topic for virologists around the world. As evidence of their ubiquity and ecological impact, mimiviruses have been found in multiple environmental samples. However, isolation of these viruses from environmental samples is inefficient, mainly due to methodological limitations and lack of information regarding the interactions between viruses and substrates. In this work, we demonstrate the long-lasting stability of mimivirus in environmental (freshwater and saline water) and hospital (ventilator plastic device tube) substrates, showing the detection of infectious particles after more than 9 months. In addition, an enrichment protocol was implemented that remarkably increased mimivirus detection from all tested substrates, including field tests. Moreover, biological, morphological and genetic tests revealed that the enrichment protocol maintained mimivirus particle integrity. In conclusion, our work demonstrated the stability of APMV in samples of environmental and health interest and proposed a reliable and easy protocol to improve giant virus isolation. The data presented here can guide future giant virus detection and isolation studies.
C1 [Dornas, Fabio P.; Silva, Lorena C. F.; de Almeida, Gabriel M.; Campos, Rafael K.; Boratto, Paulo V. M.; Franco-Luiz, Ana P. M.; Ferreira, Paulo C. P.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, URMITE, CNRS, IRD 3R198,UMR 6236, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Almeida, Gabriel MF/I-8910-2012; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015; Abrahao, Jonatas/B-3895-2015; LA SCOLA,
   Bernard/P-6477-2016; Dornas, Fabio/AAI-3582-2020; Campos, Rafael
   Kroon/AAB-5135-2020
OI Almeida, Gabriel MF/0000-0003-2317-5092; Kroon, Erna
   Geessien/0000-0003-2721-3826; Abrahao, Jonatas/0000-0001-9420-1791; LA
   SCOLA, Bernard/0000-0001-8006-7704; Dornas, Fabio/0000-0001-7926-5551;
   Campos, Rafael Kroon/0000-0002-4852-0449
CR Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Boughalmi M., 2012, ENV MICROBIOL
   Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108
   Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042
   Campos RK, 2012, J CLIN VIROL, V55, P323, DOI 10.1016/j.jcv.2012.08.009
   Desnues C, 2010, INTERVIROLOGY, V53, P293, DOI 10.1159/000312914
   Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109
   GERBA CP, 1975, J WATER POLLUT CON F, V47, P93
   Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905
   La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218
   La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919
   Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12
   Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   Raoult D, 2007, CLIN INFECT DIS, V45, P95, DOI 10.1086/518608
   Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x
   Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005
   Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6
   Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338
   Wetz JJ, 2004, MAR POLLUT BULL, V48, P698, DOI 10.1016/j.marpolbul.2003.09.008
   Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109
NR 25
TC 12
Z9 12
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 3
PY 2014
VL 9
IS 2
AR e87811
DI 10.1371/journal.pone.0087811
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 302TD
UT WOS:000330626900125
PM 24498379
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Zolini, GP
   Lima, GK
   Lucinda, N
   Silva, MA
   Dias, MF
   Pessoa, NL
   Coura, BP
   Cartelle, CT
   Arantes, RME
   Kroon, EG
   Campos, MA
AF Zolini, Guilherme Pimenta
   Lima, Graciela Kunrath
   Lucinda, Natalia
   Silva, Mariana Almeida
   Dias, Marcela Franca
   Pessoa, Natalia Lima
   Coura, Bruna Pizziolo
   Cartelle, Christiane Teixeira
   Esteves Arantes, Rosa Maria
   Kroon, Erna Geessien
   Campos, Marco Antonio
TI Defense against HSV-1 in a murine model is mediated by iNOS and
   orchestrated by the activation of TLR2 and TLR9 in trigeminal ganglia
SO JOURNAL OF NEUROINFLAMMATION
LA English
DT Article
DE Encephalitis; HSV-1; Innate immunity; Toll-like receptors; Host immune
   response
ID TIME QUANTITATIVE PCR; TOLL-LIKE RECEPTORS; INTERFERON-GAMMA;
   NITRIC-OXIDE; VIRAL REPLICATION; VIRUS-INFECTION; HERPES; MECHANISMS;
   INDUCTION; INHIBITION
AB Background: Herpes simplex 1 (HSV-1) causes various human clinical manifestations, ranging from simple cold sores to encephalitis. Innate immune cells recognize pathogens through Toll-like receptors (TLRs), thus initiating the immune response. Previously, we demonstrated that the immune response against HSV-1 is dependent on TLR2 and TLR9 expression and on IFN gamma production in the trigeminal ganglia (TG) of infected mice. In this work, we further investigated the cells, molecules, and mechanisms of HSV-1 infection control, especially those that are TLR-dependent.
   Methods: C57BL/6 wild-type (WT), TLR2(-/-), TLR9(-/-), and TLR2/9(-/-) mice were intranasally infected with HSV-1. On the viral peak day, the TG and brains were collected from mice and TLR expression was measured in the TG and brain and inducible nitric oxide synthase (iNOS) expression was measured in the TG by real-time PCR. Immunofluorescence assays were performed in mice TG to detect iNOS production by F4/80(+) cells. Intraperitoneal macrophages nitric oxide (NO) production was evaluated by the Griess assay. WT, CD8(-/-), RAG(-/-), and iNOS(-/-) mice were intranasally infected in a survival assay, and their cytokine expression was measured in the TG by real-time PCR.
   Results: Infected WT mice exhibited significantly increased TLR expression, compared with their respective controls, in the TG but not in the brain. TLR-deficient mice had moderately increased TLR expression in the TG and brain in compare with the non-infected animals. iNOS expression in the WT infected mice TG was higher than in the other groups with increased production by macrophages in the WT infected mice, which did not occur in the TLR2/9(-/-) mice. Additionally, the intraperitoneal macrophages of the WT mice had a higher production of NO compared with those of the TLR-deficient mice. The CD8(-/-), RAG(-/-), and iNOS(-/-) mice had 100% mortality after the HSV-1 infection compared with 10% of the WT mice. Cytokines were overexpressed in the iNOS(-/-) infected mice, while the RAG(-/-) mice were nearly unresponsive to the virus.
   Conclusion: TLRs efficiently orchestrate the innate immune cells, eliciting macrophage response (with NO production by the macrophages), thereby controlling the HSV-1 infection through the immune response in the TG of mice.
C1 [Zolini, Guilherme Pimenta; Lucinda, Natalia; Silva, Mariana Almeida; Dias, Marcela Franca; Pessoa, Natalia Lima; Coura, Bruna Pizziolo; Campos, Marco Antonio] Fiocruz MS, Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Imunopatol Imunol Doencas Virais, BR-30190002 Belo Horizonte, MG, Brazil.
   [Lima, Graciela Kunrath] Univ Fed Minas Gerais, Escola Vet, Belo Horizonte, MG, Brazil.
   [Cartelle, Christiane Teixeira; Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Dept Patol, Belo Horizonte, MG, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
RP Campos, MA (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Imunopatol Imunol Doencas Virais, Av Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM marcoasc@cpqrr.fiocruz.br
RI Kroon, Erna Geessien/B-3631-2015; Arantes, Rosa ME/C-5749-2013; Kroon,
   Erna/V-5444-2019; Campos, Marco A/C-4000-2013; Pessoa,
   Natalia/AAL-6775-2020
OI Kroon, Erna Geessien/0000-0003-2721-3826; Arantes, Rosa
   ME/0000-0003-1428-9717; Campos, Marco A/0000-0003-4683-0176; Pessoa,
   Natalia/0000-0002-4284-2674; Coura, Bruna/0000-0002-9987-5311; Lucinda
   Pacheco Chaves, Natalia/0000-0001-7499-9687
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG,
   Brazil)Minas Gerais State Research Foundation (FAPEMIG); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Instituto Nacional de Ciencia e Tecnologia de
   Vacinas/CNPq/FAPEMIG (INCTV/CNPq/FAPEMIG; Brazil); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)CAPES;
   Programa Estrategico de Pesquisa em Saude V/VI (PAPES)/FIOCRUZ/CNPq
   (Brazil)National Council for Scientific and Technological Development
   (CNPq)
FX Work supported by the Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG, Brazil, to MAC and EGK), the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil, to MAC and EGK),
   Instituto Nacional de Ciencia e Tecnologia de Vacinas/CNPq/FAPEMIG
   (INCTV/CNPq/FAPEMIG; Brazil, to MAC), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES, Brazil), and the Programa Estrategico
   de Pesquisa em Saude V/VI (PAPES)/FIOCRUZ/CNPq (Brazil, to MAC). EGK,
   MAC, and RMEA are Fellows from CNPq. We thank the Program for
   Technological Development in Tools for Health-PDTIS-FIOCRUZ for use of
   its facilities and Ricardo Tostes Gazzinelli for analysis tools.
CR Aravalli RN, 2007, J NEUROIMMUNE PHARM, V2, P297, DOI 10.1007/s11481-007-9071-5
   Arduino PG, 2008, J ORAL PATHOL MED, V37, P107, DOI 10.1111/j.1600-0714.2007.00586.x
   Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001
   Boivin G, 2002, EUR J NEUROSCI, V16, P29, DOI 10.1046/j.1460-9568.2002.02057.x
   Boivin N, 2008, J INFECT DIS, V198, P664, DOI 10.1086/590671
   Broberg EK, 2003, J VIROL METHODS, V112, P53, DOI 10.1016/S0166-0934(03)00191-5
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Carr DJJ, 2006, VIRAL IMMUNOL, V19, P741, DOI 10.1089/vim.2006.19.741
   Conrady CD, 2010, J NEUROIMMUNOL, V220, P1, DOI 10.1016/j.jneuroim.2009.09.013
   Cook WJ, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-5
   Cunningham AL, 2006, J INFECT DIS, V194, pS11, DOI 10.1086/505359
   Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4
   DRAPIER JC, 1988, EUR J IMMUNOL, V18, P1587, DOI 10.1002/eji.1830181018
   Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128
   Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261
   Halford WP, 1996, J VIROL, V70, P5051, DOI 10.1128/JVI.70.8.5051-5060.1996
   Herbst-Kralovetz M, 2006, Herpes, V13, P37
   Hufner K, 2006, J NEUROPATH EXP NEUR, V65, P1022, DOI 10.1097/01.jnen.0000235852.92963.bf
   KARUPIAH G, 1995, J EXP MED, V181, P2171, DOI 10.1084/jem.181.6.2171
   KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156
   Kodukula P, 1999, J IMMUNOL, V162, P2895
   Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674
   Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364
   Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100
   Lima GK, 2010, THESIS U FEDERAL MIN
   Lima GK, 2007, THESIS U FEDERAL MIN
   Lima GK, 2010, AM J PATHOL, V177, P2433, DOI 10.2353/ajpath.2010.100121
   Lint A, 2004, J IMMUNOL, V172, P392
   Liu T, 1996, J VIROL, V70, P264, DOI 10.1128/JVI.70.1.264-271.1996
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mansur DS, 2005, AM J PATHOL, V166, P1419, DOI 10.1016/S0002-9440(10)62359-0
   Mansur DS, 2007, THESIS U FEDERAL MIN
   Marques CP, 2008, J NEUROVIROL, V14, P229, DOI 10.1080/13550280802093927
   Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009
   Nogueira ML, 2001, J CLIN PATHOL, V54, P103, DOI 10.1136/jcp.54.2.103
   Pierce AT, 2005, J GEN VIROL, V86, P2421, DOI 10.1099/vir.0.80979-0
   Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005
   Preston CM, 2000, J GEN VIROL, V81, P1
   ROIZMAN B, 2007, FIELDS VIROLOGY, P2502
   Sarangi PP, 2007, J VIROL, V81, P11128, DOI 10.1128/JVI.01008-07
   Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101
   Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193
   Schmutzhard E, 2001, J NEUROL, V248, P469, DOI 10.1007/s004150170155
   Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993
NR 46
TC 16
Z9 16
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-2094
J9 J NEUROINFLAMM
JI J. Neuroinflamm.
PD JAN 30
PY 2014
VL 11
AR 20
DI 10.1186/1742-2094-11-20
PG 12
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA AD4QX
UT WOS:000333236700002
PM 24479442
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Oliveira, DB
   Assis, FL
   Ferreira, PCP
   Bonjardim, CA
   Trindade, GD
   Kroon, EG
   Abrahao, JS
AF Oliveira, Danilo Bretas
   Assis, Felipe Lopes
   Peregrino Ferreira, Paulo Cesar
   Bonjardim, Claudio Antonio
   Trindade, Giliane de Souza
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
TI Short Report: Group 1 Vaccinia virus Zoonotic Outbreak in Maranhao
   State, Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID CANTAGALO VIRUS; SMALLPOX; POXVIRUS; STRAINS; HUMANS
AB In Brazil, several exanthematic autochthone Vaccinia virus (VACV) outbreaks affecting dairy cattle and rural workers have been reported since 1999. Although outbreaks had been first described in the Brazilian Southeast, VACV outbreaks were notified in all Brazilian regions in < 10 years. However, in this context, VACV outbreaks had not been described in some Brazilian States, likely because of a lack of notification, or yet unknown epidemiological reasons. Here, we describe the first VACV outbreak in Maranhao State, northeastern Brazil. The virus isolated from this outbreak showed several biological and molecular features that resemble other Group 1 Brazilian VACV, including a deletion signature in the A56R gene. This study raises new questions about diversity and epidemiology of Brazilian VACV.
C1 [Oliveira, Danilo Bretas; Assis, Felipe Lopes; Peregrino Ferreira, Paulo Cesar; Bonjardim, Claudio Antonio; Trindade, Giliane de Souza; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM danilobretas@yahoo.com.br; felipelopesassis@gmail.com;
   peregrinopcp@hotmail.com; claudio.bonjardim@pq.cnpq.br;
   gitrindade@yahoo.com.br; ernagkroon@gmail.com; jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Abrahao, Jonatas/B-3895-2015; Kroon, Erna
   Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014
OI Abrahao, Jonatas/0000-0001-9420-1791; Kroon, Erna
   Geessien/0000-0003-2721-3826; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA); Pro-Reitoria de Pesquisa
   da Universidade Federal de Minas Gerais (PRPq-UFMG)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais (FAPEMIG), Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA), and Pro-Reitoria de
   Pesquisa da Universidade Federal de Minas Gerais (PRPq-UFMG).
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Abrahao JS, 2009, VIROL J, V6, P1
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I, 2007, FIELDS VIROLOGY, P2079
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Heymann DL, 2006, CURR TOP MICROBIOL, V304, P1
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Posada D, 2006, NUCLEIC ACIDS RES, V34, P112
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Sambrook J., 2001, MOL CLONING LAB MANU
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
NR 21
TC 13
Z9 16
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2013
VL 89
IS 6
BP 1142
EP 1145
DI 10.4269/ajtmh.13-0369
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 276CQ
UT WOS:000328726100015
PM 24166043
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU de Assis, FL
   Vinhote, WM
   Barbosa, JD
   de Oliveira, CHS
   de Oliveira, CMG
   Campos, KF
   Silva, NS
   Trindade, GD
   Abrahao, JS
   Kroon, EG
AF de Assis, Felipe L.
   Vinhote, Wagner M.
   Barbosa, Jose D.
   de Oliveira, Cairo H. S.
   de Oliveira, Carlos M. G.
   Campos, Karinny F.
   Silva, Natalia S.
   Trindade, Giliane de Souza
   Abrahao, Jonatas S.
   Kroon, Erna G.
TI Reemergence of Vaccinia Virus during Zoonotic Outbreak, Para State,
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID ORTHOPOXVIRUS; SMALLPOX; POXVIRUS; STRAINS
AB In 2010, vaccinia virus caused an outbreak of bovine vaccinia that affected dairy cattle and rural workers in Para State, Brazil. Genetic analyses identified the virus as distinct from BeAn58058 vaccinia virus (identified in 1960s) and from smallpox vaccine virus strains. These findings suggest spread of autochthonous group 1 vaccinia virus in this region.
C1 [de Assis, Felipe L.; Trindade, Giliane de Souza; Abrahao, Jonatas S.; Kroon, Erna G.] Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil.
   [Vinhote, Wagner M.; Barbosa, Jose D.; de Oliveira, Cairo H. S.; de Oliveira, Carlos M. G.; Campos, Karinny F.; Silva, Natalia S.] Fed Univ Para, BR-66059 Belem, Para, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Abrahao, Jonatas/B-3895-2015; Kroon,
   Erna/B-3631-2015
OI Abrahao, Jonatas/0000-0001-9420-1791; Kroon, Erna/0000-0003-2721-3826;
   De Oliveira, Cairo/0000-0002-3474-2796
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao de Amparo
   a Pesquisa do Estado de Minas GeraisMinas Gerais State Research
   Foundation (FAPEMIG); Ministerio da Agricultura, Pecuaria e
   Abastecimento
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais,
   and Ministerio da Agricultura, Pecuaria e Abastecimento.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Abrahao JS, 2009, PLOS ONE, V4, DOI DOI 10.1371/J0UNTAL.P0NE.0007428
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
NR 13
TC 15
Z9 16
U1 0
U2 11
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2013
VL 19
IS 12
BP 2017
EP 2020
DI 10.3201/eid1912.130589
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 263RV
UT WOS:000327826600021
PM 24274374
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Assis, FL
   Borges, IA
   Mesquita, VS
   Ferreira, PC
   Trindade, GS
   Kroon, EG
   Abrahao, JS
AF Assis, Felipe L.
   Borges, Iara A.
   Mesquita, Vaz S.
   Ferreira, Paulo C.
   Trindade, Giliane S.
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI Vaccinia Virus in Household Environment during Bovine Vaccinia Outbreak,
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Assis, Felipe L.; Borges, Iara A.; Ferreira, Paulo C.; Trindade, Giliane S.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil.
   [Mesquita, Vaz S.] Serv Med Municipal, Carangola, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna Geessien/B-3631-2015; Abrahao, Jonatas/B-3895-2015; Kroon,
   Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Abrahao,
   Jonatas/0000-0001-9420-1791; 
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1
   ABRAHAO JS, 2009, VIROL J, V6, DOI DOI 10.1186/1743-422X-6
   Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P478
   Batista V. H., 2009, VIRUS REV RES, V14, P1
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Zafar A, 2007, EMERG INFECT DIS, V13, P902, DOI 10.3201/eid1306.061068
NR 10
TC 7
Z9 8
U1 0
U2 6
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2013
VL 19
IS 12
BP 2045
EP 2047
DI 10.3201/eid1912.120937
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 263RV
UT WOS:000327826600030
PM 24274787
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Guedes, MIMC
   Rehfeld, IS
   de Oliveira, TML
   Assis, FL
   Matos, ACD
   Abrahao, JS
   Kroon, EG
   Lobato, ZIP
AF Guedes, M. I. M. C.
   Rehfeld, I. S.
   de Oliveira, T. M. L.
   Assis, F. L.
   Matos, A. C. D.
   Abrahao, J. S.
   Kroon, E. G.
   Lobato, Z. I. P.
TI Detection of Vaccinia Virus in Blood and Faeces of Experimentally
   Infected Cows
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article
DE Vaccinia virus; bovine; epidemiology; viremia; faeces
ID HORIZONTAL TRANSMISSION; OUTBREAK; CATTLE; BRAZIL; ORTHOPOXVIRUS;
   POXVIRUS; RODENTS; DISEASE; HUMANS
AB Bovine vaccinia (BV), a zoonosis caused by Vaccinia virus (VACV), affects dairy cattle and milkers, causing economic, veterinary and human health impacts. Despite such impacts, there are no experimental studies about the pathogenesis of BV in cows to assess whether there is a systemic spread of the virus and whether there are different ways of VACV shedding. Trying to answer some of these questions, a study was proposed using experimental inoculation of VACV in cows. All experimentally infected cows developed lesions compatible with VACV infection in cattle. Two of the six animals presented VACV DNA in blood and faecal samples, starting at the 2nd and the 3rd day post-infection (d.p.i.), respectively, and lasting until the 36th d.p.i., in an intermittent way. This study provides new evidence that VACV can be detected in blood and faeces of infected cows, suggesting that BV could be a systemic disease, and also bringing new information about the epidemiology and pathogenesis of BV.
C1 [Guedes, M. I. M. C.; Rehfeld, I. S.; de Oliveira, T. M. L.; Matos, A. C. D.; Lobato, Z. I. P.] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Lab Pesquisa Virol Anim, Belo Horizonte, MG, Brazil.
   [Assis, F. L.; Abrahao, J. S.; Kroon, E. G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
RP Lobato, ZIP (corresponding author), Univ Fed Minas Gerais, Lab Pesquisa Virol Anim, Belo Horizonte, MG, Brazil.
EM ziplobato@gmail.com
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; Abrahao,
   Jonatas/B-3895-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Abrahao,
   Jonatas/0000-0001-9420-1791; Lobato, Zelia/0000-0002-9399-3691; DINIZ
   MATOS, ANA CAROLINA/0000-0003-3175-2590
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA); FAPEMIGMinas Gerais State
   Research Foundation (FAPEMIG)
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG) and Ministerio da Agricultura, Pecuaria
   e Abastecimento (MAPA). M. I. M. C. G. was supported by a fellowship
   from FAPEMIG. Z.I.P.L. and E. G. K. are researchers of CNPq.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   D'Anunciacao L, 2012, VECTOR-BORNE ZOONOT, V12, P61, DOI 10.1089/vbz.2011.0671
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
NR 12
TC 5
Z9 6
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
PD DEC
PY 2013
VL 60
IS 6
BP 552
EP 555
DI 10.1111/j.1865-1682.2012.01372.x
PG 4
WC Infectious Diseases; Veterinary Sciences
SC Infectious Diseases; Veterinary Sciences
GA 248JU
UT WOS:000326696500008
PM 22909142
DA 2020-11-30
ER

PT J
AU Charuthamrong, P
   Kaeratiswetanun, W
   Yamkram, T
   Sarovat, L
   Sawangying, T
   Thaitawat, N
   Likhitwonnawut, U
   Vasan, S
   Robb, M
   Churikanont, N
   Getchalarat, S
   Kroon, E
   Nitayaphan, S
   Eamsila, C
   Sriplienchan, S
   Ngauy, V
AF Charuthamrong, P.
   Kaeratiswetanun, W.
   Yamkram, T.
   Sarovat, L.
   Sawangying, T.
   Thaitawat, N.
   Likhitwonnawut, U.
   Vasan, S.
   Robb, M.
   Churikanont, N.
   Getchalarat, S.
   Kroon, E.
   Nitayaphan, S.
   Eamsila, C.
   Sriplienchan, S.
   Ngauy, V.
TI Early and Continuous Engagement of the CAB Is Essential to the
   Successful Implementation of Invasive Procedures in Clinical Trials
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT Conference on AIDS Vaccine
CY OCT 07-10, 2013
CL Barcelona, SPAIN
C1 [Charuthamrong, P.] Armed Forces Res Inst Med Sci MHRP AFRIMS, Rayong, Thailand.
   [Kaeratiswetanun, W.; Yamkram, T.; Thaitawat, N.; Vasan, S.; Churikanont, N.; Getchalarat, S.; Kroon, E.; Sriplienchan, S.; Ngauy, V.] Armed Forces Res Inst Med Sci, Banglamung Dist, Thailand.
   [Sarovat, L.; Sawangying, T.; Likhitwonnawut, U.] CAB, Bangkok, Thailand.
   [Robb, M.] US Mil HIV Res Program, Bethesda, MD USA.
   [Nitayaphan, S.; Eamsila, C.] Royal Thai Army AFRIMS, Bangkok, Thailand.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV 1
PY 2013
VL 29
IS 11
SI SI
BP A67
EP A67
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 239PI
UT WOS:000326037500168
DA 2020-11-30
ER

PT J
AU Rehfeld, IS
   Guedes, MIMC
   Matos, ACD
   de Oliveira, TML
   Rivetti, AV
   Moura, ACJ
   Paes, PRO
   do Lago, LA
   Kroon, EG
   Lobato, ZIP
AF Rehfeld, Izabelle S.
   Guedes, Maria Isabel M. C.
   Matos, Ana Carolina D.
   de Oliveira, Tercia M. L.
   Rivetti Junior, Anselmo V.
   Moura, Ana Carolina J.
   Paes, Paulo Ricardo O.
   do Lago, Luiz Alberto
   Kroon, Erna G.
   Lobato, Zelia Ines P.
TI Clinical, hematological and biochemical parameters of dairy cows
   experimentally infected with Vaccinia virus
SO RESEARCH IN VETERINARY SCIENCE
LA English
DT Article
DE Vaccinia virus; Bovine vaccinia; Experimental infection; Clinical
   course; Hematological and biochemical parameters; lmmunosuppression;
   Reinfection
ID BOVINE VACCINIA; CATTLE; OUTBREAK; BRAZIL; ASSAY; MILK
AB Vaccinia virus (VACV) is the etiological agent of bovine vaccinia (BY), an important zoonosis that affects dairy cattle. There are many aspects of the disease that remain unknown, and aiming to answer some of these questions, the clinical, hematological, and biochemical parameters of VACV experimentally infected cows were evaluated. In the first part of the study, lactating cows were infected with VACV-GP2 strain. In the second part, animals previously infected with VACV-GP2 were divided into two treatment groups: Group 1, immunosuppressed cows; and Group 2, re-infected cows. In this study, BV could be experimentally reproduced, with similar lesions as observed in natural infections. Moreover, a short incubation period and local lymphadenopathy were also observed. VACV could be detected by PCR and isolated from scabs taken from teat lesions of all inoculated and re-inoculated animals. Lymphocytosis and neutrophilia were observed in all animals from the first part of the experiment, and lymphopenia and relative neutrophilia were observed in the immunosuppressed animals. Detection of viral DNA in oral mucosa lesions suggests that viral reactivation might occur in immunosuppressed animals. Moreover, clinical disease with teat lesions may occur in previously VACV-infected cows under the experimental conditions of the present study. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Rehfeld, Izabelle S.; Guedes, Maria Isabel M. C.; Matos, Ana Carolina D.; de Oliveira, Tercia M. L.; Rivetti Junior, Anselmo V.; Lobato, Zelia Ines P.] Univ Fed Minas Gerais, Dept Med Vet Prevent, Lab Pesquisa Virol Anim, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kroon, Erna G.] Univ Fed Minas Gerais, ICB, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [Moura, Ana Carolina J.; Paes, Paulo Ricardo O.] Univ Fed Minas Gerais, Dept Med Vet Prevent, Lab Patol Clin, Dept Clin & Cirurgia, BR-31270901 Belo Horizonte, MG, Brazil.
   [do Lago, Luiz Alberto] Univ Fed Minas Gerais, Dept Clin & Cirurgia, BR-31270901 Belo Horizonte, MG, Brazil.
RP Lobato, ZIP (corresponding author), Univ Fed Minas Gerais, Dept Med Vet Prevent, Lab Pesquisa Virol Anim, Escola Vet, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM ziplobato@gmail.com
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; DINIZ MATOS, ANA
   CAROLINA/0000-0003-3175-2590; Lobato, Zelia/0000-0002-9399-3691
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); MAPA
FX We would like to thank LANAGRO-MG for providing the animal facilities
   where the experiment was performed, as well as the Virus Laboratory at
   ICB/UFMG and Clinical Pathology Laboratory and the Milk Analysis
   Laboratory at the Veterinary School/UFMG for helping in the laboratory
   analysis. Our sincere gratitude to Ronaldo Sanches for taking the
   pictures of the lesions, as well as "Seu Ze" and "Seu Geraldo", who
   helped us with the animals husbandry throughout the experiment. We also
   would like to thank Grazielle Cossenzo Florentino Gallinari, for her
   excellent technical support. Financial support was provided by CNPq,
   CAPES, FAPEMIG and MAPA. MIMCG, EGK, and ZIPL received fellowship from
   CNPq. The study sponsors above described had no involvement in the study
   design; in the collection, analysis and interpretation of data; in the
   writing of the manuscript; and in the decision to submit the manuscript
   for publication.
CR Abrahao J. S., 2009, ARCH VIROLOGY, V154, P1551
   Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324
   Almeida SR, 2008, PESQUISA VET BRASIL, V28, P87, DOI 10.1590/S0100-736X2008000100014
   Berkelman RL, 2003, CLIN INFECT DIS, V37, P407, DOI 10.1086/375595
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   COHEN JJ, 1991, ADV IMMUNOL, V50, P55
   COSTA JN, 1994, THESIS U SAO PAULO S
   Fagliari JJ, 1998, ARQ BRAS MED VET ZOO, V50, P263
   Gerber PF, 2012, J VET DIAGN INVEST, V24, P355, DOI 10.1177/1040638711435231
   Greco D., 2002, TXB VET PHYSL, P333
   Harvey J., 2001, ATLAS VET HEMATOLOGY
   Iketani Y, 2002, MICROBIOL IMMUNOL, V46, P285, DOI 10.1111/j.1348-0421.2002.tb02697.x
   Jain N. C., 1993, VET HEMATOL, P178
   LAUDER IM, 1971, VET REC, V89, P571, DOI 10.1136/vr.89.22.571
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   de Oliveira TML, 2011, AM J TROP MED HYG, V85, P152, DOI 10.4269/ajtmh.2011.11-0144
   de Oliveira TML, 2010, FOODBORNE PATHOG DIS, V7, P1491, DOI 10.1089/fpd.2010.0597
   Meyer D. J, 2004, VET LAB MED INTERPRE, P368
   Paes P.R.O., 2009, HEMATOLOGIA ANIMAIS
   ROSS JS, 1990, IMMUNOPHARM IMMUNOT, V12, P439, DOI 10.3109/08923979009006472
   Sambrook J., 1989, MOL CLONING LAB MANU, P956
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Thrall M.A., 2004, VET HEMATOLOGY CLIN
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Tscharke DC, 1999, J GEN VIROL, V80, P2751, DOI 10.1099/0022-1317-80-10-2751
NR 28
TC 12
Z9 12
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0034-5288
EI 1532-2661
J9 RES VET SCI
JI Res. Vet. Sci.
PD OCT
PY 2013
VL 95
IS 2
BP 752
EP 757
DI 10.1016/j.rvsc.2013.05.005
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA 210UU
UT WOS:000323861000075
PM 23747141
DA 2020-11-30
ER

PT J
AU de Souza, KPR
   Silva, EG
   Rocha, ESD
   Figueiredo, LB
   de Almeida-Leite, CM
   Arantes, RME
   Gomes, JDS
   Ferreira, GP
   de Oliveira, JG
   Kroon, EG
   Campos, MA
AF Ribeiro de Souza, Katia Paulino
   Silva, Emanuele Guimaraes
   de Oliveira Rocha, Eliseu Soares
   Figueiredo, Leandra Barcelos
   de Almeida-Leite, Camila Megale
   Esteves Arantes, Rosa Maria
   Silva Gomes, Juliana de Assis
   Ferreira, Gustavo Portela
   de Oliveira, Jaquelline Germano
   Kroon, Erna Geessien
   Campos, Marco Antonio
TI Nitric oxide synthase expression correlates with death in an
   experimental mouse model of dengue with CNS involvement
SO VIROLOGY JOURNAL
LA English
DT Article
DE Dengue virus; Murine model; Neurovirulence; Neuropathogenesis;
   Immunopathogenesis; Encephalitis; Nitric oxide synthase 2; Nitric oxide;
   Interferon gamma
ID IFN-GAMMA; NEUROLOGICAL MANIFESTATIONS; HEMORRHAGIC-FEVER; TNF-ALPHA;
   INFECTION; SYSTEM; CYTOKINE
AB Background: The clinical presentation of dengue is classified by the World Health Organization into dengue without warning signs, dengue with warning signs and severe dengue. Reports of neurological disease caused by Dengue virus (DENV) are becoming frequent, with symptoms that include reduced consciousness, severe headache, neck stiffness, focal neurological signs, tense fontanelle and convulsions. However, the immune mechanisms involved in neurovirulence remain poorly understood. Here we present a mouse model in which one genotype of DENV is inoculated by the intracranial route and infects C57/BL6 mice and replicates in the brain, causing death of mice.
   Methods: Mice were infected with different serotypes/genotypes of DENV by the intracranial route to evaluate viral replication, host cytokine and nitric oxide synthase 2 (Nos2) expression in the brain via real-time PCR. Histological analysis of the brain tissues was also performed. An analysis of which cells were responsible for the expression of cytokines and Nos2 was performed using flow cytometry. Survival curves of infected animals were also generated.
   Results: DENV 3 genotype I infected mice and replicated in the brain, causing death in our murine model. The increased levels of NOS2 could be the cause of the death of infected mice, as viral replication correlates with increased Nos2 and cytokine expression in the brain of C57BL/6 mice. In Nos2(-/-) mice that were infected with DENV, no clinical signs of infection were observed and cytokines were expressed at low levels, with the exception of interferon gamma (Ifng). Additionally, the Ifng(-/-) mice infected with DENV exhibited a severe and lethal disease, similar to the disease observed in C57BL/6 mice, while the DENV-infected Nos2(-/-) mice did not display increased mortality. Analyses of the brains from infected C57BL/6 mice revealed neuronal degeneration and necrosis during histopathologic examination. IFNg and NOS2 were produced in the brains of infected mice by CD4(+) T cells and macrophages, respectively.
   Conclusion: The neurovirulence of DENV 3 genotype I is associated with a deleterious role of NOS2 in the brain, confirming this murine model as an appropriate tool to study DENV neurovirulence.
C1 [Ribeiro de Souza, Katia Paulino; Silva, Emanuele Guimaraes; de Oliveira Rocha, Eliseu Soares; Figueiredo, Leandra Barcelos; de Almeida-Leite, Camila Megale; Esteves Arantes, Rosa Maria; Silva Gomes, Juliana de Assis; Kroon, Erna Geessien] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Ferreira, Gustavo Portela] Univ Fed Piaui, Parnaiba, Piaui, Brazil.
   [de Oliveira, Jaquelline Germano; Campos, Marco Antonio] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
RP Campos, MA (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
EM marcoasc@cpqrr.fiocruz.br
RI Kroon, Erna Geessien/B-3631-2015; Campos, Marco A/C-4000-2013; Gomes,
   Juliana A. S./M-4083-2017; Arantes, Rosa ME/C-5749-2013; Kroon,
   Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Campos, Marco
   A/0000-0003-4683-0176; Gomes, Juliana A. S./0000-0002-8332-2907;
   Arantes, Rosa ME/0000-0003-1428-9717; Rocha, Eliseu/0000-0002-2854-0768
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG,
   Brazil)Minas Gerais State Research Foundation (FAPEMIG); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Instituto Nacional de Ciencia e Tecnologia de
   Vacinas/CNPq/FAPEMIG (INCTV/CNPq/FAPEMIG, Brazil); Instituto Nacional de
   Ciencia e Tecnologia Dengue CNPq/FAPEMIG (INCTDengue/CNPq/FAPEMIG,
   Brazil); PRONEXDENGUE; DECIT-Ministerio da Saude; Programa Estrategico
   de Pesquisa em Saude VI (PAPES)/FIOCRUZ/CNPq (Brazil); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)CAPES
FX This work was supported by the Fundacao de Amparo a Pesquisa do Estado
   de Minas Gerais (FAPEMIG, Brazil, to MAC and EGK), the Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil, to MAC and
   EGK), Instituto Nacional de Ciencia e Tecnologia de Vacinas/CNPq/FAPEMIG
   (INCTV/CNPq/FAPEMIG, Brazil, to MAC), Instituto Nacional de Ciencia e
   Tecnologia Dengue CNPq/FAPEMIG (INCTDengue/CNPq/FAPEMIG, Brazil, to
   EGK), PRONEXDENGUE, DECIT-Ministerio da Saude (to EGK), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil), and the
   Programa Estrategico de Pesquisa em Saude VI (PAPES)/FIOCRUZ/CNPq
   (Brazil, to MAC). EGK, MAC and RMEA are Fellows of CNPq. We thank the
   Program for Technological Development in Tools for Health-PDTIS-FIOCRUZ
   for the use of its facilities and to Joao Rodrigues dos Santos for
   technical support.
CR Akaike T, 2000, IMMUNOLOGY, V101, P300, DOI 10.1046/j.1365-2567.2000.00142.x
   Amorim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044984
   Araujo FMC, 2012, NEUROLOGY, V78, P736, DOI 10.1212/WNL.0b013e31824b94e9
   Araujo F, 2012, EMERG INFECT DIS, V18, P677, DOI [10.3201/eid1804.111522, 10.3201/eid1804.111552]
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Bethell DB, 1998, J INFECT DIS, V177, P778, DOI 10.1086/517807
   Blais V, 2004, J IMMUNOL, V172, P7043, DOI 10.4049/jimmunol.172.11.7043
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Chaturvedi UC, 2009, FEMS IMMUNOL MED MIC, V56, P9, DOI 10.1111/j.1574-695X.2009.00544.x
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Costa VV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001663
   de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215
   Ferreira GP, 2010, MICROBES INFECT, V12, P546, DOI 10.1016/j.micinf.2010.03.007
   Ferreira MLB, 2005, ARQ NEURO-PSIQUIAT, V63, P488, DOI 10.1590/S0004-282X2005000300023
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   Garcia-Rivera EJ, 2009, P R HEALTH SCI J, V28, P114
   Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   HOTTA S, 1952, J INFECT DIS, V90, P1, DOI 10.1093/infdis/90.1.1
   Jackson ST, 2008, W INDIAN MED J, V57, P373
   JIANG H, 1995, IMMUNOBIOLOGY, V192, P321, DOI 10.1016/S0171-2985(11)80173-7
   Kankirawatana P, 2000, J CHILD NEUROL, V15, P544, DOI 10.1177/088307380001500809
   Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854
   Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395
   Nsakran S, 2008, EXP BIOL MED, V233, P401, DOI 10.3181/0707-MR-198
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106
   Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08
NR 36
TC 12
Z9 15
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD AUG 26
PY 2013
VL 10
AR 267
DI 10.1186/1743-422X-10-267
PG 10
WC Virology
SC Virology
GA 211CB
UT WOS:000323880600001
PM 23978258
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Salgado, APC
   Soares-Martins, JAP
   Andrade, LG
   Albarnaz, JD
   Ferreira, PCP
   Kroon, EG
   Bonjardim, CA
AF Carneiro Salgado, Ana Paula
   Pinheiro Soares-Martins, Jamaria Adriana
   Andrade, Luciana Garcia
   Albarnaz, Jonas Dutra
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
   Bonjardim, Claudio Antonio
TI Study of Vaccinia and Cowpox viruses' replication in Rac1-N17
   dominant-negative cells
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Rac1; Akt; Vaccinia virus; Cowpox virus; virus-host interaction
ID SARCOMA-ASSOCIATED HERPESVIRUS; RHO-GTPASES; PROTEIN-KINASE; SIGNALING
   PATHWAYS; EARLY-STAGE; ACTIVATION; INFECTION; PI3K/AKT; RAC; JNK
AB Interfering with cellular signal transduction pathways is a common strategy used by many viruses to create a propitious intracellular environment for an efficient replication. Our group has been studying cellular signalling pathways activated by the orthopoxviruses Vaccinia (VACV) and Cowpox (CPXV) and their significance to viral replication. In the present study our aim was to investigate whether the GTPase Rac1 was an upstream signal that led to the activation of MEK/ERK1/2, JNK1/2 or Akt pathways upon VACV or CPXV' infections. Therefore, we generated stable murine fibroblasts exhibiting negative dominance to Rac1-N17 to evaluate viral growth and the phosphorylation status of ERK1/2, JNK1/2 and Akt. Our results demonstrated that VACV replication, but not CPXV, was affected in dominant-negative (DN) Rac1-N17 cell lines in which viral yield was reduced in about 10-fold. Viral late gene expression, but not early, was also reduced. Furthermore, our data showed that Akt phosphorylation was diminished upon VACV infection in DN Rac1-N17 cells, suggesting that Rac1 participates in the phosphoinositide-3 kinase pathway leading to the activation of Akt. In conclusion, our results indicate that while Rac1 indeed plays a role in VACV biology, perhaps another GTPase may be involved in CPXV replication.
C1 [Carneiro Salgado, Ana Paula; Pinheiro Soares-Martins, Jamaria Adriana; Andrade, Luciana Garcia; Albarnaz, Jonas Dutra; Bonjardim, Claudio Antonio] Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal Orthopoxvirus & Flavivirus L, Belo Horizonte, MG, Brazil.
   [Carneiro Salgado, Ana Paula; Pinheiro Soares-Martins, Jamaria Adriana; Andrade, Luciana Garcia; Albarnaz, Jonas Dutra; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien; Bonjardim, Claudio Antonio] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Pinheiro Soares-Martins, Jamaria Adriana] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal Orthopoxvirus & Flavivirus L, Belo Horizonte, MG, Brazil.
EM claudio.bonjardim@pq.cnpq.br
RI Albarnaz, Jonas Dutra/E-4526-2010; Bonjardim, Claudio A/J-2601-2014;
   Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Albarnaz, Jonas Dutra/0000-0002-8792-813X; Kroon, Erna
   Geessien/0000-0003-2721-3826
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); CAPESCAPES;
   MCT-Brazil; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX FAPEMIG, CAPES, MCT-Brazil, CNPq
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609
   Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10
   Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200
   Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000
   Chen SY, 2002, J VIROL, V76, P9556, DOI 10.1128/JVI.76.18.9556-9561.2002
   Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8
   Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729
   Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091
   Esfandiarei M, 2004, J VIROL, V78, P4289, DOI 10.1128/JVI.78.8.4289-4298.2004
   Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148
   Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Formenty P, 2010, EMERG INFECT DIS, V16, P1539, DOI 10.3201/eid1610.100713
   Greber UF, 2002, CELL MOL LIFE SCI, V59, P608, DOI 10.1007/s00018-002-8453-3
   Gunduz D, 2010, ARTERIOSCL THROM VAS, V30, P1237, DOI 10.1161/ATVBAHA.110.203901
   Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891
   Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632
   Hamza MS, 2004, J BIOL CHEM, V279, P38325, DOI 10.1074/jbc.M400964200
   Harokopakis E, 2006, J IMMUNOL, V176, P7645, DOI 10.4049/jimmunol.176.12.7645
   Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647
   He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002
   Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476
   Holloway G, 2006, J VIROL, V80, P10624, DOI 10.1128/JVI.00390-06
   Hoppe S, 2006, J GEN VIROL, V87, P3483, DOI 10.1099/vir.0.82231-0
   Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079
   Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Katsuma S, 2007, J VIROL, V81, P13700, DOI 10.1128/JVI.01683-07
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Lin CH, 2011, J BIOL CHEM, V286, P10483, DOI 10.1074/jbc.M110.112433
   Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497
   Mehrotra S, 2007, J LEUKOCYTE BIOL, V81, P539, DOI 10.1189/jlb.0706479
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6
   Missy K, 1998, J BIOL CHEM, V273, P30279, DOI 10.1074/jbc.273.46.30279
   Moss B., 2007, VIROLOGY, V2905-2946
   Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153
   Pei Rongjuan, 2012, Virologica Sinica, V27, P278, DOI 10.1007/s12250-012-3257-6
   Pereira ACTC, 2012, ANTIVIR RES, V93, P69, DOI 10.1016/j.antiviral.2011.10.020
   Pereira ACTC, 2012, J VIROL, V86, P172, DOI 10.1128/JVI.05638-11
   Perkins D, 2003, J NEUROVIROL, V9, P101, DOI 10.1080/13550280390173427
   Pontow SE, 2004, J VIROL, V78, P7138, DOI 10.1128/JVI.78.13.7138-7147.2004
   Qin D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-240
   Quetglas JI, 2012, J VIROL, V86, P1758, DOI 10.1128/JVI.05666-11
   Reynolds MG, 2004, LANCET INFECT DIS, V4, P604, DOI 10.1016/S1473-3099(04)01139-9
   Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587
   Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141
   Sambrook J., 1989, MOL CLONING LAB MANU
   SEGER R, 1995, FASEB J, V9, P726
   Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039
   Shao HS, 2008, WOUND REPAIR REGEN, V16, P551, DOI 10.1111/j.1524-475X.2008.00402.x
   Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005
   Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07
   Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509
   Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09
   Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179
   Tan TL, 2008, BBA-MOL CELL RES, V1783, P360, DOI 10.1016/j.bbamcr.2007.10.024
   Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74
   Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1
   Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071
   Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217
   Zamudio-Meza H, 2009, J GEN VIROL, V90, P2902, DOI 10.1099/vir.0.014159-0
   Zapata HJ, 2007, J VIROL, V81, P977, DOI 10.1128/JVI.01470-06
NR 72
TC 1
Z9 1
U1 0
U2 10
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2013
VL 108
IS 5
BP 554
EP 562
DI 10.1590/S0074-02762013000500004
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 192XI
UT WOS:000322520800004
PM 23903969
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Brandao, GC
   Kroon, EG
   Souza, DER
   Souza, JD
   Oliveira, AB
AF Brandao, Geraldo Celio
   Kroon, Erna G.
   Souza, Danielle E. R.
   Souza Filho, Jose D.
   Oliveira, Alaide Braga
TI Chemistry and Antiviral Activity of Arrabidaea pulchra (Bignoniaceae)
SO MOLECULES
LA English
DT Article
DE antiviral activity; dengue virus; Arrabidaea pulchra; verbascoside;
   caffeoylcallerianin
ID MINAS-GERAIS; STATE; APOPTOSIS
AB The aim of the present work was to carry out a bioguided isolation of antiviral chemical constituents from an ethanol extract of leaves from Arrabidaea pulchra (Cham.) Sandwith (EEAPL) that had shown in vitro activity in a previous screening using DNA and RNA viruses. The activity of EEPAL was evaluated against the DNA viruses Human herpesvirus 1 (HSV-1) and Vaccinia virus Western Reserve (VACV-WR) as well as against the RNA viruses Murine encephalomyocarditis virus (EMCV), and Dengue virus 2 (DENV-2) by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay. Cytotoxicity was determined in LLCMK2 and Vero cells and the Selectivity Indexes (SI) were calculated. The most potent effect was observed against DENV-2 (EC50 46.8 +/- 1.6 mu g mL(-1); SI 2.7). For HSV-1 and VACV-WR EC50 values > 200 mu g mL(-1) were determined, while no inhibition of the cytopathic effect was observed with EMCV. Bioguided fractionation of EEAPL by partition between immiscible solvents followed by chromatography over a Sephadex LH20 column afforded two arylpropanoid glycosides, verbascoside (AP 1) and caffeoylcalleryanin (AP 2), along with a terpenoid, ursolic acid (AP 3). AP 1 and AP 3 exhibited similar anti-DENV-2 profiles, with SI values of 3.8 and 3.1, respectively, while AP 2 was the most effective anti-DENV-2 constituent, with a SI of 20.0. Our results show that A. pulchra leaves ethanol extract (EEAPL) affords compounds with antiviral activity, mainly against DENV-2.
C1 [Brandao, Geraldo Celio; Souza, Danielle E. R.; Oliveira, Alaide Braga] Univ Fed Minas Gerais, Dept Prod Farmaceut, Fac Farm, BR-31270901 Belo Horizonte, MG, Brazil.
   [Brandao, Geraldo Celio] Univ Fed Ouro Preto, Dept Farm, Escola Farm, BR-35400000 Ouro Preto, MG, Brazil.
   [Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
   [Souza Filho, Jose D.] Univ Fed Minas Gerais, Dept Quim, ICEX, BR-31270901 Belo Horizonte, MG, Brazil.
RP Oliveira, AB (corresponding author), Univ Fed Minas Gerais, Dept Prod Farmaceut, Fac Farm, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM alaide.braga@pq.cnpq.br
RI Kroon, Erna Geessien/B-3631-2015; DE SOUZA FILHO, Jose
   DIAS/ABF-1983-2020; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; DE SOUZA FILHO, Jose
   DIAS/0000-0002-3656-4882; Brandao, Geraldo Celio/0000-0002-7330-051X
FU FAPEMIG-Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (Brazil)Minas Gerais State Research Foundation (FAPEMIG); CNPq
   (Brazil)National Council for Scientific and Technological Development
   (CNPq); CAPES (Brazil)CAPES
FX This work was supported by funds from FAPEMIG-Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (Brazil) and CNPq (Brazil). CAPES
   (Brazil) and CNPq (Brazil) are also acknowledged for PhD (to GCB) and
   research fellowships (to ABO and EGK).
CR Alvarenga T. A., 2012, International Journal of Biotechnology for Wellness Industries, V1, P122
   Betancur-Galvis LA, 1999, MEM I OSWALDO CRUZ, V94, P531, DOI 10.1590/S0074-02761999000400019
   Brandao GC, 2010, LETT APPL MICROBIOL, V51, P469, DOI 10.1111/j.1472-765X.2010.02924.x
   Brandao GC, 2010, REV BRAS FARMACOGN, V20, P742, DOI [10.1590/S0102-695X2010005000035, 10.1590/S0102-695X2010000500015]
   CHALLICE JS, 1968, PHYTOCHEMISTRY, V7, P119, DOI 10.1016/S0031-9422(00)88214-X
   Chattopadhyay D, 2007, MINI-REV MED CHEM, V7, P275, DOI 10.2174/138955707780059844
   DERODRIGUEZ DJ, 1990, PLANTA MED, V56, P59, DOI 10.1055/s-2006-960884
   Fischer E, 2004, FA GE VAS P, V7, P9
   GENTRY AH, 1992, ANN MO BOT GARD, V79, P53, DOI 10.2307/2399809
   Ghisalberti EL, 2000, FITOTERAPIA, V71, P467, DOI 10.1016/S0367-326X(00)00202-1
   Kernan MR, 1998, J NAT PROD, V61, P564, DOI 10.1021/np9703914
   Lima Cláudia Sampaio de Andrade, 2003, Rev. Bras. Cienc. Farm., V39, P77, DOI 10.1590/S1516-93322003000100008
   Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2
   Lohmann LG, 2006, AM J BOT, V93, P304, DOI 10.3732/ajb.93.2.304
   Martins FO, 2009, NAT PROD COMMUN, V4, P1693
   Mukhtar M, 2008, VIRUS RES, V131, P111, DOI 10.1016/j.virusres.2007.09.008
   Oliveira A.B., 2011, Brazilian Patent, Patent No. [PI BR 014110003098, 014110003098]
   Sarkhail Parisa, 2006, Daru, V14, P115
   Scudeller V.V., 1998, IHERINGIA SER BOT, V51, P79
   Selisco B., OPPORTUNITIES DEV AN
   Simoes LR, 2011, LETT APPL MICROBIOL, V53, P602, DOI 10.1111/j.1472-765X.2011.03146.x
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Yang HJ, 2010, CURR DRUG TARGETS, V11, P733, DOI 10.2174/138945010791170842
   Zheng QY, 2013, CELL SIGNAL, V25, P206, DOI 10.1016/j.cellsig.2012.09.012
NR 24
TC 10
Z9 11
U1 0
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD AUG
PY 2013
VL 18
IS 8
BP 9919
EP 9932
DI 10.3390/molecules18089919
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 298DL
UT WOS:000330304100076
PM 23959197
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Rivetti, AV
   Guedes, MIMC
   Rehfeld, IS
   Oliveira, TML
   Matos, ACD
   Abrahao, JS
   Kroon, EG
   Lobato, ZIP
AF Rivetti, Anselmo V., Jr.
   Guedes, Maria Isabel M. C.
   Rehfeld, Izabelle S.
   Oliveira, Tercia M. L.
   Matos, Ana Carolina D.
   Abrahao, Jonatas S.
   Kroon, Erna G.
   Lobato, Zelia I. P.
TI Bovine vaccinia, a systemic infection: Evidence of fecal shedding,
   viremia and detection in lymphoid organs
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE Poxvirus; Vaccinia virus; Pathogenesis; Tissues; Feces; Shedding
ID HORIZONTAL TRANSMISSION; ECTROMELIA-VIRUS; MONKEYPOX VIRUS; PCR
   DETECTION; CATTLE; ORTHOPOXVIRUS; DISEASE; OUTBREAK; MOUSEPOX; STRAINS
AB Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus (VACV) that affects dairy cattle and milkers, causing economic losses and impacting animal and human health. Based on the clinical presentation, BV appears to be a localized disease, with lesions restricted to the skin of affected individuals. However, there are no studies on the pathogenesis of the disease in cows to determine if there is a systemic spread of the virus and if there are different ways of VACV shedding. The objective of this work was to study if there is a systemic spread of VACV in experimentally infected cows and to study the kinetics of VACV circulation in the blood and shedding in the feces of these animals. To this end, eight crossbred lactating cows were used. Three teats of each cow were inoculated with the GP2V strain of VACV. All animals were monitored daily, and blood and fecal samples were collected for 67 days post-infection (dpi). After this period, four of these previously infected cows were immunosuppressed using dexamethasone. Viral DNA was continuously detected and quantified in the blood and feces of these animals in an intermittent way, even after the resolution of the lesions. At slaughter, tissues were collected, and viral DNA was detected and quantified in the mesenteric and retromammary lymph nodes, ileum, spleen and liver. The detection of VACV DNA in the feces for a longer period (67 dpi) and in the lymphatic organs provides new evidence about VACV elimination and suggests that BV could be a systemic infection with a chronic course and viral shedding through the feces. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Rivetti, Anselmo V., Jr.; Guedes, Maria Isabel M. C.; Rehfeld, Izabelle S.; Oliveira, Tercia M. L.; Matos, Ana Carolina D.; Lobato, Zelia I. P.] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, BR-30123970 Belo Horizonte, MG, Brazil.
   [Rivetti, Anselmo V., Jr.] MAPA, Belo Horizonte, MG, Brazil.
   [Abrahao, Jonatas S.; Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-30123970 Belo Horizonte, MG, Brazil.
RP Lobato, ZIP (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, Av Antonio Carlos 6627,Caixa Postal 567,Campus UF, BR-30123970 Belo Horizonte, MG, Brazil.
EM ziplobato@gmail.com
RI Abrahao, Jonatas/B-3895-2015; Kroon, Erna Geessien/B-3631-2015; Kroon,
   Erna/V-5444-2019
OI Abrahao, Jonatas/0000-0001-9420-1791; Kroon, Erna
   Geessien/0000-0003-2721-3826; Lobato, Zelia/0000-0002-9399-3691; DINIZ
   MATOS, ANA CAROLINA/0000-0003-3175-2590
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico"
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa de Minas Gerais" (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA); Pro-Reitoria de Pesquisa
   da Universidade Federal de Minas Gerais; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX We would like to thank LANAGRO-MG for providing the animal facilities
   where the experiment was performed and the Virus Laboratory at ICB/UFMG
   for helping with the laboratory analysis. Our sincere gratitude to Mr.
   Ze and Geraldo, who helped us with the animal husbandry throughout the
   experiment and to Grazielle Cossenzo Florentino Gallinari for her
   excellent technical support. We are grateful for the financial support
   provided by the "Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico" (CNPq), the "Fundacao de Amparo a Pesquisa de Minas Gerais"
   (FAPEMIG), the "Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), the "Ministerio da Agricultura, Pecuaria e
   Abastecimento (MAPA) and the "Pro-Reitoria de Pesquisa da Universidade
   Federal de Minas Gerais"". MIMCG, EGK, and ZIPL received fellowships
   from CNPq.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140
   Abrahao JS, 2009, ARCH VIROL, V155, P1200
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Cargnelutti JF, 2012, MICROB PATHOGENESIS, V52, P192, DOI 10.1016/j.micpath.2011.12.005
   D'Anunciacao L, 2012, VECTOR-BORNE ZOONOT, V12, P61, DOI 10.1089/vbz.2011.0671
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0
   Fenner F, 2000, FEMS MICROBIOL REV, V24, P123, DOI 10.1111/j.1574-6976.2000.tb00536.x
   Gerber PF, 2012, J VET DIAGN INVEST, V24, P355, DOI 10.1177/1040638711435231
   GLEDHILL AW, 1962, NATURE, V196, P298, DOI 10.1038/196298a0
   Goff A, 2007, VIRUS RES, V128, P88, DOI 10.1016/j.virusres.2007.04.014
   Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0
   Iketani Y, 2002, MICROBIOL IMMUNOL, V46, P285, DOI 10.1111/j.1348-0421.2002.tb02697.x
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   Maiboroda A.D., 1982, ACTA VIROL, V2, P106
   Megid J, 2012, EMERG INFECT DIS, V18, P189, DOI 10.3201/eid1801.110692
   Nitsche A, 2006, CLIN CHEM, V52, P316, DOI 10.1373/clinchem.2005.060335
   Paranhos da Costa M.J.R., 1992, P 9 INT SCI C IFOAM
   Quixabeira-Santos JC, 2011, EMERG INFECT DIS, V17, P726, DOI 10.3201/eid1704.101581
   Rehfeld I.S., 2011, THESIS U FEDERAL MIN
   Sambrook J., 1989, MOL CLONING LAB MANU, P956
   Sampaio I. B. M., 1998, ESTATISTICA APLICADA
   Savona MR, 2006, JAMA-J AM MED ASSOC, V295, P1898, DOI 10.1001/jama.295.16.1898
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Von Brodorotti H.S., 1972, ZBL VET MED, V167, P74
   Wahl-Jensen V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024832
   WALLACE GD, 1985, LAB ANIM SCI, V35, P41
   Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373
NR 36
TC 18
Z9 19
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD FEB 22
PY 2013
VL 162
IS 1
BP 103
EP 111
DI 10.1016/j.vetmic.2012.09.005
PG 9
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA 090TL
UT WOS:000315002800012
PM 23021861
DA 2020-11-30
ER

PT J
AU Vilela, MC
   Lima, GK
   Rodrigues, DH
   Lacerda-Queiroz, N
   Pedroso, VSP
   Miranda, AS
   Rachid, MA
   Kroon, EG
   Campos, MA
   Teixeira, MM
   Sellner, J
   Teixeira, AL
AF Vilela, Marcia Carvalho
   Lima, Graciela Kunrath
   Rodrigues, David Henrique
   Lacerda-Queiroz, Norinne
   Pietra Pedroso, Vinicius Sousa
   Miranda, Aline Silva
   Rachid, Milene Alvarenga
   Kroon, Erna Geessien
   Campos, Marco Antonio
   Teixeira, Mauro Martins
   Sellner, Johann
   Teixeira, Antonio Lucio
TI Absence of CCR5 increases neutrophil recruitment in severe herpetic
   encephalitis
SO BMC NEUROSCIENCE
LA English
DT Article
DE Herpes simplex virus type 1; CCR5(-/-); Neuroinflammation
ID CD8(+) T-CELLS; CHEMOKINE RECEPTOR DEFICIENCY; CENTRAL-NERVOUS-SYSTEM;
   LEUKOCYTE RECRUITMENT; CCR5-DEFICIENT MICE; CEREBROSPINAL-FLUID; OCULAR
   INFECTION; EXPRESSION; INFLAMMATION; MECHANISMS
AB Background: The neuroinflammatory response aimed at clearance of herpes simplex virus-1 (HSV-1) plays a key role in the pathogenesis of neuroaxonal damage in herpetic encephalitis. Leukocytes activated in an adaptive immune response access brain tissue by passing through the blood-brain barrier. The chemokine CCL5/RANTES is involved in recruitment of these cells to the brain acting via the receptors CCR1, CCR3 and mainly CCR5. Here, we evaluated the role of CCR5 on traffic of leukocytes in the brain microvasculature, cellular and cytokines profile in a severe form of herpetic encephalitis.
   Results: Wild type and mice lacking CCR5 (CCR5(-/-)) were inoculated intracerebrally with 10(4) PFU of neurotropic HSV-1. We evaluated the traffic of leukocytes in the brain microvasculature using intravital microscopy and the profile of cytokines by Enzyme-Linked Immunosorbent Assay at 1 day post infection. Flow cytometry and histopathological analyses were also carried out in brain tissue. Absence of CCR5 leads to lower viral load and an increased leukocyte adhesion in brain microvasculature, predominantly of neutrophils (CD11(+) Ly6G(+) cells). Moreover, there was a significant increase in the levels of MIP-1/CCL2, RANTES/CCL5, KC/CXCL1 and MIG/CXCL9 in the brain of infected CCR5(-/-) mice.
   Conclusions: These results suggest that the absence of CCR5 may boost the immune response with a high neutrophil recruitment which most likely helps in viral clearance. Nonetheless, the elevated immune response may be detrimental to the host.
C1 [Vilela, Marcia Carvalho; Rodrigues, David Henrique; Lacerda-Queiroz, Norinne; Pietra Pedroso, Vinicius Sousa; Miranda, Aline Silva; Rachid, Milene Alvarenga; Teixeira, Mauro Martins; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Lab Imunofarmacol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Vilela, Marcia Carvalho] Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil.
   [Lima, Graciela Kunrath; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
   [Campos, Marco Antonio] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Sellner, Johann] Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria.
   [Sellner, Johann] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany.
RP Vilela, MC (corresponding author), Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Lab Imunofarmacol, Av Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM vilelamc@gmail.com; altexr@gmail.com
RI Selllner, Johann/AAB-1263-2019; Rachid, Milene Alvarenga/C-3530-2017;
   Kroon, Erna/V-5444-2019; Teixeira, Antonio L/N-3315-2014; Campos, Marco
   A/C-4000-2013; Kroon, Erna Geessien/B-3631-2015
OI Rachid, Milene Alvarenga/0000-0002-3142-6552; Teixeira, Antonio
   L/0000-0002-9621-5422; Campos, Marco A/0000-0003-4683-0176; Kroon, Erna
   Geessien/0000-0003-2721-3826
FU CapesCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); INCT em Dengue, Brazil; European Federation of
   Neurological Societies
FX This work was supported by Capes, CNPq and INCT em Dengue, Brazil. JS
   was supported by a scientific fellowship from the European Federation of
   Neurological Societies.
CR Alexander SPH, 2008, BRIT J PHARMACOL, V153, pS1, DOI 10.1038/sj.bjp.0707746
   Ali S, 2000, J BIOL CHEM, V275, P11721, DOI 10.1074/jbc.275.16.11721
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497
   Carr DJJ, 2006, J GEN VIROL, V87, P489, DOI 10.1099/vir.0.81339-0
   CHAN WL, 1989, J NEUROIMMUNOL, V23, P195, DOI 10.1016/0165-5728(89)90051-9
   Domingues RB, 2009, BRAZ J INFECT DIS, V13, P433, DOI 10.1590/S1413-86702009000600009
   Dorries R, 2001, CURR TOP MICROBIOL, V253, P219
   Glass WG, 2003, VIROLOGY, V312, P407, DOI 10.1016/S0042-6822(03)00237-X
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kamei S, 2009, CYTOKINE, V46, P187, DOI 10.1016/j.cyto.2009.01.004
   Kennedy PGE, 2002, J NEUROL NEUROSUR PS, V73, P237, DOI 10.1136/jnnp.73.3.237
   Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000
   Kubes P, 2000, BRAIN PATHOL, V10, P127
   Lang A, 2005, J IMMUNOL, V174, P2919, DOI 10.4049/jimmunol.174.5.2919
   Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1
   Lundberg P, 2007, J VIROL, V81, P1451, DOI 10.1128/JVI.02243-06
   Mansur DS, 2005, AM J PATHOL, V166, P1419, DOI 10.1016/S0002-9440(10)62359-0
   METCALF JF, 1979, INVEST OPHTH VIS SCI, V18, P1123
   MEYERSELLIOTT RH, 1981, INVEST OPHTH VIS SCI, V20, P784
   Milligan GN, 2001, J REPROD IMMUNOL, V49, P49, DOI 10.1016/S0165-0378(00)00080-2
   Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001
   Nogueira ML, 2001, J CLIN PATHOL, V54, P103, DOI 10.1136/jcp.54.2.103
   Petri B, 2008, J IMMUNOL, V180, P6439, DOI 10.4049/jimmunol.180.10.6439
   Rosler A, 1998, J NEUROL SCI, V157, P82, DOI 10.1016/S0022-510X(98)00061-6
   Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217
   Rottman JB, 1997, AM J PATHOL, V151, P1341
   SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0
   Sellner J, 2005, NEUROSCI LETT, V374, P197, DOI 10.1016/j.neulet.2004.10.054
   Skelly Michael J., 2012, Antiviral Chemistry & Chemotherapy, V23, P13, DOI 10.3851/IMP2129
   Stuart PM, 2004, J GEN VIROL, V85, P2055, DOI 10.1099/vir.0.80049-0
   Teixeira MM, 2010, J NEUROIMMUNOL, V224, P62, DOI 10.1016/j.jneuroim.2010.05.018
   Thapa M, 2007, J VIROL, V81, P3704, DOI 10.1128/JVI.02626-06
   Thomas J, 1997, J IMMUNOL, V158, P1383
   Torres-Munoz JE, 2004, MOL BRAIN RES, V127, P105, DOI 10.1016/j.molbrainres.2004.05.017
   Tumpey TM, 1996, J VIROL, V70, P898, DOI 10.1128/JVI.70.2.898-904.1996
   Vilela MC, 2008, NEUROSCI LETT, V445, P18, DOI 10.1016/j.neulet.2008.08.072
   Vilela MC, 2010, NEUROSCI LETT, V479, P58, DOI 10.1016/j.neulet.2010.05.028
   Vilela MC, 2009, ANN NY ACAD SCI, V1153, P256, DOI 10.1111/j.1749-6632.2008.03959.x
   Westmoreland SV, 2002, J NEUROIMMUNOL, V122, P146, DOI 10.1016/S0165-5728(01)00457-X
   Wickham S, 2005, J NEUROIMMUNOL, V162, P51, DOI 10.1016/j.jneuroim.2005.01.001
   ZISMAN B, 1970, J IMMUNOL, V104, P1155
NR 42
TC 12
Z9 12
U1 0
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2202
J9 BMC NEUROSCI
JI BMC Neurosci.
PD FEB 7
PY 2013
VL 14
AR 19
DI 10.1186/1471-2202-14-19
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA 119XV
UT WOS:000317134000001
PM 23391218
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Rocha, ESD
   de Oliveira, JG
   dos Santos, JR
   Rodrigues, GOL
   Figueiredo, LB
   Pessanha, JEM
   Proietti, FA
   da Fonseca, FG
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF de Oliveira Rocha, Eliseu Soares
   de Oliveira, Jaquelline Germano
   dos Santos, Joao Rodrigues
   Libanio Rodrigues, Gisele Olinto
   Figueiredo, Leandra Barcelos
   Marques Pessanha, Jose Eduardo
   Proietti, Fernando Augusto
   da Fonseca, Flavio Guimaraes
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Recombinant envelope protein-based enzyme immunoassay for IgG antibodies
   is comparable to neutralization tests for epidemiological studies of
   dengue infection
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Dengue virus; Serology; Diagnosis; ELISA; Recombinant envelope proteins
ID LINKED-IMMUNOSORBENT-ASSAY; RAPID IMMUNOCHROMATOGRAPHIC TEST; PLAQUE
   REDUCTION NEUTRALIZATION; CAPTURE ELISA; VIRUS-INFECTIONS; DIAGNOSIS;
   FEVER; IMMUNOGENICITY; GLYCOPROTEINS; POLYPEPTIDES
AB Dengue virus (DENV) is the most prevalent arbovirus in the world, found mainly in tropical regions. As clinical manifestations present frequently as nonspecific febrile illness, laboratory diagnosis is essential to confirm DENV infections and for epidemiological studies. Recombinant envelope (E) antigens of four serotypes of DENV were used to develop an immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA). To evaluate the IgG-ELISA, a panel of serum samples that had been tested previously by a plaque reduction neutralization test (PRNT) was investigated for the presence of anti-E antibodies against the four DENV serotypes. IgG-ELISA was found to have a sensitivity (91%) and specificity (98%) at a receiver-operating characteristic (ROC) optimized cutoff and demonstrated high performance as well as good indexes. A concordance of 97% was achieved between both assays, and only 21/704(3%) samples were not concordant. The results of the present study demonstrate a moderate correlation between neutralizing antibody titers and IgG-ELISA values. These findings indicate that the recombinant protein-based IgG-ELISA is a suitable method for routine serodiagnosis, monitoring and seroepidemiological studies of DENV infections. (C) 2012 Elsevier B.V. All rights reserved.
C1 [de Oliveira Rocha, Eliseu Soares; de Oliveira, Jaquelline Germano; dos Santos, Joao Rodrigues; Libanio Rodrigues, Gisele Olinto; Figueiredo, Leandra Barcelos; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Oliveira, Jaquelline Germano] Fundacao Oswaldo Cruz, Lab Imunol Celular & Mol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Marques Pessanha, Jose Eduardo] Prefeitura Municipal Belo Horizonte, Secretaria Municipal Saude, Belo Horizonte, MG, Brazil.
   [Proietti, Fernando Augusto] Univ Fed Minas Gerais, Fac Med, Dept Prevent & Social Med, BR-31270901 Belo Horizonte, MG, Brazil.
   [da Fonseca, Flavio Guimaraes] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virol Comparada, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Bonjardim,
   Claudio A/J-2601-2014
OI Kroon, Erna Geessien/0000-0003-2721-3826; Rocha,
   Eliseu/0000-0002-2854-0768
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); INCT and
   PRONEX-Dengue; Departamento de Ciencia e Tecnologia do Ministerio da
   Saude (DECIT/MS)
FX The authors are grateful to Angela Sana Lopes, Ilda V. Gama, Andresa A.
   Carvalho, Edel F.B. Stancioli, Mauricio L. Nogueira and Jordana G.A.
   Coelho-dos-Reis, Glaura C. Franco and colleagues from Laboratbrio de
   Virus (ICB-UFMG) for their excellent technical support. The authors are
   also thankful to all of the volunteers, without whom this work would not
   have been possible, and for the financial support provided by Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), INCT and
   PRONEX-Dengue, Departamento de Ciencia e Tecnologia do Ministerio da
   Saude (DECIT/MS). FGF, CAB, PCP and EGK are fellows from CNPq.
CR ANVISA, 2003, PROJ AV COMP PROD US
   Buerano Corazon C., 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P524
   de Lima VLC, 2007, CAD SAUDE PUBLICA, V23, P669, DOI 10.1590/S0102-311X2007000300025
   Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022
   Cuzzubbo AJ, 1999, CLIN DIAGN LAB IMMUN, V6, P705, DOI 10.1128/CDLI.6.5.705-712.1999
   Cuzzubbo AJ, 2001, CLIN DIAGN LAB IMMUN, V8, P1150, DOI 10.1128/CDLI.8.6.1150-1155.2001
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   De Paula Sérgio Oliveira, 2004, Braz J Infect Dis, V8, P390, DOI 10.1590/S1413-86702004000600002
   Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5
   DELENDA C, 1994, J GEN VIROL, V75, P1569, DOI 10.1099/0022-1317-75-7-1569
   Dos Santos FB, 2004, AM J TROP MED HYG, V71, P144, DOI 10.4269/ajtmh.2004.71.144
   Dos Santos FB, 2007, CLIN VACCINE IMMUNOL, V14, P641, DOI 10.1128/CVI.00474-06
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lima V L, 1999, Rev Saude Publica, V33, P566
   LIN B, 1994, VIROLOGY, V202, P885, DOI 10.1006/viro.1994.1410
   Ludolfs D, 2002, J CLIN MICROBIOL, V40, P4317, DOI 10.1128/JCM.40.11.4317-4320.2002
   MAKINO Y, 1991, AM J TROP MED HYG, V45, P636, DOI 10.4269/ajtmh.1991.45.636
   Pessanha JEM, 2010, REV PANAM SALUD PUBL, V27, P252, DOI 10.1590/S1020-49892010000400003
   Men R, 2000, VACCINE, V18, P3113, DOI 10.1016/S0264-410X(00)00121-3
   MEN R, 1991, J VIROL, V65, P1400, DOI 10.1128/JVI.65.3.1400-1407.1991
   MORENS DM, 1985, MICROBIOL IMMUNOL, V29, P1197, DOI 10.1111/j.1348-0421.1985.tb00909.x
   Nawa M, 2000, CLIN DIAGN LAB IMMUN, V7, P774, DOI 10.1128/CDLI.7.5.774-777.2000
   Nunes MRT, 2011, J VIROL METHODS, V171, P13, DOI 10.1016/j.jviromet.2010.09.021
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Palmer CJ, 1999, J CLIN MICROBIOL, V37, P1600, DOI 10.1128/JCM.37.5.1600-1601.1999
   Parida MM, 2001, ACTA VIROL, V45, P299
   Putnak JR, 2005, VACCINE, V23, P4442, DOI 10.1016/j.vaccine.2005.03.042
   Putnak R., 1994, MODERN VACCINOLOGY
   Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8
   Rivetz B, 2009, CLIN BIOCHEM, V42, P180, DOI 10.1016/j.clinbiochem.2008.10.017
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Sathish N, 2002, INDIAN J MED RES, V115, P31
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   SVS (Secretaria de Vigilancia em Saude), 2007, INF EP DENG
   Teixeira Maria da Glória, 2005, Cad. Saúde Pública, V21, P1307, DOI 10.1590/S0102-311X2005000500002
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Tripathi NK, 2008, J BIOTECHNOL, V134, P278, DOI 10.1016/j.jbiotec.2008.02.001
   Vasconcelos P F, 2000, Rev Soc Bras Med Trop, V33, P61
   Vasconcelos P F, 1999, Rev Soc Bras Med Trop, V32, P171
   Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693
   Videa E, 2005, CLIN DIAGN LAB IMMUN, V12, P882, DOI 10.1128/CDLI.12.7.882-884.2005
   WHO, 2007, GUID PLAQ RED NEUTR
   Wu SJL, 1997, CLIN DIAGN LAB IMMUN, V4, P452, DOI 10.1128/CDLI.4.4.452-457.1997
   Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667
   ZWEIG MH, 1993, CLIN CHEM, V39, P561
NR 49
TC 10
Z9 10
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD JAN
PY 2013
VL 187
IS 1
BP 114
EP 120
DI 10.1016/j.jviromet.2012.09.012
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 058BR
UT WOS:000312609600019
PM 23018061
DA 2020-11-30
ER

PT J
AU Assis, FL
   Borges, IA
   Ferreira, PCP
   Bonjardim, CA
   Trindade, GD
   Lobato, ZIP
   Guedes, MIM
   Mesquita, V
   Kroon, EG
   Abrahao, JS
AF Assis, Felipe Lopes
   Borges, Iara Apolinario
   Peregrino Ferreira, Paulo Cesar
   Bonjardim, Claudio Antonio
   Trindade, Giliane de Souza
   Portela Lobato, Zelia Ines
   Maldonado Guedes, Maria Isabel
   Mesquita, Vaz
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
TI Group 2 Vaccinia Virus, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID STRAINS; SMALLPOX; POXVIRUS
AB In 2011, vaccinia virus caused an outbreak of bovine vaccinia, affecting dairy cattle and dairy workers in Brazil. Genetic and phenotypic analyses identified this isolate as distinct from others recently identified, thereby reinforcing the hypothesis that different vaccinia virus strains co-circulate in Brazil.
C1 [Assis, Felipe Lopes; Borges, Iara Apolinario; Peregrino Ferreira, Paulo Cesar; Bonjardim, Claudio Antonio; Trindade, Giliane de Souza; Portela Lobato, Zelia Ines; Maldonado Guedes, Maria Isabel; Mesquita, Vaz; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais Microbiol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015; Abrahao, Jonatas/B-3895-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Abrahao,
   Jonatas/0000-0001-9420-1791; Lobato, Zelia/0000-0002-9399-3691
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Fundacao de Amparo a Pesquisa do Estado de Minas
   GeraisMinas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior, Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais, and Ministerio da Agricultura,
   Pecuaria e Abastecimento. F.L.A.received fellowship funding from CNPq;
   I.A.B. received fellowship funding from Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior; and E.G.K., C.A.B., G.T., and P.C.P.F. are
   researchers from CNPq.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I, 2007, FIELDS VIROLOGY, P2947
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Sambrook E., 1989, MOL CLONING
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
NR 15
TC 10
Z9 11
U1 0
U2 1
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2012
VL 18
IS 12
BP 2035
EP 2038
DI 10.3201/eid1812.120145
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 268LR
UT WOS:000328172700019
PM 23171598
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Campos, RK
   Andrade, KR
   Ferreira, PCP
   Bonjardim, CA
   La Scola, B
   Kroon, EG
   Abrahao, JS
AF Campos, Rafael Kroon
   Andrade, Ketyllen Reis
   Peregrino Ferreira, Paulo Cesar
   Bonjardim, Claudio Antonio
   La Scola, Bernard
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
TI Virucidal activity of chemical biocides against mimivirus, a putative
   pneumonia agent
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Acanthamoeba polyphaga mimivirus; Giant viruses; Disinfectants;
   Pneumonia; Nosocomial infection
ID INANIMATE SURFACES; A VIRUS; INACTIVATION; SURVIVAL
AB Background: Acanthamoeba polyphaga mimivirus (APMV), the largest known virus, has been studied as a putative pneumonia agent, especially in hospital environments. Despite the repercussions of the discovery of APMV, there has been no study related to the control of APMV and the susceptibility of this virus to disinfectants.
   Objectives: This work investigated the virucidal activity against mimivirus of chemical biocides commonly used in clinical practice for the disinfection of hospital equipment and rooms.
   Study design: APMV was dried on sterilized steel coupons, exposed to different concentrations of alcohols (ethanol, 1-propanol and 2-propanol) and commercial disinfectants (active chlorine, glutaraldehyde and benzalkonium chloride) and titrated in amoebas using the TCID50 value. The stability of APMV on an inanimate surface was also tested in the presence and absence of organic matter for 30 days.
   Results: APMV showed a high level of resistance to chemical biocides, especially alcohols. Only active chlorine and glutaraldehyde were able to decrease the APMV titers to undetectable levels. Dried APMV showed long-lasting stability on an inanimate surface (30 days), even in the absence of organic matter.
   Conclusions: The data presented herein may help health and laboratory workers plan the best strategy to control this putative pneumonia agent from surfaces and devices. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, IRD 3R198, URMITE, CNRS,UMR 6236, Marseille, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, Av Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Abrahao, Jonatas/B-3895-2015; Kroon, Erna Geessien/B-3631-2015;
   Bonjardim, Claudio A/J-2601-2014; LA SCOLA, Bernard/P-6477-2016; Campos,
   Rafael Kroon/AAB-5135-2020; Kroon, Erna/V-5444-2019
OI Abrahao, Jonatas/0000-0001-9420-1791; Kroon, Erna
   Geessien/0000-0003-2721-3826; LA SCOLA, Bernard/0000-0001-8006-7704;
   Campos, Rafael Kroon/0000-0002-4852-0449; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA); Pro-Reitoria de Pesquisa
   da Universidade Federal de Minas Gerais (PRPq-UFMG)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais (FAPEMIG), Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA) and Pro-Reitoria de
   Pesquisa da Universidade Federal de Minas Gerais (PRPq-UFMG). E.G.
   Kroon, C.A. Bonjardim, and P.C.P. Ferreira are researchers from CNPq.
CR ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994
   Doerrbecker J, 2011, J INFECT DIS, V204, P1830, DOI 10.1093/infdis/jir535
   Eterpi M, 2009, J HOSP INFECT, V73, P64, DOI 10.1016/j.jhin.2009.05.016
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   Jeong EK, 2010, AM J INFECT CONTROL, V38, P354, DOI 10.1016/j.ajic.2010.03.003
   Khan M, 2007, MICROB PATHOGENESIS, V42, P56, DOI 10.1016/j.micpath.2006.08.004
   Klose T, 2010, INTERVIROLOGY, V53, P268, DOI 10.1159/000312911
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130
   La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919
   Magulski T, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-107
   MBITHI JN, 1991, APPL ENVIRON MICROB, V57, P1394, DOI 10.1128/AEM.57.5.1394-1399.1991
   Rabenau HF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-185
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   Raoult D, 2006, ANN INTERN MED, V144, P702, DOI 10.7326/0003-4819-144-9-200605020-00025
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Seibert MM, 2011, NATURE, V470, P78, DOI 10.1038/nature09748
   Vincent A, 2009, CRIT CARE MED, V37, P111, DOI 10.1097/CCM.0b013e318192fa8b
NR 19
TC 13
Z9 13
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
J9 J CLIN VIROL
JI J. Clin. Virol.
PD DEC
PY 2012
VL 55
IS 4
BP 323
EP 328
DI 10.1016/j.jcv.2012.08.009
PG 6
WC Virology
SC Virology
GA 028WH
UT WOS:000310454900007
PM 22947947
DA 2020-11-30
ER

PT J
AU Assis, FL
   Almeida, GMF
   Oliveira, DB
   Franco-Luiz, APM
   Campos, RK
   Guedes, MIM
   Fonseca, FG
   Trindade, GS
   Drumond, BP
   Kroon, EG
   Abrahao, JS
AF Assis, Felipe L.
   Almeida, Gabriel M. F.
   Oliveira, Danilo B.
   Franco-Luiz, Ana P. M.
   Campos, Rafael K.
   Guedes, Maria I. M.
   Fonseca, Flavio G.
   Trindade, Giliane S.
   Drumond, Betania P.
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI Characterization of a New Vaccinia virus Isolate Reveals the C23L Gene
   as a Putative Genetic Marker for Autochthonous Group 1 Brazilian
   Vaccinia virus
SO PLOS ONE
LA English
DT Article
ID CHEMOKINE ACTIVITY; CANTAGALO VIRUS; ORTHOPOXVIRUS; STRAINS; POXVIRUS;
   OUTBREAK; CATTLE; DISCRIMINATION; SMALLPOX; PROTEIN
AB Since 1999, several Vaccinia virus (VACV) isolates, the etiological agents of bovine vaccinia (BV), have been frequently isolated and characterized with various biological and molecular methods. The results from these approaches have grouped these VACV isolates into two different clusters. This dichotomy has elicited debates surrounding the origin of the Brazilian VACV and its epidemiological significance. To ascertain vital information to settle these debates, we and other research groups have made efforts to identify molecular markers to discriminate VACV from other viruses of the genus Orthopoxvirus (OPV) and other VACV-BR groups. In this way, some genes have been identified as useful markers to discriminate between the VACV-BR groups. However, new markers are needed to infer ancestry and to correlate each sample or group with its unique epidemiological and biological features. The aims of this work were to characterize a new VACV isolate (VACV DMTV-2005) molecularly and biologically using conserved and non-conserved gene analyses for phylogenetic inference and to search for new genes that would elucidate the VACV-BR dichotomy. The VACV DMTV-2005 isolate reported in this study is biologically and phylogenetically clustered with other strains of Group 1 VACV-BR, the most prevalent VACV group that was isolated during the bovine vaccinia outbreaks in Brazil. Sequence analysis of C23L, the gene that encodes for the CC-chemokine-binding protein, revealed a ten-nucleotide deletion, which is a new Group 1 Brazilian VACV genetic marker. This deletion in the C23L open reading frame produces a premature stop-codon that is shared by all Group 1 VACV-BR strains and may also reflect the VACV-BR dichotomy; the deletion can also be considered to be a putative genetic marker for non-virulent Brazilian VACV isolates and may be used for the detection and molecular characterization of new isolates.
C1 [Assis, Felipe L.; Almeida, Gabriel M. F.; Oliveira, Danilo B.; Franco-Luiz, Ana P. M.; Campos, Rafael K.; Fonseca, Flavio G.; Trindade, Giliane S.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Guedes, Maria I. M.] Univ Fed Minas Gerais, Dept Med Vet Prevent, Belo Horizonte, MG, Brazil.
   [Drumond, Betania P.] Univ Fed Juiz de Fora, Dept Parasitol Microbiol & Imunol, Juiz De Fora, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Abrahao, Jonatas/B-3895-2015; Kroon, Erna/V-5444-2019; Almeida, Gabriel
   MF/I-8910-2012; Kroon, Erna Geessien/B-3631-2015; Campos, Rafael
   Kroon/AAB-5135-2020
OI Abrahao, Jonatas/0000-0001-9420-1791; Almeida, Gabriel
   MF/0000-0003-2317-5092; Kroon, Erna Geessien/0000-0003-2721-3826;
   Campos, Rafael Kroon/0000-0002-4852-0449
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais(FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG);
   Ministerio da Agricultura, Pecuaria e Abastecimento (MAPA); Pro-Reitoria
   de Pesquisa (PRPq-UFMG); Pro-Reitoria de Pesquisa da Universidade
   Federal de Minas Gerais (PRPq-UFMG); Fundacao de Amparo a Pesquisa de
   Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais(FAPEMIG) and Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA) and Pro-Reitoria de
   Pesquisa (PRPq-UFMG). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.; We thank colleagues from the Laboratory of Virus for their
   excellent technical support. We thank Pro-Reitoria de Pesquisa da
   Universidade Federal de Minas Gerais (PRPq-UFMG) and Fundacao de Amparo
   a Pesquisa de Minas Gerais (FAPEMIG) for the financial support.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Abrahao JS, 2009, VIROL J, V6, P1
   Alcami A, 1998, J IMMUNOL, V160, P624
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Carroll DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023086
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I, 2007, FIELDS VIROLOGY, P2079
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Graham KA, 1997, VIROLOGY, V229, P12, DOI 10.1006/viro.1996.8423
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   Heymann DL, 2006, CURR TOP MICROBIOL, V304, P1
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Laassri M, 2003, J VIROL METHODS, V112, P67, DOI 10.1016/S0166-0934(03)00193-9
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Ryabinin VA, 2006, J MED VIROL, V78, P1325, DOI 10.1002/jmv.20698
   Sambrook J., 2001, MOL CLONING LAB MANU
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
NR 34
TC 4
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 26
PY 2012
VL 7
IS 11
AR e50413
DI 10.1371/journal.pone.0050413
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 048RI
UT WOS:000311929800077
PM 23189200
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Borges, IA
   Mazur, C
   Lobato, ZIP
   Ferreira, PCP
   Bonjardim, CA
   Trindade, GS
   Kroon, EG
AF Abrahao, J. S.
   Borges, I. A.
   Mazur, C.
   Lobato, Z. I. P.
   Ferreira, P. C. P.
   Bonjardim, C. A.
   Trindade, G. S.
   Kroon, E. G.
TI Looking back: a genetic retrospective study of Brazilian Orf virus
   isolates
SO VETERINARY RECORD
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; GOATS; SHEEP; IDENTIFICATION
AB Orf virus (ORFV), the prototype of the genus Parapoxvirus, is the aetiological agent of contagious ecthyma (CE), a pustular dermatitis that afflicts domestic and wild small ruminants. CE is one of the most widespread poxvirus diseases in the world, causing public health impacts. Outbreaks of ORFV have been observed in all geographical regions of Brazil, affecting ovine and caprine herds. The origins, epidemiology and identity of Brazilian ORFVs are unknown, and no comparative or phylogenetic studies of these viruses have been performed. In the present study, we revisited CE outbreaks which occurred until 32 years ago, and we assessed, genetically, five viral isolates. We performed the sequencing and analysis of the three ORFV molecular markers: B2L gene, virus interferon resistance gene (VIR) and the vascular endothelial growth factor gene. Nucleotide and amino acid analysis of the analysed genes demonstrated that Brazilian ORFVs do not form a unique cluster, and presented more similarity to other worldwide ORFV samples than with each other. These data raise the questions of whether there are different worldwide ORFVs circulating in Brazil, or if all the Brazilian ORFV samples are of the same virus taken at distinct time points.
C1 [Abrahao, J. S.; Borges, I. A.; Ferreira, P. C. P.; Bonjardim, C. A.; Trindade, G. S.; Kroon, E. G.] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Mazur, C.] Univ Fed Rural Rio de Janeiro, Dept Microbiol & Imunol Vet, BR-23890000 Rio De Janeiro, Brazil.
   [Lobato, Z. I. P.] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, BR-31270901 Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna Geessien/B-3631-2015; Abrahao, Jonatas/B-3895-2015; Kroon,
   Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; brasileira, Inct
   Pecuaria/J-9542-2013
OI Kroon, Erna Geessien/0000-0003-2721-3826; Abrahao,
   Jonatas/0000-0001-9420-1791; Lobato, Zelia/0000-0002-9399-3691
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA); CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX We thank MSc Joao R dos Santos, Angela S Lopes, Ilda MV Gama, Andreza de
   Carvalho and colleagues from Laboratorio de Virus (ICB-UFMG). Financial
   support was provided by Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Fundacao de Amparo a Pesquisa do estado de Minas
   Gerais (FAPEMIG) and Ministerio da Agricultura, Pecuaria e Abastecimento
   (MAPA). EGK, CAB, ZIPL and PCPF received fellowship from CNPq.
CR ABRAHAO J. S., 2009, VIROL J, V6, P40
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-47
   Ara M, 2008, J AM ACAD DERMATOL, V58, pS39, DOI 10.1016/j.jaad.2006.04.027
   CDC, 2007, FREQ ASK QUEST SOR M
   Chan KW, 2007, VIRUS GENES, V35, P705, DOI 10.1007/s11262-007-0144-6
   Damon I, 2007, FIELDS VIROLOGY, P2079
   GROVES R, 1990, ARCH DERMATOL, V126, P1649, DOI 10.1001/archderm.126.12.1649
   Guo J, 2004, VET MICROBIOL, V99, P81, DOI 10.1016/j.vetmic.2003.11.010
   Guo J, 2003, VIRUS RES, V93, P169, DOI 10.1016/S0168-1702(03)00095-9
   Hosamani M, 2006, VET MICROBIOL, V116, P317, DOI 10.1016/j.vetmic.2006.04.028
   Inoshima Y, 2002, MICROBIOL IMMUNOL, V46, P583, DOI 10.1111/j.1348-0421.2002.tb02738.x
   Inoshima Y, 2010, J VET MED SCI, V72, P701, DOI 10.1292/jvms.09-0467
   Leite-Browning M., 2008, ALABAMA COOPERATIVE
   MAZUR C, 1990, REV MICROBIOL, V21, P127
   Mazur C, 2000, VET MICROBIOL, V73, P253, DOI 10.1016/S0378-1135(99)00151-0
   Nobrega JE, 2008, PESQUISA VET BRASIL, V28, P135, DOI 10.1590/S0100-736X2008000300002
   Sambrook J., 1989, MOL CLONING LAB MANU, P417
   Vikoren T, 2008, VET MICROBIOL, V127, P10, DOI 10.1016/j.vetmic.2007.07.029
   Zhang KS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-78
NR 19
TC 5
Z9 6
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0042-4900
EI 2042-7670
J9 VET REC
JI Vet. Rec.
PD NOV 10
PY 2012
VL 171
IS 19
BP 476
EP +
DI 10.1136/vr.100634
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA 045ZF
UT WOS:000311734600018
PM 23065256
DA 2020-11-30
ER

PT J
AU de Miranda, AS
   Rodrigues, DH
   Amaral, DCG
   Campos, RDD
   Cisalpino, D
   Vilela, MC
   Lacerda-Queiroz, N
   de Souza, KPR
   Vago, JP
   Campos, MA
   Kroon, EG
   de Souza, DD
   Teixeira, MM
   Teixeira, AL
   Rachid, MA
AF de Miranda, Aline Silva
   Rodrigues, David Henrique
   Guerra Amaral, Debora Cristina
   de Lima Campos, Roberta Dayrell
   Cisalpino, Daniel
   Vilela, Marcia Carvalho
   Lacerda-Queiroz, Norinne
   Ribeiro de Souza, Katia Paulino
   Vago, Juliana Priscila
   Campos, Marco Antonio
   Kroon, Erna Geesien
   de Souza, Danielle da Gloria
   Teixeira, Mauro Martins
   Teixeira, Antonio Lucio
   Rachid, Milene Alvarenga
TI Dengue-3 encephalitis promotes anxiety-like behavior in mice
SO BEHAVIOURAL BRAIN RESEARCH
LA English
DT Article
DE Non-adapted DENV-3; Anxiety-like behavior; Hippocampus; Inflammation;
   Elevated plus maze
ID CENTRAL-NERVOUS-SYSTEM; ELEVATED PLUS-MAZE; WEST-NILE; INFECTION;
   LIPOPOLYSACCHARIDE; APOPTOSIS; ABSENCE; BRAIN
AB Dengue virus is a human pathogen that may cause meningoencephalitis and other neurological syndromes. The current study investigated anxiety-like behavior and expression of proinflammatory cytokines and pro-apoptotic caspase-3 in the hippocampus of C57BL/6 mice infected with non-adapted Dengue virus 3 genotype I (DENV-3) inoculated intracranially with 4 x 10(3) (plaque-forming unit) PFU. Anxiety-like behavior was assessed in control and DENV-3 infected mice using the elevated plus maze. The open field test was performed to evaluate locomotor activity. Histopathological changes in CA regions of the hippocampus were assessed by haematoxylin and eosin staining. Immunoreactive and protein levels of cleaved caspase-3 were also analyzed in the hippocampus. The mRNA expression of IL-6 and TNF-alpha in the hippocampus were estimated by quantitative real time (polymerase chain reaction) PCR. All procedures were conducted on day 5 post-infection. We found that DENV-3 infected mice presented higher levels of anxiety in comparison with controls (p <= 0.05). No difference in motor activity was found between groups (p = 0.77). The infection was followed by a significant increase of TNF-alpha and IL-6 mRNA expression in the hippocampus (p <= 0.05). Histological analysis demonstrated meningoencephalitis with formation of perivascular cuffs, infiltration of immune cells and loss of neurons at CA regions of hippocampus. Numerous caspase-3 positive neurons were visualized at CA areas in DENV-3 infected mice. Marked increase of cleaved caspase-3 levels were observed after infection. This study described anxiety-like behavior, hippocampal inflammation and neuronal apoptosis associated with DENV-3 infection in the central nervous system. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Rachid, Milene Alvarenga] Univ Fed Minas Gerais, Dept Patol Geral, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Miranda, Aline Silva; Guerra Amaral, Debora Cristina; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Dept Clin Med, Inst Ciencias Biol, Fac Med, BR-31270901 Belo Horizonte, MG, Brazil.
   [Cisalpino, Daniel; Ribeiro de Souza, Katia Paulino; Kroon, Erna Geesien; de Souza, Danielle da Gloria] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Lacerda-Queiroz, Norinne; Vago, Juliana Priscila] Univ Fed Minas Gerais, Dept Morfol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Rodrigues, David Henrique; de Lima Campos, Roberta Dayrell; Vilela, Marcia Carvalho; Teixeira, Mauro Martins; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Campos, Marco Antonio] Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190 Belo Horizonte, MG, Brazil.
RP Rachid, MA (corresponding author), Univ Fed Minas Gerais, Dept Patol Geral, Inst Ciencias Biol, Av Antonio Carlos 6-627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM milenerachid@gmail.com
RI Rachid, Milene Alvarenga/C-3530-2017; Teixeira, Antonio L/N-3315-2014;
   souza, danielle/D-3378-2014; Dayrell, Roberta LC/L-7063-2016; DA SILVA,
   JULIANA PRISCILA VAGO/F-7386-2019; Campos, Marco A/C-4000-2013; Kroon,
   Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Rachid, Milene Alvarenga/0000-0002-3142-6552; Teixeira, Antonio
   L/0000-0002-9621-5422; Dayrell, Roberta LC/0000-0002-4770-9100; DA
   SILVA, JULIANA PRISCILA VAGO/0000-0001-8188-3738; Campos, Marco
   A/0000-0003-4683-0176; Kroon, Erna Geessien/0000-0003-2721-3826;
   Cisalpino, Daniel/0000-0003-1611-0661
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); INCT em Dengue
FX This work was supported by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq), FAPEMIG and INCT em Dengue.
CR Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Anisman H, 1999, ADV EXP MED BIOL, V461, P199
   Barichello T, 2010, BRAIN RES BULL, V82, P243, DOI 10.1016/j.brainresbull.2010.04.015
   Bergmann CC, 2004, J VIROL, V78, P1739, DOI 10.1128/JVI.78.4.1739-1750.2004
   Buenz EJ, 2009, AM J PATHOL, V175, P668, DOI 10.2353/ajpath.2009.081126
   Connor TJ, 1998, NEUROSCIENCE, V84, P923, DOI 10.1016/S0306-4522(97)00533-2
   de Miranda AS, 2011, NEUROSCI LETT, V491, P202, DOI 10.1016/j.neulet.2011.01.038
   Despres P, 1998, J VIROL, V72, P823
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3
   Freeman-Daniels E, 2011, PSYCHOPHARMACOLOGY, V213, P453, DOI 10.1007/s00213-010-2030-5
   Lacosta S, 1999, BRAIN RES, V818, P291, DOI 10.1016/S0006-8993(98)01288-8
   LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Misra UK, 2006, J NEUROL SCI, V244, P117, DOI 10.1016/j.jns.2006.01.011
   O'Donovan A, 2010, BRAIN BEHAV IMMUN, V24, P1074, DOI 10.1016/j.bbi.2010.03.003
   PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7
   Peruga I, 2011, BEHAV BRAIN RES, V220, P20, DOI 10.1016/j.bbr.2011.01.018
   Phares TW, 2010, J IMMUNOL, V185, P5607, DOI 10.4049/jimmunol.1001984
   Pinto LMO, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000300019
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Sanchez-Burgos G, 2004, NEUROREPORT, V15, P37, DOI [10.1097/01.wnr.0000093581.33576.70, 10.1097/00001756-200401190-00009]
   Skurlova M, 2011, NEUROSCI LETT, V487, P250, DOI 10.1016/j.neulet.2010.10.032
   Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Swiergiel AH, 2007, PHARMACOL BIOCHEM BE, V86, P651, DOI 10.1016/j.pbb.2007.02.010
   Varatharaj A, 2010, NEUROL INDIA, V58, P585, DOI 10.4103/0028-3886.68655
   Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44
   *WHO, 2009, IMP DENG
   Yeo P. S. D., 2005, SMJ Singapore Medical Journal, V46, P647
NR 31
TC 15
Z9 15
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-4328
EI 1872-7549
J9 BEHAV BRAIN RES
JI Behav. Brain Res.
PD APR 21
PY 2012
VL 230
IS 1
BP 237
EP 242
DI 10.1016/j.bbr.2012.02.020
PG 6
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA 973SJ
UT WOS:000306379800028
PM 22366269
DA 2020-11-30
ER

PT J
AU de Oliveira, CHS
   Assis, FL
   Neto, JDB
   Oliveira, CMC
   Lopes, CTD
   Bomjardim, HD
   Vinhote, WMS
   Silva, AGM
   Abrahao, JS
   Kroon, EG
AF de Oliveira, Cairo H. S.
   Assis, Felipe L.
   Neto, Jose Diomedes B.
   Oliveira, Carlos M. C.
   Lopes, Cinthia Tavora de A.
   Bomjardim, Henrique dos A.
   Vinhote, Wagner M. S.
   Silva, Andre G. M.
   Abrahao, Jonatas S.
   Kroon, Erna G.
TI Multifocal Cutaneous Orf Virus Infection in Goats in the Amazon Region,
   Brazil
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Animals; Diagnostics; Domestic; Field studies; Microbiology; Orf virus;
   Zoonosis
AB Orf virus is the etiological agent of contagious ecthyma, a severe exanthematic disease that affects small ruminants. Orf virus is zoonosis that is associated with occupational contact with infected animals in human disease. Clinically, contagious ecthyma is characterized by the appearance of vesicles, pustules, ulcers, and papillomatous proliferative lesions on the skin of the lips and nostrils. Here we describe a case of lethal cutaneous multifocal Orf virus infection in goats in the Amazon region of Brazil. Exanthematic lesions were collected and epidemiological and clinical data were obtained. Orf virus was detected using PCR amplification of the whole B2L, VIR, and VEGF open reading frame. Phylogenetic analysis revealed that this virus clustered together with the Orf virus samples isolated during classical contagious ecthyma. The present work is the first to report a severe proliferative Orf virus case in South America.
C1 [Kroon, Erna G.] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Oliveira, Cairo H. S.] Univ Fed Minas Gerais, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
   [Neto, Jose Diomedes B.; Oliveira, Carlos M. C.; Lopes, Cinthia Tavora de A.; Bomjardim, Henrique dos A.; Vinhote, Wagner M. S.; Silva, Andre G. M.] Fed Univ Para, Cent Diagnost Vet Fac Vet, BR-66059 Belem, PA, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Maciel e Silva, Andre Guimaraes/V-2737-2019; Kroon, Erna/V-5444-2019;
   Silva, Andre G. M./Q-6858-2016; Abrahao, Jonatas/B-3895-2015; Kroon,
   Erna Geessien/B-3631-2015
OI Maciel e Silva, Andre Guimaraes/0000-0002-0020-2951; Abrahao,
   Jonatas/0000-0001-9420-1791; Kroon, Erna Geessien/0000-0003-2721-3826;
   De Oliveira, Cairo/0000-0002-3474-2796
FU Conselho Nacional de Desenvolvimento Cientifico e Technologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundagao de Amparo a Pesquisa de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura Pecuaria e Abastecimento (MAPA)
FX We thank MSc. Joao R. dos Santos, Angela S. Lopes, Ilda M. V. Gama,
   Andreza de Carvalho, and colleagues from Laboratorio de Virus
   (ICB-UFMG). Financial support was provided by Conselho Nacional de
   Desenvolvimento Cientifico e Technologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundagao de Amparo
   a Pesquisa de Minas Gerais (FAPEMIG), and Ministerio da Agricultura
   Pecuaria e Abastecimento (MAPA).
CR Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-47
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Ara M, 2008, J AM ACAD DERMATOL, V58, pS39, DOI 10.1016/j.jaad.2006.04.027
   Damon I, 2007, FIELDS VIROLOGY, P2079
   GROVES R, 1990, ARCH DERMATOL, V126, P1649, DOI 10.1001/archderm.126.12.1649
   Haig DM, 1998, VET RES, V29, P311
   Hosamani M, 2006, VET MICROBIOL, V116, P317, DOI 10.1016/j.vetmic.2006.04.028
   Housawi FM, 2010, REV SCI TECH, V28, P1025
   Inoshima Y, 2010, J VET MED SCI, V72, P701, DOI 10.1292/jvms.09-0467
   Leite-Browning M, 2008, CONTAGIOUS ECTHYMA O
   Mazur C, 2000, VET MICROBIOL, V73, P253, DOI 10.1016/S0378-1135(99)00151-0
NR 11
TC 15
Z9 17
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD APR
PY 2012
VL 12
IS 4
BP 336
EP 340
DI 10.1089/vbz.2011.0725
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 925OC
UT WOS:000302769700013
PM 22225424
DA 2020-11-30
ER

PT J
AU de Assis, FL
   Pereira, G
   Oliveira, C
   Rodrigues, GOL
   Cotta, MMG
   Silva-Fernandes, AT
   Ferreira, PCP
   Bonjardim, CA
   Trindade, GD
   Kroon, EG
   Abrahao, JS
AF de Assis, Felipe Lopes
   Pereira, Graziele
   Oliveira, Cairo
   Libanio Rodrigues, Gisele Olinto
   Gomes Cotta, Marcela Menezas
   Silva-Fernandes, Andre Tavares
   Peregrino Ferreira, Paulo Cesar
   Bonjardim, Claudio Antonio
   Trindade, Giliane de Souza
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
TI Serologic Evidence of Orthopoxvirus Infection in Buffaloes, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID VACCINIA-VIRUS; HUMANS; CATTLE; ASSAY
C1 [Abrahao, Jonatas Santos] Univ Fed Minas Gerais, ICB, Virus Lab, Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, ICB, Virus Lab, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Abrahao, Jonatas/B-3895-2015; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014
OI Abrahao, Jonatas/0000-0001-9420-1791; Kroon, Erna
   Geessien/0000-0003-2721-3826; De Oliveira, Cairo/0000-0002-3474-2796
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140
   Bhanuprakash V, 2010, ZOONOSES PUBLIC HLTH, V57, pE149, DOI 10.1111/j.1863-2378.2009.01314.x
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I, 2007, FIELDS VIROLOGY, P2947
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Newman FK, 2003, J CLIN MICROBIOL, V41, P3154, DOI 10.1128/JCM.41.7.3154-3157.2003
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
NR 10
TC 4
Z9 5
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2012
VL 18
IS 4
BP 698
EP 700
DI 10.3201/eid1804.111800
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 919MJ
UT WOS:000302331600035
PM 22469217
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Silva, EF
   Orsi, M
   Andrade, AL
   Domingues, RZ
   Silva, BM
   de Araujo, HRC
   Pimenta, PFP
   Diamond, MS
   Rocha, ESO
   Kroon, EG
   Malaquias, LCC
   Coelho, LFL
AF Silva, Elisangela F.
   Orsi, Mariana
   Andrade, Angela L.
   Domingues, Rosana Z.
   Silva, Breno M.
   de Araujo, Helena R. C.
   Pimenta, Paulo F. P.
   Diamond, Michael S.
   Rocha, Eliseu S. O.
   Kroon, Erna G.
   Malaquias, Luiz C. C.
   Coelho, Luiz F. L.
TI A tetravalent dengue nanoparticle stimulates antibody production in mice
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE inactivated Dengue virus; Nanoparticles; humoral response
ID VIRUS-INFECTION; IMMUNE-RESPONSE
AB Background: Dengue is a major public health problem worldwide, especially in the tropical and subtropical regions of the world. Infection with a single Dengue virus (DENV) serotype causes a mild, self-limiting febrile illness called dengue fever. However, a subset of patients experiencing secondary infection with a different serotype progresses to the severe form of the disease, dengue hemorrhagic fever/dengue shock syndrome. Currently, there are no licensed vaccines or antiviral drugs to prevent or treat dengue infections. Biodegradable nanoparticles coated with proteins represent a promising method for in vivo delivery of vaccines.
   Findings: Here, we used a murine model to evaluate the IgG production after administration of inactivated DENV corresponding to all four serotypes adsorbed to bovine serum albumin nanoparticles. This formulation induced a production of anti-DENV IgG antibodies (p < 0.001). However, plaque reduction neutralization assays with the four DENV serotypes revealed that these antibodies have no neutralizing activity in the dilutions tested.
   Conclusions: Our results show that while the nanoparticle system induces humoral responses against DENV, further investigation with different DENV antigens will be required to improve immunogenicity, epitope specicity, and functional activity to make this platform a viable option for DENV vaccines.
C1 [Silva, Elisangela F.; Orsi, Mariana; Malaquias, Luiz C. C.; Coelho, Luiz F. L.] Univ Fed Alfenas, Inst Biomed Sci, Belo Horizonte, MG, Brazil.
   [Andrade, Angela L.] Univ Fed Ouro Preto, Dept Chem, Ouro Preto, MG, Brazil.
   [Domingues, Rosana Z.] Univ Fed Minas Gerais, Dept Chem, Belo Horizonte, MG, Brazil.
   [Silva, Breno M.] Univ Fed Ouro Preto, Dept Biol Sci, Ouro Preto, MG, Brazil.
   [de Araujo, Helena R. C.; Pimenta, Paulo F. P.] Fundacao Oswaldo Cruz, Inst Rene Rachou, Lab Med Entomol, Belo Horizonte, MG, Brazil.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO USA.
   [Rocha, Eliseu S. O.; Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, Inst Biol Sci, Virus Lab, Belo Horizonte, MG, Brazil.
RP Coelho, LFL (corresponding author), Univ Fed Alfenas, Inst Biomed Sci, Belo Horizonte, MG, Brazil.
EM coelho@unifal-mg.edu.br
RI Malaquias, Luiz Cosme/K-7210-2013; Andrade, Angela/O-2985-2015; Diamond,
   Michael/AAH-1733-2019; Kroon, Erna/V-5444-2019; Araujo,
   Helena/J-9209-2015; Coelho, Luiz FL/G-5853-2012; Domingues,
   Rosana/P-2017-2014; Domingues, Rosana/C-3174-2013; Kroon, Erna
   Geessien/B-3631-2015; Pimenta, Paulo/AAH-1502-2020; silva,
   breno/W-5122-2018
OI Malaquias, Luiz Cosme/0000-0002-4920-072X; Diamond,
   Michael/0000-0002-8791-3165; Domingues, Rosana/0000-0001-5667-2031;
   Domingues, Rosana/0000-0001-5667-2031; Kroon, Erna
   Geessien/0000-0003-2721-3826; silva, breno/0000-0003-2472-8111; Coelho,
   Luiz Felipe/0000-0003-4289-384X; Rocha, Eliseu/0000-0002-2854-0768
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG) [APQ-04684-10];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [565778/2008-0]
FX Financial support was provided by FAPEMIG (APQ-04684-10) and CNPq
   (565778/2008-0).
CR Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Ferreira GP, 2010, MICROBES INFECT, V12, P546, DOI 10.1016/j.micinf.2010.03.007
   Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086
   Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Klippstein R, 2010, NANOMED-NANOTECHNOL, V6, P523, DOI 10.1016/j.nano.2010.01.001
   KRONE B, 1990, HEPATOLOGY, V11, P1050, DOI 10.1002/hep.1840110622
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008
   Rice-Ficht AC, 2010, CURR OPIN MICROBIOL, V13, P106, DOI 10.1016/j.mib.2009.12.001
   Schieffelin JS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-28
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Stephenson JR, 2005, B WORLD HEALTH ORGAN, V83, P308
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114
NR 23
TC 7
Z9 7
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD MAR 22
PY 2012
VL 10
AR 13
DI 10.1186/1477-3155-10-13
PG 5
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 942KI
UT WOS:000304042500001
PM 22439913
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Reis, JKP
   Diniz, RS
   Haddad, JPA
   Ferraz, IBF
   Carvalho, AF
   Kroon, EG
   Ferreira, PCP
   Leite, RC
AF Reis, Jenner K. P.
   Diniz, Rejane S.
   Haddad, Joao P. A.
   Ferraz, Isabella B. F.
   Carvalho, Alex F.
   Kroon, Erna G.
   Ferreira, Paulo C. P.
   Leite, Romulo C.
TI Recombinant envelope protein (rgp90) ELISA for equine infectious anemia
   virus provides comparable results to the agar gel immunodiffusion
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Equine infectious anemia; Recombinant protein; ELISA; AGID
ID ANTIGENIC DOMAINS; DIAGNOSIS; GLYCOPROTEIN; TRANSMISSION; VALIDATION;
   ANTIBODIES; RESPONSES; EIAV; P26
AB Equine infectious anemia (EIA) is an important viral infection affecting horses worldwide. The course of infection is accompanied generally by three characteristic stages: acute, chronic and inapparent. There is no effective EIA vaccine or treatment, and the control of the disease is based currently on identification of EIAV inapparent carriers by laboratory tests. Recombinant envelope protein (rgp90) was expressed in Escherichia coli and evaluated via enzyme-linked immunosorbent assay (ELISA). There was an excellent agreement (95.42%) between the ELISA results using rgp90 and agar gel immunodiffusion test results. ACID is considered the "gold-standard" serologic test for equine infectious anemia (EIA). After 1160 serum samples were tested, the relative sensitivity and specificity of the ELISA were 96.1% and 96.4%, respectively. Moreover, analysis diagnostic accuracy of the ELISA was performed. The ELISA proved robust. Furthermore, good reproducibility was observed for the negative controls and, positive controls for all plates tested. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Reis, Jenner K. P.; Diniz, Rejane S.; Haddad, Joao P. A.; Ferraz, Isabella B. F.; Leite, Romulo C.] Univ Fed Minas Gerais, Dept Vet Prevent Med, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
   [Carvalho, Alex F.; Kroon, Erna G.; Ferreira, Paulo C. P.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Reis, JKP (corresponding author), Univ Fed Minas Gerais, Dept Vet Prevent Med, Escola Vet, Campus Pampulha,Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jenner@ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; CARVALHO, ALEX F/K-1947-2015; Kroon,
   Erna/V-5444-2019; Reis, Jenner/AAJ-9164-2020
OI Kroon, Erna Geessien/0000-0003-2721-3826; Reis,
   Jenner/0000-0003-0395-358X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG);
   FEP/MVZ; Pro-Reitoria de Pesquisa da UFMG
FX The authors wish to thank Dr. Reiner Gentz (Human Genome, Science, USA)
   for his cooperation, and CNPq, FAPEMIG, FEP/MVZ and Pro-Reitoria de
   Pesquisa da UFMG for financial support. JKPR, EGK, PCPF and RCL are CNPq
   fellowship recipients.
CR Alvarez I, 2007, VET MICROBIOL, V121, P344, DOI 10.1016/j.vetmic.2007.01.007
   ARCHAMBAULT D, 1989, J CLIN MICROBIOL, V27, P1167, DOI 10.1128/JCM.27.6.1167-1173.1989
   BALL JM, 1992, J VIROL, V66, P732, DOI 10.1128/JVI.66.2.732-742.1992
   CARPENTER S, 1987, J VIROL, V61, P3783, DOI 10.1128/JVI.61.12.3783-3789.1987
   CHONG YH, 1991, J VIROL, V65, P1007, DOI 10.1128/JVI.65.2.1007-1012.1991
   COGGINS L, 1972, AM J VET RES, V33, P11
   COGGINS L, 1970, CORNELL VET, V60, P330
   Cullinane A, 2007, VET REC, V161, P647, DOI 10.1136/vr.161.19.647
   DOSREIS JKP, 1994, PREV VET MED, V20, P261, DOI 10.1016/0167-5877(94)90059-0
   DOSREIS JKP, 1994, TROP ANIM HEALTH PRO, V26, P65, DOI 10.1007/BF02239899
   Hammond SA, 1997, J VIROL, V71, P3840, DOI 10.1128/JVI.71.5.3840-3852.1997
   HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4
   Issel C.J., 1988, EQUINE INFECTIOUS DI, V5, P196
   Issel C.J., 2004, US AN HLTH ASS P, V108, P316
   ISSEL CJ, 1993, J VET DIAGN INVEST, V5, P137, DOI 10.1177/104063879300500136
   ISSEL CJ, 1988, VET MICROBIOL, V17, P251, DOI 10.1016/0378-1135(88)90069-7
   ISSEL CJ, 1984, J AM VET MED ASSOC, V184, P293
   Issel CJ, 1999, J EQUINE VET SCI, V19, P728, DOI 10.1016/S0737-0806(99)80140-3
   Issel CJ, 2007, US AN HLTH ASS P, V111, P90
   Jacobson RH, 1998, REV SCI TECH OIE, V17, P469, DOI 10.20506/rst.17.2.1119
   KAWAKAMI T, 1987, VIROLOGY, V158, P300, DOI 10.1016/0042-6822(87)90202-9
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leroux C, 2004, VET RES, V35, P485, DOI 10.1051/vetres:2004020
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Montelaro R. C., 1993, The Retroviridae, volume 2., P257
   MONTELARO RC, 1984, VIROLOGY, V136, P368, DOI 10.1016/0042-6822(84)90173-9
   OROURKE K, 1988, J GEN VIROL, V69, P667, DOI 10.1099/0022-1317-69-3-667
   PALKER TJ, 1988, P NATL ACAD SCI USA, V85, P1932, DOI 10.1073/pnas.85.6.1932
   PAYNE SL, 1989, VIROLOGY, V172, P609, DOI 10.1016/0042-6822(89)90203-1
   Pearson J. E., 1971, P US ANIM HLTH ASS, V74, P259
   RWAMBO PM, 1990, ARCH VIROL, V111, P199, DOI 10.1007/BF01311054
   Sugiura Takeo, 1995, Journal of Equine Science, V6, P15, DOI 10.1294/jes.6.15
   THOMAS LM, 1992, VET MICROBIOL, V31, P127, DOI 10.1016/0378-1135(92)90071-Z
   World Health Organization, 1999, OP CHAR COMM AV ASS
NR 34
TC 8
Z9 8
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD MAR
PY 2012
VL 180
IS 1-2
BP 62
EP 67
DI 10.1016/j.jviromet.2011.12.012
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 913NH
UT WOS:000301884200011
PM 22227617
DA 2020-11-30
ER

PT J
AU Pereira, ACTC
   Soares-Martins, JAP
   Leite, FGG
   Da Cruz, AFP
   Torres, AA
   Souto-Padron, T
   Kroon, EG
   Ferreira, PCP
   Bonjardim, CA
AF Pereira, Anna C. T. C.
   Soares-Martins, Jamaria A. P.
   Leite, Flavia G. G.
   Da Cruz, Andre F. P.
   Torres, Alice A.
   Souto-Padron, Thais
   Kroon, Erna G.
   Ferreira, Paulo C. P.
   Bonjardim, Claudio A.
TI SP600125 inhibits Orthopoxviruses replication in a JNK1/2-independent
   manner: Implication as a potential antipoxviral
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Poxvirus; SP600125; Antipoxviral; Antiviral; JNK; Morphogenesis
ID N-TERMINAL KINASE; TEMPERATURE-SENSITIVE MUTANTS; VACCINIA VIRUS
   MORPHOGENESIS; CHRONIC MYELOID-LEUKEMIA; JUN NH2-TERMINAL KINASE; FAMILY
   TYROSINE KINASES; ISCHEMIC BRAIN-INJURY; JNK SIGNALING PATHWAY;
   PROTEIN-KINASE; HUMAN MONKEYPOX
AB The pharmacological inhibitor SP600125 [anthra(1,9-cd)pyrazol-6(2H)-one 1,9-pyrazoloanthrone] has been largely employed as a c-JUN N-terminal kinase (JNK1/2) inhibitor. In this study, we evaluated whether pretreatment with SP600125 was able to prevent Orthopoxviruses Vaccinia virus (VACV), Cowpox virus (CPXV) and modified Vaccinia virus Ankara (MVA) replication. We found that incubation with SP600125 not only blocked virus-stimulated JNK phosphorylation, but also, significantly reduced virus production. We observed 1-3 log decline in viral yield depending on the cell line infected (A31. BSC-40 or BHK-21). The reduction in viral yield correlated with a dramatic impact on virus morphogenesis progress, intracellular mature viruses (IMV) were barely detected. Despite the fact that SP600125 can act as an efficient anti-orthopoxviral compound, we also provide evidence that this antiviral effect is not specifically exerted through JNK1/2 inhibition. This conclusion is supported by the fact that viral titers measured after infections of JNK1/2 knockout cells were not altered as compared to those of wild-type cells. In contrast, a decline in viral titers was verified when the infection of KO cells was carried out in the presence of the pharmacological inhibitor. SP600125 has been the focus of recent studies that have evaluated its action on diverse viral infections including DNA viruses. Our data support the notion that SP600125 can be regarded as a potential antipoxviral compound. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Pereira, Anna C. T. C.; Soares-Martins, Jamaria A. P.; Leite, Flavia G. G.; Da Cruz, Andre F. P.; Torres, Alice A.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Grp Transducao Sinal Orthopoxvirus, Lab Virus, Dept Microbiol,Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Souto-Padron, Thais] Univ Fed Rio de Janeiro, Lab Biol Celular & Ultraestrutura, BR-21941590 Rio De Janeiro, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Grp Transducao Sinal Orthopoxviruses, Lab Virus, Dept Microbiol,Inst Ciencias Biol, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM claudio.bonjardim@pq.cnpq.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Bonjardim,
   Claudio A/J-2601-2014; Abreu Torres, Alice/B-1475-2018
OI Kroon, Erna Geessien/0000-0003-2721-3826; Abreu Torres,
   Alice/0000-0003-2352-2584
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Coordenadoria de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Brazilian
   Ministry of Culture, Science and Technology; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); CNPq (PIBIC)National
   Council for Scientific and Technological Development (CNPq)
FX The authors are grateful to Angela S. Lopes, Ilda M. V. Gama, Joao R.
   dos Santos and Andreza A. Carvalho for their secretarial/technical
   assistance. We also thank Dr. M. C. Sogayar (Department of Biochemistry,
   University of Sao Paulo, Brazil), who kindly provided us with the A31
   cell line and Dr. R. Davis (Howard Hughes Medical Institute, University
   of Massachusetts Medical School, Worcester, MS) for the WT and JNK1/2 KO
   cells. VACV WR and CPXV BR were from Dr. C. Jungwirth (Universitat
   Wurzburg, Germany). MVA was from Dr. B. Moss (NIAID, Bethesda, MD)/Dr.
   Flavio G. da Fonseca (Universidade Federal de Minas Gerais). Dr.
   Kathleen A. Boyle, Department of Microbiology and Molecular Genetics,
   Medical College of Wisconsin, Milwaukee, WI, for critically reading the
   manuscript. This work was supported by grants from Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG), Coordenadoria de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry
   of Culture, Science and Technology and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq). Drs. ACTCP, JAPSM AND
   FGGL were recipients of predoctoral fellowships from CNPq. AFPC and AAT
   were recipients of undergraduate students from CNPq (PIBIC) and CAB,
   EGK, TSP, and PCPF are recipients of research fellowships from CNPq.
CR Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535
   Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797
   Barquet N, 1997, ANN INTERN MED, V127, P635, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00010
   Becker MN, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-58
   Begleiter A, 2006, ONCOL REP, V15, P1575
   Bennett BL, 2006, EUR RESPIR J, V28, P651, DOI 10.1183/09031936.06.00012106
   Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298
   Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016
   Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013
   Chen SY, 2002, J VIROL, V76, P9556, DOI 10.1128/JVI.76.18.9556-9561.2002
   Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8
   da Fonseca FG, 2000, J VIROL, V74, P7518, DOI 10.1128/JVI.74.16.7518-7528.2000
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   de Borst MH, 2009, J PHARMACOL EXP THER, V331, P896, DOI 10.1124/jpet.109.154179
   De Clercq E, 2003, CLIN MICROBIOL REV, V16, P569, DOI 10.1128/CMR.16.4.569-596.2003
   De Clercq E, 2002, TRENDS PHARMACOL SCI, V23, P456, DOI 10.1016/S0165-6147(02)02091-6
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   Domi A, 2000, J GEN VIROL, V81, P1231, DOI 10.1099/0022-1317-81-5-1231
   Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Formenty P, 2010, EMERG INFECT DIS, V16, P1539, DOI 10.3201/eid1610.100713
   Frischknecht F, 1999, CURR BIOL, V9, P89, DOI 10.1016/S0960-9822(99)80020-7
   Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062
   Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086
   Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045
   Gupta N, 2011, FEMS IMMUNOL MED MIC, V62, P110, DOI 10.1111/j.1574-695X.2011.00792.x
   Hamza MS, 2004, J BIOL CHEM, V279, P38325, DOI 10.1074/jbc.M400964200
   Han Ya-Ling, 2005, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V21, P388
   Hassan M, 2005, VIROLOGY, V333, P324, DOI 10.1016/j.virol.2005.01.008
   Holloway G, 2006, J VIROL, V80, P10624, DOI 10.1128/JVI.00390-06
   Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149
   Hu YB, 2009, SCAND J GASTROENTERO, V44, P1356, DOI 10.3109/00365520903312441
   Ikezumi Y, 2004, J AM SOC NEPHROL, V15, P1775, DOI 10.1097/01.ASN.0000131272.06958.DE
   Jesus DM, 2009, J VIROL, V83, P11477, DOI 10.1128/JVI.01061-09
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Jordan R, 2008, ANTIMICROB AGENTS CH, V52, P1721, DOI 10.1128/AAC.01303-07
   Jordan R, 2010, ANTIMICROB AGENTS CH, V54, P2560, DOI 10.1128/AAC.01689-09
   Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446
   LIN SQ, 1992, J VIROL, V66, P2717, DOI 10.1128/JVI.66.5.2717-2723.1992
   LIN SQ, 1994, P NATL ACAD SCI USA, V91, P7653, DOI 10.1073/pnas.91.16.7653
   Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132
   McNulty S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010884
   Mehrotra S, 2007, J LEUKOCYTE BIOL, V81, P539, DOI 10.1189/jlb.0706479
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Mizutani T, 2005, BBA-MOL BASIS DIS, V1741, P4, DOI 10.1016/j.bbadis.2005.04.004
   Moss B., 2007, VIROLOGY, V2905-2946
   Perkins D, 2003, J NEUROVIROL, V9, P101, DOI 10.1080/13550280390173427
   Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P689, DOI 10.1128/AAC.00879-06
   RAVANELLO MP, 1994, J VIROL, V68, P6401, DOI 10.1128/JVI.68.10.6401-6410.1994
   Reeves PM, 2011, J VIROL, V85, P21, DOI 10.1128/JVI.01814-10
   Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265
   REMPEL RE, 1990, J VIROL, V64, P574, DOI 10.1128/JVI.64.2.574-583.1990
   REMPEL RE, 1992, J VIROL, V66, P4413, DOI 10.1128/JVI.66.7.4413-4426.1992
   Resch W, 2005, J VIROL, V79, P6598, DOI 10.1128/JVI.79.11.6598-6609.2005
   Reynolds MG, 2004, LANCET INFECT DIS, V4, P604, DOI 10.1016/S1473-3099(04)01139-9
   Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422
   Sbrana E, 2007, AM J TROP MED HYG, V76, P155, DOI 10.4269/ajtmh.2007.76.155
   Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039
   Sharma N, 2010, PHARMACOL BIOCHEM BE, V96, P386, DOI 10.1016/j.pbb.2010.06.010
   Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509
   Smee DF, 2002, ANTIMICROB AGENTS CH, V46, P1329, DOI 10.1128/AAC.46.5.1329-1335.2002
   Smith GL, 2002, NAT REV IMMUNOL, V2, P521, DOI 10.1038/nri845
   Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09
   Song ZF, 2008, J CELL MOL MED, V12, P1220, DOI 10.1111/j.1582-4934.2008.00183.x
   Syrkina OL, 2007, AM J PHYSIOL-LUNG C, V292, pL984, DOI 10.1152/ajplung.00248.2006
   Takamura M, 2007, LIFE SCI, V80, P1335, DOI 10.1016/j.lfs.2006.12.034
   Tolomeo M, 2009, ANTI-CANCER AGENT ME, V9, P853, DOI 10.2174/187152009789124637
   Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870
   TRAKTMAN P, 1989, J BIOL CHEM, V264, P21458
   TRAKTMAN P, 1995, J VIROL, V69, P6581, DOI 10.1128/JVI.69.10.6581-6587.1995
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Unger B, 2004, J VIROL, V78, P8885, DOI 10.1128/JVI.78.16.8885-8901.2004
   Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021
   Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74
   WANG SP, 1995, J VIROL, V69, P6376, DOI 10.1128/JVI.69.10.6376-6388.1995
   Wang YS, 2009, J NEUROL SCI, V285, P172, DOI 10.1016/j.jns.2009.06.034
   Wickramasekera NT, 2010, J VIROL, V84, P6846, DOI 10.1128/JVI.00399-10
   Wolf D, 2009, DRUG SAFETY, V32, P1001, DOI 10.2165/11314600-000000000-00000
   Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005
   Yang HL, 2005, J CLIN INVEST, V115, P379, DOI 10.1172/jc1200523200
   Zapata HJ, 2007, J VIROL, V81, P977, DOI 10.1128/JVI.01470-06
NR 83
TC 5
Z9 5
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2012
VL 93
IS 1
BP 69
EP 77
DI 10.1016/j.antiviral.2011.10.020
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA 899FP
UT WOS:000300802100009
PM 22068148
OA Green Published
DA 2020-11-30
ER

PT J
AU D'Anunciacao, L
   Guedes, MIM
   Oliveira, TL
   Rehfeld, I
   Bonjardim, CA
   Ferreira, PP
   Trindade, GD
   Lobato, ZP
   Kroon, EG
   Abrahao, JS
AF D'Anunciacao, Lorena
   Maldonado Guedes, Maria Isabel
   Oliveira, Tercia Ludolfo
   Rehfeld, Izabelle
   Bonjardim, Claudio Antonio
   Ferreira, Paulo Peregrino
   Trindade, Giliane de Souza
   Lobato, Zelia Portela
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
TI Filling One More Gap: Experimental Evidence of Horizontal Transmission
   of Vaccinia Virus Between Bovines and Rodents
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE PCR; Rodent-borne; Rodents
ID OUTBREAK; ASSAY
AB Vaccinia virus (VACV) has been associated with several exanthematic outbreaks in bovine, human, and equine species in Brazilian rural areas. Little is known about VACV reservoirs, although it is believed that rodents could be associated with VACV outbreaks. With the goal of filling one more gap in the VACV ecological puzzle, the present work aimed at mimicking a potential transmission route of VACV between cows and rodents, both known as natural VACV hosts. Balb/c mice were exposed to feces of experimentally VACV infected cows for 20 days, and samples from these mice were examined by using molecular and serological tests. VACV DNA was detected in feces and blood samples after several days of exposure; infectious VACV particles were also detected in the feces. The presence of anti-VACV neutralizing antibodies in murine sera further suggested horizontal transmission. If the transmission model described here can be applied to natural environments, exposure to bovine feces could be considered a risk factor for the spread of VACV; consequently, the traditional use of bovine manure as a fertilizer in agricultural activities may be promoting the infection of
C1 [D'Anunciacao, Lorena; Bonjardim, Claudio Antonio; Ferreira, Paulo Peregrino; Trindade, Giliane de Souza; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Maldonado Guedes, Maria Isabel; Oliveira, Tercia Ludolfo; Rehfeld, Izabelle; Lobato, Zelia Portela] Univ Fed Minas Gerais, Lab Pesquisa Virol Anim, Escola Vet, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Abrahao,
   Jonatas/B-3895-2015; brasileira, Inct Pecuaria/J-9542-2013; Bonjardim,
   Claudio A/J-2601-2014
OI Kroon, Erna Geessien/0000-0003-2721-3826; Abrahao,
   Jonatas/0000-0001-9420-1791; Lobato, Zelia/0000-0002-9399-3691
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); MAPA
FX The authors thank MSc. Joao R. dos Santos, Angela S. Lopes, Ilda M. V.
   Gama, Andreza de Carvalho, and colleagues from Laboratorio de Virus
   (ICB-UFMG). Financial support was provided by CNPq, CAPES, FAPEMIG, and
   MAPA.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140
   Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Damon I, 2007, FIELDS VIROLOGY, P2079
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Guedes MIM, 2010, VIRUS REV RES, V15, P172
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   Newman FK, 2003, J CLIN MICROBIOL, V41, P3154, DOI 10.1128/JCM.41.7.3154-3157.2003
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
NR 18
TC 12
Z9 12
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD JAN
PY 2012
VL 12
IS 1
BP 61
EP 64
DI 10.1089/vbz.2011.0671
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 876MY
UT WOS:000299112800010
PM 21923268
DA 2020-11-30
ER

PT J
AU Gomes, JAS
   de Araujo, FF
   Trindade, GD
   Quinan, BR
   Drumond, BP
   Ferreira, JMS
   Mota, BEF
   Nogueira, ML
   Kroon, EG
   Abrahao, JS
   Correa-Oliveira, R
   da Fonseca, FG
AF Silva Gomes, Juliana Assis
   de Araujo, Fernanda Fortes
   Trindade, Giliane de Souza
   Quinan, Barbara Resende
   Drumond, Betania Paiva
   Siqueira Ferreira, Jaqueline Maria
   Fernandes Mota, Bruno Eduardo
   Nogueira, Mauricio Lacerda
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
   Correa-Oliveira, Rodrigo
   da Fonseca, Flavio Guimaraes
TI Immune Modulation in Primary Vaccinia virus Zoonotic Human Infections
SO CLINICAL & DEVELOPMENTAL IMMUNOLOGY
LA English
DT Article
ID T-CELL RESPONSES; MHC CLASS-II; SMALLPOX VACCINATION; ANTIGEN
   PRESENTATION; POXVIRUS INFECTION; MONKEYPOX VIRUS; BRAZIL; IMMUNIZATION;
   PROTECTION; EVASION
AB In 2010, the WHO celebrated the 30th anniversary of the smallpox eradication. Ironically, infections caused by viruses related to smallpox are being increasingly reported worldwide, including Monkeypox, Cowpox, and Vaccinia virus (VACV). Little is known about the human immunological responses elicited during acute infections caused by orthopoxviruses. We have followed VACV zoonotic outbreaks taking place in Brazil and analyzed cellular immune responses in patients acutely infected by VACV. Results indicated that these patients show a biased immune modulation when compared to noninfected controls. Amounts of B cells are low and less activated in infected patients. Although present, T CD4(+) cells are also less activated when compared to noninfected individuals, and so are monocytes/macrophages. Similar results were obtained when Balb/C mice were experimentally infected with a VACV sample isolated during the zoonotic outbreaks. Taking together, the data suggest that zoonotic VACVs modulate specific immune cell compartments during an acute infection in humans.
C1 [Trindade, Giliane de Souza; Quinan, Barbara Resende; Drumond, Betania Paiva; Fernandes Mota, Bruno Eduardo; Kroon, Erna Geessien; Abrahao, Jonatas Santos; da Fonseca, Flavio Guimaraes] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva Gomes, Juliana Assis] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva Gomes, Juliana Assis; de Araujo, Fernanda Fortes; Siqueira Ferreira, Jaqueline Maria; Correa-Oliveira, Rodrigo; da Fonseca, Flavio Guimaraes] Fundacao Oswaldo Cruz, IRR, BR-30190002 Belo Horizonte, MG, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Dept Doencas Infecciosas & Parasitarias, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com; fdafonseca@cpqrr.fiocruz.br
RI Nogueira, Mauricio L/B-7599-2012; Ferreira, Jaqueline/E-4630-2018;
   Abrahao, Jonatas/B-3895-2015; Kroon, Erna Geessien/B-3631-2015; Gomes,
   Juliana A. S./M-4083-2017; Kroon, Erna/V-5444-2019
OI Nogueira, Mauricio L/0000-0003-1102-2419; Ferreira,
   Jaqueline/0000-0002-1779-1975; Abrahao, Jonatas/0000-0001-9420-1791;
   Kroon, Erna Geessien/0000-0003-2721-3826; Gomes, Juliana A.
   S./0000-0002-8332-2907; Mota, Bruno/0000-0003-0348-4875;
   Correa-Oliveira, Rodrigo/0000-0001-6419-9459
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [473205/2009-2]; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [CBB-APQ-00299-08]; National Institute of Science and Technology in
   Vaccines (INCTV)
FX The authors thank all patients for their willingness to participate in
   this study and Jaqueline de Oliveira and Luciana Arruda for critical
   reading of the paper. Special thanks to Clari Gandra, for administrative
   support. They also thank health officials and professionals from the
   cities of Serro, Ponte Nova, and Bambui, MG, Brazil. J. A. S. Gomes, G.
   S. Trindade, M. L. Nogueira, E. G. Kroon, R. Correa-Oliveira, and F. G.
   da Fonseca are CNPq fellowship recipients. This work was supported by
   Grants from FAPEMIG (CBB-APQ-00299-08, Universal Demand), CNPq
   (473205/2009-2, Universal Demand) and by the National Institute of
   Science and Technology in Vaccines (INCTV). Other than funding,
   supporting agencies had no role in conducting the study or writing the
   paper.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   AlYaman F, 1997, PARASITE IMMUNOL, V19, P207, DOI 10.1046/j.1365-3024.1997.d01-198.x
   Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x
   Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123
   Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100
   Blendon RJ, 2003, NEW ENGL J MED, V348, P426, DOI 10.1056/NEJMsa023184
   Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06
   da Fonseca FG, 2011, FUTURE VIROL, V6, P697, DOI 10.2217/FVL.11.46
   Dasgupta A, 2007, J IMMUNOL, V178, P1654, DOI 10.4049/jimmunol.178.3.1654
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Dunlop LR, 2003, MICROBES INFECT, V5, P1049, DOI 10.1016/S1286-4579(03)00194-1
   Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829
   Frey SE, 2004, NEW ENGL J MED, V350, P324, DOI 10.1056/NEJMp038208
   Haga IR, 2005, PARASITOLOGY, V130, pS11, DOI 10.1017/S0031182005008127
   Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917
   Hammarlund E, 2008, P NATL ACAD SCI USA, V105, P14567, DOI 10.1073/pnas.0800589105
   Johnston JB, 2003, J VIROL, V77, P6093, DOI 10.1128/JVI.77.11.6093-6100.2003
   Kennedy RB, 2009, CURR OPIN IMMUNOL, V21, P314, DOI 10.1016/j.coi.2009.04.004
   Lauterbach H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009659
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Li GY, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-88
   Li P, 2005, J IMMUNOL, V175, P6481, DOI 10.4049/jimmunol.175.10.6481
   Martinez J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000811
   Mathew A, 2000, CLIN IMMUNOL, V96, P100, DOI 10.1006/clim.2000.4887
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Moulton EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000249
   Moyron-Quiroz JE, 2009, VACCINE, V28, P140, DOI 10.1016/j.vaccine.2009.09.086
   Panchanathan V, 2010, IMMUNOL CELL BIOL, V88, P461, DOI 10.1038/icb.2009.110
   Parker AK, 2007, J VIROL, V81, P4070, DOI 10.1128/JVI.02061-06
   Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363
   Putz MM, 2006, NAT MED, V12, P1310, DOI 10.1038/nm1457
   Rehm KE, 2010, VIROLOGY, V397, P176, DOI 10.1016/j.virol.2009.11.008
   Rehm KE, 2009, IMMUNOLOGY, V128, P381, DOI 10.1111/j.1365-2567.2009.03120.x
   RILEY E, 1990, IMMUNOL LETT, V25, P221, DOI 10.1016/0165-2478(90)90119-B
   Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049
   Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039
   Sepkowitz KA, 2003, NEW ENGL J MED, V348, P439, DOI 10.1056/NEJMra022500
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912
   Venkatesan G, 2010, VET ITAL, V46, P439
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74
   Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265
NR 49
TC 4
Z9 4
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1740-2522
EI 1740-2530
J9 CLIN DEV IMMUNOL
JI Clin. Dev. Immunol.
PY 2012
AR 974067
DI 10.1155/2012/974067
PG 11
WC Immunology
SC Immunology
GA 872OX
UT WOS:000298820300001
PM 22229039
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Megid, J
   Borges, IA
   Abrahao, JS
   Trindade, GS
   Appolinario, CM
   Ribeiro, MG
   Allendorf, SD
   Antunes, JMAP
   Silva-Fernandes, AT
   Kroon, EG
AF Megid, Jane
   Borges, Iara A.
   Abrahao, Jonatas S.
   Trindade, Giliane S.
   Appolinario, Camila M.
   Ribeiro, Marcio G.
   Allendorf, Susan D.
   Antunes, Joao Marcelo A. P.
   Silva-Fernandes, Andre T.
   Kroon, Erna G.
TI Vaccinia Virus Zoonotic Infection, Sao Paulo State, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID CANTAGALO VIRUS; HUMANS; CATTLE; SMALLPOX
C1 [Megid, Jane] Univ Estadual Paulista, Fac Med Vet & Zootecnia, Dept Higiene Vet & Saude Publ, BR-18610250 Sao Paulo, Brazil.
   [Borges, Iara A.; Abrahao, Jonatas S.; Trindade, Giliane S.; Silva-Fernandes, Andre T.; Kroon, Erna G.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
RP Megid, J (corresponding author), Univ Estadual Paulista, Fac Med Vet & Zootecnia, Dept Higiene Vet & Saude Publ, BR-18610250 Sao Paulo, Brazil.
EM jane@fmvz.unesp.br
RI Antunes, Joao Marcelo/D-2467-2012; Ribeiro, Marcio/C-9745-2012;
   Allendorf, Susan/F-2325-2013; Abrahao, Jonatas/B-3895-2015; Megid,
   Jane/C-3413-2012; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015
OI Antunes, Joao Marcelo/0000-0003-3922-1428; Allendorf,
   Susan/0000-0002-8390-2952; Abrahao, Jonatas/0000-0001-9420-1791; Kroon,
   Erna Geessien/0000-0003-2721-3826; Garcia Ribeiro,
   Marcio/0000-0003-2682-9389; Megid, Jane/0000-0002-6540-7157
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Inoshima Y, 2000, J VIROL METHODS, V84, P201, DOI 10.1016/S0166-0934(99)00144-5
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
NR 10
TC 24
Z9 27
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2012
VL 18
IS 1
BP 189
EP 191
DI 10.3201/eid1801.110692
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 874QK
UT WOS:000298973000049
PM 22260819
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Pereira, ACTC
   Leite, FGG
   Brasil, BSAF
   Soares-Martins, JAP
   Torres, AA
   Pimenta, PFP
   Souto-Padron, T
   Traktman, P
   Ferreira, PCP
   Kroon, EG
   Bonjardim, CA
AF Pereira, Anna C. T. C.
   Leite, Flavia G. G.
   Brasil, Bruno S. A. F.
   Soares-Martins, Jamaria A. P.
   Torres, Alice A.
   Pimenta, Paulo F. P.
   Souto-Padron, Thais
   Traktman, Paula
   Ferreira, Paulo C. P.
   Kroon, Erna G.
   Bonjardim, Claudio A.
TI A Vaccinia Virus-Driven Interplay between the MKK4/7-JNK1/2 Pathway and
   Cytoskeleton Reorganization
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID KINASE SIGNALING CASCADES; INDUCED CELL MOTILITY; PROTEIN-KINASE; VIRAL
   REPLICATION; MAP KINASES; JNK; MICROTUBULES; ACTIN; ACTIVATION;
   INFECTION
AB Viral manipulation of transduction pathways associated with key cellular functions such as survival, response to microbial infection, and cytoskeleton reorganization can provide the supportive milieu for a productive infection. Here, we demonstrate that vaccinia virus (VACV) infection leads to activation of the stress-activated protein kinase (SAPK)/extracellular signal-regulated kinase (ERK) 4/7 (MKK4/7)-c-Jun N-terminal protein kinase 1/2 (JNK1/2) pathway; further, the stimulation of this pathway requires postpenetration, prereplicative events in the viral replication cycle. Although the formation of intracellular mature virus (IMV) was not affected in MKK4/7- or JNK1/2-knockout (KO) cells, we did note an accentuated deregulation of microtubule and actin network organization in infected JNK1/2-KO cells. This was followed by deregulated viral trafficking to the periphery and enhanced enveloped particle release. Furthermore, VACV infection induced alterations in the cell contractility and morphology, and cell migration was reduced in the JNK-KO cells. In addition, phosphorylation of proteins implicated with early cell contractility and cell migration, such as microtubule-associated protein 1B and paxillin, respectively, was not detected in the VACV-infected KO cells. In sum, our findings uncover a regulatory role played by the MKK4/7-JNK1/2 pathway in cytoskeleton reorganization during VACV infection.
C1 [Pereira, Anna C. T. C.; Leite, Flavia G. G.; Brasil, Bruno S. A. F.; Torres, Alice A.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Grp Transducao Sinal Orthopoxvirol, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Pereira, Anna C. T. C.; Leite, Flavia G. G.; Brasil, Bruno S. A. F.; Torres, Alice A.; Ferreira, Paulo C. P.; Kroon, Erna G.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Virus Lab, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Soares-Martins, Jamaria A. P.; Traktman, Paula] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.
   [Pimenta, Paulo F. P.] Ctr Pesquisa Rene Rachou, Belo Horizonte, MG, Brazil.
   [Souto-Padron, Thais] Univ Fed Rio de Janeiro, Lab Biol Celular & Ultraestrut, Inst Nacl Ciencia & Tecnol Biol Estrut & Bioimage, Rio De Janeiro, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Grp Transducao Sinal Orthopoxvirol, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
EM claudio.bonjardim@pq.cnpq.br
RI Brasil, Bruno S. A. F./E-8817-2012; Pimenta, Paulo/AAH-1502-2020; Abreu
   Torres, Alice/B-1475-2018; Bonjardim, Claudio A/J-2601-2014; Kroon,
   Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Brasil, Bruno S. A. F./0000-0002-8690-2157; Abreu Torres,
   Alice/0000-0003-2352-2584; Kroon, Erna Geessien/0000-0003-2721-3826; ,
   Bruno/0000-0002-3587-7983; Traktman, Paula/0000-0002-6517-0225
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Brazilian Federal Agency for
   Support and Evaluation of Graduate Education (CAPES)CAPES; National
   Council for Scientific and Technological Development (CNPq)National
   Council for Scientific and Technological Development (CNPq)
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG), the Brazilian Federal Agency for
   Support and Evaluation of Graduate Education (CAPES), and the National
   Council for Scientific and Technological Development (CNPq). A.C.T.C.P.,
   B.S.A.F.B., F.G.G.L., and J.A.P.S.-M. were recipients of predoctoral
   fellowships from CNPq. C.A.B., E.G.K., T.S.-P., P.F.P.P., and P.C.P.F.
   are recipients of research fellowships from CNPq.
CR Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06
   Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000
   Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7
   Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8
   Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x
   Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124
   Hu W, 2008, CANCER GENE THER, V15, P616, DOI 10.1038/cgt.2008.32
   Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481
   Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745
   Husain M, 2003, J VIROL, V77, P9008, DOI 10.1128/JVI.77.16.9008-9019.2003
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   KATES JR, 1967, P NATL ACAD SCI USA, V57, P314, DOI 10.1073/pnas.57.2.314
   Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   Moss B., 2007, FIELDS VIROLOGY, V2, P2905
   Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932
   Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x
   Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5
   Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992
   Rochester SC, 1998, J VIROL, V72, P2917, DOI 10.1128/JVI.72.4.2917-2926.1998
   Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004
   Sanderson CM, 1998, J VIROL, V72, P1235, DOI 10.1128/JVI.72.2.1235-1243.1998
   Schepis A, 2006, TRAFFIC, V7, P308, DOI 10.1111/j.1600-0854.2005.00381.x
   Schramm B, 2006, TRAFFIC, V7, P1352, DOI 10.1111/j.1600-0854.2006.00470.x
   Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509
   Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915
   Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09
   Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695
   Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870
   ULLOA L, 1993, J NEUROCHEM, V61, P961, DOI 10.1111/j.1471-4159.1993.tb03609.x
   Valderrama F, 2006, SCIENCE, V311, P377, DOI 10.1126/science.1122411
   Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021
   Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132
   Wang G, 2006, P NATL ACAD SCI USA, V103, P4640, DOI 10.1073/pnas.0509341103
   Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001
   Watanabe N, 1999, NAT CELL BIOL, V1, P136
   Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018
   Wittmann T, 2001, J CELL SCI, V114, P3795
   WOLFFE EJ, 1995, VIROLOGY, V211, P53, DOI 10.1006/viro.1995.1378
   WOODSON B, 1968, BACTERIOL REV, V32, P127, DOI 10.1128/MMBR.32.2.127-137.1968
   Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3
NR 46
TC 18
Z9 18
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
J9 J VIROL
JI J. Virol.
PD JAN
PY 2012
VL 86
IS 1
BP 172
EP 184
DI 10.1128/JVI.05638-11
PG 13
WC Virology
SC Virology
GA 865YV
UT WOS:000298347700017
PM 22031940
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Simoes, LR
   Maciel, GM
   Brandao, GC
   Kroon, EG
   Castilho, RO
   Oliveira, AB
AF Simoes, L. R.
   Maciel, G. M.
   Brandao, G. C.
   Kroon, E. G.
   Castilho, R. O.
   Oliveira, A. B.
TI Antiviral activity of Distictella elongata (Vahl) Urb. (Bignoniaceae), a
   potentially useful source of anti-dengue drugs from the state of Minas
   Gerais, Brazil
SO LETTERS IN APPLIED MICROBIOLOGY
LA English
DT Article
DE acacetin-7-O-rutinoside; antiviral activity; Bignoniaceae; DENV-2;
   Distictella elongata; pectolinarin; triterpenes
ID CONSTITUENTS; FLAVONOIDS; AGENTS
AB Aims: To investigate the in vitro antiviral activity of Distictella elongata (Vahl) Urb. ethanol extracts from leaves (LEE), fruits (FEE), stems and their main components.
   Methods and Results: The antiviral activity was evaluated against human herpesvirus type 1 (HSV-1), murine encephalomyocarditis virus (EMCV), vaccinia virus Western Reserve (VACV-WR) and dengue virus 2 (DENV-2) by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay. LEE presented anti-HSV-1 [EC50 142.8 +/- 5.3 mu g ml(-1); selectivity index (SI) 2 0] and anti-DENV-2 activity (EC50 9.8 +/- 1.3 mu g ml(-1); SI 1.5). The pectolinarin (1) isolated from LEE was less active against HSV-1 and DENV-2. A mixture of the triterpenoids ursolic, pomolic and oleanolic acids was also obtained. Ursolic and oleanolic acids have shown antiviral activity against HSV1. A mixture of pectolinarin (1) and acacetin-7-O-rutinoside (2) was isolated from FEE and has presented anti-DENV-2 activity (EC50 11.1 +/- 1.6 mu g ml(-1); SI > 45). Besides the antiviral activity, D. elongata has disclosed antioxidant effect.
   Conclusions: These data shows that D. elongata has antiviral activity mainly against HSV-1 and DENV-2, besides antioxidant activity. These effects might be principally attributed to flavonoids isolated.
   Significance and Impact of the Study: Distictella elongata might be considered a promising source of anti-dengue fever phytochemicals.
C1 [Simoes, L. R.; Maciel, G. M.; Brandao, G. C.; Castilho, R. O.; Oliveira, A. B.] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kroon, E. G.] Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Castilho, RO (corresponding author), Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM roc2006@farmacia.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Brandao, Geraldo
   Celio/0000-0002-7330-051X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
FX To CNPq and FAPEMIG for financial support and fellowship (G. M. M. and
   A.B.O.); to Dr Lucia Lohmann, USP, Sao Paulo, SP, Brazil, for
   taxonomical identification of the plant species and to Dr Norberto P.
   Lopes, USP, Ribeirao Preto, SP, Brazil, for MS of pectolinarin.
CR Akaike T, 2001, REV MED VIROL, V11, P87, DOI 10.1002/rmv.303
   Akaike T, 2000, IMMUNOLOGY, V101, P300, DOI 10.1046/j.1365-2567.2000.00142.x
   AMOROS M, 1992, J NAT PROD, V55, P1732, DOI 10.1021/np50090a003
   Andres A, 2009, J NUTR BIOCHEM, V20, P563, DOI 10.1016/j.jnutbio.2009.04.004
   Asres K, 2005, PHYTOTHER RES, V19, P557, DOI 10.1002/ptr.1629
   Bedir E, 2009, J BRAZIL CHEM SOC, V20, P383, DOI 10.1590/S0103-50532009000200026
   Brandao GC, 2010, LETT APPL MICROBIOL, V51, P469, DOI 10.1111/j.1472-765X.2010.02924.x
   Castellanos JRG, 2009, J ETHNOPHARMACOL, V121, P1, DOI 10.1016/j.jep.2008.10.004
   Castilho RO, 2008, QUIM NOVA, V31, P66, DOI 10.1590/S0100-40422008000100014
   Cipriani F.A., 2007, REV BRAS BIOL, V5, P612
   de Oliveira A. B., 1990, QUIM NOVA, V13, P302
   Forero JE, 2008, PHYTOCHEMISTRY, V69, P2815, DOI 10.1016/j.phytochem.2008.09.003
   GENTRY AH, 1992, ANN MO BOT GARD, V79, P53, DOI 10.2307/2399809
   HATANO T, 1988, CHEM PHARM BULL, V36, P2090
   Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x
   Jeong DM, 2008, ARCH PHARM RES, V31, P28, DOI 10.1007/s12272-008-1116-7
   Kinney RM, 2005, J VIROL, V79, P5116, DOI 10.1128/JVI.79.8.5116-5128.2005
   Muhamad M, 2010, INT J BIOL SCI, V6, P294
   Naithani R, 2008, MINI-REV MED CHEM, V8, P1106, DOI 10.2174/138955708785909943
   Yim SH, 2003, ARCH PHARM RES, V26, P128
NR 20
TC 13
Z9 13
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0266-8254
EI 1472-765X
J9 LETT APPL MICROBIOL
JI Lett. Appl. Microbiol.
PD DEC
PY 2011
VL 53
IS 6
BP 602
EP 607
DI 10.1111/j.1472-765X.2011.03146.x
PG 6
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 861KM
UT WOS:000298017800004
PM 21895729
DA 2020-11-30
ER

PT J
AU Kroon, EG
   Mota, BEF
   Abrahao, JS
   da Fonseca, FG
   Trindade, GD
AF Kroon, Erna Geessien
   Mota, Bruno Eduardo F.
   Abrahao, Jonatas Santos
   da Fonseca, Flavio Guimaraes
   Trindade, Giliane de Souza
TI Zoonotic Brazilian Vaccinia virus: From field to therapy
SO ANTIVIRAL RESEARCH
LA English
DT Review
DE Orthopoxvirus; Vaccinia virus (VACV); Bovine vaccinia (BV); Antiviral
   drugs; Zoonosis; Occupational disease
ID ANTIPOXVIRUS COMPOUND ST-246; RIO-DE-JANEIRO; MOLLUSCUM CONTAGIOSUM;
   CANTAGALO VIRUS; BOVINE VACCINIA; CUTANEOUS INFECTIONS; CLINICAL
   DESCRIPTION; CYTOKINE INDUCTION; ANTIVIRAL ACTIVITY; TOPICAL IMIQUIMOD
AB Vaccinia virus (VACV), the prototype species of the Orthopoxvirus (OPV) genus, causes an occupational zoonotic disease in Brazil that is primarily associated with the handling of infected dairy cattle. Cattle and human outbreaks have been described in southeastern Brazil since 1999 and have now occurred in almost half of the territory. Phylogenetic studies have shown high levels of polymorphisms among isolated VACVs, which indicate the existence of at least two genetically divergent clades; this has also been proven in virulence assays in a mouse model system. In humans, VACV infection is characterized by skin lesions, primarily on the hands, accompanied by systemic symptoms such as fever, myalgia, headache. and lymphadenopathy. In this review, we will discuss the virological, epidemiological, ecological and clinical aspects of VACV infection, its diagnosis and compounds that potentially could be used for the treatment of severe cases. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Kroon, Erna Geessien; Mota, Bruno Eduardo F.; Abrahao, Jonatas Santos; da Fonseca, Flavio Guimaraes; Trindade, Giliane de Souza] Univ Fed Minas Gerais UFMG, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [da Fonseca, Flavio Guimaraes] Fundacao Oswaldo Cruz, Inst Rene Rachou IRR, BR-30190002 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais UFMG, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Abrahao, Jonatas/B-3895-2015; Kroon, Erna
   Geessien/B-3631-2015
OI Abrahao, Jonatas/0000-0001-9420-1791; Kroon, Erna
   Geessien/0000-0003-2721-3826; Mota, Bruno/0000-0003-0348-4875
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2010, J CLIN VIROL, V48, P69, DOI 10.1016/j.jcv.2010.02.001
   Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140
   Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1
   Altmann SE, 2009, VIROLOGY, V388, P248, DOI 10.1016/j.virol.2009.03.023
   Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   Ara M, 2008, J AM ACAD DERMATOL, V58, pS39, DOI 10.1016/j.jaad.2006.04.027
   Arican O, 2006, PEDIATR INT, V48, P403, DOI 10.1111/j.1442-200X.2006.02229.x
   Batista V. H., 2009, VIRUS REV RES, V14, P1
   Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100
   Berhanu A, 2010, VACCINE, V29, P289, DOI 10.1016/j.vaccine.2010.10.039
   Berhanu A, 2009, ANTIMICROB AGENTS CH, V53, P4999, DOI 10.1128/AAC.00678-09
   Bhanuprakash V, 2010, ZOONOSES PUBLIC HLTH, V57, pE149, DOI 10.1111/j.1863-2378.2009.01314.x
   BLASCO R, 1991, J VIROL, V65, P5910, DOI 10.1128/JVI.65.11.5910-5920.1991
   Brandao GC, 2010, LETT APPL MICROBIOL, V51, P469, DOI 10.1111/j.1472-765X.2010.02924.x
   Brandao GC, 2010, PHYTOMEDICINE, V17, P926, DOI 10.1016/j.phymed.2010.03.004
   Bray M, 2003, CLIN INFECT DIS, V36, P766, DOI 10.1086/374244
   Bristol N, 2007, DISASTER MED PUBLIC, V1, P11, DOI 10.1097/DMP.0b013e3180690d58
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Charrel RN, 2010, VET MICROBIOL, V140, P213, DOI 10.1016/j.vetmic.2009.08.027
   Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06
   Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8
   Coras B, 2005, LANCET, V365, P446
   Costa R.V.C., 2007, VIRUS REV RES, V12, P33
   D'Anunciacao L., VECTOR BORN IN PRESS
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   da Fonseca FG, 2011, FUTURE VIROL, V6, P697, DOI 10.2217/FVL.11.46
   da Silva AC, 2008, REV SOC BRAS MED TRO, V41, P507, DOI 10.1590/S0037-86822008000500015
   Damaso CRA, 2007, DIAGN MICR INFEC DIS, V57, P39, DOI 10.1016/j.diagmicrobio.2006.07.012
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Dave RS, 2006, VIROLOGY, V348, P489, DOI 10.1016/j.virol.2006.01.013
   De Clercq E, 2002, ANTIVIR RES, V55, P1, DOI 10.1016/S0166-3542(02)00008-6
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   Dearing MD, 2010, ANN NY ACAD SCI, V1195, P99, DOI 10.1111/j.1749-6632.2010.05452.x
   DECLERCQ E, 1986, NATURE, V323, P464, DOI 10.1038/323464a0
   Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9
   Diniz S, 2001, ARQ BRAS MED VET ZOO, V53, P152, DOI 10.1590/S0102-09352001000200003
   Donatele D. M., 2007, Brazilian Journal of Veterinary Research and Animal Science, V44, P275
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Duraffour S, 2007, ANTIVIR THER, V12, P1205
   Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261
   Emonet SF, 2009, INFECT GENET EVOL, V9, P417, DOI 10.1016/j.meegid.2009.03.005
   Erbagci Z, 2005, J DERMATOL TREAT, V16, P353, DOI 10.1080/09546630500375734
   Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829
   Fenner F., 1989, ORTHOPOXVIRUSES
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Frandsen Jonathan, 2011, Dermatol Online J, V17, P9
   Fundacao Nacional de Saude, 2002, MAN CONTR ROED
   Gammon DB, 2008, J VIROL, V82, P12520, DOI 10.1128/JVI.01528-08
   Geerinck K, 2001, J MED VIROL, V64, P543, DOI 10.1002/jmv.1084
   Grosenbach DW, 2010, P NATL ACAD SCI USA, V107, P838, DOI 10.1073/pnas.0912134107
   Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917
   Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758
   Henderson D.A., 2009, SAMLLPOX DEATH DIS, P79
   Honlinger B, 2005, BRIT J DERMATOL, V153, P451, DOI 10.1111/j.1365-2133.2005.06731.x
   Huggins J, 2009, ANTIMICROB AGENTS CH, V53, P2620, DOI 10.1128/AAC.00021-09
   Jesus DM, 2009, INT J ANTIMICROB AG, V33, P75, DOI 10.1016/j.ijantimicag.2008.07.015
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Jordan R, 2009, ANTIMICROB AGENTS CH, V53, P1817, DOI 10.1128/AAC.01596-08
   Keith KA, 2003, ANTIMICROB AGENTS CH, V47, P2193, DOI 10.1128/AAC.47.7.2193-2198.2003
   Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   LAI ACK, 1989, MICROB PATHOGENESIS, V6, P219, DOI 10.1016/0882-4010(89)90071-5
   Langhammer S, 2011, ANTIVIR RES, V89, P64, DOI 10.1016/j.antiviral.2010.11.006
   Lanier R, 2010, VIRUSES-BASEL, V2, P2740, DOI 10.3390/v2122740
   Lauterbach H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009659
   Lederman ER, 2007, CLIN INFECT DIS, V44, pE100, DOI 10.1086/517509
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lin HY, 2010, J LOW GENIT TRACT DI, V14, P134, DOI 10.1097/LGT.0b013e3181bf1a50
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   de Oliveira TML, 2010, FOODBORNE PATHOG DIS, V7, P1491, DOI 10.1089/fpd.2010.0597
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Medeiros-Silva DC, 2010, BRAZ J INFECT DIS, V14, P129, DOI 10.1590/S1413-86702010000200003
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Moss B, 2007, FIELDS VIROLOGY, P2906
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Mota BEF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018924
   Moussatche N, 2008, J INFECT DEV COUNTR, V2, P156, DOI 10.3855/jidc.258
   Myskiw C, 2010, ANTIVIR RES, V88, P304, DOI 10.1016/j.antiviral.2010.10.001
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Neyts J, 2004, ANTIMICROB AGENTS CH, V48, P2267, DOI 10.1128/AAC.48.6.2267-2273.2004
   Nitsche A, 2007, J CLIN VIROL, V40, P160, DOI 10.1016/j.jcv.2007.07.014
   Panchanathan V, 2010, IMMUNOL CELL BIOL, V88, P461, DOI 10.1038/icb.2009.110
   Parker S, 2008, FUTURE VIROL, V3, P595, DOI 10.2217/17460794.3.6.595
   Quenelle DC, 2004, ANTIVIR RES, V63, P33, DOI 10.1016/j.antiviral.2004.02.003
   Quenelle DC, 2003, ANTIMICROB AGENTS CH, V47, P3275, DOI 10.1128/AAC.47.10.3275-3280.2003
   Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P4118, DOI 10.1128/AAC.00762-07
   Quixabeira-Santos JC, 2011, EMERG INFECT DIS, V17, P726, DOI 10.3201/eid1704.101581
   Reeves PM, 2011, J VIROL, V85, P21, DOI 10.1128/JVI.01814-10
   Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265
   REITER MJ, 1994, J LEUKOCYTE BIOL, V55, P234
   Saijo M, 2008, JPN J INFECT DIS, V61, P140
   Sbrana E, 2007, AM J TROP MED HYG, V76, P768, DOI 10.4269/ajtmh.2007.76.768
   Schatzmayr HG, 2009, REV SOC BRAS MED TRO, V42, P672, DOI 10.1590/S0037-86822009000600012
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Simonetti B.R., 2007, VIRUS REV RES, V12, P32, DOI DOI 10.17525/VRR.V12I1-2.10
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   Skinner RB, 2002, J AM ACAD DERMATOL, V47, pS221, DOI 10.1067/mjd.2002.126578
   Sliva K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-8
   Smee DF, 2004, J INFECT DIS, V190, P1132, DOI 10.1086/422696
   Smith SK, 2009, ANTIMICROB AGENTS CH, V53, P1007, DOI 10.1128/AAC.01044-08
   Stittelaar KJ, 2006, NATURE, V439, P745, DOI 10.1038/nature04295
   Strenger V, 2009, CLIN INFECT DIS, V48, P91, DOI 10.1086/595004
   Syed Tanweer A., 1998, Journal of Dermatology (Tokyo), V25, P309
   Tarbet EB, 2011, ANTIVIR RES, V90, P126, DOI 10.1016/j.antiviral.2011.03.181
   TESTERMAN TL, 1995, J LEUKOCYTE BIOL, V58, P365
   Theos AU, 2004, CUTIS, V74, P134
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Toutous-Trellu L, 2004, ANN DERMATOL VENER, V131, P445, DOI 10.1016/S0151-9638(04)93637-X
   Trindade GS, 2007, J VIROL METHODS, V141, P198, DOI 10.1016/j.jviromet.2006.12.006
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06
   Tzahar E, 1998, EMBO J, V17, P5948, DOI 10.1093/emboj/17.20.5948
   Valadares YM, 2009, Z NATURFORSCH C, V64, P813
   Vestergaard L, 2008, ACTA DERM-VENEREOL, V88, P188, DOI 10.2340/00015555-0375
   Vigne S, 2008, ANTIVIR THER, V13, P357
   Vigne S, 2009, ANTIMICROB AGENTS CH, V53, P2579, DOI 10.1128/AAC.01626-08
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Wagner TL, 1999, CELL IMMUNOL, V191, P10, DOI 10.1006/cimm.1998.1406
   Wilson D. E., 2005, MAMMAL SPECIES WORLD, P142
   Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265
   Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005
NR 138
TC 54
Z9 55
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD NOV
PY 2011
VL 92
IS 2
BP 150
EP 163
DI 10.1016/j.antiviral.2011.08.018
PG 14
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA 853LG
UT WOS:000297427200003
PM 21896287
DA 2020-11-30
ER

PT J
AU de Freitas, MHA
   de Oliveira, LC
   Mugge, FLB
   Ferreira, PCP
   Trindade, GD
   Kroon, EG
   Bonjardim, CA
AF de Freitas, Marcelo H. A.
   de Oliveira, Leonardo C.
   Muegge, Fernanda L. B.
   Ferreira, Paulo C. P.
   Trindade, Giliane de S.
   Kroon, Erna G.
   Bonjardim, Claudio A.
TI The interplay between Aracatuba virus and host signaling pathways: role
   of PI3K/Akt in viral replication
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; POXVIRUS TROPISM;
   CANTAGALO VIRUS; EARLY-STAGE; VACCINIA; INFECTION; BRAZIL; STRAINS; B5R
AB In this study, we describe the interaction between Aracatuba virus (ARAV), a naturally occurring Brazilian vaccinia virus isolated from an outbreak at a dairy farm, and the host cell's signal transduction pathways. Even though ARAV infection led to phosphorylation of MAPKs MEK/ERK, JNK, and p38MAPK, genetic or pharmacological inhibition of these pathways had no impact on viral replication. We also provide evidence that ARAV stimulated the phosphorylation of Akt (PKB) at serine 473 (S473-P), a signaling event that is required for full activation of Akt during the infectious cycle. Furthermore, pharmacological inhibition of PI3K (LY294002) abrogated ARAV-induced Akt activation (S473-P) and affected early and late viral gene expression, which was followed by a decrease in virus yield (similar to 1 log). Taken together, our data shed some light onto the biological differences between ARAV and vaccinia virus strain WR (VACV-WR), which could contribute, at least in part, to the low-virulence phenotype displayed by ARAV. Thus, while the requirement for the PI3K/Akt pathway for successful ARAV replication is also shared with VACV-WR and cowpox virus strain BR (CPXV-BR), ARAV showed a lower replicative capacity, as well as a smaller plaque-size phenotype after infection of A31 cells when compared to VACV-WR.
C1 [de Freitas, Marcelo H. A.; de Oliveira, Leonardo C.; Muegge, Fernanda L. B.; Ferreira, Paulo C. P.; Trindade, Giliane de S.; Kroon, Erna G.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Freitas, Marcelo H. A.; de Oliveira, Leonardo C.; Muegge, Fernanda L. B.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Grp Transducao Sinal Orthopoxviruses, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos,6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM claudio.bonjardim@pq.cnpq.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Bonjardim,
   Claudio A/J-2601-2014
OI Kroon, Erna Geessien/0000-0003-2721-3826; Mugge,
   Fernanda/0000-0003-2224-4551
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Coordenadoria de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Brazilian
   Ministry of Culture, Science, and Technology; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq).National Council for
   Scientific and Technological Development (CNPq)
FX We are grateful to Angela S. Lopes, Ilda M. V. Gama, Joao R. dos Santos,
   and Andreza A. Carvalho for their secretarial and technical assistance.
   We also thank Dr. Bruno S. A. F. Brasil for critical reading of the
   manuscript. We are grateful to Dr. M. C. Sogayar (Department of
   Biochemistry, University of Sao Paulo, Brazil), who kindly provided us
   with the A31 cell line, and Dr. R. Davis (Howard Hughes Medical
   Institute, University of Massachusetts Medical School, Worcester,
   Massachusetts, USA) for the WT and JNK1/2 double KO cells. WT and egr-1
   KO cells were kindly provided by Dr. E. Adamson (The Burnham Institute,
   Torrey Pines Road, La Jolla, CA, USA). The rabbit polyclonal antibodies
   against viral proteins CrmA/SPI-2 were a gift from Dr. D. Pickup
   (Department of Molecular Genetics and Microbiology, Duke University
   Medical Center, Durham, NC, USA), and A17, D8, F18 and H3 were from Dr.
   B. Moss (NIAID, Bethesda, MD, USA). The rabbit polyclonal antibody
   against the viral A3 protein was from Dr. P. Traktman (Department of
   Microbiology and Molecular Genetics, Medical College of Wisconsin,
   Milwaukee, WI, USA). This work was supported by Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG), Coordenadoria de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry
   of Culture, Science, and Technology, and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq). MHAF was a recipient
   and LCO is recipient of a pre-doctoral fellowship from CNPq. FLBM is
   recipient of an undergraduate fellowship from CNPq (PIBIC). CAB, EGK,
   GST and PCPF are recipients of research fellowships from CNPq.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Aldaz-Carroll L, 2005, J VIROL, V79, P6260, DOI 10.1128/JVI.79.10.6260-6271.2005
   Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8
   Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002
   Johnston JB, 2003, J VIROL, V77, P6093, DOI 10.1128/JVI.77.11.6093-6100.2003
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lu ZM, 2004, J BIOL CHEM, V279, P35664, DOI 10.1074/jbc.M403385200
   Mathew EC, 2001, J GEN VIROL, V82, P1199, DOI 10.1099/0022-1317-82-5-1199
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05
   Rahaus M, 2006, J GEN VIROL, V87, P749, DOI 10.1099/vir.0.81571-0
   Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05
   Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09
   Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124
   Werden SJ, 2008, BBA-PROTEINS PROTEOM, V1784, P228, DOI 10.1016/j.bbapap.2007.08.001
   Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217
   Zapata HJ, 2007, J VIROL, V81, P977, DOI 10.1128/JVI.01470-06
NR 35
TC 1
Z9 1
U1 0
U2 4
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
J9 ARCH VIROL
JI Arch. Virol.
PD OCT
PY 2011
VL 156
IS 10
BP 1775
EP 1785
DI 10.1007/s00705-011-1052-6
PG 11
WC Virology
SC Virology
GA 841KC
UT WOS:000296510200008
PM 21735213
DA 2020-11-30
ER

PT J
AU Rodrigues, RA
   Ruiz, ACR
   Branddo, GC
   Evangelista, KS
   Oliveira, HA
   Kroon, EG
   De Oliveira, AB
AF Rodrigues, R. A.
   Games Ruiz, A. C.
   Branddo, G. C.
   Evangelista, K. S.
   Oliveira Junior, H. A.
   Kroon, E. G.
   De Oliveira, A. B.
TI Anti-Dengue virus activity of Polygonum spectabile (Polygonaceae)
SO PLANTA MEDICA
LA English
DT Meeting Abstract
CT 59th International Congress and Annual Meeting of the
   Society-for-Medicinal-Plant-and-Natural-Product-Research
CY SEP 04-09, 2011
CL Antalya, TURKEY
SP Soc Med Plant & Nat Prod Res
DE Dengue virus; antiviral activity; Polygonum spectabile
C1 [Rodrigues, R. A.; Games Ruiz, A. C.; Evangelista, K. S.; Oliveira Junior, H. A.] Viriontech Brasil Ind Insumos & Serv Biotecnol Lt, Belo Horizonte, MG, Brazil.
   [Kroon, E. G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Branddo, G. C.; De Oliveira, A. B.] Univ Fed Minas Gerais, Dept Prod Farmaceut, Fac Farm, Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019
CR Brandao GC, 2010, PHYTOMEDICINE, V17, P926, DOI 10.1016/j.phymed.2010.03.004
NR 1
TC 0
Z9 0
U1 0
U2 0
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0032-0943
J9 PLANTA MED
JI Planta Med.
PD AUG
PY 2011
VL 77
IS 12
BP 1373
EP 1373
PG 1
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 810PT
UT WOS:000294139000575
DA 2020-11-30
ER

PT J
AU de Oliveira, TML
   Rehleld, IS
   Guedes, MIMC
   Ferreira, JMS
   Kroon, EG
   Lobato, ZIP
AF Ludolfo de Oliveira, Tercia Moreira
   Rehleld, Izabelle Silva
   Maldonado Coelho Guedes, Maria Isabel
   Siqueira Ferreira, Jaqueline Maria
   Kroon, Erna Geessien
   Portela Lobato, Zelia Ines
TI Susceptibility of Vaccinia Virus to Chemical Disinfectants
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID INFECTION; CATTLE
AB Vaccinia virus (VACV) is the cause of bovine vaccinia (BV), an emerging zoonotic disease that affects dairy cows and milkers. Some chemical disinfectants have been used on farms affected by BV to disinfect cow teats and milkers' hands. To date, there is no information about the efficacy of disinfectants against VACV. Therefore, this study aimed to assess the virucidal activity of some active disinfectants commonly used in the field. Sodium hypochlorite, quaternary ammonium combined with chlorhexidine, and quaternary ammonium combined with glutaraldehyde were effective in inactivating the virus at all concentrations tested. Iodine and quaternary ammonium as the only active component were partially effective. The presence of bovine feces as organic matter and light decreased the effectiveness of sodium hypochlorite. These results show that an appropriated disinfection and asepsis of teats and hands may be helpful in the control and prevention of BV and other infections with VACV.
C1 [Ludolfo de Oliveira, Tercia Moreira; Rehleld, Izabelle Silva; Maldonado Coelho Guedes, Maria Isabel; Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, Lab Pesquisa Virol Anim, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Lobato, ZIP (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, Lab Pesquisa Virol Anim, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM tercialud@gmail.com; izarehfeld@gmail.com; mariaisabel.guedes@gmail.com;
   jackmaria4@gmail.com; kroone@icb.ufmg.br; ziplobato@gmail.com
RI brasileira, Inct Pecuaria/J-9542-2013; Kroon, Erna Geessien/B-3631-2015;
   Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Lobato,
   Zelia/0000-0002-9399-3691
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais,
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Pro-Reitoria
   de Pesquisa/ Universidade Federal de Minas Gerais; CNPq/ Ministerio de
   AgriculturaNational Council for Scientific and Technological Development
   (CNPq)
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais, (FAPEMIG), and Pro-Reitoria de Pesquisa/
   Universidade Federal de Minas Gerais. E. G. Kroon and Z. I. P. Lobato
   were supported by fellowships from CNPq I. S. Rehfeld was supported by a
   fellowship from CNPq/ Ministerio de Agricultura, and M. I. M. C. Guedes
   was supported by a fellowship from FAPEMIG.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1
   ANVISA (Agencia Nacional de Vigilancia Sanitaria) Brasil, 1994, DET QUE REG PROD SAN
   Block S. S., 2001, DISINFECTION STERILI
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Centers for Disease Control and Prevention (CDC), 2003, GUID F ENV CONTR SMA
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   European Committee for Standardization, 2006, EN14675 CEN EUR COMM
   Jones GM, 1998, MILKING PRACTICES RE, P404
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Malik YS, 2006, AM J INFECT CONTROL, V34, P31, DOI 10.1016/j.ajic.2005.05.012
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Oliveira JM, 2006, INFORM DETERMINACAO
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   SCHUMANN KO, 1977, ZBL BAKT MIK HYG B, V164, P45
   TANABE I, 1976, APPL ENVIRON MICROB, V32, P209, DOI 10.1128/AEM.32.2.209-212.1976
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
NR 21
TC 5
Z9 6
U1 0
U2 7
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUL
PY 2011
VL 85
IS 1
BP 152
EP 157
DI 10.4269/ajtmh.2011.11-0144
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 788GK
UT WOS:000292433200027
PM 21734141
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Magalhaes, CLD
   Drumond, BP
   Novaes, RFV
   Quinan, BR
   de Magalhaes, JC
   dos Santos, JR
   Pinto, CD
   Assis, MTD
   Bonjardim, CA
   Kroon, EG
   Ferreira, PCP
AF de Brito Magalhaes, Cintia Lopes
   Drumond, Betania Paiva
   Vianna Novaes, Renata Franco
   Quinan, Barbara Rezende
   de Magalhaes, Jose Carlos
   dos Santos, Joao Rodrigues
   Pinto, Carla do Amaral
   de Abreu Assis, Marieta Torres
   Bonjardim, Claudio Antonio
   Kroon, Erna Geessien
   Peregrino Ferreira, Paulo Cesar
TI Identification of a phylogenetically distinct orthobunyavirus from group
   C
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID ARTHROPOD-BORNE VIRUSES; FAMILY BUNYAVIRIDAE; RNA SEGMENT;
   NUCLEOTIDE-SEQUENCE; HEMORRHAGIC-FEVER; BUNYAMWERA VIRUS; OROPOUCHE
   VIRUS; AMAZON REGION; BRAZIL; EPIDEMIOLOGY
AB Apeu virus (APEUV) (family Bunyaviridae, genus Orthobunyavirus) was plaque purified and characterised by serological and molecular analysis. Neutralising assays confirmed cross-reactivity between purified APEUV clones and the Caraparu virus complex of group C orthobunyaviruses. Partial sequencing of the L, M and S segments of one APEUV clone (APEUV-CL5) was carried out. A phylogenetic tree constructed with the L amino acid sequences clustered APEUV-CL5 within the genus Orthobunyavirus, confirming its serological classification. Analysis of M segment sequences clustered APEUV-CL5 in the Caraparu virus complex (Group C), in agreement with serological tests and previous molecular characterisation. However, the sequence of the nucleocapsid gene (N) gave low identity values when compared to those of the group C viruses. The phylogenetic tree based on N nucleotide sequences clustered APEUV-CL5 next to the California and Bwamba groups. This remarkable S nucleotide variability suggests that APEUV-CL5 could be a genetic reassortant and that this evolutionary mechanism is present in the history of the group C viruses.
C1 [de Brito Magalhaes, Cintia Lopes; Drumond, Betania Paiva; Vianna Novaes, Renata Franco; Quinan, Barbara Rezende; dos Santos, Joao Rodrigues; Pinto, Carla do Amaral; de Abreu Assis, Marieta Torres; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; Peregrino Ferreira, Paulo Cesar] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Brito Magalhaes, Cintia Lopes] Univ Fed Ouro Preto, Dept Ciencias Biol, Lab Bioquim Metabol, Inst Ciencias Exatas & Biol, Ouro Preto, MG, Brazil.
   [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Dept Parasitol Microbiol & Imunol, Virol Lab, Inst Ciencias Biol, Juiz De Fora, MG, Brazil.
   [Vianna Novaes, Renata Franco] Dept Policia Civil Estado Minas Gerais, Secao Reg Criminalist Delegacia Reg Policia 2A 5, Araxa, MG, Brazil.
   [Quinan, Barbara Rezende] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Lab Virol Comparada, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Magalhaes, Jose Carlos] Univ Fed Sao Joao, Microbiol Lab, Ouro Branco, MG, Brazil.
RP Ferreira, PCP (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM cintia.magalhaes@gmail.com; paulo.peregrino@pq.cnpq.br
RI Bonjardim, Claudio A/J-2601-2014; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX The authors are grateful to colleagues from Virus Laboratory (ICB-UFMG)
   for their technical and scientific supports. This work was supported by
   research grants from Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenadoria de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG). P.C.P. Ferreira, E. G. Kroon, and C. A. Bonjardim are
   CNPq researchers. We thank Dr. G. S. Trindade and Dr. Jaquelline G.
   Oliveira for helpful scientific discussions. We thank the Laboratory of
   Biodiversity and Molecular Evolution (ICB-UFMG), where sequences were
   determined.
CR Aquino VH, 2004, J VIROL METHODS, V115, P51, DOI 10.1016/j.jviromet.2003.09.018
   BISHOP DHL, 1985, INTERVIROLOGY, V24, P79, DOI 10.1159/000149623
   Bowen MD, 2001, VIROLOGY, V291, P185, DOI 10.1006/viro.2001.1201
   Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664
   Calisher C. H., 1996, The Bunyaviridae., P1
   CALISHER CH, 1988, INTERVIROLOGY, V29, P268, DOI 10.1159/000150055
   CASALS J, 1961, AM J TROP MED HYG, V10, P250, DOI 10.4269/ajtmh.1961.10.250
   CAUSEY OR, 1961, AM J TROP MED HYG, V10, P227, DOI 10.4269/ajtmh.1961.10.227
   DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747
   Eifan SA, 2009, J VIROL, V83, P11307, DOI 10.1128/JVI.01460-09
   Elliott RM, 1997, MOL MED, V3, P572, DOI 10.1007/BF03401814
   ELLIOTT RM, 1985, VIROLOGY, V143, P119, DOI 10.1016/0042-6822(85)90101-1
   ELLIOTT RM, 1989, VIROLOGY, V173, P426, DOI 10.1016/0042-6822(89)90555-2
   Fauquet C. M., 2005, 8 ICTV
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   GENTSCH JR, 1979, J VIROL, V30, P767, DOI 10.1128/JVI.30.3.767-770.1979
   Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004
   GIBBS CJ, 1964, AM J TROP MED HYG, V13, P108, DOI 10.4269/ajtmh.1964.13.108
   Henderson WW, 1995, VIROLOGY, V214, P602, DOI 10.1006/viro.1995.0071
   Holland J, 1998, VIRUS GENES, V16, P13, DOI 10.1023/A:1007989407305
   HRONOVSKY V, 1981, ACTA VIROL, V25, P295
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Kuno G, 1996, J CLIN MICROBIOL, V34, P1184, DOI 10.1128/JCM.34.5.1184-1188.1996
   MACIAS JD, 1969, SALUD PUBLICA MEXICO, V11, P323
   Magalhaes CLD, 2007, VIRUS GENES, V35, P681, DOI 10.1007/s11262-007-0138-4
   Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490
   Nichol S. T., 2001, FIELDS VIROLOGY, P1603
   Nunes MRT, 2005, J VIROL, V79, P10561, DOI 10.1128/JVI.79.16.10561-10570.2005
   Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042
   Reese SM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-164
   Saeed MF, 2001, VIRUS RES, V77, P25, DOI 10.1016/S0168-1702(01)00262-3
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sall AA, 1999, J VIROL, V73, P8196, DOI 10.1128/JVI.73.10.8196-8200.1999
   Schmaljohn CS, 2007, FIELDS VIROLOGY, P1741
   SHOPE RE, 1962, AM J TROP MED HYG, V11, P283, DOI 10.4269/ajtmh.1962.11.283
   SHOPE RE, 1966, AM J TROP MED HYG, V15, P772, DOI 10.4269/ajtmh.1966.15.772
   Soldan SS, 2005, J NEUROVIROL, V11, P412, DOI 10.1080/13550280591002496
   TAMURA K, 1992, MOL BIOL EVOL, V9, P678
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   van Knippenberg I, 2010, J GEN VIROL, V91, P2002, DOI 10.1099/vir.0.021774-0
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007
   Weber F, 2002, VIRUS RES, V88, P129, DOI 10.1016/S0168-1702(02)00125-9
   Yanase T, 2006, ARCH VIROL, V151, P2253, DOI 10.1007/s00705-006-0808-x
NR 48
TC 13
Z9 13
U1 0
U2 4
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD JUL
PY 2011
VL 156
IS 7
BP 1173
EP 1184
DI 10.1007/s00705-011-0976-1
PG 12
WC Virology
SC Virology
GA 784LW
UT WOS:000292159800008
PM 21465087
DA 2020-11-30
ER

PT J
AU Silva, BM
   Sousa, LP
   Gomes-Ruiz, AC
   Leite, FGG
   Teixeira, MM
   da Fonseca, FG
   Pimenta, PFP
   Ferreira, PCP
   Kroon, EG
   Bonjardim, CA
AF Silva, Breno M.
   Sousa, Lirlandia P.
   Gomes-Ruiz, Alessandra C.
   Leite, Flavia G. G.
   Teixeira, Mauro M.
   da Fonseca, Flavio G.
   Pimenta, Paulo F. P.
   Ferreira, Paulo C. P.
   Kroon, Erna G.
   Bonjardim, Claudio A.
TI The dengue virus nonstructural protein 1 (NS1) increases NF-kappa B
   transcriptional activity in HepG2 cells
SO ARCHIVES OF VIROLOGY
LA English
DT Article
DE Dengue virus; Nonstructural protein 1; HepG2; NF-kappa B;
   Transcriptional activity
ID SIGNAL-TRANSDUCTION; GLYCOPROTEIN NS1; PATHOGENESIS; EXPRESSION;
   REPLICATION; PATHWAY; FORM
AB Dengue virus nonstructural protein 1 (NS1) is a glycoprotein involved in viral RNA replication. NS1 associates with host cell proteins and can be found in lipid raft domains on the host cell surface, suggesting an involvement in signal transduction events. In this work, we observed that NS1 expression in HepG2 cells increases nuclear translocation of NF-kappa B p65 protein, which was paralleled by DNA-protein complex formation. Luciferase assays showed an increase in NF-kappa B transcriptional activities in NS1-expressing cells when compared to parental cells. NS1 may enhance NF-kappa B function in host cells and contribute to the pathogenesis of dengue.
C1 [Silva, Breno M.; Pimenta, Paulo F. P.] Fiocruz MS, Lab Entomol Med, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
   [Silva, Breno M.; Leite, Flavia G. G.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Dept Microbiol, Grp Transducao Sinal, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Gomes-Ruiz, Alessandra C.; da Fonseca, Flavio G.; Ferreira, Paulo C. P.; Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Sousa, Lirlandia P.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Sousa, Lirlandia P.] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Silva, BM (corresponding author), Fiocruz MS, Lab Entomol Med, Ctr Pesquisas Rene Rachou, Av Augusto de Lima, BR-30190002 Belo Horizonte, MG, Brazil.
EM brenomello@pq.cnpq.br
RI Teixeira, Mauro M/A-4587-2008; Pimenta, Paulo/AAH-1502-2020; Kroon,
   Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; silva,
   breno/W-5122-2018; Kroon, Erna Geessien/B-3631-2015
OI Teixeira, Mauro M/0000-0002-6944-3008; silva, breno/0000-0003-2472-8111;
   Kroon, Erna Geessien/0000-0003-2721-3826; Sousa,
   Lirlandia/0000-0002-1042-9762
FU FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)Minas
   Gerais State Research Foundation (FAPEMIG); CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico)National Council for Scientific
   and Technological Development (CNPq); CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior)CAPES; INCT Dengue
   (Institute for Science and Technology in Dengue)
FX The authors are grateful to Angela S. Lopes, Ilda M. V. Gama, Joao R.
   dos Santos, Helena R. C. Araujo, Fernanda Gambogi, Juliana P. V. Silva
   and Camila R. C. Nogueira for their secretarial/technical assistance.
   This work was supported by grants from FAPEMIG (Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais), CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior) and INCT Dengue (Institute
   for Science and Technology in Dengue).
CR Alcon-LePoder S, 2005, J VIROL, V79, P11403, DOI 10.1128/JVI.79.17.11403-11411.2005
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   BARONTI C, VIROLOGY, V404, P319
   Chua JJE, 2005, VIRUS RES, V112, P85, DOI 10.1016/j.virusres.2005.03.025
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x
   Noisakran S, 2008, J GEN VIROL, V89, P2492, DOI 10.1099/vir.0.83620-0
   Noisakran S, 2008, BIOCHEM BIOPH RES CO, V372, P67, DOI 10.1016/j.bbrc.2008.04.165
   Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042
   Pattanakitsakul S, 2007, J PROTEOME RES, V6, P4592, DOI 10.1021/pr070366b
   Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083
   Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007
   Sousa LP, 2005, BIOCHEM BIOPH RES CO, V337, P1065, DOI 10.1016/j.bbrc.2005.09.154
   Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08
NR 20
TC 13
Z9 13
U1 0
U2 7
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
J9 ARCH VIROL
JI Arch. Virol.
PD JUL
PY 2011
VL 156
IS 7
BP 1275
EP 1279
DI 10.1007/s00705-011-0969-0
PG 5
WC Virology
SC Virology
GA 784LW
UT WOS:000292159800019
PM 21424730
DA 2020-11-30
ER

PT J
AU da Fonseca, FG
   Kroon, EG
   Nogueira, ML
   Trindade, GD
AF da Fonseca, Flavio Guimaraes
   Kroon, Erna Geessien
   Nogueira, Mauricio Lacerda
   Trindade, Giliane de Souza
TI Zoonotic vaccinia virus outbreaks in Brazil
SO FUTURE VIROLOGY
LA English
DT Review
DE bovine vaccinia; orthopoxvirus; phylogenetic analysis; vaccinia virus;
   zoonosis
ID GENERALIZED COWPOX INFECTION; RIO-DE-JANEIRO; HUMAN MONKEYPOX; CLINICAL
   CHARACTERISTICS; SMALLPOX VACCINES; CANTAGALO VIRUS; UNITED-STATES;
   RISK-FACTORS; COTIA VIRUS; ORTHOPOXVIRUS
AB The vaccinia virus (VACV) was used as a live vaccine during the WHO-led smallpox eradication campaign in the second half of the 20th century. The program culminated with the obliteration of the disease, one of the most important achievements in modern medicine. Interestingly, one of the key factors in the successful vaccination campaign - the VACV itself - is poorly understood in relation to its natural reservoirs, evolutionary history and origins, being frequently considered extinct as a naturally occurring virus. Nevertheless, orthopoxviruses other than variola virus have been known to circulate in Brazil since the early 1960s. More specifically, VACV has been associated with naturally acquired infections in humans, cattle and possibly other reservoirs since 1999, when bovine vaccinia outbreaks started to be consistently described year after year. In this article, we list and discuss the most important VACV outbreaks that have occurred in Brazil in the last 20 years. Phylogenetic issues are considered, as the latest studies point to large genetic variance among isolates. Clinical and epidemiological data, both published and new, are presented.
C1 [da Fonseca, Flavio Guimaraes; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [da Fonseca, Flavio Guimaraes] Fundacao Oswaldo Cruz, IRR, BR-30190002 Belo Horizonte, MG, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Dept Doencas Infecciosas & Parasitarias, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RP da Fonseca, FG (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RI Nogueira, Mauricio L/B-7599-2012; Kroon, Erna/V-5444-2019; Kroon,
   Erna/B-3631-2015
OI Nogueira, Mauricio L/0000-0003-1102-2419; Kroon,
   Erna/0000-0003-2721-3826
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [473205/2009-2]
FX FG da Fonseca, EG Kroon, ML Nogueira and G de Souza Trindade are CNPq
   fellowship recipients. Parts of the work described in this article were
   supported by a CNPq grant, process number 473205/2009-2. The authors
   have no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2010, J CLIN VIROL, V48, P69, DOI 10.1016/j.jcv.2010.02.001
   Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Baxby D, 1997, ARCH VIROL, P1
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8
   Coras B, 2005, LANCET, V365, P446
   Croft DR, 2007, EMERG INFECT DIS, V13, P1150, DOI 10.3201/eid1308.061365
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I, 2007, FIELDS VIROLOGY, P2947
   Dhar AD, 2004, NEW ENGL J MED, V350, P361, DOI 10.1056/NEJMoa031467
   Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Fuller T, 2011, ECOHEALTH, V8, P14, DOI 10.1007/s10393-010-0355-5
   Haase O, 2011, BRIT J DERMATOL, V164, P1116, DOI 10.1111/j.1365-2133.2011.10226.x
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   Honlinger B, 2005, BRIT J DERMATOL, V153, P451, DOI 10.1111/j.1365-2133.2005.06731.x
   Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115
   Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757
   JEZEK Z, 1986, J INFECT DIS, V154, P551, DOI 10.1093/infdis/154.4.551
   Lederman ER, 2007, PEDIATR INFECT DIS J, V26, P740, DOI 10.1097/INF.0b013e31806211bf
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104
   Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   de Oliveira TML, 2010, FOODBORNE PATHOG DIS, V7, P1491, DOI 10.1089/fpd.2010.0597
   MacNeil A, 2009, AM J TROP MED HYG, V80, P503, DOI 10.4269/ajtmh.2009.80.503
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Moss B., 2007, VIROLOGY, V2905-2946
   Moss B, 2011, IMMUNOL REV, V239, P8, DOI 10.1111/j.1600-065X.2010.00975.x
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Moussatche N, 2008, J INFECT DEV COUNTR, V2, P156, DOI 10.3855/jidc.258
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Paran N, 2009, HUM VACCINES, V5, P824, DOI 10.4161/hv.10295
   Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299
   Reynolds MG, 2007, EMERG INFECT DIS, V13, P1332, DOI 10.3201/eid1309.070175
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   Reynolds MG, 2010, AM J TROP MED HYG, V82, P746, DOI 10.4269/ajtmh.2010.09-0716
   SAMBYAL DS, 1983, INDIAN VET J, V60, P327
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039
   SILVA P L D, 1986, Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, V38, P323
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   UEDA Y, 1995, VIROLOGY, V210, P67, DOI 10.1006/viro.1995.1317
   Venkatesan G, 2010, VET ITAL, V46, P439
   Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74
   Wellenberg GJ, 2002, VET MICROBIOL, V88, P27, DOI 10.1016/S0378-1135(02)00098-6
NR 61
TC 9
Z9 9
U1 0
U2 1
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JUN
PY 2011
VL 6
IS 6
BP 697
EP 707
DI 10.2217/FVL.11.46
PG 11
WC Virology
SC Virology
GA 788DI
UT WOS:000292425200008
DA 2020-11-30
ER

PT J
AU Pereira, ACP
   Soares, JAP
   Leite, FGG
   da Cruz, AF
   Torres, AA
   Kroon, EG
   Ferreira, PCP
   Bonjardim, CA
AF Pereira, Anna C. P.
   Soares, Jamaria A. P.
   Leite, Flavia G. G.
   da Cruz, Andre F.
   Torres, Alice A.
   Kroon, Erna G.
   Ferreira, Paulo C. P.
   Bonjardim, Claudio A.
TI SP600125 Inhibits Orthopoxviruses Replication on a JNK1/2-Independent
   Manner - Implication as a Potential Anti-Poxviral
SO ANTIVIRAL RESEARCH
LA English
DT Meeting Abstract
CT 24th International Conference on Antiviral Research (ICAR)
CY MAY 08-11, 2011
CL Sofia, BULGARIA
SP Int Soc Antiviral Res
C1 [da Cruz, Andre F.; Torres, Alice A.; Kroon, Erna G.; Ferreira, Paulo C. P.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Grp Transducao Sinal, Virus Lab, Belo Horizonte, MG, Brazil.
   [Pereira, Anna C. P.] Univ Fed Piaui, Parnaiba, Brazil.
   [Soares, Jamaria A. P.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.
   [Leite, Flavia G. G.] Inst Sci & Technol, Viena, Austria.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
J9 ANTIVIR RES
JI Antiviral Res.
PD MAY
PY 2011
VL 90
IS 2
MA 68
BP A38
EP A39
DI 10.1016/j.antiviral.2011.03.054
PG 2
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA 771TB
UT WOS:000291182500053
DA 2020-11-30
ER

PT J
AU Mota, BEF
   Gallardo-Romero, N
   Trindade, G
   Keckler, MS
   Karem, K
   Carroll, D
   Campos, MA
   Vieira, LQ
   da Fonseca, FG
   Ferreira, PCP
   Bonjardim, CA
   Damon, IK
   Kroon, EG
AF Mota, Bruno E. F.
   Gallardo-Romero, Nadia
   Trindade, Giliane
   Keckler, M. Shannon
   Karem, Kevin
   Carroll, Darin
   Campos, Marco A.
   Vieira, Leda Q.
   da Fonseca, Flavio G.
   Ferreira, Paulo C. P.
   Bonjardim, Claudio A.
   Damon, Inger K.
   Kroon, Erna G.
TI Adverse Events Post Smallpox-Vaccination: Insights from Tail
   Scarification Infection in Mice with Vaccinia virus
SO PLOS ONE
LA English
DT Article
ID CELL-DEFICIENT MICE; IMMUNE-RESPONSE; POXVIRUS INFECTION; PROGRESSIVE
   VACCINIA; ANTIBODY; REPLICATION; INHIBITION; PROTECTION; CLEARANCE;
   MONKEYPOX
AB Adverse events upon smallpox vaccination with fully-replicative strains of Vaccinia virus (VACV) comprise an array of clinical manifestations that occur primarily in immunocompromised patients leading to significant host morbidity/mortality. The expansion of immune-suppressed populations and the possible release of Variola virus as a bioterrorist act have given rise to concerns over vaccination complications should more widespread vaccination be reinitiated. Our goal was to evaluate the components of the host immune system that are sufficient to prevent morbidity/mortality in a murine model of tail scarification, which mimics immunological and clinical features of smallpox vaccination in humans. Infection of C57BL/6 wild-type mice led to a strictly localized infection, with complete viral clearance by day 28 p.i. On the other hand, infection of T and B-cell deficient mice (Rag1(-/-)) produced a severe disease, with uncontrolled viral replication at the inoculation site and dissemination to internal organs. Infection of B-cell deficient animals (mu MT) produced no mortality. However, viral clearance in mMT animals was delayed compared to WT animals, with detectable viral titers in tail and internal organs late in infection. Treatment of Rag1(-/-) with rabbit hyperimmune anti-vaccinia serum had a subtle effect on the morbidity/mortality of this strain, but it was effective in reduce viral titers in ovaries. Finally, NUDE athymic mice showed a similar outcome of infection as Rag1(-/-), and passive transfer of WT T cells to Rag1(-/-) animals proved fully effective in preventing morbidity/mortality. These results strongly suggest that both T and B cells are important in the immune response to primary VACV infection in mice, and that T-cells are required to control the infection at the inoculation site and providing help for B-cells to produce antibodies, which help to prevent viral dissemination. These insights might prove helpful to better identify individuals with higher risk of complications after infection with poxvirus.
C1 [Mota, Bruno E. F.; Trindade, Giliane; Ferreira, Paulo C. P.; Bonjardim, Claudio A.; Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
   [Gallardo-Romero, Nadia; Keckler, M. Shannon; Karem, Kevin; Carroll, Darin; Damon, Inger K.] Ctr Dis Control & Prevent, Poxvirus Program, Atlanta, GA USA.
   [Campos, Marco A.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Vieira, Leda Q.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   [da Fonseca, Flavio G.] Univ Fed Minas Gerais, Dept Microbiol, Lab Virol Comparada, Belo Horizonte, MG, Brazil.
RP Mota, BEF (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Keckler, M. Shannon/S-8970-2019; Bonjardim, Claudio A/J-2601-2014;
   Kroon, Erna Geessien/B-3631-2015; Campos, Marco A/C-4000-2013; Kroon,
   Erna/V-5444-2019; Vieira, Leda Quercia/AAD-3424-2019; Vieira, Leda
   Q/G-7487-2014; Keckler, M. Shannon/C-3864-2009
OI Kroon, Erna Geessien/0000-0003-2721-3826; Campos, Marco
   A/0000-0003-4683-0176; Vieira, Leda Quercia/0000-0001-5481-9618; Mota,
   Bruno/0000-0003-0348-4875; Keckler, M. Shannon/0000-0002-2275-4730
FU Brazilian Ministry of Agriculture, Livestock and Supply (MAPA);
   Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq); Brazilian Coordination for Improvement of Graduated Personnel;
   Foundation for Research Development of Minas Gerais; Oak Ridge Institute
   for Science and Education; CDCCentre National de la Recherche
   Scientifique (CNRS)United States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA
FX This work was supported by funds from the Brazilian Ministry of
   Agriculture, Livestock and Supply (MAPA), Brazilian National Council for
   Scientific and Technological Development (CNPq-http://www.cnpq.br),
   Brazilian Coordination for Improvement of Graduated Personnel
   (CAPES-http://www.capes.gov.br), Foundation for Research Development of
   Minas Gerais (FAPEMIG-http://www.fapemig.br), the Oak Ridge Institute
   for Science and Education (ORISE-http://www.orise.orau.gov) and CDC
   intramural funds. GT, MAC, LQV, FGF, PCPF, CAB and EGK are CNPq fellows.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100
   Bray M, 2003, CLIN INFECT DIS, V36, P766, DOI 10.1086/374244
   Brundler MA, 1996, EUR J IMMUNOL, V26, P2257, DOI 10.1002/eji.1830260943
   Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06
   Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261
   Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0
   Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Freyschmidt EJ, 2007, J ALLERGY CLIN IMMUN, V119, P671, DOI 10.1016/j.jaci.2006.12.645
   Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825
   Gherardi MM, 2003, J GEN VIROL, V84, P1961, DOI 10.1099/vir.0.19120-0
   HARRIS N, 1995, J VIROL, V69, P910, DOI 10.1128/JVI.69.2.910-915.1995
   Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006
   KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156
   Kawakami Y, 2009, J EXP MED, V206, P1219, DOI 10.1084/jem.20082835
   Kohno K, 1998, CLIN IMMUNOL IMMUNOP, V86, P11, DOI 10.1006/clin.1997.4475
   Kohyama S, 2007, J IMMUNOL, V179, P3917, DOI 10.4049/jimmunol.179.6.3917
   Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078
   Lustig S, 2009, VACCINE, V27, P1691, DOI 10.1016/j.vaccine.2009.01.038
   MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G
   Mortimer PP, 2003, CLIN MED, V3, P255, DOI 10.7861/clinmedicine.3-3-255
   MOSS B, 2001, FUNDAMENTAL VIROLOGY
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Neyts J, 2004, ANTIMICROB AGENTS CH, V48, P2267, DOI 10.1128/AAC.48.6.2267-2273.2004
   Orr N, 2004, J INFECT DIS, V190, P1295, DOI 10.1086/423851
   Panchanathan V, 2006, J VIROL, V80, P6333, DOI 10.1128/JVI.00115-06
   PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0
   Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17
   Perera LP, 2001, P NATL ACAD SCI USA, V98, P5146, DOI 10.1073/pnas.081080298
   Puissant-Lubrano B, 2010, J CLIN INVEST, V120, P1636, DOI 10.1172/JCI38506
   Ramirez JC, 2002, J GEN VIROL, V83, P1059, DOI 10.1099/0022-1317-83-5-1059
   Rolph MS, 1996, VIROLOGY, V217, P470, DOI 10.1006/viro.1996.0141
   Saito T, 2009, JAMA-J AM MED ASSOC, V301, P1025, DOI 10.1001/jama.2009.289
   Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06
   Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018
   Sharon M, 2007, VACCINE, V25, P7743, DOI 10.1016/j.vaccine.2007.09.023
   SPRIGGS MK, 1992, P NATL ACAD SCI USA, V89, P6070, DOI 10.1073/pnas.89.13.6070
   Tian T, 2009, J INVEST DERMATOL, V129, P70, DOI 10.1038/jid.2008.191
   Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74
   Worthington M, 2003, CLIN INFECT DIS, V37, P864, DOI 10.1086/377275
   Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265
   Xu RH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000768
NR 42
TC 14
Z9 16
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 15
PY 2011
VL 6
IS 4
AR e18924
DI 10.1371/journal.pone.0018924
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 750WK
UT WOS:000289578600039
PM 21526210
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Leite, JA
   da Fonseca, FG
   Trindade, GD
   Abrahao, JS
   Arantes, RME
   de Almeida-Leite, CM
   dos Santos, JR
   Guedes, MIMC
   Ribeiro, BM
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Leite, Juliana Almeida
   da Fonseca, Flavio Guimares
   Trindade, Giliane de Souza
   Abrahao, Jonatas Santos
   Esteves Arantes, Rosa Maria
   de Almeida-Leite, Camila Megale
   dos Santos, Joao Rodrigues
   Maldonado Coelho Guedes, Maria Isabel
   Ribeiro, Bergmann Morais
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI A-type inclusion bodies: a factor influencing cowpox virus lesion
   pathogenesis
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; VACCINIA-VIRUS; MAJOR PROTEIN; BODY PROTEIN;
   GENE; POXVIRUS; ORTHOPOXVIRUSES; REPLICATION; INFECTION; ENVELOPE
AB The family Poxviridae comprises the most complex animal DNA viruses. During some poxvirus infections, A-type inclusion bodies (ATIs), codified by the ati gene, are produced. Although some studies have compared poxviruses that encode these inclusion bodies with those that do not, the biological function of ATIs is poorly understood. A recombinant ati-deleted cowpox virus was constructed and compared with the wild-type virus in in vitro experiments including electron microscopy and plaque and viral growth assays. No significant differences were observed in vitro. This reinforces the conclusion that the inclusion body is not essential for in vitro viral replication and morphogenesis. Additionally, different lesion progressions in vivo were observed by macroscopic and histological analysis, suggesting that the presence or absence of ATIs could result in different healing dynamics. This is the first time that the role of ATIs during viral replication has been studied based solely on one variable, the presence or absence of ATIs.
C1 [Leite, Juliana Almeida; da Fonseca, Flavio Guimares; Trindade, Giliane de Souza; Abrahao, Jonatas Santos; dos Santos, Joao Rodrigues; Maldonado Coelho Guedes, Maria Isabel; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Esteves Arantes, Rosa Maria; de Almeida-Leite, Camila Megale] Univ Fed Minas Gerais, Lab Neuroimuno Patol Expt, Dept Patol Geral, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Ribeiro, Bergmann Morais] Univ Brasilia, Dept Biol Celular, Inst Ciencias Biol, BR-70910900 Brasilia, DF, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM juufmg@yahoo.com.br; fdafonseca@cpqrr.fiocruz.br; giliane@icb.ufmg.br;
   jonatas.abrahao@yahoo.com.br; rosa@icb.ufmg.br; camila@icb.ufmg.br;
   santosjr@icb.ufmg.br; coel0010@umn.edu; bergmann@unb.br;
   claubonj@icb.ufmg.br; paulocpf@icb.ufmg.br; kroone@icb.ufmg.br
RI Ribeiro, Bergmann Morais/C-7114-2015; Bonjardim, Claudio A/J-2601-2014;
   Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; Abrahao,
   Jonatas/B-3895-2015; Arantes, Rosa ME/C-5749-2013
OI Ribeiro, Bergmann Morais/0000-0002-1061-196X; Kroon, Erna
   Geessien/0000-0003-2721-3826; Abrahao, Jonatas/0000-0001-9420-1791;
   Arantes, Rosa ME/0000-0003-1428-9717
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX We gratefully thank Angela S. Lopes, Ilda M. V. Gamma, and colleagues
   from the Virus Laboratory. Financial support for this work was provided
   by grants from the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG). FGF, GST, RMEA, CAB, PCPF and EGK are CNPq fellows.
CR AMEGADZIE BY, 1992, VIROLOGY, V186, P777, DOI 10.1016/0042-6822(92)90046-R
   Butler-Cole C, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-76
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Da Fonseca F, 2003, P NATL ACAD SCI USA, V100, P11291, DOI 10.1073/pnas.1534874100
   da Fonseca FG, 2000, J VIROL, V74, P7508, DOI 10.1128/JVI.74.16.7508-7517.2000
   da Fonseca FG, 2000, J VIROL, V74, P7518, DOI 10.1128/JVI.74.16.7518-7528.2000
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   DAMON IK, 2007, FIELDS VIROLOGY, P2947
   Dvoracek B, 2003, PLASMID, V49, P9, DOI 10.1016/S0147-619X(02)00154-3
   EARL P, 1998, CURRENT PROTOCOLS MO
   ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4
   Fenner Frank, 2002, P359
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   FUNAHASHI S, 1988, J GEN VIROL, V69, P35, DOI 10.1099/0022-1317-69-1-35
   Howard AR, 2010, J VIROL, V84, P7592, DOI 10.1128/JVI.00704-10
   Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926
   ICHIHASHI Y, 1966, VIROLOGY, V29, P264, DOI 10.1016/0042-6822(66)90033-X
   ICHIHASHI Y, 1971, VIROLOGY, V46, P507, DOI 10.1016/0042-6822(71)90056-0
   ICHIHASHI Y, 1973, VIROLOGY, V51, P297, DOI 10.1016/0042-6822(73)90430-3
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   KNIGHT JC, 1992, VIROLOGY, V190, P423, DOI 10.1016/0042-6822(92)91228-M
   Kochneva G, 2005, ARCH VIROL, V150, P1857, DOI 10.1007/s00705-005-0530-0
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   Martin KH, 1999, VIRUS RES, V60, P147, DOI 10.1016/S0168-1702(99)00013-1
   McKelvey TA, 2002, J VIROL, V76, P11216, DOI 10.1128/JVI.76.22.11216-11225.2002
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   MEYER H, 1993, J GEN VIROL, V74, P1679, DOI 10.1099/0022-1317-74-8-1679
   MEYER H, 1994, J GEN VIROL, V75, P1975, DOI 10.1099/0022-1317-75-8-1975
   Moss B, 2001, SEMIN IMMUNOL, V13, P59, DOI 10.1006/smim.2000.0296
   Moss B, 2007, FIELDS VIROLOGY, P2906
   Okeke MI, 2009, VIRUS GENES, V39, P200, DOI 10.1007/s11262-009-0376-8
   OSTERRIEDER N, 1994, VIRUS GENES, V8, P125, DOI 10.1007/BF01703611
   PATEL DD, 1986, VIROLOGY, V149, P174, DOI 10.1016/0042-6822(86)90119-4
   Perdiguero B, 2008, J VIROL, V82, P2150, DOI 10.1128/JVI.01969-07
   Pfeffer M, 2007, POXVIRUSES, P355
   PICKUP DJ, 1986, P NATL ACAD SCI USA, V83, P7698, DOI 10.1073/pnas.83.20.7698
   SADASIV EC, 1985, AM J VET RES, V46, P529
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977
   Tscharke DC, 1999, J GEN VIROL, V80, P2751, DOI 10.1099/0022-1317-80-10-2751
   Ulaeto D, 1996, J VIROL, V70, P3372, DOI 10.1128/JVI.70.6.3372-3377.1996
   Whitton J. L., 2001, FIELDS VIROLOGY, P285
   Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009
NR 49
TC 5
Z9 5
U1 0
U2 5
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
J9 ARCH VIROL
JI Arch. Virol.
PD APR
PY 2011
VL 156
IS 4
BP 617
EP 628
DI 10.1007/s00705-010-0900-0
PG 12
WC Virology
SC Virology
GA 742PI
UT WOS:000288956300008
PM 21212997
DA 2020-11-30
ER

PT J
AU Vilela, MC
   Campos, RDD
   Mansur, DS
   Rodrigues, DH
   Lacerda-Queiroz, N
   Lima, GK
   Rachid, MA
   Kroon, EG
   Campos, MA
   Teixeira, AL
AF Vilela, Marcia Carvalho
   de Lima Campos, Roberta Dayrell
   Mansur, Daniel Santos
   Rodrigues, David Henrique
   Lacerda-Queiroz, Norinne
   Lima, Graciela Kunrath
   Rachid, Milene Alvarenga
   Kroon, Erna Geessien
   Campos, Marco Antonio
   Teixeira, Antonio Lucio
TI Role of IL-4 in an experimental model of encephalitis induced by
   intracranial inoculation of herpes simplex virus-1 (HSV-1)
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE herpes simplex virus type 1; IL-4; neuroinflammation
ID OVERCOMES GENETIC-RESISTANCE; CENTRAL-NERVOUS-SYSTEM; LEUKOCYTE
   RECRUITMENT; ENDOTHELIAL-CELLS; MESSENGER-RNA; P-SELECTIN; T-CELLS;
   EXPRESSION; INTERLEUKIN-4; MECHANISMS
AB Herpes simplex virus-1 (HSV-1) is a pathogen that may cause severe encephalitis in humans. In this study, we aimed to investigate the role of interleukin-4 (IL-4) in a model of HSV-1 brain infection. IL-4 knockout (IL-4(-/-)) and wild type (WT) C57BL/6 mice were inoculated with 104 plaque-forming units of HSV-1 by the intracranial route. Histopathologic analysis revealed a distinct profile of infiltrating cells at 3 days post-infection (dpi). Infected WT mice presented mononuclear inflammatory cells while IL-4(-/-) mice developed meningoencephalitis with predominance of neutrophils. IL-4(-/-) mice had diminished leukocyte adhesion at 3 dpi when compared to infected WT animals in intravital microscopy study. Conversely no differences were found in cerebral levels of CXCL1, CXCL9, CCL3, CCL5 and TNF-alpha between WT and IL-4(-/-) infected mice. IL-4 may play a role in the recruitment of cells into central nervous system in this acute model of severe encephalitis caused by HSV-1.
C1 [Vilela, Marcia Carvalho; de Lima Campos, Roberta Dayrell; Mansur, Daniel Santos; Rodrigues, David Henrique; Lacerda-Queiroz, Norinne; Rachid, Milene Alvarenga; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Lab Imunofarmacol, Dept Bioquim & Imunol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Lima, Graciela Kunrath; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
   [Campos, Marco Antonio] Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190 Belo Horizonte, MG, Brazil.
RP Teixeira, AL (corresponding author), Univ Fed Minas Gerais, Lab Imunofarmacol, Dept Bioquim & Imunol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM altexr@gmail.com
RI Dayrell, Roberta LC/L-7063-2016; Kroon, Erna/V-5444-2019; Teixeira,
   Antonio L/N-3315-2014; Mansur, Daniel/AAQ-8062-2020; Campos, Marco
   A/C-4000-2013; Kroon, Erna Geessien/B-3631-2015; Rachid, Milene
   Alvarenga/C-3530-2017
OI Dayrell, Roberta LC/0000-0002-4770-9100; Teixeira, Antonio
   L/0000-0002-9621-5422; Mansur, Daniel/0000-0001-6773-9334; Campos, Marco
   A/0000-0003-4683-0176; Kroon, Erna Geessien/0000-0003-2721-3826; Rachid,
   Milene Alvarenga/0000-0002-3142-6552
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (Fapemig), BrazilMinas Gerais State Research Foundation (FAPEMIG)
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (Fapemig), Brazil
CR CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Domingues RB, 2009, BRAZ J INFECT DIS, V13, P433, DOI 10.1590/S1413-86702009000600009
   Ghiasi H, 1999, J INFECT DIS, V179, P1086, DOI 10.1086/314736
   Ghiasi H, 2001, J VIROL, V75, P9029, DOI 10.1128/JVI.75.19.9029-9036.2001
   Huang H, 2007, AM J PHYSIOL-LUNG C, V292, pL1147, DOI 10.1152/ajplung.00294.2006
   Inomata M, 2009, MOL IMMUNOL, V46, P2080, DOI 10.1016/j.molimm.2009.02.015
   Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000
   Kerr PJ, 2004, VIROLOGY, V324, P117, DOI 10.1016/j.virol.2004.02.031
   Kubes P, 2000, BRAIN PATHOL, V10, P127
   Lacerda-Queiroz N, 2010, EXP PARASITOL, V125, P271, DOI 10.1016/j.exppara.2010.02.002
   Lampinen M, 2004, ALLERGY, V59, P793, DOI 10.1111/j.1398-9995.2004.00469.x
   Lee YW, 2004, MOL MED, V10, P19, DOI 10.2119/2004-00024.Lee
   Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1
   Liu T, 1996, J VIROL, V70, P264, DOI 10.1128/JVI.70.1.264-271.1996
   MASINOVSKY B, 1990, J IMMUNOL, V145, P2886
   McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321
   Nogueira ML, 2001, J CLIN PATHOL, V54, P103, DOI 10.1136/jcp.54.2.103
   PAUL WE, 1991, BLOOD, V77, P1859
   Rodrigues DH, 2010, J NEUROIMMUNOL, V222, P90, DOI 10.1016/j.jneuroim.2010.02.016
   SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086
   SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223
   THORNHILL MH, 1991, J IMMUNOL, V146, P592
   Vilela MC, 2008, NEUROSCI LETT, V445, P18, DOI 10.1016/j.neulet.2008.08.072
   Vilela MC, 2010, NEUROSCI LETT, V479, P58, DOI 10.1016/j.neulet.2010.05.028
   Vilela MC, 2009, ANN NY ACAD SCI, V1153, P256, DOI 10.1111/j.1749-6632.2008.03959.x
   Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9
   Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81
NR 29
TC 5
Z9 5
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD APR
PY 2011
VL 69
IS 2A
BP 237
EP 241
DI 10.1590/S0004-282X2011000200019
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 757XV
UT WOS:000290122900019
PM 21537568
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Amaral, DCG
   Rachid, MA
   Vilela, MC
   Campos, RDL
   Ferreira, GP
   Rodrigues, DH
   Lacerda-Queiroz, N
   Miranda, AS
   Costa, VV
   Campos, MA
   Kroon, EG
   Teixeira, MM
   Teixeira, AL
AF Amaral, Debora C. G.
   Rachid, Milene A.
   Vilela, Marcia C.
   Campos, Roberta D. L.
   Ferreira, Gustavo P.
   Rodrigues, David H.
   Lacerda-Queiroz, Norinne
   Miranda, Aline S.
   Costa, Vivian V.
   Campos, Marco A.
   Kroon, Erna G.
   Teixeira, Mauro M.
   Teixeira, Antonio L.
TI Intracerebral infection with dengue-3 virus induces meningoencephalitis
   and behavioral changes that precede lethality in mice
SO JOURNAL OF NEUROINFLAMMATION
LA English
DT Article
ID CELL-ADHESION MOLECULES; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA;
   MURINE MODEL; ENCEPHALITIS; CHEMOKINE; PATHOGENESIS; LYMPHOCYTES;
   NEUTROPHILS; LEUKOCYTES
AB Background: Dengue, one of the most important arboviral diseases of humans, may cause severe systemic disease. Although dengue virus (DENV) has been considered to be a non-neurotropic virus, dengue infection has been associated recently with a series of neurological syndromes, including encephalitis. In this work, we evaluated behavioral changes and inflammatory parameters in C57BL/6 mice infected with non-adapted dengue virus 3 (DENV-3) genotype I.
   Methods: C57BL/6 mice received 4 x 10(3) PFU of DENV-3 by an intracranial route. We evaluated the trafficking of leukocytes in brain microvasculature using intravital microscopy, and evaluated chemokine and cytokine profiling by an ELISA test at 3 and 6 days post infection (p.i.). Furthermore, we determined myeloperoxidase activity and immune cell populations, and also performed histopathological analysis and immunostaining for the virus in brain tissue.
   Results: All animals developed signs of encephalitis and died by day 8 p.i. Motor behavior and muscle tone and strength parameters declined at day 7 p.i. We observed increased leukocyte rolling and adhesion in brain microvasculature of infected mice at days 3 and 6 p.i. The infection was followed by significant increases in IFN-gamma, TNF-alpha, CCL2, CCL5, CXCL1, and CXCL2. Histological analysis showed evidence of meningoencephalitis and reactive gliosis. Increased numbers of neutrophils, CD4(+) and CD8(+) T cells were detected in brain of infected animals, notably at day 6 p.i. Cells immunoreactive for anti-NS-3 were visualized throughout the brain.
   Conclusion: Intracerebral infection with non-adapted DENV-3 induces encephalitis and behavioral changes that precede lethality in mice.
C1 [Amaral, Debora C. G.; Rachid, Milene A.; Vilela, Marcia C.; Campos, Roberta D. L.; Rodrigues, David H.; Lacerda-Queiroz, Norinne; Miranda, Aline S.; Costa, Vivian V.; Teixeira, Mauro M.; Teixeira, Antonio L.] Univ Fed Minas Gerais, ICB, Lab Imunofarmacol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   [Ferreira, Gustavo P.; Kroon, Erna G.] Univ Fed Minas Gerais, ICB, Virus Lab, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Campos, Marco A.] Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190 Belo Horizonte, MG, Brazil.
RP Teixeira, AL (corresponding author), Univ Fed Minas Gerais, ICB, Lab Imunofarmacol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
EM altexr@gmail.com
RI Costa, Vivian VVC/I-2499-2018; Kroon, Erna/V-5444-2019; Rachid, Milene
   Alvarenga/C-3530-2017; Teixeira, Antonio L/N-3315-2014; Kroon, Erna
   Geessien/B-3631-2015; Dayrell, Roberta LC/L-7063-2016; Campos, Marco
   A/C-4000-2013
OI Costa, Vivian VVC/0000-0002-0175-642X; Rachid, Milene
   Alvarenga/0000-0002-3142-6552; Teixeira, Antonio L/0000-0002-9621-5422;
   Kroon, Erna Geessien/0000-0003-2721-3826; Dayrell, Roberta
   LC/0000-0002-4770-9100; Campos, Marco A/0000-0003-4683-0176
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); "INCT
   em Dengue", Brazil
FX This work was supported by CNPq, FAPEMIG, and "INCT em Dengue", Brazil.
CR Azeredo EL, 2006, MEM I OSWALDO CRUZ, V101, P437, DOI 10.1590/S0074-02762006000400016
   Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Deb C, 2009, J NEUROIMMUNOL, V214, P33, DOI 10.1016/j.jneuroim.2009.06.013
   Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   Ferreira GP, 2010, MICROBES INFECT, V12, P546, DOI 10.1016/j.micinf.2010.03.007
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   Gerber J, 2004, NEUROBIOL DIS, V16, P133, DOI 10.1016/j.nbd.2004.01.013
   Getts DR, 2007, J NEUROCHEM, V103, P1019, DOI 10.1111/j.1471-4159.2007.04798.x
   Gil L, 2009, VIRAL IMMUNOL, V22, P23, DOI 10.1089/vim.2008.0063
   Guabiraba R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015680
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Jan JT, 2000, J VIROL, V74, P8680, DOI 10.1128/JVI.74.18.8680-8691.2000
   Konsman JP, 2007, CLIN SCI, V112, P1, DOI 10.1042/CS20060043
   Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Malavige G N, 2007, Indian J Med Microbiol, V25, P143
   McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005
   McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130
   Rodriguez M, 2009, BRAIN PATHOL, V19, P12, DOI 10.1111/j.1750-3639.2008.00151.x
   Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551
   SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0
   Sellner J, 2006, BRAIN RES, V1125, P155, DOI 10.1016/j.brainres.2006.09.093
   Sergerie Y, 2007, J INFECT DIS, V195, P817, DOI 10.1086/511987
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106
   Vilela MC, 2008, NEUROSCI LETT, V445, P18, DOI 10.1016/j.neulet.2008.08.072
   Vilela MC, 2010, NEUROSCI LETT, V479, P58, DOI 10.1016/j.neulet.2010.05.028
   Vilela MC, 2009, ANN NY ACAD SCI, V1153, P256, DOI 10.1111/j.1749-6632.2008.03959.x
   *WHO, 2009, IMP DENG
   Wong D, 2007, J NEUROIMMUNOL, V184, P136, DOI 10.1016/j.jneuroim.2006.12.003
   Yauch LE, 2008, ANTIVIR RES, V80, P87, DOI 10.1016/j.antiviral.2008.06.010
   Zhou JH, 2003, J IMMUNOL, V170, P3331, DOI 10.4049/jimmunol.170.6.3331
NR 42
TC 38
Z9 38
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-2094
J9 J NEUROINFLAMM
JI J. Neuroinflamm.
PD MAR 9
PY 2011
VL 8
AR 23
DI 10.1186/1742-2094-8-23
PG 12
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA 738BX
UT WOS:000288615400001
PM 21388530
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Campos, RK
   Brum, MCS
   Nogueira, CEW
   Drumond, BP
   Alves, PA
   Siqueira-Lima, L
   Assis, FL
   Trindade, GS
   Bonjardim, CA
   Ferreira, PC
   Weiblen, R
   Flores, EF
   Kroon, EG
   Abrahao, JS
AF Campos, Rafael K.
   Brum, Mario C. S.
   Nogueira, Carlos E. W.
   Drumond, Betania P.
   Alves, Pedro A.
   Siqueira-Lima, Larissa
   Assis, Felipe L.
   Trindade, Giliane S.
   Bonjardim, Claudio A.
   Ferreira, Paulo C.
   Weiblen, Rudi
   Flores, Eduardo F.
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI Assessing the variability of Brazilian Vaccinia virus isolates from a
   horse exanthematic lesion: coinfection with distinct viruses
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID VESICULAR STOMATITIS-VIRUS; SMALLPOX VACCINE; BOVINE VACCINIA;
   LYMPHOID-TISSUE; STRAINS; ORTHOPOXVIRUS; OUTBREAK; POXVIRUS; GENOME
AB During the last bovine vaccinia (BV) outbreaks, several Vaccinia virus (VACV) strains were isolated and characterised, revealing significant polymorphisms between strains, even within conserved genes. Although the epidemiology of VACV has been studied in BV outbreaks, there is little data about the circulation of the Brazilian VACV isolates. This study describes the genetic and biological characterisation of two VACV isolates, Pelotas 1 virus (P1V) and Pelotas 2 virus (P2V), which were obtained concomitantly from a horse affected by severe cutaneous disease. Despite being isolated from the same exanthematic clinical sample, P1V and P2V showed differences in their plaque phenotype and in one-step growth curves. Moreover, P1V and P2V presented distinct virulence profiles in a BALB/c mouse model, as observed with other Brazilian VACV isolates. Sequencing and phylogenetic analysis of four different genes demonstrated that the isolates are segregated in different VACV clusters. Our results raise interesting questions about the diversity of VACV isolates in Brazil.
C1 [Campos, Rafael K.; Drumond, Betania P.; Alves, Pedro A.; Siqueira-Lima, Larissa; Assis, Felipe L.; Trindade, Giliane S.; Bonjardim, Claudio A.; Ferreira, Paulo C.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Brum, Mario C. S.; Weiblen, Rudi; Flores, Eduardo F.] Univ Fed Santa Maria, Dept Vet Prevent Med, BR-97105900 Santa Maria, RS, Brazil.
   [Nogueira, Carlos E. W.] Univ Fed Pelotas, Dept Clin Vet, BR-96010610 Pelotas, RS, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Alves, Pedro/T-7203-2019; flores, eduardo furtado/H-5125-2016; Kroon,
   Erna/V-5444-2019; Weiblen, Rudi/H-7003-2014; Kroon, Erna
   Geessien/B-3631-2015; Abrahao, Jonatas/B-3895-2015; Campos, Rafael
   Kroon/AAB-5135-2020; Bonjardim, Claudio A/J-2601-2014; Brum, Mario Celso
   Sperotto/M-8557-2017
OI Alves, Pedro/0000-0002-9659-5621; Weiblen, Rudi/0000-0002-1737-9817;
   Kroon, Erna Geessien/0000-0003-2721-3826; Abrahao,
   Jonatas/0000-0001-9420-1791; Campos, Rafael Kroon/0000-0002-4852-0449;
   Brum, Mario Celso Sperotto/0000-0002-1643-1126
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and the Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA). The study sponsors had no
   involvement in the study design, the collection, analysis and
   interpretation of data, the writing of the manuscript, or the decision
   to submit the manuscript for publication.
CR Abrahao JS, 2010, J CLIN VIROL, V48, P69, DOI 10.1016/j.jcv.2010.02.001
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   Carrillo FYE, 2008, INFECT GENET EVOL, V8, P614, DOI 10.1016/j.meegid.2008.04.008
   Carrillo FYE, 2007, INFECT GENET EVOL, V7, P69, DOI 10.1016/j.meegid.2006.04.004
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DAMON I, 2007, FIELDS VIROLOGY, P2079
   Dasgupta A, 2007, J IMMUNOL, V178, P1654, DOI 10.4049/jimmunol.178.3.1654
   Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Fenner F., 1989, ORTHOPOXVIRUSES
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   KATZ E, 1973, J GEN VIROL, V21, P469, DOI 10.1099/0022-1317-21-3-469
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lisco A, 2007, J VIROL, V81, P708, DOI 10.1128/JVI.01367-06
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   MARQUES JT, 2006, AM J TROP MED HYG, V75, P486
   Osborne JD, 2007, VACCINE, V25, P8807, DOI 10.1016/j.vaccine.2007.10.040
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   SAMBROOK J, 1989, MOL CLONING LAB MANU, V3, pA1
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Stapleton JT, 2009, AIDS, V23, P605, DOI 10.1097/QAD.0b013e32831f1b00
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06
   Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364
   Zhang WH, 2000, J VIROL, V74, P11654, DOI 10.1128/JVI.74.24.11654-11662.2000
NR 32
TC 35
Z9 36
U1 0
U2 4
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD FEB
PY 2011
VL 156
IS 2
BP 275
EP 283
DI 10.1007/s00705-010-0857-z
PG 9
WC Virology
SC Virology
GA 714SE
UT WOS:000286828500009
PM 21080203
DA 2020-11-30
ER

PT J
AU Silva, ML
   Martins, MA
   Espirito-Santo, LR
   Campi-Azevedo, AC
   Silveira-Lemos, D
   Ribeiro, JGL
   Homma, A
   Kroon, EG
   Teixeira-Carvalho, A
   Eloi-Santos, SM
   Martins, OA
AF Silva, Maria Luiza
   Martins, Marina Angela
   Espirito-Santo, Lucandra Ramos
   Campi-Azevedo, Ana Carolina
   Silveira-Lemos, Denise
   Leite Ribeiro, Jose Geraldo
   Homma, Akira
   Kroon, Erna Geessien
   Teixeira-Carvalho, Andrea
   Eloi-Santos, Silvana Maria
   Martins-Filho, Olinda Assis
TI Characterization of main cytokine sources from the innate and adaptive
   immune responses following primary 17DD yellow fever vaccination in
   adults
SO VACCINE
LA English
DT Article
DE 17DD vaccine; Yellow fever; Cytokines; Innate and adaptive immunity
ID SIMULTANEOUS RAISE; B-CELLS; INTERLEUKIN-10; ACTIVATION; VIRUS;
   DIFFERENTIATION; IMMUNIZATION; INTERFERON; ANTIBODIES; PROFILE
AB The mechanisms of immune response following yellow fever (YF-17DD) vaccination are still poorly understood. In this study, we have performed a longitudinal investigation (days 0, 7, 15 and 30) to characterize the cytokine profile of innate and adaptive immunity following YF-17DD first-time vaccination. Data from non-stimulated cultures demonstrated a prominent participation of the innate immunity with increased frequency of TNF-alpha(+) neutrophils and IFN-gamma(+) NK-cells at day 7 besides TNF-alpha(+) monocytes at day 7, day 15 and day 30. Increased frequency of IL-10(+). monocytes was observed at day 15 and day 30, and decreased percentage of IL-4(+). NK-cells were detected at day 7, day 15 and day 30. Time-dependent and oscillating cytokine pattern was observed in CD4(+) T-cells, with low percentage of IL-12(+), IL-4(+) and IL-10(+) cells at day 7 and increased frequency of TNF-alpha(+) cells at day 15 besides and IFN-gamma(+) IL-5(+) cells at day 15 and day 30. Later changes with increased percentage of IL-12(+) and IL-5(+) CD8(+) T-cells were observed at day 30. Increased frequency of IL-10(+) B-cells was observed at day 15, when seroconversion was detected in all vaccinees. The overall cytokine analysis of non-stimulated leukocytes showed a transient shift towards a pro-inflammatory profile at day 7, mainly due to changes in the innate immunity, which draws back toward a mixed/regulatory pattern at day 15 and day 30. The changes induced by the in vitro YF-17DD vaccine-stimulation were mainly observed at day 0 and day 7 (before seroconversion) with minor changes at clay 15 and day 30 (after seroconversion). These data support the hypothesis that a complex network with mixed pro/anti-inflammatory cytokine profile is associated with the establishment of the protective immunity following YF-17DD primo-vaccination, free of adverse events. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Silva, Maria Luiza; Martins, Marina Angela; Espirito-Santo, Lucandra Ramos; Campi-Azevedo, Ana Carolina; Silveira-Lemos, Denise; Teixeira-Carvalho, Andrea; Eloi-Santos, Silvana Maria; Martins-Filho, Olinda Assis] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, BR-30190002 Belo Horizonte, MG, Brazil.
   [Silva, Maria Luiza] Univ Fed Minas Gerais, Fac Med, Curso Patol, Ctr Posgrad, Belo Horizonte, MG, Brazil.
   [Eloi-Santos, Silvana Maria] Univ Fed Minas Gerais, Fac Med, Dept Propedeut Complementar, Belo Horizonte, MG, Brazil.
   [Martins, Marina Angela] Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   [Espirito-Santo, Lucandra Ramos] Univ Estadual Montes Claros, Montes Claros, MG, Brazil.
   [Leite Ribeiro, Jose Geraldo] Secretaria Estadual Saude Estado Minas Gerais, Belo Horizonte, MG, Brazil.
   [Homma, Akira] Fundacao Oswaldo Cruz, Inst Biomanguinhos, BR-30190002 Belo Horizonte, MG, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, ICB, Dept Microbiol, Belo Horizonte, MG, Brazil.
RP Martins, OA (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Ave Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM oamfilho@cpqrr.fiocruz.br
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Silveira Lemos,
   Denise/0000-0003-0955-458X; Martins-Filho, Olindo
   Assis/0000-0002-5494-4889; Campi-Azevedo, Ana
   Carolina/0000-0001-6306-3605
FU Centro de Pesquisas Rene Rachou - FIOCRUZ-MG; Instituto Bio-manguinhos
   FIOCRUZ-RJ; carta compromisso [05/05 05/08]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [422782/09];
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG) [APQ 01183-08,
   PDJ 00265/09]
FX This work was supported by Centro de Pesquisas Rene Rachou - FIOCRUZ-MG
   and Instituto Bio-manguinhos FIOCRUZ-RJ by the grant # carta compromisso
   05/05 05/08, CNPq (Grant #422782/09) and FAPEMIG (APQ 01183-08). The
   authors thank the program for technological development in tools for
   health - PDTIS - FIOCRUZ for the use of its facilities. EGK, ATC and
   OAMF thank CNPq for fellowships (PQ). ACCA acknowledge the FAPEMIG for
   the fellowship (PDJ 00265/09).
CR Ahmad SM, 2008, J NUTR, V138, P2276, DOI 10.3945/jn.108.092056
   Bae HG, 2008, J INFECT DIS, V197, P1577, DOI 10.1086/587844
   Barrett ADT, 1997, BIOLOGICALS, V25, P17, DOI 10.1006/biol.1997.0056
   BONNEVIENIELSEN V, 1995, CLIN DIAGN LAB IMMUN, V2, P302, DOI 10.1128/CDLI.2.3.302-306.1995
   Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255
   COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x
   Neves PCD, 2009, VACCINE, V27, P5543, DOI 10.1016/j.vaccine.2009.07.028
   DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671
   FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   GROOT H, 1962, B WORLD HEALTH ORGAN, V27, P699
   Gubler DJ, 1996, T ROY SOC TROP MED H, V90, P449, DOI 10.1016/S0035-9203(96)90286-2
   Hacker UT, 1998, J INFECT DIS, V177, P774, DOI 10.1086/517806
   Herbein G, 2000, P SOC EXP BIOL MED, V223, P241, DOI 10.1046/j.1525-1373.2000.22335.x
   KISHIMOTO T, 1988, ANNU REV IMMUNOL, V6, P485, DOI 10.1146/annurev.iy.06.040188.002413
   LEVY Y, 1994, J CLIN INVEST, V93, P424, DOI 10.1172/JCI116977
   MALEFYT RD, 1991, J EXP MED, V174, P1209
   Martins MA, 2007, CLIN EXP IMMUNOL, V148, P90, DOI 10.1111/j.1365-2249.2006.03317.x
   Martins MA, 2008, VACCINE, V26, P1173, DOI 10.1016/j.vaccine.2007.12.035
   Monath T. P, 2004, VACCINES, P1095
   Monath TP, 2008, VACCINES, P959
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Mori A, 1997, J ALLERGY CLIN IMMUN, V100, pS56, DOI 10.1016/S0091-6749(97)70006-X
   Munno I, 1998, HEADACHE, V38, P465, DOI 10.1046/j.1526-4610.1998.3806465.x
   Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Pugachev KV, 2005, CURR OPIN INFECT DIS, V18, P387, DOI 10.1097/01.qco.0000178823.28585.ad
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   RASMUSSEN R, 1988, J IMMUNOL, V140, P705
   Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B
   ROUSSET F, 1995, INT IMMUNOL, V7, P1243, DOI 10.1093/intimm/7.8.1243
   ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890
   Santos AP, 2008, CYTOKINE, V42, P152, DOI 10.1016/j.cyto.2008.02.007
   Silva ML, 2010, CLIN VACCINE IMMUNOL, V17, P118, DOI 10.1128/CVI.00369-09
   SILVEIRALEMOS D, 2008, CURR TRENDS IMMUNOL, V9, P1
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474
   Vasconcelos P. F, 2003, REV SOC BRAS MED TRO, V36, P275, DOI DOI 10.1590/S0037-86822003000200012
   Vitelli-Avelar DM, 2008, SCAND J IMMUNOL, V68, P516, DOI 10.1111/j.1365-3083.2008.02167.x
   Wehinger J, 1996, FEBS LETT, V394, P365, DOI 10.1016/0014-5793(96)00990-8
   WHEELOCK EF, 1965, NEW ENGL J MED, V273, P194, DOI 10.1056/NEJM196507222730404
   World Health Organization, 2003, Wkly Epidemiol Rec, V78, P349
NR 42
TC 35
Z9 35
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JAN 10
PY 2011
VL 29
IS 3
BP 583
EP 592
DI 10.1016/j.vaccine.2010.08.046
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 715AQ
UT WOS:000286853200029
PM 20732465
DA 2020-11-30
ER

PT J
AU Pessanha, JEM
   Caiaffa, WT
   Cecilio, AB
   Iani, FCD
   Araujo, SC
   Nascimento, JC
   Kroon, EG
   Proietti, FA
   Arias, JR
AF Marques Pessanha, Jose Eduardo
   Caiaffa, Waleska Teixeira
   Cecilio, Alzira Batista
   de Melo Iani, Felipe Campos
   Araujo, Simone Costa
   Nascimento, Jose Carlos
   Kroon, Erna Geessien
   Proietti, Fernando Augusto
   Arias, Jorge Rodriguez
TI Cocirculation of two dengue virus serotypes in individual and pooled
   samples of Aedes aegypti and Aedes albopictus larvae
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Dengue; Virus; Serotypes; Vectors
ID BELO-HORIZONTE; BRAZIL
AB Introduction: To detect dengue virus, eggs of Aedes sp were collected in the city of Belo Horizonte, Brazil, in 2007. Methods: Egg samples were subsequently hatched and the larvae were tested for the presence of dengue virus RNA by RT-PCR. Results: Among the Aedes aegypti larvae samples, 163 (37.4%) out of 435 were positive, including 32 (10.9%) of 293 individual larvae samples concomitantly positive for two serotypes. Conclusions: Virological surveillance detecting coinfected vectors in the field could represent an important strategy for understanding the numerous factors involved in the transmission and clinical presentation of dengue.
C1 [Marques Pessanha, Jose Eduardo; Araujo, Simone Costa; Nascimento, Jose Carlos] Municipal Hlth Secretariat Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Marques Pessanha, Jose Eduardo; Caiaffa, Waleska Teixeira; Proietti, Fernando Augusto] Univ Fed Minas Gerais, Urban Hlth Observ, Belo Horizonte, MG, Brazil.
   [Caiaffa, Waleska Teixeira] Univ Fed Minas Gerais, Dept Social & Prevent Med, Res Grp Epidemiol, Belo Horizonte, MG, Brazil.
   [Cecilio, Alzira Batista; de Melo Iani, Felipe Campos] Fundacao Ezequiel Dias, Dept Res & Dev, Mol Virol & Bioprod Lab, Belo Horizonte, MG, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Biol Sci, Virus Lab, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Arias, Jorge Rodriguez] Dept Hlth, Dis Carrying Insects Program, Fairfax, VA USA.
RP Pessanha, JEM (corresponding author), BH, SMS, Av Afonso Pena 2336 4 Andar, BR-30130007 Belo Horizonte, MG, Brazil.
EM edumpessanha@hotmail.com
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
FU Pan-American Health Organization; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX This study was partially funded by the Pan-American Health Organization
   and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq). The authors EGK, FAP and WTC are recipients of research
   fellowships from the CNPq.
CR BIGGERSTAFF BJ, 2006, POOLEDINFRATE VERSIO
   BOOM S, 1990, J CLIN MICROBIOL, V28, P495
   CECLIO AB, 2004, VRUS REV RES, V9, P57
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Correa PRL, 2005, REV SAUDE PUBL, V39, P33, DOI 10.1590/S0034-89102005000100005
   Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   GOMES AC, 1998, MEDIDAS NVEIS INFEST, P49
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   HULL B, 1984, AM J TROP MED HYG, V33, P1248, DOI 10.4269/ajtmh.1984.33.1248
   Cunha MDM, 2008, EPIDEMIOL SERV SAUDE, V17, P217
   Almeida MCD, 2008, CAD SAUDE PUBLICA, V24, P2385, DOI 10.1590/S0102-311X2008001000019
   Rocco Iray Maria, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P151, DOI 10.1590/S0036-46651998000300004
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   *SECR VIG SAUD, 2006, SAUD BRAS 2005 UM AN
NR 15
TC 7
Z9 7
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2011
VL 44
IS 1
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 723VT
UT WOS:000287536100023
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU de Oliveira, TML
   Rehfeld, IS
   Siqueira, JMF
   Abrahao, JS
   Campos, RK
   dos Santos, AKR
   Cerqueira, MMOP
   Kroon, EG
   Lobato, ZIP
AF Ludoulfo de Oliveira, Tercia M.
   Rehfeld, Izabelle S.
   Ferreira Siqueira, Jaqueline Maria
   Abrahao, Jonatas S.
   Campos, Rafael K.
   dos Santos, Andreia Kelly R.
   Cerqueira, Monica Maria O. P.
   Kroon, Erna G.
   Lobato, Zelia I. P.
TI Vaccinia Virus Is Not Inactivated After Thermal Treatment and Cheese
   Production Using Experimentally Contaminated Milk
SO FOODBORNE PATHOGENS AND DISEASE
LA English
DT Article
ID BULK TANK MILK; FOODBORNE PATHOGENS; PREVALENCE; ENVIRONMENT; STABILITY;
   OUTBREAK; STRAINS; HUMANS; CATTLE; FOOD
AB Bovine vaccinia is an emergent zoonosis caused by the Vaccinia virus (VACV). The disease is characterized by the appearance of exanthematic lesions that occur in humans and dairy cows. Previous studies have revealed the presence of infectious viral particles in milk samples during an outbreak of bovine vaccinia in Brazil, indicating the possibility of disease transmission through raw milk. To assess the viability of the virus in milk after thermal treatment and processing procedures, milk samples were experimentally contaminated with 10(3) plaque forming units (PFU)/mL (group I) and 10(5) PFU/mL (group II) VACV Guarani P2 virus, and the third group was not contaminated and served as a control. The samples were submitted to storage temperatures in a cold chamber, freezer for 48 hours, and to low temperature long-time treatment. Moreover, the viral viability was evaluated in cheese produced with contaminated milk using 10(4) PFU/mL VACV Guarani P2. Notably, the virus remained viable in milk after storage for 48 hours in both the cold chamber and the freezer, with a reduction in viral titer of 14.49% and 25.86%, respectively. Group II showed a viral reduction in titer of 61.88% and 75.98%, respectively. Thermal treatment 65 degrees C for 30 minutes showed a reduction of viral titer of 94.83% and 99.99%, respectively, in group I and group II, but still showed remaining viable virus particles. In addition, it was possible to recover infectious viral particles from both the solid curds and the whey of the cheese produced with experimentally contaminated milk. The cheese shows a reduction in viral titer of 84.87% after storage at 4 degrees C for 24 hours. The presence of viable viral particles in milk after both thermal treatment and cheese production indicates a potential public health risk.
C1 [Ludoulfo de Oliveira, Tercia M.; Rehfeld, Izabelle S.; Lobato, Zelia I. P.] Univ Fed Minas Gerais, Lab Pesquisa Virol Anim, Dept Vet Prevent Med, Escola Vet, BR-30123970 Belo Horizonte, MG, Brazil.
   [Ferreira Siqueira, Jaqueline Maria; Abrahao, Jonatas S.; Campos, Rafael K.; Kroon, Erna G.] Univ Fed Minas Gerais, Virus Lab, Inst Ciencias Biol, BR-30123970 Belo Horizonte, MG, Brazil.
   [dos Santos, Andreia Kelly R.; Cerqueira, Monica Maria O. P.] Univ Fed Minas Gerais, Lab Microbiol Leite, Dept Tecnol & Inspecao Prod Origem Anim, Escola Vet, BR-30123970 Belo Horizonte, MG, Brazil.
RP Lobato, ZIP (corresponding author), Univ Fed Minas Gerais, Lab Pesquisa Virol Anim, Dept Vet Prevent Med, Escola Vet, Av Antonio Carlos 6627, BR-30123970 Belo Horizonte, MG, Brazil.
EM ziplobato@gmail.com
RI Kroon, Erna Geessien/B-3631-2015; Abrahao, Jonatas/B-3895-2015; Campos,
   Rafael Kroon/AAB-5135-2020; Kroon, Erna/V-5444-2019; brasileira, Inct
   Pecuaria/J-9542-2013
OI Kroon, Erna Geessien/0000-0003-2721-3826; Abrahao,
   Jonatas/0000-0001-9420-1791; Campos, Rafael Kroon/0000-0002-4852-0449;
   Lobato, Zelia/0000-0002-9399-3691
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX We thank Grazielle Gallinari, Fabia Campos, and colleagues from
   Laboratorio de Virus (ICB-UFMG/Escola de Veterinaria) for their
   excellent technical support. Financial support was provided by the CNPq,
   CAPES, and FAPEMIG. E.G. Kroon and Z.I.P. Lobato receive fellowships
   from CNPq.
CR Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-47
   Berkelman RL, 2003, CLIN INFECT DIS, V37, P407, DOI 10.1086/375595
   BHATT PN, 1987, LAB ANIM SCI, V37, P33
   Bona C, 2005, J DAIRY SCI, V88, P3079, DOI 10.3168/jds.S0022-0302(05)72989-1
   *BRAZ MIN AGR PEC, 2002, DIARIO OFICIAL  0920, P13
   *BRAZ MIN AGR PEC, 1952, REG INSP IND SAN PRO
   Callis J. J., 1975, Bulletin de l'Office International des Epizooties, V83, P183
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   HUQ F, 1976, B WORLD HEALTH ORGAN, V54, P710
   Jayarao BM, 2001, J DAIRY SCI, V84, P2157, DOI 10.3168/jds.S0022-0302(01)74661-9
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   LeJeune JT, 2009, CLIN INFECT DIS, V48, P93, DOI 10.1086/595007
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Machado E. C., 2004, Ciencia e Tecnologia de Alimentos, V24, P516, DOI 10.1590/S0101-20612004000400006
   MADUREIRA M, 2009, THESIS U FEDERAL MIN
   Malik YS, 2006, AM J INFECT CONTROL, V34, P31, DOI 10.1016/j.ajic.2005.05.012
   Murinda SE, 2002, J FOOD PROTECT, V65, P752, DOI 10.4315/0362-028X-65.5.752
   Oliver SP, 2005, FOODBORNE PATHOG DIS, V2, P115, DOI 10.1089/fpd.2005.2.115
   SAMPAIO I.B.M., 2007, ESTATISTICA APLICADA
   Sauerbrei A, 2009, ARCH VIROL, V154, P115, DOI 10.1007/s00705-008-0264-x
   Silva IMM, 2003, INT J FOOD MICROBIOL, V81, P241, DOI 10.1016/S0168-1605(02)00223-4
   Tomasula PM, 2004, J DAIRY SCI, V87, P1115, DOI 10.3168/jds.S0022-0302(04)73258-0
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Van Kessel JS, 2004, J DAIRY SCI, V87, P2822, DOI 10.3168/jds.S0022-0302(04)73410-4
NR 30
TC 13
Z9 13
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1535-3141
EI 1556-7125
J9 FOODBORNE PATHOG DIS
JI Foodborne Pathog. Dis.
PD DEC
PY 2010
VL 7
IS 12
BP 1491
EP 1496
DI 10.1089/fpd.2010.0597
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA 688GH
UT WOS:000284837300007
PM 20707725
DA 2020-11-30
ER

PT J
AU Lima, GK
   Zolini, GP
   Mansur, DS
   Lima, BHF
   Wischhoff, U
   Astigarraga, RG
   Dias, MF
   Silva, MDA
   Bela, SR
   Antonelli, LRD
   Arantes, RM
   Gazzinelli, RT
   Bafica, A
   Kroon, EG
   Campos, MA
AF Lima, Graciela Kunrath
   Zolini, Guilherme Pimenta
   Mansur, Daniel Santos
   Freire Lima, Braulio Henrique
   Wischhoff, Uschi
   Astigarraga, Ruiz Gerhardt
   Dias, Marcela Franca
   Almeida Silva, Mariana das Graces
   Bela, Samantha Ribeiro
   do Valle Antonelli, Lis Ribeiro
   Arantes, Rosa Maria
   Gazzinelli, Ricardo Tostes
   Bafica, Andre
   Kroon, Erna Geessien
   Campos, Marco Antonio
TI Toll-Like Receptor (TLR) 2 and TLR9 Expressed in Trigeminal Ganglia are
   Critical to Viral Control During Herpes Simplex Virus 1 Infection
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID INNATE RECOGNITION; IMMUNE-RESPONSE; TYPE-1; MICE; ENCEPHALITIS;
   INTERFERON; CYTOKINE; RESISTANCE; CELLS; INFLAMMATION
AB Herpes simplex virus 1 (HSV-1) is a neurotropic DNA virus that is responsible for several clinical manifestations in humans, including encephalitis. HSV-1 triggers toll-like receptors (TLRs), which elicit cytokine production. Viral multiplication and cytokine expression in C57BL/6 wild-type (WT) mice infected with HSV-1 were evaluated. Virus was found in the trigeminal ganglia (TG), but not in the brains of animals without signs of encephalitis, between 2 and 6 days postinfection (d.p.i.). Cytokine expression in the TG peaked at 5 d.p.i. TLR9(-/-) and TLR2/9(-/-) mice were more susceptible to the virus, with 60% and 100% mortality, respectively, as opposed to 10% in the WT and TLR2(-/-) mice. Increased levels of both CXCL10/IP-10 and CCL2/MCP-1, as well as reduced levels of interferon-gamma and interleukin 1-beta transcripts, measured in both the TG and brains at 5 d.p.i., and the presence of virus in the brain were correlated with total mortality in TLR2/9(-/-) mice. Cytokine alterations in TLR2/9(-/-) mice coincided with histopathological changes in their brains, which did not occur in WT and TLR2(-/-) mice and occurred only slightly in TLR9(-/-) mouse brain. Increased cellularity, macrophages, CD8 T cells producing interferon-gamma, and expression levels of TLR2 and TLR9 were detected in the TG of WT-infected mice. We hypothesize that HSV-1 infection is controlled by TLR-dependent immune response; in the TG, which prevent HSV-1 encephalitis. (Am J Pathol 2010, 177:2433-2445; DOI: 10.2353/ajpath.2010.100121)
C1 [Zolini, Guilherme Pimenta; Freire Lima, Braulio Henrique; Wischhoff, Uschi; Astigarraga, Ruiz Gerhardt; Dias, Marcela Franca; Almeida Silva, Mariana das Graces; Bela, Samantha Ribeiro; do Valle Antonelli, Lis Ribeiro; Gazzinelli, Ricardo Tostes; Campos, Marco Antonio] Fiocruz MS, Ctr Pesquisas Rene Rachou, Imunopathol Lab, BR-30190002 Belo Horizonte, MG, Brazil.
   [Lima, Graciela Kunrath; Mansur, Daniel Santos; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Arantes, Rosa Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil.
   [Gazzinelli, Ricardo Tostes] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   [Gazzinelli, Ricardo Tostes] Univ Massachusetts, Sch Med, Worcester, MA USA.
   [Bafica, Andre] Univ Fed Santa Catarina, Dept Microbiol & Parasitol, Lab Imunol & Doencas Infecciosas, Florianopolis, SC, Brazil.
RP Campos, MA (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Imunopathol Lab, Av Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM marcoasc@cpqrr.fiocruz.br
RI Antonelli, Guido/K-7915-2016; Kroon, Erna Geessien/B-3631-2015;
   Antonelli, Lis/G-2907-2012; Arantes, Rosa ME/C-5749-2013; Kroon,
   Erna/V-5444-2019; Campos, Marco A/C-4000-2013; Antonelli,
   Lis/R-4910-2019; Bela, Samantha Ribeiro/O-5616-2016; Wischhoff,
   Uschi/H-4888-2015; Mansur, Daniel/AAQ-8062-2020
OI Kroon, Erna Geessien/0000-0003-2721-3826; Arantes, Rosa
   ME/0000-0003-1428-9717; Campos, Marco A/0000-0003-4683-0176; Antonelli,
   Lis/0000-0002-4969-8812; Wischhoff, Uschi/0000-0002-7593-5068; Mansur,
   Daniel/0000-0001-6773-9334; Gazzinelli, Ricardo/0000-0003-2427-7699
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Brazil)Minas
   Gerais State Research Foundation (FAPEMIG); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (Brazil)National Council for
   Scientific and Technological Development (CNPq); Instituto Nacional de
   Ciencia e Tecnologia de Vacinas/Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (INCTV/CNPq; Brazil)National Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)CAPES;
   Programa Estrategico de Pesquisa ern Saude IV (PAPES) IV/FIOCRUZ/CNPq
   (Brazil)National Council for Scientific and Technological Development
   (CNPq); CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX Supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (Brazil), the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (Brazil), Instituto Nacional de Ciencia e Tecnologia de
   Vacinas/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (INCTV/CNPq; Brazil), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES, Brazil), and the Programa Estrategico de Pesquisa ern
   Saude IV (PAPES) IV/FIOCRUZ/CNPq (Brazil). E.G.K.. MAC., R.T.G., A.B.,
   L.R.A., and R.M.A. have fellowships from CNPq.
CR Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560
   Boivin G, 2002, EUR J NEUROSCI, V16, P29, DOI 10.1046/j.1460-9568.2002.02057.x
   Broberg EK, 2003, J VIROL METHODS, V112, P53, DOI 10.1016/S0166-0934(03)00191-5
   Campos MA, 2004, INFECT IMMUN, V72, P176, DOI 10.1128/IAI.72.1.176-186.2004
   Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Carr DJJ, 2006, VIRAL IMMUNOL, V19, P741, DOI 10.1089/vim.2006.19.741
   Carr DJJ, 2003, J VIROL, V77, P10037, DOI 10.1128/JVI.77.18.10037-10046.2003
   Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346
   Cowan FM, 2003, SEX TRANSM INFECT, V79, P286, DOI 10.1136/sti.79.4.286
   Ellermann-Eriksen S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-59
   Fatahzadeh M, 2007, J AM ACAD DERMATOL, V57, P737, DOI 10.1016/j.jaad.2007.06.027
   Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836
   Garner JA, 2003, ADV DRUG DELIVER REV, V55, P1497, DOI 10.1016/j.addr.2003.07.006
   Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261
   Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106
   He JC, 1999, J INTERF CYTOK RES, V19, P609, DOI 10.1089/107999099313749
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101
   Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003
   KERN ER, 1982, ENVIRON HEALTH PERSP, V43, P71, DOI 10.2307/3429170
   Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674
   Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364
   Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100
   Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200
   Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541
   LOPEZ C, 1975, NATURE, V258, P152, DOI 10.1038/258152a0
   Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08
   Mansur DS, 2005, AM J PATHOL, V166, P1419, DOI 10.1016/S0002-9440(10)62359-0
   Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009
   Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001
   McKimmie CS, 2009, BLOOD, V113, P4224, DOI 10.1182/blood-2008-08-174698
   Nogueira ML, 2001, J CLIN PATHOL, V54, P103, DOI 10.1136/jcp.54.2.103
   Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005
   Rasmussen SB, 2009, APMIS, V117, P323, DOI 10.1111/j.1600-0463.2009.02456.x
   Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0
   ROIZMAN B, 2007, FIELDS VIROLOGY, P2501, DOI DOI 10.1148/RADIOL.14144045
   Sainz B, 2002, J VIROL, V76, P11541, DOI 10.1128/JVI.76.22.11541-11550.2002
   Sancho-Shimizu V, 2007, CURR OPIN ALLERGY CL, V7, P495, DOI 10.1097/ACI.0b013e3282f151d2
   Sarangi PP, 2007, J VIROL, V81, P11128, DOI 10.1128/JVI.01008-07
   Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103
   SCHMIDT NJ, 1979, DIAGNOSTIC PROCEDURE, P100
   Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094
   Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604
   Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308
   Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3
   Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4
   Vaknin I, 2008, BLOOD, V111, P1437, DOI 10.1182/blood-2007-07-100404
   Vollstedt S, 2004, J VIROL, V78, P3846, DOI 10.1128/JVI.78.8.3846-3850.2004
   Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002
   Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006
   Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522
NR 56
TC 54
Z9 56
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD NOV
PY 2010
VL 177
IS 5
BP 2433
EP 2445
DI 10.2353/ajpath.2010.100121
PG 13
WC Pathology
SC Pathology
GA 679TE
UT WOS:000284182900030
PM 20864677
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Assis, MTA
   Pinto, CA
   Magalhaes, CLB
   Santos, JR
   Bonjardim, CA
   Kroon, EG
   Ferreira, PCP
AF Assis, Marieta T. A.
   Pinto, Carla A.
   Magalhaes, Cintia L. B.
   Santos, Joao R.
   Bonjardim, Claudio A.
   Kroon, Erna G.
   Ferreira, Paulo C. P.
TI Antiviral activity of Type I and Type III interferons against Oriboca
   virus (Orhtounyaviridae)
SO CYTOKINE
LA English
DT Meeting Abstract
CT 8th Joint Conference of the
   International-Cytokine-Society/International-Society-for-and-Cytokine-Re
   search
CY OCT 03-07, 2010
CL Chicago, IL
SP Int Cytokine Soc, Int Soc Interferon & Cytokine Res
C1 [Assis, Marieta T. A.; Pinto, Carla A.; Magalhaes, Cintia L. B.; Santos, Joao R.; Bonjardim, Claudio A.; Kroon, Erna G.; Ferreira, Paulo C. P.] Univ Fed Minas Gerais, ICB, Virus Lab, Dept Microbioloya, Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
J9 CYTOKINE
JI Cytokine
PD OCT-NOV
PY 2010
VL 52
IS 1-2
SI SI
BP 64
EP 64
DI 10.1016/j.cyto.2010.07.270
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 657NC
UT WOS:000282418400246
DA 2020-11-30
ER

PT J
AU Pinto, CA
   Magalhaes, CLB
   Assis, MTA
   Cascao, LG
   Santos, JR
   Bonjardim, CA
   Kroon, EG
   Trindade, GS
   Ferreira, PCP
AF Pinto, Carla A.
   Magalhaes, Cintia L. B.
   Assis, Marieta T. A.
   Cascao, Luma G.
   Santos, Joao R.
   Bonjardim, Claudio A.
   Kroon, Erna G.
   Trindade, Giliane S.
   Ferreira, Paulo C. P.
TI Interferon-stimulated genes (ISGs) and expression in A549 cells after
   Caraparu virus infection (Bunyaviridae)
SO CYTOKINE
LA English
DT Meeting Abstract
CT 8th Joint Conference of the
   International-Cytokine-Society/International-Society-for-and-Cytokine-Re
   search
CY OCT 03-07, 2010
CL Chicago, IL
SP Int Cytokine Soc, Int Soc Interferon & Cytokine Res
C1 [Pinto, Carla A.; Magalhaes, Cintia L. B.; Assis, Marieta T. A.; Cascao, Luma G.; Santos, Joao R.; Bonjardim, Claudio A.; Kroon, Erna G.; Trindade, Giliane S.; Ferreira, Paulo C. P.] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, ICB, Belo Horizonte, MG, Brazil.
RI Bonjardim, Claudio A/J-2601-2014; Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
J9 CYTOKINE
JI Cytokine
PD OCT-NOV
PY 2010
VL 52
IS 1-2
SI SI
BP 64
EP 64
DI 10.1016/j.cyto.2010.07.271
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 657NC
UT WOS:000282418400247
DA 2020-11-30
ER

PT J
AU Brandao, GC
   Kroon, EG
   dos Santos, JR
   Stehmann, JR
   Lombardi, JA
   de Oliveira, AB
AF Brandao, G. C.
   Kroon, E. G.
   dos Santos, J. R.
   Stehmann, J. R.
   Lombardi, J. A.
   de Oliveira, A. Braga
TI Antiviral activity of Bignoniaceae species occurring in the State of
   Minas Gerais (Brazil): part 1
SO LETTERS IN APPLIED MICROBIOLOGY
LA English
DT Article
DE antiviral activity; Bignoniaceae; EMCV; HSV-1; in vitro assays; plant
   extracts; VACV
ID ENCEPHALOMYOCARDITIS VIRUS-INFECTION; NATURAL-PRODUCTS; AGENTS; ASSAY
AB Aims:
   To evaluate the antiviral activity of Bignoniaceae species occurring in the state of Minas Gerais, Brazil.
   Methods and Results:
   Ethanol extracts of different anatomical parts of bignoniaceous plant species have been evaluated in vitro against human herpesvirus type 1 (HSV-1), vaccinia virus (VACV) and murine encephalomyocarditis virus (EMCV) by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. A total of 34 extracts from 18 plant species selected according to ethnopharmacological and taxonomic criteria were screened. Fifteen of the 34 extracts (44 center dot 1%) have disclosed antiviral activity against one or more of the viruses assayed with EC50 values in the range of 23 center dot 2 +/- 2 center dot 5-422 center dot 7 +/- 10 center dot 9 mu g ml-1.
   Conclusions:
   Twelve of the 34 extracts (35 center dot 3%) might be considered promising sources of antiviral natural products, as they have shown EC50 < 100 mu g ml-1. The present screening discloses the high potential of the Bignoniaceae family as source of antiviral agents.
   Significance and Impact of the Study:
   Active extracts were identified and deserve bioguided studies for the isolation of antiviral compounds and studies on mechanism of action.
C1 [Brandao, G. C.; de Oliveira, A. Braga] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Lab Fitoquim, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kroon, E. G.; dos Santos, J. R.] Univ Fed Minas Gerais, Dept Microbiol ICB, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Stehmann, J. R.] Univ Fed Minas Gerais, Dept Bot ICB, Lab Taxon Vegetal, BR-31270901 Belo Horizonte, MG, Brazil.
   [Lombardi, J. A.] Univ Estadual Paulista, Inst Biociencias Rio Claro, Dept Bot, Rio Claro, SP, Brazil.
RP de Oliveira, AB (corresponding author), Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Lab Fitoquim, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM alaide.braga@pq.cnpq.br
RI Kroon, Erna Geessien/B-3631-2015; Stehmann, Joao R/C-2611-2009;
   Lombardi, Julio/E-7722-2012; Herbario Virtual, Inct/J-8725-2013; Kroon,
   Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Stehmann, Joao
   R/0000-0002-9504-5441; Brandao, Geraldo Celio/0000-0002-7330-051X
FU CNPq (Brazil)National Council for Scientific and Technological
   Development (CNPq); FAPEMIG (Brazil)Minas Gerais State Research
   Foundation (FAPEMIG)
FX To CNPq (Brazil) for financial support and research fellowships (A.B.O.
   and E. G. K.) and to FAPEMIG (Brazil) for a Doctorate fellowship (G. C.
   B.).
CR Alcerito T, 2002, BIOCHEM SYST ECOL, V30, P677, DOI 10.1016/S0305-1978(01)00149-1
   Bastos MLA, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-16
   Betancur-Galvis LA, 1999, MEM I OSWALDO CRUZ, V94, P531, DOI 10.1590/S0074-02761999000400019
   Castellanos JRG, 2009, J ETHNOPHARMACOL, V121, P1, DOI 10.1016/j.jep.2008.10.004
   CHATTOPADHYAY D, 2008, ANN REV, V14, P297
   Chattopadhyay D, 2007, MINI-REV MED CHEM, V7, P275, DOI 10.2174/138955707780059844
   Cipriani F.A., 2007, REV BRAS BIOL, V5, P612
   Cos P, 2006, J ETHNOPHARMACOL, V106, P290, DOI 10.1016/j.jep.2006.04.003
   De Clercq E, 2001, REV MED VIROL, V11, P381, DOI 10.1002/rmv.336
   De Clercq E, 2001, CLIN MICROBIOL REV, V14, P382, DOI 10.1128/CMR.14.2.382-397.2001
   de Oliveira A. B., 1990, QUIM NOVA, V13, P302
   GENTRY AH, 1992, ANN MO BOT GARD, V79, P53, DOI 10.2307/2399809
   Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x
   LAGROTA MHD, 1983, REV MICROBIOL, V14, P21
   Mujtaba MG, 2006, CLIN VACCINE IMMUNOL, V13, P944, DOI 10.1128/CVI.00021-06
   Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v
   Oberste MS, 2009, EMERG INFECT DIS, V15, P640, DOI 10.3201/eid1504.081428
   Perez Sacau Elisa, 2003, Bioorganic & Medicinal Chemistry, V11, P483
   Plochmann K, 2007, ARCH BIOCHEM BIOPHYS, V460, P1, DOI 10.1016/j.abb.2007.02.003
   RAO MM, 1982, J NAT PROD, V45, P600, DOI 10.1021/np50023a014
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Simoes CMO, 1999, PHYTOMEDICINE, V6, P205, DOI 10.1016/S0944-7113(99)80010-5
   TAKEUCHI H, 1991, J VIROL METHODS, V33, P61, DOI 10.1016/0166-0934(91)90008-N
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Verpoorte R, 1998, DRUG DISCOV TODAY, V3, P232, DOI 10.1016/S1359-6446(97)01167-7
   VLIETINCK AJ, 1995, J ETHNOPHARMACOL, V46, P31, DOI 10.1016/0378-8741(95)01226-4
   Wagner H., 1984, PLANT DRUG ANAL, P320, DOI [10.1007/978-3-642-00574-9, DOI 10.1007/978-3-662-02398-3]
NR 29
TC 8
Z9 10
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0266-8254
EI 1472-765X
J9 LETT APPL MICROBIOL
JI Lett. Appl. Microbiol.
PD OCT
PY 2010
VL 51
IS 4
BP 469
EP 476
DI 10.1111/j.1472-765X.2010.02924.x
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 650DL
UT WOS:000281829100017
PM 20840554
OA Bronze
DA 2020-11-30
ER

PT J
AU Brandao, GC
   Kroon, EG
   Duarte, MGR
   Braga, FC
   de Souza, JD
   de Oliveira, AB
AF Brandao, Geraldo Celio
   Kroon, Erna Gessien
   Duarte, Maria Gorette R.
   Braga, Fernao Castro
   de Souza Filho, Jose Dias
   de Oliveira, Alaide Braga
TI Antimicrobial, antiviral and cytotoxic activity of extracts and
   constituents from Polygonum spectabile Mart.
SO PHYTOMEDICINE
LA English
DT Article
DE Polygonaceae; Polygonum spectabile; Antimicrobial; Antiviral;
   Cytotoxicity
ID CHALCONE DERIVATIVES; PLANT-EXTRACTS; BACTERIA
AB Polygonum spectabile is used in Brazil for treatment of several infection diseases. Extracts and constituents isolated from this species were evaluated for cytotoxicity and effects on 15 bacterias and yeasts as well on 4 viruses strains (HHV-1, VACV-WR, EMCV, DEN-2). Less polar extracts were effective against Staphylococcus aureus, Bacillus subtillis, Micrococcus luteus, M. canis and Tricophyton mentagrophytes and T. rubrum. Two known chalcones and 3-O-beta-D-glucosyl-beta-sitosterol were isolated. The ethanol extract was the only one to show antiviral activity (CE50 < 30 mu g/ml). One chalcone has inhibited the growth of several bacteria and was significantly active against dermathophytes. The 3 compounds isolated have shown moderate cytotoxicity against Vero and LLCMK2 cells (CC50 <50 mu g/ml). These results support the use of P. spectabile as antimicrobial agent. (C) 2010 Elsevier GmbH. All rights reserved.
C1 [Brandao, Geraldo Celio; Duarte, Maria Gorette R.; Braga, Fernao Castro; de Oliveira, Alaide Braga] Univ Fed Minas Gerais, Dept Prod Farmaceut, Fac Farm, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kroon, Erna Gessien] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Souza Filho, Jose Dias] Univ Fed Minas Gerais, Dept Quim, Inst Ciencias Exatas, BR-31270901 Belo Horizonte, MG, Brazil.
RP de Oliveira, AB (corresponding author), Univ Fed Minas Gerais, Dept Prod Farmaceut, Fac Farm, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM alaidebraga@terra.com.br
RI DE SOUZA FILHO, Jose DIAS/ABF-1983-2020; Kroon, Erna/V-5444-2019; Braga,
   Fernao/AAO-3888-2020; Braga, Fernao C/E-3236-2016; Kroon, Erna
   Geessien/B-3631-2015
OI DE SOUZA FILHO, Jose DIAS/0000-0002-3656-4882; Braga,
   Fernao/0000-0001-9468-376X; Braga, Fernao C/0000-0001-9468-376X; Kroon,
   Erna Geessien/0000-0003-2721-3826; Brandao, Geraldo
   Celio/0000-0002-7330-051X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
FX To CNPq and FAPEMIG for financial support (ABO, EGK) and PhD fellowship
   (GCB); to Dr. E. A. Nunan, Faculdade de Farmacia/UFMG for helpful
   assistance in the antimicrobial assays, and to Dr. J. F. Macedo/EPAMIG
   for collection and taxonomic identification of P. spectabile.
CR AHMED M, 1990, PHYTOCHEMISTRY, V29, P2009, DOI 10.1016/0031-9422(90)85057-M
   Betancur-Galvis LA, 1999, MEM I OSWALDO CRUZ, V94, P531, DOI 10.1590/S0074-02761999000400019
   Bhattacharjee I, 2006, MEM I OSWALDO CRUZ, V101, P645, DOI 10.1590/S0074-02762006000600011
   Chang JS, 2005, ANTIVIR RES, V66, P29, DOI 10.1016/j.antiviral.2004.12.006
   De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003
   Eloff JN, 1998, PLANTA MED, V64, P711, DOI 10.1055/s-2006-957563
   GAVIN JJ, 1957, APPL MICROBIOL, V5, P25, DOI 10.1128/AEM.5.1.25-33.1957
   Koduru S, 2006, PHARM BIOL, V44, P283, DOI 10.1080/13880200600714145
   Kott V, 1999, J ETHNOPHARMACOL, V64, P79, DOI 10.1016/S0378-8741(98)00098-1
   Lopez SN, 2001, BIOORGAN MED CHEM, V9, P1999, DOI 10.1016/S0968-0896(01)00116-X
   MARADUFU A, 1978, PHYTOCHEMISTRY, V17, P823, DOI 10.1016/S0031-9422(00)94251-1
   Mishra Nagendra Nath, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P201, DOI 10.1556/AMicr.54.2007.3.1
   PioCorrea M, 1978, DICIONARIO PLANTAS U
   RODRIGUEZ DJD, 1990, PLANTA MED, V56, P59
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   ZHENG M, 1988, Journal of Traditional Chinese Medicine, V8, P203
NR 17
TC 14
Z9 14
U1 0
U2 5
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0944-7113
J9 PHYTOMEDICINE
JI Phytomedicine
PD OCT
PY 2010
VL 17
IS 12
BP 926
EP 929
DI 10.1016/j.phymed.2010.03.004
PG 4
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 679WC
UT WOS:000284190500003
PM 20382006
DA 2020-11-30
ER

PT J
AU Brandao, GC
   Kroon, EG
   dos Santos, JR
   Stehmann, JR
   Lombardi, JA
   de Oliveira, AB
AF Brandao, Geraldo Celio
   Kroon, Erna G.
   dos Santos, Joao Rodrigues
   Stehmann, Joao Renato
   Lombardi, Julio A.
   de Oliveira, Alaide Braga
TI Antiviral activities of plants occurring in the state of Minas Gerais,
   Brazil. Part 2. Screening Bignoniaceae species
SO REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY
LA English
DT Article
DE Bignoniaceae; antiviral activity; cytotoxicity; HHV-1; VACV; EMCV
ID HERPES-SIMPLEX VIRUS; ARRABIDAEA-CHICA; NATURAL-PRODUCTS; MANGIFERIN;
   EXTRACTS; INTERFERON; INFECTION; SYNOPSIS; LEAVES; DRUGS
AB Ethanol extracts of eighteen Bignoniaceae species have been evaluated by the MTT assay for cytotoxicity in Vero cells and for antiviral activity against Human herpes virus type 1, Vaccinia virus and murine Encephalomyocarditis virus. Among such species, seven are reported to be of traditional medicinal use No cytotoxicity was observed for most of the extracts up to the concentration of 500 mu g/mL. Fourteen (50%) of the 28 extracts assayed have disclosed antiviral activity with EC50 values in the range of 4.6+0.3 to 377.2+17.7 mu g/mL. Only two species, Arrabidaea samydoides and Callichlamys latifolia, have shown activity against all the three viruses. The extracts were chemically characterized by their TLC and HPLC-DAD profiles. Mangiferin is the major constituent of A. samydoides but the isolated compound has been less active than the crude extract. This is the first report on the antiviral evaluation of the eighteen Bignoniaceae species assayed.
C1 [Brandao, Geraldo Celio; de Oliveira, Alaide Braga] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Lab Fitoquim, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kroon, Erna G.; dos Santos, Joao Rodrigues] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Stehmann, Joao Renato] Univ Fed Minas Gerais, Dept Bot, Inst Ciencias Biol, Lab Taxon Vegetal, BR-31270901 Belo Horizonte, MG, Brazil.
   [Lombardi, Julio A.] Univ Estadual Paulista, Inst Biociencias Rio Claro, Dept Bot, BR-13506900 Rio Claro, SP, Brazil.
RP Brandao, GC (corresponding author), Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Lab Fitoquim, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM alaide.braga@pq.cnpq.br
RI Herbario Virtual, Inct/J-8725-2013; Kroon, Erna/V-5444-2019; Stehmann,
   Joao R/C-2611-2009; Kroon, Erna/B-3631-2015
OI Stehmann, Joao R/0000-0002-9504-5441; Brandao, Geraldo
   Celio/0000-0002-7330-051X; Kroon, Erna/0000-0003-2721-3826
FU CNPq (Brazil)National Council for Scientific and Technological
   Development (CNPq); FAPEMIG (Brazil)Minas Gerais State Research
   Foundation (FAPEMIG)
FX To CNPq (Brazil) for financial support and research fellowships (ABO and
   EGK) and to FAPEMIG (Brazil) for a Doctorate fellowship (GCB).
CR Agra Maria de Fátima, 2007, Rev. bras. farmacogn., V17, P114, DOI 10.1590/S0102-695X2007000100021
   Betancur-Galvis LA, 2002, MEM I OSWALDO CRUZ, V97, P541, DOI 10.1590/S0074-02762002000400017
   Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m
   Castellanos JRG, 2009, J ETHNOPHARMACOL, V121, P1, DOI 10.1016/j.jep.2008.10.004
   Chattopadhyay D, 2007, MINI-REV MED CHEM, V7, P275, DOI 10.2174/138955707780059844
   CORREA MP, 1975, DICIONARIO PLANTAS U, V6, P777
   CRUZ GL, 1985, DICIONARIO PLANTAS U, P600
   De Clercq E, 2001, CLIN MICROBIOL REV, V14, P382, DOI 10.1128/CMR.14.2.382-397.2001
   de Oliveira A. B., 1990, QUIM NOVA, V13, P302
   Devia B, 2002, PHYTOCHEM ANALYSIS, V13, P114, DOI 10.1002/pca.632
   EMPERAIRE L, 1983, CAATINGA SUD EST PIA, P135
   Franco GR, 1999, PLACENTA, V20, P189, DOI 10.1053/plac.1998.0364
   GENTRY AH, 1992, ANN MO BOT GARD, V79, P53, DOI 10.2307/2399809
   Gibbons S, 2003, EXPERT OPIN THER PAT, V13, P489
   Gomez-Zaleta B, 2006, SPECTROCHIM ACTA A, V64, P1002, DOI 10.1016/j.saa.2005.09.009
   Jorge MP, 2008, J ETHNOPHARMACOL, V118, P361, DOI 10.1016/j.jep.2008.04.024
   Khan MTH, 2005, ANTIVIR RES, V67, P107, DOI 10.1016/j.antiviral.2005.05.002
   LOHMANN LG, 2007, CALLICHLAMYS LATIFOL
   LOHMANN LG, 2006, TABEBUIA IMPETIGINOS
   Mujtaba MG, 2006, CLIN VACCINE IMMUNOL, V13, P944, DOI 10.1128/CVI.00021-06
   Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v
   Oberste MS, 2009, EMERG INFECT DIS, V15, P640, DOI 10.3201/eid1504.081428
   Pauletti PM, 2003, J NAT PROD, V66, P1384, DOI 10.1021/np030100t
   Barbosa WLR, 2008, REV BRAS FARMACOGN, V18, P544, DOI 10.1590/S0102-695X2008000400008
   REID WV, 1996, MED RESOURCES TROPIC, P142
   Rios M, 2007, PLANTAS UTILES ECUAD, P652
   SCHULZ PV, 2001, RATIONAL PHYTOTHERAP, P383
   TAKEMURA OS, 1995, PHYTOCHEMISTRY, V38, P1299, DOI 10.1016/0031-9422(94)00786-S
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Wagner H, 1998, Z PHYTOTHERAPIE, V19, P226
   Warashina T, 2006, CHEM PHARM BULL, V54, P14, DOI 10.1248/cpb.54.14
   ZHENG MS, 1989, ACTA PHARM SINIC, V10, P85
   ZHU XM, 1993, ACTA PHARM SINIC, V14, P452
   Zorn B, 2001, PHYTOCHEMISTRY, V56, P831, DOI 10.1016/S0031-9422(01)00038-3
NR 35
TC 10
Z9 12
U1 0
U2 13
PU SOC BRASILEIRA FARMACOGNOSIA
PI CURITIBA-PR
PA C/O PROF CID AIMBIRE DE MORAES SANTOS, UFPR-LAB FARM, RUA PREF LOTHARIO
   MEISSNER, 632-JD BOTANICO, CURITIBA-PR, 80210-170, BRAZIL
SN 0102-695X
J9 REV BRAS FARMACOGN
JI Rev. Bras. Farmacogn.-Braz. J. Pharmacogn.
PD OCT-NOV
PY 2010
VL 20
IS 5
BP 742
EP 750
DI 10.1590/S0102-695X2010005000035
PG 9
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 691TQ
UT WOS:000285104100015
OA Other Gold, Green Published
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Drummond, BP
   Trindade, GD
   da Silva-Fernandes, AT
   Ferreira, JMS
   Alves, PA
   Campos, RK
   Siqueira, L
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Abrahao, J. S.
   Drummond, B. P.
   Trindade, de Souza G.
   da Silva-Fernandes, A. T.
   Ferreira, J. M. S.
   Alves, P. A.
   Campos, R. K.
   Siqueira, L.
   Bonjardim, C. A.
   Ferreira, P. C. P.
   Kroon, E. G.
TI Rapid detection of Orthopoxvirus by semi-nested PCR directly from
   clinical specimens: A useful alternative for routine laboratories. (vol
   82, pg 692, 2010)
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Correction
RI Bonjardim, Claudio A/J-2601-2014; Abrahao, Jonatas/B-3895-2015; Campos,
   Rafael Kroon/AAB-5135-2020; Ferreira, Jaqueline/E-4630-2018; Kroon,
   Erna/B-3631-2015
OI Abrahao, Jonatas/0000-0001-9420-1791; Campos, Rafael
   Kroon/0000-0002-4852-0449; Ferreira, Jaqueline/0000-0002-1779-1975;
   Kroon, Erna/0000-0003-2721-3826
CR Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
NR 1
TC 0
Z9 0
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0146-6615
J9 J MED VIROL
JI J. Med. Virol.
PD SEP
PY 2010
VL 82
IS 9
BP 1626
EP 1626
DI 10.1002/jmv.21885
PG 1
WC Virology
SC Virology
GA 628MS
UT WOS:000280124900021
OA Bronze
DA 2020-11-30
ER

PT J
AU Vilela, MC
   Lima, GK
   Rodrigues, DH
   Lacerda-Queiroz, N
   Mansur, DS
   de Miranda, AS
   Rachid, MA
   Kroon, EG
   Vieira, LQ
   Campos, MA
   Teixeira, MM
   Teixeira, AL
AF Vilela, Marcia Carvalho
   Lima, Graciela Kunrath
   Rodrigues, David Henrique
   Lacerda-Queiroz, Norinne
   Mansur, Daniel Santos
   de Miranda, Aline Silva
   Rachid, Milene Alvarenga
   Kroon, Erna Geessien
   Vieira, Leda Quercia
   Campos, Marco Antonio
   Teixeira, Mauro Martins
   Teixeira, Antonio Lucio
TI TNFR1 plays a critical role in the control of severe HSV-1 encephalitis
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE Herpes simplex virus type 1; TNFR1; Neuroinflammation
ID HERPES-SIMPLEX-VIRUS; TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM;
   INTRAVITAL MICROSCOPY; LEUKOCYTE RECRUITMENT; MULTIPLE-SCLEROSIS;
   RECEPTOR 1; T-CELLS; MICE; ALPHA
AB Herpes simplex virus-1 (HSV-1) is a pathogen for humans that may cause severe encephalitis. Tumor necrosis factor a (TNF-alpha) plays a role in several viral diseases of the central nervous system (CNS). The classic proinflammatory activities of TNF-alpha. are mediated mainly through activation of the receptor 1 for TNF-alpha (TNFR1). However, when HSV-1 is inoculated in the periphery, TNF-alpha seems to protect C57BI/6 mice against encephalitis by a mechanism independent of TNFR1. This study aims to investigate the role of TNFR1 in HSV-1 encephalitis induced by the inoculation of the virus into the brain. Wild-type C57BL/6 (WT) and TNFR1(-/-) were inoculated with 102 plaque-forming units of HSV-1 by the intracranial route. Infection with HSV-1 was lethal in TNFR1(-/-) mice in early times after infection. TNFR1(-/-) mice had reduced expression of the chemokines CCL3 and CCL5, and decreased leukocyte adhesion in the brain vasculature compared to WT mice 4 days post-infection (dpi). At this time point TNFR1(-/-) infected mice also had higher HSV-1 viral replication and more injuries in the brain, especially in the hippocampus. In conclusion, TNFR1 seems to play a relevant role in the control of viral replication in the CNS when HSV-1 is inoculated by intracranial route. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Dept Clin Med, Fac Med, BR-30130100 Belo Horizonte, MG, Brazil.
   [Campos, Marco Antonio] Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190 Belo Horizonte, MG, Brazil.
RP Teixeira, AL (corresponding author), Univ Fed Minas Gerais, Dept Clin Med, Fac Med, Av Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
EM marciacvilela@gmail.com; altexr@gmail.com
RI Vieira, Leda Quercia/AAD-3424-2019; Vieira, Leda Q/G-7487-2014; Kroon,
   Erna Geessien/B-3631-2015; Rachid, Milene Alvarenga/C-3530-2017;
   Teixeira, Antonio L/N-3315-2014; Mansur, Daniel/AAQ-8062-2020; Kroon,
   Erna/V-5444-2019; Campos, Marco A/C-4000-2013
OI Vieira, Leda Quercia/0000-0001-5481-9618; Kroon, Erna
   Geessien/0000-0003-2721-3826; Rachid, Milene
   Alvarenga/0000-0002-3142-6552; Teixeira, Antonio L/0000-0002-9621-5422;
   Mansur, Daniel/0000-0001-6773-9334; Campos, Marco A/0000-0003-4683-0176
FU Rede Instituto Brasileiro de Neurociencia (Rede IBN Net); CapesCAPES;
   CNPq, BrazilNational Council for Scientific and Technological
   Development (CNPq)
FX This work was supported by Rede Instituto Brasileiro de Neurociencia
   (Rede IBN Net), Capes and CNPq, Brazil. We thank Antonio Mesquita Vaz
   for excellent animal care.
CR Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873
   Bradford RD, 2009, CLIN INFECT DIS, V49, P924, DOI 10.1086/605498
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Carr DJJ, 2006, J GEN VIROL, V87, P489, DOI 10.1099/vir.0.81339-0
   Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141
   CHAN WL, 1989, J NEUROIMMUNOL, V23, P195, DOI 10.1016/0165-5728(89)90051-9
   DECLERCQ E, 1991, ANTIMICROB AGENTS CH, V35, P701, DOI 10.1128/AAC.35.4.701
   DECLERCQ E, 1976, J INFECT DIS, V133, P226
   DOMINGUES RB, 2009, MIGRANEAS CEFALEIAS, V12, P126
   dos Santos AC, 2005, J NEUROIMMUNOL, V162, P122, DOI 10.1016/j.jneuroim.2005.01.020
   Guo YJ, 2010, EUR J PHARMACOL, V635, P79, DOI 10.1016/j.ejphar.2010.02.049
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   KERN ER, 1978, ANTIMICROB AGENTS CH, V14, P817, DOI 10.1128/AAC.14.6.817
   KERN ER, 1978, ANTIMICROB AGENTS CH, V13, P53, DOI 10.1128/AAC.13.1.53
   Lokensgard JR, 2001, J NEUROVIROL, V7, P208
   Lundberg P, 2007, J VIROL, V81, P1451, DOI 10.1128/JVI.02243-06
   Mao XJ, 2010, NEUROSCI LETT, V470, P19, DOI 10.1016/j.neulet.2009.12.045
   Marques CP, 2004, GLIA, V47, P358, DOI 10.1002/glia.20045
   Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417
   Minagawa H, 2004, J GEN VIROL, V85, P343, DOI 10.1099/vir.0.19627-0
   Nogueira ML, 2001, J CLIN PATHOL, V54, P103, DOI 10.1136/jcp.54.2.103
   Okabe S, 2001, BIOL PHARM BULL, V24, P1145, DOI 10.1248/bpb.24.1145
   Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160
   Shimeld C, 1997, J GEN VIROL, V78, P3317, DOI 10.1099/0022-1317-78-12-3317
   Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150
   TAUB DD, 1995, J IMMUNOL, V155, P3877
   Vilela MC, 2008, NEUROSCI LETT, V445, P18, DOI 10.1016/j.neulet.2008.08.072
   Vilela MC, 2009, ANN NY ACAD SCI, V1153, P256, DOI 10.1111/j.1749-6632.2008.03959.x
NR 28
TC 17
Z9 17
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD JUL 19
PY 2010
VL 479
IS 1
BP 58
EP 62
DI 10.1016/j.neulet.2010.05.028
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA 627AS
UT WOS:000280010800014
PM 20478363
DA 2020-11-30
ER

PT J
AU Mota, BEF
   Trindade, GS
   Diniz, TC
   da Silva-Nunes, M
   Braga, EM
   Urbano-Ferreira, M
   Rodrigues, GOL
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Mota, B. E. F.
   Trindade, G. S.
   Diniz, T. C.
   da Silva-Nunes, M.
   Braga, E. M.
   Urbano-Ferreira, M.
   Rodrigues, G. O. L.
   Bonjardim, C. A.
   Ferreira, P. C. P.
   Kroon, E. G.
TI Seroprevalence of orthopoxvirus in an Amazonian rural village, Acre,
   Brazil
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID VACCINIA-VIRUS; INFECTION; MONKEYPOX; PREVALENCE; ANTIBODIES; ZOONOSIS;
   OUTBREAK; IMMUNITY; HUMANS; THREAT
AB Vaccinia virus strains from the family Poxviridae have been frequently isolated in Brazil and associated with outbreaks of exanthematic disease affecting cows and humans. An ELISA IgG was applied to evaluate the seroprevalence of orthopoxviruses in a community located in a rural settlement in the Amazon region, where no orthopoxvirus outbreaks have yet been reported. An overall seroprevalence of 27.89% was found, and it was 23.38% in the non-vaccinated population (smallpox vaccination). These results strongly suggest that orthopoxviruses circulate in this population, and it is the first finding of seropositivity for orthopoxviruses in a population without any previously reported outbreaks.
C1 [Mota, B. E. F.; Trindade, G. S.; Diniz, T. C.; Rodrigues, G. O. L.; Bonjardim, C. A.; Ferreira, P. C. P.; Kroon, E. G.] Univ Fed Minas Gerais, Lab Virus, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [da Silva-Nunes, M.] Univ Fed Acre, Dept Ciencias Saude Educ Fis, BR-69915900 Rio Branco, Brazil.
   [Braga, E. M.] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Urbano-Ferreira, M.] Univ Sao Paulo, Inst Ciencias Biomed, BR-05508900 Sao Paulo, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Lab Virus, Dept Microbiol, Inst Ciencias Biol, Ave Presidente Antonio Carlos 6627,Caixa Postal 4, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Braga, Erika M/A-6776-2008; da Silva-Nunes, Monica/A-1885-2008; Kroon,
   Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015; Ferreira, Marcelo U/G-8289-2011
OI Braga, Erika M/0000-0001-5550-7157; Kroon, Erna
   Geessien/0000-0003-2721-3826; Ferreira, Marcelo U/0000-0002-5293-9090;
   Mota, Bruno/0000-0003-0348-4875
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); MAPA; CAPESCAPES; FAPEMIG, BrazilMinas Gerais State Research
   Foundation (FAPEMIG)
FX The authors are grateful to Kezia K.G. Scopel, Joao R. dos Santos,
   Angela S. Lopes, Ilda M.V. Gama, Priscila A. Martins and Andreza de
   Carvalho. E. G.K, G.S. T P.C.P.F. and C.A.B. are recipients of research
   fellowships from CNPq. Financial support was provided by CNPq, MAPA,
   CAPES and FAPEMIG, Brazil.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Fujisaka S, 1996, AGR ECOSYST ENVIRON, V59, P115, DOI 10.1016/0167-8809(96)01015-8
   Hatakeyama S, 2005, CLIN DIAGN LAB IMMUN, V12, P520, DOI 10.1128/CDLI.12.4.520-524.2005
   Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005
   Lederman ER, 2007, AM J TROP MED HYG, V77, P1150, DOI 10.4269/ajtmh.2007.77.1150
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003
   Ludwig B, 2003, INTERVIROLOGY, V46, P71, DOI 10.1159/000069749
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Moss B., 2001, FIELDS VIROLOGY, P2849
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Putz MM, 2005, J GEN VIROL, V86, P2955, DOI 10.1099/vir.0.81265-0
   Schatzmayr H G, 2001, Cad Saude Publica, V17, P1525, DOI 10.1590/S0102-311X2001000600037
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74
NR 24
TC 18
Z9 18
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD JUL
PY 2010
VL 155
IS 7
BP 1139
EP 1144
DI 10.1007/s00705-010-0675-3
PG 6
WC Virology
SC Virology
GA 619TM
UT WOS:000279453200013
PM 20428903
DA 2020-11-30
ER

PT J
AU Ferreira, GP
   Figueiredo, LB
   Coelho, LFL
   Junior, PAS
   Cecilio, AB
   Ferreira, PCP
   Bonjardim, CA
   Arantes, RME
   Campos, MA
   Kroon, EG
AF Ferreira, Gustavo P.
   Figueiredo, Leandra B.
   Coelho, Luiz F. L.
   Junior, Policarpo A. S.
   Cecilio, Alzira B.
   Ferreira, Paulo C. P.
   Bonjardim, Claudio A.
   Arantes, Rosa M. E.
   Campos, Marco A.
   Kroon, Erna G.
TI Dengue virus 3 clinical isolates show different patterns of virulence in
   experimental mice infection
SO MICROBES AND INFECTION
LA English
DT Article
DE Dengue virus; Dengue fever; Dengue hemorrhagic fever
ID DENGUE HEMORRHAGIC-FEVER; MOLECULAR EVOLUTION; DISEASE SEVERITY;
   VIRUS-INFECTION; MANIFESTATIONS; IMMUNOPATHOGENESIS; ENCEPHALOPATHY;
   EPIDEMIOLOGY; ENCEPHALITIS; CHILDREN
AB Dengue virus (DENV) may cause symptomatic infection with mild, undifferentiated febrile illness called classical dengue fever (DF) or a more severe disease, potentially fatal, known as dengue hemorrhagic fever (DHF) or dengue shock syndrome. The pathogenesis of DHF is based on the virulence of the infecting DENV and depends on the infecting serotypes and genotypes; it is also based on the immunopathogenesis that is mediated by host immune responses, including dengue virus-cross-reactive antibodies that augment the severity of infections. Involvement of central nervous system (CNS) is extensively described. The present study describes the virulence of DENV-3 isolates in a mouse model by intracranial (i.c.) inoculation with genotypes I and III. Our data suggest that, in this experimental model, DENV-3 genotype I may have the propensity to cause neurological disease in mice, whereas the genotype III is associated with asymptomatic infection in mice. Additionally, the symptomatic mice show a decrease of white blood cell count, infectious DENV in the brains and alterations in levels of IFN-gamma, IL-6 and MCP-1. The results confirm the mouse model as a way to study the biology of DENV-3 isolates and to improve the knowledge about the neurovirulence of the different genotypes of DENV. (C) 2010 Published by Elsevier Masson SAS.
C1 [Ferreira, Gustavo P.; Figueiredo, Leandra B.; Ferreira, Paulo C. P.; Bonjardim, Claudio A.; Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Coelho, Luiz F. L.] Univ Fed Alfenas, Dept Ciencias Biomed, BR-37130000 Alfenas, MG, Brazil.
   [Cecilio, Alzira B.] Fundacao Ezequiel Dias, Lab Virol & Microbiol Mol, BR-30510010 Belo Horizonte, MG, Brazil.
   [Arantes, Rosa M. E.] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Neuroimunopatol Expt, BR-31270901 Belo Horizonte, MG, Brazil.
   [Junior, Policarpo A. S.; Campos, Marco A.] FIOCRUZ MG, Inst Rene Rachou, Lab Imunopatol, BR-30190002 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Arantes, Rosa
   ME/C-5749-2013; Coelho, Luiz FL/G-5853-2012; Campos, Marco
   A/C-4000-2013; Bonjardim, Claudio A/J-2601-2014
OI Kroon, Erna Geessien/0000-0003-2721-3826; Arantes, Rosa
   ME/0000-0003-1428-9717; Campos, Marco A/0000-0003-4683-0176; Coelho,
   Luiz Felipe/0000-0003-4289-384X
FU Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG, MG, Brazil)Minas
   Gerais State Research Foundation (FAPEMIG); Conselho Nacional de
   Pesquisas (CNPq, Brazil)National Council for Scientific and
   Technological Development (CNPq)
FX This work was supported by the Fundacao de Amparo a Pesquisa de Minas
   Gerais (FAPEMIG, MG, Brazil) and the Conselho Nacional de Pesquisas
   (CNPq, Brazil). CAB, EGK, MAC, PCPF and RMEA are Research Fellows from
   CNPq.
CR Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710
   Bente Dennis A, 2006, Drug Discov Today Dis Models, V3, P97, DOI 10.1016/j.ddmod.2006.03.014
   Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Cologna R, 2003, J VIROL, V77, P3929, DOI 10.1128/JVI.77.7.3929-3938.2003
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x
   Hommel D, 1998, RES VIROLOGY, V149, P235, DOI 10.1016/S0923-2516(98)80005-8
   KHO L K, 1981, Southeast Asian Journal of Tropical Medicine and Public Health, V12, P83
   Kurane I, 2007, COMP IMMUNOL MICROB, V30, P329, DOI 10.1016/j.cimid.2007.05.010
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279
   Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0
   Lee YR, 2005, INTERVIROLOGY, V48, P161, DOI 10.1159/000081744
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   MEIKLEJOHN G, 1952, AM J TROP MED HYG, V1, P51, DOI 10.4269/ajtmh.1952.1.51
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Murgue B, 2000, J MED VIROL, V60, P432, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;432::AID-JMV11&gt;3.0.CO;2-7
   NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P398
   NOGUEIRA RM, 2002, J TROP MED PUBLIC HL, V33, P68
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   PATEY O, 1993, AM J TROP MED HYG, V48, P793, DOI 10.4269/ajtmh.1993.48.793
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   Rico-Hesse R, 2007, CLIN INFECT DIS, V44, P1462, DOI 10.1086/517587
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Row D, 1996, AM J TROP MED HYG, V54, P253, DOI 10.4269/ajtmh.1996.54.253
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Strobel M, 1999, ANN MED INTERNE, V150, P79
   Thakare Jyotsna, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P471
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   *WHO, 2002, 117 WHO
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 40
TC 22
Z9 23
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD JUL
PY 2010
VL 12
IS 7
BP 546
EP 554
DI 10.1016/j.micinf.2010.03.007
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 621FS
UT WOS:000279561500006
PM 20381635
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Silva-Fernandes, AT
   Lima, LS
   Campos, RK
   Guedes, MIMC
   Cota, MMG
   Assis, FL
   Borges, IA
   Souza, MF
   Lobato, ZIP
   Bonjardim, CA
   Ferreira, PCP
   Trindade, GS
   Kroon, EG
AF Abrahao, Jonatas S.
   Silva-Fernandes, Andre T.
   Lima, Larissa S.
   Campos, Rafael K.
   Guedes, Maria I. M. C.
   Cota, Marcela M. G.
   Assis, Felipe L.
   Borges, Iara A.
   Souza-Junior, Milton F.
   Lobato, Zelia I. P.
   Bonjardim, Claudio A.
   Ferreira, Paulo C. P.
   Trindade, Giliane S.
   Kroon, Erna G.
TI Vaccinia Virus Infection in Monkeys, Brazilian Amazon
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID SMALLPOX VACCINE; CANTAGALO VIRUS; CATTLE; POXVIRUS; HUMANS; BLOOD; DNA
AB To detect orthopoxvirus in the Brazilian Amazon, we conducted a serosurvey of 344 wild animals. Neutralizing antibodies against orthopoxvirus were detected by plaque-reduction neutralizing tests in 84 serum samples. Amplicons from 6 monkey samples were sequenced. These amplicons identified vaccinia virus genetically similar to strains from bovine vaccinia outbreaks in Brazil.
C1 [Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Campos, Rafael Kroon/AAB-5135-2020;
   Kroon, Erna/V-5444-2019; brasileira, Inct Pecuaria/J-9542-2013;
   Bonjardim, Claudio A/J-2601-2014; Abrahao, Jonatas/B-3895-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Campos, Rafael
   Kroon/0000-0002-4852-0449; Abrahao, Jonatas/0000-0001-9420-1791; Lobato,
   Zelia/0000-0002-9399-3691
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao de Amparo
   Pesquisa do Estado de Minas GeraisMinas Gerais State Research Foundation
   (FAPEMIG); Ministerio da Agricultura, Pecuaria e Abastecimento
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior, Fundacao de Amparo Pesquisa do Estado de Minas Gerais,
   and Ministerio da Agricultura, Pecuaria e Abastecimento. J.S.A. was
   supported by a fellowship from Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior. E.G.K., CAB.. G.S.T., and P.C.P.F. are researchers of
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.
CR Cohen JI, 2007, VACCINE, V25, P4571, DOI 10.1016/j.vaccine.2007.03.044
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I, 2007, FIELDS VIROLOGY, P2947
   DELOPES S, 1965, AM J TROP MED HYG, V14, P156
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   MADUREIRA M, 2009, THESIS U FEDERAL MIN
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   *OFF INT EP, 1999, MAN STAND TECHN, P150
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Savona MR, 2006, JAMA-J AM MED ASSOC, V295, P1898, DOI 10.1001/jama.295.16.1898
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
NR 15
TC 39
Z9 40
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2010
VL 16
IS 6
BP 976
EP 979
DI 10.3201/eid1606.091187
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 602UJ
UT WOS:000278164000011
PM 20507750
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Vilela, APP
   Figueiredo, LB
   dos Santos, JR
   Eiras, AE
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Vilela, Ana P. P.
   Figueiredo, Leandra B.
   dos Santos, Joao R.
   Eiras, Alvaro E.
   Bonjardim, Claudio A.
   Ferreira, Paulo C. P.
   Kroon, Erna G.
TI Dengue Virus 3 Genotype I in Aedes aegypti Mosquitoes and Eggs, Brazil,
   2005-2006
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID HEMORRHAGIC-FEVER; CIRCULATION; TYPE-3; ADULT
AB Dengue virus type 3 genotype I was detected in Brazil during epidemics in 2002-2004. To confirm this finding, we identified this virus genotype in naturally infected field-caught Aedes aegypti mosquitoes and eggs. Results showed usefulness of virus investigations in vectors as a component of active epidemiologic surveillance.
C1 [Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Vilela, Ana Paula Pessoa/Q-7538-2018; Kroon, Erna/V-5444-2019; Kroon,
   Erna Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014; Eiras,
   Alvaro/Z-6023-2019
OI Vilela, Ana Paula Pessoa/0000-0001-9030-0688; Kroon, Erna
   Geessien/0000-0003-2721-3826; Eiras, Alvaro/0000-0002-3045-0673
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Departamento de
   Ciencia, Tecnologia da Secretaria de Ciencia, Tecnologia e Insumos
   Estrategicos/Departamento de Ciencia e Tecnologia-Ministerio da Saude;
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, BrazilMinas
   Gerais State Research Foundation (FAPEMIG)
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior; Departamento de Ciencia, Tecnologia da Secretaria de
   Ciencia, Tecnologia e Insumos Estrategicos/Departamento de Ciencia e
   Tecnologia-Ministerio da Saude; and Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais, Brazil. C.A.B, P.C.P.F., and E.G.K are
   recipients of research fellowships from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico.
CR BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005
   Correa PRL, 2005, REV SAUDE PUBL, V39, P33, DOI 10.1590/S0034-89102005000100005
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   Favaro EA, 2008, J VECTOR ECOL, V33, P8, DOI 10.3376/1081-1710(2008)33[8:AOEIOA]2.0.CO;2
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   Gama RA, 2007, REV SOC BRAS MED TRO, V40, P640, DOI 10.1590/S0037-86822007000600008
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gunther J, 2007, INTERVIROLOGY, V50, P347, DOI 10.1159/000107272
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Nogueira MB, 2008, MEM I OSWALDO CRUZ, V103, P483, DOI 10.1590/S0074-02762008000500013
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   *SECR SECC SAL PRO, 2009, IND BAS 2008, P1
   Usme-Ciro JA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-101
NR 15
TC 33
Z9 35
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2010
VL 16
IS 6
BP 989
EP 992
DI 10.3201/eid1606.091000
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 602UJ
UT WOS:000278164000015
PM 20507754
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Silva-Fernandes, AT
   Assis, FL
   Guedes, MI
   Drumond, BP
   Leite, JA
   Coelho, LFL
   Turrini, F
   Fonseca, FG
   Lobato, ZIP
   Madureira, M
   Ferreira, PC
   Bonjardim, CA
   Trindade, GS
   Kroon, EG
AF Abrahao, Jonatas S.
   Silva-Fernandes, Andre T.
   Assis, Felipe L.
   Guedes, Maria I.
   Drumond, Betania P.
   Leite, Juliana A.
   Coelho, Luiz F. L.
   Turrini, Filippo
   Fonseca, Flavio G.
   Lobato, Zelia I. P.
   Madureira, Marieta
   Ferreira, Paulo C.
   Bonjardim, Claudio A.
   Trindade, Giliane S.
   Kroon, Erna G.
TI Human Vaccinia virus and Pseudocowpox virus co-infection: Clinical
   description and phylogenetic characterization
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Vaccinia virus; Orthopoxvirus; Pseudocowpox virus; Parapoxvirus;
   Co-infection
ID RIO-DE-JANEIRO; PARAPOXVIRUS; INFECTION; DIAGNOSIS; SMALLPOX; POXVIRUS;
   STRAIN; CATTLE; STATE
AB Background: Occupational exanthematic diseases represent an important cause of public health impact and economical losses. Among the viral exanthematic diseases, two caused by poxviruses are noteworthy: the bovine vaccinia (BV), caused by the Vaccinia virus (VACV); and the milker's nodule, in which the agent is the Pseudocowpox virus (PCPV). Both agents are zoonotic and have been associated with several cases of bovine infection. In Brazilian rural areas BV has been highly prevalent, particularly in milk herds. Farmers, milkers and their close contacts developed lesions on the hands, forearms, legs and face accompanied by several systemic symptoms. Although VACV and PCPV present with similar epidemiological and transmission patterns, no VACV and PCPV co-infection cases have to date been described.
   Objectives: To describe the first case of zoonotic VACV and PCVP co-infection, based on serological and molecular methods.
   Study design and results: In this work we report a case of a Brazilian rural worker who presented with a large severely ulcerated-pustule skin lesion, associated with fever, headache, malaise, myalgia and axillary, inguinal and cervical limphadenopathy. The worker declared occupational contact with cattle that had notable injuries on their teats. Human and bovine clinical samples were collected and submitted to serological and molecular tests. PCR and phylogenetic analysis revealed the presence of VACV DNA and PCPV DNA in the patient's lesion. Serological tests indicated anti-VACV neutralizing antibodies and molecular assays showed the presence of VACV and PCPV DNA in the patient sera. VACV and PCPV also were detected in dairy cattle.
   Conclusion: Together, these results indicate a case of zoonotic VACV/PCPV co-infection. Epidemiological surveillance and appropriate medical treatment are essential for the control of both diseases, especially in the most severe cases, as described in the present study. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Kroon, Erna G.] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Drumond, Betania P.] Ctr Pesquisas Rene Rachou Fiocruz, BR-30190 Belo Horizonte, MG, Brazil.
   [Leite, Juliana A.] Embrapa Gado Leite, Empresa Brasileira Pesquisa Agropecuaria, Juiz De Fora, MG, Brazil.
   [Coelho, Luiz F. L.] Univ Fed Alfenas, Alfenas, MG, Brazil.
   [Turrini, Filippo] Alma Mater Studiorum Univ Bologna, Bologna, Italy.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014;
   Coelho, Luiz FL/G-5853-2012; Abrahao, Jonatas/B-3895-2015; Kroon,
   Erna/V-5444-2019; Turrini, Filippo/I-3677-2018; brasileira, Inct
   Pecuaria/J-9542-2013
OI Kroon, Erna Geessien/0000-0003-2721-3826; Abrahao,
   Jonatas/0000-0001-9420-1791; Turrini, Filippo/0000-0002-9121-9117;
   Lobato, Zelia/0000-0002-9399-3691; Coelho, Luiz
   Felipe/0000-0003-4289-384X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); MAPA
FX We thank MSc. Joao R. dos Santos, Angela S. Lopes, Ilda M. V. Gama, and
   colleagues from Laboratorio de Virus (ICB-UFMG). Financial support was
   provided by CNPq, CAPES, FAPEMIG and MAPA. GST, FGF, ZIPL, EGK, CAB and
   PCPF received fellowship from CNPq.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-47
   Cohen JI, 2007, VACCINE, V25, P4571, DOI 10.1016/j.vaccine.2007.03.044
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DAMON IK, 2007, FIELDS VIROLOGY, V2, P181
   Erbagci Z, 2005, J DERMATOL TREAT, V16, P353, DOI 10.1080/09546630500375734
   Iketani Y, 2002, MICROBIOL IMMUNOL, V46, P285, DOI 10.1111/j.1348-0421.2002.tb02697.x
   Inoshima Y, 2000, J VIROL METHODS, V84, P201, DOI 10.1016/S0166-0934(99)00144-5
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Nitsche A, 2006, CLIN CHEM, V52, P316, DOI 10.1373/clinchem.2005.060335
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
NR 17
TC 30
Z9 34
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD MAY
PY 2010
VL 48
IS 1
BP 69
EP 72
DI 10.1016/j.jcv.2010.02.001
PG 4
WC Virology
SC Virology
GA 583JC
UT WOS:000276669700017
PM 20207192
DA 2020-11-30
ER

PT J
AU Andrade, AA
   Brasil, BSAF
   Pereira, ACTC
   Ferreira, PCP
   Kroon, EG
   Bonjardim, CA
AF Andrade, Anderson A.
   Brasil, Bruno S. A. F.
   Pereira, Anna C. T. C.
   Ferreira, Paulo C. P.
   Kroon, Erna G.
   Bonjardim, Claudio A.
TI Vaccinia virus regulates expression of p21WAF1/Cip1 in A431 cells
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Vaccinia virus; virus-host cell interaction; p21WAF1/Cip1; MEK/ERK1/2;
   signal transduction
ID EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; P21(WAF1/CIP1) EXPRESSION;
   IMMUNE EVASION; PATHWAY; TRANSCRIPTION; POXVIRUS; P53; PHOSPHORYLATION;
   MULTIPLICATION
AB In this paper, we provide evidence that both the mRNA and protein levels of the cyclin-dependent kinase (CDK) inhibitor p21WAF1/CDK-interacting protein 1 (Cip1) increase upon infection of A431 cells with Vaccinia virus (VACV). In addition, the VACV growth factor (VGF) seems to be required for the gene expression because infection carried out with the mutant virus VACV-VGF-revealed that this strain was unable to stimulate its transcription. Our findings are also consistent with the notion that the VGF-mediated change in p21WAF1/Cip1 expression is dependent on tyrosine kinase pathway(s) and is partially dependent on mitogen-activated protein kinase/extracellular-signal regulated kinase 1/2. We believe that these pathways are biologically significant because VACV replication and dissemination was drastically affected when the infection was carried out in the presence of the relevant pharmacological inhibitors.
C1 [Andrade, Anderson A.; Brasil, Bruno S. A. F.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal, BR-31270901 Belo Horizonte, MG, Brazil.
   [Andrade, Anderson A.; Brasil, Bruno S. A. F.; Ferreira, Paulo C. P.; Kroon, Erna G.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pereira, Anna C. T. C.] Univ Fed Piaui, Parnaiba, PI, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM claudio.bonjardim@pq.cnpq.br
RI Bonjardim, Claudio A/J-2601-2014; Andrade, Anderson/H-4022-2012; Kroon,
   Erna/V-5444-2019; Brasil, Bruno S. A. F./E-8817-2012; Kroon, Erna
   Geessien/B-3631-2015
OI Andrade, Anderson/0000-0001-9569-6503; Brasil, Bruno S. A.
   F./0000-0002-8690-2157; Kroon, Erna Geessien/0000-0003-2721-3826; ,
   Bruno/0000-0002-3587-7983
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); CAPESCAPES;
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX Financial support: FAPEMIG, CAPES, CNPq (AAA, ACTCP and BSAFB were
   recipients of pre-doctoral fellowships; CAB, EGK and PCPF are recipients
   of research fellowships)
CR Akashi M, 1999, BIOCHEM J, V337, P607, DOI 10.1042/0264-6021:3370607
   Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   BARNES DW, 1982, J CELL BIOL, V93, P1, DOI 10.1083/jcb.93.1.1
   BROWN JP, 1985, NATURE, V313, P491, DOI 10.1038/313491a0
   Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0
   BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0
   BULLER RML, 1988, VIROLOGY, V164, P182, DOI 10.1016/0042-6822(88)90635-6
   BURNET FM, 1936, SPEC REP SER MED RES, V220, P555
   Cereseto A, 1996, BLOOD, V88, P1551, DOI 10.1182/blood.V88.5.1551.bloodjournal8851551
   Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   De Sousa LP, 2005, BIOCHEM BIOPH RES CO, V329, P237, DOI 10.1016/j.bbrc.2005.01.123
   DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   GILL GN, 1981, NATURE, V431, P293
   HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0
   Husain M, 2001, J VIROL, V75, P7528, DOI 10.1128/JVI.75.16.7528-7542.2001
   Johannessen LE, 1999, BIOCHEM J, V337, P599, DOI 10.1042/0264-6021:3370599
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Katsafanas GC, 2004, J BIOL CHEM, V279, P52210, DOI 10.1074/jbc.M411033200
   Katz RA, 2005, J CELL BIOCHEM, V94, P880, DOI 10.1002/jcb.20358
   KIM HS, 1995, VIROLOGY, V214, P21, DOI 10.1006/viro.1995.9958
   KING CS, 1986, MOL CELL BIOL, V6, P332, DOI 10.1128/MCB.6.1.332
   Knutson BA, 2009, J GEN VIROL, V90, P1592, DOI 10.1099/vir.0.006924-0
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   Mo M, 2009, P NATL ACAD SCI USA, V106, P19527, DOI 10.1073/pnas.0905893106
   Moss B., 2007, FIELDS VIROLOGY, V2, P2905
   Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001
   Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509
   Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x
   Toyoda M, 1998, BIOCHEM BIOPH RES CO, V250, P430, DOI 10.1006/bbrc.1998.9332
   TWARDZIK DR, 1985, P NATL ACAD SCI USA, V82, P5300, DOI 10.1073/pnas.82.16.5300
   Tzahar E, 1998, EMBO J, V17, P5948, DOI 10.1093/emboj/17.20.5948
   Wali A, 1999, DNA CELL BIOL, V18, P837, DOI 10.1089/104454999314836
   Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132
   WOLFFE EJ, 1995, VIROLOGY, V211, P53, DOI 10.1006/viro.1995.1378
   Zhou YH, 2002, CANCER INVEST, V20, P348, DOI 10.1081/CNV-120001180
NR 40
TC 1
Z9 2
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2010
VL 105
IS 3
BP 269
EP 277
DI 10.1590/S0074-02762010000300005
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 603MV
UT WOS:000278213600005
PM 20512239
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Drumond, BP
   Trindade, GD
   da Silva-Fernandes, AT
   Ferreira, JMS
   Alves, PA
   Campos, RK
   Siqueira, L
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Trindade, Giliane de Souza
   da Silva-Fernandes, Andre Tavares
   Siqueira Ferreira, Jaqueline Maria
   Alves, Pedro Augusto
   Campos, Rafael Kroon
   Siqueira, Larissa
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Rapid Detection of Orthopoxvirus by Semi-Nested PCR Directly From
   Clinical Specimens: A Useful Alternative for Routine Laboratories
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE viral diagnosis; vaccinia outbreaks; poxvirus; Orthopoxvirus
ID VACCINIA-VIRUS-STRAINS; REAL-TIME PCR; BOVINE VACCINIA; DIAGNOSTIC PCR;
   INFECTION; ASSAY; SMALLPOX; OUTBREAK; BRAZIL; DIFFERENTIATION
AB Orthopoxvirus (OPV) has been associated with worldwide exanthematic outbreaks, which have resulted in serious economic losses as well as impact on public health. Although the current classical and molecular methods are useful for the diagnosis of OPV, they are largely inaccessible to unsophisticated clinical laboratories. The major reason for the inaccessibility is that they require both virus isolation and DNA manipulation. In this report, a rapid, sensitive and low-cost semi-nested PCR method is described for the detection of OPV DNA directly from clinical specimens. A set of primers was designed to amplify the conserved OPV vgf gene. The most useful thermal and chemical conditions were selected and minimum non-inhibitory dilutions were determined. More than 100 Brazilian Vaccinia virus (VACV) field clinical specimens were tested using this semi-nested PCR in order to confirm its applicability. Cowpox virus was also detected by PCR from the ear scabs of scarified Balb/c mice. In addition, the method was highly sensitive for the detection of VACV DNA in murine blood and excreta, which are among the suggested reservoirs of OPV. Together, these data suggest that semi-nested PCR can be used for initial screening for OPV and as a routine diagnostic laboratory method. J. Med. Virol. 82:692-699, 2010. (C) 2010 Wiley-Liss, Inc.
C1 [Abrahao, Jonatas Santos; Drumond, Betania Paiva; Trindade, Giliane de Souza; da Silva-Fernandes, Andre Tavares; Siqueira Ferreira, Jaqueline Maria; Alves, Pedro Augusto; Campos, Rafael Kroon; Siqueira, Larissa; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Alves, Pedro/T-7203-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; Campos, Rafael
   Kroon/AAB-5135-2020; Abrahao, Jonatas/B-3895-2015
OI Alves, Pedro/0000-0002-9659-5621; Kroon, Erna
   Geessien/0000-0003-2721-3826; Campos, Rafael Kroon/0000-0002-4852-0449;
   Abrahao, Jonatas/0000-0001-9420-1791
FU CNPq CAPES FAPEMIG
FX Grant sponsor: CNPq CAPES FAPEMIG.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P4463, DOI 10.1128/JCM.38.12.4463-4470.2000
   BOUILLANT A, 1965, CAN J COMP MED VET S, V29, P125
   Damaso CRA, 2007, DIAGN MICR INFEC DIS, V57, P39, DOI 10.1016/j.diagmicrobio.2006.07.012
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   Fedorko DP, 2005, J CLIN MICROBIOL, V43, P4602, DOI 10.1128/JCM.43.9.4602-4606.2005
   Fenner F., 1989, ORTHOPOXVIRUSES
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   GLEDHILL AW, 1962, NATURE, V196, P298, DOI 10.1038/196298a0
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720
   JAHRLING PB, 2007, MED ASPECTS BIOL WAR, P215
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005
   Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004
   Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817
   LEDERMAN E, 2008, VACCINE
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   Malorny B, 2005, J CLIN MICROBIOL, V43, P3033, DOI 10.1128/JCM.43.7.3033-3037.2005
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   Moss B., 2007, FIELDS VIROLOGY, V2, P2905
   Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814
   Putkuri N, 2009, J MED VIROL, V81, P146, DOI 10.1002/jmv.21385
   Saijo M, 2008, JPN J INFECT DIS, V61, P140
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sanchez-Seco MP, 2006, BRIT J BIOMED SCI, V63, P79, DOI 10.1080/09674845.2006.11732725
   SARKAR JK, 1974, INDIAN J MED RES, V62, P1800
   SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P517
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Singh RK, 2008, J VIROL METHODS, V154, P146, DOI 10.1016/j.jviromet.2008.08.009
   Singh RX, 2006, REV SCI TECH OIE, V25, P981, DOI 10.20506/rst.25.3.1708
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   STRENGER V, 2009, CLIN INFECT DIS, V34, P133
   Trindade GS, 2007, J VIROL METHODS, V141, P198, DOI 10.1016/j.jviromet.2006.12.006
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Tscharke DC, 1999, J GEN VIROL, V80, P2751, DOI 10.1099/0022-1317-80-10-2751
   Vestergaard L, 2008, ACTA DERM-VENEREOL, V88, P188, DOI 10.2340/00015555-0375
NR 42
TC 25
Z9 25
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD APR
PY 2010
VL 82
IS 4
BP 692
EP 699
DI 10.1002/jmv.21617
PG 8
WC Virology
SC Virology
GA 560SA
UT WOS:000274921300021
PM 20166167
DA 2020-11-30
ER

PT J
AU Pessanha, JEM
   Caiaffa, WT
   Kroon, EG
   Proietti, FA
AF Marques Pessanha, Jose Eduardo
   Caiaffa, Waleska Teixeira
   Kroon, Erna Gessien
   Proietti, Fernando Augusto
TI Dengue fever in three sanitary districts in the city of Belo Horizonte,
   Brazil: a population-based seroepidemiological survey, 2006 to 2007
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA Portuguese
DT Article
DE Dengue virus; seroepidemiologic studies; health vulnerability; housing;
   Brazil
ID VIRUS; STATE; AREA
AB Objective. To determine the seroprevalence of dengue fever serotypes in three sanitary districts in the city of Belo Horizonte and investigate the association of seroprevalence with contextual and individual variables.
   Method. The survey was conducted in the sanitary districts of Venda Nova, Leste and Centro-Oeste between June 2006 and March 2007. All residents aged 1 year or older were eligible for the study. Participants answered a questionnaire and had a 5 mL blood sample collected to determine the presence of anti-dengue types 1, 2, and 3 virus antibodies by seroneutralization. The questionnaire covered demographic aspects, socioeconomic status, physical characteristics of the home, residential mobility between cities, previous history of signs and symptoms associated with dengue fever, and knowledge concerning dengue fever prevention measures, among others.
   Results. Seroprevalence was 11.9% (95% CI: 9.7-14.6) among the 709 individuals included in the study, and it was not associated with sex, age, family income, and having moved to another town in the past 10 years. Seropositivity was associated with type of construction (apartment or house/shanty, with apartment being a protection factor) and with an elevated health vulnerability index where the dwelling was located.
   Conclusions. In this study, seroprevalence was lower than in previous studies carried out in mid-size and large Brazilian cities. This suggests that Belo Horizonte has employed efficient control measures. However, heterogeneity within the city was observed in terms of dengue fever transmission, which was largely associated with contextual indicators of vulnerability. The number of susceptibles is still high, and the control of dengue fever remains a difficult public health issue.
C1 [Marques Pessanha, Jose Eduardo; Caiaffa, Waleska Teixeira; Proietti, Fernando Augusto] Univ Fed Minas Gerais, Observ Saude Urbana Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Caiaffa, Waleska Teixeira; Proietti, Fernando Augusto] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   [Kroon, Erna Gessien] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
RP Pessanha, JEM (corresponding author), Rua Curitiba 1588,Apto 1101, BR-30170122 Belo Horizonte, MG, Brazil.
EM edumpessanha@hotmail.com
RI Kroon, Erna/V-5444-2019; Kroon, Erna/B-3631-2015
OI Kroon, Erna/0000-0003-2721-3826
CR Caiaffa Waleska Teixeira, 2005, Cad. Saúde Pública, V21, P958, DOI 10.1590/S0102-311X2005000300032
   de Lima VLC, 2007, CAD SAUDE PUBLICA, V23, P669, DOI 10.1590/S0102-311X2007000300025
   Coelho GE, 2008, EPIDEMIOL SERV SAUDE, V17, P231
   Correa PRL, 2005, REV SAUDE PUBL, V39, P33, DOI 10.1590/S0034-89102005000100005
   Costenbader V, 1999, J EMOT BEHAV DISORD, V7, P2, DOI 10.1177/106342669900700101
   Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   Ferreira BJ, 2009, CIENC SAUDE COLETIVA, V14, P961, DOI 10.1590/S1413-81232009000300032
   Figueiredo L T, 1990, Bull Pan Am Health Organ, V24, P217
   FIGUEIREDO LTM, 1986, REV SAUDE PUBL, V20, P204, DOI 10.1590/S0034-89101986000300003
   FIGUEIREDO LTM, 1998, MEDICINA RIBEIRAO PR, V31, P410
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Holzmann H, 1996, J MED VIROL, V48, P102, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;102::AID-JMV16&gt;3.0.CO;2-I
   Instituto Brasileiro de Geografia e Estatistica, PERF MUN
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   LUNA CF, 2008, AN 7 C BRAS EP 2008
   Cunha MDM, 2008, EPIDEMIOL SERV SAUDE, V17, P217
   MARQUES RM, 1976, REV BRAS ESTAT, V37, P81
   Marzochi Keyla Belizia Feldman, 2004, Rev. Soc. Bras. Med. Trop., V37, P413, DOI 10.1590/S0037-86822004000500009
   Almeida MCD, 2008, CAD SAUDE PUBLICA, V24, P2385, DOI 10.1590/S0102-311X2008001000019
   *PREF BEL HOR SECR, 2003, IND VULN SAUD 2003
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Teixeira M.d.G., 2003, EPIDEMIOL SERV SAUDE, V12, P87
   Vasconcelos P F, 2000, Rev Soc Bras Med Trop, V33, P61
   Vasconcelos P F, 1999, Rev Soc Bras Med Trop, V32, P171
   Vasconcelos PFC, 1998, REV SAUDE PUBL, V32, P447, DOI 10.1590/S0034-89101998000500007
NR 26
TC 18
Z9 19
U1 0
U2 5
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PD APR
PY 2010
VL 27
IS 4
BP 252
EP 258
DI 10.1590/S1020-49892010000400003
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 597NG
UT WOS:000277764200003
PM 20512227
OA Bronze
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Oliveira, TML
   Campos, RK
   Madureira, MC
   Kroon, EG
   Lobato, ZIP
AF Abrahao, Jonatas S.
   Oliveira, Tercia M. L.
   Campos, Rafael K.
   Madureira, Marieta C.
   Kroon, Erna G.
   Lobato, Zelia I. P.
TI Bovine Vaccinia Outbreaks: Detection and Isolation of Vaccinia Virus in
   Milk Samples
SO FOODBORNE PATHOGENS AND DISEASE
LA English
DT Article
ID POXVIRUS; CATTLE; PREVALENCE; STRAINS; HERDS
AB The vaccinia virus (VACV), which causes exanthemous lesions in dairy cattle and humans, has been associated with several bovine vaccinia outbreaks in Brazil. Currently, no data are available about the safety of milk produced in VACV-affected areas. In this study, 47 milk samples were collected during bovine vaccinia outbreaks and submitted to viral isolation, DNA detection, and nucleotide sequencing of the conserved tk gene. The appearance of characteristic white pocks on the chorioallantoic membranes of chicken eggs, in association with viral cytopathic effects in chicken embryo fibroblasts and phylogenetic data, strongly suggest milk contamination by VACV. This is the first report of VACV detection in and isolation from milk.
C1 [Abrahao, Jonatas S.; Campos, Rafael K.; Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Oliveira, Tercia M. L.; Madureira, Marieta C.; Lobato, Zelia I. P.] Univ Fed Minas Gerais, Escola Vet, Lab Pesquisa Virol Anim, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Campos, Rafael Kroon/AAB-5135-2020; Abrahao, Jonatas/B-3895-2015; Kroon,
   Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Campos, Rafael Kroon/0000-0002-4852-0449; Abrahao,
   Jonatas/0000-0001-9420-1791; Kroon, Erna Geessien/0000-0003-2721-3826;
   Lobato, Zelia/0000-0002-9399-3691
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG), BrazilMinas Gerais State Research Foundation (FAPEMIG)
FX We thank Joao Rodrigues dos Santos, Angela Sana Lopes, Ilda Gamma, and
   colleagues from Laboratorio de Virus (ICB-UFMG/Escola de Veterinaria)
   for their excellent technical support, and Dr. Bernard Moss (National
   Institute of Allergy and Infectious Diseases, USA) for anti-B5R
   antibodies. Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   Berkelman RL, 2003, CLIN INFECT DIS, V37, P407, DOI 10.1086/375595
   Buzby J C, 1997, World Health Stat Q, V50, P57
   CONDIT RC, 2007, FIELDS VIROLOGY, V2, P25
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DAMON I, 2007, FIELDS VIROLOGY, P2079
   FENNER F, 1989, ORTHOPOXVIRUSES, P85
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Garoussi MT, 2008, PREV VET MED, V84, P171, DOI 10.1016/j.prevetmed.2007.12.016
   Giannino ML, 2009, INT J FOOD MICROBIOL, V130, P188, DOI 10.1016/j.ijfoodmicro.2009.01.022
   Holm C, 2004, J DAIRY SCI, V87, P1151, DOI 10.3168/jds.S0022-0302(04)73263-4
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   MADUREIRA M, 2009, THESIS U FEDERAL MIN
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   Nair MKM, 2004, FOOD MICROBIOL, V21, P611, DOI 10.1016/j.fm.2004.01.003
   Oliver SP, 2005, FOODBORNE PATHOG DIS, V2, P115, DOI 10.1089/fpd.2005.2.115
   Salimi-Bejestani MR, 2005, VET REC, V156, P729, DOI 10.1136/vr.156.23.729
   Sambrook J., 1989, MOL CLONING LAB MANU
   SILVAFERNANDES AT, 2009, J CLIN VIROL, V156, P729
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   TRINDADE GS, 2007, J VIROL METHODS, V75, P486
NR 26
TC 22
Z9 22
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1535-3141
EI 1556-7125
J9 FOODBORNE PATHOG DIS
JI Foodborne Pathog. Dis.
PD NOV
PY 2009
VL 6
IS 9
BP 1141
EP 1146
DI 10.1089/fpd.2009.0324
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA 515DL
UT WOS:000271446900013
PM 19888798
DA 2020-11-30
ER

PT J
AU Valadares, YM
   Brandao, GC
   Kroon, EG
   Souza, JD
   Oliveira, AB
   Braga, FC
AF Valadares, Ydia M.
   Brandao, Geraldo C.
   Kroon, Erna G.
   Souza Filho, Jose D.
   Oliveira, Alaide B.
   Braga, Fernao C.
TI Antiviral Activity of Solanum paniculatum Extract and Constituents
SO ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES
LA English
DT Article
DE Solanum paniculatum; Delta(25(27))-Tigogenin-3-O-beta-D-glucopyranoside;
   Antiviral Activity
ID STEROIDAL GLYCOSIDES; CYTOTOXIC ACTIVITY; SAPONINS; SAPOGENINS
AB Solanum species are traditionally employed as antiherpes and anticancer agents ill different countries. S. paniculatum has widespread ethnomedical uses in Brazil, including the treatment of viral infections. This paper reports on the isolation of neotigogenin (1) and the new compound Delta(25(27))-tigogenin-3-O-beta-D-glucopyranoside (2), obtained as a mixture of R and S diastereoisomers at C22 from an ethanol extract of S. paniculatum? leaves, along with the determination of their cytotoxicity against Vero cells and antiviral effect against human herpes virus type I (HHV-1), murine encephalomyocarditis Virus (EMCv), and vaccinia virus strain Western Reserve (VACV-WR). The extract of S paniculatum inhibited HHV-1 replication [EC50 = (298.0 +/- 11.2) mu g/ml] and showed no effect oil EMCv and VACV-WR. On its turn. I was inactive against the assayed strains but presented high cytotoxicity [CC50 = (2.03 +/- 0.03) mu g/ml], whereas 2 exhibited significant antiherpes [EC50 = (170.8 +/- 1.7) mu g/ml] and antivaccinia virus effects [EC50 = (177.0 +/- 3.3) mu g/ml], with low cytotoxicity (CC50 > 400 mu g/ml). The results corroborate Solanum paniculatum as a source of cytotoxic and antiviral compounds.
C1 [Valadares, Ydia M.; Brandao, Geraldo C.; Oliveira, Alaide B.; Braga, Fernao C.] Univ Fed Minas Gerais, Fac Pharm, Dept Pharmaceut Prod, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kroon, Erna G.] Univ Fed Minas Gerais, ICB, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Souza Filho, Jose D.] Univ Fed Minas Gerais, ICEX, Dept Chem, BR-31270901 Belo Horizonte, MG, Brazil.
RP Braga, FC (corresponding author), Univ Fed Minas Gerais, Fac Pharm, Dept Pharmaceut Prod, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM fernao@netuno.lcc.ufmg.br
RI Kroon, Erna/V-5444-2019; Braga, Fernao/AAO-3888-2020; Braga, Fernao
   C/E-3236-2016; Kroon, Erna Geessien/B-3631-2015; DE SOUZA FILHO, Jose
   DIAS/ABF-1983-2020
OI Braga, Fernao/0000-0001-9468-376X; Braga, Fernao C/0000-0001-9468-376X;
   Kroon, Erna Geessien/0000-0003-2721-3826; DE SOUZA FILHO, Jose
   DIAS/0000-0002-3656-4882
FU FAPEMIG - Fundacao de Amparo a Pesquisa de Minas Gerais (Brazil)Minas
   Gerais State Research Foundation (FAPEMIG); CAPES (Brazil)CAPES; CNPq
   (Brazil)National Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by funds from FAPEMIG - Fundacao de Amparo a
   Pesquisa de Minas Gerais (Brazil). CAPES (Brazil) and CNPq (Brazil) are
   also acknowledged for PhD (to Y. M. V. and G. C. B.) and research (to A.
   B. O., E. G. K. and F. C. B.) fellowships.
CR Acharya D, 2009, J NAT PROD, V72, P177, DOI 10.1021/np800559z
   AGRAWAL PK, 1985, PHYTOCHEMISTRY, V24, P2479, DOI 10.1016/S0031-9422(00)80653-6
   Bernardo RR, 1996, PHYTOCHEMISTRY, V43, P465, DOI 10.1016/0031-9422(96)00274-9
   Betancur-Galvis LA, 1999, MEM I OSWALDO CRUZ, V94, P531, DOI 10.1590/S0074-02761999000400019
   Blankemeyer JT, 1998, FOOD CHEM TOXICOL, V36, P383, DOI 10.1016/S0278-6915(97)00164-6
   Botion LM, 2005, J ETHNOPHARMACOL, V102, P137, DOI 10.1016/j.jep.2005.05.046
   BRUNENGO MC, 1988, PHYTOCHEMISTRY, V27, P2943, DOI 10.1016/0031-9422(88)80693-9
   Chattopadhyay D, 2007, MINI-REV MED CHEM, V7, P275, DOI 10.2174/138955707780059844
   COSTA AF, 1975, FARMACOGNOSIA
   Di Stasi LC, 2002, PLANTAS MED AMAZONIA
   Ikeda T, 2003, BIOL PHARM BULL, V26, P1198, DOI 10.1248/bpb.26.1198
   Ikeda T, 2000, BIOL PHARM BULL, V23, P363, DOI 10.1248/bpb.23.363
   Kumar PA, 1996, VET RES COMMUN, V20, P513, DOI 10.1007/BF00396294
   Nakamura T, 1996, BIOL PHARM BULL, V19, P564, DOI 10.1248/bpb.19.564
   PioCorrea M, 1978, DICIONARIO PLANTAS U
   RIPPERGER H, 1968, CHEM BER-RECL, V101, P2450, DOI 10.1002/cber.19681010721
   RIPPERGER H, 1967, CHEM BER-RECL, V100, P1741, DOI 10.1002/cber.19671000545
   RODRIGUEZ DJD, 1990, PLANTA MED, V56, P59
   SCHREIBER K., 1966, TETRAHEDRON LETT, V48, P5997
   Zamilpa A, 2002, J NAT PROD, V65, P1815, DOI 10.1021/np020261h
NR 20
TC 10
Z9 10
U1 0
U2 3
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0939-5075
EI 1865-7125
J9 Z NATURFORSCH C
JI Z.Naturforsch.(C)
PD NOV-DEC
PY 2009
VL 64
IS 11-12
BP 813
EP 818
PG 6
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 550FK
UT WOS:000274113500010
PM 20158151
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Guedes, MIM
   Trindade, GS
   Fonseca, FG
   Campos, RK
   Mota, BF
   Lobato, ZIP
   Silva-Fernandes, AT
   Rodrigues, GOL
   Lima, LS
   Ferreira, PCP
   Bonjardim, CA
   Kroon, EG
AF Abrahao, Jonatas S.
   Guedes, Maria Isabel M.
   Trindade, Giliane S.
   Fonseca, Flavio G.
   Campos, Rafael K.
   Mota, Bruno F.
   Lobato, Zelia I. P.
   Silva-Fernandes, Andre T.
   Rodrigues, Gisele O. L.
   Lima, Larissa S.
   Ferreira, Paulo C. P.
   Bonjardim, Claudio A.
   Kroon, Erna G.
TI One More Piece in the VACV Ecological Puzzle: Could Peridomestic Rodents
   Be the Link between Wildlife and Bovine Vaccinia Outbreaks in Brazil?
SO PLOS ONE
LA English
DT Article
ID VIRUS-STRAINS; TRANSMISSION; INFECTION; SMALLPOX; HUMANS; POXVIRUS;
   CATTLE; MODEL; RATS; MICE
AB Background: Despite the fact that smallpox eradication was declared by the World Health Organization (WHO) in 1980, other poxviruses have emerged and re-emerged, with significant public health and economic impacts. Vaccinia virus (VACV), a poxvirus used during the WHO smallpox vaccination campaign, has been involved in zoonotic infections in Brazilian rural areas (Bovine Vaccinia outbreaks - BV), affecting dairy cattle and milkers. Little is known about VACV's natural hosts and its epidemiological and ecological characteristics. Although VACV was isolated and/or serologically detected in Brazilian wild animals, the link between wildlife and farms has not yet been elucidated.
   Methodology/Principal Findings: In this study, we describe for the first time, to our knowledge, the isolation of a VACV (Mariana virus - MARV) from a mouse during a BV outbreak. Genetic data, in association with biological assays, showed that this isolate was the same etiological agent causing exanthematic lesions observed in the cattle and human inhabitants of a particular BV-affected area. Phylogenetic analysis grouped MARV with other VACV isolated during BV outbreaks.
   Conclusion/Significance: These data provide new biological and epidemiological information on VACV and lead to an interesting question: could peridomestic rodents be the link between wildlife and BV outbreaks?
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Campos, Rafael Kroon/AAB-5135-2020; Bonjardim,
   Claudio A/J-2601-2014; Abrahao, Jonatas/B-3895-2015; Kroon, Erna
   Geessien/B-3631-2015
OI Campos, Rafael Kroon/0000-0002-4852-0449; Abrahao,
   Jonatas/0000-0001-9420-1791; Kroon, Erna Geessien/0000-0003-2721-3826;
   Lobato, Zelia/0000-0002-9399-3691; Mota, Bruno/0000-0003-0348-4875
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DAMON I, 2007, FIELDS VIROLOGY, P2079
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Fenner F., 1989, ORTHOPOXVIRUSES
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   GUEDES MIM, 2005, BRAZ SOC VIR C
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   Heymann DL, 2006, CURR TOP MICROBIOL, V304, P1
   Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   MADUREIRA M, 2009, THESIS U FEDERAL MIN
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   Ninove L, 2009, EMERG INFECT DIS, V15, P781, DOI 10.3201/eid1505.090235
   OVERMAN JR, 1957, VIROLOGY, V3, P173, DOI 10.1016/0042-6822(57)90031-4
   Parrino J, 2006, J ALLERGY CLIN IMMUN, V118, P1320, DOI 10.1016/j.jaci.2006.09.037
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   SILVAFERNANDES AT, 2008, THESIS U FEDERAL NOR
   SIMONETTI BR, 2007, VIRUS REV RES, V12, P1
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
NR 35
TC 74
Z9 77
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 19
PY 2009
VL 4
IS 10
AR e7428
DI 10.1371/journal.pone.0007428
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 507UP
UT WOS:000270880900002
PM 19838293
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Lima, LS
   Assis, FL
   Alves, PA
   Silva-Fernandes, AT
   Cota, MMG
   Ferreira, VM
   Campos, RK
   Mazur, C
   Lobato, ZIP
   Trindade, GS
   Kroon, EG
AF Abrahao, Jonatas S.
   Lima, Larissa S.
   Assis, Felipe L.
   Alves, Pedro A.
   Silva-Fernandes, Andre T.
   Cota, Marcela M. G.
   Ferreira, Vanessa M.
   Campos, Rafael K.
   Mazur, Carlos
   Lobato, Zelia I. P.
   Trindade, Giliane S.
   Kroon, Erna G.
TI Nested-multiplex PCR detection of Orthopoxvirus and Parapoxvirus
   directly from exanthematic clinical samples
SO VIROLOGY JOURNAL
LA English
DT Article
ID VIRUS DETECTION; VACCINIA-VIRUS; INFECTION; DIAGNOSIS; MONKEYPOX;
   OUTBREAK; ASSAYS
AB Background: Orthopoxvirus (OPV) and Parapoxvirus (PPV) have been associated with worldwide exanthematic outbreaks. Some species of these genera are able to infect humans and domestic animals, causing serious economic losses and public health impact. Rapid, useful and highly specific methods are required to detect and epidemiologically monitor such poxviruses. In the present paper, we describe the development of a nested-multiplex PCR method for the simultaneous detection of OPV and PPV species directly from exanthematic lesions, with no previous viral isolation or DNA extraction.
   Methods and Results: The OPV/PPV nested-multiplex PCR was developed based on the evaluation and combination of published primer sets, and was applied to the detection of the target pathogens. The method showed high sensitivity, and the specificity was confirmed by amplicon sequencing. Exanthematic lesion samples collected during bovine vaccinia or contagious ecthyma outbreaks were submitted to OPV/PPV nested-multiplex PCR and confirmed its applicability.
   Conclusion: These results suggest that the presented multiplex PCR provides a highly robust and sensitive method to detect OPV and PPV directly from clinical samples. The method can be used for viral identification and monitoring, especially in areas where OPV and PPV co-circulate.
C1 [Abrahao, Jonatas S.; Lima, Larissa S.; Assis, Felipe L.; Alves, Pedro A.; Silva-Fernandes, Andre T.; Cota, Marcela M. G.; Ferreira, Vanessa M.; Campos, Rafael K.; Trindade, Giliane S.; Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Lobato, Zelia I. P.] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, BR-31270901 Belo Horizonte, MG, Brazil.
   [Mazur, Carlos] Univ Fed Rural Rio de Janeiro, Dept Microbiol & Imunol Vet, BR-23890000 Rio De Janeiro, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos,6627 Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com; laroka.siqueira@gmail.com;
   felipelopesassis@gmail.com; pedroaugustoalves@yahoo.com.br;
   fernandeserthal@yahoo.com.br; marcelacota@yahoo.com.br;
   vanmferreira_1@yahoo.com.br; rafaklugleafar@msn.com; mazur@ufrj.br;
   ziplobat@vet.ufmg.br; giliane@icb.ufmg.br; kroone@icb.ufmg.br
RI Campos, Rafael Kroon/AAB-5135-2020; Kroon, Erna Geessien/B-3631-2015;
   Alves, Pedro/T-7203-2019; Kroon, Erna/V-5444-2019; brasileira, Inct
   Pecuaria/J-9542-2013; Abrahao, Jonatas/B-3895-2015
OI Campos, Rafael Kroon/0000-0002-4852-0449; Kroon, Erna
   Geessien/0000-0003-2721-3826; Alves, Pedro/0000-0002-9659-5621; Abrahao,
   Jonatas/0000-0001-9420-1791; Lobato, Zelia/0000-0002-9399-3691
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); MAPA; CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX We thank MSc. Joao R. dos Santos, Angela S. Lopes, Ilda M. V. Gamma, and
   colleagues from the Laboratorio de Virus (ICB-UFMG). Financial support
   was provided by CNPq, MAPA, CAPES and FAPEMIG. EGK and ZIP received
   fellowships from CNPq.
CR Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-47
   DAMON I, 2007, POXVIRIDAE THEIR REP, P2079
   Fenner F., 1989, ORTHOPOXVIRUSES
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Haenssle H.A., 2006, J AM ACAD DERMATOL S, V54, P1
   Haig DM, 1998, VET RES, V29, P311
   Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720
   Hosamani M, 2006, VET MICROBIOL, V116, P317, DOI 10.1016/j.vetmic.2006.04.028
   Inoshima Y, 2002, MICROBIOL IMMUNOL, V46, P583, DOI 10.1111/j.1348-0421.2002.tb02738.x
   Inoshima Y, 2000, J VIROL METHODS, V84, P201, DOI 10.1016/S0166-0934(99)00144-5
   KALENDAR R, 2007, FASTPCR PCR PRIMER P
   Kulesh DA, 2004, LAB INVEST, V84, P1200, DOI 10.1038/labinvest.3700143
   Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   Saijo M, 2008, JPN J INFECT DIS, V61, P140
   Sambrook J., 1989, MOL CLONING LAB MANU
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   STRENGER V, 2009, CLIN INFECT DIS, V91, P133
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Vestergaard L, 2008, ACTA DERM-VENEREOL, V88, P188, DOI 10.2340/00015555-0375
NR 22
TC 25
Z9 25
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD SEP 11
PY 2009
VL 6
AR 140
DI 10.1186/1743-422X-6-140
PG 5
WC Virology
SC Virology
GA 499GO
UT WOS:000270206300001
PM 19747382
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Trindade, GD
   Ferreira, JMS
   Campos, RK
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Abrahao, Jonatas S.
   Trindade, Giliane de Souza
   Siqueira Ferreira, Jaqueline M.
   Campos, Rafael K.
   Bonjardim, Claudio A.
   Peregrino Ferreira, Paulo C.
   Kroon, Erna Geessien
TI Long-lasting stability of Vaccinia virus strains in murine feces:
   implications for virus circulation and environmental maintenance
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID OUTBREAK
AB Vaccinia virus (VACV) has been associated with several bovine vaccinia outbreaks in Brazil, causing exanthematic lesions in dairy cattle and humans. The way that VACV circulates in the environment is unknown, as is the way that this virus is transferred from wildlife to farms. Rodents are hypothetical VACV reservoirs, and murine feces has been identified as a potential source of viral shedding and transmission. In this work, we analyzed the stability of VACV infectious particles and DNA in feces from intranasally infected mice, exposed to environmental temperature and humidity, by titration assays and PCR, respectively. The results showed that VACV infectious particles were still detected at 20 days post-environmental-exposure (d.p.e.), while viral DNA was detected until 60 d.p.e. A gradual decrease in fecal viral load could be detected in all analyzed VACV strains. This work indicates long-lasting stability of VACV in murine feces and reinforces the idea that fecal matter may represent a potential source of circulating virus among rodents.
C1 [Abrahao, Jonatas S.; Trindade, Giliane de Souza; Siqueira Ferreira, Jaqueline M.; Campos, Rafael K.; Bonjardim, Claudio A.; Peregrino Ferreira, Paulo C.; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Bonjardim,
   Claudio A/J-2601-2014; Abrahao, Jonatas/B-3895-2015; Campos, Rafael
   Kroon/AAB-5135-2020
OI Kroon, Erna Geessien/0000-0003-2721-3826; Abrahao,
   Jonatas/0000-0001-9420-1791; Campos, Rafael Kroon/0000-0002-4852-0449
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG), BrazilMinas Gerais State Research Foundation (FAPEMIG)
FX We thank Joao Rodrigues dos Santos, Angela Sana Lopes, Ilda Gama, and
   colleagues from Laboratorio de Virus (ICB-UFMG) for their excellent
   technical support. Financial support was provided by the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   BOUILLANT A, 1965, CAN J COMP MED VET S, V29, P125
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0
   Lederman E, 2009, VACCINE, V27, P375, DOI 10.1016/j.vaccine.2008.11.019
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   MADUREIRA M, 2009, THESIS U FEDERAL MIN
   Mills JN, 2005, ARCH VIROL, P45
   Pastoret PP, 1996, DEV BIOL STAND, V87, P245
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   SIMONETTI BR, 2007, VIRUS REV RES, V12, P1
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
NR 17
TC 18
Z9 18
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD SEP
PY 2009
VL 154
IS 9
BP 1551
EP 1553
DI 10.1007/s00705-009-0470-1
PG 3
WC Virology
SC Virology
GA 495GN
UT WOS:000269878900023
PM 19710997
DA 2020-11-30
ER

PT J
AU Souza, DG
   Fagundes, CT
   Sousa, LP
   Amaral, FA
   Souza, RS
   Souza, AL
   Kroon, EG
   Sachs, D
   Cunha, FQ
   Bukin, E
   Atrasheuskaya, A
   Ignatyev, G
   Teixeira, MM
AF Souza, Danielle G.
   Fagundes, Caio T.
   Sousa, Lirlandia P.
   Amaral, Flavio A.
   Souza, Rafael S.
   Souza, Adriano L.
   Kroon, Erna G.
   Sachs, Daniela
   Cunha, Fernando Q.
   Bukin, Eugenij
   Atrasheuskaya, Alena
   Ignatyev, George
   Teixeira, Mauro M.
TI Essential role of platelet-activating factor receptor in the
   pathogenesis of Dengue virus infection
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE inflammation; cytokines; shock
ID FACTOR ANTAGONIST; DEFICIENT MICE; ORGAN FAILURE; PAF RECEPTOR;
   DOUBLE-BLIND; MOUSE MODEL; IMMUNITY; SHOCK
AB Severe dengue infection in humans causes a disease characterized by thrombocytopenia, increased levels of cytokines, increased vascular permeability, hemorrhage, and shock. Treatment is supportive. Activation of platelet-activating factor (PAF) receptor (PAFR) on endothelial cells and leukocytes induces increase in vascular permeability, hypotension, and production of cytokines. We hypothesized that activation of PAFR could account for the major systemic manifestations of dengue infection. Inoculation of adult mice with an adapted strain of Dengue virus caused a systemic disease, with several features of the infection in humans. In PAFR(-/-) mice, there was decreased thrombocytopenia, hemoconcentration, decreased systemic levels of cytokines, and delay of lethality, when compared with WT infected mice. Treatment with UK-74,505, an orally active PAFR antagonist, prevented the above-mentioned manifestations, as well as hypotension and increased vascular permeability, and decreased lethality, even when started 5 days after virus inoculation. Similar results were obtained with a distinct PAFR antagonist, PCA-4246. Despite decreased disease manifestation, viral loads were similar (PAFR(-/-)) or lower (PAFR antagonist) than in WT mice. Thus, activation of PAFR plays a major role in the pathogenesis of experimental dengue infection, and its blockade prevents more severe disease manifestation after infection with no increase in systemic viral titers, suggesting that there is no interference in the ability of the murine host to deal with the infection. PAFR antagonists are disease-modifying agents in experimental dengue infection.
C1 [Souza, Danielle G.; Fagundes, Caio T.; Sousa, Lirlandia P.; Amaral, Flavio A.; Souza, Rafael S.; Souza, Adriano L.; Sachs, Daniela; Teixeira, Mauro M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Souza, Danielle G.; Fagundes, Caio T.; Amaral, Flavio A.; Souza, Rafael S.; Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Cunha, Fernando Q.] Univ Sao Paulo, Dept Farmacol, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, Brazil.
   [Bukin, Eugenij; Atrasheuskaya, Alena] State Res Ctr Virol & Biotechnol Vector, Lab Immunol Safety, Koltsov 630559, Novosibirsk Reg, Russia.
   [Ignatyev, George] Tarasevich State Inst Stand & Control, Biotechnol & Mol Biol Lab, Moscow 119002, Russia.
RP Teixeira, MM (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
EM mmtex@icb.ufmg.br
RI Amaral, Flavio Almeida/C-3768-2018; Kroon, Erna/V-5444-2019; Sachs,
   Daniela DS/I-3741-2012; Teixeira, Mauro M/A-4587-2008; Cunha, Fernando
   Q/M-3090-2014; Amaral, Flavio/D-5489-2014; souza, danielle/D-3378-2014;
   Kroon, Erna Geessien/B-3631-2015; Fagundes, Caio/AAK-9336-2020
OI Amaral, Flavio Almeida/0000-0002-1695-0612; Teixeira, Mauro
   M/0000-0002-6944-3008; Amaral, Flavio/0000-0002-1695-0612; Kroon, Erna
   Geessien/0000-0003-2721-3826; Fagundes, Caio/0000-0002-6747-5233; Cunha,
   Fernando Queiroz/0000-0003-4755-1670; Ignatyev,
   George/0000-0002-9731-3681
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil)National Council for Scientific and Technological
   Development (CNPq); Instituto Nacional de Ciencia e Tecnologia (INCT em
   Dengue, Brazil); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG/Brazil)Minas Gerais State Research Foundation (FAPEMIG); Simon
   Guggenheim Memorial Foundation
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq/Brazil), Instituto Nacional de Ciencia e
   Tecnologia (INCT em Dengue, Brazil), Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG/Brazil), and Simon Guggenheim Memorial
   Foundation.
CR ALABASTER VA, 1991, AGENT ACTION SUPPL, V34, P221
   An J, 1999, VIROLOGY, V263, P70, DOI 10.1006/viro.1999.9887
   Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x
   Bente DA, 2005, J VIROL, V79, P13797, DOI 10.1128/JVI.79.21.13797-13799.2005
   BENVENISTE J, 1972, J EXP MED, V136, P1356, DOI 10.1084/jem.136.6.1356
   Charlier N, 2004, ANTIVIR RES, V63, P67, DOI 10.1016/j.antiviral.2004.06.007
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102
   FERNANDEZGALLARDO S, 1990, J PHARMACOL EXP THER, V255, P34
   Freire MS, 2007, MEM I OSWALDO CRUZ, V102, P203, DOI 10.1590/S0074-02762007005000011
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8
   Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Johnson CD, 2001, GUT, V48, P62, DOI 10.1136/gut.48.1.62
   Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047
   KUITERT LM, 1995, AM J RESP CRIT CARE, V151, P1331, DOI 10.1164/ajrccm.151.5.7735582
   Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998
   Marrache AM, 2002, J IMMUNOL, V169, P6474, DOI 10.4049/jimmunol.169.11.6474
   Moreno SE, 2006, J IMMUNOL, V177, P1264, DOI 10.4049/jimmunol.177.2.1264
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   Poeze M, 2000, SHOCK, V14, P421, DOI 10.1097/00024382-200014040-00001
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI 10.1172/JCI200421512
   Santiago HC, 2006, MICROBES INFECT, V8, P2569, DOI 10.1016/j.micinf.2006.06.011
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Souza DG, 2003, BRIT J PHARMACOL, V139, P733, DOI 10.1038/sj.bjp.0705296
   Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693
   Talvani A, 2003, MICROBES INFECT, V5, P789, DOI 10.1016/S1286-4579(03)00146-1
   TERASHITA ZI, 1987, J PHARMACOL EXP THER, V243, P378
   TERASHITA ZI, 1985, BIOCHEM PHARMACOL, V34, P1491, DOI 10.1016/0006-2952(85)90689-6
   YANG ZM, 1995, MOL REPROD DEV, V42, P407, DOI 10.1002/mrd.1080420406
NR 32
TC 87
Z9 89
U1 0
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 18
PY 2009
VL 106
IS 33
BP 14138
EP 14143
DI 10.1073/pnas.0906467106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 484WE
UT WOS:000269078700092
PM 19666557
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Soares, JAP
   Leite, FGG
   Andrade, LG
   Torres, AA
   De Sousa, LP
   Barcelos, LS
   Teixeira, MM
   Ferreira, PCP
   Kroon, EG
   Souto-Padron, T
   Bonjardim, CA
AF Soares, Jamaria A. P.
   Leite, Flavia G. G.
   Andrade, Luciana G.
   Torres, Alice A.
   De Sousa, Lirlandia P.
   Barcelos, Luciola S.
   Teixeira, Mauro M.
   Ferreira, Paulo C. P.
   Kroon, Erna G.
   Souto-Padron, Thais
   Bonjardim, Claudio A.
TI Activation of the PI3K/Akt Pathway Early during Vaccinia and Cowpox
   Virus Infections Is Required for both Host Survival and Viral
   Replication
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID PROTEIN-KINASE-B; DOUBLE-STRANDED-RNA; SIGNALING PATHWAYS;
   CELL-SURVIVAL; EARLY-STAGE; IN-VITRO; AKT; APOPTOSIS; MTOR; 3-KINASE
AB Viral manipulation of the transduction pathways associated with key cellular functions such as actin remodeling, microtubule stabilization, and survival may favor a productive viral infection. Here we show that consistent with the vaccinia virus (VACV) and cowpox virus (CPXV) requirement for cytoskeleton alterations early during the infection cycle, PBK/Akt was phosphorylated at S473 [Akt(S473-P)], a modification associated with the mammalian target of rapamycin complex 2 (mTORC2), which was paralleled by phosphorylation at T308 [Akt(T308-P)] by PI3K/PDK1, which is required for host survival. Notably, while VACV stimulated Akt(S473-P/T308-P) at early (1 h postinfection [p.i.]) and late (24 h p.i.) times during the infective cycle, CPXV stimulated Akt at early times only. Pharmacological and genetic inhibition of PI3K (LY294002) or Akt (Akt-X and a dominant-negative form of Akt-K179M) resulted in a significant decline in virus yield (from 80% to >= 90%). This decline was secondary to the inhibition of late viral gene expression, which in turn led to an arrest of virion morphogenesis at the immature-virion stage of the viral growth cycle. Furthermore, the cleavage of both caspase-3 and poly(ADP-ribose) polymerase and terminal deoxynucleotidyl transferase-mediated deoxyuridine nick end labeling assays confirmed that permissive, spontaneously immortalized cells such as A31 cells and mouse embryonic fibroblasts (MEFs) underwent apoptosis upon orthopoxvirus infection plus LY294002 treatment. Thus, in A31 cells and MEFs, early viral receptor-mediated signals transmitted via the PI3K/Akt pathway are required and precede the expression of viral antiapoptotic genes. Additionally, the inhibition of these signals resulted in the apoptosis of the infected cells and a significant decline in viral titers.
C1 [Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab,Grp Transducao Sinal, BR-31270901 Belo Horizonte, MG, Brazil.
   [De Sousa, Lirlandia P.] Univ Fed Minas Gerais, Inst Ciencias Biol, Coltec, Setor Patol, BR-31270901 Belo Horizonte, MG, Brazil.
   [De Sousa, Lirlandia P.; Barcelos, Luciola S.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab Imunofarmacol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Barcelos, Luciola S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, BR-31270901 Belo Horizonte, MG, Brazil.
   [Souto-Padron, Thais] Univ Fed Rio de Janeiro, Lab Biol Celular & Ultraestrutura, BR-21941590 Rio De Janeiro, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab,Grp Transducao Sinal, Av Antonio Carlos,6627 Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM claudio.bonjardim@gmail.com
RI Abreu Torres, Alice/B-1475-2018; Barcelos, Luciola S/A-1109-2013; Kroon,
   Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Bonjardim, Claudio
   A/J-2601-2014; Teixeira, Mauro M/A-4587-2008
OI Abreu Torres, Alice/0000-0003-2352-2584; Barcelos, Luciola
   S/0000-0001-9133-4011; Kroon, Erna Geessien/0000-0003-2721-3826;
   Teixeira, Mauro M/0000-0002-6944-3008
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais,Minas Gerais
   State Research Foundation (FAPEMIG); Coordenadoria de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; Brazilian Ministry of Culture,
   Science, and Technology; Conselho Nacional de Desenvolvimento Cientfico
   e Tecnologico(CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais, the Coordenadoria de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES), the Brazilian Ministry of Culture, Science,
   and Technology, and the Conselho Nacional de Desenvolvimento Cientfico e
   Tecnologico(CNPq). J. A. P. S. was a recipient of a predoctoral
   fellowship from the CAPES, and F. G. G. L. and L. G. A. are recipients
   of predoctoral fellowships from the CNPq. L. S. B. holds a PRODOC
   research fellowship from the CAPES. C. A. B., E. G. K., P. C. P. F., M.
   M. T., and T.S.-P. are recipients research fellowships from the CNPq.
CR Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980
   Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x
   Amiri A, 2007, ONCOGENE, V26, P3027, DOI 10.1038/sj.onc.1210101
   Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882
   BABLANIAN R, 1981, VIROLOGY, V112, P1, DOI 10.1016/0042-6822(81)90606-1
   Benetti L, 2006, J VIROL, V80, P3341, DOI 10.1128/JVI.80.7.3341-3348.2006
   Bondar VM, 2002, MOL CANCER THER, V1, P989
   Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855
   Buttrick GJ, 2008, CELL CYCLE, V7, P2621, DOI 10.4161/cc.7.17.6514
   Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318
   Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8
   Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0
   Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5
   Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   Esfandiarei M, 2004, J VIROL, V78, P4289, DOI 10.1128/JVI.78.8.4289-4298.2004
   Everett H, 2002, J EXP MED, V196, P1127, DOI 10.1084/jem.20011247
   Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003
   FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0
   Fujiwara Y, 2007, MOL CANCER THER, V6, P1133, DOI 10.1158/1535-7163.MCT-06-0639
   Galetic I, 1999, PHARMACOL THERAPEUT, V82, P409, DOI 10.1016/S0163-7258(98)00071-0
   Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002
   Humlova Z, 2002, J GEN VIROL, V83, P2821, DOI 10.1099/0022-1317-83-11-2821
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Johnson RA, 2001, J VIROL, V75, P6022, DOI 10.1128/JVI.75.13.6022-6032.2001
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005
   Kibler KV, 1997, J VIROL, V71, P1992, DOI 10.1128/JVI.71.3.1992-2003.1997
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333
   Kudchodkar SB, 2006, P NATL ACAD SCI USA, V103, P14182, DOI 10.1073/pnas.0605825103
   Kudchodkar SB, 2004, J VIROL, V78, P11030, DOI 10.1128/JVI.78.20.11030-11039.2004
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151
   Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000
   Lin SYJ, 2004, MOL CELL ENDOCRINOL, V214, P127, DOI 10.1016/j.mce.2003.10.064
   Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365
   Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497
   Lu ZM, 2004, J BIOL CHEM, V279, P35664, DOI 10.1074/jbc.M403385200
   Macen JL, 1996, VIROLOGY, V218, P232, DOI 10.1006/viro.1996.0183
   Mallardo M, 2001, MOL BIOL CELL, V12, P3875, DOI 10.1091/mbc.12.12.3875
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Moody CA, 2005, J VIROL, V79, P5499, DOI 10.1128/JVI.79.9.5499-5506.2005
   MOSS B, 2006, FIELDS VIROLOGY, V2, P2905
   MOSS B, 1996, FIELDS VIROLOGY, P2637
   MUNTER S, 2006, SCI STKE, pRE5, DOI DOI 10.1126/STKE.3352006RE5
   O'Shea CC, 2005, CELL CYCLE, V4, P883, DOI 10.4161/cc.4.7.1791
   Onishi K, 2007, GENES CELLS, V12, P535, DOI 10.1111/j.1365-2443.2007.01071.x
   Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929
   Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203
   PICKUP DJ, 1986, P NATL ACAD SCI USA, V83, P7698, DOI 10.1073/pnas.83.20.7698
   Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003
   Rahaus M, 2007, CELL SIGNAL, V19, P312, DOI 10.1016/j.cellsig.2006.07.003
   RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y
   Rodriguez JR, 1998, J VIROL, V72, P1287
   Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002
   Schepis A, 2006, TRAFFIC, V7, P308, DOI 10.1111/j.1600-0854.2005.00381.x
   Schwarzer R, 2005, ONCOGENE, V24, P1138, DOI 10.1038/sj.onc.1208236
   Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049
   Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509
   Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209
   Swart R, 2000, J VIROL, V74, P10838, DOI 10.1128/JVI.74.22.10838-10845.2000
   Taylor JM, 2006, VIROLOGY, V344, P139, DOI 10.1016/j.virol.2005.09.032
   Taylor JM, 2006, J BIOL CHEM, V281, P39728, DOI 10.1074/jbc.M607465200
   Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998
   Thomas KW, 2002, J BIOL CHEM, V277, P492, DOI 10.1074/jbc.M108107200
   Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200
   Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701
   Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535
   Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124
   VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241
   Walsh D, 2006, GENE DEV, V20, P461, DOI 10.1101/gad.1375006
   Walsh D, 2005, J VIROL, V79, P8057, DOI 10.1128/JVI.79.13.8057-8064.2005
   Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304
   Walsh D, 2008, MOL CELL BIOL, V28, P2648, DOI 10.1128/MCB.01631-07
   Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132
   Wang G, 2006, P NATL ACAD SCI USA, V103, P4640, DOI 10.1073/pnas.0509341103
   Wang L, 2008, CANCER RES, V68, P4640, DOI 10.1158/0008-5472.CAN-07-5988
   Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100
   Wasilenko ST, 2005, J VIROL, V79, P14031, DOI 10.1128/JVI.79.22.14031-14043.2005
   Werden SJ, 2008, BBA-PROTEINS PROTEOM, V1784, P228, DOI 10.1016/j.bbapap.2007.08.001
   Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217
   Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6
   Yu YJ, 2005, J VIROL, V79, P6882, DOI 10.1128/JVI.79.11.6882-6889.2005
   Zhang BY, 2002, J VIROL, V76, P220, DOI 10.1128/JVI.76.1.220-231.2002
   Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07
NR 97
TC 78
Z9 83
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2009
VL 83
IS 13
BP 6883
EP 6899
DI 10.1128/JVI.00245-09
PG 17
WC Virology
SC Virology
GA 462LM
UT WOS:000267354100054
PM 19386722
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Abrahao, JS
   Campos, RK
   Trindade, GS
   Guedes, MIM
   Lobato, ZIP
   Mazur, C
   Ferreira, PCP
   Bonjardim, CA
   Kroon, EG
AF Abrahao, Jonatas S.
   Campos, Rafael K.
   Trindade, Giliane S.
   Guedes, Maria I. M.
   Lobato, Zelia I. P.
   Mazur, Carlos
   Ferreira, Paulo C. P.
   Bonjardim, Claudio A.
   Kroon, Erna G.
TI Detection and phylogenetic analysis of Orf virus from sheep in Brazil: a
   case report
SO VIROLOGY JOURNAL
LA English
DT Article
ID MOLECULAR CHARACTERIZATION; DIAGNOSIS; GOATS
AB Background: Orf virus (ORFV), the prototype of the genus Parapoxvirus (PPV), is the etiological agent of contagious ecthyma, a severe exanthematic dermatitis that afflicts domestic and wild small ruminants. Although South American ORFV outbreaks have occurred and diagnosed there are no South American PPV major membrane glycoprotein B2L gene nucleotide sequences available.
   Case presentation: an outbreak of ovine contagious ecthyma in Midwest Brazil was investigated. The diagnosis was based on clinical examinations and molecular biology techniques. The molecular characterization of the virus was done using PCR amplification, cloning and DNA sequencing of the B2L gene. The phylogenetic analysis demonstrated a high degree of identity with ORFV strains, and the isolate was closest to the ORFV-India 82/04 isolate. Another Brazilian ORFV isolate, NE1, was sequenced for comparative analysis and also showed a high degree of identity with an Asian ORFV strain.
   Conclusion: Distinct ORFV strains are circulating in Brazil. This is the first report on the phylogenetic analysis of an ORFV in South America.
C1 [Abrahao, Jonatas S.; Campos, Rafael K.; Trindade, Giliane S.; Guedes, Maria I. M.; Ferreira, Paulo C. P.; Bonjardim, Claudio A.; Kroon, Erna G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Lobato, Zelia I. P.] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, BR-31270901 Belo Horizonte, MG, Brazil.
   [Mazur, Carlos] Univ Fed Rural Rio de Janeiro, Dept Microbiol & Imunol Vet, BR-23890000 Rio De Janeiro, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com; rafaklugleafar@msn.com;
   gitrindade@yahoo.com.br; isabelguedes@icb.ufmg.br; ziplobat@vet.ufmg.br;
   mazur@ufrj.br; pauloferreira120@hotmail.com;
   claudio.bonjardim@pq.cnpq.br; kroone@icb.ufmg.br
RI Campos, Rafael Kroon/AAB-5135-2020; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015; Abrahao, Jonatas/B-3895-2015; Bonjardim, Claudio
   A/J-2601-2014
OI Campos, Rafael Kroon/0000-0002-4852-0449; Kroon, Erna
   Geessien/0000-0003-2721-3826; Abrahao, Jonatas/0000-0001-9420-1791;
   Lobato, Zelia/0000-0002-9399-3691
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIG. EGKMinas Gerais State Research Foundation
   (FAPEMIG); CAB; PCPF
FX We thank MSc. Joao R. dos Santos, Angela S. Lopes, Ilda M. V. Gamma, and
   colleagues from Laboratorio de VIrus (ICB-UFMG). Financial support was
   provided by CNPq, CAPES and FAPEMIG. EGK, CAB and PCPF received
   fellowship from CNPq.
CR Almagro M, 1991, Enferm Infecc Microbiol Clin, V9, P286
   Ara M, 2008, J AM ACAD DERMATOL, V58, pS39, DOI 10.1016/j.jaad.2006.04.027
   Chan KW, 2007, VIRUS GENES, V35, P705, DOI 10.1007/s11262-007-0144-6
   *COCA C CALL, COCA C CALL ROCK MOU
   DAMON I, 2007, FIELDS VIROLOGY, P2079
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Gallina L, 2006, J VIROL METHODS, V134, P140, DOI 10.1016/j.jviromet.2005.12.014
   GROVES R, 1990, ARCH DERMATOL, V126, P1649, DOI 10.1001/archderm.126.12.1649
   Guo J, 2004, VET MICROBIOL, V99, P81, DOI 10.1016/j.vetmic.2003.11.010
   Guo J, 2003, VIRUS RES, V93, P169, DOI 10.1016/S0168-1702(03)00095-9
   Haig DM, 1998, VET RES, V29, P311
   Hosamani M, 2006, VET MICROBIOL, V116, P317, DOI 10.1016/j.vetmic.2006.04.028
   Inoshima Y, 2002, MICROBIOL IMMUNOL, V46, P583, DOI 10.1111/j.1348-0421.2002.tb02738.x
   Inoshima Y, 2000, J VIROL METHODS, V84, P201, DOI 10.1016/S0166-0934(99)00144-5
   Mazur C, 2000, VET MICROBIOL, V73, P253, DOI 10.1016/S0378-1135(99)00151-0
   Nobrega JE, 2008, PESQUISA VET BRASIL, V28, P135, DOI 10.1590/S0100-736X2008000300002
   Torfason EG, 2002, J CLIN VIROL, V24, P79, DOI 10.1016/S1386-6532(01)00232-3
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   WHEELER CE, 1956, AM J PATHOL, V32, P535
NR 19
TC 32
Z9 40
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD MAY 4
PY 2009
VL 6
AR 47
DI 10.1186/1743-422X-6-47
PG 4
WC Virology
SC Virology
GA 452IR
UT WOS:000266534200001
PM 19413907
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Ferreira, JMS
   Drumond, BP
   Abrahao, JS
   Lobato, ZIP
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Siqueira Ferreira, Jaqueline Maria
   Drumond, Betania Paiva
   Abrahao, Jonatas Santos
   Portal Lobato, Zelia Ines
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Brazilian vaccinia virus strains show a classical orthopoxvirus
   infection course and cross-protection
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Orthopoxvirus; Zoonoses; Balb/c mice; Intradermal injection; Vaccinia
   virus; Bovine vaccinia outbreaks
ID RIO-DE-JANEIRO; COWPOX VIRUS; POXVIRUS PATHOGENESIS; RESERVOIR HOSTS;
   HUMAN MONKEYPOX; OUTBREAK; CATTLE; MICE; HUMANS; STATE
AB Objectives: The purpose of this work was to study the infection course and cross-protection in mice after intradermal injection of Vaccinia virus (VACV) strain Western Reserve and three Brazilian VACV strains: Aracatuba, Muriae and BeAn58058 isolated from cow, human and rodent, respectively. Methods: Balb/c mice were inoculated by footpad and back scarification and daily monitored regarding lesion development and weight loss. To check cross protection after intradermal VACV inoculation, mice were subsequently infected with different VACV strains and monitored to check lesion development. Serum neutralization assays were performed to check for the presence of antibodies against Orthopoxvirus. Results: After VACV intradermal inoculation the lesion development pattern was similar in mice infected with the different virus strains. By using the footpad scarification model, cross-protection among VACV strains was observed. Moreover, neutralizing antibodies against Orthopoxvirus were detected in sera from mice infected with all VACV strains. Conclusion: Although it was not possible to observe virulence differences among VACV strains isolated from cow, rodent and human using the murine model, this inoculation route showed to be an appropriated model to study lesions development since it mimics natural infections by VACV in nature.
C1 [Siqueira Ferreira, Jaqueline Maria; Drumond, Betania Paiva; Abrahao, Jonatas Santos; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Portal Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM masc.egk@terra.com.br
RI Abrahao, Jonatas/B-3895-2015; Kroon, Erna/V-5444-2019; Ferreira,
   Jaqueline/E-4630-2018; Bonjardim, Claudio A/J-2601-2014
OI Abrahao, Jonatas/0000-0001-9420-1791; Ferreira,
   Jaqueline/0000-0002-1779-1975; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX Financial support was provided by CNPq, CAPES and FAPEMIG. Jaqueline M.
   S. Ferreira received fellowship from CAPES. R. M. E. P. C. P. Ferreira,
   C. A. Bonjardim, Z. I. P. Lobato and E. G. Kroon are recipients of
   research fellowship from CNPq.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   BAXBY D, 1994, BRIT J DERMATOL, V131, P598, DOI 10.1111/j.1365-2133.1994.tb04969.x
   Baxby D, 1981, J Hist Med Allied Sci, V36, P218
   Brandt T, 2005, VIROLOGY, V333, P263, DOI 10.1016/j.virol.2005.01.006
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423
   CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Diniz S, 2001, ARQ BRAS MED VET ZOO, V53, P152, DOI 10.1590/S0102-09352001000200003
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   FENNER F, 1949, J IMMUNOL, V63, P341
   FENNER F, 1989, RES VIROLOGY, V140, P465, DOI 10.1016/S0923-2516(89)80126-8
   Fenner F., 1988, SMALLPOX ITS ERADICA
   FERREIRA JMS, PLOS ONE, V3, pE3043
   Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005
   Kolhapure RM, 1997, INDIAN J MED RES, V106, P441
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   MILLER CG, 1995, CELL IMMUNOL, V162, P326, DOI 10.1006/cimm.1995.1086
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Pahlitzsch R, 2006, CLIN INFECT DIS, V43, P737, DOI 10.1086/506937
   Quenelle DC, 2004, ANTIVIR RES, V63, P33, DOI 10.1016/j.antiviral.2004.02.003
   Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977
   Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
NR 38
TC 1
Z9 1
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD APR
PY 2009
VL 2
IS 2
BP 21
EP 26
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 662CU
UT WOS:000282785500004
DA 2020-11-30
ER

PT J
AU Silva-Fernandes, AT
   Travassos, CEPF
   Ferreira, JMS
   Abrahao, JS
   Rocha, ESD
   Viana-Ferreira, F
   dos Santos, JR
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Silva-Fernandes, Andre Tavares
   Pires Ferreira Travassos, Carlos Eurico
   Siqueira Ferreira, Jaqueline Maria
   Abrahao, Jonatas Santos
   de Oliveira Rocha, Eliseu Soares
   Viana-Ferreira, Flavia
   dos Santos, Joao Rodrigues
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Natural human infections with Vaccinia virus during bovine vaccinia
   outbreaks
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Bovine vaccinia outbreaks; Vaccinia virus; Zoonosis; Poxvirus;
   Epidemiology
ID RIO-DE-JANEIRO; CATTLE; BUFFALOPOX; POXVIRUS; IMMUNITY; STRAINS; BRAZIL;
   STATE
AB Background: Bovine vaccinia is an exanthematic disease caused by Vaccinia virus (VACV). This zoonosis has been associated with several cases of bovine infection, particularly in milk herds. Farmers, milkers and their close contacts developed lesions on the hands, forearms, legs and face accompanied by fever, headache, malaise, myalgia and axillary, inguinal and cervical lymphadenopathy. VACV infections have a significant public health impact due to their occupational character, high frequency of transmission and the improper medical treatment often applied.
   Objectives: To study natural human infection by VACV and to analyze clinical and epidemiological aspects, emphasizing the patients' immunological status.
   Study design: Ninety-eight individuals from rural properties with bovine vaccinia (BV) outbreaks who were at risk due to contact were submitted to epidemiological and clinical studies. From these individuals, 54 sera were analyzed by serological and molecular procedures. This study was conducted in Rio de Janeiro State from September 2002 to October 2006.
   Results: The clinical frequency of infection was 52.0%, with 57.4% ELISA and 43.0% PRNT-positive reactions. DNAemia was detected in 18.5% of the analyzed sera, and 50% of smallpox-vaccinated individuals developed symptoms.
   Conclusions: This study confirms the high clinical frequency of human VACV infection, even among vaccinated individuals. The infection was related to detection of IgG- or IgM-specific antibodies that correlates in most of the cases with positive PRNT. The DNAemia suggests viremia during VACV natural infections. Our data indicate that patients vaccinated against smallpox may no longer be protected. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Silva-Fernandes, Andre Tavares; Siqueira Ferreira, Jaqueline Maria; Abrahao, Jonatas Santos; de Oliveira Rocha, Eliseu Soares; Viana-Ferreira, Flavia; dos Santos, Joao Rodrigues; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva-Fernandes, Andre Tavares; Pires Ferreira Travassos, Carlos Eurico] Univ Estadual Norte Fluminense, Ctr Ciencias & Tecnol Agropecuarias, Hosp Vet, Lab Sanidade Anim, BR-28015620 Rio De Janeiro, Brazil.
RP Silva-Fernandes, AT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos,6627 Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM fernandeserthal@gmail.com; cakatrav@uenf.br; jackmaria4@gmail.com;
   jonatas.abrahao@gmail.com; eliseubiologia@gmail.com;
   fvianaferreira@yahoo.com.br; santosjr@icb.ufmg.br; claubonj@icb.ufmg.br;
   peregrino@icb.ufmg.br; kroone@icb.ufmg.br
RI Bonjardim, Claudio A/J-2601-2014; Kroon, Erna/V-5444-2019; Ferreira,
   Jaqueline/E-4630-2018; Abrahao, Jonatas/B-3895-2015; Kroon, Erna
   Geessien/B-3631-2015
OI Ferreira, Jaqueline/0000-0002-1779-1975; Abrahao,
   Jonatas/0000-0001-9420-1791; Kroon, Erna Geessien/0000-0003-2721-3826;
   Silva Ferreira, Antonio Cesar/0000-0002-1188-1021; Rocha,
   Eliseu/0000-0002-2854-0768
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); FAPEMIGMinas Gerais
   State Research Foundation (FAPEMIG)
FX We thank Iara A. Borges for critical reading of the manuscript, as well
   as Jaquelline G. de Oliveira PhD, Angela S. Lopes, Ilda M.V. Gamma and
   colleagues from the Laboratorio de Virus (ICB-UFMG). Financial support
   was provided by CNPq, CAPES, FAPERJ and FAPEMIG. Andre T.
   Silva-Fernandes received fellowship support from FAPERJ. Erna G. Kroon,
   Claudio A. Bonjardim, and Paulo C.P. Ferreira received fellowships from
   CNPq.
CR Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Cohen JI, 2007, VACCINE, V25, P4571, DOI 10.1016/j.vaccine.2007.03.044
   CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258
   da Fonseca FG, 1998, ARCH VIROL, V143, P1171
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I, 2007, FIELDS VIROLOGY, P2947
   Donatele D. M., 2007, Brazilian Journal of Veterinary Research and Animal Science, V44, P275
   DUMBELL K, 1993, ARCH VIROL, V128, P257, DOI 10.1007/BF01309438
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karem KL, 2007, CLIN VACCINE IMMUNOL, V14, P1318, DOI 10.1128/CVI.00148-07
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leparc-Goffart I, 2005, J CLIN VIROL, V32, P47, DOI 10.1016/j.jcv.2004.07.005
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Mazur C, 2000, VET MICROBIOL, V73, P253, DOI 10.1016/S0378-1135(99)00151-0
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Nitsche A, 2007, J CLIN VIROL, V40, P160, DOI 10.1016/j.jcv.2007.07.014
   Panchanathan V, 2008, IMMUNOL CELL BIOL, V86, P80, DOI 10.1038/sj.icb.7100118
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   SAVONA MR, 2006, JAMA-J AM MED ASSOC, V26, P1898
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Singh RX, 2006, REV SCI TECH OIE, V25, P981, DOI 10.20506/rst.25.3.1708
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Zafar A, 2007, EMERG INFECT DIS, V13, P902, DOI 10.3201/eid1306.061068
NR 31
TC 57
Z9 58
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD APR
PY 2009
VL 44
IS 4
BP 308
EP 313
DI 10.1016/j.jcv.2009.01.007
PG 6
WC Virology
SC Virology
GA 436WL
UT WOS:000265446700011
PM 19243990
DA 2020-11-30
ER

PT J
AU Trindade, GS
   Guedes, MIC
   Drumond, BP
   Mota, BEF
   Abrahao, JS
   Lobato, ZIP
   Gomes, JAS
   Correa-Oliveira, R
   Nogueira, ML
   Kroon, EG
   da Fonseca, FG
AF Trindade, Giliane S.
   Guedes, Maria I. C.
   Drumond, Betania P.
   Mota, Bruno E. F.
   Abrahao, Jonatas S.
   Lobato, Zelia I. P.
   Gomes, Juliana A. S.
   Correa-Oliveira, Rodrigo
   Nogueira, Mauricio L.
   Kroon, Erna G.
   da Fonseca, Flavio G.
TI Zoonotic Vaccinia Virus: Clinical and Immunological Characteristics in a
   Naturally Infected Patient
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID COWPOX; BRAZIL; HUMANS
AB Vaccinia virus was used as vaccine to eradicate smallpox. We report a zoonotic case of vaccinia virus infection in a 30-year-old patient who became infected after handling sick dairy cattle. The patient had inflamed lesions and systemic symptoms. Laboratory findings were indicative of down-modulated immune responses to the virus.
C1 [Trindade, Giliane S.; Guedes, Maria I. C.; Drumond, Betania P.; Mota, Bruno E. F.; Abrahao, Jonatas S.; Kroon, Erna G.; da Fonseca, Flavio G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Lobato, Zelia I. P.] Univ Fed Minas Gerais, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
   [Gomes, Juliana A. S.; Correa-Oliveira, Rodrigo; da Fonseca, Flavio G.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Dept Doencas Infecciosas & Parasitarias, Sao Jose Do Rio Preto, Brazil.
RP da Fonseca, FG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM fdafonseca@cpqrr.fiocruz.br
RI Abrahao, Jonatas/B-3895-2015; Gomes, Juliana A. S./M-4083-2017;
   Nogueira, Mauricio L/B-7599-2012; Kroon, Erna Geessien/B-3631-2015;
   Kroon, Erna/V-5444-2019
OI Abrahao, Jonatas/0000-0001-9420-1791; Gomes, Juliana A.
   S./0000-0002-8332-2907; Nogueira, Mauricio L/0000-0003-1102-2419; Kroon,
   Erna Geessien/0000-0003-2721-3826; Mota, Bruno/0000-0003-0348-4875;
   Correa-Oliveira, Rodrigo/0000-0001-6419-9459; Lobato,
   Zelia/0000-0002-9399-3691
FU Brazilian National Council of Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas GeraisMinas
   Gerais State Research Foundation (FAPEMIG); Division of Microbiology and
   Infectious Diseases; National Institute of Allergy and Infectious
   DiseaseUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA
FX Brazilian National Council of Scientific and Technological Development
   (through a Strategic Program for Health Research IV grant and
   fellowships to F.G.d.F., E.G.K., Z.I.P.L., and R.C.-O.), Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais, and the Division of
   Microbiology and Infectious Diseases, National Institute of Allergy and
   Infectious Disease, National Institutes of Health Opportunity Pool fund.
CR Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x
   Coras B, 2005, LANCET, V365, P446
   Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011
   Gomes JAS, 2005, INFECT IMMUN, V73, P7960, DOI 10.1128/IAI.73.12.7960-7966.2005
   Honlinger B, 2005, BRIT J DERMATOL, V153, P451, DOI 10.1111/j.1365-2133.2005.06731.x
   Johnston JB, 2003, J VIROL, V77, P6093, DOI 10.1128/JVI.77.11.6093-6100.2003
   Kolhapure RM, 1997, INDIAN J MED RES, V106, P441
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
NR 13
TC 27
Z9 27
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD FEB 1
PY 2009
VL 48
IS 3
BP E37
EP E40
DI 10.1086/595856
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 392GM
UT WOS:000262291200022
PM 19115976
OA Bronze
DA 2020-11-30
ER

PT J
AU Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Bonjardim, Claudio A.
   Ferreira, Paulo C. P.
   Kroon, Erna G.
TI Interferons: Signaling, antiviral and viral evasion
SO IMMUNOLOGY LETTERS
LA English
DT Review
DE Interferons; Innate immune recognition/evasion; Antiviral
ID PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNE-RESPONSES;
   DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; TOLL-LIKE RECEPTORS; KAPPA-B
   KINASE; ACTIVATED PROTEIN-KINASE; IFN-BETA PROMOTER; INDUCIBLE GENE-I;
   P70 S6 KINASE
AB Interferons (IFNs) were discovered as antiviral agents 50 years ago, and enormous progress has been made since then. Nowadays, IFNs (specifically type I IFNs), have been ascribed as the cytokines that bridge the innate and adaptive immunity soon after the recognition of pathogen-associated molecular patterns (PAMPs)by the infected host. Notably, a unifying mechanism for type IIFN production has been established upon innate immune detection. Thus, TLR 3,4,7 and 9 associate endosomal recognition of PAMPs to type I IFN responses, a mechanism that has been shown in plasmacytoid dendritic cells to be dependent on the PI3K/mTOR/S6K pathway. It is worth noting that pathogen recognition triggers a fine-tuned controlled program that not only includes the production of antiviral (IFN) and pro-inflammatory cytokines to initiate the antiviral response but also signals the cessation of the response through the induction of suppressors of cytokine signaling (SOCS). SOCS in turn is under tight regulation of the TAM receptors (protein tyrosine kinase receptors TYRO3, AXL and MER), and activation of which thereby protects the host from the threats of autoimmune diseases. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Bonjardim, Claudio A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Grp Transducao Sinal,Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Grp Transducao Sinal,Lab Virus, Av Antonio Carlos,6627 Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM claudio.bonjardim@pq.cnpq.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Bonjardim,
   Claudio A/J-2601-2014
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101
   Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104
   Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124
   Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010
   Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06
   Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280
   Bochud PY, 2007, J INFECT DIS, V196, P505, DOI 10.1086/519693
   Bonjardim CA, 2005, MICROBES INFECT, V7, P569, DOI 10.1016/j.micinf.2005.02.001
   Bottazzi B, 2006, CURR OPIN IMMUNOL, V18, P10, DOI 10.1016/j.coi.2005.11.009
   Brand S, 2005, BIOCHEM BIOPH RES CO, V331, P543, DOI 10.1016/j.bbrc.2005.04.004
   Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056
   Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645
   Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346
   Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002
   Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022
   Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730
   Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141
   DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455
   DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900
   Almeida GMD, 2008, ANTIVIR RES, V80, P302, DOI 10.1016/j.antiviral.2008.06.016
   Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267
   Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4
   Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623
   DeVries TA, 2004, J BIOL CHEM, V279, P45603, DOI 10.1074/jbc.M407448200
   Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616
   Douagi I, 2007, J VIROL, V81, P2758, DOI 10.1128/JVI.01555-06
   Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200
   FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035
   Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921
   Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358
   Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103
   Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891
   HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13
   Hahn AM, 2005, J VIROL, V79, P10040, DOI 10.1128/JVI.79.15.10040-10052.2005
   Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1
   Hargreaves DC, 2005, J CLIN IMMUNOL, V25, P503, DOI 10.1007/s10875-005-8065-4
   Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652
   Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954
   Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009
   Honda K, 2006, IUBMB LIFE, V58, P290, DOI 10.1080/15216540600702206
   Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505
   Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048
   Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282
   Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112
   Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07
   Kadowaki N, 2001, J IMMUNOL, V166, P2291, DOI 10.4049/jimmunol.166.4.2291
   Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569
   Kalvakolanu DV, 2003, PHARMACOL THERAPEUT, V100, P1, DOI 10.1016/S0163-7258(03)00070-6
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010
   Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105
   Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200
   Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243
   Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821
   Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Krause CD, 2005, PHARMACOL THERAPEUT, V106, P299, DOI 10.1016/j.pharmthera.2004.12.002
   Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674
   Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200
   Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792
   Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100
   Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571
   Lee HK, 2008, CURR OPIN IMMUNOL, V20, P23, DOI 10.1016/j.coi.2008.01.001
   Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880
   Lefort S, 2007, J VIROL, V81, P10950, DOI 10.1128/JVI.00183-07
   Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021
   Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Coelho LFL, 2008, IMMUNOL LETT, V118, P110, DOI 10.1016/j.imlet.2008.03.016
   Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161
   Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385
   Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0
   Li H, 2008, J BIOL CHEM, V283, P13077, DOI 10.1074/jbc.M800604200
   Li H, 2007, CELL MOL IMMUNOL, V4, P407
   Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102
   Li YZ, 2004, J BIOL CHEM, V279, P970, DOI 10.1074/jbc.M309927200
   Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05
   Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633
   Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103
   Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663
   Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042
   Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299
   Mansur DS, 2005, AM J PATHOL, V166, P1419, DOI 10.1016/S0002-9440(10)62359-0
   Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660
   Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205
   Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07
   Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200
   Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06
   Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200
   Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279
   Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200
   NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6
   Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374
   Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200
   Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003
   Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x
   Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012
   Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Prakash A, 2006, BIOCHEM BIOPH RES CO, V342, P50, DOI 10.1016/j.bbrc.2006.01.122
   Ramsauer K, 2002, P NATL ACAD SCI USA, V99, P12859, DOI 10.1073/pnas.192264999
   Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020
   Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Saha SK, 2006, CELL CYCLE, V5, P804, DOI 10.4161/cc.5.8.2637
   Sarangi PP, 2007, J VIROL, V81, P11128, DOI 10.1128/JVI.01008-07
   Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847
   Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27
   Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   Sousa LP, 2005, FRONT BIOSCI-LANDMRK, V10, P2534, DOI 10.2741/1718
   Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007
   Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004
   Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297
   Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009
   Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520
   Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308
   Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002
   Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013
   Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003
   Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573
   Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034
   Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080
   TANIGUCHI T, 1980, P NATL ACAD SCI-BIOL, V77, P4003, DOI 10.1073/pnas.77.7.4003
   Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567
   Thompson JM, 2008, ADV DRUG DELIVER REV, V60, P786, DOI 10.1016/j.addr.2007.11.003
   Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131
   Uddin S, 2000, J BIOL CHEM, V275, P27634
   Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127
   UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938
   Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200
   Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200
   Ulane CM, 2005, J VIROL, V79, P10180, DOI 10.1128/JVI.79.16.10180-10189.2005
   Valledor AF, 2008, J IMMUNOL, V180, P4523, DOI 10.4049/jimmunol.180.7.4523
   van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014
   Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444
   Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597
   Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132
   Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014
   Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104
   Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104
   Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093
   Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465
   Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599
   Zitzmann K, 2007, CANCER RES, V67, P5025, DOI 10.1158/0008-5472.CAN-06-2575
NR 159
TC 127
Z9 139
U1 0
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD JAN 29
PY 2009
VL 122
IS 1
BP 1
EP 11
DI 10.1016/j.imlet.2008.11.002
PG 11
WC Immunology
SC Immunology
GA 417BP
UT WOS:000264049900001
PM 19059436
OA Green Published
DA 2020-11-30
ER

PT S
AU Vilela, MC
   Mansur, DS
   Lacerda-Queiroz, N
   Rodrigues, DH
   Lima, GK
   Arantes, RME
   Kroon, EG
   Campos, MAD
   Teixeira, MM
   Teixeira, AL
AF Vilela, Marcia Carvalho
   Mansur, Daniel Santos
   Lacerda-Queiroz, Norinne
   Rodrigues, David Henrique
   Lima, Graciela Kunrath
   Esteves Arantes, Rosa Maria
   Kroon, Erna Geessien
   da Silva Campos, Marco Antonio
   Teixeira, Mauro Martins
   Teixeira, Antonio Lucio
BE Savino, W
   Silva, PO
   Besedovsky, H
TI The Chemokine CCL5 Is Essential for Leukocyte Recruitment in a Model of
   Severe Herpes simplex Encephalitis
SO NEUROIMMUNOMODULATION: FROM FUNDAMENTAL BIOLOGY TO THERAPY
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 7th Congress of the International-Society-for-Neuroimmunomodulation
CY APR 14-27, 2008
CL Rio de Janerio, BRAZIL
SP Int Soc Neuroimmunomoduat
DE CCL5; Met-RANTES; Herpes virus; encephalitis; intravital microscopy
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM;
   MULTIPLE-SCLEROSIS; RECEPTOR ANTAGONIST; VIRUS TYPE-2; RANTES; MICE
AB The Herpes simplex virus-1 (HSV-1) is responsible for several clinical manifestations in humans, including encephalitis. To induce encephalitis, C57BL/6 mice were inoculated with 104 plaque-forming cells of HSV-1 by the intracranial route. Met-RANTES (regulated upon activation, normal T cell expressed and presumably secreted) (10 mu g/mouse), a CC chemokine family receptor (CCR)1 and CCR5 antagonist, was given subcutaneously the day before, immediately after, and at days 1, 2, and 3 after infection. Treatment with Met-RANTES had no effect on the viral titers. In contrast, intravital microscopy revealed that treatment with Met-RANTES decreased the number of leukocytes adherent to the pial microvasculature at days I and 3 after infection. The levels of the chemokines CCL3, CCL5, CXCL1, and CXCL9 increased after infection and were enhanced further by the treatment with Met-RANTES. Treatment with a polyclonal anti-CCL5 antibody 2 h before the intravital microscopy decreased leukocyte adhesion in the microcirculation of infected mice. In conclusion, CCL5, a chemokine that binds to CCR1 and CCR5, is essential for leukocyte adhesion during HSV-1 encephalitis. However, blocking of CCR1 and CCR5 did not affect HSV-1 replication, suggesting that other immune mechanisms are involved in the process of infection control.
C1 [Vilela, Marcia Carvalho; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, BR-30130100 Belo Horizonte, MG, Brazil.
   [Mansur, Daniel Santos; Lima, Graciela Kunrath; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-30130100 Belo Horizonte, MG, Brazil.
   [Lacerda-Queiroz, Norinne; Rodrigues, David Henrique; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-30130100 Belo Horizonte, MG, Brazil.
   [Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, BR-30130100 Belo Horizonte, MG, Brazil.
   [da Silva Campos, Marco Antonio] Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190 Belo Horizonte, MG, Brazil.
RP Teixeira, AL (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Av Alfredo Balena,190 Santa Efigenia, BR-30130100 Belo Horizonte, MG, Brazil.
EM altexr@gmail.com
RI Mansur, Daniel/AAQ-8062-2020; Arantes, Rosa ME/C-5749-2013; Campos,
   Marco A/C-4000-2013; Kroon, Erna Geessien/B-3631-2015; Kroon,
   Erna/V-5444-2019
OI Mansur, Daniel/0000-0001-6773-9334; Arantes, Rosa
   ME/0000-0003-1428-9717; Campos, Marco A/0000-0003-4683-0176; Kroon, Erna
   Geessien/0000-0003-2721-3826; Teixeira, Antonio
   Lucio/0000-0002-9621-5422
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo A Pesquisa do Estado de Minas Gerais
   (Fapemig), BrazilMinas Gerais State Research Foundation (FAPEMIG)
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo A Pesquisa do
   Estado de Minas Gerais (Fapemig), Brazil.
CR Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340
   Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x
   Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141
   Coelho PS, 2002, J LEUKOCYTE BIOL, V71, P837
   dos Santos AC, 2005, J NEUROIMMUNOL, V162, P122, DOI 10.1016/j.jneuroim.2005.01.020
   Glass WG, 2004, J IMMUNOL, V172, P4018, DOI 10.4049/jimmunol.172.7.4018
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kennedy PGE, 2002, J NEUROL NEUROSUR PS, V73, P237, DOI 10.1136/jnnp.73.3.237
   Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000
   Kubes P, 2000, BRAIN PATHOL, V10, P127
   Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1
   Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706
   Matsui M, 2002, J NEUROIMMUNOL, V128, P16, DOI 10.1016/S0165-5728(02)00121-2
   Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001
   Morteau O, 2002, GASTROENTEROLOGY, V122, P725, DOI 10.1053/gast.2002.31873
   Nogueira ML, 2001, J CLIN PATHOL, V54, P103, DOI 10.1136/jcp.54.2.103
   PlaterZyberk C, 1997, IMMUNOL LETT, V57, P117, DOI 10.1016/S0165-2478(97)00075-8
   Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599
   Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405
   SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0
   Sorensen LN, 2004, SCAND J IMMUNOL, V59, P321, DOI 10.1111/j.0300-9475.2004.01399.x
   Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150
   Thapa M, 2007, J VIROL, V81, P3704, DOI 10.1128/JVI.02626-06
   VILELA MC, 2008, THESIS U FEDERAL MIN
   Wells TNC, 1998, TRENDS PHARMACOL SCI, V19, P376, DOI 10.1016/S0165-6147(98)01247-4
   Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9
NR 28
TC 35
Z9 35
U1 0
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA
SN 0077-8923
BN 978-1-57331-746-7
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2009
VL 1153
BP 256
EP 263
DI 10.1111/j.1749-6632.2008.03959.x
PG 8
WC Multidisciplinary Sciences; Neurosciences
SC Science & Technology - Other Topics; Neurosciences & Neurology
GA BIY82
UT WOS:000263827300028
PM 19236348
DA 2020-11-30
ER

PT J
AU Almeida, GMD
   de Oliveira, DB
   Magalhaes, CLD
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF de Freitas Almeida, Gabriel Magno
   de Oliveira, Danilo Bretas
   de Brito Magalhaes, Cintia Lopes
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Antiviral activity of type I interferons and interleukins 29 and 28a
   (type III interferons) against Apeu virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Interferon; Interleukin; Lambda; Antiviral; Apeu; Bunyaviridae
ID HEMORRHAGIC-FEVER; ANTITUMOR-ACTIVITY; AMAZON REGION; IFN-LAMBDA; VERO
   CELLS; RECEPTOR; INHIBITION; INDUCE; ALPHA; BUNYAVIRUSES
AB Interferons (IFNs) are cytokines with important immunomodulatory activity in vertebrates. Although type I IFNs and interleukins (IL) 29 and 28a (type III IFNs) bind to different cellular receptors and have distinct structures, most of their biological activities are redundant. Apeu virus (APEUV) is a member of the Bunyaviridae family isolated from the Brazilian rain forest. In this paper we evaluated the antiviral activity of type I and type III IFNs against APEUV. All tested IFNs were able to induce an antiviral state against the virus in a dose-dependent way. The activity of type III IFNs did not need the presence of type I IFNs. Mixing both types of IFNs did not improve the biological activity of each type alone. The tested IFNs were also able to protect human peripheral blood mononuclear cells from infection. IFN alpha2, IFN beta, IL-29 and IL-28a induced the expression of 2',5'-oligoadenylate synthetase (2'5'OAS) and 6-16 genes. Although MxA gene was related to antiviral activity against Bunyaviruses, there was no induction of MxA in our model. We were able to show activity of type I and type III IFNs against a RNA virus, and that this activity is not dependent on MxA gene. (C) 2008 Elsevier B.V. All rights reserved.
C1 [de Freitas Almeida, Gabriel Magno; de Oliveira, Danilo Bretas; de Brito Magalhaes, Cintia Lopes; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM gb_mfa@yahoo.com.br; kroone@icb.ufmg.br
RI Bonjardim, Claudio A/J-2601-2014; Kroon, Erna/V-5444-2019; Almeida,
   Gabriel MF/I-8910-2012; Kroon, Erna Geessien/B-3631-2015
OI Almeida, Gabriel MF/0000-0003-2317-5092; Kroon, Erna
   Geessien/0000-0003-2721-3826
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX We would like to thank Angela S. Lopes, JoAo Rodrigues dos Santos and
   Ilda M. V. Gama for their secretarial/technical assistance. We also
   thank Dr. Gilles Uze for kindly donating the plasmids for IL-29 and
   IL-28a production.; This work was supported by research grants from
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG).
   G.M.F. Almeida and C.L.B. Magalhaes received fellowships from CAPES. DB
   Oliveira received fellowships from CNPq. C.A. Bonjardim, E.G. Kroon and
   P.C.P. Ferreira are recipients of research fellowships from CNPq.
CR Alcami A, 2002, J GEN VIROL, V83, P545, DOI 10.1099/0022-1317-83-3-545
   Andersson I, 2004, J VIROL, V78, P4323, DOI 10.1128/JVI.78.8.4323-4329.2004
   Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006
   Bartlett NW, 2005, J GEN VIROL, V86, P1589, DOI 10.1099/vir.0.80904-0
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005
   Brand S, 2005, BIOCHEM BIOPH RES CO, V331, P543, DOI 10.1016/j.bbrc.2005.04.004
   Bridgen A, 2004, VIRUS RES, V99, P47, DOI 10.1016/j.virusres.2003.10.002
   Calisher C. H., 1996, The Bunyaviridae., P1
   CAUSEY OR, 1961, AM J TROP MED HYG, V10, P227, DOI 10.4269/ajtmh.1961.10.227
   Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610
   DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259
   DULBECCO R, 1953, COLD SPRING HARB SYM, V18, P273, DOI 10.1101/SQB.1953.018.01.039
   Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200
   Elliott RM, 1997, MOL MED, V3, P572, DOI 10.1007/BF03401814
   FERREIRA PCP, 1979, J CLIN MICROBIOL, V9, P471
   Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996
   Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004
   GIBBS CJ, 1964, AM J TROP MED HYG, V13, P108, DOI 10.4269/ajtmh.1964.13.108
   Huang JY, 2007, P NATL ACAD SCI USA, V104, P9822, DOI 10.1073/pnas.0610352104
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048
   Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382
   Jordan WJ, 2007, GENES IMMUN, V8, P13, DOI 10.1038/sj.gene.6364348
   Kanerva M, 1996, VIROLOGY, V224, P55, DOI 10.1006/viro.1996.0506
   Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399
   Kontsek P, 2003, ACTA VIROL, V47, P201
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Krause CD, 2005, PHARMACOL THERAPEUT, V106, P299, DOI 10.1016/j.pharmthera.2004.12.002
   Livonesi MC, 2007, ANTIVIR RES, V75, P121, DOI 10.1016/j.antiviral.2007.01.158
   MACIAS JD, 1969, HISTOPATHOLOGICAL IN, V11, P323
   Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003
   Mennechet FJD, 2006, BLOOD, V107, P4417, DOI 10.1182/blood-2005-10-4129
   MORRILL JC, 1989, REV INFECT DIS, V11, pS815
   Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x
   PETRILLOPEIXOTO ML, 1980, INTERVIROLOGY, V14, P16, DOI 10.1159/000149157
   PINTO AJ, 1990, J INTERFERON RES, V10, P293, DOI 10.1089/jir.1990.10.293
   Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005
   Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686
   Schmaljohn C., 2001, BUNYAVIRIDAE VIRUSES, P1581
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   TAMURA M, 1987, ANTIVIR RES, V8, P171, DOI 10.1016/0166-3542(87)90071-4
   VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007
   Weber F, 2002, VIRUS RES, V88, P129, DOI 10.1016/S0168-1702(02)00125-9
   Zitzmann K, 2007, CANCER RES, V67, P5025, DOI 10.1158/0008-5472.CAN-06-2575
   Zitzmann K, 2006, BIOCHEM BIOPH RES CO, V344, P1334, DOI 10.1016/j.bbrc.2006.04.043
NR 45
TC 21
Z9 23
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2008
VL 80
IS 3
BP 302
EP 308
DI 10.1016/j.antiviral.2008.06.016
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA 386AM
UT WOS:000261854700009
PM 18657576
DA 2020-11-30
ER

PT J
AU Ferreira, JMS
   Abrahao, JS
   Drumond, BP
   Oliveira, FM
   Alves, PA
   Pascoal-Xavier, MA
   Lobato, ZIP
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Siqueira Ferreira, Jaqueline Maria
   Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Oliveira, Fernando Meireles
   Alves, Pedro Augusto
   Pascoal-Xavier, Marcelo Antonio
   Portela Lobato, Zelia Ines
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Vaccinia virus: shedding and horizontal transmission in a murine model
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID SENTINEL MICE; COWPOX VIRUS; INFECTION; ORTHOPOXVIRUS; OUTBREAK;
   POXVIRUS; STRAINS; BRAZIL; REPLICATION; ANTIBODIES
AB Vaccinia virus (VACV) has been associated with several bovine vaccinia outbreaks in Brazil, affecting cattle and humans. There are no available data about VACV environmental circulation or the role of wildlife in the emergence of an outbreak. Since VACV was isolated from rodents in Brazil, we investigated shedding and transmission of VACV strains in mice. The VACV excretion profile was assessed by PCR and chicken chorioallantoic membrane infection, revealing viral DNA and infectious virus in the faeces and urine of intranasally infected mice. Horizontal transmission was assessed by exposure of sentinel mice to wood shavings contaminated with excrement, to mimic a natural infection. Sentinel mice showed orthopoxvirus antibodies, and VACV DNA and infectious virus were detected in their faeces and intestines, even after six rounds of natural transmission. Together, these data suggest that murine excrement could play a relevant role in VACV spread and transmission, perhaps helping to explain how these viruses circulate between their natural hosts.
C1 [Siqueira Ferreira, Jaqueline Maria; Abrahao, Jonatas Santos; Drumond, Betania Paiva; Oliveira, Fernando Meireles; Alves, Pedro Augusto; Pascoal-Xavier, Marcelo Antonio; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM masc.egk@terra.com.br
RI Alves, Pedro/T-7203-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015; Ferreira, Jaqueline/E-4630-2018; Kroon,
   Erna/V-5444-2019; Abrahao, Jonatas/B-3895-2015
OI Alves, Pedro/0000-0002-9659-5621; Kroon, Erna
   Geessien/0000-0003-2721-3826; Ferreira, Jaqueline/0000-0002-1779-1975;
   Abrahao, Jonatas/0000-0001-9420-1791; Lobato, Zelia/0000-0002-9399-3691
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX We thank Jaquelline G. de Oliveira for critical reading of the
   Marioscript; Joao R. dos Santos, Angela S. Lopes, Ilda M. V. Garnina and
   colleagues from Laboratorio de Virus (ICB-UFMG). Financial Support was
   provided by CNPq, CAPES and FAPEMIG. E.G.K., C. A. B., P. C. P. F. and
   Z. I. P. L. received fellowships from CNPq.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   FENNER F, 1989, ORTHOPOXVIRUSES, P85
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Gaertner DJ, 2003, COMPARATIVE MED, V53, P85
   GLEDHILL AW, 1962, NATURE, V196, P298, DOI 10.1038/196298a0
   Goff A, 2007, VIRUS RES, V128, P88, DOI 10.1016/j.virusres.2007.04.014
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   HJELLE B, 1995, CRIT REV CL LAB SCI, V32, P469, DOI 10.3109/10408369509082592
   Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Laakkonen J, 2006, J WILDLIFE DIS, V42, P672, DOI 10.7589/0090-3558-42.3.672
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   MOSS B, 1970, J VIROL, V5, P99, DOI 10.1128/JVI.5.2.99-108.1970
   Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P523
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Tryland M, 1998, VET REC, V143, P105, DOI 10.1136/vr.143.4.105
   Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373
NR 32
TC 21
Z9 21
U1 0
U2 5
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD DEC
PY 2008
VL 89
BP 2986
EP 2991
DI 10.1099/vir.0.2008/003947-0
PN 12
PG 6
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA 381HY
UT WOS:000261527800007
PM 19008383
OA Bronze
DA 2020-11-30
ER

PT J
AU Vilela, MC
   Mansur, DS
   Lacerda-Queiroz, N
   Rodrigues, DH
   Arantes, RME
   Kroon, EG
   Campos, MA
   Teixeira, MM
   Teixeira, AL
AF Vilela, Marcia Carvalho
   Mansur, Daniel Santos
   Lacerda-Queiroz, Norinne
   Rodrigues, David Henrique
   Esteves Arantes, Rosa Maria
   Kroon, Erna Geessien
   Campos, Marco Antonio
   Teixeira, Mauro Martins
   Teixeira, Antonio Lucio
TI Traffic of leukocytes in the central nervous system is associated with
   chemokine up-regulation in a severe model of herpes simplex
   encephalitis: An intravital microscopy study
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE Herpes simplex virus-1; Encephalitis; Intravital microscopy; Chemokines
ID VIRUS TYPE-1; NATURAL-RESISTANCE; IMMUNE-RESPONSE; INFECTION; MICE;
   RECRUITMENT; EXPRESSION; RECEPTORS; GENETICS; INNATE
AB Herpes simplex virus type I (HSV-1) is a human pathogen that may cause severe encephalitis. The development of experimental models of HSV-1 encephalitis is relevant for the comprehension of the immune mechanisms involved in this infection. C57BL/6 mice were inoculated intracranially with 104 PFU of neurotropic HSV-1. All animals developed signs of encephalitis and died until day 6 post-infection (pi). Using intravital microscopy, we demonstrated increased leukocyte rolling and adhesion in the brain Microvasculature of infected mice at days 1, 3 and 5 pi. The infection was followed by a significant increase in chemokine levels, including CCL2, CCL3, CCL5, CXCL1 and CXCL9. TNF-alpha also showed a significant increase at day 3 pi. Histological analyses demonstrated diffuse meningoencephalitis characterized mainly by mononuclear cell infiltrates. The present model of HSV-1 encephalitis exhibits high mortality in the very first days of infection. Accordingly, there were increased rolling and adhesion of leukocytes along the brain endothelium wall and a high expression of chemokines in the central nervous system. These results corroborate the role of chemokines in leukocyte recruitment following HSV-1 infection in the central nervous system. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, BR-30130100 Belo Horizonte, MG, Brazil.
   [Vilela, Marcia Carvalho; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Posgrad Infectol & Med Trop, BR-30130100 Belo Horizonte, MG, Brazil.
   [Mansur, Daniel Santos; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, BR-30130100 Belo Horizonte, MG, Brazil.
   [Lacerda-Queiroz, Norinne; Rodrigues, David Henrique; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-30130100 Belo Horizonte, MG, Brazil.
   [Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Dept Patol Geral, BR-30130100 Belo Horizonte, MG, Brazil.
   [Campos, Marco Antonio] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
RP Teixeira, AL (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Av Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.
EM altexr@gmai.com
RI Mansur, Daniel/AAQ-8062-2020; Campos, Marco A/C-4000-2013; Kroon, Erna
   Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; Arantes, Rosa
   ME/C-5749-2013; Teixeira, Antonio L/N-3315-2014
OI Mansur, Daniel/0000-0001-6773-9334; Campos, Marco A/0000-0003-4683-0176;
   Kroon, Erna Geessien/0000-0003-2721-3826; Arantes, Rosa
   ME/0000-0003-1428-9717; Teixeira, Antonio L/0000-0002-9621-5422
FU Rede Instituto Brasileiro de Neurociencia (IBN Net/Finep)Ciencia
   Tecnologia e Inovacao (FINEP); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (Fapemig), BrazilMinas Gerais State Research
   Foundation (FAPEMIG)
FX This work was supported by Rede Instituto Brasileiro de Neurociencia
   (IBN Net/Finep), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (Fapemig), Brazil.
CR Bener D, 2007, NEUROENDOCRINOLOGY, V85, P207, DOI 10.1159/000102976
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Carr DJJ, 2006, VIRAL IMMUNOL, V19, P741, DOI 10.1089/vim.2006.19.741
   Carr DJJ, 2006, J GEN VIROL, V87, P489, DOI 10.1099/vir.0.81339-0
   Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141
   dos Santos AC, 2005, J NEUROIMMUNOL, V162, P122, DOI 10.1016/j.jneuroim.2005.01.020
   Gilden DH, 2007, NAT CLIN PRACT NEURO, V3, P82, DOI 10.1038/ncpneuro0401
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kasama Tsuyoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P273, DOI 10.2174/1568010054022114
   KASTRUKOFF LF, 1986, J GEN VIROL, V67, P613, DOI 10.1099/0022-1317-67-4-613
   Kubes P, 2000, BRAIN PATHOL, V10, P127
   Kumaraswamy GK, 2006, J NEUROVIROL, V12, P365, DOI 10.1080/13550280600970417
   Lang A, 2005, J IMMUNOL, V174, P2919, DOI 10.4049/jimmunol.174.5.2919
   LOPEZ C, 1975, NATURE, V258, P152, DOI 10.1038/258152a0
   Lundberg PS, 2003, CURR EYE RES, V26, P137, DOI 10.1076/ceyr.26.3.137.14898
   Mansur DS, 2005, AM J PATHOL, V166, P1419, DOI 10.1016/S0002-9440(10)62359-0
   McKie EA, 1998, NEUROPATH APPL NEURO, V24, P367
   Mossman KL, 2005, VIRAL IMMUNOL, V18, P267, DOI 10.1089/vim.2005.18.267
   Nogueira ML, 2001, J CLIN PATHOL, V54, P103, DOI 10.1136/jcp.54.2.103
   Ransohoff RM, 2007, INT REV NEUROBIOL, V82, P187, DOI 10.1016/S0074-7742(07)82010-1
   Sellner J, 2005, NEUROSCI LETT, V374, P197, DOI 10.1016/j.neulet.2004.10.054
   Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3
   Wickham S, 2005, J NEUROIMMUNOL, V162, P51, DOI 10.1016/j.jneuroim.2005.01.001
   Wuest TR, 2008, FRONT BIOSCI-LANDMRK, V13, P4862, DOI 10.2741/3045
   Zhou JH, 2003, J IMMUNOL, V170, P3331, DOI 10.4049/jimmunol.170.6.3331
NR 25
TC 35
Z9 35
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD NOV 7
PY 2008
VL 445
IS 1
BP 18
EP 22
DI 10.1016/j.neulet.2008.08.072
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA 368IN
UT WOS:000260614900004
PM 18782601
DA 2020-11-30
ER

PT J
AU Trindade, GD
   Li, Y
   Olson, VA
   Emerson, G
   Regnery, RL
   da Fonseca, FG
   Kroon, EG
   Damon, I
AF Trindade, Giliane de Souza
   Li, Yu
   Olson, Victoria A.
   Emerson, Ginny
   Regnery, Russell L.
   da Fonseca, Flavio Guimaraes
   Kroon, Erna Geessien
   Damon, Inger
TI Real-time PCR assay to identify variants of Vaccinia virus: Implications
   for the diagnosis of bovine vaccinia in Brazil
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE vaccinia virus; bovine vaccinia outbreaks; diagnostic; real-time PCR
ID RIO-DE-JANEIRO; VARIOLA VIRUS; SMALLPOX; POXVIRUS; ORTHOPOXVIRUSES;
   DIFFERENTIATION; STRAINS; CATTLE; IDENTIFICATION; INFECTION
AB Naturally occurring infections of Vaccinia virus (VACV) have been recognized in Brazil during the past 10 years. Human Brazilian Vaccinia virus (BVV) infections typically occur as a zoonosis transferred from affected dairy cows to their handlers. Outbreaks have caused notable economic losses to the rural community in the region. The origins of BVV are unclear but previous analyses have shown that at least two distinct clades of BVV exist. The aim of this study was to develop a rapid and inexpensive process for identification and differentiation of BVV that should facilitate epidemiological and ecological investigations including the improved diagnosis of Brazilian Orthopoxvirus infections. A SYBR green quantitative real-time polymerase chain reaction (PCR) targeting the hernagglutinin gene was developed to identify different populations of BVV, VACV vaccine strains used in Brazil during the smallpox eradication campaign (Vaccinia Lister (VACV-LIS) and New York City Board of Health (VACV-NYCBH)), and currently available vaccines (VACV-NYCBH DRYVAX and VACV-NYCBH Acambis 2000). Three primer combinations (one to amplify many orthopoxviruses including all vaccinia viruses described so far; one to differentiate BVV from vaccine strains (VACV-LIS, VACV-NYCBH DRYVAX and VACV-NYCBH Acambis 2000); and one to differentiate BVV clades) were designed to work at the same annealing temperature and reaction conditions. In addition, these methods were able to detect orthopoxvirus viral DNA in lesion biopsy material without the need for DNA extraction. Published by Elsevier B.V.
C1 [Trindade, Giliane de Souza; Li, Yu; Olson, Victoria A.; Emerson, Ginny; Regnery, Russell L.; Damon, Inger] Ctr Dis Control & Prevent, Coordinating Ctr Infect Dis, Poxvirus & Rabies Branch, Div Viral & Rickettsial Dis,Natl Ctr Zoonot Vecto, Atlanta, GA 30333 USA.
   [Trindade, Giliane de Souza] Atlanta Res & Educ Fdn, Atlanta, GA USA.
   [da Fonseca, Flavio Guimaraes; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Damon, I (corresponding author), Ctr Dis Control & Prevent, Coordinating Ctr Infect Dis, Poxvirus & Rabies Branch, Div Viral & Rickettsial Dis,Natl Ctr Zoonot Vecto, 1600 Clifton Rd NE,Mailstop G-06, Atlanta, GA 30333 USA.
EM gitrindade@yahoo.com.br; lay4@cdc.gov; vao9@cdc.gov; dtt4@cdc.gov;
   rur1@cdc.gov; fdafonseca@cpqrr.fiocruz.br; kroone@icb.ufmg.br;
   idamon@cdc.gov
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826
CR Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P478
   Carletti F, 2005, J VIROL METHODS, V129, P97, DOI 10.1016/j.jviromet.2005.05.020
   *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P537
   Damaso CRA, 2007, DIAGN MICR INFEC DIS, V57, P39, DOI 10.1016/j.diagmicrobio.2006.07.012
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Fedele CG, 2006, J CLIN MICROBIOL, V44, P4464, DOI 10.1128/JCM.00276-06
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Gallina L, 2006, J VIROL METHODS, V134, P140, DOI 10.1016/j.jviromet.2005.12.014
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003
   Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104
   Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Loparev VN, 2001, J CLIN MICROBIOL, V39, P94, DOI 10.1128/JCM.39.1.94-100.2001
   McLaughlin J., 2007, Morbidity and Mortality Weekly Report, V56, P417
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   MOSS B, 2001, POXVIRIDAE VIRUSES T, P2849
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Nitsche A, 2006, CLIN CHEM, V52, P316, DOI 10.1373/clinchem.2005.060335
   Nitsche A, 2005, J VIROL METHODS, V126, P187, DOI 10.1016/j.jviromet.2005.02.007
   Olson VA, 2004, J CLIN MICROBIOL, V42, P1940, DOI 10.1128/JCM.42.5.1940-1946.2004
   Panning M, 2004, CLIN CHEM, V50, P702, DOI 10.1373/clinchem.2003.026781
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Scaramozzino N, 2007, CLIN CHEM, V53, P606, DOI 10.1373/clinchem.2006.068635
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   SOFI IM, 2003, J CLIN MICROBIOL, V41, P3835, DOI DOI 10.1128/JCM.41.8.3835-3839.2003
   Trindade GS, 2007, J VIROL METHODS, V141, P198, DOI 10.1016/j.jviromet.2006.12.006
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Weltzin R, 2003, NAT MED, V9, P1125, DOI 10.1038/nm916
NR 34
TC 25
Z9 26
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD SEP
PY 2008
VL 152
IS 1-2
BP 63
EP 71
DI 10.1016/j.jviromet.2008.05.028
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 344BR
UT WOS:000258900800011
PM 18602170
DA 2020-11-30
ER

PT J
AU Ferreira, JMS
   Drumond, BP
   Guedes, MIMC
   Pascoal-Xavier, MA
   Almeida-Leite, CM
   Arantes, RME
   Mota, BEF
   Abrahao, JS
   Alves, PA
   Oliveira, FM
   Ferreira, PCP
   Bonjardim, CA
   Lobato, ZIP
   Kroon, EG
AF Siqueira Ferreira, Jaqueline Maria
   Drumond, Betania Paiva
   Maldonado Coelho Guedes, Maria Isabel
   Pascoal-Xavier, Marcelo Antonio
   Almeida-Leite, Camila Megale
   Esteves Arantes, Rosa Maria
   Fernandes Mota, Bruno Eduardo
   Abrahao, Jonatas Santos
   Alves, Pedro Augusto
   Oliveira, Fernando Meireles
   Peregrino Ferreira, Paulo Cesar
   Bonjardim, Claudio Antonio
   Portela Lobato, Zelia Ines
   Kroon, Erna Geessien
TI Virulence in Murine Model Shows the Existence of Two Distinct
   Populations of Brazilian Vaccinia virus Strains
SO PLOS ONE
LA English
DT Article
AB Brazilian Vaccinia virus had been isolated from sentinel mice, rodents and recently from humans, cows and calves during outbreaks on dairy farms in several rural areas in Brazil, leading to high economic and social impact. Some phylogenetic studies have demonstrated the existence of two different populations of Brazilian Vaccinia virus strains circulating in nature, but little is known about their biological characteristics. Therefore, our goal was to study the virulence pattern of seven Brazilian Vaccinia virus strains. Infected BALB/c mice were monitored for morbidity, mortality and viral replication in organs as trachea, lungs, heart, kidneys, liver, brain and spleen. Based on the virulence potential, the Brazilian Vaccinia virus strains were grouped into two groups. One group contained GP1V, VBH, SAV and BAV which caused disease and death in infected mice and the second one included ARAV, GP2V and PSTV which did not cause any clinical signals or death in infected BALB/c mice. The subdivision of Brazilian Vaccinia virus strains into two groups is in agreement with previous genetic studies. Those data reinforce the existence of different populations circulating in Brazil regarding the genetic and virulence characteristics.
C1 [Siqueira Ferreira, Jaqueline Maria; Drumond, Betania Paiva; Maldonado Coelho Guedes, Maria Isabel; Pascoal-Xavier, Marcelo Antonio; Fernandes Mota, Bruno Eduardo; Abrahao, Jonatas Santos; Alves, Pedro Augusto; Oliveira, Fernando Meireles; Peregrino Ferreira, Paulo Cesar; Bonjardim, Claudio Antonio; Kroon, Erna Geessien] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Virus Lab, Belo Horizonte, MG, Brazil.
   [Almeida-Leite, Camila Megale; Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Lab Neuro Imuno Patol Expt, Belo Horizonte, MG, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Ave Antonio Carlos, Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg
RI Arantes, Rosa ME/C-5749-2013; brasileira, Inct Pecuaria/J-9542-2013;
   Ferreira, Jaqueline/E-4630-2018; Alves, Pedro/T-7203-2019; Abrahao,
   Jonatas/B-3895-2015; Bonjardim, Claudio A/J-2601-2014; Kroon,
   Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Arantes, Rosa ME/0000-0003-1428-9717; Ferreira,
   Jaqueline/0000-0002-1779-1975; Alves, Pedro/0000-0002-9659-5621;
   Abrahao, Jonatas/0000-0001-9420-1791; Kroon, Erna
   Geessien/0000-0003-2721-3826; Lobato, Zelia/0000-0002-9399-3691; Mota,
   Bruno/0000-0003-0348-4875
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [fellowship]; CAPESCAPES [fellowship]; FAPEMIGMinas Gerais State
   Research Foundation (FAPEMIG); PCPF [fellowship]; CAB [fellowship]; ZILP
   [fellowship]; RMEA [fellowship]; EGK [fellowship]
FX Sources of support was provided by CNPq, CAPES and FAPEMIG. J. M. S.
   Ferreira received fellowship from CAPES and PCPF, CAB, ZILP, RMEA and
   EGK are CNPq fellows.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   ANDREW ME, 1989, IMMUNOL CELL BIOL, V67, P331, DOI 10.1038/icb.1989.48
   Baxby D, 1981, J Hist Med Allied Sci, V36, P218
   Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001
   Bray M, 2000, J INFECT DIS, V181, P10, DOI 10.1086/315190
   Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025
   BRIODY BA, 1959, BACTERIOL REV, V23, P61, DOI 10.1128/MMBR.23.2.61-95.1959
   BULLER RML, 1985, CURR TOP MICROBIOL, V122, P148
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   da Fonseca FG, 2000, J VIROL, V74, P7508, DOI 10.1128/JVI.74.16.7508-7517.2000
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DAMON IK, 2007, FIELDS VIROLOGY, P2947
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   FENNER R, 1988, SMALLPOX ITS ERADICA
   Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22
   Jacobs N, 2006, J GEN VIROL, V87, P1157, DOI 10.1099/vir.0.81556-0
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Pahlitzsch R, 2006, CLIN INFECT DIS, V43, P737, DOI 10.1086/506937
   Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003
   Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540
   SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P523
   SEHGAL C L, 1977, Journal of Communicable Diseases, V9, P171
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977
   Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
NR 42
TC 31
Z9 32
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 26
PY 2008
VL 3
IS 8
AR e3043
DI 10.1371/journal.pone.0003043
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 427RL
UT WOS:000264796300001
PM 18725979
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Ferreira, GP
   Trindade, GS
   Vilela, JMC
   Da Silva, MIN
   Andrade, MS
   Kroon, EG
AF Ferreira, G. P.
   Trindade, G. S.
   Vilela, J. M. C.
   Da Silva, M. I. N.
   Andrade, M. S.
   Kroon, E. G.
TI Climbing the steps of viral atomic force microscopy: visualization of
   Dengue virus particles
SO JOURNAL OF MICROSCOPY
LA English
DT Article
DE atomic force microscopy; Dengue virus
ID CYCLIZATION SEQUENCES; RNA; INFECTION; FUSION; TOOL
AB In recent years, the application of atomic force microscopy (AFM) to biological systems has highlighted the potential of this technology. AFM provides insights into studies of biological structures and interactions and can also identify and characterize a large panel of pathogens, including viruses. The Flaviviridae family contains a number of viruses that are important human and animal pathogens. Among them, Dengue virus causes epidemics with fatal outcomes mainly in the tropics. In this study, Dengue virus is visualized for the first time using the in air AFM technique. Images were obtained from a potassium-tartrate gradient-purified virus. This study enhances the application of AFM as a novel tool for the visualization and characterization of virus particles. Because flavivirus members are closely related, studies of the morphologic structure of the Dengue virus can reveal strategies that may be useful to identify and study other important viruses in the family, including the West Nile virus.
C1 [Ferreira, G. P.; Trindade, G. S.; Kroon, E. G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Vilela, J. M. C.; Da Silva, M. I. N.; Andrade, M. S.] Ctr Tecnol Minas Gerais CETEC, Lab Nanoscopia Fdn, BR-31170000 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826
CR Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Dubrovin EV, 2007, NANOMED-NANOTECHNOL, V3, P128, DOI 10.1016/j.nano.2007.01.005
   Dufrene YF, 2004, NAT REV MICROBIOL, V2, P451, DOI 10.1038/nrmicro905
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuznetsov YG, 2005, J MOL BIOL, V347, P41, DOI 10.1016/j.jmb.2005.01.006
   Kuznetsov YG, 2006, VIROLOGY, V352, P329, DOI 10.1016/j.virol.2006.04.008
   Lee JW, 2004, J NANOBIOTECHNOL, V2, P6, DOI DOI 10.1186/1477-3155-2-6
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Malkin AJ, 2003, J VIROL, V77, P6332, DOI 10.1128/JVI.77.11.6332-6340.2003
   Santos NC, 2004, BIOPHYS CHEM, V107, P133, DOI 10.1016/j.bpc.2003.09.001
   Schmatulla A, 2007, J MICROSC-OXFORD, V225, P264, DOI 10.1111/j.1365-2818.2007.01741.x
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Trindade GS, 2007, J VIROL METHODS, V141, P198, DOI 10.1016/j.jviromet.2006.12.006
   WHO, DENG DENG HAEM FEV
   Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
NR 22
TC 9
Z9 9
U1 0
U2 8
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc..
PD JUL
PY 2008
VL 231
IS 1
BP 180
EP 185
DI 10.1111/j.1365-2818.2008.02028.x
PG 6
WC Microscopy
SC Microscopy
GA 324CH
UT WOS:000257494800018
PM 18638201
DA 2020-11-30
ER

PT J
AU Coelho, LFL
   de Oliveira, JG
   Kroon, EG
AF Leomil Coelho, Luiz Felipe
   de Oliveira, Jaquelline Germano
   Kroon, Erna Geessien
TI Interferons and scleroderma - A new clue to understanding the
   pathogenesis of scleroderma?
SO IMMUNOLOGY LETTERS
LA English
DT Review
DE scleroderma; interferons; dendritic cell
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; CONNECTIVE-TISSUE DISEASE; BLOOD
   T-LYMPHOCYTES; II GENE-EXPRESSION; GROWTH-FACTOR; SCLEROSIS PATIENTS;
   ENDOTHELIAL-CELLS; STIMULATORY AUTOANTIBODIES; THERAPEUTIC TARGETS;
   MOLECULAR PATHWAYS
AB Scleroderma or systemic sclerosis (SSc) is a complex disease characterized by vasculopathy and deregulated immune and fibroblast activation. The resulting excessive production of collagens and other extracellular matrix proteins by fibroblasts as well as the inflammatory response leads to the development of scleroderma. Recently, some emerging data have been showing a possible link between the type I and II interferons (IFNs) and SSc pathogenesis. IFNs are well-known immunomodulators and inhibitors of collagen production. However, IFN therapy also has been implicated in the development or exacerbation of several autoimmune diseases, including SSc. Some studies also showed an increase mRNA and protein levels of IFNs and several interferon stimulated genes in cells and tissues from SSc patients. In this review we discuss about a possible role for IFNs in SSc development and pathogenesis. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Leomil Coelho, Luiz Felipe] Univ Fed Piaui, Ctr Ciencias Saude, Dept Microbiol & Parasitol, Microbiol Lab, Teresina, PI, Brazil.
   [de Oliveira, Jaquelline Germano; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Minas Gerais, Brazil.
RP Coelho, LFL (corresponding author), Univ Fed Piaui, Ctr Ciencias Saude, Dept Microbiol & Parasitol, Microbiol Lab, Teresina, PI, Brazil.
EM luleomil@yahoo.com
RI Kroon, Erna Geessien/B-3631-2015; Coelho, Luiz FL/G-5853-2012; Kroon,
   Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Coelho, Luiz
   Felipe/0000-0003-4289-384X
CR Abraham D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2186
   Abu-Shakra M, 2000, CLIN RHEUMATOL, V19, P378, DOI 10.1007/s100670070031
   AIRO P, 2007, RHEUMATOL INT
   Alba A, 2004, J IMMUNOL, V173, P6667, DOI 10.4049/jimmunol.173.11.6667
   ARNAUDOVA P, 1993, J RHEUMATOL, V20, P1445
   Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x
   Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6
   Baroni SS, 2006, NEW ENGL J MED, V354, P2667
   Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612
   Beretta L, 2002, BRIT J DERMATOL, V147, P385, DOI 10.1046/j.1365-2133.2002.48901.x
   Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552
   Black CM, 1999, ARTHRITIS RHEUM, V42, P299, DOI 10.1002/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R
   Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422
   Bottazzo G F, 1986, Ann Ital Med Int, V1 Suppl 1, P20
   BOTTAZZO GF, 1985, NEW ENGL J MED, V313, P353, DOI 10.1056/NEJM198508083130604
   BOTTAZZO GF, 1983, LANCET, V2, P1115
   Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845
   BURMESTER GR, 1987, J CLIN INVEST, V80, P595, DOI 10.1172/JCI113111
   Caposio P, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M701846200
   Chao MJ, 2007, HUM MOL GENET, V16, P1951, DOI 10.1093/hmg/ddm142
   Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040
   Crow MK, 2004, CURR OPIN RHEUMATOL, V16, P541, DOI 10.1097/01.bor.0000135453.70424.1b
   Danese S, 2000, J RHEUMATOL, V27, P1568
   de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912
   Denny MF, 2007, BLOOD, V110, P2907, DOI 10.1182/blood-2007-05-089086
   Denton CP, 2004, BEST PRACT RES CL RH, V18, P271, DOI 10.1016/j.berh.2004.03.001
   Devendra D, 2004, CLIN IMMUNOL, V111, P225, DOI 10.1016/j.clim.2004.01.008
   Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399
   DUNCAN MR, 1987, J CLIN INVEST, V79, P1318, DOI 10.1172/JCI112956
   DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3
   Fairbrother WJ, 2001, PROTEIN SCI, V10, P1911, DOI 10.1110/ps.13801
   Ferri C, 2005, BRIT J DERMATOL, V152, P819, DOI 10.1111/j.1365-2133.2005.06515.x
   Filali SM, 2006, JOINT BONE SPINE, V73, P479, DOI 10.1016/j.jbspin.2006.02.002
   Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452
   FREUNDLICH B, 1992, ARTHRITIS RHEUM, V35, P1134, DOI 10.1002/art.1780351005
   Fujii H, 2002, CLIN EXP IMMUNOL, V130, P548, DOI 10.1046/j.1365-2249.2002.02017.x
   Gabrielli A, 2007, AUTOIMMUN REV, V7, P121, DOI 10.1016/j.autrev.2007.02.020
   Gabrielli A, 2007, CURR OPIN IMMUNOL, V19, P640, DOI 10.1016/j.coi.2007.11.004
   Giacomelli R, 2001, CLIN EXP IMMUNOL, V125, P310, DOI 10.1046/j.1365-2249.2001.01603.x
   GRANSTEIN RD, 1990, J INVEST DERMATOL S, V95, P75
   Guiducci S, 2007, AUTOIMMUN REV, V6, P520, DOI 10.1016/j.autrev.2006.12.006
   Harris PE, 2006, BBA-MOL BASIS DIS, V1762, P627, DOI 10.1016/j.bbadis.2006.05.001
   HEIN R, 1992, BRIT J DERMATOL, V126, P496, DOI 10.1111/j.1365-2133.1992.tb11824.x
   Horikawa M, 2005, J INVEST DERMATOL, V125, P731, DOI 10.1111/j.0022-202X.2005.23767.x
   HUGLE T, 2008, ANN RHEUM DIS
   Hunzelmann N, 1997, ARCH DERMATOL, V133, P609, DOI 10.1001/archderm.133.5.609
   Ihn H, 2008, J DERMATOL SCI, V49, P103, DOI 10.1016/j.jdermsci.2007.05.014
   Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122
   Jimenez SA, 2004, ANN INTERN MED, V140, P37, DOI 10.7326/0003-4819-140-1-200401060-00010
   KAHAN A, 1989, AM J MED, V87, P273
   Kontsek P, 2003, ACTA VIROL, V47, P201
   Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188
   Leask A, 2004, J INVEST DERMATOL, V122, P1, DOI 10.1046/j.0022-202X.2003.22133.x
   Lee PY, 2007, ARTHRITIS RHEUM-US, V56, P3759, DOI 10.1002/art.23035
   Coelho LFL, 2007, ARCH DERMATOL RES, V299, P259, DOI 10.1007/s00403-007-0737-x
   Magro CM, 2007, HUM PATHOL, V38, P42, DOI 10.1016/j.humpath.2006.06.002
   Magro CM, 2006, APPL IMMUNOHISTO M M, V14, P208, DOI 10.1097/01.pai.0000160730.54062.6d
   Mayes MD, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2189
   Mayes MD, 1998, SEMIN CUTAN MED SURG, V17, P22, DOI 10.1016/S1085-5629(98)80058-8
   Molteni M, 1999, CLIN EXP IMMUNOL, V116, P164
   Mondini M, 2006, ARTHRITIS RHEUM, V54, P3939, DOI 10.1002/art.22266
   Montani V, 1998, ENDOCRINOLOGY, V139, P290, DOI 10.1210/en.139.1.290
   Ohtsuka T, 2006, INT J DERMATOL, V45, P86, DOI 10.1111/j.1365-4632.2004.02576.x
   Oiso N, 2003, CLIN EXP DERMATOL, V28, P380, DOI 10.1046/j.1365-2230.2003.01298.x
   Pannu J, 2004, ARTHRITIS RHEUM-US, V50, P1566, DOI 10.1002/art.20225
   Pannu J, 2006, ARTHRITIS RHEUM-US, V54, P3011, DOI 10.1002/art.22063
   Pavlovic D, 1997, J CLIN ENDOCR METAB, V82, P2329, DOI 10.1210/jc.82.7.2329
   Pirila L, 2006, J CLIN MICROBIOL, V44, P2295, DOI 10.1128/JCM.00002-06
   Polisson RP, 1996, J RHEUMATOL, V23, P654
   Rajagopalan S, 2004, BLOOD, V103, P3677, DOI 10.1182/blood-2003-09-3198
   Rosloniec EF, 2002, ARTHRITIS RES, V4, P333, DOI 10.1186/ar432
   Sakkas LI, 2004, ARTHRITIS RHEUM-US, V50, P1721, DOI 10.1002/art.20315
   Salpietro DC, 2004, PEDIATR ALLERGY IMMU, V15, P570, DOI 10.1111/j.1399-3038.2004.00189.x
   SEELIG HP, 1994, ARTHRITIS RHEUM-US, V37, P1672, DOI 10.1002/art.1780371117
   SIDKY YA, 1987, CANCER RES, V47, P5155
   Solans R, 2004, CLIN EXP RHEUMATOL, V22, P625
   Sontheimer RD, 2004, BEST PRACT RES CL RH, V18, P429, DOI 10.1016/j.berh.2004.03.003
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Staub E, 2001, TRENDS BIOCHEM SCI, V26, P83, DOI 10.1016/S0968-0004(00)01717-5
   STEEN VD, 1990, RHEUM DIS CLIN N AM, V16, P641
   Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x
   STEVENS W, 1992, BRIT J RHEUMATOL, V31, P683
   Tahara H, 2007, INTERNAL MED, V46, P473, DOI 10.2169/internalmedicine.46.6328
   Tan FK, 2006, RHEUMATOLOGY, V45, P694, DOI 10.1093/rheumatology/kei244
   Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843
   Trojanowska M, 2007, CURR OPIN RHEUMATOL, V19, P568, DOI 10.1097/BOR.0b013e3282e6f495
   Uchida K, 2005, IMMUNOLOGY, V116, P53, DOI 10.1111/j.1365-2567.2005.02197.x
   Uze G, 2007, CURR TOP MICROBIOL, V316, P71
   Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008
   Valentini G, 2001, J CLIN IMMUNOL, V21, P210, DOI 10.1023/A:1011024313525
   Varga J, 1997, ARCH DERMATOL, V133, P637, DOI 10.1001/archderm.133.5.637
   Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139
   Verrecchia F, 2006, AUTOIMMUN REV, V5, P563, DOI 10.1016/j.autrev.2006.06.001
   Wu Z, 1999, CLIN EXP IMMUNOL, V116, P62
   York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382
NR 95
TC 20
Z9 20
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
EI 1879-0542
J9 IMMUNOL LETT
JI Immunol. Lett.
PD JUN 30
PY 2008
VL 118
IS 2
BP 110
EP 115
DI 10.1016/j.imlet.2008.03.016
PG 6
WC Immunology
SC Immunology
GA 329WJ
UT WOS:000257901000002
PM 18499269
DA 2020-11-30
ER

PT J
AU Quinan, BR
   Magalhaes, CLD
   Novaes, RFV
   dos Santos, JR
   Kroon, EG
   Bonjardim, CA
   Ferreira, PCP
AF Quinan, Barbara Resende
   de Brito Magalhaes, Cintia Lopes
   Vianna Novaes, Renata Franco
   dos Santos, Joao Rodrigues
   Kroon, Erna Geessien
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
TI Sequence and phylogenetic analysis of the large (L) segment of the
   Tahyna virus genome
SO VIRUS GENES
LA English
DT Article
DE Tahyna virus; California serogroup; Orthobunyavirus; Bunyaviridae; L
   segment; RNA polymerase
ID RNA SEGMENT; BUNYAVIRUSES; INKOO
AB The Tahyna virus (TAHV) is an important human pathogen in the Bunyaviridae family. To date, only the S and M segments of this virus have been sequenced, but the sequence of the L segment hasn't been established yet. In this study, we sequenced 963 nucleotides of the L segment of TAHV, comprising pre-motif A and motif A in region 3 of the RNA polymerase gene.
C1 [Quinan, Barbara Resende; de Brito Magalhaes, Cintia Lopes; Vianna Novaes, Renata Franco; dos Santos, Joao Rodrigues; Kroon, Erna Geessien; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Ferreira, PCP (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM quinanb@yahoo.com.br; cintia.magalhaes@gmail.com;
   franco_vianna@yahoo.com.br; santosjr@icb.ufmg.br; kroone@icb.ufmg.br;
   claubonj@icb.ufmg.br; peregrino@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; Bonjardim,
   Claudio A/J-2601-2014
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR Aquino VH, 2003, ARCH VIROL, V148, P19, DOI 10.1007/s00705-002-0913-4
   Campbell WP, 1999, VIRUS RES, V61, P137, DOI 10.1016/S0168-1702(99)00033-7
   Huang C, 1996, J GEN VIROL, V77, P1761, DOI 10.1099/0022-1317-77-8-1761
   Magalhaes CLD, 2007, VIRUS GENES, V35, P681, DOI 10.1007/s11262-007-0138-4
   Medlock JM, 2007, EPIDEMIOL INFECT, V135, P466, DOI 10.1017/S0950268806007047
   MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345
   POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x
   ROBERTS A, 1995, VIROLOGY, V206, P742, DOI 10.1016/S0042-6822(95)80001-8
   Vapalahti O, 1996, J GEN VIROL, V77, P1769, DOI 10.1099/0022-1317-77-8-1769
NR 9
TC 5
Z9 5
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PD JUN
PY 2008
VL 36
IS 3
BP 435
EP 437
DI 10.1007/s11262-008-0212-6
PG 3
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA 296LJ
UT WOS:000255544700001
PM 18351450
DA 2020-11-30
ER

PT J
AU Martins, MA
   Silva, ML
   Eloi-Santos, SM
   Ribeiro, JGL
   Hype-Magalhaes, VP
   Marciano, APV
   Homma, A
   Kroon, EG
   Teixeira-Carvalho, A
   Martins-Filho, OA
AF Martins, Marina Angela
   Silva, Maria Luiza
   Eloi-Santos, Silvana Maria
   Ribeiro, Jose Geraldo Leite
   Hype-Magalhaes, Vanessa Peru
   Vieira Marciano, Ana Paula
   Homma, Akira
   Kroon, Erna Geessien
   Teixeira-Carvalho, Andrea
   Martins-Filho, Olindo Assis
TI Innate immunity phenotypic features point toward simultaneous raise of
   activation and modulation events following 17DD live attenuated yellow
   fever first-time vaccination
SO VACCINE
LA English
DT Article
DE 17DD vaccine; yellow fever; innate immunity
ID NILE-VIRUS-INFECTION; NATURAL-KILLER-CELLS; HUMAN-MONOCYTES; HUMAN
   NEUTROPHILS; INTERLEUKIN-10 RECEPTOR; CHEMOKINE EXPRESSION;
   HUMAN-LEUKOCYTES; DENDRITIC CELLS; DENGUE VIRUS; IN-VITRO
AB Detailed multiparametric phenotypic investigation aiming to characterize the kinetics of the innate immune response in the peripheral blood following 17DD yellow fever (17DD-YF) first-time vaccination was performed. Results showed increased frequency of monocytes and NK cell subpopulations besides unexpected up-regulation of granulocytes activation status (CD28(+)/CD23(+) and CD28(+)/HLA-DR+, respectively). Up-regulation of Fc gamma-R and IL-10-R expression emerge as putative events underlying the mixed pattern of phenotypic features triggered by the 17DD yellow fever (17DD-YF) vaccination. Mixed pattern of chemokine receptors expression further support our hypothesis that a parallel establishment of activation/ modulation microenvironment plays a pivotal role in the protective immunity triggered by the 17DD-YF vaccine. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Martins, Marina Angela; Silva, Maria Luiza; Eloi-Santos, Silvana Maria; Vieira Marciano, Ana Paula; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis] Fundacao Oswaldo Cruz, Inst Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, BR-30190002 Belo Horizonte, MG, Brazil.
   [Martins, Marina Angela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva, Maria Luiza] Univ Fed Minas Gerais, Fac Med, Dept Postgrad Patol, BR-130100 Belo Horizonte, MG, Brazil.
   [Eloi-Santos, Silvana Maria] Univ Fed Minas Gerais, Fac Med, Dept Propedeut Complementar, BR-130100 Belo Horizonte, MG, Brazil.
   [Ribeiro, Jose Geraldo Leite] Secretaria Estadual Saude Minas Gerais, BR-30170007 Belo Horizonte, MG, Brazil.
   [Hype-Magalhaes, Vanessa Peru] Fundacao Oswaldo Cruz, Inst Rene Rachou, Lab Pesquisas Clinicas, BR-30190001 Belo Horizonte, MG, Brazil.
   [Homma, Akira] Fundacao Oswaldo Cruz, Inst Biomanguinhos, BR-21040900 Rio De Janeiro, Brazil.
   [Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Martins-Filho, OA (corresponding author), Fundacao Oswaldo Cruz, Inst Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Avenida Augusto Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM oamfilho@cpqrr.fiocruz.br
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Martins-Filho, Olindo
   Assis/0000-0002-5494-4889
CR Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   BERKMAN N, 1995, J IMMUNOL, V155, P4412
   Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97
   Bussolati B, 1997, IMMUNOLOGY, V90, P440, DOI 10.1111/j.1365-2567.1997.00440.x
   Capsoni F, 1997, SCAND J IMMUNOL, V45, P269, DOI 10.1046/j.1365-3083.1997.d01-393.x
   CARSON WE, 1995, BLOOD, V85, P3577, DOI 10.1182/blood.V85.12.3577.bloodjournal85123577
   Chan RC, 2001, LANCET, V358, P121, DOI 10.1016/S0140-6736(01)05341-7
   Chaves MM, 1996, INFLAMM RES, V45, P313, DOI 10.1007/BF02252942
   Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255
   Elbim C, 2001, J IMMUNOL, V166, P5201, DOI 10.4049/jimmunol.166.8.5201
   FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
   Freestone DS, 1994, VACCINES, P741
   Gaddy J, 1997, CELL IMMUNOL, V180, P132, DOI 10.1006/cimm.1997.1175
   Gerber JS, 2001, MICROBES INFECT, V3, P131, DOI 10.1016/S1286-4579(00)01360-5
   Germain RN, 2004, NAT MED, V10, P1307, DOI 10.1038/nm1159
   Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530
   Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970
   GRUBER MF, 1994, J IMMUNOL, V152, P1354
   Hacker UT, 1998, J INFECT DIS, V177, P774, DOI 10.1086/517806
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Juffrie M, 2000, INFECT IMMUN, V68, P702, DOI 10.1128/IAI.68.2.702-707.2000
   Kopydlowski KM, 1999, J IMMUNOL, V163, P1537
   KU B, 2002, J IMMUNOL, V168, P3536
   Laichalk LL, 1996, FEMS IMMUNOL MED MIC, V15, P181, DOI 10.1111/j.1574-695X.1996.tb00084.x
   LECOANETHENCHOZ S, 1995, IMMUNITY, V3, P119, DOI 10.1016/1074-7613(95)90164-7
   LIPRANDI F, 1983, ARCH VIROL, V76, P51, DOI 10.1007/BF01315703
   MALEFYT RD, 1991, J EXP MED, V174, P1209
   MALEFYT RD, 1993, J IMMUNOL, V151, P6370
   Martin M, 2001, LANCET, V358, P98, DOI 10.1016/S0140-6736(01)05327-2
   Martins MA, 2007, CLIN EXP IMMUNOL, V148, P90, DOI 10.1111/j.1365-2249.2006.03317.x
   MERTZ PM, 1994, J BIOL CHEM, V269, P21322
   Monath TP, 1999, VACCINES, P815
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998
   Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007
   NIIRO H, 1994, INT IMMUNOL, V6, P661, DOI 10.1093/intimm/6.4.661
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2007, ADV EXP MED BIOL, V590, P43
   Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608
   Robertson SE, 1996, JAMA-J AM MED ASSOC, V276, P1157, DOI 10.1001/jama.276.14.1157
   Rossi DL, 1997, J IMMUNOL, V158, P1033
   Shirato K, 2004, J MED VIROL, V74, P507, DOI 10.1002/jmv.20205
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   SVETLANA FK, 2005, VIROLOGY, V342, P167
   ter Meulen J, 2004, J INFECT DIS, V190, P1821, DOI 10.1086/425016
   THEOFILOPOULOS AN, 1976, J IMMUNOL, V117, P953
   Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232
   VANDEWINKEL JGJ, 1991, J LEUKOCYTE BIOL, V49, P511
   VASCONCELOS PF, 2002, REV BRAS EPIDEMIOL, V5, P244
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
   Venuprasad K, 2003, HUM IMMUNOL, V64, P38, DOI 10.1016/S0198-8859(02)00689-4
   Venuprasad K, 2001, EUR J IMMUNOL, V31, P1536, DOI 10.1002/1521-4141(200105)31:5<1536::AID-IMMU1536>3.0.CO;2-8
   *WHO, 1998, WHOEPIGEN9808
   Woerly G, 1999, J EXP MED, V190, P487, DOI 10.1084/jem.190.4.487
NR 56
TC 26
Z9 26
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD FEB 26
PY 2008
VL 26
IS 9
BP 1173
EP 1184
DI 10.1016/j.vaccine.2007.12.035
PG 12
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 275ON
UT WOS:000254081600005
PM 18243433
DA 2020-11-30
ER

PT J
AU Figueiredo, LB
   Cecilio, AB
   Ferreira, GP
   Drumond, BP
   de Oliveira, JG
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Figueiredo, Leandra Barcelos
   Cecilio, Alzira Batista
   Ferreira, Gustavo Portela
   Drumond, Betnia Paiva
   de Oliveira, Jaquelline Germano
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Dengue virus 3 genotype I associated with dengue fever and dengue
   hemorrhagic fever, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID RIO-DE-JANEIRO; MOLECULAR EVOLUTION; TYPE-3 VIRUS; EPIDEMIOLOGY; STATE
AB Dengue serotype 3 viruses were isolated from patients in Brazil from 2002 through 2004. On the basis of phylogenetic analyses, these isolates were assigned genotype 1. This genotype had never been reported in South America before. Its appearance indicates a major risk factor for dengue epidemics and severe disease.
C1 [Figueiredo, Leandra Barcelos; Ferreira, Gustavo Portela; Drumond, Betnia Paiva; de Oliveira, Jaquelline Germano; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Cecilio, Alzira Batista] Fundacao Ezequiel Dias, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826
CR Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Correa PRL, 2005, REV SAUDE PUBL, V39, P33, DOI 10.1590/S0034-89102005000100005
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Kobayashi N, 1999, AM J TROP MED HYG, V60, P904, DOI 10.4269/ajtmh.1999.60.904
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   OSATOMI K, 1990, VIROLOGY, V176, P643, DOI 10.1016/0042-6822(90)90037-R
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
NR 15
TC 35
Z9 38
U1 0
U2 3
PU CENTER DISEASE CONTROL
PI ATLANTA
PA ATLANTA, GA 30333 USA
SN 1080-6040
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2008
VL 14
IS 2
BP 314
EP 316
DI 10.3201/eid1402.070278
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 259VS
UT WOS:000252969600020
PM 18258129
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Drumond, BP
   Leite, JA
   da Fonseca, FG
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Drumond, Betania Paiva
   Leite, Juliana Almeida
   da Fonseca, Flavio Guimaraes
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Brazilian Vaccinia virus strains are genetically divergent and differ
   from the Lister vaccine strain
SO MICROBES AND INFECTION
LA English
DT Article
DE poxvirus; Vaccinia virus; smallpox; vaccine; poxvirus infections;
   phylogeny; genetic diversity; genetic polymorphisms
ID GENOME SEQUENCE; POXVIRUS; ATI
AB Vaccinia virus is responsible for an important zoonotic disease affecting dairy cattle and humans in Brazil, but little is known about the origin, epidemiology and evolution of these Brazilian Vaccinia virus strains. In this work, seven Brazilian Vaccinia virus strains and the Lister-derived Brazilian vaccine strain, named Lister-Butantan, were compared based on the sequences of ten host range and virulence related genes. Comparison of Brazilian Vaccinia virus strains with Lister-Butantan revealed several differences. Phylogenetic analyses confirmed the existence of genetically distinct Brazilian Vaccinia virus groups and has not thus far demonstrated a close relationship between Brazilian strains and Lister-Butantan. In this study, the BeAn58058 and SPAn232 strains were grouped together with the Belo Horizonte and Guarani PI strains. Additionally, genetic polymorphisms in host range and virulence genes as well as differences in the deduced amino acid sequences were detected among Brazilian Vaccinia virus. This genetic diversity may result in a plethora of different biological properties presented by Brazilian Vaccinia virus, including differences in adaptation to the host as well as pathogenic properties. Furthermore, co-circulation of these divergent strains could increase the possibility of recombination events in nature, leading to the formation of new variants with unpredictable pathogenic potential. (C) 2007 Elsevier Masson SAS. All rights reserved.
C1 [Drumond, Betania Paiva; Leite, Juliana Almeida; da Fonseca, Flavio Guimaraes; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Avenida Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014;
   Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR Aldaz-Carroll L, 2005, J VIROL, V79, P6260, DOI 10.1128/JVI.79.10.6260-6271.2005
   BULLER RM, 2005, POXVIRIDAE VIRUS TAX, P117
   Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134
   FENNER R, 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003
   Li G, 2005, J GEN VIROL, V86, P2969, DOI 10.1099/vir.0.81331-0
   Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490
   Meng XZ, 2006, VIROLOGY, V353, P220, DOI 10.1016/j.virol.2006.05.032
   Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005
   Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   RISI JB, 1968, ARQUIVOS HIGIENE, V24, P119
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06
   Turner PC, 2006, VIROLOGY, V347, P88, DOI 10.1016/j.virol.2005.11.012
NR 30
TC 35
Z9 36
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD FEB
PY 2008
VL 10
IS 2
BP 185
EP 197
DI 10.1016/j.micinf.2007.11.005
PG 13
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 285OF
UT WOS:000254785400011
PM 18248758
DA 2020-11-30
ER

PT J
AU Trindade, GD
   da Fonseca, FG
   Lobato, ZIP
   Guedes, MIMC
   Kroon, EG
   Damon, I
AF Trindade, Giliane de Souza
   da Fonseca, Flavio Guimaraes
   Portela Lobato, Zelia Ines
   Guedes, Maria Isabel M. C.
   Kroon, Erna Geessien
   Damon, Inger
TI The emergence of vaccinia virus in Brazil
SO INDIAN JOURNAL OF VIROLOGY
LA English
DT Meeting Abstract
C1 [Trindade, Giliane de Souza; Damon, Inger] Ctr Dis Control & Prevent CCID CDC, Coordinating Ctr Infect Dis, Atlanta, GA USA.
   [Trindade, Giliane de Souza] Atlanta Res & Educ Fdn, Atlanta, GA USA.
   [Trindade, Giliane de Souza; da Fonseca, Flavio Guimaraes; Portela Lobato, Zelia Ines; Kroon, Erna Geessien] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU INDIAN VIROLOGICAL SOC
PI HISAR
PA CCS HARYANA AGRICULTURAL UNIV, DEPT PLANT PATHOLOGY, HISAR, 125 004,
   INDIA
SN 0970-2822
J9 INDIAN J VIROL
JI Indian J. Virol.
PD JAN
PY 2008
VL 19
IS 1
BP 63
EP 63
PG 1
WC Virology
SC Virology
GA 349TB
UT WOS:000259305100051
DA 2020-11-30
ER

PT J
AU Leite, JA
   Drumond, BP
   Trindade, GD
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Leite, Juliana Almeida
   Drumond, Betania Paiva
   Trindade, Giliane de Souza
   Bonjardim, Claudio Antonio
   Ferreira, Paulo Cesar Peregrino
   Kroon, Erna Geessien
TI Brazilian Vaccinia virus strains show genetic polymorphism at the ati
   gene
SO VIRUS GENES
LA English
DT Article
DE Brazilian vaccinia virus; bovine vaccinia outbreak; ati gene; genetic
   polymorphism; poxvirus; ha gene
ID A-TYPE INCLUSION; MAJOR PROTEIN; BODY PROTEIN; DIFFERENTIATION;
   POXVIRUS; HUMANS; DNA; ORTHOPOXVIRUSES; IDENTIFICATION; INFECTION
AB Nucleotide sequence comparison of the internal region of the ati gene of members of the Orthopoxvirus genera revealed that this gene is variable among different species, although within members of the same species it is considered to be well conserved. Previous studies indicated that there is genetic variability in the ati gene among some Brazilian Vaccinia virus strains. To further investigate this variability, we performed molecular analysis of the internal region of the ati gene of eight Brazilian Vaccinia virus strains. While the internal region of this gene in one strain was similar to the Western Reserve strain, four strains presented two blocks of deletions in the analyzed region, and the ati gene was almost entirely deleted from three other strains. These findings demonstrate that there is genetic polymorphism within the ati gene among different Brazilian Vaccinia virus strains.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Leite, JA (corresponding author), Brazilian Agr Res Corp, EMBRAPA Dairy Cattle, Rue Eugenio Do Nascimento 610,Dom Bosco, BR-36038330 Juiz De Fora, Brazil.
EM ju@icb.ufmg.br; betaniadrumond@yahoo.com.br; dzj2@cdc.gov;
   claubonj@icb.ufmg.br; paulocpf@icb.ufmg.br; kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826
CR AMEGADZIE BY, 1992, VIROLOGY, V186, P777, DOI 10.1016/0042-6822(92)90046-R
   Boulanger D, 2002, J VIROL, V76, P9844, DOI 10.1128/JVI.76.19.9844-9855.2002
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2007, DIAGN MICR INFEC DIS, V57, P39, DOI 10.1016/j.diagmicrobio.2006.07.012
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Diniz S, 2001, ARQ BRAS MED VET ZOO, V53, P152, DOI 10.1590/S0102-09352001000200003
   Downie AW, 1939, J PATHOL BACTERIOL, V48, P361, DOI 10.1002/path.1700480212
   Esposito J., 2001, FIELDS VIROLOGY, P2885
   ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   FUNAHASHI S, 1988, J GEN VIROL, V69, P35, DOI 10.1099/0022-1317-69-1-35
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   ICHIHASHI Y, 1966, VIROLOGY, V29, P264, DOI 10.1016/0042-6822(66)90033-X
   ICHIHASHI Y, 1971, VIROLOGY, V46, P507, DOI 10.1016/0042-6822(71)90056-0
   JOHNSON GP, 1993, VIROLOGY, V196, P381, DOI 10.1006/viro.1993.1494
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   KNIGHT JC, 1992, VIROLOGY, V190, P423, DOI 10.1016/0042-6822(92)91228-M
   KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Loparev VN, 2001, J CLIN MICROBIOL, V39, P94, DOI 10.1128/JCM.39.1.94-100.2001
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   MEYER H, 1993, J GEN VIROL, V74, P1679, DOI 10.1099/0022-1317-74-8-1679
   MEYER H, 1994, J GEN VIROL, V75, P1975, DOI 10.1099/0022-1317-75-8-1975
   OSTERRIEDER N, 1994, VIRUS GENES, V8, P125, DOI 10.1007/BF01703611
   PATEL DD, 1986, VIROLOGY, V149, P174, DOI 10.1016/0042-6822(86)90119-4
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   SADASIV EC, 1985, AM J VET RES, V46, P529
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Ulaeto D, 1996, J VIROL, V70, P3372, DOI 10.1128/JVI.70.6.3372-3377.1996
NR 38
TC 16
Z9 16
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PD DEC
PY 2007
VL 35
IS 3
BP 531
EP 539
DI 10.1007/s11262-007-0133-9
PG 9
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA 232ZM
UT WOS:000251060200008
PM 17671837
DA 2020-11-30
ER

PT J
AU Magalhaes, CLD
   Quinan, BR
   Novaes, RFV
   dos Santos, JR
   Kroon, EG
   Bonjardim, CA
   Ferreira, PCP
AF Magalhaes, Cintia Lopes de Brito
   Quinan, Barbara Resende
   Novaes, Renata Franco Vianna
   dos Santos, Joao Rodrigues
   Kroon, Erna Geessien
   Bonjardim, Claudio Antonio
   Ferreira, Paulo Cesar Peregrino
TI Caraparu virus (group C Orthobunyavirus): sequencing and phylogenetic
   analysis based on the conserved region 3 of the RNA polymerase gene
SO VIRUS GENES
LA English
DT Article
DE molecular characterization; caraparu virus; orthobunyavirus;
   bunyaviridae; l segment; RNA-dependent RNA polymerase
ID SEGMENT; VALLEY
AB Here, for the first time, we report the nucleotide sequence of Caraparu virus (CARV) L segment and the analysis of the RNA polymerase region 3 encoded by this segment. The 1,404 bp nucleotide sequence shares the highest identity with Bunyamwera, La Crosse, Oropouche, and Akabane virus sequences. The amino acid sequence was deduced and aligned with sequences from members of the Bunyaviridae family and used for phylogenetic analysis. The CARV clustered in the Orthobunyavirus genus. The premotif A and motifs A-E are present in the region 3 of the Bunyaviridae family, were also conserved in CARV L protein, as well as other conserved regions among Orthobunyavirus genus.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Magalhaes, CLD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM cintia.magalhaes@gmail.com; quinanb@yahoo.com.br; santosjr@icb.ufmg.br;
   kroone@icb.ufmg.br; claubonj@icb.ufmg.br
RI Bonjardim, Claudio A/J-2601-2014; Kroon, Erna Geessien/B-3631-2015;
   Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR Aquino VH, 2003, ARCH VIROL, V148, P19, DOI 10.1007/s00705-002-0913-4
   CAUSEY OR, 1961, AM J TROP MED HYG, V10, P227, DOI 10.4269/ajtmh.1961.10.227
   ELLIOTT RM, 1989, VIROLOGY, V173, P426, DOI 10.1016/0042-6822(89)90555-2
   GONZALEZSCARANO F, 1996, PATHOGENESIS DIS CON, P227
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   ISHIHAMA A, 1994, ARCH VIROL, V134, P235, DOI 10.1007/BF01310564
   IVERSSON LB, 1987, REV I MED TROP, V29, P112, DOI 10.1590/S0036-46651987000200009
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345
   Nunes MRT, 2005, J VIROL, V79, P10561, DOI 10.1128/JVI.79.16.10561-10570.2005
   POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x
   ROBERTS A, 1995, VIROLOGY, V206, P742, DOI 10.1016/S0042-6822(95)80001-8
   SCHMALJOHN CS, 2001, FIELDS VIROLOGY, P1581
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
NR 14
TC 5
Z9 5
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PD DEC
PY 2007
VL 35
IS 3
BP 681
EP 684
DI 10.1007/s11262-007-0138-4
PG 4
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA 232ZM
UT WOS:000251060200025
PM 17705031
DA 2020-11-30
ER

PT J
AU Trindade, G
   Emerson, G
   Sammons, S
   Frace, M
   Govil, D
   Olsen-Rasmussen, M
   Li, Y
   Carroll, D
   Regnery, R
   Da Fonseca, FG
   Kroon, E
   Damon, I
AF Trindade, Giliane
   Emerson, Ginny
   Sammons, Scott
   Frace, Mike
   Govil, Dhwani
   Olsen-Rasmussen, Melissa
   Li, Yu
   Carroll, Darin
   Regnery, Russell
   Da Fonseca, Flavio Guimaraes
   Kroon, Erna
   Damon, Inger
TI Characterization of a novel Brazilian vaccinia virus isolated from human
   and comparative analysis with orthopoxviruses
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 04-08, 2007
CL Philadelphia, PA
SP Amer Soc Trop Med & Hyg
C1 [Trindade, Giliane; Emerson, Ginny; Li, Yu; Carroll, Darin; Regnery, Russell; Damon, Inger] Ctr Dis Control & Prevent, CCID, DVRD, PRB, Atlanta, GA USA.
   [Sammons, Scott; Frace, Mike; Govil, Dhwani; Olsen-Rasmussen, Melissa] Ctr Dis Control & Prevent, CCID, Atlanta, GA USA.
   [Da Fonseca, Flavio Guimaraes; Kroon, Erna] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2007
VL 77
IS 5
SU S
MA 991
BP 283
EP 283
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 228UN
UT WOS:000250758201449
DA 2020-11-30
ER

PT J
AU Coelho, LFL
   de Oliveira, JG
   de Oliveira, DB
   Guedes, ACM
   Lanna, CCD
   Prados, RZ
   Ferreira, PCP
   Bonjardim, CA
   Kroon, EG
AF Leomil Coelho, Luiz Felipe
   de Oliveira, Jaquelline Germano
   de Oliveira, Danilo Bretas
   Martins Guedes, Antonio Carlos
   Duarte Lanna, Cristina Costa
   Prados, Roberto Zimmer
   Peregrino Ferreira, Paulo Cesar
   Bonjardim, Claudio Antonio
   Kroon, Erna Geessien
TI Increased expression of 2'5'oligoadenylate synthetase and
   double-stranded RNA dependent protein kinase messenger RNAs on affected
   skin of systemic sclerosis patients
SO ARCHIVES OF DERMATOLOGICAL RESEARCH
LA English
DT Article
DE interferon; PKR; 2'5'OAS; fibroblast; affected skin; systemic sclerosis
ID INTERFERON-STIMULATED GENES; ALPHA THERAPY; CELLS; CLASSIFICATION;
   AUTOIMMUNITY; SCLERODERMA
AB Scleroderma or systemic sclerosis (SSc) is an autoimmune disorder of unknown aetiology characterized by excessive collagen synthesis and subsequent deposition on the skin and various internal organs. Interferons (IFNs) are well-known immunomodulators and inhibitors of collagen production. However, IFN therapy has been implicated in the development or exacerbation of several autoimmune diseases, including SSc. We analyzed the expression of several interferon-stimulated genes (ISGs) in affected skin of SSc patients (skin tissue and cultured skin fibroblasts). A set of ISGs (PKR, 2'5'OAS, MxA, and 6-16) was analyzed by real-time PCR using RNA extracted from cultured skin fibroblasts and skin tissue of normal individuals and SSc patients. Both normal and SSc affected skin cultured fibroblasts were sensitive to the IFN treatment and presented similar levels of all ISGs tested. However, PKR and 2'5'OAS mRNA expression levels were significantly higher in the affected skin tissue of SSc patients when compared to normal controls. These data suggest that the IFN system plays a role in the pathogenesis of SSc.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270910 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   Hosp Balcia, Dept Cirurgia Plastica, Belo Horizonte, MG, Brazil.
   Univ Fed Piaui, Ctr Ciencias Suade, Dept Microbiol & Parasitol, Microbiol Lab, Piaui, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270910 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Coelho, Luiz FL/G-5853-2012; Kroon,
   Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014
OI Kroon, Erna Geessien/0000-0003-2721-3826; Coelho, Luiz
   Felipe/0000-0003-4289-384X
CR Abu-Shakra M, 2000, CLIN RHEUMATOL, V19, P378, DOI 10.1007/s100670070031
   [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510
   Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x
   Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6
   Beretta L, 2002, BRIT J DERMATOL, V147, P385, DOI 10.1046/j.1365-2133.2002.48901.x
   Bonjardim CA, 2005, MICROBES INFECT, V7, P569, DOI 10.1016/j.micinf.2005.02.001
   Carvalho AF, 1998, PLACENTA, V19, P307, DOI 10.1016/S0143-4004(98)90063-7
   Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040
   de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912
   Denton CP, 2004, BEST PRACT RES CL RH, V18, P271, DOI 10.1016/j.berh.2004.03.001
   Giacomelli R, 2001, CLIN EXP IMMUNOL, V125, P310, DOI 10.1046/j.1365-2249.2001.01603.x
   Harris ML, 2003, CURR OPIN RHEUMATOL, V15, P778, DOI 10.1097/00002281-200311000-00016
   Jimenez SA, 2004, ANN INTERN MED, V140, P37, DOI 10.7326/0003-4819-140-1-200401060-00010
   Kontsek P, 2003, ACTA VIROL, V47, P201
   Oliveira JG, 1999, ARCH DERMATOL RES, V291, P659, DOI 10.1007/s004030050471
   Solans R, 2004, CLIN EXP RHEUMATOL, V22, P625
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Tan FK, 2006, RHEUMATOLOGY, V45, P694, DOI 10.1093/rheumatology/kei244
   Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843
NR 19
TC 7
Z9 7
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-3696
EI 1432-069X
J9 ARCH DERMATOL RES
JI Arch. Dermatol. Res.
PD AUG
PY 2007
VL 299
IS 5-6
BP 259
EP 262
DI 10.1007/s00403-007-0737-x
PG 4
WC Dermatology
SC Dermatology
GA 200NW
UT WOS:000248771100005
PM 17541615
DA 2020-11-30
ER

PT J
AU Trindade, GS
   Emerson, GL
   Carroll, DS
   Kroon, EG
   Damon, IK
AF Trindade, Giliane S.
   Emerson, Ginny L.
   Carroll, Darin S.
   Kroon, Erna G.
   Damon, Inger K.
TI Brazilian vaccinia viruses and their origins
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID COTIA VIRUS; MAHARASHTRA STATE; POXVIRUS; BUFFALOPOX; SMALLPOX;
   INFERENCE; OUTBREAK; MRBAYES; HUMANS; CATTLE
AB Although the World Health Organization (WHO) declared global smallpox eradicated in 1980, concerns over emergent poxvirus infections have increased. Most poxvirus infections are zoonotic; exploring their genetic diversity will illuminate the genetic and evolutionary aspects of poxvirus infections, ecology, and epidemiology. In recent decades, several strains of the orthopoxvirus vaccinia virus (VACV) have been isolated throughout Brazil, including genetically distinct isolates within the same outbreak. To further investigate the diversity and origins of these viruses, we analyzed molecular data from 8 Brazilian VACV isolates and compared several genes involved in virus structure and pathogenicity. Genetic variation among isolates suggests that ancestral Brazilian VACVs existed before the beginning of the WHO smallpox eradication vaccination campaigns and that these viruses continue to circulate.
C1 Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
   Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
RP Damon, IK (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop G43, Atlanta, GA 30333 USA.
EM idamon@cdc.gov
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR BENCHIMOL JL, 2001, FEBRE AMARELA DOENCA
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   DAMASO CR, 2006, DIAGN MICROBIOL INFE, V57, P39
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DUMBELL K, 1993, ARCH VIROL, V128, P257, DOI 10.1007/BF01309438
   ESPOSITO JJ, 1980, J GEN VIROL, V47, P37, DOI 10.1099/0022-1317-47-1-37
   Fenner F., 1988, SMALLPOX ITS ERADICA
   Fernandes T, 1999, Hist Cienc Saude Manguinhos, V6, P29
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   JOHNSON GP, 1993, VIROLOGY, V196, P381, DOI 10.1006/viro.1993.1494
   Kolhapure RM, 1997, INDIAN J MED RES, V106, P441
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lewis A, 2005, ARCH VIROL, V150, P1485, DOI 10.1007/s00705-005-0498-9
   Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   MEYER H, 2001, VACCINIA VIRUS POXVI, P119
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Singh RK, 2006, ARCH VIROL, V151, P1995, DOI 10.1007/s00705-006-0761-8
   Swofford D., 2003, PAUP PHYLOGENETIC AN
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06
   Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399
   UEDA Y, 1995, VIROLOGY, V210, P67, DOI 10.1006/viro.1995.1317
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
   WOKATSCH R, 1972, STRAINS HUMAN VIRUSE
NR 34
TC 91
Z9 95
U1 0
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2007
VL 13
IS 7
BP 965
EP 972
DI 10.3201/eid1307.061404
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 186DB
UT WOS:000247758200001
PM 18214166
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Trindade, GS
   Vilela, JMC
   Ferreira, JMS
   Aguiar, PHN
   Leite, JA
   Guedes, MIMC
   Lobato, ZIP
   Madureira, MC
   da Silva, MIN
   da Fonseca, FG
   Kroon, EG
   Andrade, MS
AF Trindade, G. S.
   Vilela, J. M. C.
   Ferreira, J. M. S.
   Aguiar, P. H. N.
   Leite, J. A.
   Guedes, M. I. M. C.
   Lobato, Z. I. P.
   Madureira, M. C.
   da Silva, M. I. N.
   da Fonseca, F. G.
   Kroon, E. G.
   Andrade, M. S.
TI Use of atomic force microscopy as a diagnostic tool to identify
   orthopoxvirus
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE AFM; diagnosis; bovine vaccinia outbreaks; orthopoxviruses; Vaccinia
   virus; biosecurity
ID VACCINIA-VIRUS; ELECTRON-MICROSCOPY; HIGH-RESOLUTION; POXVIRUS; HUMANS;
   CATTLE; OUTBREAK; STRAINS; REGION; BRAZIL
AB Atomic force microscopy (AFM) is a versatile technique that permits the imaging of surfaces and generates topographical images from a variety of materials. Due to the fact that AFM requires minimum sample manipulation, it is a valuable tool for studying biological materials such as cells, DNA, bacteria and viruses. The aim of the present study was to standardize the AFM technique as a diagnostic tool for detection of naturally occurring orthopox viruses. The samples analyzed were collected during natural outbreaks of Vaccinia virus (VACV) in dairy cattle in Brazil. These viruses are zoonotic infections; and therefore safe manipulation of all samples is required. The AFM technique would provide a more secure way to diagnose infection. By using the "in air" AFM technique after purification and inactivation process, relatively crude preparations of viruses were visualized rapidly. Details for efficient sample preparation and AFM imaging are described. The AFM technique provides a rapid and biosecure tool for the diagnosis of emerging orthopoxviruses and has potential as a tool for screening bioterrorism samples. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, BR-31270901 Belo Horizonte, MG, Brazil.
   CETEC, Lab Nanoscopia, Fdn Ctr Tecnol Minas Gerais, BR-31170000 Belo Horizonte, MG, Brazil.
   CETEC, Lab Reol, Fdn Ctr Tecnol Minas Gerais, BR-31170000 Belo Horizonte, MG, Brazil.
   Inst Mineiro Agropecuaria, BR-30120010 Belo Horizonte, MG, Brazil.
   Fiocruz MS, Lab Imunol Celular & Mol, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos,6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM gitrindade@yahoo.com.br; jose.mario.vilela@cetec.br; jackie@icb.ufmg.br;
   phnaguiar@uol.com.br; ju@icb.ufmg.br; isabelguedes@icb.ufmg.br;
   ziplobat@vet.ufmg.br; marietacristinam@yahoo.com.br;
   ivonete.nogueira@cetec.br; fdafonseca@cpqrr.fiocruz.br;
   masc.egk@terra.com.br; margareth.spangler@cetec.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Lobato,
   Zelia/0000-0002-9399-3691; Aguiar, Pedro/0000-0002-4942-5021
CR BRENNER S, 1959, BIOCHIM BIOPHYS ACTA, V34, P103, DOI 10.1016/0006-3002(59)90237-9
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   CARDOSO AV, 2005, MICROSCI MICROANAL, V11, P86
   Cyrklaff M, 2005, P NATL ACAD SCI USA, V102, P2772, DOI 10.1073/pnas.0409825102
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DUBOCHET J, 1994, J VIROL, V68, P1935, DOI 10.1128/JVI.68.3.1935-1941.1994
   Dufrene YF, 2004, NAT REV MICROBIOL, V2, P451, DOI 10.1038/nrmicro905
   Hazelton PR, 2003, EMERG INFECT DIS, V9, P294, DOI 10.3201/eid0903.020327
   Johnsen CK, 2006, J VIROL METHODS, V134, P92, DOI 10.1016/j.jviromet.2005.12.007
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kitamoto N, 2005, MICROBIOL IMMUNOL, V49, P219, DOI 10.1111/j.1348-0421.2005.tb03723.x
   Kuznetsov YG, 2005, J VIROL, V79, P1970, DOI 10.1128/JVI.79.3.1970-1974.2005
   Kuznetsov YG, 2001, J GEN VIROL, V82, P2025, DOI 10.1099/0022-1317-82-9-2025
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Loparev VN, 2001, J CLIN MICROBIOL, V39, P94, DOI 10.1128/JCM.39.1.94-100.2001
   Malkin AJ, 1999, J STRUCT BIOL, V127, P35, DOI 10.1006/jsbi.1999.4128
   Malkin AJ, 2003, J VIROL, V77, P6332, DOI 10.1128/JVI.77.11.6332-6340.2003
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Nettikadan SR, 2003, BIOCHEM BIOPH RES CO, V311, P540, DOI 10.1016/j.bbrc.2003.10.022
   Plomp M, 2002, AM J PATHOL, V160, P1959, DOI 10.1016/S0002-9440(10)61145-5
   SOFI IM, 2003, J CLIN MICROBIOL, V41, P3835, DOI DOI 10.1128/JCM.41.8.3835-3839.2003
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
NR 26
TC 13
Z9 16
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD MAY
PY 2007
VL 141
IS 2
BP 198
EP 204
DI 10.1016/j.jviromet.2006.12.006
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 162JN
UT WOS:000246083200011
PM 17239966
DA 2020-11-30
ER

PT J
AU Martins, MA
   Silva, ML
   Marciano, APV
   Peruhype-Magalhaes, V
   Eloi-Santos, SM
   Ribeiro, JGL
   Correa-Oliveira, R
   Homma, A
   Kroon, EG
   Teixeira-Carvalho, A
   Martins-Filho, OA
AF Martins, M. A.
   Silva, M. L.
   Marciano, A. P. V.
   Peruhype-Magalhaes, V.
   Eloi-Santos, S. M.
   Ribeiro, J. G. L.
   Correa-Oliveira, R.
   Homma, A.
   Kroon, E. G.
   Teixeira-Carvalho, A.
   Martins-Filho, O. A.
TI Activation/modulation of adaptive immunity emerges simultaneously after
   17DD yellow fever first-time vaccination: is this the key to prevent
   severe adverse reactions following immunization?
SO CLINICAL AND EXPERIMENTAL IMMUNOLOGY
LA English
DT Article
DE 17DD vaccination; flow cytometry; lymphocyte subsets; yellow fever
ID REGULATORY T-CELLS; CYTOKINE PRODUCTION; CXC CHEMOKINE; B-LYMPHOCYTES;
   INTERLEUKIN-10; IL-10; ACTIVATION; EXPRESSION; INFECTION; RESPONSES
AB Over past decades the 17DD yellow fever vaccine has proved to be effective in controlling yellow fever and promises to be a vaccine vector for other diseases, but the cellular and molecular mechanisms by which it elicits such broad-based immunity are still unclear. In this study we describe a detailed phenotypic investigation of major and minor peripheral blood lymphocyte subpopulations aimed at characterizing the kinetics of the adaptive immune response following primary 17DD vaccination. Our major finding is a decreased frequency of circulating CD19(+) cells at day 7 followed by emerging activation/modulation phenotypic features (CD19(+)interleukin(IL)10R(+)/CD19(+)CD32(+)) at day 15. Increased frequency of CD4(+)human leucocyte antigen D-related(HLA-DR+) at day 7 and CD8(+)HLA-DR+ at day 30 suggest distinct kinetics of T cell activation, with CD4(+) T cells being activated early and CD8(+) T cells representing a later event following 17DD vaccination. Up-regulation of modulatory features on CD4(+) and CD8(+) cells at day 15 seems to be the key event leading to lower frequency of CD38(+) T cells at day 30. Taken together, our findings demonstrate the co-existence of phenotypic features associated with activation events and modulatory pathways. Positive correlations between CD4(+)HLA-DR+ cells and CD4(+)CD25(high) regulatory T cells and the association between the type 0 chemokine receptor CCR2 and the activation status of CD4(+) and CD8(+) cells further support this hypothesis. We hypothesize that this controlled microenviroment seems to be the key to prevent the development of serious adverse events, and even deaths, associated with the 17DD vaccine reported in the literature.
C1 Ctr Pesquisas Rene Rachou Fiocruz, Lab Doenca Chagas, Fdn Oswaldo Cruz, BR-190002 Belo Horizonte, MG, Brazil.
   SES, Secretaria Estadual Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   Ctr Pesquisas Rene Rachou Fiocruz, Lab Imunol Celular & Mol, Fdn Oswaldo Cruz, BR-190002 Belo Horizonte, MG, Brazil.
RP Martins-Filho, OA (corresponding author), Ctr Pesquisas Rene Rachou Fiocruz, Lab Doenca Chagas, Fdn Oswaldo Cruz, Ave Augusto Lima 1715, BR-190002 Belo Horizonte, MG, Brazil.
EM oamfilho@cpqrr.fiocruz.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Correa-Oliveira,
   Rodrigo/0000-0001-6419-9459; Martins-Filho, Olindo
   Assis/0000-0002-5494-4889
CR Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245
   Cassis L, 2005, CONTRIB NEPHROL, V146, P121, DOI 10.1159/000082072
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P989
   Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255
   Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009
   DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5
   DEWAAL MR, 1991, J EXP MED, V174, P15
   Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8
   Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246
   FIORENTINO DF, 1991, J IMMUNOL, V146, P3444
   Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002
   Groux H, 1998, J IMMUNOL, V160, P3188
   Hacker UT, 1998, J INFECT DIS, V177, P774, DOI 10.1086/517806
   Herath KB, 2005, J ANTIBIOT, V58, P686, DOI 10.1038/ja.2005.94
   HOLLUB M, 2004, KLIN MICROBIOL INFEK, V10, P229
   Jinquan T, 2000, IMMUNOLOGY, V99, P402, DOI 10.1046/j.1365-2567.2000.00954.x
   Kirschbaum J, 2006, BRIT J DERMATOL, V154, P225, DOI 10.1111/j.1365-2133.2005.07005.x
   LEVY Y, 1994, J CLIN INVEST, V93, P424, DOI 10.1172/JCI116977
   LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084
   Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655
   MALEFYT RD, 1993, J IMMUNOL, V150, P4754
   Malisan F, 1996, J EXP MED, V183, P937, DOI 10.1084/jem.183.3.937
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Monath TP, 2002, CLIN INFECT DIS, V34, P1369, DOI 10.1086/340104
   MUTA T, 1994, NATURE, V369, P340, DOI 10.1038/369340a0
   O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B
   ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890
   Rowbottom AW, 1999, IMMUNOLOGY, V98, P80
   Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875
   Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2
   Santin AD, 2000, J VIROL, V74, P4729, DOI 10.1128/JVI.74.10.4729-4737.2000
   SCHANDENE L, 1994, J IMMUNOL, V152, P4368
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   TAGA K, 1993, BLOOD, V81, P2964
   TAN JQ, 1993, J IMMUNOL, V151, P4545
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Trzonkowski P, 2004, CLIN IMMUNOL, V112, P258, DOI 10.1016/j.clim.2004.04.003
   VASCONCELOS PF, 2002, REV BRAS EPIDEMIOL, V5, P244
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
NR 41
TC 33
Z9 33
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9104
EI 1365-2249
J9 CLIN EXP IMMUNOL
JI Clin. Exp. Immunol.
PD APR
PY 2007
VL 148
IS 1
BP 90
EP 100
DI 10.1111/j.1365-2249.2006.03317.x
PG 11
WC Immunology
SC Immunology
GA 143JK
UT WOS:000244716700010
PM 17309541
OA Green Published
DA 2020-11-30
ER

PT J
AU Trindade, GDS
   Drumond, BP
   Guedes, MIMC
   Leite, JA
   Mota, BEF
   Campos, MA
   da Fonseca, FG
   Nogueira, ML
   Lobato, ZIP
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Trindade, Giliane de Souza
   Drumond, Betania Paiva
   Maldonado Coelho Guedes, Maria Isabel
   Leite, Juliana Almeida
   Fernandes Mota, Bruno Eduardo
   Campos, Marco Antnio
   da Fonseca, Flavio Guimaraes
   Nogueira, Mauricio Lacerda
   Portela Lobato, Zelia Ines
   Bonjardim, Claudio Antnio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Zoonotic vaccinia virus infection in Brazil: Clinical description and
   implications for health professionals
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID SEQUENCE ALIGNMENT; HUMANS; POXVIRUS; CATTLE
AB Bovine vaccinia virus outbreaks have been occurring in different regions of Brazil. We report here the time course of natural human infection by vaccinia virus and describe important clinical and epidemiological aspects of this zoonotic infection. The diagnosis of vaccinia virus infection was based on clinical, serological, and molecular procedures.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunopatol, BR-30190002 Belo Horizonte, MG, Brazil.
   Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, BR-30190002 Belo Horizonte, MG, Brazil.
   Fac Med Sao Jose Do Rio Preto, Dept Doencas Infecc & Parasitarias, Lab Pesquisas Virol, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   Univ Fed Minas Gerais, Dept Prevent Med, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
RP Ferreira, PCP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM masc.egk@terra.com.br
RI Nogueira, Mauricio L/B-7599-2012; Kroon, Erna/V-5444-2019; Bonjardim,
   Claudio A/J-2601-2014; Kroon, Erna Geessien/B-3631-2015; Campos, Marco
   A/C-4000-2013
OI Nogueira, Mauricio L/0000-0003-1102-2419; Kroon, Erna
   Geessien/0000-0003-2721-3826; Campos, Marco A/0000-0003-4683-0176;
   Lobato, Zelia/0000-0002-9399-3691; Mota, Bruno/0000-0003-0348-4875
CR Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003
   Malkin AJ, 2003, J VIROL, V77, P6332, DOI 10.1128/JVI.77.11.6332-6340.2003
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
NR 10
TC 40
Z9 40
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD APR
PY 2007
VL 45
IS 4
BP 1370
EP 1372
DI 10.1128/JCM.00920-06
PG 3
WC Microbiology
SC Microbiology
GA 158GI
UT WOS:000245779300055
PM 17287326
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Trindade, G
   Emerson, G
   Frace, M
   Sammons, S
   Olsen-Rasmussen, M
   Karen, K
   Carroll, D
   Li, Y
   Regnery, R
   Kroon, E
   Damon, I
AF Trindade, Gilliane
   Emerson, Ginny
   Frace, Mike
   Sammons, Scott
   Olsen-Rasmussen, Melissa
   Karen, Kevin
   Carroll, Darin
   Li, Yu
   Regnery, Russell
   Kroon, Erna
   Damon, Inger
TI Comparative analysis of Brazilian Vaccinia virus strains
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.
   ICB UFMG, Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2006
VL 75
IS 5
SU S
MA 636
BP 184
EP 184
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 109XW
UT WOS:000242343901071
DA 2020-11-30
ER

PT J
AU Trindade, GS
   Lobato, ZIP
   Drumond, BP
   Leite, JA
   Trigueiro, RC
   Guedes, MIMC
   Da Fonseca, FG
   Dos Santos, JR
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Trindade, Giliane S.
   Lobato, Zelia I. P.
   Drumond, Betania P.
   Leite, Juliana A.
   Trigueiro, Ricardo C.
   Guedes, Maria I. M. C.
   Da Fonseca, Flavio G.
   Dos Santos, Joao R.
   Bonjardim, Claudio A.
   Ferreira, Paulo C. P.
   Kroon, Erna G.
TI Short report: Isolation of two Vaccinia virus strains from a single
   bovine vaccinia outbreak in rural area from Brazil: Implications on the
   emergence of zoonotic orthopoxviruses
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; RIO-DE-JANEIRO; SEQUENCE ALIGNMENT;
   DNA-SEQUENCE; CATTLE; POXVIRUS; HUMANS; REGION; GENOME; STATE
AB Outbreaks of bovine vaccinia disease caused by circulation of Vaccinia virus (VACV) strains have been a common occurrence in Brazil in the recent years, being an important emergent zoonosis. During a single outbreak that took place in 2001, two genetically different VACV strains were isolated and named Guarani P1 virus (GP1V) and Guarani P2 virus (GP2V). Molecular diagnosis was done through restriction fragment length polymorphism (RFLP) of ati gene (A26L) and by sequence analysis of a group of five VACV genes including the C11R, J2R, A56R, B18R, and E3L genes. These findings confirmed the co-circulation of two different Vaccinia virus strains during the same outbreak, raising important questions about the origin, emergence, and circulation of VACV strains in Brazil.
C1 Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, BR-31270901 Belo Horizonte, MG, Brazil.
   Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Inmunol Celular & Mol, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Lobato,
   Zelia/0000-0002-9399-3691
CR da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   JOHNSON GP, 1993, VIROLOGY, V196, P381, DOI 10.1006/viro.1993.1494
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Malkin AJ, 2003, J VIROL, V77, P6332, DOI 10.1128/JVI.77.11.6332-6340.2003
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Neubauer H, 1997, LAB ANIM, V31, P201, DOI 10.1258/002367797780596275
   PEARSON W, 2006, LALIGN FIND MULTIPLE
   ROOP SL, 1995, J CLIN MICROBIOL, V33, P2069
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
NR 22
TC 75
Z9 77
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD SEP
PY 2006
VL 75
IS 3
BP 486
EP 490
DI 10.4269/ajtmh.2006.75.486
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 083RR
UT WOS:000240476400019
PM 16968926
OA Bronze
DA 2020-11-30
ER

PT J
AU Silva, PNG
   Soares, JAP
   Brasil, BSAF
   Nogueira, SV
   Andrade, AA
   de Magalhaes, JC
   Bonjardim, MB
   Ferreira, PCP
   Kroon, EG
   Bruna-Romero, O
   Bonjardim, CA
AF Silva, Patricia N. G.
   Soares, Jamaria A. P.
   Brasil, Bruno S. A. F.
   Nogueira, Sarah V.
   Andrade, Anderson A.
   de Magalhaes, Jos C.
   Bonjardim, Marisa B.
   Ferreira, Paulo C. P.
   Kroon, Erna G.
   Bruna-Romero, Oscar
   Bonjardim, Claudio A.
TI Differential role played by the MEK/ERK/EGR-1 pathway in orthopoxviruses
   vaccinia and cowpox biology
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE cowpox virus; early growth response 1 (EGR-1); mitogen-activated protein
   kinase/extracellular-signal-regulated kinase kinase (MEK);
   orthopoxvirus; vaccinia virus; virus-host cell interaction
ID VIRUS-INFECTION; PROTEIN-KINASE; INTERFERING RNA; GENE-EXPRESSION; LATE
   PROMOTER; EGR PROTEINS; C-FOS; TRANSCRIPTION; PURIFICATION; INDUCTION
AB Appropriation of signalling pathways facilitates poxvirus replication. Poxviruses, as do most viruses, try to modify the host cell environment to achieve favourable replication conditions. In the present study, we show that the early growth response 1 gene (egr-1) is one of the host cell factors intensely modulated by the orthopoxviruses VV (vaccinia virus) and CPV (cowpox virus). These viruses stimulated the generation of both egr-1 mRNA and its gene product, throughout their entire replication cycles, via the requirement of MEK [mitogen-activated protein kinase/ERK (extracellular-signal-regulated kinase) kinase]/ERK pathway. We showed that, upon VV infection, EGR-1 translocates into the nucleus where it binds to the EBS (egr-1-binding site) positioned at the 5' region of EGR-1-regulated genes. In spite of both viruses belonging to the same genus, several lines of evidence, however, revealed a remarkable contrast between them as far as the roles played by the MEK/ERK/EGR-1 pathway in their biological cycles are concerned. Hence (i) the knocking-down of egr-1 by siRNA (small interfering RNA) proved that this transcription factor is of critical relevance for VV biology, since a decrease of about one log cycle in virus yield was verified, along with a small virus plaque phenotype, whereas the gene silencing did not have a detrimental effect on either CPV multiplication or viral plaque size; (ii) while both pharmacological and genetic inhibition of MEK/ERK resulted in a significant decrease in VV yield, both approaches had no impact on CPV multiplication; and (iii) CPV DNA replication was unaffected by pharmacological inhibition of MEK/ERK, but phosphorylation of MEK/ERK was dependent on CPV DNA replication, contrasting with a significant VV DNA inhibition and VV DNA replication-independence to maintain ERK1/2 phosphorylation, observed under the same conditions.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Agentes Recombinantes, BR-31270901 Belo Horizonte, MG, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal, BR-31270901 Belo Horizonte, MG, Brazil.
EM claubonj@mono.icb.ufmg.br
RI Bonjardim, Claudio A/J-2601-2014; Kroon, Erna Geessien/B-3631-2015;
   BRUNA-ROMERO, OSCAR/B-3918-2010; Kroon, Erna/V-5444-2019; Andrade,
   Anderson/H-4022-2012; Brasil, Bruno S. A. F./E-8817-2012
OI Kroon, Erna Geessien/0000-0003-2721-3826; BRUNA-ROMERO,
   OSCAR/0000-0002-8855-4969; Andrade, Anderson/0000-0001-9569-6503;
   Brasil, Bruno S. A. F./0000-0002-8690-2157; , Bruno/0000-0002-3587-7983
CR Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980
   Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   BAROUDY BM, 1980, J BIOL CHEM, V255, P4372
   BEATTIE E, 1995, J VIROL, V69, P499, DOI 10.1128/JVI.69.1.499-505.1995
   Bonjardim CA, 2005, MICROBES INFECT, V7, P569, DOI 10.1016/j.micinf.2005.02.001
   Bonjardim CA, 1997, BRAZ J MED BIOL RES, V30, P41, DOI 10.1590/S0100-879X1997000100007
   Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697
   Broyles SS, 1999, J BIOL CHEM, V274, P35662, DOI 10.1074/jbc.274.50.35662
   Castro APV, 2003, J VIROL, V77, P9052, DOI 10.1128/JVI.77.16.9052-9068.2003
   Condit RC, 2002, BBA-GENE STRUCT EXPR, V1577, P325, DOI 10.1016/S0167-4781(02)00461-X
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   De Sousa LP, 2005, BIOCHEM BIOPH RES CO, V329, P237, DOI 10.1016/j.bbrc.2005.01.123
   Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129
   Feng WH, 2004, J VIROL, V78, P1893, DOI 10.1128/JVI.78.4.1893-1902.2004
   Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873
   Guerra S, 2003, J VIROL, V77, P6493, DOI 10.1128/JVI.77.11.6493-6506.2003
   Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652
   Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5
   Hung JJ, 2002, J VIROL, V76, P1379, DOI 10.1128/JVI.76.3.1379-1390.2002
   Husain M, 2003, J VIROL, V77, P9008, DOI 10.1128/JVI.77.16.9008-9019.2003
   Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427
   Lalani AS, 1999, SCIENCE, V286, P1968, DOI 10.1126/science.286.5446.1968
   Liu CT, 1998, CANCER GENE THER, V5, P3
   Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497
   Ludwig H, 2005, J VIROL, V79, P2584, DOI 10.1128/JVI.79.4.2584-2596.2005
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127
   MOSS B, 1996, FIELDS VIROLOGY, P2637
   Nilsson T, 2001, J VIROL, V75, P5796, DOI 10.1128/JVI.75.13.5796-5811.2001
   Oh J, 2005, J VIROL, V79, P12852, DOI 10.1128/JVI.79.20.12852-12860.2005
   Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199
   Randall G, 2003, P NATL ACAD SCI USA, V100, P235, DOI 10.1073/pnas.0235524100
   ROSALES R, 1994, P NATL ACAD SCI USA, V91, P3794, DOI 10.1073/pnas.91.9.3794
   Ruvkun Gary, 2004, Cell, VS116, pS93, DOI 10.1016/S0092-8674(04)00034-0
   Sambrook J., 1989, MOL CLONING LAB MANU
   Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049
   SHUMAN S, 1987, J BIOL CHEM, V262, P12372
   Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6
   Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200
   Smith GL, 2002, NAT REV IMMUNOL, V2, P521, DOI 10.1038/nri845
   Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x
   SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0
   Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186
   Tatarowicz WA, 1997, J NEUROVIROL, V3, P212, DOI 10.3109/13550289709018296
   Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132
   Wright CF, 1998, J VIROL, V72, P1446, DOI 10.1128/JVI.72.2.1446-1451.1998
   Yang YL, 2002, J BIOL CHEM, V277, P19482, DOI 10.1074/jbc.M201687200
   ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0
NR 51
TC 27
Z9 28
U1 0
U2 4
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD AUG 15
PY 2006
VL 398
BP 83
EP 95
DI 10.1042/BJ20060509
PN 1
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 074UA
UT WOS:000239836100009
PM 16686604
OA Green Published
DA 2020-11-30
ER

PT J
AU Coelho, LFL
   Mota, BEF
   Sales, PCM
   Marques, JT
   de Oliveira, JG
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Leomil Coelho, Luiz Felipe
   Fernandes Mota, Bruno Eduardo
   Motta Sales, Paula Cristiane
   Trindade Marques, Joao
   Germano de Oliveira, Jacquelline
   Antonio Bonjardim, Claudio
   Peregrino Ferreira, Paulo Cesar
   Geessien Kroon, Erna
TI Integrin alpha 11 is a novel type I interferon stimulated gene
SO CYTOKINE
LA English
DT Article
DE integrin alpha 11; interferons alpha/beta; PKR
ID DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; NF-KAPPA-B; TUMOR-SUPPRESSOR
   P53; CHROMOSOMAL LOCALIZATION; INTERSTITIAL COLLAGENS; VIRAL-INFECTION;
   CELL-MIGRATION; ADHESION; ACTIVATION
AB Interferons (IFNs) are a family of cytokines that have many biological functions in the cell, including regulation of cellular growth, differs entiation, immunomodulation, and viral replication by inducing a set of interferon stimulated genes (ISGs). Based on their structure and biological activities IFNs are subdivided into two groups: type I IFNs, which includes IFN-alpha and IFN-beta and type 11 IFNs, represented by IFN-gamma. The aim of this work was to investigate whether integrin alpha-11 (ITGA-11), a novel collagen-binding integrin, is responsive to type I IFN treatment. Our findings indicated that type I IFNs were able to induce the ITGA-11 mRNA levels in T98G cells. Increased levels of ITGA-11 protein were also observed in IFN-treated cells. The in vivo induction of ITGA-11 was detected in spleen and lungs of IFN-treated BALB/c mice. T98G cells infected with Murine encephalomyocarditis virus showed increased levels of ITGA-11 mRNA and protein. We observed that the ITGA-11 promoter has binding sites for transcriptional factors regulated by IFNs and the double-stranded RNA dependent protein kinase (PKR). Therefore we investigated the role of PKR in the induction of ITGA-11 by using a PKR deficient mouse embryo fibroblast cell line (MEFs). PKR-/- MEFs treated with IFN did not show increased levels of ITGA-11 protein nor mRNA although that could be promptly detected in wild type MEFs. Taken together our data suggest that ITGA-11 is a new interferon stimulated gene. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Virus Lab, BR-31270910 Belo Horizonte, MG, Brazil.
   Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos,6627, BR-31270910 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Coelho, Luiz FL/G-5853-2012; Bonjardim, Claudio A/J-2601-2014; Marques,
   Joao T/F-7683-2012; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015
OI Marques, Joao T/0000-0002-3457-3320; Kroon, Erna
   Geessien/0000-0003-2721-3826; Mota, Bruno/0000-0003-0348-4875; Coelho,
   Luiz Felipe/0000-0003-4289-384X
CR Bandyopadhyay SK, 2000, J IMMUNOL, V164, P2077, DOI 10.4049/jimmunol.164.4.2077
   Ben-Horin S, 2004, CLIN IMMUNOL, V113, P119, DOI 10.1016/j.clim.2004.06.007
   Bhatia R, 1998, LEUKEMIA LYMPHOMA, V28, P241, DOI 10.3109/10428199809092680
   Bonjardim CA, 1998, BRAZ J MED BIOL RES, V31, P1389, DOI 10.1590/S0100-879X1998001100004
   Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845
   Campos MAS, 1999, CELL BIOL INT, V23, P81, DOI 10.1006/cbir.1998.0323
   Carvalho AF, 1998, PLACENTA, V19, P307, DOI 10.1016/S0143-4004(98)90063-7
   Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6
   Cuddihy AR, 1999, MOL CELL BIOL, V19, P2475
   Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620
   DAO T, 1995, FOLIA BIOL-PRAGUE, V41, P213
   de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912
   FERREIRA PCP, 1979, J CLIN MICROBIOL, V9, P471
   Flaishon L, 2001, J BIOL CHEM, V276, P46701, DOI 10.1074/jbc.M103484200
   Gil J, 2000, ONCOGENE, V19, P1369, DOI 10.1038/sj.onc.1203448
   Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241
   Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004
   GULLBERG D, 1995, DEV DYNAM, V204, P57, DOI 10.1002/aja.1002040108
   Higuchi A, 2003, J BIOMED MATER RES A, V65A, P369, DOI 10.1002/jbm.a.10428
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049
   Kontsek P, 2003, ACTA VIROL, V47, P201
   Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406
   Lau JF, 2002, MT SINAI J MED, V69, P156
   Lee JH, 2005, GLIA, V50, P66, DOI 10.1002/glia.20156
   Lehnert K, 1999, GENOMICS, V60, P179, DOI 10.1006/geno.1999.5909
   LEVIN D, 1978, P NATL ACAD SCI USA, V75, P1121, DOI 10.1073/pnas.75.3.1121
   Maemura M, 1999, ONCOL REP, V6, P557
   Mainiero F, 1998, J EXP MED, V188, P1267, DOI 10.1084/jem.188.7.1267
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652
   Muraro PA, 2004, J NEUROIMMUNOL, V150, P123, DOI 10.1016/j.jneuroim.2004.01.002
   Oliveira JG, 1999, ARCH DERMATOL RES, V291, P659, DOI 10.1007/s004030050471
   Paludan SR, 2001, J VIROL, V75, P8008, DOI 10.1128/JVI.75.17.8008-8015.2001
   Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006
   Sambrook J., 1989, MOL CLONING LAB MANU
   SANTALA P, 1991, J BIOL CHEM, V266, P23505
   Sims TN, 2002, IMMUNOL REV, V186, P100, DOI 10.1034/j.1600-065X.2002.18610.x
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Tenaud I, 2002, INT J DERMATOL, V41, P836, DOI 10.1046/j.1365-4362.2002.01598.x
   Thomsen AR, 2003, IMMUNOL LETT, V85, P119, DOI 10.1016/S0165-2478(02)00236-5
   Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363
   Uddin S, 2004, J BIOCHEM MOL BIOL, V37, P635
   VALENZUELA D, 1985, NATURE, V313, P698, DOI 10.1038/313698a0
   Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735
   Wang K, 2002, ONCOGENE, V21, P7598, DOI 10.1038/sj.onc.1205953
   WEBER H, 1987, EMBO J, V6, P591, DOI 10.1002/j.1460-2075.1987.tb04795.x
   WILIAMS BR, 2001, SCI STKE, pRE2
   Williams BRG, 1997, BIOCHEM SOC T, V25, P509, DOI 10.1042/bst0250509
   Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291
   Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200
   Zhang WM, 2002, MATRIX BIOL, V21, P513, DOI 10.1016/S0945-053X(02)00054-9
NR 55
TC 3
Z9 3
U1 0
U2 1
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD MAR 21
PY 2006
VL 33
IS 6
BP 352
EP 361
DI 10.1016/j.cyto.2006.03.007
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 055QG
UT WOS:000238464800007
PM 16697656
DA 2020-11-30
ER

PT J
AU Sousa, LP
   Silva, BM
   Brasil, BSAF
   Nogueira, SV
   Ferreira, PCP
   Kroon, EG
   Kato, K
   Bonjardim, CA
AF Sousa, LP
   Silva, BM
   Brasil, BSAF
   Nogueira, SV
   Ferreira, PCP
   Kroon, EG
   Kato, K
   Bonjardim, CA
TI Plasminogen/plasmin regulates alpha-enolase expression through the
   MEK/ERK pathway
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE plasminogen; plasmin; alpha-enolase; MAPK-ERK1/2; signal transduction
ID TRANSCRIPTION FACTOR EGR-1; GENE-EXPRESSION; PROTEIN-KINASE;
   CELL-SURFACE; MONOCYTOID CELLS; BINDING-SITES; ACTIVATOR; RECEPTOR;
   SYSTEM; AP-1
AB Previously we have demonstrated that both plasminogen (Pig) and plasmin (Pla) regulate the expression of the transcription factors c-FOS and EGR-1 [L.P. De Sousa. B.S. Brasil, B.M. Silva, M.H. Freitas, S.V. Nogueira, P.C. Ferreira, E.G. Kroon, C.A. Borijardim, Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway, Biochem. Biophys. Res. Commun. 329 (2005) 237-245]. Here we show that Pig activates the mitogen-activated protein kinases MEK and ERK which leads to alpha-enolase (alpha-ENO) gene expression not only in fibroblasts, but also in peripheral blood mononuclear cells. The a-ENO mRNA accumulation was apparent three hours post-Plg treatment and remained elevated out to 28 h, a process that seems to require both de novo protein synthesis and active gene transcription. Pla mimics Pig-stimulated alpha-ENO expression through its serine protease activity, suggesting that con,version of Pla to active Pla is required. Pharmacological and genetic blockade of MEK Caused inhibition of a-ENO mRNA accumulation, implicating MEK/ERK as the transduction pathway that leads to a-ENO expression Upon Pig stimulation. Furthermore, Pig stimulated DNA binding activity of the transcription factors activator-protein I and early growth response gene-1 to their cognate regulatory sequences at alpha-ENO promoter. Altogether, our data show that Plg/Pla regulates alpha-ENO expression through the MEK/ERK pathway. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Grp Transducao Sinal, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   Inst Dev Res, Dept Biochem, Aichi, Japan.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Grp Transducao Sinal, BR-31270901 Belo Horizonte, MG, Brazil.
EM claubonj@mono.icb.ufmg.br
RI silva, breno/W-5122-2018; Kroon, Erna/V-5444-2019; Brasil, Bruno S. A.
   F./E-8817-2012; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015
OI silva, breno/0000-0003-2472-8111; Brasil, Bruno S. A.
   F./0000-0002-8690-2157; Kroon, Erna Geessien/0000-0003-2721-3826; ,
   Bruno/0000-0002-3587-7983; Sousa, Lirlandia/0000-0002-1042-9762
CR Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   Arza B, 1997, THROMB HAEMOSTASIS, V78, P1097
   Bergman AC, 1997, FEBS LETT, V417, P17, DOI 10.1016/S0014-5793(97)01247-7
   Bonjardim CA, 1997, BRAZ J MED BIOL RES, V30, P41, DOI 10.1590/S0100-879X1997000100007
   Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   De Sousa LP, 2005, BIOCHEM BIOPH RES CO, V329, P237, DOI 10.1016/j.bbrc.2005.01.123
   Dear AE, 1997, FEBS LETT, V402, P265, DOI 10.1016/S0014-5793(97)00002-1
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   Dumler I, 1998, J BIOL CHEM, V273, P315, DOI 10.1074/jbc.273.1.315
   FELEZ J, 1991, BLOOD, V78, P2318
   Gavrilov D, 2001, EUR J CANCER, V37, P1033, DOI 10.1016/S0959-8049(01)00077-6
   GIALLONGO A, 1986, P NATL ACAD SCI USA, V83, P6741, DOI 10.1073/pnas.83.18.6741
   Hawley SB, 2000, THROMB HAEMOSTASIS, V84, P882
   Herren T, 2001, BLOOD, V97, P1070, DOI 10.1182/blood.V97.4.1070
   Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5
   KATO K, 1981, J NEUROCHEM, V37, P998, DOI 10.1111/j.1471-4159.1981.tb04487.x
   Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427
   Konakova M, 1998, EUR J BIOCHEM, V253, P421, DOI 10.1046/j.1432-1327.1998.2530421.x
   Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226
   Liu CT, 2000, J BIOL CHEM, V275, P20315, DOI 10.1074/jbc.M909046199
   Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70
   Lohmann K, 1934, BIOCHEM Z, V273, P60
   Lopez-Alemany R, 2003, AM J HEMATOL, V72, P234, DOI 10.1002/ajh.10299
   MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034
   Mizukami Y, 2004, J BIOL CHEM, V279, P50120, DOI 10.1074/jbc.M402299200
   Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502
   Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200
   Pendurthi UR, 2002, ARTERIOSCL THROM VAS, V22, P1421, DOI 10.1161/01.ATV.0000030200.59331.3F
   Pendurthi UR, 2000, THROMB RES, V97, P179, DOI 10.1016/S0049-3848(99)00148-6
   PLOW EF, 1995, FASEB J, V9, P939
   PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411
   REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x
   Sambrook J., 1989, MOL CLONING LAB MANU
   Scharte M, 2003, AM J PHYSIOL-GASTR L, V284, pG373, DOI 10.1152/ajpgi.00076.2002
   Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529
   SHIMIZU A, 1983, BIOCHIM BIOPHYS ACTA, V748, P278, DOI 10.1016/0167-4838(83)90305-9
   Sousa LP, 2005, FRONT BIOSCI-LANDMRK, V10, P2534, DOI 10.2741/1718
   Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200
   Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941
   Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200
NR 42
TC 41
Z9 45
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 2
PY 2005
VL 337
IS 4
BP 1065
EP 1071
DI 10.1016/j.bbrc.2005.09.154
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 981XF
UT WOS:000233120600007
PM 16225843
DA 2020-11-30
ER

PT J
AU Leite, JA
   Drumond, BP
   Trindade, GS
   Lobato, ZIP
   da Fonseca, FG
   dos Santos, JR
   Madureira, MC
   Guedes, MIMC
   Ferreira, JMS
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Leite, JA
   Drumond, BP
   Trindade, GS
   Lobato, ZIP
   da Fonseca, FG
   dos Santos, JR
   Madureira, MC
   Guedes, MIMC
   Ferreira, JMS
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
TI Passatempo virus, a vaccinia virus strain, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID SEQUENCE ALIGNMENT; COWPOX VIRUS; GENE; SMALLPOX; POXVIRUS; HUMANS;
   FOREST; CATTLE
AB Passatempo virus was isolated during a zoonotic outbreak. Biologic features and molecular characterization of hemagglutinin, thymidine kinase, and vaccinia growth factor genes suggested a vaccinia virus infection, which strengthens the idea of the reemergence and circulation of vaccinia virus in Brazil. Molecular polymorphisms indicated that Passatemoo virus is a different isolate.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   Fdn Inst Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   Inst Mineiro Agropecuaria, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Lobato,
   Zelia/0000-0002-9399-3691
CR CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   da Fonseca FG, 1999, VIRUS GENES, V18, P151, DOI 10.1023/A:1008072720217
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1646/0006-3606(2000)032[0786:ITBAF]2.0.CO;2
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   UNIVERSAL VIRUS DATA
NR 14
TC 79
Z9 81
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2005
VL 11
IS 12
BP 1935
EP 1938
DI 10.3201/eid1112.050773
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 990UI
UT WOS:000233768300021
PM 16485483
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Sousa, LP
   Brasil, BSAF
   Silva, BD
   Nogueira, SV
   Andrade, AA
   Ferreira, PCP
   Teixeira, SMR
   Gollob, KJ
   Kroon, EG
   Kato, K
   Bonjardim, CA
AF Sousa, LP
   Brasil, BSAF
   Silva, BD
   Nogueira, SV
   Andrade, AA
   Ferreira, PCP
   Teixeira, SMR
   Gollob, KJ
   Kroon, EG
   Kato, K
   Bonjardim, CA
TI Characterization of alpha-enolase as an interferon-alpha(2) alpha(1)
   regulated gene
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Article
DE alpha-enolase; interferon; ISG; plasminogen receptor; MAPK-ERK1/2;
   c-fos; egr-1; CREB/ ATF-1
ID NECROSIS-FACTOR-ALPHA; MEDIATED PLASMINOGEN ACTIVATION; TRANSCRIPTION
   FACTOR EGR-1; BINDING-PROTEIN; HUMAN-MONOCYTES; IFN-GAMMA; C-FOS;
   LACTATE-DEHYDROGENASE; STIMULATED GENES; RAT FIBROBLASTS
AB Interferons (IFNs) are multifunctional cytokines that after binding to the cell surface receptor induce the expression of a large number of genes, which in turn, mediate many biological processes including host defense, cell growth control, signaling, and metabolism. Here we show that IFN-alpha activates the mitogen-activated protein kinases ( MAPK) ERK1/2 and the transcription factor CREB/ATF-1, which lead to the alpha-enolase ( alpha-ENO) gene expression in fibroblasts. Alpha-ENO mRNA accumulation was apparent 6 h post-IFN stimulation and required both de novo protein synthesis and active gene transcription, which is typical of a secondary response gene. Alpha-ENO expression does not appear to be restricted to fibroblasts, since it was equally verified in peripheral blood mononuclear cells ( PBMC). Furthermore, IFN-alpha stimulates the expression of the primary response genes c-fos and egr-1, which was followed by an increase in DNA binding activity of c-FOS and EGR-1 proteins, as verified by shift assays using the cis-acting elements AP-1 and EGR-1 localized at the alpha-ENO promoter. Finally, we also demonstrated that IFN treatment of PBMC cause an increase in both, alpha-ENO expression on the cell surface and plasmin generation followed addition of exogenous plasminogen.
C1 Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol,Grp Transducao Sinal, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   Inst Dev Res, Dept Biochem, Aichi, Japan.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol,Grp Transducao Sinal, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM claubonj@mono.icb.ufmg.br
RI Bonjardim, Claudio A/J-2601-2014; Andrade, Anderson/H-4022-2012; Gollob,
   Kenneth J/C-1341-2008; Kroon, Erna Geessien/B-3631-2015; Brasil, Bruno
   S. A. F./E-8817-2012; Kroon, Erna/V-5444-2019; silva, breno/W-5122-2018
OI Andrade, Anderson/0000-0001-9569-6503; Gollob, Kenneth
   J/0000-0003-4184-3867; Kroon, Erna Geessien/0000-0003-2721-3826; Brasil,
   Bruno S. A. F./0000-0002-8690-2157; silva, breno/0000-0003-2472-8111; ,
   Bruno/0000-0002-3587-7983
CR Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Arza B, 1997, THROMB HAEMOSTASIS, V78, P1097
   Bergman AC, 1997, FEBS LETT, V417, P17, DOI 10.1016/S0014-5793(97)01247-7
   Bonjardim CA, 1997, BRAZ J MED BIOL RES, V30, P41, DOI 10.1590/S0100-879X1997000100007
   BONJARDIN CA, 2005, IN PRESS MICROBES IN
   Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   Corssmit EPM, 1996, THROMB HAEMOSTASIS, V75, P113
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912
   Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426
   Dear AE, 1997, FEBS LETT, V402, P265, DOI 10.1016/S0014-5793(97)00002-1
   Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   Dumler I, 1999, ARTERIOSCL THROM VAS, V19, P290, DOI 10.1161/01.ATV.19.2.290
   FELEZ J, 1990, J CELL BIOL, V111, P1673, DOI 10.1083/jcb.111.4.1673
   Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0
   Fontan PA, 2000, J INFECT DIS, V182, P1712, DOI 10.1086/317604
   Gavrilov D, 2001, EUR J CANCER, V37, P1033, DOI 10.1016/S0959-8049(01)00077-6
   GIALLONGO A, 1986, P NATL ACAD SCI USA, V83, P6741, DOI 10.1073/pnas.83.18.6741
   GIALLONGO A, 1986, BIOCHEM BIOPH RES CO, V134, P1238, DOI 10.1016/0006-291X(86)90383-9
   GYETKO MR, 1992, J LEUKOCYTE BIOL, V51, P256
   Hasegawa T, 1997, AM J RESP CELL MOL, V16, P683, DOI 10.1165/ajrcmb.16.6.9191470
   Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200
   Kalvakolanu DV, 2003, PHARMACOL THERAPEUT, V100, P1, DOI 10.1016/S0163-7258(03)00070-6
   Kasza A, 2002, J PHYSIOL PHARMACOL, V53, P95
   KATO K, 1983, CLIN CHIM ACTA, V127, P353, DOI 10.1016/0009-8981(83)90162-6
   KATO K, 1981, J NEUROCHEM, V37, P998, DOI 10.1111/j.1471-4159.1981.tb04487.x
   Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888
   Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427
   KIM RY, 1991, GENE, V103, P193, DOI 10.1016/0378-1119(91)90273-E
   KIRCHHEIMER JC, 1988, J IMMUNOL, V141, P4229
   Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0
   Koshelnick Y, 1997, J BIOL CHEM, V272, P28563, DOI 10.1074/jbc.272.45.28563
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Kunigal S, 2003, BLOOD, V102, P4377, DOI 10.1182/blood-2002-12-3872
   LEE WMF, 1988, MOL CELL BIOL, V8, P5521, DOI 10.1128/MCB.8.12.5521
   LEW DJ, 1989, MOL CELL BIOL, V9, P5404, DOI 10.1128/MCB.9.12.5404
   LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182
   LIDA H, 1985, NATURE, V315, P688
   Liu CT, 2000, J BIOL CHEM, V275, P20315, DOI 10.1074/jbc.M909046199
   Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70
   Lopez-Alemany R, 2003, AM J HEMATOL, V72, P234, DOI 10.1002/ajh.10299
   MARSHALL BC, 1992, J BIOL CHEM, V267, P11462
   Martensen PM, 2004, J INTERF CYTOK RES, V24, P1, DOI 10.1089/107999004772719864
   MATRISIAN LM, 1985, NUCLEIC ACIDS RES, V13, P711, DOI 10.1093/nar/13.3.711
   MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034
   Mizukami Y, 2004, J BIOL CHEM, V279, P50120, DOI 10.1074/jbc.M402299200
   Mustjoki S, 1998, LEUKEMIA, V12, P164, DOI 10.1038/sj.leu.2400918
   Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200
   Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503
   Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910
   Pendurthi UR, 2000, THROMB RES, V97, P179, DOI 10.1016/S0049-3848(99)00148-6
   PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x
   REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x
   Scharte M, 2003, AM J PHYSIOL-GASTR L, V284, pG373, DOI 10.1152/ajpgi.00076.2002
   Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001
   Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529
   SHIMIZU A, 1983, BIOCHIM BIOPHYS ACTA, V748, P278, DOI 10.1016/0167-4838(83)90305-9
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958
   SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0
   Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200
   Syrovets T, 1997, BLOOD, V89, P4574, DOI 10.1182/blood.V89.12.4574
   Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941
   Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443
   WEBER H, 1987, EMBO J, V6, P591, DOI 10.1002/j.1460-2075.1987.tb04795.x
   WEIDE I, 1994, BLOOD, V83, P1941
   Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002
   Yousefi S, 2000, BIOCHEM BIOPH RES CO, V277, P401, DOI 10.1006/bbrc.2000.3678
NR 70
TC 9
Z9 14
U1 0
U2 4
PU FRONTIERS IN BIOSCIENCE INC
PI IRVINE
PA 16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA
SN 1093-9946
EI 1093-4715
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD SEP 1
PY 2005
VL 10
SU S
BP 2534
EP 2547
DI 10.2741/1718
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 970OU
UT WOS:000232320300045
PM 15970516
DA 2020-11-30
ER

PT J
AU Lobato, ZIP
   Trindade, GS
   Frois, MCM
   Ribeiro, EBT
   Dias, GRC
   Teixeira, BM
   Lima, FA
   Almeida, GMF
   Kroon, EG
AF Lobato, ZIP
   Trindade, GS
   Frois, MCM
   Ribeiro, EBT
   Dias, GRC
   Teixeira, BM
   Lima, FA
   Almeida, GMF
   Kroon, EG
TI Outbreak of exantemal disease caused by Vaccinia virus in human and
   cattle in Zona da Mata region, Minas Gerais
SO ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA
LA Portuguese
DT Article
DE exantemal disease; zoonosis; orthopoxvirus; Vaccinia virus
ID RIO-DE-JANEIRO; MOLECULAR CHARACTERIZATION; POXVIRUS; STATE
AB It was investigated an outbreak of exantemal disease in human and cattle in Zona da Mata region, Minas Gerais's State, Brazil. Seventy two farms located in 20 counties locating in this region were visited and disease pattern was studied. 1020 cows got sick in the visited herds and in 83% of them human cases occurred together with disease in animals. Drop in milk production and secondary infection were,frequently observed. The disease occurred mainly from may to September. Serum and scars from sick and convalescent animals were collected and laboratory diagnostic showed that an orthopoxvirus, more precisely vaccinia virus was involved in the outbreak
C1 Univ Fed Minas Gerais, Escola Vet, BR-30123970 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, BR-30123970 Belo Horizonte, MG, Brazil.
RP Lobato, ZIP (corresponding author), Univ Fed Minas Gerais, Escola Vet, Caixa Postal 567, BR-30123970 Belo Horizonte, MG, Brazil.
EM ziplobat@vct.ufmg.br
RI Almeida, Gabriel MF/I-8910-2012; Kroon, Erna/V-5444-2019; Kroon,
   Erna/B-3631-2015
OI Almeida, Gabriel MF/0000-0003-2317-5092; Kroon,
   Erna/0000-0003-2721-3826; Lobato, Zelia/0000-0002-9399-3691
CR Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Diniz S, 2001, ARQ BRAS MED VET ZOO, V53, P152, DOI 10.1590/S0102-09352001000200003
   FAGLIARI JJ, 1999, ARQ I BIOL-SAO PAULO, V66, P128
   Fenner F, 2000, FEMS MICROBIOL REV, V24, P123, DOI 10.1111/j.1574-6976.2000.tb00536.x
   Fenner F., 1989, ORTHOPOXVIRUSES
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Inoshima Y, 2001, J GEN VIROL, V82, P1215, DOI 10.1099/0022-1317-82-5-1215
   Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003
   Mazur C, 2000, VET MICROBIOL, V73, P253, DOI 10.1016/S0378-1135(99)00151-0
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   MOSS B, 2001, VIROLOGY, P2849
   NAGASSESHUGARA TK, 2005, REV INST MED TROP SP, V46, P315
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   SILVA P L D, 1986, Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, V38, P323
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
NR 19
TC 50
Z9 50
U1 1
U2 3
PU ARQUIVO BRASILEIRO MEDICINA VETERINARIA ZOOTECNIA
PI MINAS GERAIS
PA FEDERAL MINAS GERAIS CAIXA POSTAL 567-BELO HORIZ, MINAS GERAIS, BRAZIL
SN 0102-0935
EI 1678-4162
J9 ARQ BRAS MED VET ZOO
JI Arq. Bras. Med. Vet. Zootec.
PD JUN
PY 2005
VL 57
IS 4
BP 423
EP 429
DI 10.1590/S0102-09352005000400001
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA 975KE
UT WOS:000232660600001
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Mansur, DS
   Kroon, EG
   Nogueira, ML
   Arantes, RME
   Rodrigues, SCO
   Akira, S
   Gazzinelli, RT
   Campos, MA
AF Mansur, DS
   Kroon, EG
   Nogueira, ML
   Arantes, RME
   Rodrigues, SCO
   Akira, S
   Gazzinelli, RT
   Campos, MA
TI Lethal encephalitis in myeloid differentiation factor 88-deficient mice
   infected with herpes simplex virus 1
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID SIMPLEX-VIRUS TYPE-1; TOLL-LIKE RECEPTOR-2; GAMMA-INTERFERON; VACCINIA
   VIRUS; RECOGNITION; DNA; CELLS; TLR4; LIPOPOLYSACCHARIDE; REPLICATION
AB Herpes simplex virus 1 (HSV-1), a large DNA virus from the Herpesviridae family, is the major cause of sporadic lethal encephalitis and blindness in humans. Recent studies have shown the importance of Toll-like receptors (TLRs) in the immune response to HSV-1 infection. Myeloid differentiation factor 88 (MyD88) is a critical adaptor protein that is downstream to mediated TLR activation and is essential for the production of inflammatory cytokines. Here, we studied the relationship between MyD88 and HSV-1 using a purified HSV-1 isolated from a natural oral recurrent human infection. We observed the activation of TLR-2 by HSV-1 in vitro using Chinese hamster ovary cells stably transfected with a reporter gene. Interestingly, we found that only peritoneal macrophages from MyD88(-/-) mice, but not macrophages from TRL2(-/-) or from wild-type mice, were unable to produce tumor necrosis factor-a in response to HSV-1 exposure. Additionally, although TLR2(-/-) mice showed no enhanced susceptibility to intranasal infection with HSV-1, MyD88(-/-) mice were highly susceptible to infection and displayed viral migration to the brain, severe neuropathological signs of encephalitis, and 100% mortality by day 10 after infection. Together, our results suggest that innate resistance to HSV-1 is mediated by MyD88 and may rely on activation of multiple TLRs.
C1 Fiocruz MS, Ctr Pesquisas Rene Rachou, Immunopathol Lab, BR-30190002 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Patol, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
   Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka, Japan.
RP Campos, MA (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Immunopathol Lab, Av Augusto Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM marcoasc@cpqrr.fiocruz.br
RI Nogueira, Mauricio L/B-7599-2012; Kroon, Erna Geessien/B-3631-2015;
   Arantes, Rosa ME/C-5749-2013; Kroon, Erna/V-5444-2019; Mansur,
   Daniel/AAQ-8062-2020; Campos, Marco A/C-4000-2013; Akira,
   Shizuo/C-3134-2009
OI Nogueira, Mauricio L/0000-0003-1102-2419; Kroon, Erna
   Geessien/0000-0003-2721-3826; Arantes, Rosa ME/0000-0003-1428-9717;
   Mansur, Daniel/0000-0001-6773-9334; Campos, Marco A/0000-0003-4683-0176;
   Gazzinelli, Ricardo/0000-0003-2427-7699
CR Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560
   Boivin G, 2002, EUR J NEUROSCI, V16, P29, DOI 10.1046/j.1460-9568.2002.02057.x
   Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697
   Campos MA, 2004, INFECT IMMUN, V72, P176, DOI 10.1128/IAI.72.1.176-186.2004
   Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Delude RL, 1998, J IMMUNOL, V161, P3001
   Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   Hirsch HH, 1999, J MED VIROL, V57, P31, DOI 10.1002/(SICI)1096-9071(199901)57:1&lt;31::AID-JMV5&gt;3.0.CO;2-J
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Keadle TL, 2001, OCUL IMMUNOL INFLAMM, V9, P193, DOI 10.1076/ocii.9.3.193.3967
   Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674
   Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100
   Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833
   Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541
   Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419
   Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001
   Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162
   Lundberg P, 2003, J VIROL, V77, P11158, DOI 10.1128/JVI.77.20.11158-11169.2003
   Minagawa H, 2004, J GEN VIROL, V85, P343, DOI 10.1099/vir.0.19627-0
   Nogueira ML, 2001, J CLIN PATHOL, V54, P103, DOI 10.1136/jcp.54.2.103
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Roizman B, 2001, Herpes, V8, P23
   Sainz B, 2002, J VIROL, V76, P11541, DOI 10.1128/JVI.76.22.11541-11550.2002
   Schmidt N.J., 1979, CELL CULTURE TECHNIQ, P100
   SMITH PM, 1994, VIROLOGY, V202, P76, DOI 10.1006/viro.1994.1324
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3
   Vollstedt S, 2004, J VIROL, V78, P3846, DOI 10.1128/JVI.78.8.3846-3850.2004
   Whitley R.J., 2001, FIELDS VIROLOGY, V2, P2461
   Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006
NR 32
TC 65
Z9 67
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD MAY
PY 2005
VL 166
IS 5
BP 1419
EP 1426
DI 10.1016/S0002-9440(10)62359-0
PG 8
WC Pathology
SC Pathology
GA 920AE
UT WOS:000228658500013
PM 15855642
OA Green Published
DA 2020-11-30
ER

PT J
AU De Sousa, LP
   Brasil, BSAF
   Silva, BM
   Freitas, MHA
   Nogueira, SV
   Ferreira, PCB
   Kroon, EG
   Bonjardim, CA
AF De Sousa, LP
   Brasil, BSAF
   Silva, BM
   Freitas, MHA
   Nogueira, SV
   Ferreira, PCB
   Kroon, EG
   Bonjardim, CA
TI Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEWERK
   pathway
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE plasminogen; plasmin; MAPK; ERK1/2; c-fos; egr-1
ID TRANSCRIPTION FACTOR EGR-1; OVARIAN-CANCER CELLS; GENE-EXPRESSION;
   PROTEIN-KINASE; GROWTH-FACTOR; ENDOTHELIAL-CELLS; SIGNALING PATHWAY;
   TISSUE FACTOR; ACTIVATOR; RECEPTOR
AB in this study, we showed that plasminogen (Plg) and plasmin (Pla) bind to lysine-binding sites on cell surface and trigger a signaling pathway that activates the mitogen-activated protein kinase (MAPK) MEK and ERK1/2, which in turn leads to the expression of the primary response genes c-fos and early growth response gene egr-1. Our data show that the Plg/Pla-stimulated steady-state mRNA levels of both genes reached a maximum by 30 min and then returned to basal levels by 1 h. The gene induction was sensitive to both pharmacological and genetic inhibition of MEK. Leupeptin, a serine protease inhibitor, suppressed Pla bill not Plg-induced c-fos and egr-1 expression, emphasizing the role played by the serine protease activity associated with Pla. Pre-incubation with cholera toxin completely blocked the Plg/Pla-induced gene expression, suggesting that another signaling pathway, which recruits G protein-coupled receptors, may also be involved. Furthermore, Plg/Pla also stimulated AP-1 and EGR-1 DNA-binding activities. which were abrogated by pharmacological inhibition of MEK. Altogether, these results suggest that Plg/Pla stimulates c-fos and egr-1 expression via activation of the MEK/ERK pathway. (C) 2005 Elsevier Inc. All rights reserved.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal, BR-31270901 Belo Horizonte, MG, Brazil.
EM claubonj@mono.icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Brasil, Bruno S. A. F./E-8817-2012; Bonjardim,
   Claudio A/J-2601-2014; Kroon, Erna Geessien/B-3631-2015; silva,
   breno/W-5122-2018
OI Brasil, Bruno S. A. F./0000-0002-8690-2157; Kroon, Erna
   Geessien/0000-0003-2721-3826; silva, breno/0000-0003-2472-8111; Sousa,
   Lirlandia/0000-0002-1042-9762; , Bruno/0000-0002-3587-7983
CR Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375
   Bonjardim CA, 1997, BRAZ J MED BIOL RES, V30, P41, DOI 10.1590/S0100-879X1997000100007
   Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   Dear AE, 1997, FEBS LETT, V402, P265, DOI 10.1016/S0014-5793(97)00002-1
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   DUMLER I, 1994, FEBS LETT, V343, P103, DOI 10.1016/0014-5793(94)80298-X
   Dumler I, 1998, J BIOL CHEM, V273, P315, DOI 10.1074/jbc.273.1.315
   Feng H, 2004, ONCOGENE, V23, P7310, DOI 10.1038/sj.onc.1208041
   Gavrilov D, 2001, EUR J CANCER, V37, P1033, DOI 10.1016/S0959-8049(01)00077-6
   Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5
   Jones N, 2003, J CELL PHYSIOL, V196, P326, DOI 10.1002/jcp.10308
   KHACHIGIAN LM, 1995, J BIOL CHEM, V270, P27679, DOI 10.1074/jbc.270.46.27679
   Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427
   KIM SJ, 1989, J BIOL CHEM, V264, P402
   Konakova M, 1998, EUR J BIOCHEM, V253, P421, DOI 10.1046/j.1432-1327.1998.2530421.x
   LEE WMF, 1988, MOL CELL BIOL, V8, P5521, DOI 10.1128/MCB.8.12.5521
   Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226
   Liu CT, 2000, J BIOL CHEM, V275, P20315, DOI 10.1074/jbc.M909046199
   Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70
   MACKMAN N, 1995, FASEB J, V9, P883
   MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034
   Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502
   Pendurthi UR, 2002, ARTERIOSCL THROM VAS, V22, P1421, DOI 10.1161/01.ATV.0000030200.59331.3F
   Pendurthi UR, 2000, THROMB RES, V97, P179, DOI 10.1016/S0049-3848(99)00148-6
   PLOW EF, 1995, FASEB J, V9, P939
   PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411
   Sambrook J., 1989, MOL CLONING
   Sieuwerts AM, 2002, THROMB HAEMOSTASIS, V87, P674
   SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0
   Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941
   Tanaka Y, 2004, J BIOL CHEM, V279, P8567, DOI 10.1074/jbc.M309131200
   Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200
   VERDE P, 1988, NUCLEIC ACIDS RES, V16, P10699, DOI 10.1093/nar/16.22.10699
NR 35
TC 28
Z9 29
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD APR 1
PY 2005
VL 329
IS 1
BP 237
EP 245
DI 10.1016/j.bbrc.2005.01.123
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 903HE
UT WOS:000227415700036
PM 15721299
DA 2020-11-30
ER

PT J
AU Andrade, AA
   Silva, PNG
   Pereira, ACTC
   De Sousa, LP
   Ferreira, PCP
   Gazzinelli, RT
   Kroon, EG
   Ropert, C
   Bonjardim, CA
AF Andrade, AA
   Silva, PNG
   Pereira, ACTC
   De Sousa, LP
   Ferreira, PCP
   Gazzinelli, RT
   Kroon, EG
   Ropert, C
   Bonjardim, CA
TI The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK)
   pathway is required for virus multiplication
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE egr-1; extracellular-signal-regulated kinase 1/2; (ERK1/2); MAPK/ERK
   kinase (MEK); signal transduction; vaccinia virus (VV); VV growth factor
   (VGF)
ID HIPPOCAMPAL-NEURONS; MESSENGER-RNAS; GROWTH-FACTOR; GENE; RECEPTOR;
   INFECTION; APOPTOSIS; PHOSPHORYLATION; TRANSCRIPTION; TRANSDUCTION
AB Early events play a decisive role in virus multiplication. We have shown previously that activation of MAPK/ERK1/2 (mitogen-activated protein kinase/extracellular-signal-regulated kinase 1/2) and protein kinase A are pivotal for vaccinia virus (VV) multiplication [de Magalhaes, Andrade, Silva, Sousa, Ropert, Ferreira, Kroon, Gazzinelli and Bonjardim (2001) J. Biol. Chem. 276, 38353-38360]. In the present study, we show that VV infection provoked a sustained activation of both ERK1/2 and RSK2 (ribosomal S6 kinase 2). Our results also provide evidence that this pattern of kinase activation depends on virus multiplication and ongoing protein synthesis and is maintained independently of virus DNA synthesis. It is noteworthy that the VGF (VV growth factor), although involved. is not essential for prolonged ERK1/2 activation. Furthermore, our findings suggest that the VV-stimulated ERK1/2 activation also seems to require actin dynamics, microtubule polymerization and tyrosine kinase phosphorylation. The VV-stimulated pathway MEK/ERK1/2/RSK2 (where MEK stands for MAPK/ERK kinase) leads to phosphorylation of the ternary complex factor Elk-1 and expression of the early growth response (egr-1) gene, which kinetically paralleled the kinase activation. The recruitment of this pathway is biologically relevant, since its disruption caused a profound effect on viral thymidine kinase gene expression, viral DNA replication and VV multiplication. This pattern of sustained kinase activation after VV infection is unique. In addition, by connecting upstream signals generated at the cytoskeleton and by tyrosine kinase, the MEK/ERK1/2/RSK2 cascade seems to play a decisive role not only at early stages of the infection, i.e. post-penetration, but is also crucial to define the fate of virus progeny.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil.
   Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, BR-31270901 Belo Horizonte, MG, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Grp Transducao Sinal, Av Antonio 6627,Campus Pamplha, BR-31270901 Belo Horizonte, MG, Brazil.
EM claubonj@mono.icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Bonjardim,
   Claudio A/J-2601-2014; Ropert, Catherine/G-2463-2012; Andrade,
   Anderson/H-4022-2012
OI Kroon, Erna Geessien/0000-0003-2721-3826; Andrade,
   Anderson/0000-0001-9569-6503; Gazzinelli, Ricardo/0000-0003-2427-7699
CR Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980
   ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5
   BALDICK CJ, 1993, J VIROL, V67, P3515, DOI 10.1128/JVI.67.6.3515-3527.1993
   Barber SA, 2002, J VIROL, V76, P817, DOI 10.1128/JVI.76.2.817-828.2002
   Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358
   Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697
   BROWN JP, 1985, NATURE, V313, P491, DOI 10.1038/313491a0
   BULLER RML, 1988, J VIROL, V62, P866, DOI 10.1128/JVI.62.3.866-874.1988
   BULLER RML, 1988, VIROLOGY, V164, P182, DOI 10.1016/0042-6822(88)90635-6
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Davidson L, 2004, J BIOL CHEM, V279, P1980, DOI 10.1074/jbc.M309827200
   de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200
   Franco GR, 1999, PLACENTA, V20, P189, DOI 10.1053/plac.1998.0364
   Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860
   Garcia MA, 2002, ONCOGENE, V21, P8379, DOI 10.1038/sj.onc.1206036
   Giambartolomei S, 2001, ONCOGENE, V20, P2606, DOI 10.1038/sj.onc.1204372
   Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200
   Greber UF, 2002, CELL MOL LIFE SCI, V59, P608, DOI 10.1007/s00018-002-8453-3
   Guerra S, 2003, J VIROL, V77, P6493, DOI 10.1128/JVI.77.11.6493-6506.2003
   Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715
   Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607
   JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x
   Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200
   Kibler KV, 1997, J VIROL, V71, P1992, DOI 10.1128/JVI.71.3.1992-2003.1997
   LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801
   Lee S, 2002, J BIOL CHEM, V277, P8730, DOI 10.1074/jbc.M108025200
   Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497
   Mallardo M, 2001, MOL BIOL CELL, V12, P3875, DOI 10.1091/mbc.12.12.3875
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   MOSS B, 1996, FIELDS VIROLOGY, P2637
   Opavsky MA, 2002, J CLIN INVEST, V109, P1561, DOI 10.1172/JCI200213971
   Perkins D, 2003, J VIROL, V77, P1292, DOI 10.1128/JVI.77.2.1292-1305.2003
   Perkins D, 2002, J VIROL, V76, P1435, DOI 10.1128/JVI.76.3.1435-1449.2002
   Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098
   Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932
   REMPEL RE, 1990, J VIROL, V64, P574, DOI 10.1128/JVI.64.2.574-583.1990
   Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108
   Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200
   Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893
   Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505
   SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0
   SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2
   SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4
   TWARDZIK DR, 1985, P NATL ACAD SCI USA, V82, P5300, DOI 10.1073/pnas.82.16.5300
   Tzahar E, 1998, EMBO J, V17, P5948, DOI 10.1093/emboj/17.20.5948
   UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233
   Yang XY, 1998, J BIOL CHEM, V273, P29879, DOI 10.1074/jbc.273.45.29879
   Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3
NR 51
TC 102
Z9 103
U1 0
U2 9
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD JUL 15
PY 2004
VL 381
BP 437
EP 446
DI 10.1042/BJ20031375
PN 2
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 840SA
UT WOS:000222878600014
PM 15025565
OA Green Published
DA 2020-11-30
ER

PT J
AU Trindade, GS
   da Fonseca, FG
   Marques, JT
   Diniz, S
   Leite, JA
   De Bodt, S
   Van der Peer, Y
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Trindade, GS
   da Fonseca, FG
   Marques, JT
   Diniz, S
   Leite, JA
   De Bodt, S
   Van der Peer, Y
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
TI Belo Horizonte virus: a vaccinia-like virus lacking the A-type inclusion
   body gene isolated from infected mice
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID EVOLUTIONARY DISTANCE; PROTEIN; SEQUENCE; MOUSEPOX; COWPOX; DNA;
   ALIGNMENT; POXVIRUS; HUMANS; GENOME
AB Here is described the isolation of a naturally occurring A-type inclusion body (ATI)-negative vaccinia-like virus, Belo Horizonte virus (VBH), obtained from a mousepox-like outbreak in Brazil. The isolated virus was identified and characterized as an orthopoxvirus by conventional methods. Molecular characterization of the virus was done by DNA cross-hybridization using Vaccinia virus (VACV) DNA. In addition, conserved orthopoxvirus genes such as vaccinia growth factor, thymidine kinase and haemagglutinin were amplified by PCR and sequenced. All sequences presented high similarity to VACV genes. Based on the sequences, phenograms were constructed for comparison with other poxviruses; VBH clustered consistently with VACV strains. Attempts to amplify the ATI gene (ati) by PCR, currently used to identify orthopoxviruses, were unsuccessful. Results presented here suggest that most of the ati gene is deleted in the VBH genome.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   State Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.
   Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA.
   Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, BR-30190002 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Biol Microorganismos, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Marques, Joao T/F-7683-2012; Kroon, Erna Geessien/B-3631-2015; Kroon,
   Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014
OI Marques, Joao T/0000-0002-3457-3320; Kroon, Erna
   Geessien/0000-0003-2721-3826; 
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   da Fonseca FG, 1999, VIRUS GENES, V18, P151, DOI 10.1023/A:1008072720217
   da Fonseca FG, 1998, ARCH VIROL, V143, P1171
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Diniz S, 2001, ARQ BRAS MED VET ZOO, V53, P152, DOI 10.1590/S0102-09352001000200003
   ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4
   FENNER F, 1989, ORTHOPOXVIRUSES, P317
   FUNAHASHI S, 1988, J GEN VIROL, V69, P35, DOI 10.1099/0022-1317-69-1-35
   GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2
   HALL TA, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.5598/IMAFUNGUS.2011.02.02.06
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hazel SM, 2000, EPIDEMIOL INFECT, V124, P551, DOI 10.1017/S0950268899003799
   JOHNSON GP, 1993, VIROLOGY, V196, P381, DOI 10.1006/viro.1993.1494
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   JUKES TH, 1969, MAMMALIAN PROTEIN ME, V3, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   MASSUNG RF, 1991, VIROLOGY, V180, P347, DOI 10.1016/0042-6822(91)90039-E
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   MEYER H, 1994, J GEN VIROL, V75, P1975, DOI 10.1099/0022-1317-75-8-1975
   Neubauer H, 1997, LAB ANIM, V31, P201, DOI 10.1258/002367797780596275
   OSTERRIEDER N, 1994, VIRUS GENES, V8, P125, DOI 10.1007/BF01703611
   RAES J, 1999, EMBNET NEWS, V6
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sambrook J., 1989, MOL CLONING LAB MANU, V2
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664
   SWOFFORD DL, 1998, PAUL ASTERISK PHYLOG
   TAJIMA F, 1984, MOL BIOL EVOL, V1, P269
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   vandePeer Y, 1997, COMPUT APPL BIOSCI, V13, P227
NR 36
TC 29
Z9 31
U1 0
U2 6
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD JUL
PY 2004
VL 85
BP 2015
EP 2021
DI 10.1099/vir.0.79840-0
PN 7
PG 7
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA 837ML
UT WOS:000222639500024
PM 15218187
OA Bronze
DA 2020-11-30
ER

PT J
AU Ungsedhapand, C
   Srasuebkul, P
   Cardiello, P
   Ruxrungtham, K
   Ratanasuwan, W
   Kroon, EDMB
   Tongtalung, M
   Juengprasert, N
   Ubolyam, S
   Siangphoe, U
   Emery, S
   Lange, JMA
   Cooper, DA
   Phanuphak, P
AF Ungsedhapand, C
   Srasuebkul, P
   Cardiello, P
   Ruxrungtham, K
   Ratanasuwan, W
   Kroon, EDMB
   Tongtalung, M
   Juengprasert, N
   Ubolyam, S
   Siangphoe, U
   Emery, S
   Lange, JMA
   Cooper, DA
   Phanuphak, P
CA HIV-NAT 002
   HIV-NAT 003 Study Team
TI Three-year durability of dual-nucleoside versus triple-nucleoside
   therapy in a Thai population with HIV infection
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE abacavir; didanosine; lamivudine; stavudine; triple-nucleoside
   antiretroviral therapy; zidovudine
ID ACTIVE ANTIRETROVIRAL THERAPY; VIRAL LOAD; SUPPRESSION; NAIVE;
   ZIDOVUDINE; LAMIVUDINE; DIDANOSINE; REGIMENS; DURATION; TRIAL
AB We compared the long-term immunologic and virologic efficacy of the dual- and triple-nucleoside therapy for HIV infection. This was a retrospective analysis of 2 randomized clinical trials in antiretroviral-naive patients. In the dual-nucleoside group, 15 started with didanosine (ddI) monotherapy and then added stavudine (d4T) after 24 weeks, 63 started with various doses of d4T and ddI, and 53 started with zidovudine (ZDV) and lamivudine (3TC). In the triple-nucleoside group, 53 started with ZDV, 3TC, and ddI. After 48 weeks, patients who were not failing were randomized to immediate (before treatment failure) versus delayed (at the time of virologic failure) switching from ddI and d4T to ZDV and 3TC or vice versa and from ZDV, 3TC, and ddI to d4T, 3TC, and abacavir (ABC). Failure was defined as a plasma HIV-1 RNA level greater than or equal to1 log(10) above nadir or greater than or equal to10,000 copies/mL when nadir was <500 copies/mL. Patients failing therapy before week 48 received the new treatment as in the immediate switching group. Hydroxyurea was added to the last treatment regimen if patients failed after week 96. CD4 count and plasma HIV-1 RNA level (branched DNA assay with a cutoff point of 50 copies/mL) at week 144 were analyzed by intention to treat. Compared with the dual-nucleoside group, the triple-nucleoside group had a higher proportion of patients with <50 copies/mL at 144 weeks (60% vs. 18%; P < 0.001), higher median CD4 count (388 cells/muL vs. 346 cells/muL; P = 0.018), and longer duration of response, defined as the time from onset of viral suppression (<500 copies/mL) to the time of treatment failure (the first of 2 consecutive HIV-1 RNA measurements >500 copies/mL never followed by 2 consecutive visits showing suppressible viremia to <500 copies/mL) or discontinuation from the study (144 weeks vs. 104 weeks; P = 0.002). Multivariate regression analyses showed that significant predictors for treatment success, defined as a plasma viral load <50 copies/mL at week 144, were asymptomatic clinical status at enrollment, a baseline plasma viral load less than or equal to30,000 copies/mL, treatment with triple nucleosides, and a viral load response of <500 copies/mL by week 12. Triple-nucleoside therapy with ZDV, 3TC, and ddI or d4T, 3TC, and ABC in patients with HIV infection is more effective in inducing a sustained virologic response than the dual combinations of ZDV and 3TC or ddI and d4T.
C1 Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Colaborat, Bangkok 10330, Thailand.
   Univ Amsterdam, Acad Med Ctr, Natl AIDS Therapy Evaluat Ctr, NL-1105 AZ Amsterdam, Netherlands.
   Chulalongkorn Univ, Fac Med, Dept Internal Med, Bangkok 10330, Thailand.
   Mahidol Univ, Dept Prevent & Social Med, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand.
   Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia.
RP Ungsedhapand, C (corresponding author), Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Colaborat, 104 Ratchadamri Rd, Bangkok 10330, Thailand.
EM chaiwat.u@chula.ac.th
RI Emery, Sean/J-3825-2017; Emery, Sean/O-9122-2019; Kroon,
   Erna/V-5444-2019
OI Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309;
   Siangphoe, Uma/0000-0002-0560-6314
CR Aboulker JP, 1999, AIDS, V13, P57
   ALBRECHT M, 2001, 8 C RETR OPP INF CHI
   CAROSI G, 2001, 1 INT AIDS SOC C HIB
   Chen RY, 2003, CLIN INFECT DIS, V37, P714, DOI 10.1086/377271
   Deeks SG, 2000, CLIN INFECT DIS, V30, pS177, DOI 10.1086/313855
   FARTHING C, 2003, 2 INT AIDS SOC C HIV
   GALLANT JE, 2003, 43 INT C ANT AG CHEM
   Gulick RM, 2000, ANN INTERN MED, V133, P35, DOI 10.7326/0003-4819-133-1-200007040-00007
   Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984
   Hoesley CJ, 2000, CLIN INFECT DIS, V31, P1095, DOI 10.1086/318143
   Jenwitheesuk Ekachai, 2003, Ann Clin Microbiol Antimicrob, V2, P4, DOI 10.1186/1476-0711-2-4
   Kaufmann GR, 2000, AIDS, V14, P959, DOI 10.1097/00002030-200005260-00007
   Manfredi R, 2001, J ANTIMICROB CHEMOTH, V48, P299, DOI 10.1093/jac/48.2.299
   Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003
   Miller V, 1999, J INFECT DIS, V180, P530, DOI 10.1086/314890
   Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2
   Morlat P, 2000, J ACQ IMMUN DEF SYND, V23, P255
   Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301
   Palella FJ, 2002, AIDS, V16, P1617, DOI 10.1097/00002030-200208160-00007
   *PAN CLIN PRACT TR, 2003, GUID US ANT AG HIV I
   PARRUTI G, 2000, 5 INT C DRUG THER HI
   Pathipvanich P, 2003, JAIDS-J ACQ IMM DEF, V32, P157, DOI 10.1097/00126334-200302010-00007
   Phanuphak P, 1998, AIDS, V12, pS77
   Phillips AN, 2001, AIDS, V15, P2379, DOI 10.1097/00002030-200112070-00005
   Ruxrungtham K, 2000, AIDS, V14, P1375, DOI 10.1097/00002030-200007070-00010
   Servais J, 2000, HIV Clin Trials, V1, P17
   Skowron G, 2001, J ACQ IMMUN DEF SYND, V28, P313, DOI 10.1097/00126334-200112010-00002
   Ungsedhapand C, 2001, J ACQ IMMUN DEF SYND, V27, P116, DOI 10.1097/00126334-200106010-00003
   Van Vaerenbergh K, 2002, AIDS RES HUM RETROV, V18, P419, DOI 10.1089/088922202753614182
   Vidal C, 1998, J ACQ IMMUN DEF SYND, V19, P55, DOI 10.1097/00042560-199809010-00009
NR 30
TC 8
Z9 14
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD JUN 1
PY 2004
VL 36
IS 2
BP 693
EP 701
DI 10.1097/00126334-200406010-00006
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 825PC
UT WOS:000221769400006
PM 15167288
DA 2020-11-30
ER

PT J
AU Coelho, PMZ
   Antunes, CMF
   Costa, HMA
   Kroon, EG
   Lima, MCS
   Linardi, PM
AF Coelho, PMZ
   Antunes, CMF
   Costa, HMA
   Kroon, EG
   Lima, MCS
   Linardi, PM
TI The use and misuse if the "impact factor" as a parameter for evaluation
   of scientific publication quality: a proposal to rationalize its
   application
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Editorial Material
DE impact factor; multidisciplinary adjustment; citation index;
   bibliometric evaluation
AB We present a critical analysis of the generalized use of the "impact factor". By means of the Kruskal-Wallis test, it was shown that it is not possible to compare distinct disciplines using the "impact factor" without adjustments. After assigning the median journal the value of one (1.000), the "impact factor" value for each journal was calculated by the rule of three. The adjusted values were homogeneous, thus permitting comparison among distinct disciplines.
C1 Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Biblioteca Setorial, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   Santa Casa Misericordia Belo Horizonte, Belo Horizonte, MG, Brazil.
RP Coelho, PMZ (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Av Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM coelhopm@cpqrr.fiocruz.br
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR *CONS NAC PESQ, 1997, BRAS IND NAC CIEN TE
   Coura JR, 2003, MEM I OSWALDO CRUZ, V98, P293, DOI 10.1590/S0074-02762003000300001
   Forrest MC, 1997, J CHEMOTHERAPY, V9, P3, DOI 10.1179/joc.1997.9.1.3
   *ISI, 1997, ANN GUID LIST SOURC, P1
   Linardi PM, 1996, BRAZ J MED BIOL RES, V29, P555
   Marshall E, 1999, SCIENCE, V283, P1610, DOI 10.1126/science.283.5408.1610
   *SCI, 1988, J RANKING, P1633
NR 7
TC 24
Z9 32
U1 0
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD DEC
PY 2003
VL 36
IS 12
BP 1605
EP 1612
DI 10.1590/S0100-879X2003001200001
PG 8
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 752NX
UT WOS:000187175000001
PM 14666244
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Kroon, E
   Mayotte, N
   Featherstone, M
   Sauvageau, G
AF Kroon, E
   Mayotte, N
   Featherstone, M
   Sauvageau, G
TI Molecular characterization of Hoxa9-Meis1-PBX1 collaboration in AML.
SO BLOOD
LA English
DT Meeting Abstract
CT 45th Annual Meeting of the American-Society-of-Hematology
CY DEC 06-09, 2003
CL SAN DIEGO, CALIFORNIA
SP Amer Soc Hematol
C1 Univ Montreal, Res Inst Immunol & Canc, Montreal, PQ H3C 3J7, Canada.
   CyThera Inc, San Diego, CA USA.
   McGill Univ, McGill Canc Ctr, Dept Oncol, Montreal, PQ H3A 2T5, Canada.
   Hop Maison Neuve Rosemont, Div Hematol, Montreal, PQ H1T 2M4, Canada.
RI Kroon, Erna/V-5444-2019
NR 0
TC 1
Z9 1
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 16
PY 2003
VL 102
IS 11
MA 2153
BP 584A
EP 584A
PN 1
PG 1
WC Hematology
SC Hematology
GA 742UP
UT WOS:000186536702151
DA 2020-11-30
ER

PT J
AU Koks, CHW
   Huitema, ADR
   Kroon, EDMB
   Chuenyam, T
   Sparidans, RW
   Lange, JMA
   Beijnen, JH
AF Koks, CHW
   Huitema, ADR
   Kroon, EDMB
   Chuenyam, T
   Sparidans, RW
   Lange, JMA
   Beijnen, JH
TI Population pharmacokinetics of itraconazole in Thai HIV-1-Infected
   persons
SO THERAPEUTIC DRUG MONITORING
LA English
DT Article
DE itraconazole; hydroxyitraconazole; population pharmacokinetics; NONMEM
AB The authors describe the development of a population pharmacokinetic model using NONMEM for itraconazole and its active metabolite hydroxyitraconazole in a Thai cohort of HIV-infected patients who were using itraconazole as an addition to their antiretroviral therapy. The data were best described with an open two-compartment model for both itraconazole and hydroxyitraconazole. The model adequately described the data and provided population pharmacokinetic parameters which were not different from those described for other populations. The authors found that concomitant use of co-trimoxazole leads to a reduced formation rate (-51%) of hydroxyitraconazole.
C1 Slotervaart Hosp, Dept Pharm & Pharmacol, NL-1006 EC Amsterdam, Netherlands.
   Univ Utrecht, Fac Pharm, Dept Biomed Anal, Div Drug Toxicol, Utrecht, Netherlands.
   Univ Amsterdam, Natl AIDS Therapy Evaluat Ctr, Amsterdam, Netherlands.
   HIV Netherlands Australia Thailand Res Collaborat, Thai Red Cross AIS Res Ctr, Bangkok, Thailand.
RP Koks, CHW (corresponding author), Slotervaart Hosp, Dept Pharm & Pharmacol, Louwesweg 6, NL-1006 EC Amsterdam, Netherlands.
EM apkko@slz.nl
RI Kroon, Erna/V-5444-2019
CR BEAL SL, 1998, NONMEM USERS GUIDES
   De Beule K, 2001, DRUGS, V61, P27, DOI 10.2165/00003495-200161001-00003
   Haria M, 1996, DRUGS, V51, P585, DOI 10.2165/00003495-199651040-00006
   HEYKANTS J, 1989, MYCOSES, V32, P67, DOI 10.1111/j.1439-0507.1989.tb02296.x
   Jonsson EN, 1999, COMPUT METH PROG BIO, V58, P51
   KARLSSON MO, 1993, J PHARMACOKINET BIOP, V21, P735, DOI 10.1007/BF01113502
   Koks CHW, 2002, J CHROMATOGR B, V767, P103, DOI 10.1016/S0378-4347(01)00550-3
   MAY DB, 1994, PHARMACOTHERAPY, V14, P509
   MORENO F, 1993, JAMA-J AM MED ASSOC, V269, P1508, DOI 10.1001/jama.269.12.1508
   Poirier JM, 1998, CLIN PHARMACOKINET, V35, P461, DOI 10.2165/00003088-199835060-00004
   Prentice HG, 1999, ACTA HAEMATOL-BASEL, V101, P56, DOI 10.1159/000040923
   Rex JH, 1997, CLIN INFECT DIS, V24, P235, DOI 10.1093/clinids/24.2.235
   Venkatakrishnan K, 2000, CLIN PHARMACOKINET, V38, P111, DOI 10.2165/00003088-200038020-00002
NR 13
TC 12
Z9 12
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0163-4356
EI 1536-3694
J9 THER DRUG MONIT
JI Ther. Drug Monit.
PD APR
PY 2003
VL 25
IS 2
BP 229
EP 233
DI 10.1097/00007691-200304000-00014
PG 5
WC Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology
SC Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology
GA 661DJ
UT WOS:000181875700014
PM 12657919
DA 2020-11-30
ER

PT J
AU Trindade, GD
   da Fonseca, FG
   Marques, JT
   Nogueira, ML
   Mendes, LCN
   Borges, AS
   Peiro, JR
   Pituco, EM
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Trindade, GD
   da Fonseca, FG
   Marques, JT
   Nogueira, ML
   Mendes, LCN
   Borges, AS
   Peiro, JR
   Pituco, EM
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
TI Aracatuba virus: A vaccinialike m virus associated with infection in
   humans and cattle
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; RIO-DE-JANEIRO; MOLECULAR CHARACTERIZATION;
   POXVIRUS; ORTHOPOXVIRUS; STATE; DIFFERENTIATION; BEAN-58058; SMALLPOX;
   PROTEIN
AB We describe a vaccinialike virus, Aragatuba virus, associated with a cowpoxlike outbreak in a dairy herd and a related case of human infection. Diagnosis was based on virus growth characteristics, electron microscopy, and molecular biology techniques. Molecular characterization of the virus was done by using polymerase chain reaction amplification, cloning, an DNA sequencing of conserved orthopoxvirus genes such as the vaccinia growth factor (VGF), thymidine kinase (TK), and hemagglutinin. We used VGF-homologous and TK gene nucleoticle sequences to construct a phylogenetic tree for comparison with other poxviruses. Gene sequences showed 99% homology with vaccinia virus genes and were clustered together with the isolated virus in the phylogenetic tree. Aragatuba virus is very similar to Cantagalo virus, showing the same signature deletion in the gene. Aragatuba virus could be a novel vaccinialike virus or could represent the spread of Cantagalo virus.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   NIH, Bethesda, MD 20892 USA.
   Univ Estadual Paulista, Sao Paulo, Brazil.
   Inst Biol, Sao Paulo, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
RI Mendes, Luiz Claudio/B-8095-2012; Peiro, Juliana/C-4880-2012; Marques,
   Joao T/F-7683-2012; Borges, Alexandre S/B-5506-2013; Bonjardim, Claudio
   A/J-2601-2014; Mendes, Luiz Claudio Nogueira/N-2232-2019; Nogueira,
   Mauricio L/B-7599-2012; Kroon, Erna/V-5444-2019; Pituco, Edviges
   Maristela/J-2424-2012; Kroon, Erna/B-3631-2015
OI Mendes, Luiz Claudio/0000-0002-7696-6018; Marques, Joao
   T/0000-0002-3457-3320; Mendes, Luiz Claudio
   Nogueira/0000-0002-7696-6018; Nogueira, Mauricio L/0000-0003-1102-2419;
   Pituco, Edviges Maristela/0000-0003-1469-9257; Kroon,
   Erna/0000-0003-2721-3826; Secorun Borges, Alexandre/0000-0001-6256-8089
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   BLOOD DC, 1979, CAN VET J, V20, P341
   BRENNER S, 1959, BIOCHIM BIOPHYS ACTA, V34, P103, DOI 10.1016/0006-3002(59)90237-9
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DUMBELL K, 1993, ARCH VIROL, V128, P257, DOI 10.1007/BF01309438
   ESPOSITO JJ, 1980, J GEN VIROL, V47, P37, DOI 10.1099/0022-1317-47-1-37
   FENNER F, 1989, ORTHOPOXVIRUSES, P317
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   GIBBS EPJ, 1973, VET REC, V92, P56, DOI 10.1136/vr.92.3.56
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   LAUDER IM, 1971, VET REC, V89, P571, DOI 10.1136/vr.89.22.571
   LUM GS, 1967, AM J TROP MED HYG, V16, P332, DOI 10.4269/ajtmh.1967.16.332
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   MAZUR C, 1989, VET REC, V125, P419, DOI 10.1136/vr.125.16.419
   Mazur C, 2000, VET MICROBIOL, V73, P253, DOI 10.1016/S0378-1135(99)00151-0
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   MEYER H, 1994, J GEN VIROL, V75, P1975, DOI 10.1099/0022-1317-75-8-1975
   Moss B, 1996, FIELDS VIROLOGY, V2, P2637
   REIS R, 1970, ARQUIVOS DA ESCOLA DE VETERINARIA UNIVERSIDADE FEDERAL DE MINAS GERAIS, V22, P213
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   SILVA P L D, 1986, Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, V38, P323
   Topciu V, 1976, Virologie, V27, P279
   Tryland M, 1998, J WILDLIFE DIS, V34, P240, DOI 10.7589/0090-3558-34.2.240
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
   VANBRESSEM MF, 1993, J WILDLIFE DIS, V29, P109, DOI 10.7589/0090-3558-29.1.109
   VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569
NR 30
TC 103
Z9 106
U1 0
U2 0
PU CENTER DISEASE CONTROL
PI ATLANTA
PA ATLANTA, GA 30333 USA
SN 1080-6040
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2003
VL 9
IS 2
BP 155
EP 160
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 646KR
UT WOS:000181034600002
PM 12603984
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Pfeilsticker, OM
   Guedes, A
   Martins, ML
   Proietti, AB
   Kroon, EG
AF Pfeilsticker, OM
   Guedes, A
   Martins, ML
   Proietti, AB
   Kroon, EG
CA I GIPH
TI Ultrastructural analysis of skin biopsies in HTLV-I seropositive
   patients with cutaneous lesions.
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 11th International Conference on Human Retrovirology: HTLV and Related
   Viruses
CY JUN 09-12, 2003
CL SAN FRANCISCO, CALIFORNIA
C1 Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Dermatol, Belo Horizonte, MG, Brazil.
   Fdn Hemominas, Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PY 2003
VL 19
SU S
MA P99
BP S57
EP S58
PG 2
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 685TU
UT WOS:000183280000175
DA 2020-11-30
ER

PT J
AU Martins, ML
   Soares, BC
   Ribas, JG
   Thorun, GW
   Johnson, J
   Kroon, EG
   Carneiro-Prioetti, A
   Bonjardim, CA
AF Martins, ML
   Soares, BC
   Ribas, JG
   Thorun, GW
   Johnson, J
   Kroon, EG
   Carneiro-Prioetti, A
   Bonjardim, CA
CA GIPH
TI Frequency of p12K and p12R alleles of HTLV type 1 in HAM/TSP patients
   and in asymptomatic HTLV type 1 carriers
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID P12(I) PROTEIN; EXPRESSION; CELLS; BINDS
AB HTLV-1 has a complex genome, and contains four open reading frames (ORFs) in the 3' region encoding viral and cellular regulatory proteins. p12 is a small, ORF I-encoded hydrophobic protein, the function of which is not well understood. It has been shown that p12 enhances the E5-transforming ability of bovine papillomavirus; and binds to the 16-kDa subunit of the vacuolar ATPase pump, immature forms of the beta and gamma(c), chains of the interleukin 2 receptor, and the free chain of MHC I. p12 carrying a lysine residue (p12K) at position 88 of its sequence may be rapidly degraded in the cell via proteasome, whereas p12 with an arginine residue (p12R) at the same position is severalfold more stable. These alleles are found in proviral DNA of HTLV-1-infected individuals and it was previously observed that the p12K allele was more frequent in HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis) patients and was not found at all in asymptomatic carriers, whereas patients with adult T cell leukemia/lymphoma (ATLL) carry the p12R allele. To extend these observations and verify whether the p12K mutation could be used as a marker of progression to HAM/TSP, we analyzed 37 HAM/TSP patients and 40 asymptomatic carriers at different stages of infection. In our cohort, only one HAM/TSP patient carried the p12K phenotype, which accounted for a frequency of 2.7% (1 of 37). We also found, among the 40 asymptomatic HTLV-1 carriers, one who presented the p12K phenotype, contrasting with previous publications. Thus, p12K does not seem to be universally diagnostic for HTLV-1-associated neurological disease. Further screening of HTLV-1-infected individuals in other populations may elucidate this observation.
C1 Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   Fdn Hemominas, BR-30130110 Belo Horizonte, MG, Brazil.
   Hosp Sarah Kubistchek, BR-30510000 Belo Horizonte, MG, Brazil.
   NCI, Basic Res Lab, Bethesda, MD 20892 USA.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Bonjardim,
   Claudio A/J-2601-2014
OI Kroon, Erna Geessien/0000-0003-2721-3826; RIBAS, JOAO
   GABRIEL/0000-0002-7352-8602
CR BERNEMAN ZN, 1992, P NATL ACAD SCI USA, V89, P3005, DOI 10.1073/pnas.89.7.3005
   Collins ND, 1998, BLOOD, V91, P4701, DOI 10.1182/blood.V91.12.4701.412k23_4701_4707
   FRANCHINI G, 1993, J VIROL, V67, P7701, DOI 10.1128/JVI.67.12.7701-7704.1993
   FRANCHINI G, 1995, BLOOD, V86, P3619, DOI 10.1182/blood.V86.10.3619.bloodjournal86103619
   Johnson JM, 2001, J VIROL, V75, P6086, DOI 10.1128/JVI.75.13.6086-6094.2001
   Mulloy JC, 1996, J VIROL, V70, P3599, DOI 10.1128/JVI.70.6.3599-3605.1996
   Nicot C, 2001, BLOOD, V98, P823, DOI 10.1182/blood.V98.3.823
   Trovato R, 1999, J VIROL, V73, P6460, DOI 10.1128/JVI.73.8.6460-6467.1999
   Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15
NR 9
TC 12
Z9 12
U1 0
U2 0
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD SEP 1
PY 2002
VL 18
IS 13
BP 899
EP 902
DI 10.1089/088922202760265560
PG 4
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 590HW
UT WOS:000177814500001
PM 12230932
DA 2020-11-30
ER

PT J
AU Ruxrungtham, K
   Ubolyam, S
   Hassink, EA
   Ungsedhapand, C
   Kroon, E
   Duncombe, C
   Weverling, GJ
   Nookai, S
   Lange, J
   Cooper, D
   Phanuphak, P
AF Ruxrungtham, K
   Ubolyam, S
   Hassink, EA
   Ungsedhapand, C
   Kroon, E
   Duncombe, C
   Weverling, GJ
   Nookai, S
   Lange, J
   Cooper, D
   Phanuphak, P
TI Significant differences between plasma HIV-1 RNA assays in HIV-1 subtype
   E infected patients treated with anti-retroviral therapy
SO ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; AMPLICOR MONITOR VERSION-1.5; VIRAL LOAD;
   QUANTIPLEX VERSION-3.0; QUANTIFICATION; QUANTITATION; THAILAND;
   PERFORMANCE; INDIVIDUALS; DIDANOSINE
AB A total of 72 HIV-1 infected Thai patients treated with didanosine (ddI) or stavudine (d4T) plus ddI at the time of interim analysis were analyzed. Sixty patients (83%) carried subtype E documented by HIV-1 V3 serotyping. HIV-1 RNA levels were measured using three commercial viral load assays. At baseline (n = 57), Quantiplex 2.0 and NucliSens 2.0 showed mean log(10) HIV-1 RNA of 0.7 log(10) or 5 fold lower than Amplicor 1.5 (mean 4.29 versus 5.0 log(10), respectively, p < 0.001). At week 20 of treatment (n = 29), HIV-1 RNA levels were detected In 55.2%, 31%, and 33.5% of subjects tested by Amplicor 1.5, Quantiplex 2.0, and NucliSens 2.0, respectively. In conclusion: plasma HIV-1 RNA analyses showed comparable values with Quantiplex 2.0 and NucliSens 2.0 assays. In contrast, Amplicor 1.5 resulted in approximately 5 folds higher HIV-1 RNA levels and a 25% higher rate of detection of plasma HIV-1 RNA as compared to the other two assays. As the current goal of therapy is to suppress plasma viral load below the detection limit of the assays, the significant differences between the assays may influence antiretroviral efficacy evaluation and management.
C1 Thai Red Cross AIDS Res Ctr, Netherlands Australia Thailand Res Collaborat HIV, Bangkok, Thailand.
   Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand.
   Univ Amsterdam, Dept Internal Med, Natl AIDS Therapy Evaluat Ctr, Amsterdam, Netherlands.
   Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia.
RP Ruxrungtham, K (corresponding author), Thai Red Cross AIDS Res Ctr, Netherlands Australia Thailand Res Collaborat HIV, Bangkok, Thailand.
RI Kroon, Erna/V-5444-2019
CR Alaeus A, 1999, AIDS RES HUM RETROV, V15, P889, DOI 10.1089/088922299310593
   Alaeus A, 1997, AIDS, V11, P859, DOI 10.1097/00002030-199707000-00004
   Anastassopoulou CG, 2001, J VIROL METHODS, V91, P67, DOI 10.1016/S0166-0934(00)00245-7
   *BRIT HIV ASS, 2001, GUID ANT TREATM HIV
   Burgisser P, 2000, J ACQ IMMUN DEF SYND, V23, P138
   Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381
   Carr JK, 1996, J VIROL, V70, P5935, DOI 10.1128/JVI.70.9.5935-5943.1996
   Chew CB, 1999, J CLIN VIROL, V14, P87, DOI 10.1016/S1386-6532(99)00053-0
   Clarke JR, 2000, J MED VIROL, V62, P445, DOI 10.1002/1096-9071(200012)62:4&lt;445::AID-JMV8&gt;3.0.CO;2-N
   Coste J, 1996, J MED VIROL, V50, P293, DOI 10.1002/(SICI)1096-9071(199612)50:4&lt;293::AID-JMV3&gt;3.0.CO;2-3
   Elbeik T, 2000, J CLIN MICROBIOL, V38, P1113, DOI 10.1128/JCM.38.3.1113-1120.2000
   Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996
   GAO R, 1996, J VIROL, V70, P7013
   Holguin A, 1999, EUR J CLIN MICROBIOL, V18, P256, DOI 10.1007/s100960050273
   Kilmarx PH, 2000, J INFECT DIS, V181, P1598, DOI 10.1086/315469
   MCCUTCHAN F, 1996, AIDS S, V10, P13
   Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167
   MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003
   Michael NL, 1999, J CLIN MICROBIOL, V37, P2557, DOI 10.1128/JCM.37.8.2557-2563.1999
   *MIN PUBL HLTH, 2000, NAT GUID CLIN MAN HI, P57
   Murphy DG, 2000, J CLIN MICROBIOL, V38, P4034, DOI 10.1128/JCM.38.11.4034-4041.2000
   Nolte FS, 1998, J CLIN MICROBIOL, V36, P716, DOI 10.1128/JCM.36.3.716-720.1998
   Parekh B, 1999, AIDS RES HUM RETROV, V15, P133, DOI 10.1089/088922299311556
   Ruxrungtham K, 2000, AIDS, V14, P1375, DOI 10.1097/00002030-200007070-00010
   Schmid I, 2000, Clin Lab, V46, P355
   Segondy M, 1998, J CLIN MICROBIOL, V36, P3392, DOI 10.1128/JCM.36.11.3392-3395.1998
   Triques K, 1999, J CLIN MICROBIOL, V37, P110, DOI 10.1128/JCM.37.1.110-116.1999
   UBOLYAM S, 1994, LANCET, V344, P485, DOI 10.1016/S0140-6736(94)91825-2
   *US HHS, 2000, JAMA-J AM MED ASSOC, V2803, P381
NR 29
TC 5
Z9 5
U1 0
U2 0
PU ALLERGY IMMUNOL SOC THAILAND,
PI BANGKOK
PA MAHIDOL UNIV, DEPT MICROBIOL IMMUNOL, FACULTY TROPICAL MED, BANGKOK
   10400, THAILAND
SN 0125-877X
J9 ASIAN PAC J ALLERGY
JI Asian Pac. J. Allergy Immunol.
PD JUN
PY 2002
VL 20
IS 2
BP 105
EP 111
PG 7
WC Allergy; Immunology
SC Allergy; Immunology
GA 606RY
UT WOS:000178748000005
PM 12403195
DA 2020-11-30
ER

PT J
AU Sauvageau, G
   Yao, J
   Kroon, E
AF Sauvageau, G
   Yao, J
   Kroon, E
TI Molecular dissection of HOX-induced leukemia
SO EXPERIMENTAL HEMATOLOGY
LA English
DT Meeting Abstract
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0301-472X
J9 EXP HEMATOL
JI Exp. Hematol.
PD JUN
PY 2002
VL 30
IS 6
SU 1
MA 135
BP 70
EP 70
PG 1
WC Hematology; Medicine, Research & Experimental
SC Hematology; Research & Experimental Medicine
GA 562FP
UT WOS:000176187000133
DA 2020-11-30
ER

PT J
AU Bilodeau, M
   Thorsteinsdottir, U
   Kroon, E
   Mayotte, N
   Sauvageau, G
AF Bilodeau, M
   Thorsteinsdottir, U
   Kroon, E
   Mayotte, N
   Sauvageau, G
TI Ectopic expression of HOX11 is not permissive for hemopoietic
   reconstitution in mice
SO EXPERIMENTAL HEMATOLOGY
LA English
DT Meeting Abstract
C1 Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0301-472X
J9 EXP HEMATOL
JI Exp. Hematol.
PD JUN
PY 2002
VL 30
IS 6
SU 1
MA 236
BP 95
EP 95
PG 1
WC Hematology; Medicine, Research & Experimental
SC Hematology; Research & Experimental Medicine
GA 562FP
UT WOS:000176187000234
DA 2020-11-30
ER

PT J
AU de Oliveira, JG
   Guedes, ACM
   Lanna, CCD
   Coelho, LFL
   Prados, RZ
   Feghali, C
   Ferreira, PCP
   Kroon, EG
AF de Oliveira, JG
   Guedes, ACM
   Lanna, CCD
   Coelho, LFL
   Prados, RZ
   Feghali, C
   Ferreira, PCP
   Kroon, EG
TI Protease nexin-1 messenger RNA levels are not affected by serum or
   interferon beta in cultured systemic sclerosis fibroblasts
SO ARCHIVES OF DERMATOLOGICAL RESEARCH
LA English
DT Article
DE scleroderma; systemic sclerosis; protease nexin-1 (PN-1); interferon
   beta
ID SCLERODERMA; EXPRESSION; CELLS; IDENTIFICATION; THROMBIN; PROMOTER;
   RECEPTOR; BINDING; MUSCLE; GAMMA
AB The aim of the present study was to analyze the effect of serum and human recombinant beta interferon (rIFNbeta) treatment on PN-1 mRNA levels in cultured dermal fibroblasts obtained from the skin of healthy donors and from lesional skin of systemic sclerosis (SSc) patients with the limited (CREST syndrome) or the diffuse form of SSc. Total RNA was isolated from fibroblasts derived from the skin of healthy individuals and from lesional skin of patients with CREST syndrome and the diffuse form of SSc cultured under different conditions (1% or 10% serum-supplemented medium) and treated with 500 IU/ml of rIFNbeta. PN-1 gene expression was assessed by Northern blot analysis. We detected variable PN-1 mRNA levels in normal control fibroblasts as well as in SSc fibroblasts under the different culture conditions (1% or 10% serum-supplemented medium). Accumulated PN-1 mRNA levels found in normal cultured fibroblasts were similar to or even higher than in SSc fibroblasts. PN-1 messenger levels were not significantly altered by IFNbeta treatment in normal or SSc cultured fibroblasts despite the presence of an IFN-stimulated responsive element (ISRE) in the promoter of the PN-1 gene. Our findings suggest that PN-1 expression in SSc fibroblasts at the mRNA level requires further investigation in a large number of SSc patients to better characterize the role of this serpin in the pathogenesis of SSc. We conclude that the transcriptional regulation of PN-1 is not associated with IFNbeta, an antifibrotic cytokine naturally produced by fibroblasts.
C1 Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Fac Med, Serv Dermatol, Dept Clin Med, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Fac Med, Serv Reumatol, Dept Aparelho Locomotor, BR-31270901 Belo Horizonte, MG, Brazil.
   Hosp Baleia, Dept Cirurgia Plast, Fundacao Benjamin Guimaraes, Belo Horizonte, MG, Brazil.
   Univ Pittsburgh, Dept Med, Div Clin Immunol & Rheumatol, Pittsburgh, PA USA.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Avenida Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@mono.icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Coelho, Luiz FL/G-5853-2012; Kroon, Erna
   Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Coelho, Luiz
   Felipe/0000-0003-4289-384X
CR [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510
   BAKER JB, 1980, CELL, V21, P37, DOI 10.1016/0092-8674(80)90112-9
   Black CM, 1999, ARTHRITIS RHEUM, V42, P299, DOI 10.1002/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R
   BUCKINGHAM RB, 1978, J LAB CLIN MED, V92, P5
   Carvalho AF, 1998, PLACENTA, V19, P307, DOI 10.1016/S0143-4004(98)90063-7
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   Docagne F, 1999, FASEB J, V13, P1315
   DUNCAN MR, 1987, J CLIN INVEST, V79, P1318, DOI 10.1172/JCI112956
   EATON DL, 1983, J CELL PHYSIOL, V117, P175, DOI 10.1002/jcp.1041170207
   FARRELL DH, 1986, P NATL ACAD SCI USA, V83, P6858, DOI 10.1073/pnas.83.18.6858
   Feghali CA, 1999, ARTHRITIS RHEUM-US, V42, P1451, DOI 10.1002/1529-0131(199907)42:7<1451::AID-ANR19>3.0.CO;2-6
   FREUNDLICH B, 1992, ARTHRITIS RHEUM, V35, P1134, DOI 10.1002/art.1780351005
   FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8
   GRANSTEIN RD, 1990, J INVEST DERMATOL, V95, pS75, DOI 10.1111/1523-1747.ep12874789
   GUTTRIDGE DC, 1993, J BIOL CHEM, V268, P18966
   Guttridge DC, 1996, J NEUROCHEM, V67, P498
   Haustein UF, 1998, J EUR ACAD DERMATOL, V11, P1
   HOWARD EW, 1987, J CELL PHYSIOL, V131, P276, DOI 10.1002/jcp.1041310219
   Hunzelmann N, 1997, ARCH DERMATOL, V133, P609, DOI 10.1001/archderm.133.5.609
   KAHARI VM, 1988, J INVEST DERMATOL, V90, P664, DOI 10.1111/1523-1747.ep12560826
   Kury P, 1997, DEVELOPMENT, V124, P1251
   LEROY EC, 1988, J RHEUMATOL, V15, P202
   LEROY EC, 1972, J EXP MED, V135, P1351, DOI 10.1084/jem.135.6.1351
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   Mbebi C, 1999, J CELL PHYSIOL, V179, P305
   MCGROGAN M, 1988, BIO-TECHNOL, V6, P172, DOI 10.1038/nbt0288-172
   Moll S, 1996, KIDNEY INT, V50, P1936, DOI 10.1038/ki.1996.516
   Niclou SP, 1998, EUR J NEUROSCI, V10, P1590, DOI 10.1046/j.1460-9568.1998.00183.x
   Oliveira JG, 1999, ARCH DERMATOL RES, V291, P659, DOI 10.1007/s004030050471
   P Liang, 1997, DIFFERENTIAL DISPLAY
   PEREZ MI, 1993, J AM ACAD DERMATOL, V28, P525, DOI 10.1016/0190-9622(93)70072-2
   SCOTT RW, 1983, J BIOL CHEM, V258, P439
   Sonoda T, 1999, J INVEST DERMATOL, V113, P308, DOI 10.1046/j.1523-1747.1999.00707.x
   Strehlow D, 1999, J CLIN INVEST, V103, P1179, DOI 10.1172/JCI1918
   Varga J, 1997, ARCH DERMATOL, V133, P637, DOI 10.1001/archderm.133.5.637
   VAUGHAN PJ, 1993, J BIOL CHEM, V268, P3720
   VerdiereSahuque M, 1996, EXP CELL RES, V222, P70, DOI 10.1006/excr.1996.0009
   VILCEK I, 1996, VIROLOGY, P375
NR 39
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-3696
EI 1432-069X
J9 ARCH DERMATOL RES
JI Arch. Dermatol. Res.
PD JAN
PY 2002
VL 293
IS 11
BP 584
EP 589
DI 10.1007/s00403-001-0281-z
PG 6
WC Dermatology
SC Dermatology
GA 528KT
UT WOS:000174243500006
PM 11876527
DA 2020-11-30
ER

PT J
AU da Fonseca, FG
   Trindade, GS
   Silva, RLA
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF da Fonseca, FG
   Trindade, GS
   Silva, RLA
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
TI Characterization of a vaccinia-like virus isolated in a Brazilian forest
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; THYMIDINE KINASE; COWPOX VIRUS;
   ORTHOPOXVIRUSES; POXVIRUS; SEQUENCE; GENOME; GENE; DNA; MONKEYPOX
AB The SPAn232 virus (SPAnv) was isolated from sentinel mice in the forest of Cotia, Sao Paulo, Brazil. It was grouped originally as a Cotia virus (CV) sample due to serological cross-reaction with the latter. However, SPAnv presented genetic characteristics that differed from CV and indicated that SPAnv is a member of the vaccinia virus (VV) subgroup. SPAnv showed a Hindilll-digested DNA pattern similar to those of the WR and Lister strains of VV. Also, SPAnv presented genes homologous to the vaccinia growth factor, thymidine kinase and A-type inclusion (ATI) genes from VV. RFLP analysis of the SPAnv ATI homologous gene indicated that the virus belongs to the VV group. Nucleotide sequences from SPAnv genes showed up to 99% similarity with the same genes from VV. Such a relationship was confirmed visually through the drawing of phylogenetic trees. The results point out the occurrence of a VV strain that is possibly in active circulation in the forests of Southeast Brazil.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antoni Carlos 6627,Caixa Postal 2496, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014;
   Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   BAXBY D, 1986, LANCET, V2, P850
   Boulanger D, 1996, VET REC, V138, P247, DOI 10.1136/vr.138.11.247
   da Fonseca FG, 1999, VIRUS GENES, V18, P151, DOI 10.1023/A:1008072720217
   da Fonseca FG, 1998, ARCH VIROL, V143, P1171
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DUMBELL K, 1993, ARCH VIROL, V128, P257, DOI 10.1007/BF01309438
   ESPOSITO JJ, 1980, J GEN VIROL, V47, P37, DOI 10.1099/0022-1317-47-1-37
   FENNER F, 1989, ORTHOPOXVIRUSES, P317
   Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720
   JAMES R, 1984, ANNU REV BIOCHEM, V53, P259
   JEZEK Z, 1986, J INFECT DIS, V154, P551, DOI 10.1093/infdis/154.4.551
   JOHNSON GP, 1993, VIROLOGY, V196, P381, DOI 10.1006/viro.1993.1494
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   LUM GS, 1967, AM J TROP MED HYG, V16, P332, DOI 10.4269/ajtmh.1967.16.332
   MASSUNG RF, 1991, VIROLOGY, V180, P347, DOI 10.1016/0042-6822(91)90039-E
   MAZUR C, 1989, VET REC, V125, P419, DOI 10.1136/vr.125.16.419
   Mazur C, 2000, VET MICROBIOL, V73, P253, DOI 10.1016/S0378-1135(99)00151-0
   McFadden G, 1995, VIROCEPTORS VIROKINE, P1
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   MEYER H, 1994, J GEN VIROL, V75, P1975, DOI 10.1099/0022-1317-75-8-1975
   PICKUP DJ, 1984, P NATL ACAD SCI-BIOL, V81, P6817, DOI 10.1073/pnas.81.21.6817
   SAMBROOK J, 1989, MOL CLONING LAB MANU, P383
   Sandvik T, 1998, J CLIN MICROBIOL, V36, P2542, DOI 10.1128/JCM.36.9.2542-2547.1998
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Tryland M, 1998, J WILDLIFE DIS, V34, P443, DOI 10.7589/0090-3558-34.3.443
   Tryland M, 1998, J WILDLIFE DIS, V34, P240, DOI 10.7589/0090-3558-34.2.240
   UEDA Y, 1995, VIROLOGY, V210, P67, DOI 10.1006/viro.1995.1317
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
   VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569
   WEIR JP, 1983, J VIROL, V46, P530, DOI 10.1128/JVI.46.2.530-537.1983
   WOODALL JP, 1967, ATAS S BIOTA AMAZON, V6, P31
NR 33
TC 50
Z9 55
U1 0
U2 3
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 0022-1317
J9 J GEN VIROL
JI J. Gen. Virol.
PD JAN
PY 2002
VL 83
BP 223
EP 228
DI 10.1099/0022-1317-83-1-223
PN 1
PG 6
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA 508LM
UT WOS:000173090200025
PM 11752719
OA Bronze
DA 2020-11-30
ER

PT J
AU Kroon, E
   Yao, J
   Sauvageau, G
AF Kroon, E
   Yao, J
   Sauvageau, G
TI HOX-PBX interaction is not required for the induction of AML by
   NUP98-HOXA9 or HOXA9.
SO BLOOD
LA English
DT Meeting Abstract
C1 Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada.
   Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada.
RI Kroon, Erna/V-5444-2019
NR 0
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 16
PY 2001
VL 98
IS 11
MA 398
BP 95A
EP 96A
PN 1
PG 2
WC Hematology
SC Hematology
GA 491WY
UT WOS:000172134100399
DA 2020-11-30
ER

PT J
AU Sauvageau, G
   Hendrix, A
   Denis, DC
   Kroon, E
   Hebert, J
   Mayotte, N
AF Sauvageau, G
   Hendrix, A
   Denis, DC
   Kroon, E
   Hebert, J
   Mayotte, N
TI BCR-ABL interacts with NUP98-HOXA9 and with E2a-PBX1 in human leukemias.
SO BLOOD
LA English
DT Meeting Abstract
C1 IRCM, Montreal, PQ, Canada.
   Hop Maison Neuve Rosemont, Div Hematol, Montreal, PQ, Canada.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 16
PY 2001
VL 98
IS 11
MA 3477
BP 837A
EP 837A
PN 1
PG 1
WC Hematology
SC Hematology
GA 491WY
UT WOS:000172134103490
DA 2020-11-30
ER

PT J
AU de Magalhaes, JC
   Andrade, AA
   Silva, PNG
   Sousa, LP
   Ropert, C
   Ferreira, PCP
   Kroon, EG
   Gazzinelli, RT
   Bonjardim, CA
AF de Magalhaes, JC
   Andrade, AA
   Silva, PNG
   Sousa, LP
   Ropert, C
   Ferreira, PCP
   Kroon, EG
   Gazzinelli, RT
   Bonjardim, CA
TI A mitogenic signal triggered at an early stage of vaccinia virus
   infection - Implication of MEK/ERK and protein kinase in a virus
   multiplication
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID EPIDERMAL GROWTH-FACTOR; C-FOS PROMOTER; HUMAN PAPILLOMAVIRUS TYPE-11;
   TRANSCRIPTION FACTOR AP-1; HTLV-I TAX; NEURITE OUTGROWTH; CELL-DEATH; S6
   KINASE; ACTIVATION; GENE
AB Vaccinia virus (VV) triggers a mitogenic signal at an early stage of infection. VV-induced proto-oncogene c-fos mRNA with kinetics paralleling that stimulated by serum. The VV virokine, or vaccinia virus growth factor (VGF), was not crucial for c-fos induction because it was observed upon infection with the virokine-minus mutant VV (VGF(-)). Furthermore, c-fos expression did not require infectious virus particles, as it occurred even with UV-inactivated VV and was equally induced by the different multiplicities of infection, i.e. 1.0, 5.0, and 25.0. c-fos expression was preceded by W-induced DNA binding activity and was mediated via the cis-acting elements serum response element (SRE), activating protein-1 (AP-1), and CAMP-response element (CRE). VV activated the protein kinases p42MAPK/ERK2 and p44MAPK/ERK1 and the transcription factor ATF1 in a time-dependent manner with kinetics that paralleled those of W-stimulated DNA-protein complex formation. The mitogenic signal transmission pathways leading to c-fos activation upon VV infection were apparently mediated by the protein kinases MEK, ERK, and PKA. This assumption was based on the findings that: 1) c-fos transcript was down-regulated; 2) the SRE, AP-1, and CRE binding activities were significantly reduced; and 3) the activation of p42MAPK/ERK2, p44MAPK/ERK1, and ATF1 were drastically affected when the viral infections were carried out in the presence of specific protein kinase inhibitor. Moreover, the mutant VV (VGF-) was also able to activate ERK1/2. It is noteworthy that virus multiplication was equally affected by the same kinase inhibitors. Taken together, our data provide evidence that the early mitogenic signal triggered upon VV infection relies upon the activation of the protein kinases MEK, ERK, and PKA, which are needed for both signal transduction and virus multiplication.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Grp Transducao Sinal Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil.
   Fdn Oswaldo Cruz, Ctr Pesquisas Rene Rachou, BR-31270901 Belo Horizonte, MG, Brazil.
RP Bonjardim, CA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Grp Transducao Sinal Lab Virus, Av Antonio Carlos 6627 Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; Andrade,
   Anderson/H-4022-2012; Bonjardim, Claudio A/J-2601-2014; Ropert,
   Catherine/G-2463-2012
OI Kroon, Erna Geessien/0000-0003-2721-3826; Andrade,
   Anderson/0000-0001-9569-6503; Gazzinelli, Ricardo/0000-0003-2427-7699
CR Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4
   ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489
   ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0
   Benn J, 1996, J VIROL, V70, P4978, DOI 10.1128/JVI.70.8.4978-4985.1996
   BLOMQUIST MC, 1984, P NATL ACAD SCI-BIOL, V81, P7363, DOI 10.1073/pnas.81.23.7363
   BOLDOGH I, 1990, SCIENCE, V247, P561, DOI 10.1126/science.1689075
   Bonjardim CA, 1997, BRAZ J MED BIOL RES, V30, P41, DOI 10.1590/S0100-879X1997000100007
   BROWN JP, 1985, NATURE, V313, P491, DOI 10.1038/313491a0
   BRUSSELBACH S, 1995, ONCOGENE, V10, P79
   BULLER RML, 1988, VIROLOGY, V164, P182, DOI 10.1016/0042-6822(88)90635-6
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   BURGERING BMT, 1993, MOL CELL BIOL, V13, P7248, DOI 10.1128/MCB.13.12.7248
   BURNET FM, 1936, SPECIAL REPORT SERIE, V220, P4
   CAHILL MA, 1995, SIGNALING UPTAKE C F
   Caivano M, 2000, J IMMUNOL, V164, P3018, DOI 10.4049/jimmunol.164.6.3018
   Chen SL, 1996, J VIROL, V70, P8558, DOI 10.1128/JVI.70.12.8558-8563.1996
   CHIJIWA T, 1990, J BIOL CHEM, V265, P5267
   Chow JYC, 2000, J BIOL CHEM, V275, P21169, DOI 10.1074/jbc.M002160200
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   COOPER GM, 1995, ONCOGENES, P255
   Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362
   da Fonseca FG, 1999, VIRUS GENES, V18, P151, DOI 10.1023/A:1008072720217
   De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202
   DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8
   Fanidi A, 1998, J VIROL, V72, P8392, DOI 10.1128/JVI.72.10.8392-8395.1998
   FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321
   FLEMINGTON E, 1990, J VIROL, V64, P4549, DOI 10.1128/JVI.64.9.4549-4552.1990
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Franco GR, 1999, PLACENTA, V20, P189, DOI 10.1053/plac.1998.0364
   FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8
   FUJII M, 1995, ONCOGENE, V11, P7
   FUJITA M, 1995, ONCOGENE, V11, P15
   Gibellini D, 1997, BLOOD, V89, P1654, DOI 10.1182/blood.V89.5.1654.1654_1654_1664
   GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0
   GREEN DA, 1984, MON NOT R ASTRON SOC, V211, P433, DOI 10.1093/mnras/211.2.433
   HIPSKIND RA, 1991, J BIOL CHEM, V266, P19583
   Hirasawa K, 1999, J VIROL, V73, P8541, DOI 10.1128/JVI.73.10.8541-8548.1999
   JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5
   KIMURA K, 1994, J BIOL CHEM, V269, P18961
   LEE WMF, 1988, MOL CELL BIOL, V8, P5521, DOI 10.1128/MCB.8.12.5521
   LIN SQ, 1994, P NATL ACAD SCI USA, V91, P7653, DOI 10.1073/pnas.91.16.7653
   Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497
   MARK R, 1988, J VIROL, V62, P866
   MOSS B, 1990, VIROLOGY, V2, P2079
   MOSS B, 1996, VIROLOGY, V2, P2637
   MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0
   NATOLI G, 1995, J HEPATOL, V22, P14
   NOVOGRODSKY A, 1994, SCIENCE, V264, P1319, DOI 10.1126/science.8191285
   Oliveira JG, 1997, PLACENTA, V18, P163, DOI 10.1016/S0143-4004(97)90088-6
   Rosl F, 1997, J VIROL, V71, P362
   SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445
   SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0
   SU ZZ, 1995, ONCOGENE, V10, P2037
   Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859
   Tomas-Zuber M, 2000, J BIOL CHEM, V275, P23549, DOI 10.1074/jbc.M002586200
   Tsao YP, 1996, J VIROL, V70, P7535, DOI 10.1128/JVI.70.11.7535-7539.1996
   TWARDZIK DR, 1985, P NATL ACAD SCI USA, V82, P5300, DOI 10.1073/pnas.82.16.5300
   Tzahar E, 1998, EMBO J, V17, P5948, DOI 10.1093/emboj/17.20.5948
   Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360
   Zachos G, 1999, J BIOL CHEM, V274, P5097, DOI 10.1074/jbc.274.8.5097
   ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0
NR 63
TC 81
Z9 83
U1 1
U2 10
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 19
PY 2001
VL 276
IS 42
BP 38353
EP 38360
DI 10.1074/jbc.M100183200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 484CT
UT WOS:000171673200006
PM 11459835
DA 2020-11-30
ER

PT J
AU Ungsedhapand, C
   Kroon, EDMB
   Suwanagool, S
   Ruxrungtham, K
   Yimsuan, N
   Sonjai, A
   Ubolyam, S
   Buranapraditkun, S
   Tiengrim, S
   Pakker, N
   Kunanusont, C
   Lange, JMA
   Cooper, DA
   Phanuphak, P
AF Ungsedhapand, C
   Kroon, EDMB
   Suwanagool, S
   Ruxrungtham, K
   Yimsuan, N
   Sonjai, A
   Ubolyam, S
   Buranapraditkun, S
   Tiengrim, S
   Pakker, N
   Kunanusont, C
   Lange, JMA
   Cooper, DA
   Phanuphak, P
TI A randomized, open-label, comparative trial of zidovudine plus
   lamivudine versus zidovudine plus lamivudine plus didanosine in
   antiretroviral-naive HIV-1-infected Thai patients
SO JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE antiretroviral treatment-naive; didanosine; HIV; lamivudine; triple
   nucleoside reverse transcriptase inhibitor therapy; zidovudine
ID IMMUNODEFICIENCY-VIRUS INFECTION; CD4 CELL COUNTS; CUBIC MILLIMETER;
   THERAPY; INDINAVIR; ADULTS
AB Objective: To assess the efficacy and tolerability of a triple nucleoside reverse transcriptase inhibitor combination of zidovudine, lamivudine, and didanosine therapy,
   Design: A randomized open-label trial.
   Patients: Antiretroviral-naive HIV-infected patients with CD4(+) cell counts of 100 to 500 cells/mul.
   Methods: A total of 106 patients were randomly assigned to 300 mg of zidovudine (200 mg for body weight < 60 kg) twice daily plus 150 mg of lamivudine twice daily plus 200 mg of didanosine (125 mg for body weight < 60 kg) twice daily (n = 53) or to zidovudine plus lamivudine (n = 53) for 48 weeks.
   Main Outcome Measures: Degree and duration of reduction of HIV-1 RNA load and increase in CD4(+) cell counts from baseline and development of drug-related toxicities.
   Results: At 48 weeks, triple drug therapy showed greater declines in plasma HIV-RNA levels from the beginning of treatment than double drug therapy (1.86 vs, 1.15 log(10) copies/ml, respectively; p < .001). The proportions of patients with HIV-RNA < 50 copies/ml in an intention-to-treat analysis were 54.7% (29 of 53 patients) and 11.3% (6 of 53 patients) in the triple and double drug therapy, respectively (p = .001). There was no significant difference in increase of CD4 count.
   Conclusion: Triple drug therapy with zidovudine, lamivudine, and didanosine was significantly more effective in inducing sustained immunologic and virologic responses than the double combination of zidovudine and lamivudine.
C1 Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok 10330, Thailand.
   Univ Amsterdam, Acad Med Ctr, Natl AIDS Therapy Evaluat Ctr, Amsterdam, Netherlands.
   Mahidol Univ, Siriraj Hosp, Fac Med, Dept Prevent & Social Med, Bangkok, Thailand.
   Chulalongkorn Univ, Fac Med, Dept Internal Med, Bangkok, Thailand.
   Minist Publ Hlth, Dept Communicable Dis Control, Div AIDS, Nonthaburi, Thailand.
   Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia.
RP Ungsedhapand, C (corresponding author), Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, 104 Ratchadamri Rd, Bangkok 10330, Thailand.
RI Kroon, Erna/V-5444-2019
CR Aber V, 1996, LANCET, V348, P283
   Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78
   COLLIER AC, 1990, NEW ENGL J MED, V323, P1015, DOI 10.1056/NEJM199010113231502
   ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502
   FISCHL MA, 1990, NEW ENGL J MED, V323, P1009, DOI 10.1056/NEJM199010113231501
   Gartland M, 2000, AIDS, V14, P367
   GILDON BM, 1998, 12 WORLD AIDS C GEN
   Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102
   Hammer S M, 1998, AIDS, V12 Suppl A, pS181
   Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101
   Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501
   Harrington M, 2000, LANCET, V355, P2147, DOI 10.1016/S0140-6736(00)02388-6
   Hoetelmans RMW, 1998, ANTIVIR THER, V3, P13
   KIMURA S, 1992, INTERNAL MED, V31, P871, DOI 10.2169/internalmedicine.31.871
   Kunanusont Chaiyos, 1999, Journal of the Medical Association of Thailand, V82, P425
   Lafeuillade A, 1997, Antivir Ther, V2, P219
   Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002
   PRESCOTT N, 1966, 11 WORLD AIDS C VANC
   Sommadossi JP, 1998, ANTIVIR THER, V3, P9
   SQUIRES K, 2000, 13 WORLD AIDS C DURB
   STASZEWSKI S, 1999, 39 INT C ANT AG CHEM
   STCLAIR MH, 1995, J ACQ IMMUN DEF SYND, V10, pS83
NR 22
TC 11
Z9 11
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1525-4135
J9 J ACQ IMMUN DEF SYND
JI J. Acquir. Immune Defic. Syndr.
PD JUN 1
PY 2001
VL 27
IS 2
BP 116
EP 123
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 442YK
UT WOS:000169312400003
PM 11404532
DA 2020-11-30
ER

PT J
AU Diniz, S
   Trindade, GS
   Fonseca, FG
   Kroon, EG
AF Diniz, S
   Trindade, GS
   Fonseca, FG
   Kroon, EG
TI An outbreak of mousepox in Swiss mice in a laboratory animal facility -
   Case report
SO ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA
LA Portuguese
DT Article
DE mice; mousepox; poxvirus
ID ECTROMELIA VIRUS; INNATELY RESISTANT; LETHAL INFECTION; MOSCOW-STRAIN;
   COLONIES
AB Two hundred Swiss mice were housed following the requirements to produce healthy laboratory animals. After 14 days two mice had an acute lethal infection and one week later 74 animals (37%) presented multiple skin lesions some of them associated with conjunctivitis. Necropsy of 10 mice with clinical signs (swelling of feet and facial area) revealed alterations in the spleen, liver and lymphonodes. Samples of hepatic and splenic tissues and of tail lesions were inoculated on chorioallantoic membrane (MCA) of embrionated chicken eggs and pocks lesions were detected. The MCAs were grinded and inoculated in Vero cell cultures and the cytophatic effect was detected after 72 hours. Diagnosis of mousepox was based on clinical signs, lesions and virus isolation and identification.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019; Kroon, Erna/B-3631-2015
OI Kroon, Erna/0000-0003-2721-3826
CR ALLEN AM, 1981, LAB ANIM SCI, V31, P599
   ANDREWES CH, 1972, VIRUSES VERTEBRATES, P373
   BHATT PN, 1988, ARCH VIROL, V100, P221, DOI 10.1007/BF01487685
   BROWNSTEIN D, 1989, ARCH VIROL, V107, P35, DOI 10.1007/BF01313876
   *CEPANZO, 1971, SER MON CIENT TECN, P61
   COLLINS MJ, 1981, LAB ANIM SCI, V31, P595
   Dick EJ, 1996, LAB ANIM SCI, V46, P602
   DIXON IW, 1981, LAB ANIM SCI, V31, P585
   FAUNDEZ IS, 1990, ARCH VIROL, V114, P285
   FENNER F, 1982, MOUSE BIOMEDICAL RES, P209
   Gilioli R, 1996, LAB ANIM SCI, V46, P582
   HARKNESS JE, 1977, BIOL MED RABBITS ROD, P85
   Lipman NS, 1999, SCIENCE, V284, P1123
   NEWBAUER H, 1997, LAB ANIM SCI, V31, P201
   NIEMIALTOWSKI MG, 1994, ACTA VIROL, V38, P299
   Schmidt NJ, 1979, DIAGNOSTIC PROCEDURE, P65
   WALLACE GD, 1981, LAB ANIM SCI, V31, P609
   WERNER RM, 1981, LAB ANIM SCI, V31, P590
NR 18
TC 6
Z9 6
U1 0
U2 1
PU ARQUIVO BRASILEIRO MEDICINA VETERINARIA ZOOTECNIA
PI MINAS GERAIS
PA FEDERAL MINAS GERAIS CAIXA POSTAL 567-BELO HORIZ, MINAS GERAIS, BRAZIL
SN 0102-0935
J9 ARQ BRAS MED VET ZOO
JI Arq. Bras. Med. Vet. Zootec.
PD APR
PY 2001
VL 53
IS 2
BP 152
EP 156
DI 10.1590/S0102-09352001000200003
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 458FD
UT WOS:000170181800003
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Nogueira, ML
   Siqueira, RC
   Freitas, N
   Amorim, JB
   Bonjardim, CA
   Ferreira, PCP
   Orefice, F
   Kroon, EG
AF Nogueira, ML
   Siqueira, RC
   Freitas, N
   Amorim, JB
   Bonjardim, CA
   Ferreira, PCP
   Orefice, F
   Kroon, EG
TI Detection of herpesvirus DNA by the polymerase chain reaction (PCR) in
   vitreous samples from patients with necrotising retinitis
SO JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
DE polymerase chain reaction; uveitis; retinitis
ID RETINAL NECROSIS SYNDROME; HUMAN-IMMUNODEFICIENCY-VIRUS;
   IMMUNE-DEFICIENCY SYNDROME; AQUEOUS-HUMOR; VIRAL RETINITIS; DIAGNOSIS;
   SIMPLEX; UVEITIS; FLUIDS; AIDS
AB Aims-Viral uveitis and retinitis, usually caused by herpesviruses, are common in immunosuppressed patients. The diagnosis of viral anterior uveitis and retinitis is usually clinical. The polymerase chain reaction (PCR) has been used for the diagnosis of some viral infections, especially those caused by herpesviruses. This paper reports the use of PCR in the diagnosis of viral retinitis in vitreous samples from Brazilian patients.
   Methods-PCR was used for the diagnosis of necrotising retinitis in vitreous samples from patients from the Hospital Sao Geraldo, Universidade Federal de Minas Gerais, Brazil. The vitreous samples were collected by paracentesis and stored until analysis. Samples were analysed by PCR using specific primers designed to amplify herpes simplex virus 1 (HSV-1), varicella tester virus (VZV), or human cytomegalovirus (HCMV). In a case of anterior uveitis, PCR was performed with a sample from the anterior chamber.
   Results-Herpesvirus DNA was amplified in 11 of 17 samples. HCVM DNA was detected in nine samples but DNA from HSV-1 and VZV were detected only once each.
   Conclusion-These results strongly suggest that PCR could be used for a rapid complementary diagnosis of viral uveitis and retinitis. A prospective study to evaluate the PCR results, clinical evolution, and treatment is imperative to corroborate the real value of FCR in diagnosis and how it could help the clinicians' approach.
C1 Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Fac Med, Hosp Sao Geraldo, Serv Uveites, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Av Antonio Carlos,6627, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; Bonjardim,
   Claudio A/J-2601-2014; Nogueira, Mauricio L/B-7599-2012
OI Kroon, Erna Geessien/0000-0003-2721-3826; Nogueira, Mauricio
   L/0000-0003-1102-2419; Orefice, Fernando/0000-0002-7008-601X; Siqueira,
   Rubens/0000-0003-4563-1570
CR Abe T, 1996, GRAEF ARCH CLIN EXP, V234, P419, DOI 10.1007/BF02539407
   Boivin G, 1998, J CLIN MICROBIOL, V36, P2509, DOI 10.1128/JCM.36.9.2509-2513.1998
   BROWN HH, 1988, AM J OPHTHALMOL, V106, P102, DOI 10.1016/S0002-9394(14)76402-5
   CLEWLEY JP, 1995, POLYMERASE CHAIN REA
   Danise A, 1997, CLIN INFECT DIS, V24, P1100, DOI 10.1086/513625
   DeBoer JH, 1996, AM J OPHTHALMOL, V121, P650, DOI 10.1016/S0002-9394(14)70631-2
   Dennett C, 1997, J MED VIROL, V53, P1, DOI 10.1002/(SICI)1096-9071(199709)53:1&lt;1::AID-JMV1&gt;3.0.CO;2-4
   FIELD HJ, 1992, RES VIROLOGY, V143, P120, DOI 10.1016/S0923-2516(06)80092-0
   FREEMAN WR, 1984, AM J OPHTHALMOL, V97, P133, DOI 10.1016/S0002-9394(14)76082-9
   GARWEG J, 1993, GRAEF ARCH CLIN EXP, V231, P508, DOI 10.1007/BF00921115
   GRIFFITHS PD, 1997, CLIN VIROLOGY, P445
   HOLLAND GN, 1983, OPHTHALMOLOGY, V90, P859
   HOLLAND GN, 1994, AM J OPHTHALMOL, V117, P663, DOI 10.1016/S0002-9394(14)70075-3
   HOLLAND GN, 1994, INT OPHTHALMOL, V18, P163, DOI 10.1007/BF00915966
   MITCHELL SM, 1994, J MED VIROL, V43, P336, DOI 10.1002/jmv.1890430404
   Muccioli C, 1994, Rev Assoc Med Bras (1992), V40, P155
   NAHASS GT, 1992, JAMA-J AM MED ASSOC, V268, P2541, DOI 10.1001/jama.268.18.2541
   Nogueira ML, 1998, MEM I OSWALDO CRUZ, V93, P213, DOI 10.1590/S0074-02761998000200015
   OBRIEN JJ, 1989, DRUGS, V37, P233, DOI 10.2165/00003495-198937030-00002
   PEPOSE JS, 1985, OPHTHALMOLOGY, V92, P474
   Schacher S, 1998, KLIN MONATSBL AUGENH, V212, P359, DOI 10.1055/s-2008-1034906
   Short GA, 1997, AM J OPHTHALMOL, V123, P157, DOI 10.1016/S0002-9394(14)71031-1
   SHUTTLEWORTH G, 1997, CLIN VIROLOGY, P159
   Verbraak FD, 1996, AIDS, V10, P1091, DOI 10.1097/00002030-199609000-00006
   WIEDBRAUK DL, 1995, J CLIN MICROBIOL, V33, P2643, DOI 10.1128/JCM.33.10.2643-2646.1995
   Yamakami T, 1996, ANN PURE APPL LOGIC, V80, P1, DOI 10.1016/0168-0072(95)00043-7
NR 26
TC 32
Z9 33
U1 0
U2 1
PU BRITISH MED JOURNAL PUBL GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0021-9746
J9 J CLIN PATHOL
JI J. Clin. Pathol.
PD FEB
PY 2001
VL 54
IS 2
BP 103
EP 106
DI 10.1136/jcp.54.2.103
PG 4
WC Pathology
SC Pathology
GA 399CC
UT WOS:000166792600005
PM 11215276
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Marques, JT
   Trindade, GD
   Da Fonseca, FG
   Dos Santos, JR
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Marques, JT
   Trindade, GD
   Da Fonseca, FG
   Dos Santos, JR
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
TI Characterization of ATI, TK and IFN-alpha/beta R genes in the genome of
   the BeAn 58058 virus, a naturally attenuated wild Orthopoxvirus
SO VIRUS GENES
LA English
DT Article
DE BeAn 58058 virus; B18R gene; ATI; TK; vaccinia virus; IFN-alpha/beta R
ID INCLUSION-BODY; VACCINIA; INTERFERON; POXVIRUS; REPLICATION; PROTEIN;
   CELLS; RECEPTOR; STRAINS; ENCODES
AB The lack of knowledge about the natural host of Vaccinia virus (VV) along with the description of human infections caused by poxviruses after smallpox eradication has increased the need to characterize poxviruses isolated from the wild. Moreover, in the past years poxviruses have been widely studied as potential vaccination tools, with the discovery of several genes implicated in the evasion of the host immune response involved in virus pathogenesis. Among them, an Interferon (IFN)-binding protein was identified in the supernatant of VV strain WR infected cells coded by the B18R gene. It was shown that many other Orthopoxviruses also encode and express this soluble receptor although some VV strains such as Lister and modified Ankara, which were less reactogenic vaccines, do not. The BeAn 58058 virus (BAV) has been recently characterized and proposed to be an Orthopoxvirus. BAV was also shown to be less virulent in animal models than VV Lister. Here we report the identification of an IFN-alpha/betaR gene in the BAV genome with 99% of sequence identity with the VVWR B18R gene. The identified gene encodes a B18R-like IFN binding protein as demonstrated by its capacity to inhibit the IFN-mediated protection of VERO cells against EMC virus. In order to better characterize the virus we have searched for the A type inclusion body (ATI) gene currently used in the classification of Orthopoxviruses but did not detect it in the BAV genome. We have also sequenced the BAV thymidine kinase (TK) gene, a poxvirus-conserved gene, which, as expected, showed high homology with the TK gene of other poxviruses. Phylogenetic trees were constructed based on sequences of the IFN-alpha/betaR and TK genes from several poxviruses and in both cases BAV was placed in the same cluster as other VV strains. These observations strengthened the hypothesis that this virus is a variant of the VV vaccine used in Brazil. However the explanation for the BAV lack of virulence remains to be discovered.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 2496, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@mono.icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015; Marques, Joao T/F-7683-2012
OI Kroon, Erna Geessien/0000-0003-2721-3826; Marques, Joao
   T/0000-0002-3457-3320
CR ALCAMI A, 1995, IMMUNOL TODAY, V16, P474, DOI 10.1016/0167-5699(95)80030-1
   Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   AMANO H, 1979, J GEN VIROL, V44, P265, DOI 10.1099/0022-1317-44-1-265
   BAXBY D, 1977, ARCH VIROL, V55, P169, DOI 10.1007/BF01319903
   BAXBY D, 1986, LANCET, V2, P850
   Bender BS, 1996, J VIROL, V70, P6418, DOI 10.1128/JVI.70.9.6418-6424.1996
   BLACK ME, 1992, J BIOL CHEM, V267, P9743
   Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159
   Boulanger D, 1996, VET REC, V138, P247, DOI 10.1136/vr.138.11.247
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974
   da Fonseca FG, 1998, ARCH VIROL, V143, P1171
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4
   ESPOSITO JJ, 1980, J GEN VIROL, V47, P37, DOI 10.1099/0022-1317-47-1-37
   FERREIRA PCP, 1979, J CLIN MICROBIOL, V9, P471
   FUNAHASHI S, 1988, J GEN VIROL, V69, P35, DOI 10.1099/0022-1317-69-1-35
   INNIS MA, 1990, OPTIMIZATION PERS, P3
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Mayr A., 1975, INFECTION, V3, P6, DOI DOI 10.1007/BF01641272
   Men R, 2000, VACCINE, V18, P3113, DOI 10.1016/S0264-410X(00)00121-3
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   Miller CG, 1997, VIROLOGY, V229, P126, DOI 10.1006/viro.1996.8396
   MOSS B, 1990, ANNU REV BIOCHEM, V59, P661, DOI 10.1146/annurev.biochem.59.1.661
   Nam JH, 1999, VACCINE, V17, P261, DOI 10.1016/S0264-410X(98)00156-X
   Ourmanov I, 2000, J VIROL, V74, P2740, DOI 10.1128/JVI.74.6.2740-2751.2000
   Sambrook J., 1989, MOL CLONING LAB MANU
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Smith GL, 1996, CURR OPIN IMMUNOL, V8, P467, DOI 10.1016/S0952-7915(96)80032-X
   Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x
   STUBER D, 1990, IMMUNOLOGICAL METHOD, V4, P121
   SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847
   SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
   VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569
   WOODAL JP, 1967, S A BIOT AM BEL, P31
   Wyatt LS, 1998, VIROLOGY, V251, P334, DOI 10.1006/viro.1998.9397
   Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2
NR 42
TC 18
Z9 20
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PY 2001
VL 23
IS 3
BP 291
EP 301
DI 10.1023/A:1012521322845
PG 11
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA 490BZ
UT WOS:000172031600006
PM 11778697
DA 2020-11-30
ER

PT J
AU Thorsteinsdottir, U
   Jerome, L
   Kroon, E
   Sauvageau, G
AF Thorsteinsdottir, U
   Jerome, L
   Kroon, E
   Sauvageau, G
TI Evidence for a mitotic clock in HSC which impairs Hoxa9-induced leukemic
   transformation.
SO BLOOD
LA English
DT Meeting Abstract
C1 Inst Rech Clin Montreal, Div Hematol, Hop Maison Neuve Rosemont, Montreal, PQ H2W 1R7, Canada.
RI Kroon, Erna/V-5444-2019
OI Sauvageau, Guy/0000-0002-4333-7266
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 16
PY 2000
VL 96
IS 11
MA 4243
BP 128B
EP 128B
PN 2
PG 1
WC Hematology
SC Hematology
GA 372WC
UT WOS:000165256200583
DA 2020-11-30
ER

PT J
AU Ruxrungtham, K
   Suwanagool, S
   Tavel, JA
   Cheunyam, M
   Kroon, E
   Ubolyam, S
   Buranapraditkun, S
   Techasathit, W
   Li, YM
   Emery, S
   Davey, RT
   Fosdick, L
   Kunanusont, C
   Lane, HC
   Phanuphak, P
AF Ruxrungtham, K
   Suwanagool, S
   Tavel, JA
   Cheunyam, M
   Kroon, E
   Ubolyam, S
   Buranapraditkun, S
   Techasathit, W
   Li, YM
   Emery, S
   Davey, RT
   Fosdick, L
   Kunanusont, C
   Lane, HC
   Phanuphak, P
CA Vanguard Study Grp
TI A randomized, controlled 24-week study of intermittent subcutaneous
   interleukin-2 in HIV-1 infected patients in Thailand
SO AIDS
LA English
DT Article
DE Asia; CD4; immune-based therapy; Thailand
ID HUMAN-IMMUNODEFICIENCY-VIRUS; INTRAVENOUS INTERLEUKIN-2; CONTROLLED
   TRIAL; LYMPHOCYTES; IMPACT
AB Objectives: To assess the immunological and virological effects, safety profile and feasibility of subcutaneous interleukin-2 (sCIL-2) therapy in an HIV-infected Thai population.
   Design: Seventy-two patients with baseline CD4 cell count of greater than or equal to 350 x 10(6)/L and no history of opportunistic infection were randomized to receive antiretroviral therapy plus scIL-2 (scIL-2 group) or antiretroviral therapy alone (control group). scIL-2 was administered at one of three doses for at least 24 weeks. The main measure of treatment efficacy was change in CD4 cell count.
   Results: The time-weighted mean change in CD4 cell count from baseline to week 24 was + 252 x 10(6)/l for the scIL-2 group compared with + 42 x 10(6)/l for the control group (P < 0.0001). Changes in plasma HIV RNA were not significantly different between the groups over the same time period: there was a 0.83 log(10) copies/ml decrease for the scIL-2 group and a 0.70 log copies/ml decrease for the control group (P = 0.362).
   Conclusions: This study provides the most extensive experience of scIL-2 therapy in HIV-1 infected women and Asians, and demonstrates the immunological efficacy, tolerability and feasability of scIL-2 therapy in this population. Data from this study were instrumental in guiding the selection of the scIL-2 dosing regimen for ongoing phase III trials. (C) 2000 Lippincott Williams & Wilkins.
C1 Thai Red Cross, AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok 10330, Thailand.
   Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand.
   Mahidol Univ, Siriraj Hosp, Bangkok 10700, Thailand.
   NIAID, NIH, Bethesda, MD 20892 USA.
   Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Natl AIDS Therapy Evaluat Ctr, NL-1105 AZ Amsterdam, Netherlands.
   Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok 10330, Thailand.
   Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia.
   Univ Minnesota, Coordinating Ctr Biometr Res, Minneapolis, MN 55455 USA.
   Minist Publ Hlth, Div Communicable Dis, Div AIDS, Bangkok, Thailand.
   NCHECR, Sydney, NSW, Australia.
   NATEC, Amsterdam, Netherlands.
   HIV NAT, Bangkok, Thailand.
   MOPH, Bangkok, Thailand.
RP Ruxrungtham, K (corresponding author), Thai Red Cross, AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, 104 Rajadamri Rd,Lumpini, Bangkok 10330, Thailand.
RI Kroon, Erna/V-5444-2019; Emery, Sean/J-3825-2017; Emery,
   Sean/O-9122-2019
OI Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [Z01AI000636, Z01AI000636, ZIAAI000865, Z01AI000636, Z01AI000865,
   Z01AI000636, Z01AI000865, Z01AI000636, ZIAAI000636, Z01AI000636,
   ZIAAI000865, Z01AI000865, Z01AI000636, Z01AI000865, Z01AI000865,
   Z01AI000636, Z01AI000865, Z01AI000636, Z01AI000636, Z01AI000636,
   ZIAAI000865, Z01AI000636, ZIAAI000865, ZIAAI000865, ZIAAI000865,
   ZIAAI000865, ZIAAI000865, Z01AI000636, Z01AI000636, Z01AI000865,
   Z01AI000636, Z01AI000865, ZIAAI000865, Z01AI000865, Z01AI000636,
   ZIAAI000865] Funding Source: NIH RePORTER
CR Carr A, 1998, J INFECT DIS, V178, P992, DOI 10.1086/515653
   Davey RT, 1997, J INFECT DIS, V175, P781
   Davey RT, 1999, J INFECT DIS, V179, P849
   DEWAR RL, 1994, J INFECT DIS, V170, P1172, DOI 10.1093/infdis/170.5.1172
   HEFENEIDER SH, 1983, J IMMUNOL, V130, P220
   Kovacs JA, 1996, NEW ENGL J MED, V335, P1350, DOI 10.1056/NEJM199610313351803
   KOVACS JA, 1995, NEW ENGL J MED, V332, P567, DOI 10.1056/NEJM199503023320904
   Levy Y, 1999, LANCET, V353, P1923, DOI 10.1016/S0140-6736(98)07345-0
   Losso MH, 2000, J INFECT DIS, V181, P1614, DOI 10.1086/315430
   ROOK AH, 1983, J CLIN INVEST, V72, P398, DOI 10.1172/JCI110981
   SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876
   Surasiengsunk S, 1998, AIDS, V12, P775, DOI 10.1097/00002030-199807000-00014
NR 12
TC 34
Z9 34
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0269-9370
J9 AIDS
JI Aids
PD NOV 10
PY 2000
VL 14
IS 16
BP 2509
EP 2513
DI 10.1097/00002030-200011100-00013
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 373ZW
UT WOS:000165320800013
PM 11101062
DA 2020-11-30
ER

PT J
AU Kroon, EDMB
   Ungsedhapand, C
   Ruxrungtham, K
   Chuenyam, M
   Ubolyam, S
   Newell, ME
   van Leeuwen, R
   Kunanusont, C
   Buranapraditkul, S
   Sirivichayakul, S
   Lange, JMA
   Cooper, DA
   Phanuphak, P
AF Kroon, EDMB
   Ungsedhapand, C
   Ruxrungtham, K
   Chuenyam, M
   Ubolyam, S
   Newell, ME
   van Leeuwen, R
   Kunanusont, C
   Buranapraditkul, S
   Sirivichayakul, S
   Lange, JMA
   Cooper, DA
   Phanuphak, P
TI A randomized, double-blind trial of half versus standard dose of
   zidovudine plus zalcitabine in Thai HIV-1-infected patients (study
   HIV-NAT 001)
SO AIDS
LA English
DT Article; Proceedings Paper
CT 12th International Conference on AIDS
CY JUN-JUL -, 1998
CL GENEVA, SWITZERLAND
DE clinical trials; Asia; antiretroviral therapy; combination therapy;
   reverse transcriptase inhibitors; viral load; healthcare/economics
ID ACTIVE ANTIRETROVIRAL THERAPY; CUBIC MILLIMETER; INFECTED ADULTS; VIRAL
   LOAD; INDIVIDUALS
AB Background: Triple combination antiretroviral therapy, recommended as standard of care, is unaffordable for much of the developing world.
   Objectives: To establish whether half doses of zidovudine (AZT) and zalcitabine (ddC) are as effective as standard doses in a Thai population with lower body weight than Western populations and predominantly infected with HIV-1 subtype E.
   Methods: A group of 116 antiretroviral naive patients, with CD4 cell counts 100-500 x 10(6) cells/l, were randomized to: AZT 200 mg three times daily plus ddC 0.75 mg three times daily versus AZT 100 mg three times daily plus ddC 0.375 mg three times daily and followed-up regularly for 48 weeks.
   Results: The study enrolled 111 patients: 59 men and 52 women, body weight (mean +/- standard deviation) 56.4 +/- 12.3 kg, mean CD4 cell count 324 X 10(6) cells/l, mean HIV RNA 4.7 log(10) copies/ml. There were no significant differences between the two groups. Twelve patients discontinued, including two deaths that were unrelated to study medication. No significant differences in adverse events were seen. Week 48 data for the standard dose and half dose arms, respectively, were mean CD4 cell count increases of 52 and 78 x 10(6) cells/l (P = 0.34), mean plasma HIV-1 RNA reduction of 1.4 and 1.1 log(10) copies/ml (P = 0.10), HIV RNA of < 400 copies/ml in 52 and 20% (P = 0.001). Participants with higher than mean baseline CD8 cell counts (mean 1062 x 10(6) cells/l) showed greater decline in CD8 cells on standard doses. Further analysis showed improved reduction in HIV RNA (P < 0.0001) and in the percentage with undetectable HIV RNA (P = 0.0137) in the standard dose arm, corrected for baseline HIV RNA, which if < 4.75 log(10) copies/ml significantly correlated with HIV RNA < 400 copies/ml at week 48.
C1 Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand.
   Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand.
   Chulalongkorn Hosp, Dept Microbiol, Bangkok, Thailand.
   Minist Publ Hlth, Div AIDS, Dept Communicable Dis Control, Nonthaburi, Thailand.
   Univ New S Wales, NCHECR, Sydney, NSW, Australia.
   Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NATEC, NL-1105 AZ Amsterdam, Netherlands.
RP Cooper, DA (corresponding author), Natl Ctr HIV Epiemiol & Clin Res, 376 Victoria St, Darlinghurst, NSW 2010, Australia.
RI Kroon, Erna/V-5444-2019
CR [Anonymous], 1996, Lancet, V348, P283
   BrunVezinet F, 1997, LANCET, V350, P983, DOI 10.1016/S0140-6736(97)03380-1
   *CDC, 1998, MMWR-MORBID MORTAL W, V47, pRR5
   COLLIER AC, 1990, NEW ENGL J MED, V323, P1015, DOI 10.1056/NEJM199010113231502
   Curtis H, 1998, LANCET, V352, P1379
   DEEKS SG, 1999, 6 C RETR OPP INF CHI
   Dore G J, 1998, AIDS, V12 Suppl B, pS1
   FISCHL MA, 1990, NEW ENGL J MED, V323, P1009, DOI 10.1056/NEJM199010113231501
   Gazzard B, 1998, LANCET, V352, P314, DOI 10.1016/S0140-6736(98)04084-7
   Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501
   Hogg RS, 1997, LANCET, V350, P1406, DOI 10.1016/S0140-6736(05)65188-4
   Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502
   Kaufmann D, 1998, LANCET, V351, P723, DOI 10.1016/S0140-6736(98)24010-4
   KIMURA S, 1992, INTERNAL MED, V31, P871, DOI 10.2169/internalmedicine.31.871
   Kroes ACM, 1999, LANCET, V353, P153, DOI 10.1016/S0140-6736(05)76194-8
   NORRBY SR, 1992, BRIT MED J, V304, P13
   Phanuphak P, 1998, AIDS, V12, pS77
   Reiser M, 1999, Eur J Med Res, V4, P54
   Rhone SA, 1998, J INFECT DIS, V178, P662, DOI 10.1086/515365
   RUXRUNGTHAM K, 1998, 12 INT C AIDS GEN JU
   SCHOOLEY RT, 1994, J INFECT DIS, V169, P968
   Stewart GJ, 1996, MED J AUSTRALIA, V165, P499, DOI 10.5694/j.1326-5377.1996.tb138616.x
   UBOLYAM S, 1994, LANCET, V344, P485, DOI 10.1016/S0140-6736(94)91825-2
   Wit FWNM, 1999, J INFECT DIS, V179, P790, DOI 10.1086/314675
NR 24
TC 21
Z9 21
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD JUL 7
PY 2000
VL 14
IS 10
BP 1349
EP 1356
DI 10.1097/00002030-200007070-00007
PG 8
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 333RW
UT WOS:000088145400007
PM 10930149
DA 2020-11-30
ER

PT J
AU Ruxrungtham, K
   Kroon, EDMB
   Ungsedhapand, C
   Teeratakulpisarn, S
   Ubolyam, S
   Buranapraditkun, S
   van Leeuwen, R
   Weverling, GJ
   Kunanusont, C
   Lange, JMA
   Cooper, DA
   Phanuphak, P
AF Ruxrungtham, K
   Kroon, EDMB
   Ungsedhapand, C
   Teeratakulpisarn, S
   Ubolyam, S
   Buranapraditkun, S
   van Leeuwen, R
   Weverling, GJ
   Kunanusont, C
   Lange, JMA
   Cooper, DA
   Phanuphak, P
TI A randomized, dose-finding study with didanosine plus stavudine versus
   didanosine alone in antiviral-naive, HIV-infected Thai patients
SO AIDS
LA English
DT Article; Proceedings Paper
CT 12th International Conference on AIDS
CY JUN-JUL -, 1998
CL GENEVA, SWITZERLAND
DE clinical trials; Asia; Thailand; antiretroviral therapy;
   stavudine/didanosine combination; reverse transcriptase inhibitors;
   viral load; healthcare/economics; HIV subtype E
ID CUBIC MILLIMETER; ANTIRETROVIRAL THERAPY; COMBINATION THERAPY;
   CONTROLLED TRIAL; VIRAL LOAD; ZIDOVUDINE; TYPE-1; CELLS; AZIDOTHYMIDINE;
   MONOTHERAPY
AB Objectives: To evaluate the safety and efficacy of four different regimens of didanosine (ddl) + stavudine (d4T) in HIV-infected Thais.
   Design: Prospective, open-label, randomized study.
   Methods: Patients were randomized to four regimens of high and low doses of ddl and d4T or to ddl alone. D4T was added to the ddl-alone arm after week 24. The duration of study was 48 weeks.
   Results: Seventy-eight patients were randomized (mean CD4 cell count, 255 x 10(6)/l; mean plasma HIV-1 RNA; 4.3 log(10) copies/ml). In the intent-to-treat analysis, 78% of patients in the pooled combination arms and 20% of the patients in the ddl alone arm (to which d4T was added after 24 weeks) showed plasma HIV-1 RNA < 500 copies/ml at week 24 (P < 0.001), and 59% versus 53% at week 48, respectively. In addition, the proportion of patients with < 50 HIV-1 RNA copies/ml was 13% versus 7% at week 24 (P = 0.5) and 17% versus 20% at week 48 respectively. At week 24, median CD4 cell count increases from baseline were 101 x 10(6)/l in the pooled combination versus 76 x 10(6)/l in the ddl alone arm (P = 0.78). Logistic regression modeling suggested a correlation between receiving high dose ddl and achieving HIV-1 RNA < 500 copies/ml at week 48 (P = 0.07).
   Conclusions: The d4T/ddl combination was superior to ddl alone in producing HIV-1 viral suppression. At week 48, > 60% of patients treated with this combination reached HIV-1 RNA levels < 500 copies/ml. Receiving high dose ddl but not d4T may correlate with a better viral suppression. (C) 2000 Lippincott Williams & Wilkins.
C1 Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok 10330, Thailand.
   Chulalongkorn Univ, Dept Med, Fac Med, Bangkok, Thailand.
   Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NATEC, NL-1105 AZ Amsterdam, Netherlands.
   Chulalongkorn Hosp, Dept Microbiol, Bangkok, Thailand.
   Minist Publ Hlth, Ctr Dis Control, AIDS Div, Nonthaburi, Thailand.
   Univ New S Wales, NCHECR, Sydney, NSW, Australia.
RP Ruxrungtham, K (corresponding author), Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, 104 Rajdumri Rd, Bangkok 10330, Thailand.
RI Kroon, Erna/V-5444-2019
CR [Anonymous], 1996, Lancet, V348, P283
   BrunVezinet F, 1997, LANCET, V350, P983, DOI 10.1016/S0140-6736(97)03380-1
   Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381
   Castro KG, 1992, MMWR-MORBID MORTAL W, V41, P1, DOI DOI 10.2307/42000431
   CDC, 1998, MMWR-MORBID MORTAL W, V47, P1
   COLLIER AC, 1990, NEW ENGL J MED, V323, P1015, DOI 10.1056/NEJM199010113231502
   ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502
   FISCHL MA, 1990, NEW ENGL J MED, V323, P1009, DOI 10.1056/NEJM199010113231501
   GAO WY, 1993, J CLIN INVEST, V91, P2326, DOI 10.1172/JCI116463
   Gaywee J, 1996, J ACQ IMMUN DEF SYND, V13, P392, DOI 10.1097/00042560-199612010-00014
   Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501
   ISARASENA T, 1996, THAI TXB PEDIAT, P21
   Katlama C, 1996, JAMA-J AM MED ASSOC, V276, P118, DOI 10.1001/jama.276.2.118
   Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502
   KIMURA S, 1992, INTERNAL MED, V31, P871, DOI 10.2169/internalmedicine.31.871
   KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8
   Lange JMA, 1997, SCIENCE, V276, P548, DOI 10.1126/science.276.5312.548
   Phanuphak P, 1998, AIDS, V12, pS77
   Pollard RB, 1999, J ACQ IMMUN DEF SYND, V22, P39, DOI 10.1097/00042560-199909010-00005
   Pollard RB, 1996, ANTIVIR RES, V29, P101, DOI 10.1016/0166-3542(95)00929-9
   Rhone SA, 1998, J INFECT DIS, V178, P662, DOI 10.1086/515365
   Rutschmann OT, 1998, AIDS, V12, pF71, DOI 10.1097/00002030-199808000-00003
   SCHOOLEY RT, 1994, J INFECT DIS, V169, P968
   SEIFERT RD, 1994, BRIT J CLIN PHARMACO, V38, P405, DOI 10.1111/j.1365-2125.1994.tb04374.x
   Subbarao S, 1998, AIDS RES HUM RETROV, V14, P319, DOI 10.1089/aid.1998.14.319
   UBOLYAM S, 1994, LANCET, V344, P485, DOI 10.1016/S0140-6736(94)91825-2
   Wit FWNM, 1999, J INFECT DIS, V179, P790, DOI 10.1086/314675
NR 27
TC 24
Z9 24
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD JUL 7
PY 2000
VL 14
IS 10
BP 1375
EP 1382
DI 10.1097/00002030-200007070-00010
PG 8
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 333RW
UT WOS:000088145400010
PM 10930152
DA 2020-11-30
ER

PT J
AU Nogueira, ML
   Amorim, JB
   Oliveira, JG
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Nogueira, ML
   Amorim, JB
   Oliveira, JG
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
TI Comparison of virus isolation and various polymerase chain reaction
   methods in the diagnosis of mucocutaneous herpesvirus infection
SO ACTA VIROLOGICA
LA English
DT Article
DE HSV-1; VZV; PCR; virus isolation; mucocutaneous herpetic infections;
   diagnostics
ID VARICELLA-ZOSTER INFECTION; SIMPLEX VIRUS; CLINICAL-APPLICATION; TZANCK
   SMEAR; PCR; ASSAY; DNA; ENCEPHALITIS; ACYCLOVIR; DISEASE
AB We compared two polymerase chain reaction (PCR) assays (simple and multiplex) and viral isolation to detect herpes simplex virus 1 (HSV-1) and varicella-zoster virus (VZV) in 15 clinical specimens from 13 patients with mucocutaneous herpetic infections. HSV-1 or VZV DNA was detected in 13 specimens by simple PCRs (HSV-1 or VZV PCR) and in 12 specimens by multiplex PCR. On the other hand, viral isolation was positive for 9 specimens only. The PCR protocols used in this study are not only more sensitive and faster than the traditional viral isolation and conventional PCR protocols but also can distinguish rapidly HSV-1 from VZV. We propose the PCRs described here for rapid and precise identification of etiological agents of mucocutaneous herpetic infections.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@mono.icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Nogueira, Mauricio L/B-7599-2012;
   Bonjardim, Claudio A/J-2601-2014; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Nogueira, Mauricio
   L/0000-0003-1102-2419; 
CR ASHLEY R, 1995, DIAGNOSTIC PROCEDURE, P375
   Baron JM, 1996, J MED VIROL, V49, P279, DOI 10.1002/(SICI)1096-9071(199608)49:4&lt;279::AID-JMV4&gt;3.0.CO;2-0
   BOIVIN G, 1994, J INFECT DIS, V170, P68, DOI 10.1093/infdis/170.1.68
   Cassinotti P, 1996, J MED VIROL, V50, P75, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt;75::AID-JMV13&gt;3.0.CO;2-X
   CLEWLEY JP, 1995, POLYM CHAIN REACTION
   FIELD HJ, 1992, RES VIROLOGY, V143, P120, DOI 10.1016/S0923-2516(06)80092-0
   KIDO S, 1991, J CLIN MICROBIOL, V29, P76, DOI 10.1128/JCM.29.1.76-79.1991
   KIMURA H, 1990, MED MICROBIOL IMMUN, V179, P177, DOI 10.1007/BF00195248
   LAKEMAN FD, 1995, J INFECT DIS, V171, P857, DOI 10.1093/infdis/171.4.857
   Markoulatos P, 1997, J CLIN LAB ANAL, V11, P146, DOI 10.1002/(SICI)1098-2825(1997)11:3&lt;146::AID-JCLA5&gt;3.0.CO;2-8
   Mori Y, 1998, JPN J OPHTHALMOL, V42, P8, DOI 10.1016/S0021-5155(97)00108-1
   NAHASS GT, 1992, JAMA-J AM MED ASSOC, V268, P2541, DOI 10.1001/jama.268.18.2541
   NAHASS GT, 1995, J AM ACAD DERMATOL, V32, P730, DOI 10.1016/0190-9622(95)91450-1
   Nascimento Maria C. Do, 1998, Journal of Clinical Microbiology, V36, P848
   Nogueira ML, 1998, MEM I OSWALDO CRUZ, V93, P213, DOI 10.1590/S0074-02761998000200015
   OBRIEN JJ, 1989, DRUGS, V37, P233, DOI 10.2165/00003495-198937030-00002
   Read SJ, 1999, J CLIN MICROBIOL, V37, P1352, DOI 10.1128/JCM.37.5.1352-1355.1999
   Risbud A, 1999, SEX TRANSM DIS, V26, P55, DOI 10.1097/00007435-199901000-00009
   ROIZMAN B, 1990, P1787
   Rubben A, 1997, BRIT J DERMATOL, V137, P259, DOI 10.1046/j.1365-2133.1997.18161913.x
   Safrin S, 1997, SEX TRANSM DIS, V24, P176, DOI 10.1097/00007435-199703000-00010
   Scott DA, 1997, J ORAL PATHOL MED, V26, P305, DOI 10.1111/j.1600-0714.1997.tb00220.x
   Slomka MJ, 1998, J MED VIROL, V55, P177, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;177::AID-JMV15&gt;3.0.CO;2-F
   SOLOMON AR, 1986, ARCH DERMATOL, V122, P282, DOI 10.1001/archderm.122.3.282
   Stockton J, 1998, J CLIN MICROBIOL, V36, P2990, DOI 10.1128/JCM.36.10.2990-2995.1998
   Tebas P, 1998, AM J MED, V105, P287, DOI 10.1016/S0002-9343(98)00259-9
   THOMAS CA, 1994, AM J DERMATOPATH, V16, P268, DOI 10.1097/00000372-199406000-00007
NR 27
TC 9
Z9 10
U1 0
U2 0
PU AEPRESS SRO
PI BRATISLAVA
PA BAJZOVA 7, BRATISLAVA, 821 08, SLOVAKIA
SN 0001-723X
EI 1336-2305
J9 ACTA VIROL
JI Acta Virol.
PD APR
PY 2000
VL 44
IS 2
BP 61
EP 65
PG 5
WC Virology
SC Virology
GA 330LW
UT WOS:000087964400001
PM 10989695
DA 2020-11-30
ER

PT J
AU Waleria-Aleixo, A
   Kroon, EG
   Campos, MAS
   Margutti-Pinto, ME
   Bonjardim, CA
   Ferreira, PCP
AF Waleria-Aleixo, A
   Kroon, EG
   Campos, MAS
   Margutti-Pinto, ME
   Bonjardim, CA
   Ferreira, PCP
TI Heteroduplex mobility assay for rapid, sensitive and specific detection
   of mycobacteria
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Mycobacterium tuberculosis; MHMA; 16S rRNA; PCR; diagnostic
ID POLYMERASE CHAIN-REACTION; FRAGMENT-LENGTH-POLYMORPHISM; 16S
   RIBOSOMAL-RNA; CLINICAL-SAMPLES; INTERNAL CONTROL; SPUTUM SAMPLES;
   TUBERCULOSIS; DNA; AVIUM; PCR
AB We report an improved method for the detection and identification of mycobacteria using PCR and the heteroduplex mobility shift assay (HMA). The HMA for detection of mycobacteria was based on the microheterogeneity within the DNA coding sequences for 16S rRNA. A remarkable shift between single-stranded, heteroduplex and homoduplex bands in PAGE was observed among the Mycobacterium spp. tested. The Mycobacteria HMA (MHMA) of amplified PCR products from mycobacteria DNA coding for 16S rDNA derived from culture showed a specific heteroduplexes formed among different Mycobacterium species. Other bacterium species were distinguished from Mycobacterium due to slow migrating heteroduplexes mobility bands observed when M. bovis (BCG), M. avium, or M. fortuitum were used as a standard. The specific heteroduplexes were detected when as little as 1 eta g of DNA template was used, although better results were obtained with 5 eta g and when PCR products of sample test and mycobacterium standard were mixed at a ratio of 1.8. To correctly evaluate the feasibility of using MHMA to detect and identify mycobacteria, 15 clinical sample patients were tested. All MTB-positive clinical samples were identified by MHMA as well as the negative samples. In addition, MHMA will, in principle, be applicable to the detection and classification of any microorganism showing differences within the 16S rRNA as well as to the identification of new and unrecognized bacterial species. (C) 2000 Elsevier Science Inc. All rights reserved.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Ferreira, PCP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, POB 486, BR-31270901 Belo Horizonte, MG, Brazil.
RI Campos, Marco A/C-4000-2013; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014
OI Campos, Marco A/0000-0003-4683-0176; Kroon, Erna
   Geessien/0000-0003-2721-3826; 
CR Aronson T, 1999, J CLIN MICROBIOL, V37, P1008, DOI 10.1128/JCM.37.4.1008-1012.1999
   BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055
   BOCART D, 1992, AM REV RESPIR DIS, V145, P1142, DOI 10.1164/ajrccm/145.5.1142
   BODDINGHAUS B, 1990, J CLIN MICROBIOL, V28, P1751
   BRUGIERE O, 1997, J CLIN MICROBIOL, V31, P2049
   *CDC, 1993, MMWR-MORBID MORTAL W, V42, P961
   *CDC PREV, 1992, MMWR-MORBID MORTAL W, V40, P58
   CLARRIDGE JE, 1993, J CLIN MICROBIOL, V31, P2049, DOI 10.1128/JCM.31.8.2049-2056.1993
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   COUSINS DV, 1992, J CLIN MICROBIOL, V30, P255, DOI 10.1128/JCM.30.1.255-258.1992
   DELPORTILLO P, 1991, J CLIN MICROBIOL, V29, P2163, DOI 10.1128/JCM.29.10.2163-2168.1991
   DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655
   DELWART EL, 1995, AIDS RES HUM RETROV, V11, P1081, DOI 10.1089/aid.1995.11.1081
   DEWIT D, 1990, J CLIN MICROBIOL, V28, P2437, DOI 10.1128/JCM.28.11.2437-2441.1990
   DOOLEY SW, 1992, ANN INTERN MED, V117, P257, DOI 10.7326/0003-4819-117-3-257
   DROBNIEWSKI FA, 1994, J HOSP INFECT, V28, P249, DOI 10.1016/0195-6701(94)90089-2
   EISENACH KD, 1991, AM REV RESPIR DIS, V144, P1160, DOI 10.1164/ajrccm/144.5.1160
   Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177
   FOLGUEIRA L, 1993, J CLIN MICROBIOL, V31, P1019, DOI 10.1128/JCM.31.4.1019-1021.1993
   FRIES JWU, 1990, MOL CELL PROBE, V4, P87, DOI 10.1016/0890-8508(90)90011-N
   GarciadeLomas J, 1997, PEDIATR INFECT DIS J, V16, pS43, DOI 10.1097/00006454-199703001-00004
   GUERRERO C, 1995, J CLIN MICROBIOL, V33, P304, DOI 10.1128/JCM.33.2.304-307.1995
   HANCE AJ, 1989, MOL MICROBIOL, V3, P843, DOI 10.1111/j.1365-2958.1989.tb00233.x
   HUGHES MS, 1993, J CLIN MICROBIOL, V31, P3216, DOI 10.1128/JCM.31.12.3216-3222.1993
   KIRSCHNER P, 1993, J CLIN MICROBIOL, V31, P2882, DOI 10.1128/JCM.31.11.2882-2889.1993
   KOLK AHJ, 1994, J CLIN MICROBIOL, V32, P1354, DOI 10.1128/JCM.32.5.1354-1356.1994
   KOLK AHJ, 1992, J CLIN MICROBIOL, V30, P2567, DOI 10.1128/JCM.30.10.2567-2575.1992
   Kox LFF, 1996, J CLIN MICROBIOL, V34, P2117, DOI 10.1128/JCM.34.9.2117-2120.1996
   KOX LFF, 1995, J CLIN MICROBIOL, V33, P3225, DOI 10.1128/JCM.33.12.3225-3233.1995
   KUNZE ZM, 1992, J CLIN MICROBIOL, V30, P2366, DOI 10.1128/JCM.30.9.2366-2372.1992
   LINTON CJ, 1994, J CLIN MICROBIOL, V32, P2169, DOI 10.1128/JCM.32.9.2169-2174.1994
   MANJUNATH N, 1991, TUBERCLE, V72, P21, DOI 10.1016/0041-3879(91)90020-S
   NOLTE FS, 1993, J CLIN MICROBIOL, V31, P1772
   NOORDHOEK GT, 1994, J CLIN MICROBIOL, V32, P277, DOI 10.1128/JCM.32.2.277-284.1994
   PERSING DH, 1991, J CLIN MICROBIOL, V29, P1281, DOI 10.1128/JCM.29.7.1281-1285.1991
   Pestel-Caron M, 1998, J CLIN MICROBIOL, V36, P1859, DOI 10.1128/JCM.36.7.1859-1863.1998
   Picardeau M, 1996, J CLIN MICROBIOL, V34, P389, DOI 10.1128/JCM.34.2.389-392.1996
   PITCHENIK AE, 1984, ANN INTERN MED, V101, P641, DOI 10.7326/0003-4819-101-5-641
   PLIKAYTIS BB, 1992, J CLIN MICROBIOL, V30, P1815, DOI 10.1128/JCM.30.7.1815-1822.1992
   Relman David A., 1996, P3
   ROGALL T, 1990, INT J SYST BACTERIOL, V40, P323, DOI 10.1099/00207713-40-4-323
   ROIZ MP, 1995, J CLIN MICROBIOL, V33, P1389, DOI 10.1128/JCM.33.5.1389-1391.1995
   SAMBROOK KJ, 1996, MOL CLONING LAB MANU
   SCHIRM J, 1995, J CLIN MICROBIOL, V33, P3221, DOI 10.1128/JCM.33.12.3221-3224.1995
   SHANKAR P, 1990, LANCET, V335, P423, DOI 10.1016/0140-6736(90)90268-A
   SHANKAR P, 1991, LANCET, V337, P5, DOI 10.1016/0140-6736(91)93328-7
   SHAWAR RM, 1993, J CLIN MICROBIOL, V31, P61, DOI 10.1128/JCM.31.1.61-65.1993
   SRITHARAN V, 1991, MOL CELL PROBE, V5, P385, DOI 10.1016/S0890-8508(06)80011-3
   Thornton CG, 1998, J CLIN MICROBIOL, V36, P1996, DOI 10.1128/JCM.36.7.1996-2003.1998
   Van Soolingen D, 1998, J CLIN MICROBIOL, V36, P3051, DOI 10.1128/JCM.36.10.3051-3054.1998
   VICTOR T, 1992, J CLIN MICROBIOL, V30, P1514, DOI 10.1128/JCM.30.6.1514-1517.1992
   WASEM CF, 1991, J CLIN MICROBIOL, V29, P264, DOI 10.1128/JCM.29.2.264-271.1991
   WILSON SM, 1993, J CLIN MICROBIOL, V31, P776, DOI 10.1128/JCM.31.4.776-782.1993
   YUEN KY, 1995, J CLIN PATHOL, V48, P924, DOI 10.1136/jcp.48.10.924
NR 54
TC 10
Z9 10
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0732-8893
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD APR
PY 2000
VL 36
IS 4
BP 225
EP 235
DI 10.1016/S0732-8893(00)00112-7
PG 11
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA 306AP
UT WOS:000086574200003
PM 10764964
DA 2020-11-30
ER

PT J
AU Oliveira, JG
   Prados, RZ
   Guedes, ACM
   Ferreira, PCP
   Kroon, EG
AF Oliveira, JG
   Prados, RZ
   Guedes, ACM
   Ferreira, PCP
   Kroon, EG
TI The housekeeping gene glyceraldehyde-3-phosphate dehydrogenase is
   inappropriate as internal control in comparative studies between skin
   tissue and cultured skin fibroblasts using Northern blot analysis
SO ARCHIVES OF DERMATOLOGICAL RESEARCH
LA English
DT Article
DE GAPDH; 18 S ribosomal RNA; scleroderma; systemic sclerosis; normal skin;
   cultured skin fibroblast; housekeeping gene; mRNA expression
ID GROWTH-FACTOR; EXPRESSION; COLLAGENASE
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Clin Med, Setor Dermatol, Fac Med, BR-31270901 Belo Horizonte, MG, Brazil.
   Hosp Baleia, Dept Cirugia Plast, Fdn Benjamin Guimaraes, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, Avenida Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@mono.icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826
CR BATHIA P, 1993, ANAL BIOCHEM, V216, P223
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   EDWARDS DR, 1985, EXP CELL RES, V157, P127, DOI 10.1016/0014-4827(85)90157-0
   EINAT M, 1985, P NATL ACAD SCI USA, V82, P7608, DOI 10.1073/pnas.82.22.7608
   HERRMANN K, 1991, J INVEST DERMATOL, V97, P219, DOI 10.1111/1523-1747.ep12480157
   Kikuchi K, 1997, J INVEST DERMATOL, V108, P281, DOI 10.1111/1523-1747.ep12286457
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   MANSUR NR, 1993, NUCLEIC ACIDS RES, V21, P993, DOI 10.1093/nar/21.4.993
   MCNULTY SE, 1995, BIOCHEM BIOPH RES CO, V212, P165, DOI 10.1006/bbrc.1995.1951
   Sambrook J., 1989, MOL CLONING LAB MANU
   Soukri A, 1996, GENE, V181, P139, DOI 10.1016/S0378-1119(96)00494-5
   TAKEDA K, 1994, J INVEST DERMATOL, V103, P359, DOI 10.1111/1523-1747.ep12394936
   TOKUNAGA K, 1987, CANCER RES, V47, P5616
   Xu SW, 1997, ARTHRITIS RHEUM-US, V40, P1237
   Yamada H, 1997, BIOCHEM BIOPH RES CO, V231, P835, DOI 10.1006/bbrc.1997.6198
NR 16
TC 31
Z9 32
U1 1
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-3696
EI 1432-069X
J9 ARCH DERMATOL RES
JI Arch. Dermatol. Res.
PD DEC
PY 1999
VL 291
IS 12
BP 659
EP 661
DI 10.1007/s004030050471
PG 3
WC Dermatology
SC Dermatology
GA 271ZY
UT WOS:000084626700006
PM 10651167
DA 2020-11-30
ER

PT J
AU Mamo, A
   Thorsteinsdottir, U
   Kroon, E
   Bijl, J
   Lawrence, HJ
   Largman, C
   Humphries, RK
   Sauvageau, G
AF Mamo, A
   Thorsteinsdottir, U
   Kroon, E
   Bijl, J
   Lawrence, HJ
   Largman, C
   Humphries, RK
   Sauvageau, G
TI Hoxa9: A key regulator of proliferation of primitive hematopoietic
   cells.
SO BLOOD
LA English
DT Meeting Abstract
C1 IRCM, Quebec City, PQ, Canada.
   Univ Calif San Francisco, VA Med Ctr, San Francisco, CA 94143 USA.
   British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.
RI Kroon, Erna/V-5444-2019
NR 0
TC 2
Z9 2
U1 0
U2 0
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 15
PY 1999
VL 94
IS 10
SU 1
MA 1106
BP 250A
EP 250A
PN 1
PG 1
WC Hematology
SC Hematology
GA 257PH
UT WOS:000083790301155
DA 2020-11-30
ER

PT J
AU Thorsteinsdottir, U
   Kroon, E
   Jerome, L
   Sauvageau, G
AF Thorsteinsdottir, U
   Kroon, E
   Jerome, L
   Sauvageau, G
TI Bone marrow transplantation delays/inhibits the progression of
   preleukemia to leukemia in a preleukemic mouse model.
SO BLOOD
LA English
DT Meeting Abstract
C1 IRCM, Montreal, PQ, Canada.
   Univ Montreal, Hop Maison Neuve Rosemont, Div Hematol, Montreal, PQ, Canada.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 15
PY 1999
VL 94
IS 10
SU 1
MA 4502
BP 287B
EP 287B
PN 2
PG 1
WC Hematology
SC Hematology
GA 257PM
UT WOS:000083790701346
DA 2020-11-30
ER

PT J
AU Kroon, E
   Thorsteinsdottir, U
   Nakamura, T
   Sauvageau, G
AF Kroon, E
   Thorsteinsdottir, U
   Nakamura, T
   Sauvageau, G
TI Over-expression of the human AML-associated fusion gene NUP98-HOXA9, in
   murine bone marrow cells leads to myelo-proliferation and AML.
SO BLOOD
LA English
DT Meeting Abstract
C1 IRCM, Montreal, PQ, Canada.
   Inst Canc, PRESTO, JST, Tokyo, Japan.
   Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 15
PY 1999
VL 94
IS 10
SU 1
MA 3069
BP 694A
EP 694A
PN 1
PG 1
WC Hematology
SC Hematology
GA 257PH
UT WOS:000083790303118
DA 2020-11-30
ER

PT J
AU Thorsteinsdottir, U
   Kroon, E
   Sauvageau, G
AF Thorsteinsdottir, U
   Kroon, E
   Sauvageau, G
TI Co-activation of Meis1 as a common mechanism for Hox-induced leukemic
   transformation.
SO BLOOD
LA English
DT Meeting Abstract
C1 Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.
   Univ Montreal, Hop Maison Neuve Rosemont, Div Hematol, Montreal, PQ H3C 3J7, Canada.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 15
PY 1999
VL 94
IS 10
SU 1
MA 3070
BP 694A
EP 694A
PN 1
PG 1
WC Hematology
SC Hematology
GA 257PH
UT WOS:000083790303119
DA 2020-11-30
ER

PT J
AU de Oliveira, JG
   Ferreira, PCP
   Kroon, EG
AF de Oliveira, JG
   Ferreira, PCP
   Kroon, EG
TI Recovering cDNA bands from differential display RT-PCR gels using a
   transparency film mask
SO MOLECULAR BIOTECHNOLOGY
LA English
DT Article
DE mRNA differential display PCR; cDNA; band recovery; polyacrylamide gel;
   DDRT-PCR
ID MESSENGER-RNA; IDENTIFICATION
AB We describe here the use of a transparency film as a mask for recovering bands from differential display reverse transcription-polymerase chain reaction (DDRT-PCR) gels. This method represents a simple and rapid way to isolate the differentially expressed bands from dried and nondried polyacrylamide, radioactive and nonradioactive, denaturing and native DDRT gels. A transparency film is overlaid on the DDRT autoradiogram, and the marks and bands of interest are drawn using a permanent marker. The reproduced band marks are cut out of the transparency sheet with a scalpel to facilitate the recovery of the desired bands. The transparency film mask is then overlaid on the top of the gel and the bands are recovered from the gel. The use of the transparency film mask avoids damage to the autoradiogram and is also extremely,useful in DDRT-PCR experiments involving different RNA samples that produce band patterns of different intensities that require many X-ray exposures for different periods of time.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR BAUER D, 1993, NUCLEIC ACIDS RES, V21, P4272, DOI 10.1093/nar/21.18.4272
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P152
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   SAGER R, 1993, FASEB J, V7, P964
   Wang H, 1998, MOL BIOTECHNOL, V9, P171, DOI 10.1007/BF02760818
NR 5
TC 0
Z9 0
U1 0
U2 0
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1073-6085
J9 MOL BIOTECHNOL
JI Mol. Biotechnol.
PD APR
PY 1999
VL 11
IS 2
BP 195
EP 197
DI 10.1007/BF02915812
PG 3
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 223HG
UT WOS:000081835100008
PM 10464773
DA 2020-11-30
ER

PT J
AU Proietti, ABDC
   Barbosa, EF
   Silva, JG
   de Carvalho, AF
   Kroon, EG
   Ferreira, PCP
AF Proietti, ABDC
   Barbosa, EF
   Silva, JG
   de Carvalho, AF
   Kroon, EG
   Ferreira, PCP
TI Genetic variability of HIV-1 isolates from Minas Gerais, Brazil
SO REVISTA DE MICROBIOLOGIA
LA English
DT Article
DE HIV-1; genome; PCR; AIDS; hemophiliacs
ID SUBTYPE-B
AB We report results of nucleotide sequencing and phylogenetic analysis of the env gene of 11 HIV-1 isolates, in Belo Horizonte, Brazil. Ten isolates belonged to HIV-1 subtype B and one was a probable B/F mosaic. This putative B/F recombinant is similar but not identical in its nucleotide sequence to other B/F mosaics described in Brazil.
C1 Fundacao Ctr Hematol & Hemoterapia Minas Gerais H, BR-30130110 Belo Horizonte, MG, Brazil.
RP Proietti, ABDC (corresponding author), Fundacao Ctr Hematol & Hemoterapia Minas Gerais H, Alameda Ezequiel Dias 321, BR-30130110 Belo Horizonte, MG, Brazil.
EM arraia@gold.com.br
RI CARVALHO, ALEX F/K-1947-2015; Carvalho, Aline/AAZ-5257-2020; Kroon,
   Erna/V-5444-2019; Kroon, Erna/B-3631-2015
OI Kroon, Erna/0000-0003-2721-3826; Barbosa-Stancioli,
   Edel/0000-0001-6584-4333
CR DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655
   LOUWAGIE J, 1994, AIDS RES HUM RETROV, V10, P561, DOI 10.1089/aid.1994.10.561
   LOUWAGIE J, 1995, J VIROL, V69, P263, DOI 10.1128/JVI.69.1.263-271.1995
   McKeating JA, 1996, J GEN VIROL, V77, P2905, DOI 10.1099/0022-1317-77-12-2905
   MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569
   MYERS G, 1994, AIDS RES HUM RETROV, V10, P1317, DOI 10.1089/aid.1994.10.1317
   SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994
   Sambrook J., 1989, MOL CLONING LAB MANU
   VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569
   1997, B EPIDEMIOLOGICO AID, V5, P31
NR 10
TC 2
Z9 2
U1 0
U2 0
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 0001-3714
J9 REV MICROBIOL
JI Rev. Microbiol.
PD APR-JUN
PY 1999
VL 30
IS 2
BP 141
EP 143
PG 3
WC Microbiology
SC Microbiology
GA 250VQ
UT WOS:000083410000010
OA Other Gold, Bronze
DA 2020-11-30
ER

PT J
AU da Fonseca, FG
   Silva, RLA
   Marques, JT
   Ferreira, PCP
   Kroon, EG
AF da Fonseca, FG
   Silva, RLA
   Marques, JT
   Ferreira, PCP
   Kroon, EG
TI The genome of cowpox virus contains a gene related to those encoding the
   epidermal growth factor, transforming growth factor alpha and vaccinia
   growth factor
SO VIRUS GENES
LA English
DT Article
DE cowpox virus; growth factor; VGF; CGF; cowpox gene; virokine
ID INTERLEUKIN-1-BETA CONVERTING-ENZYME; TUMORIGENIC POXVIRUS; SWINEPOX
   VIRUS; IMMUNE EVASION; MYXOMA VIRUS; PROTEIN; SEQUENCE; DNA; RECEPTOR;
   SERPIN
AB Cowpox virus (CPV) is a member of the Orthopoxvirus genus and has the genetic capacity to encode a multitude of genes that interfere with the host inflammatory and immune response or modulate the physiological state of infected and non-infected cells. Among these CPV factors are receptors homologous to interferon and tumor necrosis factor receptors and also a viral cellular serine-proteinase analog. Here we describe the detection of a CPV gene that encodes a protein homologous to epidermal growth factor, transforming growth factor alpha and poxvirus growth factors, such as the vaccinia growth factor (VGF). The VGF and other poxvirus growth factors are produced early in the infection and are secreted into the medium where they bind to the EGF receptors, generating mytotic responses. The cowpox growth factor (CGF) gene was detected in three copies on the virus genome by PCR, and by northern and southern blot hybridization using VGF nucleotide sequences as primers and probes. The CPV gene has a strong nucleotide and predicted amino acid similarity with VGF, and is also produced early in the infection.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 2496, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019; Marques, Joao T/F-7683-2012; Kroon, Erna
   Geessien/B-3631-2015
OI Marques, Joao T/0000-0002-3457-3320; Kroon, Erna
   Geessien/0000-0003-2721-3826
CR ALCAMI A, 1995, IMMUNOL TODAY, V16, P474, DOI 10.1016/0167-5699(95)80030-1
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   ARCHARD LC, 1984, J GEN VIROL, V65, P875, DOI 10.1099/0022-1317-65-5-875
   Bennett M, 1996, J MED MICROBIOL, V45, P157, DOI 10.1099/00222615-45-3-157
   BLOMQUIST MC, 1984, P NATL ACAD SCI-BIOL, V81, P7363, DOI 10.1073/pnas.81.23.7363
   BROWN JP, 1985, NATURE, V313, P491, DOI 10.1038/313491a0
   BULLER RML, 1988, VIROLOGY, V164, P162
   CHANG W, 1987, MOL CELL BIOL, V7, P535, DOI 10.1128/MCB.7.1.535
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DEFILIPPES FM, 1982, J VIROL, V43, P136, DOI 10.1128/JVI.43.1.136-149.1982
   Fenner F., 1989, The orthopoxviruses., P171
   GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2
   HU FQ, 1994, VIROLOGY, V204, P343, DOI 10.1006/viro.1994.1539
   JAMES R, 1984, ANNU REV BIOCHEM, V53, P259
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   KING CS, 1986, MOL CELL BIOL, V6, P332, DOI 10.1128/MCB.6.1.332
   KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331
   MASSUNG RF, 1991, VIROLOGY, V180, P347, DOI 10.1016/0042-6822(91)90039-E
   Massung RF, 1996, VIROLOGY, V221, P291, DOI 10.1006/viro.1996.0378
   MASSUNG RF, 1993, NATURE, V366, P748, DOI 10.1038/366748a0
   MASSUNG RF, 1993, VIROLOGY, V197, P511, DOI 10.1006/viro.1993.1625
   MASSUNG RF, 1994, VIROLOGY, V201, P215, DOI 10.1006/viro.1994.1288
   McFadden G, 1995, VIROCEPTORS VIROKINE, P1
   Miller CG, 1997, VIROLOGY, V229, P126, DOI 10.1006/viro.1996.8396
   MOSSMAN K, 1995, VIROLOGY, V208, P762, DOI 10.1006/viro.1995.1208
   OPGENORTH A, 1993, VIROLOGY, V192, P701, DOI 10.1006/viro.1993.1092
   PICKUP DJ, 1986, P NATL ACAD SCI USA, V83, P7698, DOI 10.1073/pnas.83.20.7698
   PICKUP DJ, 1984, P NATL ACAD SCI-BIOL, V81, P6817, DOI 10.1073/pnas.81.21.6817
   QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377
   RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y
   REISNER AH, 1985, NATURE, V313, P801, DOI 10.1038/313801a0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHULTZ GS, 1987, SCIENCE, V235, P350, DOI 10.1126/science.3492044
   Senkevich TG, 1996, SCIENCE, V273, P813, DOI 10.1126/science.273.5276.813
   SMITH GL, 1991, J GEN VIROL, V72, P511, DOI 10.1099/0022-1317-72-3-511
   Smith GL, 1996, CURR OPIN IMMUNOL, V8, P467, DOI 10.1016/S0952-7915(96)80032-X
   Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x
   SMITH GL, 1993, J GEN VIROL, V74, P1725, DOI 10.1099/0022-1317-74-9-1725
   SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F
   STROOBANT P, 1985, CELL, V42, P383, DOI 10.1016/S0092-8674(85)80133-1
   SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4
   TEWARI M, 1995, J BIOL CHEM, V270, P22705, DOI 10.1074/jbc.270.39.22705
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   UPTON C, 1987, J VIROL, V61, P1271, DOI 10.1128/JVI.61.4.1271-1275.1987
   UPTON C, 1991, VIROLOGY, V184, P370, DOI 10.1016/0042-6822(91)90853-4
   VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569
   VENKATESAN S, 1982, J VIROL, V44, P637, DOI 10.1128/JVI.44.2.637-646.1982
   VONHERRATH MG, 1995, TRENDS MICROBIOL, V3, P424, DOI 10.1016/S0966-842X(00)88995-7
NR 48
TC 15
Z9 15
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0920-8569
J9 VIRUS GENES
JI Virus Genes
PD APR
PY 1999
VL 18
IS 2
BP 151
EP 160
DI 10.1023/A:1008072720217
PG 10
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA 203ZB
UT WOS:000080737100007
PM 10403701
DA 2020-11-30
ER

PT J
AU Franco, GR
   de Carvalho, AF
   Kroon, EG
   Lovagie, S
   Werenne, J
   Golgher, RR
   Ferreira, PCP
   Bonjardim, CA
AF Franco, GR
   de Carvalho, AF
   Kroon, EG
   Lovagie, S
   Werenne, J
   Golgher, RR
   Ferreira, PCP
   Bonjardim, CA
TI Biological activities of a human amniotic membrane interferon
SO PLACENTA
LA English
DT Article
ID CONSTITUTIVE EXPRESSION; ALPHA-INTERFERONS; PROTEIN-KINASE;
   BETA-INTERFERONS; GENE-EXPRESSION; ANTIVIRAL STATE; MESSENGER-RNAS;
   VIRUS; CELLS; RESISTANCE
AB In order to characterize further the human amniotic membrane interferon (IFN-AM), an interferon antigenically unrelated to human IFN-alpha, -beta, and -gamma or TNF, we analysed its biological activities. Here, we present direct evidence of its ability to affect cell growth and to induce the IFN-stimulated genes (ISGs) 6-16 and 2'-5' oligoadenylate synthetase (OAS), in addition to its crossed anti-viral activity. The cellular growth arrest effect of IFN-AM was dose-dependent and paralleled that of IFN-beta. IFN-AM was also able to inhibit thymidine incorporation into DNA, similar to IFN-beta. The mRNA induction of 6-16 gene with IFN-AM treatment reached its highest level at 500 IU/ml and remained constant up to 2000 IU/ml. Conversely, 2'-5' OAS mRNA induction was dose-dependent, with the maximum level detected at 2000 IU/ml of IFN-AM treatment. The time course of mRNA accumulation by ISGs with IFN-AM (500 IU/ml) stimulation was also investigated. Gene induction reached a maximum at 16 h after IFN treatment for 2'-5' OAS and at 48 h for the 6-16 gene. IFN-AM and human IFN-alpha induced similar levels of the OAS enzyme. IFN-AM also showed small but significant activity in bovine cells.
   In conclusion, the amniotic membrane IFN here studied showed both anti-cellular activity and the ability to stimulate ISG-transcriptional activation in a similar manner to IFN-beta. In addition, IFN-AM was also as able to induce the expression of the enzyme 2'-5' GAS, as did IFN-alpha. Lastly, amniotic IFN showed a significant cross-species anti-viral activity, which was different from both human IFN-alpha and -beta. Taken together, these data strongly suggest that IFN-AM is a novel sub-type I IFN.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   Free Univ Brussels, Brussels, Belgium.
   Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
RP Franco, GR (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Bloco F4-258,Av Antonio Carlos 6627,Campus Pampul, BR-31270901 Belo Horizonte, MG, Brazil.
EM claubonj@mono.icb.ufmg.br
RI Franco, Gloria/I-3654-2013; Bonjardim, Claudio A/J-2601-2014; Kroon,
   Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015; CARVALHO, ALEX
   F/K-1947-2015
OI Franco, Gloria/0000-0001-5245-2365; Kroon, Erna
   Geessien/0000-0003-2721-3826; 
CR ADOLF GR, 1987, J GEN VIROL, V68, P1669, DOI 10.1099/0022-1317-68-6-1669
   Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x
   Carvalho AF, 1998, PLACENTA, V19, P307, DOI 10.1016/S0143-4004(98)90063-7
   CHEBATH J, 1987, NATURE, V330, P587, DOI 10.1038/330587a0
   Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x
   CONSTANTOULAKIS P, 1993, SCIENCE, V259, P1314, DOI 10.1126/science.7680491
   CREASEY AA, 1983, MOL CELL BIOL, V3, P780, DOI 10.1128/MCB.3.5.780
   DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455
   De Maeyer E, 1988, INTERFERONS OTHER RE, P134
   DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616
   DUCGOIRAN P, 1983, P NATL ACAD SCI-BIOL, V80, P2628, DOI 10.1073/pnas.80.9.2628
   DUCGOIRAN P, 1985, P NATL ACAD SCI USA, V82, P5010, DOI 10.1073/pnas.82.15.5010
   DUCGOIRAN P, 1989, J BIOL CHEM, V264, P16507
   DUCKWORTHRYSIEC.G, 1989, J INTERFERON RES, V9, P649
   FARIN CE, 1990, BIOL REPROD, V43, P210, DOI 10.1095/biolreprod43.2.210
   FERREIRA PCP, 1991, BRAZ J MED BIOL RES, V24, P21
   FERREIRA PCP, 1981, ARCH VIROL, V68, P27, DOI 10.1007/BF01315164
   FERREIRA PCP, 1979, J CLIN MICROBIOL, V9, P471
   FRESHNEY RI, 1987, CULTURE ANIMAL CELLS, P397
   FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8
   Horvath CM, 1996, J VIROL, V70, P647, DOI 10.1128/JVI.70.1.647-650.1996
   HOVANESSIAN AG, 1991, J INTERFERON RES, V11, P199, DOI 10.1089/jir.1991.11.199
   KELLY JM, 1985, EUR J BIOCHEM, V153, P367, DOI 10.1111/j.1432-1033.1985.tb09312.x
   KELLY JM, 1986, EMBO J, V5, P1601, DOI 10.1002/j.1460-2075.1986.tb04402.x
   KESSLER DS, 1988, EMBO J, V7, P3779, DOI 10.1002/j.1460-2075.1988.tb03262.x
   Leaman DW, 1996, FASEB J, V10, P1578
   Martal J, 1997, REPROD FERT DEVELOP, V9, P355, DOI 10.1071/R96083
   MAZA LMO, 1983, J INTERFERON RES, V3, P359
   Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X
   NOVO MAD, 1988, REV MICROBIOL, V19, P190
   Oliveira JG, 1997, PLACENTA, V18, P163, DOI 10.1016/S0143-4004(97)90088-6
   Patterson M K Jr, 1979, Methods Enzymol, V58, P141
   PAVLOVIC J, 1995, J VIROL, V69, P4506, DOI 10.1128/JVI.69.7.4506-4510.1995
   PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.bi.56.070187.003455
   PFEFFER LM, 1983, J INTERFERON RES, V3, P395, DOI 10.1089/jir.1983.3.395
   PINE R, 1992, J VIROL, V66, P4470, DOI 10.1128/JVI.66.7.4470-4478.1992
   REIS LFL, 1989, J INTERFERON RES, V9, P573, DOI 10.1089/jir.1989.9.573
   ROBERTS RM, 1990, J REPROD FERTIL, P63
   Roberts RM, 1996, J INTERF CYTOK RES, V16, P271, DOI 10.1089/jir.1996.16.271
   RUBIN BY, 1980, P NATL ACAD SCI-BIOL, V77, P5928, DOI 10.1073/pnas.77.10.5928
   Sambrook J., 1987, MOL CLONING LAB MANU
   SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O
   SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201
   STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9
   Stark G R, 1981, Methods Enzymol, V79, P194
   STEWART WE, 1981, INTERFERON SYSTEM
   UZE G, 1995, J INTERF CYTOK RES, V15, P3, DOI 10.1089/jir.1995.15.3
   VILCEK J, 1996, VIROLOGY, P375
   WHALEY AE, 1994, J BIOL CHEM, V269, P10864
   Williams B R, 1981, Methods Enzymol, V79, P199
   Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x
   ZDRAVKOVIC M, 1994, PLACENTA, V15, P591, DOI 10.1016/S0143-4004(05)80406-0
NR 54
TC 12
Z9 13
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD MAR-APR
PY 1999
VL 20
IS 2-3
BP 189
EP 196
DI 10.1053/plac.1998.0364
PG 8
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 176YQ
UT WOS:000079180300010
PM 10195741
DA 2020-11-30
ER

PT J
AU Pakker, NG
   Kroon, EDMB
   Roos, MTL
   Otto, SA
   Hall, D
   Wit, FWNM
   Hamann, D
   van der Ende, ME
   Claessen, FAP
   Kauffmann, RH
   Koopmans, PP
   Kroon, FP
   ten Napel, CHH
   Sprenger, HG
   Weigel, HM
   Montaner, JSG
   Lange, JMA
   Reiss, P
   Schellekens, PTA
   Miedema, F
AF Pakker, NG
   Kroon, EDMB
   Roos, MTL
   Otto, SA
   Hall, D
   Wit, FWNM
   Hamann, D
   van der Ende, ME
   Claessen, FAP
   Kauffmann, RH
   Koopmans, PP
   Kroon, FP
   ten Napel, CHH
   Sprenger, HG
   Weigel, HM
   Montaner, JSG
   Lange, JMA
   Reiss, P
   Schellekens, PTA
   Miedema, F
CA INCAS Study Grp
TI Immune restoration does not invariably occur following long-term HIV-1
   suppression during antiretroviral therapy
SO AIDS
LA English
DT Article
DE long-term immune reconstitution; antiretroviral therapy; viral
   suppression
ID VIRUS TYPE-1 RNA; COMBINATION THERAPY; ZIDOVUDINE MONOTHERAPY; INFECTED
   PATIENTS; CONTROLLED TRIAL; CELL COUNTS; NEVIRAPINE; ADULTS; DIDANOSINE;
   SURVIVAL
AB Background: Current antiretroviral treatment can induce significant and sustained virological and immunological responses in HIV-1-infected persons over at least the short- to mid-term.
   Objectives: In this study, long-term immune reconstitution was investigated during highly active antiretroviral therapy.
   Methods: Patients enrolled in the INCAS study in The Netherlands were treated for 102 weeks (range 52-144 weeks) with nevirapine (NVP) + zidovudine (ZDV) (n = 9), didanosine (ddl) + ZDV (n 10), or NVP + ddl + ZDV (n = 10). Memory and naive CD4+ and CD8+ T cells were measured using CD45RA and CD27 monoclonal antibodies (mAb), T-cell function was assayed by CD3 + CD28 mAb stimulation, and plasma HIV-1 RNA load was measured by ultra-direct assay (cut-off < 20 copies/ml).
   Results: Compared to both double combination regimens the triple combination regimen resulted in the most sustained increase in CD4+ T cells (change in CD4+ + 253 x 10(6) cells/l; standard error, 79 x 10(6) cells/l) and reduction of plasma HIV-1 RNA. In nine patients (31%) (ddl + ZDV, n = 2; NVP + ddl + ZDV, n = 7) plasma HIV-1 RNA levels remained below cut-off for at least 2 years. On average, these long-term virological responders demonstrated a significantly higher increase of naive and memory CD4+ T cells (P = 0.01 and 0.02, respectively) as compared with patients with a virological failure, and showed improved T-cell function and normalization of the naive: memory CD8+ T-cell ratio. However, individual virological success or failure did not predict the degree of immunological response. T-cell patterns were independent of baseline CD4+ T-cell count, T-cell Function, HIV-1 RNA load or age. Low numbers of naive CD4+ T cells at baseline resulted in modest long-term naive T-cell recovery
   Conclusions: Patients with prolonged undetectable plasma HIV-1 RNA levels during antiretroviral therapy do not invariably show immune restoration. Naive T-cell recovery in the setting of complete viral suppression is a gradual process, similar to that reported for immune recovery in adults after chemotherapy and bone marrow transplantation. (C) 1999 Lippincott WiiIiams & Wilkins.
C1 Univ Amsterdam, Clin & Expt Immunol Lab, Dept Clin Viroimmunol, CLB,Sanquin Blood Supply Fdn, NL-1066 CX Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Natl AIDS Therapy Evaluat Ctr, NL-1105 AZ Amsterdam, Netherlands.
   Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA.
   Univ Hosp Dijkzigt, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands.
   Free Univ Amsterdam Hosp, Dept Internal Med, Amsterdam, Netherlands.
   Leijenburg Hosp, Dept Internal Med, The Hague, Netherlands.
   Univ Nijmegen St Radboud Hosp, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands.
   Univ Leiden Hosp, Dept Infect Dis, NL-2300 RC Leiden, Netherlands.
   Med Spectrum Twente, Dept Internal Med, Enschede, Netherlands.
   Univ Groningen Hosp, Dept Internal Med, NL-9713 EZ Groningen, Netherlands.
   Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands.
   Univ British Columbia, St Pauls Hosp, Canadian HIV Trials Network, Vancouver, BC V5Z 1M9, Canada.
   Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands.
RP Miedema, F (corresponding author), Univ Amsterdam, Clin & Expt Immunol Lab, Dept Clin Viroimmunol, CLB,Sanquin Blood Supply Fdn, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.
RI Kroon, Erna/V-5444-2019; Wit, Ferdinand/AAC-3803-2019
CR [Anonymous], 1996, Lancet, V348, P283
   Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112
   BINDELS PJE, 1995, J INFECT DIS, V172, P97, DOI 10.1093/infdis/172.1.97
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8
   BLOEMENA E, 1989, J IMMUNOL METHODS, V122, P161, DOI 10.1016/0022-1759(89)90260-3
   Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003
   Carr A, 1996, AIDS, V10, P635, DOI 10.1097/00002030-199606000-00009
   Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1
   Cohen J, 1998, SCIENCE, V279, P1133, DOI 10.1126/science.279.5354.1133
   CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0
   DAquila RT, 1996, ANN INTERN MED, V124, P1019, DOI 10.7326/0003-4819-124-12-199606150-00001
   deJong MD, 1997, J INFECT DIS, V175, P966, DOI 10.1086/514002
   Gorochov G, 1998, NAT MED, V4, P215, DOI 10.1038/nm0298-215
   Graham NMH, 1996, ANN INTERN MED, V124, P1031, DOI 10.7326/0003-4819-124-12-199606150-00002
   Hakim FT, 1997, BLOOD, V90, P3789, DOI 10.1182/blood.V90.9.3789
   Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407
   Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501
   HAVLIR D, 1995, J INFECT DIS, V172, P1379, DOI 10.1093/infdis/172.5.1379
   Kaufmann D, 1998, LANCET, V351, P723, DOI 10.1016/S0140-6736(98)24010-4
   Kelleher AD, 1996, J INFECT DIS, V173, P321, DOI 10.1093/infdis/173.2.321
   KOOT M, 1993, J INFECT DIS, V168, P733, DOI 10.1093/infdis/168.3.733
   Levitz SM, 1998, NEW ENGL J MED, V338, P1074, DOI 10.1056/NEJM199804093381517
   Li TS, 1998, LANCET, V351, P1682, DOI 10.1016/S0140-6736(97)10291-4
   MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303
   McCune JM, 1998, J CLIN INVEST, V101, P2301, DOI 10.1172/JCI2834
   Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930
   Mulder J, 1997, J CLIN MICROBIOL, V35, P1278, DOI 10.1128/JCM.35.5.1278-1280.1997
   MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994
   PAKER NMG, 1997, J AIDS HUM RETROVIRO, V16, P318
   Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208
   Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5
   RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994
   Roberts NA, 1998, AIDS, V12, P453, DOI 10.1097/00002030-199805000-00005
   ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892
   Roos MTL, 1998, AIDS, V12, P1745, DOI 10.1097/00002030-199814000-00005
   Schooley RT, 1996, J INFECT DIS, V173, P1354, DOI 10.1093/infdis/173.6.1354
   Weverling GJ, 1998, AIDS, V12, pF117, DOI 10.1097/00002030-199811000-00003
NR 37
TC 83
Z9 84
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD FEB 4
PY 1999
VL 13
IS 2
BP 203
EP 212
DI 10.1097/00002030-199902040-00008
PG 10
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 177EL
UT WOS:000079195900008
PM 10202826
DA 2020-11-30
ER

PT J
AU Campos, MAS
   Kroon, EG
   Gentz, R
   Ferreira, PCP
AF Campos, MAS
   Kroon, EG
   Gentz, R
   Ferreira, PCP
TI Protein domains involved in nuclear transport of Fos
SO CELL BIOLOGY INTERNATIONAL
LA English
DT Article
DE Fos intracellular localization; domains of Fos; protein translocation;
   proto-oncogene; transcription factor
ID DNA-BINDING DOMAINS; SV40 T-ANTIGEN; C-FOS; TRANSCRIPTION FACTOR;
   PHOSPHORYLATION; KINASE; IMPORT; JUN; LOCALIZATION; EXPRESSION
AB The protein encoded by the proto-oncogene c-fos is constitutively nuclear in most cell types analyzed. It has a predicted molecular weight of about 55 kDa. Proteins with a molecular weight above 40 kDa cannot enter the nucleus passively. Our interest was to study which regions in the protein are involved in the nuclear transport. We prepared a series of deletions and point mutations of the protein and cloned the mutated genes into a eukaryotic expression vector. Cos-l cells were used to express the mutants transiently. Using indirect immunofluorescence we studied the subcellular localization, analyzing the percentage of cells containing the protein in the nucleus, the cytoplasm, of both locations. Our studies showed that the Fos protein contains several regions which can act independently to translocate the protein into the nucleus. (C) 1999 Academic Press.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   Human Genome Sci Inc, Dept Prot Dev, Rockville, MD USA.
RP Ferreira, PCP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Arenida Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna Geessien/B-3631-2015; Campos, Marco A/C-4000-2013; Kroon,
   Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Campos, Marco
   A/0000-0003-4683-0176; 
CR ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032
   BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349
   CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952
   CHIDA K, 1992, P NATL ACAD SCI USA, V89, P4290, DOI 10.1073/pnas.89.10.4290
   COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063
   COHEN PT, 1989, AIDS CLIN CARE, V1, P1
   CURRAN T, 1987, ONCOGENE, V2, P79
   Curran T, 1988, ONCOGENE HDB, P307
   DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0
   GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702
   GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8
   Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7
   Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513
   GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0
   HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6
   Hurt EC, 1996, CELL, V84, P509, DOI 10.1016/S0092-8674(00)81026-0
   JANS DA, 1995, J BIOL CHEM, V270, P17064, DOI 10.1074/jbc.270.29.17064
   JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203
   KALDERON D, 1984, VIROLOGY, V139, P109, DOI 10.1016/0042-6822(84)90334-9
   KERPPOLA T, 1995, NATURE, V373, P199, DOI 10.1038/373199a0
   Koepp DM, 1996, CELL, V87, P1, DOI 10.1016/S0092-8674(00)81315-X
   LEWIN B, 1997, GENES 6, V10, P243
   MICHAUD N, 1991, J CELL BIOL, V112, P215, DOI 10.1083/jcb.112.2.215
   MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I
   MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0
   OFIR R, 1990, NATURE, V348, P80, DOI 10.1038/348080a0
   Oliveira JG, 1997, PLACENTA, V18, P163, DOI 10.1016/S0143-4004(97)90088-6
   PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925
   RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x
   ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771
   ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D
   Sambrook J., 1989, MOL CLONING LAB MANU
   STACHOWIAK MK, 1990, ONCOGENE, V5, P69
   TRATNER I, 1991, ONCOGENE, V6, P2049
   Vandromme M, 1996, TRENDS BIOCHEM SCI, V21, P59, DOI 10.1016/0968-0004(96)80867-X
NR 35
TC 5
Z9 5
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1065-6995
EI 1095-8355
J9 CELL BIOL INT
JI Cell Biol. Int.
PY 1999
VL 23
IS 1
BP 81
EP 88
DI 10.1006/cbir.1998.0323
PG 8
WC Cell Biology
SC Cell Biology
GA 251BE
UT WOS:000083424100010
PM 10527550
DA 2020-11-30
ER

PT J
AU Thorsteinsdottir, U
   Krosl, J
   Baban, S
   Kroon, E
   Sauvageau, G
AF Thorsteinsdottir, U
   Krosl, J
   Baban, S
   Kroon, E
   Sauvageau, G
TI Hoxa-9 but not Hoxb-3 collaborates with E2A-Pbx1a to transform primary
   bone marrow cells.
SO BLOOD
LA English
DT Meeting Abstract
C1 Univ Montreal, Maisonneuve Rosemont Hosp, Inst Rech Clin Montreal, Div Hematol, Montreal, PQ, Canada.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 15
PY 1998
VL 92
IS 10
SU 1
MA 1980
BP 480A
EP 480A
PN 1
PG 1
WC Hematology
SC Hematology
GA 141AW
UT WOS:000077121301970
DA 2020-11-30
ER

PT J
AU Ruxrungtham, K
   Kroon, EDMB
   Ungsedhapand, C
   Teeratakulpisarn, S
   Ubolyam, S
   van Leeuwen, R
   Buranapraditkun, S
   Sirivichayakul, S
   Lange, JMA
   Cooper, DA
   Phanuphak, P
AF Ruxrungtham, K
   Kroon, EDMB
   Ungsedhapand, C
   Teeratakulpisarn, S
   Ubolyam, S
   van Leeuwen, R
   Buranapraditkun, S
   Sirivichayakul, S
   Lange, JMA
   Cooper, DA
   Phanuphak, P
TI A randomized, open-label study to explore the antiretroviral efficacy
   and tolerability of immediate switching to therapy with AZT/3TC versus
   continuing ddI/d4T and deferred switching to AZT/3TC in Thai HIV-1
   infected population pretreated with ddI/d4T.
SO AIDS
LA English
DT Meeting Abstract
C1 Thai Red Cross, AIDS Res Ctr, HIV Netherlands Australia Thailand Collaborat, Bangkok 10330, Thailand.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA
SN 0269-9370
J9 AIDS
JI Aids
PD NOV
PY 1998
VL 12
SU 4
MA P317
BP S97
EP S97
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 144JP
UT WOS:000077311300379
DA 2020-11-30
ER

PT J
AU Ungsedhapand, C
   Kroon, EDMB
   Suwannagool, S
   Ruxrungtham, K
   Newell, M
   Yinsuan, N
   Sonjai, A
   Ubolyam, S
   Weverling, GW
   Buranapraditkun, S
   Tiengrim, S
   Sirivichayakul, S
   Kunanusont, C
   Lange, JMA
   Cooper, DA
   Phanuphak, P
AF Ungsedhapand, C
   Kroon, EDMB
   Suwannagool, S
   Ruxrungtham, K
   Newell, M
   Yinsuan, N
   Sonjai, A
   Ubolyam, S
   Weverling, GW
   Buranapraditkun, S
   Tiengrim, S
   Sirivichayakul, S
   Kunanusont, C
   Lange, JMA
   Cooper, DA
   Phanuphak, P
CA HIV Netherlands Australia Thailand Res Collabor
TI A randomized, open-label, comparative trial of AZT/3TC versus
   AZT/3TC/ddI in antiretroviral naive HIV-1 infected Thai patients.
SO AIDS
LA English
DT Meeting Abstract
C1 Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Collaborat, Bangkok 10330, Thailand.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA
SN 0269-9370
J9 AIDS
JI Aids
PD NOV
PY 1998
VL 12
SU 4
MA P316
BP S96
EP S96
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 144JP
UT WOS:000077311300378
DA 2020-11-30
ER

PT J
AU Sauvageau, G
   Kroon, E
   Lessard, J
   Krosl, J
   Humphries, RK
   Thorsteinsdottir, U
AF Sauvageau, G
   Kroon, E
   Lessard, J
   Krosl, J
   Humphries, RK
   Thorsteinsdottir, U
TI Developmental genes and hemopoietic stem cells.
SO EXPERIMENTAL HEMATOLOGY
LA English
DT Meeting Abstract
C1 Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.
   British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.
RI Kroon, Erna/V-5444-2019
OI Sauvageau, Guy/0000-0002-4333-7266
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CARDEN JENNINGS PUBL CO LTD
PI CHARLOTTESVILLE
PA BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903 USA
SN 0301-472X
J9 EXP HEMATOL
JI Exp. Hematol.
PD AUG
PY 1998
VL 26
IS 8
MA 8
BP 682
EP 682
PG 1
WC Hematology; Medicine, Research & Experimental
SC Hematology; Research & Experimental Medicine
GA 118GT
UT WOS:000075830600010
DA 2020-11-30
ER

PT J
AU Thorsteinsdottir, U
   Kroon, E
   Humphries, RK
   Sauvageau, G
AF Thorsteinsdottir, U
   Kroon, E
   Humphries, RK
   Sauvageau, G
TI Overexpression of Hoxa9 enhances the proliferative potential of
   hematopoietic cells and is highly leukemogenic
SO EXPERIMENTAL HEMATOLOGY
LA English
DT Meeting Abstract
C1 Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.
   British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.
RI Kroon, Erna/V-5444-2019
NR 0
TC 1
Z9 1
U1 0
U2 0
PU CARDEN JENNINGS PUBL CO LTD
PI CHARLOTTESVILLE
PA BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903 USA
SN 0301-472X
J9 EXP HEMATOL
JI Exp. Hematol.
PD AUG
PY 1998
VL 26
IS 8
MA 437
BP 801
EP 801
PG 1
WC Hematology; Medicine, Research & Experimental
SC Hematology; Research & Experimental Medicine
GA 118GT
UT WOS:000075830600439
DA 2020-11-30
ER

PT J
AU Carvalho, AF
   Santos, JR
   Gentz, R
   Bonjardim, CA
   Golgher, RR
   Ferreira, PCP
   Kroon, EG
AF Carvalho, AF
   Santos, JR
   Gentz, R
   Bonjardim, CA
   Golgher, RR
   Ferreira, PCP
   Kroon, EG
TI Culture of human amniotic cells: A system to study interferon production
SO PLACENTA
LA English
DT Article
ID HUMAN FIBROBLAST INTERFERON; MESSENGER-RNA; ALPHA-INTERFERON;
   ESCHERICHIA-COLI; EXPRESSION; GENES; VIRUS; BETA; LOCALIZATION;
   MEMBRANES
AB This study investigated whether primary culture of human amniotic membrane cells (PCHAM) could be used as an in vitro model system for the study of interferon (IFN) production. PCHAM cells infected with Newcastle disease virus (NDV) produced the two antigenic types of IFN, previously shown in a amniotic membrane cells (HAM) system. PCHAM IFN was detected as early as 2 h after NDV infection and was composed by two antigenically distinct fractions, one neutralized with anti-HuIFN beta antibody and another that is not related to IFN beta, -alpha and -gamma. These fractions correspond respectively to 80 and 20 per cent of the IFN produced 4 h after virus induction, 55 and 45 per cent of the IFN produced from 4 to 12 h and 67 and 33 per cent of the IFN produced 12 h after virus induction. A cDNA library, established from PCHAM with or without NDV infection, was screened for IFN alpha and -beta using specific primers. The PCR product, amplified by IFN beta primers, was cloned, sequenced and expressed in Escherichia coli M15. The sequences of several cloned cDNAs were identical to HuIFN beta gene and the antiviral activity of the expressed protein was neutralized only by anti HuIFN-beta antibody. The other IFN fraction not neutralized by polyclonal antibodies anti-IFN beta, -alpha and -gamma is now being studied. (C) 1998 W. B. Saunders Company Ltd.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   Human Genome Sci Inc, Rockville, MD USA.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@mono.icb.ufmg.br
RI Bonjardim, Claudio A/J-2601-2014; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015; CARVALHO, ALEX F/K-1947-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR ABOAGYEMATHIESEN G, 1990, J GEN VIROL, V71, P3061, DOI 10.1099/0022-1317-71-12-3061
   BERGER SL, 1975, P NATL ACAD SCI USA, V72, P3873, DOI 10.1073/pnas.72.10.3873
   BITTNER M, 1980, ANAL BIOCHEM, V102, P459, DOI 10.1016/0003-2697(80)90182-7
   CAVALIERI RL, 1977, P NATL ACAD SCI USA, V74, P4415, DOI 10.1073/pnas.74.10.4415
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CROSS JC, 1991, P NATL ACAD SCI USA, V88, P3817, DOI 10.1073/pnas.88.9.3817
   DUCGOIRAN P, 1983, P NATL ACAD SCI-BIOL, V80, P2628, DOI 10.1073/pnas.80.9.2628
   DUCGOIRAN P, 1985, P NATL ACAD SCI USA, V82, P5010, DOI 10.1073/pnas.82.15.5010
   DUCGOIRAN P, 1989, J BIOL CHEM, V264, P16507
   FERREIRA PCP, 1991, BRAZ J MED BIOL RES, V24, P21
   FERREIRA PCP, 1979, J CLIN MICROBIOL, V9, P471
   FOURNIER F, 1967, J IMMUNOL, V99, P1036
   FOWLER AK, 1980, NATURE, V286, P266, DOI 10.1038/286266a0
   Golgher RR, 1996, BRAZ J MED BIOL RES, V29, P1317
   GROSS G, 1982, FEBS LETT, V139, P201, DOI 10.1016/0014-5793(82)80851-X
   GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5
   IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0
   Innis M. A., 1990, PCR PROTOCOLS GUIDE, P3
   JOKLIK WK, 1990, VIROLOGY, P383
   KINGSBURY DW, 1970, VIROLOGY, V42, P872, DOI 10.1016/0042-6822(70)90336-3
   KLEIN F, 1984, APPL ENVIRON MICROB, V47, P1023, DOI 10.1128/AEM.47.5.1023-1026.1984
   KROON EG, 1990, REV MICROBIOL, V21, P121
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEBON P, 1982, J GEN VIROL, V59, P393, DOI 10.1099/0022-1317-59-2-393
   NAGATA S, 1980, NATURE, V284, P316, DOI 10.1038/284316a0
   OCA HM, 1973, TISSUE CULTURE METHO, P8
   OHNO S, 1981, P NATL ACAD SCI-BIOL, V78, P5305, DOI 10.1073/pnas.78.9.5305
   OKITA JR, 1983, IN VITRO CELL DEV B, V19, P117
   Oliveira JG, 1997, PLACENTA, V18, P163, DOI 10.1016/S0143-4004(97)90088-6
   POINDRON P, 1981, METHODS ENZYMOLOGY A, P165
   RAJ NBK, 1981, P NATL ACAD SCI-BIOL, V78, P7426, DOI 10.1073/pnas.78.12.7426
   REIS LFL, 1989, J INTERFERON RES, V9, P573, DOI 10.1089/jir.1989.9.573
   ROBERTS RM, 1990, OXFORD REV REPROD B, V12, P147
   RYAN AM, 1992, MAMM GENOME, V3, P575, DOI 10.1007/BF00350624
   Sambrook J., 1989, MOL CLONING LAB MANU
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SEHGAL PB, 1980, NATURE, V288, P95, DOI 10.1038/288095a0
   SORRENTINO V, 1982, J GEN VIROL, V63, P509, DOI 10.1099/0022-1317-63-2-509
   STUBER D, 1990, IMMUNOLOGICAL METHOD, V4, P121
   TANIGUCHI T, 1980, P NATL ACAD SCI-BIOL, V77, P5230, DOI 10.1073/pnas.77.9.5230
   TANIGUCHI T, 1980, P NATL ACAD SCI-BIOL, V77, P4003, DOI 10.1073/pnas.77.7.4003
   TOTH FD, 1990, J GEN VIROL, V71, P3067, DOI 10.1099/0022-1317-71-12-3067
   UTSUMI J, 1992, INTERFERON PRINCIPLE, P107
   VELAN B, 1985, J BIOL CHEM, V260, P5498
   VILCEK J, 1996, VIROLOGY, P375
   WHALEY AE, 1994, J BIOL CHEM, V269, P10864
   WHITTEMORE LA, 1990, MOL CELL BIOL, V10, P1329, DOI 10.1128/MCB.10.4.1329
   ZITCER EM, 1955, SCIENCE, V122, P30, DOI 10.1126/science.122.3157.30
NR 48
TC 7
Z9 7
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD MAY
PY 1998
VL 19
IS 4
BP 307
EP 314
DI 10.1016/S0143-4004(98)90063-7
PG 8
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA ZP581
UT WOS:000073767800010
PM 9639327
DA 2020-11-30
ER

PT J
AU Nogueira, ML
   Carvalho, AF
   Barbosa, EF
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Nogueira, ML
   Carvalho, AF
   Barbosa, EF
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
TI Diagnosis of mucocutaneous herpetic infections by PCR without DNA
   extraction
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE herpesvirus; diagnosis; PCR
C1 UFMG, ICB, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), UFMG, ICB, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019; CARVALHO, ALEX F/K-1947-2015; Nogueira,
   Mauricio L/B-7599-2012; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015
OI Nogueira, Mauricio L/0000-0003-1102-2419; Kroon, Erna
   Geessien/0000-0003-2721-3826; Barbosa-Stancioli,
   Edel/0000-0001-6584-4333
NR 0
TC 5
Z9 7
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAR-APR
PY 1998
VL 93
IS 2
BP 213
EP 214
DI 10.1590/S0074-02761998000200015
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA ZC352
UT WOS:000072569200015
PM 9698896
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Barbosa, EF
   Carneiro-Proietti, ABF
   Oliveira, DR
   Lima-Martins, MV
   Kroon, EG
   Ferreira, PCP
AF Barbosa, EF
   Carneiro-Proietti, ABF
   Oliveira, DR
   Lima-Martins, MV
   Kroon, EG
   Ferreira, PCP
TI HIV-1 detection and subtyping by PCR and heteroduplex mobility assay in
   blood donors: Can these tests help to elucidate conflicting serological
   Results?
SO TRANSFUSION SCIENCE
LA English
DT Article
ID TYPE-1 STRAINS; GENES
AB Testing blood donors for the human immunodeficiency viruses (HIV-1 and 2), requires serological tests that are frequently inconclusive. Peripheral blood mononuclear cells of 50 blood donors with the screening test (ELISA) reactive to HIV-1, but with indeterminate results in the first Western Blot (WB) performed, were submitted to the polymerase chain reaction (PCR) and heteroduplex mobility assay (HMA), a nonsequencing method that can distinguish between HIV-1 subtypes (A to I). PCR amplification of HIV-1 env gene regions has been obtained in 12 (24.0%) samples. HMA of the amplified DNA showed that 12 belonged to HIV-1 B subtype and one to F subtype. PCR testing of the amplified DNA helped to elucidate doubtful serological results and HMA proved to be a relatively simple and rapid way of subtyping HIV-1 for epidemiological purposes. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
C1 Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Barbosa, EF (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Avenida Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Barbosa-Stancioli,
   Edel/0000-0001-6584-4333
CR BACHMANN MH, 1994, AIDS RES HUM RETROV, V10, P1345, DOI 10.1089/aid.1994.10.1345
   CONSTANTINE NT, 1993, AIDS, V7, P1, DOI 10.1097/00002030-199301000-00001
   DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655
   DELWART EL, 1995, PCR STRATEGIES 1995
   DELWART EL, 1995, PCR METH APPL, P5202
   KNUVERHOPF J, 1993, VOX SANG, V64, P89
   KOSTRIKIS LG, 1995, J VIROL, V69, P6122, DOI 10.1128/JVI.69.10.6122-6130.1995
   LEE TH, 1991, AIDS, V5, P683, DOI 10.1097/00002030-199106000-00007
   Menitove JE, 1996, SEMIN HEMATOL, V33, P290
   MYERS G, 1993, HUMAN RETROVIRUSES A
   PERRIN LH, 1990, BLOOD, V3, P641
   Sharp P.M., 1994, AIDS S1, V8, pS27
   *WHO, 1995, GUID STAND HIV IS PR
NR 13
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0955-3886
J9 TRANSFUS SCI
JI Transfus. Sci.
PD MAR
PY 1998
VL 19
IS 1
BP 39
EP 43
DI 10.1016/S0955-3886(98)00008-3
PG 5
WC Hematology
SC Hematology
GA ZV874
UT WOS:000074350400007
PM 10182182
DA 2020-11-30
ER

PT J
AU Fonseca, FG
   Lanna, MCS
   Campos, MAS
   Kitajima, EW
   Peres, JN
   Golgher, RR
   Ferreira, PCP
   Kroon, EG
AF Fonseca, FG
   Lanna, MCS
   Campos, MAS
   Kitajima, EW
   Peres, JN
   Golgher, RR
   Ferreira, PCP
   Kroon, EG
TI Morphological and molecular characterization of the poxvirus BeAn 58058
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID TRANSFORMING GROWTH-FACTOR; VIRUS THYMIDINE KINASE; VACCINIA VIRUS;
   FACTOR-ALPHA; NUCLEOTIDE-SEQUENCE; MYXOMA VIRUS; DNA; GENOME; GENE;
   ORTHOPOXVIRUSES
AB BeAn 58058 virus (BAV) was isolated from an Oryzomis rodent in Brazil. BAV was shown to be antigenically related to another poxvirus also isolated in Brazil, the Cotia virus, but it remained ungrouped. Electron microscopy revealed that BAV has a typical poxvirus morphology. The Hind III DNA profile of BAV genome was similar with that of VV WR and Lister, but some differences in the profile were detected. We have also detected the presence of genes homologous to vaccinia virus (VV WR) genes in the genome of BAV. Genes related to vaccinia thymidine kinase (TK) gene and vaccinia growth factor (VGF) gene were found. The patterns of TK and VGF mRNA transcripts described for vaccinia virus infected cells were observed in BAV infected cells. Nucleotide sequence of BAV VGF homologous gene was similar to VV WR VGF sequences. This similarity was further seen when cross-hybridization of total genomes of BAV and VV was done. Polypeptide synthesis of BAV and vaccinia in infected cells also showed similar profiles. The genetic data was used to construct a phylogenetic tree where BAV and VV were placed at the same cluster. Based on our findings we propose that BAV is a vaccinia virus variant.
C1 UFMG, ICB, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   ESALQ, NAP, Fitopatol, Piracicaba, SP, Brazil.
RP Kroon, EG (corresponding author), UFMG, ICB, Dept Microbiol, Virus Lab, Av Antonio Carlos 6 627,CP 2 496, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019; Kitajima, Elliot W/C-2764-2012; Campos, Marco
   A/C-4000-2013; Kroon, Erna Geessien/B-3631-2015
OI Kitajima, Elliot W/0000-0002-9138-2918; Campos, Marco
   A/0000-0003-4683-0176; Kroon, Erna Geessien/0000-0003-2721-3826
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   BAJSZAR G, 1983, J VIROL, V45, P62
   BANFIELD WG, 1959, J BIOPHYS BIOCHEM CY, V5, P513, DOI 10.1083/jcb.5.3.513
   BAXBY D, 1986, LANCET, V2, P850
   Berge T., 1975, INT CATALOGUE ARBOVI
   BLOMQUIST MC, 1984, P NATL ACAD SCI-BIOL, V81, P7363, DOI 10.1073/pnas.81.23.7363
   Boulanger D, 1996, VET REC, V138, P247, DOI 10.1136/vr.138.11.247
   BROWN JP, 1985, NATURE, V313, P491, DOI 10.1038/313491a0
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   BULLER RML, 1988, VIROLOGY, V164, P162
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   CHANG W, 1987, MOL CELL BIOL, V7, P535, DOI 10.1128/MCB.7.1.535
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   DEFILIPPES FM, 1982, J VIROL, V43, P136, DOI 10.1128/JVI.43.1.136-149.1982
   Douglass NJ, 1996, J GEN VIROL, V77, P947, DOI 10.1099/0022-1317-77-5-947
   DUMBELL K, 1993, ARCH VIROL, V128, P257, DOI 10.1007/BF01309438
   ESPOSITO JJ, 1984, VIROLOGY, V135, P561, DOI 10.1016/0042-6822(84)90212-5
   ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4
   ESPOSITO JJ, 1985, B WORLD HEALTH ORGAN, V63, P695
   ESPOSITO JJ, 1980, J GEN VIROL, V47, P37, DOI 10.1099/0022-1317-47-1-37
   Fenner F., 1989, ORTHOPOXVIRUSES
   GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2
   HARPER L, 1979, VIROLOGY, V93, P435, DOI 10.1016/0042-6822(79)90247-2
   JEZEK Z, 1988, B WORLD HEALTH ORGAN, V66, P459
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   MACKETT M, 1979, J GEN VIROL, V45, P683, DOI 10.1099/0022-1317-45-3-683
   MARENNIKOVA SS, 1979, B WORLD HEALTH ORGAN, V57, P461
   MASSUNG RF, 1991, VIROLOGY, V180, P347, DOI 10.1016/0042-6822(91)90039-E
   MASSUNG RF, 1993, NATURE, V366, P748, DOI 10.1038/366748a0
   MASSUNG RF, 1994, VIROLOGY, V201, P215, DOI 10.1006/viro.1994.1288
   MCFADDEN G, 1995, VIROCEPTORS VIROKINE
   Monahth TP, 1996, VIROLOGY, P961
   MULLER HK, 1977, J GEN VIROL, V38, P135
   MURPHY FA, 1995, ARCH VIROL S, V10
   OPGENORTH A, 1993, VIROLOGY, V192, P701, DOI 10.1006/viro.1993.1092
   PALUMBO GJ, 1994, J VIROL, V68, P1737, DOI 10.1128/JVI.68.3.1737-1749.1994
   Sambrook J, 1989, MOL CLONING LAB MANU
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHELKUNOV SN, 1993, FEBS LETT, V319, P80
   SCHREIBER M, 1994, VIROLOGY, V204, P692, DOI 10.1006/viro.1994.1585
   SMITH GL, 1993, J GEN VIROL, V74, P1725, DOI 10.1099/0022-1317-74-9-1725
   SODEIK B, 1993, J CELL BIOL, V121, P521, DOI 10.1083/jcb.121.3.521
   STROOBANT P, 1985, CELL, V42, P383, DOI 10.1016/S0092-8674(85)80133-1
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   TRAKTMAN P, 1990, CELL, V62, P621, DOI 10.1016/0092-8674(90)90106-O
   UEDA Y, 1995, VIROLOGY, V210, P67, DOI 10.1006/viro.1995.1317
   UEDA Y, 1978, J GEN VIROL, V40, P236
   UPTON C, 1987, J VIROL, V61, P1271, DOI 10.1128/JVI.61.4.1271-1275.1987
   VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569
   VENKATESAN S, 1982, J VIROL, V44, P637, DOI 10.1128/JVI.44.2.637-646.1982
   WEIR JP, 1983, J VIROL, V46, P530, DOI 10.1128/JVI.46.2.530-537.1983
   WOODALL JP, 1967, ATAS S BIOTA AMAZON, V6, P31
NR 55
TC 60
Z9 62
U1 0
U2 2
PU SPRINGER-VERLAG WIEN
PI VIENNA
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA
SN 0304-8608
J9 ARCH VIROL
JI Arch. Virol.
PY 1998
VL 143
IS 6
BP 1171
EP 1186
DI 10.1007/s007050050365
PG 16
WC Virology
SC Virology
GA ZU638
UT WOS:000074218100012
PM 9687874
DA 2020-11-30
ER

PT J
AU Kroon, E
   Krosl, J
   Buchberg, AM
   Sauvageau, G
AF Kroon, E
   Krosl, J
   Buchberg, AM
   Sauvageau, G
TI Hoxa9 transforms primary bone marrow cells through specific
   collaboration with Meis1 but not PBX1.
SO BLOOD
LA English
DT Meeting Abstract
C1 INST RECH CLIN MONTREAL,MONTREAL,PQ H2W 1R7,CANADA.
   THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,KIMMEL CANC CTR,PHILADELPHIA,PA 19107.
RI Kroon, Erna/V-5444-2019
NR 0
TC 1
Z9 1
U1 0
U2 1
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 15
PY 1997
VL 90
IS 10
SU 1
BP 1900
EP 1900
PN 1
PG 1
WC Hematology
SC Hematology
GA YG424
UT WOS:A1997YG42401896
DA 2020-11-30
ER

PT J
AU Oliveira, JG
   Kroon, EG
   Ferreira, PCP
   Bonjardim, CA
AF Oliveira, JG
   Kroon, EG
   Ferreira, PCP
   Bonjardim, CA
TI The low proliferation rates of human amniotic cells are neither
   associated to deregulated proto-oncogenes' expression nor to the effect
   of IFN alpha 2
SO PLACENTA
LA English
DT Article
ID SENESCENT HUMAN-FIBROBLASTS; C-MYC EXPRESSION; CYCLE PROGRESSION;
   GROWTH-FACTOR; FOS; JUN; INTERFERON; GENES; AP-1; TRANSCRIPTION
AB Primary cultures of human amniotic membrane (PCHAM) cells display very lour proliferation rates while their doubling times vary between 150 h and 210 h even after mitogenic stimuli. However, the pattern of proto-oncogenes (c-fos, c-myc and c-jun) expression in these cells, upon serum restimulation, resembled that of cell lines that display shorter population doubling times. Serum stimulation of quiescent PCHAM cells promoted a rapid and transient c-fos mRNA expression, which was detected within 10 min, reached maximal levels at 30 min and decreased to undetectable levels 2-3 h later. The levels of c-myc or c-jun mRNA increased within 10 min after serum restimulation, peaked at 3 h and decreased to intermediate levels thereafter. We also present evidence showing that IFN alpha 2 treatment of PCHAM cells had no effect on their population doubling times nor in c-fos, c-myc, or c-jun mRNA expression, under conditions in which induction of IFN-stimulated genes, such as 2'-5' oligo-adenylate synthetase (OAS) and 6-16 was observed. We conclude that the growth constraints observed with this cells are not directly associated with a negative cellular growth regulation exerted by IFN alpha 2, nor due to a deregulated proto-oncogenes' expression. (C) 1997 W. B. Saunders Company Ltd.
C1 UNIV FED MINAS GERAIS,INST CIENCIAS BIOL,DEPT MICROBIOL,VIRUS LAB,BR-31270901 BELO HORIZONT,MG,BRAZIL.
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; Bonjardim,
   Claudio A/J-2601-2014
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x
   ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0
   BLANCHARD JM, 1985, NATURE, V317, P443, DOI 10.1038/317443a0
   BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349
   BOHMANN D, 1994, CELL, V78, P973, DOI 10.1016/0092-8674(94)90273-9
   BRAVO R, 1985, EXP CELL RES, V160, P540, DOI 10.1016/0014-4827(85)90200-9
   BRUSSELBACH S, 1995, ONCOGENE, V10, P79
   CHANG RS, 1968, J NATL CANCER I, V40, P491
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P151
   CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4
   De Maeyer E., 1988, INTERFERONS OTHER RE
   DELLAQUILA ML, 1982, EXP CELL RES, V137, P441, DOI 10.1016/0014-4827(82)90047-7
   EDWARDS DR, 1992, EMBO J, V11, P2415, DOI 10.1002/j.1460-2075.1992.tb05306.x
   FERREIRA PCP, 1991, BRAZ J MED BIOL RES, V24, P21
   FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8
   GAFFNEY EV, 1981, CELL TISSUE RES, V220, P611, DOI 10.1007/BF00216764
   GREEN DA, 1984, MON NOT R ASTRON SOC, V211, P433, DOI 10.1093/mnras/211.2.433
   GREENBERG ME, 1985, J BIOL CHEM, V260, P4101
   HEIKKILA R, 1987, NATURE, V328, P445, DOI 10.1038/328445a0
   HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281
   JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309
   JONAK G, 1986, IFN 7 INTERFERONS RE
   KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2
   KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466
   LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0
   LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182
   MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0
   MULLER R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P151, DOI 10.1016/0304-419X(93)90003-U
   MULLER R, 1983, NATURE, V304, P454, DOI 10.1038/304454a0
   OKITA JR, 1982, J BIOL CHEM, V257, P4029
   PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.bi.56.070187.003455
   REIS LFL, 1989, J INTERFERON RES, V9, P573, DOI 10.1089/jir.1989.9.573
   RESNITZKY D, 1991, CELL GROWTH DIFFER, V2, P33
   ROSE DW, 1992, J CELL BIOL, V119, P1405, DOI 10.1083/jcb.119.6.1405
   Sambrook J, 1989, MOL CLONING LAB MANU
   SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O
   SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680
   SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0
   Sokal R.R., 1969, BIOMETRY PRINCIPLES
   THOMPSON CB, 1985, NATURE, V314, P363, DOI 10.1038/314363a0
   VILCEK J, 1994, INT ARCH ALLERGY IMM, V104, P311
   VILCEK J, 1996, VIROLOGY, P375
   WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0
   YAMADA H, 1994, MOL CELL BIOCHEM, V136, P117, DOI 10.1007/BF00926071
   ZITCER EM, 1955, SCIENCE, V122, P30, DOI 10.1126/science.122.3157.30
NR 45
TC 6
Z9 6
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0143-4004
J9 PLACENTA
JI Placenta
PD MAR-APR
PY 1997
VL 18
IS 2-3
BP 163
EP 168
DI 10.1016/S0143-4004(97)90088-6
PG 6
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA WP744
UT WOS:A1997WP74400011
PM 9089777
DA 2020-11-30
ER

PT J
AU Kroon, E
   Puts, MJH
   de Weert, CMM
AF Kroon, E.
   Puts, M. J. H.
   de Weert, C. M. M.
TI A quantitative method to explore the assimilation effects
SO PERCEPTION
LA English
DT Meeting Abstract
C1 [Kroon, E.; Puts, M. J. H.; de Weert, C. M. M.] Univ Nijmegen, Nijmegen Inst Cognit & Informat, NL-6500 HE Nijmegen, Netherlands.
EM E.Kroon@student.kun.nl
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PION LTD
PI LONDON
PA 207 BRONDESBURY PARK, LONDON NW2 5JN, ENGLAND
SN 0301-0066
J9 PERCEPTION
JI Perception
PY 1997
VL 26
SU S
BP 22
EP 23
PG 2
WC Ophthalmology; Psychology; Psychology, Experimental
SC Ophthalmology; Psychology
GA V17AS
UT WOS:000207910700064
DA 2020-11-30
ER

PT J
AU Pakker, N
   Kroon, E
   Hall, D
   Roos, M
   Montaner, JSG
   Cooper, D
   Vella, S
   Lange, J
   Koot, M
   Reiss, P
AF Pakker, N
   Kroon, E
   Hall, D
   Roos, M
   Montaner, JSG
   Cooper, D
   Vella, S
   Lange, J
   Koot, M
   Reiss, P
TI Functional capacity of T cells and immunologic response in naive HIV-1
   patients treated with combinations of reverse transcriptase inhibitors
SO AIDS
LA English
DT Meeting Abstract
C1 BOEHRINGER INGELHEIM PHARMACEUT INC,RIDGEFIELD,CT 06877.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU RAPID SCIENCE PUBLISHERS
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH
SN 0269-9370
J9 AIDS
JI Aids
PD NOV
PY 1996
VL 10
SU 2
BP OP21
EP OP21
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA VU963
UT WOS:A1996VU96300033
DA 2020-11-30
ER

PT J
AU Golgher, RR
   Kroon, EG
   Ferreira, PCP
AF Golgher, RR
   Kroon, EG
   Ferreira, PCP
TI Distinct antigenic subtypes of human beta interferon can be
   distinguished by neutralization
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE human beta interferon; antibody neutralization; NIH antiserum to; beta
   interferon; antigenic subtype; amniotic interferon
ID HUMAN FIBROBLAST INTERFERON; ESCHERICHIA-COLI; RECOMBINANT; ANTIBODIES;
   EXPRESSION; GENE
AB Different molecular configurations of human beta interferon were titrated with the standard reference antiserum of the National Institutes of Health (NM) which had been prepared with natural beta fibroblast interferon in order to determine to what extent differences in these configurations would influence the neutralization of the antiviral action of interferon. Neutralization tests were carried out in Vero cells by diluting both interferon and antiserum. Encephalomyocarditis virus was employed as challenge virus. The neutralization titer was considered to have been reached when the effect of eight units of interferon was reduced to one. Two natural beta interferons prepared from fibroblasts and from amniotic membranes gave similar high titers. However, titers were reduced five-fold with recombinant interferons expressed in Escherichia coli, which do not contain carbohydrate, one with the natural sequence and a mutant with a single amino acid substitution (cysteine for serine). The NM antiserum did not neutralize the effect of a protein fraction from amniotic membranes antigenically different from the human alpha, beta or gamma interferons but having the biological activity of interferon. We conclude that the carbohydrate moieties of human beta interferons are essential for their recognition by the NIH antiserum and that antibodies specific for human recombinant beta interferon, which does not contain carbohydrate, are needed.
C1 UNIV FED MINAS GERAIS, INST CIENCIAS BIOL, DEPT MICROBIOL, BR-31270901 BELO HORIZONTE, MG, BRAZIL.
   FIOCRUZ MS, CTR PESQUISAS RENE RACHOU, BR-30190002 BELO HORIZONTE, MG, BRAZIL.
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR ADOLF GR, 1991, BIOCHIM BIOPHYS ACTA, V1089, P167, DOI 10.1016/0167-4781(91)90004-6
   ANTONELLI G, 1991, J INFECT DIS, V163, P882, DOI 10.1093/infdis/163.4.882
   CARTWRIGHT T, 1977, J GEN VIROL, V36, P326
   COLBY CB, 1984, J IMMUNOL, V133, P3091
   DALTON B, 1981, INTERFERONS B
   DRON M, 1992, INTERFERON PRINCIPLE
   DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655
   FERREIRA PCP, 1991, BRAZ J MED BIOL RES, V24, P21
   FERREIRA PCP, 1981, ARCH VIROL, V68, P27, DOI 10.1007/BF01315164
   GEIGERT J, 1988, J INTERFERON RES, V8, P539, DOI 10.1089/jir.1988.8.539
   IJZERMANS JNM, 1989, IMMUNOBIOLOGY, V179, P456, DOI 10.1016/S0171-2985(89)80049-X
   KAGAWA Y, 1988, J BIOL CHEM, V263, P17508
   KAWADE Y, 1986, INTERFERONS C
   *NIH, 1981, 24 NIH NAT I ALL INF
   QUESADA JR, 1992, INERFERON PRINCIPLES
   REDLICH PN, 1989, J IMMUNOL, V143, P1887
   REIS LFL, 1989, J INTERFERON RES, V9, P573, DOI 10.1089/jir.1989.9.573
   STEWART WE, 1981, INTERFERON SYSTEM
   TANIGUCHI T, 1980, P NATL ACAD SCI-BIOL, V77, P5230, DOI 10.1073/pnas.77.9.5230
   VALLBRACHT A, 1981, NATURE, V289, P496, DOI 10.1038/289496a0
   WHALEY AE, 1994, J BIOL CHEM, V269, P10864
NR 21
TC 1
Z9 1
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD OCT
PY 1996
VL 29
IS 10
BP 1317
EP 1320
PG 4
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA VM710
UT WOS:A1996VM71000010
PM 9181103
DA 2020-11-30
ER

PT J
AU MacDonald, RJ
   SouthardSmith, EM
   Kroon, E
AF MacDonald, RJ
   SouthardSmith, EM
   Kroon, E
TI Disparate tissue-specific expression of members of the tissue kallikrein
   multigene family of the rat
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID AMINO-ACID-SEQUENCE; GENE FAMILY; MESSENGER-RNA; SUBMAXILLARY-GLAND;
   MOLECULAR-BIOLOGY; SUBMANDIBULAR-GLAND; NUCLEOTIDE-SEQUENCE; SERINE
   PROTEASE; CHAIN-REACTION; KININ SYSTEM
AB To understand the regulatory diversity of the rat Family of linked kallikrein genes, we have assayed the expression of family members in 20 major organs. Reverse transcription-polymerase chain reaction analysis using primers and hybridization probes specific for each of the 10 expressed kallikrein genes showed that no two family members share the same organ-specific pattern of expression. The only common site of expression for all 10 known active genes is the submandibular gland. The presence of the mRNA for at least one family member is detected in 19 of these 20 organs (liver excepted), from as few as three organs to as many as 18 for individual family members. For individual genes there can be more than a 10(5)-fold variation in mRNA levels among organs, from a limit of detection of slightly less than 1 mRNA molecule/10 cells to more than 10,000 mRNA molecules/cell. Despite high sequence conservation and close linkage, the members of this family are expressed in very different and complex patterns. A gradient of diversity of expression corresponds to the order of the genes within the kallikrein family locus.
RP MacDonald, RJ (corresponding author), UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,MOL IMMUNOL CTR,6000 HARRY HINES BLVD,DALLAS,TX 75235, USA.
RI Southard-Smith, Michelle/C-3488-2012; Kroon, Erna/V-5444-2019
OI Southard-Smith, E Michelle/0000-0003-4718-5869; KROON,
   EVERT/0000-0002-4069-3644
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [P01GM031689,
   P01GM031689, P01GM031689, P01GM031689, P01GM031689, P01GM031689,
   P01GM031689, P01GM031689, P01GM031689, P01GM031689, P01GM031689,
   P01GM031689, P01GM031689, P01GM031689, P01GM031689, P01GM031689,
   P01GM031689, P01GM031689, P01GM031689, P01GM031689, P01GM031689,
   P01GM031689, P01GM031689, P01GM031689, P01GM031689, P01GM031689,
   P01GM031689, P01GM031689, P01GM031689, P01GM031689, P01GM031689,
   P01GM031689, P01GM031689] Funding Source: NIH RePORTER; NIGMS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM08203, GM31689] Funding Source: Medline
CR ASHLEY PL, 1985, BIOCHEMISTRY-US, V24, P4512, DOI 10.1021/bi00338a005
   ASHLEY PL, 1985, BIOCHEMISTRY-US, V24, P4520, DOI 10.1021/bi00338a006
   BERG T, 1992, J HISTOCHEM CYTOCHEM, V40, P83, DOI 10.1177/40.1.1309555
   BERG T, 1992, RECENT PROGR KININS, V1, P19
   BRADY JM, 1990, ARCH BIOCHEM BIOPHYS, V278, P342, DOI 10.1016/0003-9861(90)90269-5
   BRADY JM, 1989, BIOCHEMISTRY-US, V28, P5203, DOI 10.1021/bi00438a043
   CARRETERO OA, 1993, J HYPERTENS, V11, P693, DOI 10.1097/00004872-199307000-00002
   CHAO J, 1983, J BIOL CHEM, V258, P5173
   CHAPDELAINE P, 1984, J ANDROL, V5, P206
   CHEN YP, 1988, BIOCHEMISTRY-US, V27, P7189, DOI 10.1021/bi00419a005
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CLEMENTS JA, 1988, J BIOL CHEM, V263, P16132
   CLEMENTS JA, 1989, J NEUROENDOCRINOL, V1, P199
   CLEMENTS JA, 1989, ENDOCR REV, V10, P393, DOI 10.1210/edrv-10-4-393
   CLEMENTS JA, 1990, J BIOL CHEM, V265, P1077
   CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N
   DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0
   DOVER GA, 1986, PHILOS T R SOC B, V312, P275, DOI 10.1098/rstb.1986.0007
   DOVER GA, 1982, NATURE, V289, P111
   DUNBAR JC, 1987, BIOCHEMISTRY-US, V26, P3471, DOI 10.1021/bi00386a034
   ELMOUJAHED A, 1990, FEBS LETT, V265, P137, DOI 10.1016/0014-5793(90)80903-V
   EVANS BA, 1987, J BIOL CHEM, V262, P8027
   FIEDLER F, 1979, HDB EXPT PHARMACOLOG, V25, P103
   FULLER PJ, 1988, MOL CELL ENDOCRINOL, V60, P225, DOI 10.1016/0303-7207(88)90182-7
   FULLER PJ, 1989, BIOCHEM J, V264, P133, DOI 10.1042/bj2640133
   GERALD WL, 1986, BIOCHIM BIOPHYS ACTA, V866, P1, DOI 10.1016/0167-4781(86)90093-X
   GRISE C, 1981, CAN J BIOCHEM CELL B, V59, P250, DOI 10.1139/o81-034
   GUBITS RM, 1984, J BIOL CHEM, V259, P2803
   GUTMAN N, 1991, EUR J BIOCHEM, V197, P425, DOI 10.1111/j.1432-1033.1991.tb15928.x
   HIBNER BL, 1988, DEV BIOL, V125, P423, DOI 10.1016/0012-1606(88)90223-0
   INOUE H, 1989, J BIOCHEM-TOKYO, V105, P834, DOI 10.1093/oxfordjournals.jbchem.a122754
   KAFATOS FC, 1987, ADV GENET, V24, P223, DOI 10.1016/S0065-2660(08)60009-7
   KEDES LH, 1979, ANNU REV BIOCHEM, V48, P837, DOI 10.1146/annurev.bi.48.070179.004201
   LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185
   MA J, 1992, BIOCHEMISTRY-US, V31, P10922, DOI 10.1021/bi00159a036
   MACDONALD RJ, 1988, BIOCHEM J, V253, P313, DOI 10.1042/bj2530313
   MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219
   MASON AJ, 1983, NATURE, V303, P300, DOI 10.1038/303300a0
   MULLIS KB, 1987, METHOD ENZYMOL, V155, P335
   MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889
   NOLLY H, 1993, HYPERTENSION, V21, P911, DOI 10.1161/01.HYP.21.6.911
   NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759
   PRITCHETT DB, 1987, P NATL ACAD SCI USA, V84, P5545, DOI 10.1073/pnas.84.16.5545
   PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975
   SAED GM, 1990, CIRC RES, V67, P510, DOI 10.1161/01.RES.67.2.510
   SAED GM, 1992, HYPERTENSION, V19, P262
   SCICLI AG, 1993, J HYPERTENS, V11, P775, DOI 10.1097/00004872-199308000-00002
   SOUTHARDSMITH M, 1994, GENOMICS, V22, P404, DOI 10.1006/geno.1994.1402
   SOUTHARDSMITH M, 1992, DNA CELL BIOL, V11, P345
   SPOEREL NA, 1989, J MOL BIOL, V209, P1, DOI 10.1016/0022-2836(89)90166-6
   SWIFT GH, 1982, P NATL ACAD SCI-BIOL, V79, P7263, DOI 10.1073/pnas.79.23.7263
   VANLEEUWEN BH, 1986, J BIOL CHEM, V261, P5529
   VERES G, 1987, SCIENCE, V237, P415, DOI 10.1126/science.3603027
   WINES DR, 1989, J BIOL CHEM, V264, P7653
   WINES DR, 1991, J MOL EVOL, V32, P476, DOI 10.1007/BF02102650
   WINES DR, 1989, THESIS U TEXAS SW ME
   YAMAGUCHI T, 1991, J BIOL CHEM, V266, P5011
NR 57
TC 40
Z9 42
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 7
PY 1996
VL 271
IS 23
BP 13684
EP 13690
DI 10.1074/jbc.271.23.13684
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA UP385
UT WOS:A1996UP38500059
PM 8662704
OA Bronze
DA 2020-11-30
ER

PT J
AU KROON, E
   ANDOLF, E
AF KROON, E
   ANDOLF, E
TI DIAGNOSIS AND FOLLOW-UP OF SIMPLE OVARIAN CYSTS DETECTED BY ULTRASOUND
   IN POSTMENOPAUSAL WOMEN
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID CANCER; TUMORS; DOPPLER; CA-125; BENIGN
AB Objective: To determine the malignancy rate in ultrasound-diagnosed, anechoic, small, simple ovarian cysts in postmenopausal women, and to investigate the natural history of these cysts by ultrasound follow-up.
   Methods: Eighty-three postmenopausal women with small, completely anechoic, thin-walled ovarian cysts (less than 5 cm, mean of orthogonal diameters) were diagnosed at our ultrasound unit during the period 1983-1992. Forty-three underwent surgery; the remaining 40 were offered follow-up ultrasonography as part of the present study, and, of them, five died, two were unavailable because of intercurrent disease, and one moved abroad, leaving 32 to be included in our study.
   Results: There were no cases of ovarian cancer in the surgery group. In the nonsurgery (follow-up) group, the time since detection of the lesion ranged from 1-9 years. On follow-up ultrasonography, 12 of the 32 cysts had disappeared and only one had increased in size. According to histopathology records, no ovarian cancer was diagnosed in any of the seven cases in which the patient was not available for reexamination by ultrasound.
   Conclusion: Nonpalpable ovarian cysts are commonly detected by ultrasound in asymptomatic women, but the risk of malignancy appears to be very low. We recommend ultrasound follow-up of stationary lesions and that surgery be confined to symptomatic cases or those in which there is a family history of ovarian, breast, or colon cancer.
RP KROON, E (corresponding author), LUND UNIV, DEPT OBSTET & GYNECOL, S-22185 LUND, SWEDEN.
RI Kroon, Erna/V-5444-2019
OI Andolf, Ellika/0000-0003-3529-9471
CR ANDOLF E, 1986, BRIT J OBSTET GYNAEC, V93, P1286, DOI 10.1111/j.1471-0528.1986.tb07867.x
   ANDOLF E, 1989, BRIT J OBSTET GYNAEC, V96, P1076, DOI 10.1111/j.1471-0528.1989.tb03384.x
   ANDOLF E, 1988, J CLIN ULTRASOUND, V16, P301, DOI 10.1002/jcu.1870160504
   BERGMAN A, 1991, OBSTET GYNECOL, V78, P726
   CAMPBELL S, 1989, BMJ-BRIT MED J, V299, P1363, DOI 10.1136/bmj.299.6712.1363
   FINKLER NJ, 1988, OBSTET GYNECOL, V72, P659
   GOLDSTEIN SR, 1989, OBSTET GYNECOL, V73, P8
   HALL DA, 1986, J ULTRAS MED, V5, P503, DOI 10.7863/jum.1986.5.9.503
   HATA K, 1992, OBSTET GYNECOL, V80, P922
   LEVINE D, 1992, RADIOLOGY, V184, P653, DOI 10.1148/radiology.184.3.1509047
   MORAN O, 1993, OBSTET GYNECOL, V82, P444
   PARAZZINI F, 1991, GYNECOL ONCOL, V43, P9, DOI 10.1016/0090-8258(91)90003-N
   SASSONE AM, 1991, OBSTET GYNECOL, V78, P70
   TEKAY A, 1992, ULTRASOUND OBST GYN, V2, P338, DOI 10.1046/j.1469-0705.1992.02050338.x
   WEINER Z, 1992, OBSTET GYNECOL, V79, P159
   WESTHOFF C, 1993, AM J EPIDEMIOL, V138, P90, DOI 10.1093/oxfordjournals.aje.a116838
NR 16
TC 44
Z9 46
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD FEB
PY 1995
VL 85
IS 2
BP 211
EP 214
DI 10.1016/0029-7844(94)00366-L
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA QC632
UT WOS:A1995QC63200009
PM 7824232
DA 2020-11-30
ER

PT J
AU CAMPOS, MAD
   KROON, EG
AF CAMPOS, MAD
   KROON, EG
TI CRITICAL PERIOD FOR IRREVERSIBLE BLOCK OF VACCINIA VIRUS-REPLICATION
SO REVISTA DE MICROBIOLOGIA
LA English
DT Article
DE PROTEIN SYNTHESIS INHIBITION; VACCINIA VIRUS; CYCLOHEXIMIDE
AB Hela cells were infected with vaccinia virus and treated with cycloheximide 30 to 60 minutes after infection. The cells extracts were prepared and the proteins analysed in a 12.5% SDS-PAGE, and an early viral protein profile was observed, which is similar to that of infected cells treated with cytosine arabinoside, an inhibitor of DNA replication. In order to get some more evidence that an early viral protein could be synthesized in these conditions, enzymatic activity of thymidine kinase was assayed in vitro (thymidine kinase is an early viral protein), and was yielded 30% activity compared with infected nontreated cells extracts. The synthesis of viral DNA was measured through the incorporation of [H-3]-thymidine to DNA, in infected HeLa cells, to better localize the block in the virus growth cycle, and a strong inhibition of viral DNA synthesis was observed. Results suggest that the irreversible block in the virus multiplication, happened after the early protein synthesis and before DNA replication.
RP CAMPOS, MAD (corresponding author), UFMG,ICB,DEPT MICROBIOL,VIRUS LAB,CX POSTAL 2486,BR-30270 BELO HORIZON,MG,BRAZIL.
RI Kroon, Erna/V-5444-2019; Campos, Marco A/C-4000-2013; Kroon,
   Erna/B-3631-2015
OI Campos, Marco A/0000-0003-4683-0176; Kroon, Erna/0000-0003-2721-3826
NR 0
TC 32
Z9 32
U1 0
U2 0
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 0001-3714
J9 REV MICROBIOL
JI Rev. Microbiol.
PD APR-JUN
PY 1993
VL 24
IS 2
BP 104
EP 110
PG 7
WC Microbiology
SC Microbiology
GA LZ849
UT WOS:A1993LZ84900007
DA 2020-11-30
ER

PT J
AU FERREIRA, LAP
   FERREIRA, PCP
   KROON, EG
   TRINDADE, ML
   GOLGHER, RR
AF FERREIRA, LAP
   FERREIRA, PCP
   KROON, EG
   TRINDADE, ML
   GOLGHER, RR
TI THE CONCENTRATION OF THE HUMAN AMNIOTIC MEMBRANE INTERFERON .1. PHYSICAL
   METHODS
SO REVISTA DE MICROBIOLOGIA
LA Portuguese
DT Article
DE INTERFERON; PHYSICAL METHODS; CONCENTRATION
AB The concentration of preparations of human amniotic membrane interferon (IFN-MA) by physical methods was investigated. Preparations were obtained from amnions infected with Newcastle disease virus. Their titers (in antiviral activity) were determined in a Vero cell-encephalomyocarditis or Sindbis virus system.
   The concentration by dialysis under negative pressure was done in a tube held in a Kitasato flask with the preparations in pH 2.0. This procedure resulted in IFN recoveries above 50%. This method was considered to be convenient for small volumes - up to 100 ml - but very slow.
   With "aquacide", where water is removed from the material in a dialysis tube by a hygroscopic substance, concentration was satisfactory for small volumes, allowing a decrease in volume of 6 to 10 times in hours, and recoveries above 50%, specially if materials were dialysed after concentration in acidulated water.
   Molecular filtration did not show reproducible results when Millipore PSAC, PTGC or Amicon UM 2 membranes were used.
   Concentration of IFN-MA with total recovery of activity was possible by the precipitation of preparations with trichloroacetic acid and lyophilization after dialysis.
C1 UNIV FED MINAS GERAIS,INST CIENCIAS BIOL,DEPT MICROBIOL,VIRUS LAB,CP 2486,AV ANTONIO CARLOS 6627,BR-30161 BELO HORIZONTE,MG,BRAZIL.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 0001-3714
J9 REV MICROBIOL
JI Rev. Microbiol.
PD JUL-SEP
PY 1991
VL 22
IS 3
BP 210
EP 215
PG 6
WC Microbiology
SC Microbiology
GA HD285
UT WOS:A1991HD28500003
DA 2020-11-30
ER

PT J
AU FERREIRA, LAP
   FERREIRA, PCP
   KROON, EG
   GONZAGA, C
   DOSSANTOS, JR
   GOLGHER, RR
AF FERREIRA, LAP
   FERREIRA, PCP
   KROON, EG
   GONZAGA, C
   DOSSANTOS, JR
   GOLGHER, RR
TI CONCENTRATIONS OF THE HUMAN AMNIOTIC MEMBRANE INTERFERON .2. CHEMICAL
   METHODS
SO REVISTA DE MICROBIOLOGIA
LA Portuguese
DT Article
DE INTERFERON; CONCENTRATION; CHEMICAL METHODS
AB The concentration of the human amniotic membrane interferon (IFN-MA) by chemical methods was investigated.
   IFN-MA was produced by amnions infected with the Newcastle disease virus in medium containing various serum concentrations. Antiviral activity of the preparations was determined by a Vero cell-encephalomyocarditis virus or Sindbis virus system.
   Potassium thyocianate precipitation and ethanol or phosphate buffered saline (PBS) extraction of IFN-MA containing 2% serum resulted in low recoveries, 31% maximum. When ammonium sulphate was employed with preparations with 1% serum, recoveries were above 60%. Best results were obtained by precipitation of IFN-MA (1% serum) with trichloroacetic acid and solubilization with chloride buffer. Recoveries with this method were around 100%.
   Experiments trying to concentrate IFN-MA prepared without serum by these methods failed, because the low protein content of the preparations did not allow for a suitable precipitation.
C1 UNIV FED MINAS GERAIS,INST CIENCIAS BIOL,DEPT MICROBIOL,VIRUS LAB,CP 2486,AV ANTONIO CARLOS 6627,BR-30161 BELO HORIZONTE,MG,BRAZIL.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 0001-3714
J9 REV MICROBIOL
JI Rev. Microbiol.
PD JUL-SEP
PY 1991
VL 22
IS 3
BP 216
EP 220
PG 5
WC Microbiology
SC Microbiology
GA HD285
UT WOS:A1991HD28500004
DA 2020-11-30
ER

PT J
AU FERREIRA, PCP
   GONZAGA, C
   KROON, EG
   DOSSANTOS, JR
   BICALHO, HMS
   GOLGHER, RR
AF FERREIRA, PCP
   GONZAGA, C
   KROON, EG
   DOSSANTOS, JR
   BICALHO, HMS
   GOLGHER, RR
TI PARTIAL CHARACTERIZATION OF HUMAN AMNIOTIC MEMBRANE INTERFERON
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE HUMAN AMNIOTIC MEMBRANE; INTERFERON; MOLECULAR WEIGHT; SIALOGLYCOPROTEIN
ID HUMAN-LEUKOCYTE INTERFERON; HUMAN FIBROBLAST; PURIFICATION; VIRUS
AB 1. The molecular weight and the electrofocusing profile of human amniotic membrane interferon (IFN-AM) were determined.
   2. When submitted to gel filtration, IFN-AM showed a single 26-28 kDa component; in polyacrylamide gel electrophoresis one component of 19,500.
   3. In electrofocusing, IFN-AM displayed a heterogeneous profile with 5 to 7 peaks, but different from human alpha or beta IFNs.  This heterogeneity was reduced by previous treatment of IFN-AM with neuraminidase.
   4. IFN-AM is a sialoglycoprotein similar to human beta IFN in terms of antigenicity but different from it in electrofocusing profile.
C1 UNIV FED MINAS GERAIS,INST CIENCIAS BIOL,DEPT MICROBIOL,VIRUS LAB,CAIXA POSTAL 2486,BR-30161 BELO HORIZONTE,MG,BRAZIL.
RI Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR Ackers G. K., 1975, PROTEINS, P1
   ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   BERG K, 1982, INTERFERONS PROPERTI, P118
   CHEN JK, 1976, J VIROL, V19, P425, DOI 10.1128/JVI.19.2.425-434.1976
   DIANZANI F, 1986, J INTERFERON RES, V6, P43, DOI 10.1089/jir.1986.6.43
   DUCGOIRAN P, 1983, P NATL ACAD SCI-BIOL, V80, P2628, DOI 10.1073/pnas.80.9.2628
   DUCGOIRAN P, 1971, ARCH GES VIRUSFORSCH, V34, P232, DOI 10.1007/BF01242997
   FALCOFF E, 1966, ANN I PASTEUR PARIS, V111, P241
   FERREIRA PCP, 1981, ARCH VIROL, V68, P27, DOI 10.1007/BF01315164
   FERREIRA PCP, 1987, THESIS UFRJ RIO JANE
   FOURNIER F, 1967, J IMMUNOL, V99, P1036
   FRIESEN HJ, 1981, ARCH BIOCHEM BIOPHYS, V206, P432, DOI 10.1016/0003-9861(81)90111-9
   HOBBS DS, 1982, J BIOL CHEM, V257, P4071
   KNIGHT E, 1984, INTERFERON, V1, P61
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIN LS, 1978, J GEN VIROL, V39, P125, DOI 10.1099/0022-1317-39-1-125
   MORSER J, 1978, J GEN VIROL, V41, P175, DOI 10.1099/0022-1317-41-1-175
   OTTO MJ, 1980, J VIROL, V35, P390, DOI 10.1128/JVI.35.2.390-399.1980
   PESTKA S, 1984, BIOL INTERFERON SYST, P3
   PRESTIDGE RL, 1979, ANAL BIOCHEM, V97, P95, DOI 10.1016/0003-2697(79)90332-4
   REIS LFL, 1989, J INTERFERON RES, V9, P573, DOI 10.1089/jir.1989.9.573
   RUBINSTEIN M, 1981, ARCH BIOCHEM BIOPHYS, V210, P307, DOI 10.1016/0003-9861(81)90194-6
   STEWART WE, 1981, INTERFERON SYSTEM
   STUDIER FW, 1972, SCIENCE, V176, P367, DOI 10.1126/science.176.4033.367
   TORMA ET, 1976, J BIOL CHEM, V252, P4810
   WARD DN, 1965, ANAL BIOCHEM, V12, P296, DOI 10.1016/0003-2697(65)90094-1
   WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4
   WILKINSON M, 1983, BIOCHEM BIOPH RES CO, V111, P498, DOI 10.1016/0006-291X(83)90334-0
   ZOON KC, 1979, P NATL ACAD SCI USA, V76, P5601, DOI 10.1073/pnas.76.11.5601
NR 29
TC 6
Z9 6
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1991
VL 24
IS 1
BP 21
EP 27
PG 7
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA EX636
UT WOS:A1991EX63600003
PM 1726650
DA 2020-11-30
ER

PT J
AU KROON, EG
   FERREIRA, PCP
   GOLGHER, RR
AF KROON, EG
   FERREIRA, PCP
   GOLGHER, RR
TI EFFICIENCY OF VARIOUS STRAINS OF THE NEWCASTLE-DISEASE VIRUS IN
   PRODUCTION OF HUMAN AMNIOTIC INTERFERON
SO REVISTA DE MICROBIOLOGIA
LA Portuguese
DT Article
RP KROON, EG (corresponding author), UNIV FED MINAS GERAIS,INST CIENCIAS BIOL,DEPT MICROBIOL,VIRUS LAB,BR-30161 BELO HORIZONTE,MG,BRAZIL.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 0001-3714
J9 REV MICROBIOL
JI Rev. Microbiol.
PD JAN-MAR
PY 1990
VL 21
IS 1
BP 115
EP 120
PG 6
WC Microbiology
SC Microbiology
GA DL553
UT WOS:A1990DL55300017
DA 2020-11-30
ER

PT J
AU KROON, EG
   NOVO, MAD
   FERREIRA, PCP
   GOLGHER, RR
AF KROON, EG
   NOVO, MAD
   FERREIRA, PCP
   GOLGHER, RR
TI PRODUCTION OF HUMAN AMNIOTIC INTERFERON
SO REVISTA DE MICROBIOLOGIA
LA Portuguese
DT Article
RP KROON, EG (corresponding author), UNIV FED MINAS GERAIS,INST CIENCIAS BIOL,DEPT MICROBIOL,VIRUS LAB,CP 2486,BR-30161 BELO HORIZONTE,MG,BRAZIL.
RI Kroon, Erna/V-5444-2019
NR 0
TC 2
Z9 2
U1 0
U2 0
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 0001-3714
J9 REV MICROBIOL
JI Rev. Microbiol.
PD JAN-MAR
PY 1990
VL 21
IS 1
BP 121
EP 126
PG 6
WC Microbiology
SC Microbiology
GA DL553
UT WOS:A1990DL55300018
DA 2020-11-30
ER

PT J
AU REIS, LFL
   DOSSANTOS, JR
   FERREIRA, PCP
   KROON, EG
   GOLGHER, RR
AF REIS, LFL
   DOSSANTOS, JR
   FERREIRA, PCP
   KROON, EG
   GOLGHER, RR
TI ANTIGENIC CHARACTERIZATION OF HUMAN INTERFERON DERIVED FROM AMNIOTIC
   MEMBRANES INDUCED BY VIRUS
SO JOURNAL OF INTERFERON RESEARCH
LA English
DT Article
C1 UNIV FED MINAS GERAIS,INST CIENCIAS BIOL,DEPT MICROBIOL,VIRUS LAB,BR-30000 BELO HORIZONTE,MG,BRAZIL.
RI Reis, Luiz/C-4556-2013; Kroon, Erna Geessien/B-3631-2015; Kroon,
   Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; Reis, Luiz/0000-0002-4040-2456
CR CAPON DJ, 1985, MOL CELL BIOL, V5, P768, DOI 10.1128/MCB.5.4.768
   DIANZANI F, 1986, J INTERFERON RES, V6, P43, DOI 10.1089/jir.1986.6.43
   DUCGORIAN P, 1983, P NATL ACAD SCI USA, V80, P2528
   FERREIRA PCP, 1979, J CLIN MICROBIOL, V9, P471
   FOURNIER F, 1967, J IMMUNOL, V99, P1036
   GONZAGA C, 1984, 4 P JAP BRAZ S SCI T, P61
   HAUPTMANN R, 1985, NUCLEIC ACIDS RES, V13, P4739, DOI 10.1093/nar/13.13.4739
   KAWADE Y, 1986, METHOD ENZYMOL, V119, P558
   KELKER HC, 1984, J BIOL CHEM, V259, P4301
   KNIGHT E, 1976, P NATL ACAD SCI USA, V73, P520, DOI 10.1073/pnas.73.2.520
   LOPES JD, 1983, GENES ANTIGENS PARST, P419
   MESTAN J, 1989, J GEN VIROL, V69, P3113
   NAYLOR SL, 1983, J EXP MED, V57, P1020
   NOVO MAD, 1988, REV MICROBIOL, V19, P190
   PESTKA S, 1983, ARCH BIOCHEM BIOPHYS, V221, P1, DOI 10.1016/0003-9861(83)90118-2
   REIS LFL, 1988, BIOL INTEFERON SYSTE, P271
   STEWART WE, 1981, INTERFERON SYSTEM
   TANIGUCHI T, 1980, NATURE, V285, P547, DOI 10.1038/285547a0
   WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4
   WILKINSON M, 1983, BIOCH BIOPHYSICAL RE, V111, P489
   1984, J GEN VIROL, V65, P669
NR 21
TC 9
Z9 9
U1 0
U2 2
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538
SN 0197-8357
J9 J INTERFERON RES
JI J. Interferon Res.
PD OCT
PY 1989
VL 9
IS 5
BP 573
EP 581
DI 10.1089/jir.1989.9.573
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AU287
UT WOS:A1989AU28700008
PM 2477473
DA 2020-11-30
ER

PT J
AU DEOLIVEIRA, JC
   KROON, EG
   FERREIRA, PCP
   GOLGHER, RR
AF DEOLIVEIRA, JC
   KROON, EG
   FERREIRA, PCP
   GOLGHER, RR
TI PRODUCTION OF HUMAN AMNIOTIC INTERFERON BY MICROTECHNIQUE
SO REVISTA DE MICROBIOLOGIA
LA Portuguese
DT Article
RP DEOLIVEIRA, JC (corresponding author), UNIV FED MINAS GERAIS,INST CIENC BIOL,DEPT MICROBIOL,VIRUS LAB,CAIXA POSTAL 2486,BR-30161 BELO HORIZONTE,MG,BRAZIL.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 0001-3714
J9 REV MICROBIOL
JI Rev. Microbiol.
PD JUL-SEP
PY 1989
VL 20
IS 3
BP 358
EP 362
PG 5
WC Microbiology
SC Microbiology
GA AU673
UT WOS:A1989AU67300017
DA 2020-11-30
ER

PT J
AU GRUN, J
   KROON, E
   JUNGWIRTH, C
AF GRUN, J
   KROON, E
   JUNGWIRTH, C
TI INFECTIOUS VACCINIA RECOMBINANTS AS TOOLS TO STUDY THE MOLECULAR
   MECHANISM OF THE ANTIVIRAL INTERFERON ACTION
SO JOURNAL OF INTERFERON RESEARCH
LA English
DT Meeting Abstract
C1 UNIV WURZBURG,INST VIROL & IMMUNOL,D-8700 WURZBURG,FED REP GER.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538
SN 0197-8357
J9 J INTERFERON RES
JI J. Interferon Res.
PD DEC
PY 1987
VL 7
IS 6
BP 785
EP 785
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA K6536
UT WOS:A1987K653600212
DA 2020-11-30
ER

PT J
AU GRUN, J
   ZOLLER, B
   KROON, E
   JUNGWIRTH, C
AF GRUN, J
   ZOLLER, B
   KROON, E
   JUNGWIRTH, C
TI VACCINA-SPECIFIC EARLY RNA IS DEGRADED IN INTERFERON TREATED
   CHICK-EMBRYO FIBROBLASTS
SO ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES
   A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY
LA English
DT Meeting Abstract
C1 INST VIROL & IMMUNOBIOL,D-8700 WURZBURG,FED REP GER.
RI Kroon, Erna/V-5444-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU GUSTAV FISCHER VERLAG
PI JENA
PA VILLENGANG 2, D-07745 JENA, GERMANY
SN 0174-3031
J9 ZBL BAKT-INT J MED M
PD NOV
PY 1987
VL 267
IS 1
BP 119
EP 119
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA L1378
UT WOS:A1987L137800083
DA 2020-11-30
ER

PT J
AU GRUN, J
   KROON, E
   ZOLLER, B
   KREMPIEN, U
   JUNGWIRTH, C
AF GRUN, J
   KROON, E
   ZOLLER, B
   KREMPIEN, U
   JUNGWIRTH, C
TI REDUCED STEADY-STATE LEVELS OF VACCINIA VIRUS-SPECIFIC EARLY
   MESSENGER-RNAS IN INTERFERON-TREATED CHICK-EMBRYO FIBROBLASTS
SO VIROLOGY
LA English
DT Article
RP GRUN, J (corresponding author), UNIV WURZBURG,INST VIROL & IMMUNOBIOL,VERSBACHER STR 7,D-8700 WURZBURG,FED REP GER.
RI Kroon, Erna/V-5444-2019; Kroon, Erna/B-3631-2015
OI Kroon, Erna/0000-0003-2721-3826
CR BENAVENTE J, 1984, J VIROL, V51, P866, DOI 10.1128/JVI.51.3.866-871.1984
   BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
   BODO G, 1972, VIROLOGY, V50, P140, DOI 10.1016/0042-6822(72)90354-6
   BROWN GE, 1976, BIOCHEM BIOPH RES CO, V69, P114, DOI 10.1016/S0006-291X(76)80280-X
   GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025
   GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044
   GOSH SN, 1965, VIROLOGY, V27, P186
   HRUBY DE, 1982, J VIROL, V43, P403, DOI 10.1128/JVI.43.2.403-409.1982
   ISLE HB, 1981, VIROLOGY, V112, P306, DOI 10.1016/0042-6822(81)90636-X
   JOKLIK WK, 1966, P NATL ACAD SCI USA, V56, P558, DOI 10.1073/pnas.56.2.558
   JUNGWIRTH C, 1977, TEX REP BIOL MED, V35, P247
   JUNGWIRTH C, 1972, VIROLOGY, V48, P59, DOI 10.1016/0042-6822(72)90114-6
   KREMPIEN U, 1985, J INTERFERON RES, V5, P209, DOI 10.1089/jir.1985.5.209
   MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984
   MARTIN BAB, 1980, EXP CELL BIOL, V48, P31
   Moss B, 1983, Gene Amplif Anal, V3, P201
   NAKANO E, 1982, P NATL ACAD SCI-BIOL, V79, P1593, DOI 10.1073/pnas.79.5.1593
   NILSEN TW, 1982, J VIROL, V42, P1039, DOI 10.1128/JVI.42.3.1039-1045.1982
   OHNO S, 1964, ACTA VIROL, V8, P479
   RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3
   THOMAS PS, 1983, METHOD ENZYMOL, V100, P255
   WITTEK R, 1980, CELL, V21, P487, DOI 10.1016/0092-8674(80)90485-7
NR 22
TC 11
Z9 11
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0042-6822
J9 VIROLOGY
JI Virology
PD MAY
PY 1987
VL 158
IS 1
BP 28
EP 33
DI 10.1016/0042-6822(87)90234-0
PG 6
WC Virology
SC Virology
GA H0968
UT WOS:A1987H096800005
PM 2437697
DA 2020-11-30
ER

PT J
AU GRUN, J
   KROON, E
   JUNGWIRTH, C
AF GRUN, J
   KROON, E
   JUNGWIRTH, C
TI ENHANCED TURNOVER OF VACCINIAVIRUS WR SPECIFIC IMMEDIATE EARLY
   MESSENGER-RNAS IN INTERFERON TREATED CHICK-EMBRYO FIBROBLASTS
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
C1 UNIV WURZBURG,INST VIROL & IMMUNOBIOL,D-8700 WURZBURG,FED REP GER.
RI Kroon, Erna/V-5444-2019
CR BODO G, 1972, VIROLOGY, V50, P140, DOI 10.1016/0042-6822(72)90354-6
   JUNGWIRTH C, 1972, VIROLOGY, V48, P59, DOI 10.1016/0042-6822(72)90114-6
NR 2
TC 0
Z9 0
U1 0
U2 0
PU WISSENSCHAFTLICHE VERLAG MBH
PI STUTTGART
PA BIRKENWALDSTRASSE 44, POSTFACH 10 10 61, 70009 STUTTGART, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PY 1987
VL 43
SU 17
BP 22
EP 22
PG 1
WC Cell Biology
SC Cell Biology
GA G2170
UT WOS:A1987G217000058
DA 2020-11-30
ER

PT J
AU KROON, E
   GRUN, J
   JUNGWIRTH, C
AF KROON, E
   GRUN, J
   JUNGWIRTH, C
TI EXPRESSION OF A BACTERIAL GENE UNDER THE CONTROL OF THE
   VACCINIAVIRUS-SPECIFIC THYMIDINE KINASE PROMOTER IS SENSITIVE TO
   INTERFERON
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
C1 UNIV WURZBURG,INST VIROL & EPIDEMIOL,D-8700 WURZBURG,FED REP GER.
RI Kroon, Erna/V-5444-2019
CR JUNGWIRTH C, 1977, TEX REP BIOL MED, V35, P247
   MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984
NR 2
TC 0
Z9 0
U1 0
U2 0
PU WISSENSCHAFTLICHE VERLAG MBH
PI STUTTGART
PA BIRKENWALDSTRASSE 44, POSTFACH 10 10 61, 70009 STUTTGART, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PY 1987
VL 43
SU 17
BP 33
EP 33
PG 1
WC Cell Biology
SC Cell Biology
GA G2170
UT WOS:A1987G217000092
DA 2020-11-30
ER

EF